PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Beecham, L				Beecham, L			LMCs should be recognised in Health Bill	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 27	1999	318	7187					879	879						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185DM	10092285				2022-12-28	WOS:000079652900070
J	Zhou, D; Mooseker, MS; Galan, JE				Zhou, D; Mooseker, MS; Galan, JE			Role of the S-typhimurium actin-binding protein SipA in bacterial internalization	SCIENCE			English	Article							SALMONELLA-TYPHIMURIUM; HOST-CELLS; ENTRY; HOMOLOGY; SYSTEM	Entry of the bacterium Salmonella typhimurium into host cells, requires membrane ruffling and rearrangement of the actin cytoskeleton. Here, it is shown that the bacterial protein SipA plays a critical role in this process. SipA binds directly to actin, decreases its critical concentration, and inhibits depolymerization of actin filaments, These activities result in the spatial localization and more pronounced outward extension of the Salmonella-induced membrane ruffles, thereby facilitating bacterial uptake.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA	Yale University; Yale University	Galan, JE (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI030492, R37AI030492, R01AI030492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK025387, R01DK025387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052543] Funding Source: NIH RePORTER; NIAID NIH HHS [AI30492] Funding Source: Medline; NIDDK NIH HHS [DK25387] Funding Source: Medline; NIGMS NIH HHS [GM52543] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chen LM, 1996, SCIENCE, V274, P2115, DOI 10.1126/science.274.5295.2115; Collazo CM, 1997, MOL MICROBIOL, V24, P747, DOI 10.1046/j.1365-2958.1997.3781740.x; Fu YX, 1998, MOL MICROBIOL, V27, P359, DOI 10.1046/j.1365-2958.1998.00684.x; Galan JE, 1996, ANNU REV CELL DEV BI, V12, P221, DOI 10.1146/annurev.cellbio.12.1.221; Galan JE, 1996, MOL MICROBIOL, V20, P263, DOI 10.1111/j.1365-2958.1996.tb02615.x; Galyov E. E., 1997, MOL MICROBIOL, V25, P1903; Hardt WD, 1997, P NATL ACAD SCI USA, V94, P9887, DOI 10.1073/pnas.94.18.9887; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hardt WD, 1998, P NATL ACAD SCI USA, V95, P2574, DOI 10.1073/pnas.95.5.2574; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; KANIGA K, 1995, J BACTERIOL, V177, P7078, DOI 10.1128/jb.177.24.7078-7085.1995; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; NAMBA Y, 1992, J BIOCHEM-TOKYO, V112, P503, DOI 10.1093/oxfordjournals.jbchem.a123929; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Van Nhieu GT, 1999, CURR OPIN MICROBIOL, V2, P51; VanNhieu GT, 1997, EMBO J, V16, P2717, DOI 10.1093/emboj/16.10.2717; Wood MW, 1996, MOL MICROBIOL, V22, P327, DOI 10.1046/j.1365-2958.1996.00116.x; Zhou D., UNPUB	18	313	327	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	1999	283	5410					2092	2095		10.1126/science.283.5410.2092	http://dx.doi.org/10.1126/science.283.5410.2092			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180DH	10092234				2022-12-28	WOS:000079369800049
J	Honkinen, O; Lehtonen, OP; Ruuskanen, O; Huovinen, P; Mertsola, J				Honkinen, O; Lehtonen, OP; Ruuskanen, O; Huovinen, P; Mertsola, J			Cohort study of bacterial species causing urinary tract infection and urinary tract abnormalities in children	BRITISH MEDICAL JOURNAL			English	Article									Turku Univ Hosp, Dept Paediat, FIN-20520 Turku, Finland; Turku Univ Hosp, Lab Clin Microbiol, FIN-20520 Turku, Finland; Natl Publ Hlth Inst, Turku Dept, Turku, Finland	University of Turku; University of Turku; Finland National Institute for Health & Welfare	Mertsola, J (corresponding author), Turku Univ Hosp, Dept Paediat, FIN-20520 Turku, Finland.		Huovinen, Pentti/C-1917-2009; Mertsola, Jussi/AAE-3460-2021					DEMAN P, 1989, J PEDIATR-US, V115, P915, DOI 10.1016/S0022-3476(89)80742-5; Dick PT, 1996, J PEDIATR-US, V128, P15, DOI 10.1016/S0022-3476(96)70422-5; Rushton HG, 1997, PEDIATR CLIN N AM, V44, P1133, DOI 10.1016/S0031-3955(05)70551-4; SMELLIE JM, 1995, ARCH DIS CHILD, V72, P247, DOI 10.1136/adc.72.3.247; 1991, J R COLL PHYSICIANS, V25, P36	5	35	38	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 20	1999	318	7186					770	+		10.1136/bmj.318.7186.770	http://dx.doi.org/10.1136/bmj.318.7186.770			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BX	10082700	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000079421700025
J	Thrift, AG; McNeil, JJ; Forbes, A; Donnan, GA				Thrift, AG; McNeil, JJ; Forbes, A; Donnan, GA			Risk of primary intracerebral haemorrhage associated with aspirin and non-steroidal anti-inflammatory drugs: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CEREBRAL-ISCHEMIA; CONTROLLED TRIAL; COMMUNITY STROKE; HEMORRHAGE; PREVENTION; INFARCTION; DISEASE; PERTH; WOMEN	Objective To examine the association between use of aspirin or other non-steroidal anti-inflammatory drugs and intracerebral haemorrhage. Design Case-control study. Setting 13 major city hospitals in the Melbourne and metropolitan area. Subjects 331 consecutive cases of stroke verified by computed tomography or postmortem examination, and 331 age (+/- 5 years) and sex matched controls who were community based neighbours. Interventions (Questionnaire administered to all subjects either directly or by proxy with the next of kin. Drug use was validated by reviewing prescribing records held by the participants' doctors. Main outcome measures Previous use of aspirin or other non-steroidal anti-inflammatory drugs. Results Univariate analysis showed no increased risk of intracerebral haemorrhage with low dose aspirin use in the preceding 2 weeks. Using multiple logistic regression to control for possible confounding factors, the odds ratio associated with die use of aspirin was 1.00 (95% confidence interval 0.60 to 1.66, P = 0.998) and the odds ratio associated with the use of other non-steroidal anti-inflammatory drugs was 0.85 (0.45 to 1.61, P = 0.611) compared with respective non-users in the preceding fortnight. Moderate to high doses of aspirin (> 1225 mg/week spread over at least three doses) yielded an odds ratio of 3.05 (1.02 to 9.14, P= 0.047). There was no evidence of an increased risk among subgroups defined by age, sex, Mood pressure status, alcohol intake, smoking, and the presence or absence of previous cardiovascular disease. Conclusions No increase in risk of intracerebral haemorrhage was found among aspirin users overall or among those who took low doses of the drug or other non-steroidal anti-inflammatory drugs. These data provide evidence that doses of aspirin usually used for prophylaxis against vascular disease produce no substantial increase in risk of intracerebral haemorrhage.	Alfred Hosp, Monash Med Sch, Dept Epidemiol & Prevent Med, Prahran, Vic 3181, Australia; Austin Hosp, Dept Neurol, Heidelberg, Vic 3084, Australia; Repatriat Gen Hosp, Dept Neurol, Heidelberg, Vic 3084, Australia	Florey Institute of Neuroscience & Mental Health; Monash University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Florey Institute of Neuroscience & Mental Health	Thrift, AG (corresponding author), Austin & Repatriat Med Ctr, Natl Stroke Res Inst, Heidelberg West, Vic 3081, Australia.	thrift@austin.unimelb.edu.au	DONNAN, GEOFFREY A/A-9947-2008; McNeil, John/L-6440-2019; Thrift, Amanda/I-6251-2012	McNeil, John/0000-0002-1049-5129; Thrift, Amanda/0000-0001-8533-4170; Forbes, Andrew/0000-0003-4269-914X; Donnan, Geoffrey/0000-0001-6324-3403				ABUZEID HAH, 1977, STROKE, V8, P106, DOI 10.1161/01.STR.8.1.106; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; ANDERSON CS, 1993, MED J AUSTRALIA, V158, P85, DOI 10.5694/j.1326-5377.1993.tb137529.x; [Anonymous], 1988, Br Med J (Clin Res Ed), V296, P316; BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P16, DOI 10.1136/jnnp.53.1.16; BOUSSER MG, 1983, STROKE, V14, P5, DOI 10.1161/01.STR.14.1.5; BOUSSER MG, 1983, PRESSE MED, V12, P3049; BRESLOW NE, 1980, STAT METHODS CANC RE, P247; CALANDRE L, 1986, STROKE, V17, P1126, DOI 10.1161/01.STR.17.6.1126; *CAN COOP STUD GRO, 1978, NEW ENGL J MED, V299, P53; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; FIELDS WS, 1977, STROKE, V8, P301, DOI 10.1161/01.STR.8.3.301; FIELDS WS, 1978, STROKE, V9, P309, DOI 10.1161/01.STR.9.4.309; Goldstein LB, 1996, STROKE, V27, P32; HARKER LA, 1986, J AM COLL CARDIOL, V8, pB21, DOI 10.1016/S0735-1097(86)80004-3; HELMERS C, 1987, STROKE, V18, P325; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; JAMROZIK K, 1994, STROKE, V25, P51, DOI 10.1161/01.STR.25.1.51; LEMAK NA, 1986, NEUROLOGY, V36, P705; LOWENTHAL A, 1990, STROKE, V21, P1122; Magaziner J, 1996, AM J EPIDEMIOL, V143, P283; MANSON JE, 1991, JAMA-J AM MED ASSOC, V266, P521, DOI 10.1001/jama.266.4.521; NORRVING B, 1991, LANCET, V338, P1345; PATRONO C, 1980, THROMB RES, V17, P317, DOI 10.1016/0049-3848(80)90066-3; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; RICCI S, 1991, J NEUROL NEUROSUR PS, V54, P695, DOI 10.1136/jnnp.54.8.695; SORENSEN PS, 1983, STROKE, V14, P15, DOI 10.1161/01.STR.14.1.15; *STAT EP RES CORP, 1991, EP GRAPH EST TEST PA; Thrift AG, 1996, STROKE, V27, P2020, DOI 10.1161/01.STR.27.11.2020; VANE J, 1987, DRUGS, V33, P18, DOI 10.2165/00003495-198700331-00005; VANGIJN J, 1991, NEW ENGL J MED, V325, P1261, DOI 10.1056/NEJM199110313251801	31	65	67	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	1999	318	7186					759	764		10.1136/bmj.318.7186.759	http://dx.doi.org/10.1136/bmj.318.7186.759			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BX	10082697	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000079421700020
J	Hong, M; Kwo, J; Kortan, AR; Mannaerts, JP; Sergent, AM				Hong, M; Kwo, J; Kortan, AR; Mannaerts, JP; Sergent, AM			Epitaxial cubic gadolinium oxide as a dielectric for gallium arsenide passivation	SCIENCE			English	Article							MOLECULAR-BEAM EPITAXY	Epitaxial growth of single-crystal gadolinium oxide dielectric thin films on gallium arsenide is reported. The gadolinium oxide film has a cubic structure isomorphic to manganese oxide and is (110)-oriented in single domain on the (100) gallium arsenide surface. The gadolinium oxide film has a dielectric constant of approximately 10, with low leakage current densities of about 10(-9) to 10(-10) amperes per square centimeter at zero bias, Typical breakdown field is 4 megavolts per centimeter for an oxide film 185 angstroms thick and 10 megavolts per centimeter for an oxide 45 angstroms thick. Both accumulation and inversion layers were observed in the gadolinium oxide-gallium arsenide metal oxide semiconductor diodes, using capacitance-voltage measurements. The ability to grow thin single-crystal oxide films on gallium arsenide with a low interfacial density of states has great potential impact on the electronic industry of compound semiconductors.	AT&T Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA	Alcatel-Lucent; Lucent Technologies; AT&T; Nokia Corporation; Nokia Bell Labs	Hong, M (corresponding author), AT&T Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA.		Hong, Minghwei/C-1433-2010	Hong, Mingwei/0000-0003-4657-0933				EN F, 1996, IEEE INT EL DEV M SA, P943; GELLER S, 1971, ACTA CRYSTALL B-STRU, VB 27, P821, DOI 10.1107/S0567740871002966; HONG M, 1995, J CRYST GROWTH, V150, P277, DOI 10.1016/0022-0248(94)00985-6; Hong M, 1996, J VAC SCI TECHNOL B, V14, P2297, DOI 10.1116/1.588924; Hong M, 1998, J VAC SCI TECHNOL B, V16, P1395, DOI 10.1116/1.590082; KORTAN AR, 1981, PHYS REV LETT, V47, P1206, DOI 10.1103/PhysRevLett.47.1206; KWO J, IN PRESS J VAC SCI B; MIMURA T, 1978, IEEE T ELECTRON DEV, V25, P573, DOI 10.1109/T-ED.1978.19139; NASHIMOTO K, 1992, APPL PHYS LETT, V60, P1199, DOI 10.1063/1.107404; Passlack M, 1997, IEEE T ELECTRON DEV, V44, P214, DOI 10.1109/16.557709; Ren F, 1998, IEEE ELECTR DEVICE L, V19, P309, DOI 10.1109/55.704409; REVESZ AG, 1963, J AM CERAM SOC, V46, P606, DOI 10.1111/j.1151-2916.1963.tb14627.x; TSANG WT, 1978, APPL PHYS LETT, V33, P429; Tu LW, 1996, J APPL PHYS, V80, P6448, DOI 10.1063/1.363664; WANG Y, UNPUB; WEINREICH OA, 1966, J APPL PHYS, V37, P2924, DOI 10.1063/1.1782162; WILMSEN CW, 1985, PHYSICS CHEM 3 5 COM	17	386	397	4	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 19	1999	283	5409					1897	1900		10.1126/science.283.5409.1897	http://dx.doi.org/10.1126/science.283.5409.1897			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177UC	10082459				2022-12-28	WOS:000079228600042
J	Switkes, M; Marcus, CM; Campman, K; Gossard, AC				Switkes, M; Marcus, CM; Campman, K; Gossard, AC			An adiabatic quantum electron pump	SCIENCE			English	Article							QUANTIZED CURRENT; DOT TURNSTILE; TRANSPORT; SIGNATURES; CHAOS	A quantum pumping mechanism that produces de current or voltage in response to a cyclic deformation of the confining potential in an open quantum dot is reported. The voltage produced at zero current bias is sinusoidal in the phase difference between the two ac voltages deforming the potential and shows random fluctuations in amplitude and direction with small changes in external parameters such as magnetic field. The amplitude of the pumping response increases linearly with the frequency of the deformation. Dependencies of pumping on the strength of the deformations, temperature, and breaking of time-reversal symmetry were also investigated.	Stanford Univ, Dept Phys, Stanford, CA 94305 USA; Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA	Stanford University; University of California System; University of California Santa Barbara	Marcus, CM (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.	cmarcus@stanford.edu	Marcus, Charles M./M-4526-2014	Marcus, Charles M./0000-0003-2420-4692				BARANGER HU, 1994, PHYS REV LETT, V73, P142, DOI 10.1103/PhysRevLett.73.142; BEENAKKER CWJ, 1991, SOLID STATE PHYS, V44, P1; Brouwer PW, 1998, PHYS REV B, V58, P10135, DOI 10.1103/PhysRevB.58.R10135; BUTTIKER M, 1994, Z PHYS B CON MAT, V94, P133, DOI 10.1007/BF01307664; CHAN IH, 1995, PHYS REV LETT, V74, P3876, DOI 10.1103/PhysRevLett.74.3876; FALKO VI, 1989, ZH EKSP TEOR FIZ+, V95, P328; Huibers AG, 1998, PHYS REV LETT, V81, P1917, DOI 10.1103/PhysRevLett.81.1917; JALABERT RA, 1994, EUROPHYS LETT, V27, P255, DOI 10.1209/0295-5075/27/4/001; Keller MW, 1998, PHYS REV LETT, V80, P4530, DOI 10.1103/PhysRevLett.80.4530; KOUWENHOVEN LP, 1991, Z PHYS B CON MAT, V85, P381, DOI 10.1007/BF01307634; KOUWENHOVEN LP, 1994, PHYS REV B, V50, P2019, DOI 10.1103/PhysRevB.50.2019; KOUWENHOVEN LP, 1994, PHYS REV LETT, V73, P3443, DOI 10.1103/PhysRevLett.73.3443; KOUWENHOVEN LP, 1991, PHYS REV LETT, V67, P1626, DOI 10.1103/PhysRevLett.67.1626; KOUWENHOVEN LP, 1997, P ADV STUD I MES E E; Marcus CM, 1997, CHAOS SOLITON FRACT, V8, P1261, DOI 10.1016/S0960-0779(97)00019-2; POTHIER H, 1992, EUROPHYS LETT, V17, P249, DOI 10.1209/0295-5075/17/3/011; SPIVAK B, 1995, PHYS REV B, V51, P13226, DOI 10.1103/PhysRevB.51.13226; THOULESS DJ, 1983, PHYS REV B, V27, P6083, DOI 10.1103/PhysRevB.27.6083; Zhou F, 1999, PHYS REV LETT, V82, P608, DOI 10.1103/PhysRevLett.82.608; ZHOU F, COMMUNICATION	20	544	550	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	1999	283	5409					1905	1908		10.1126/science.283.5409.1905	http://dx.doi.org/10.1126/science.283.5409.1905			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177UC	10082462	Green Submitted			2022-12-28	WOS:000079228600045
J	Wang, RL; Stec, A; Hey, J; Lukens, L; Doebley, J				Wang, RL; Stec, A; Hey, J; Lukens, L; Doebley, J			The limits of selection during maize domestication	NATURE			English	Article							EVOLUTION; RECOMBINATION; GENE; TEOSINTE; DOMINANCE; SEQUENCE; ORIGIN	The domestication of all major crop plants occurred during a brief period in human history about 10,000 years ago(1). During this time, ancient agriculturalists selected seed of preferred forms and culled out seed of undesirable types to produce each subsequent generation. Consequently favoured alleles at genes controlling traits of interest increased in frequency, ultimately reaching fixation. When selection is strong, domestication has the potential to drastically reduce genetic diversity in a crop. To understand the impact of selection during maize domestication, we examined nucleotide polymorphism in teosinte branched1, a gene involved in maize evolution(2). Here we show that the effects of selection were limited to the gene's regulatory region and cannot be detected in the protein-coding region. Although selection was apparently strong, high rates of recombination and a prolonged domestication period probably limited its effects. Our results help to explain why maize is such a variable crop. They also suggest that maize domestication required hundreds of years, and confirm precious evidence that maize was domesticated from Balsas teosinte of southwestern Mexico.	Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA	University of Minnesota System; University of Minnesota Twin Cities; Rutgers State University New Brunswick	Doebley, J (corresponding author), Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA.		Hey, Jody/D-1257-2009	Hey, Jody/0000-0001-5358-6488; Lukens, Lewis/0000-0003-3963-2008				Beadle GW, 1939, J HERED, V30, P245, DOI 10.1093/oxfordjournals.jhered.a104728; BEAN M, 1998, NATURE, V391, P485; Buckler ES, 1996, MOL BIOL EVOL, V13, P612, DOI 10.1093/oxfordjournals.molbev.a025621; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; DOEBLEY J, 1995, GENETICS, V141, P333; DOEBLEY J, 1998, MAIZE GENET COOP NEW, V73; DOEBLEY JF, 1984, SYST BOT, V9, P203, DOI 10.2307/2418824; Dooner HK, 1997, PLANT CELL, V9, P1633, DOI 10.1105/tpc.9.9.1633; Eyre-Walker A, 1998, P NATL ACAD SCI USA, V95, P4441, DOI 10.1073/pnas.95.8.4441; GALINAT WC, 1983, MAYDICA, V28, P121; GOLOUBINOFF P, 1993, P NATL ACAD SCI USA, V90, P1997, DOI 10.1073/pnas.90.5.1997; Hanson MA, 1996, GENETICS, V143, P1395; Harlan JR, 1992, CROPS MAN, V2nd; Hilton H, 1998, GENETICS, V150, P863; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; ILTIS HH, 1983, SCIENCE, V222, P886, DOI 10.1126/science.222.4626.886; KAPLAN NL, 1989, GENETICS, V123, P887; KIMURA M, 1969, GENETICS, V61, P763; Okagaki RJ, 1997, GENETICS, V147, P815; PATTERSON GI, 1995, GENETICS, V140, P1389; Smith B.D., 1995, EMERGENCE AGR; Stam LF, 1996, GENETICS, V144, P1559; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P188; Xu XJ, 1995, PLANT CELL, V7, P2151, DOI 10.1105/tpc.7.12.2151	25	546	614	4	125	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 18	1999	398	6724					236	239		10.1038/18435	http://dx.doi.org/10.1038/18435			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177UA	10094045				2022-12-28	WOS:000079228400052
J	Morin, CM; Colecchi, C; Stone, J; Sood, R; Brink, D				Morin, CM; Colecchi, C; Stone, J; Sood, R; Brink, D			Behavioral and pharmacological therapies for late-life insomnia - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SLEEP; PREVALENCE; EFFICACY; METAANALYSIS; COMPLAINTS; TEMAZEPAM	Context Insomnia is a prevalent health complaint in older adults. Behavioral and pharmacological treatments have their benefits and limitations, but no placebo-controlled study has compared their separate and combined effects for late-life insomnia. Objective To evaluate the clinical efficacy of behavioral and pharmacological therapies, singly and combined, for late-life insomnia. Design and Setting Randomized, placebo-controlled clinical trial, at a single academic medical center. Outpatient treatment lasted 8 weeks with follow-ups conducted at 3, 12, and 24 months. Subjects Seventy-eight adults (50 women, 28 men; mean age, 65 years) with chronic and primary insomnia. Interventions Cognitive-behavior therapy (stimulus control, sleep restriction, sleep hygiene, and cognitive therapy) (n = 18), pharmacotherapy (temazepam) (n = 20), or both (n = 20) compared with placebo (n = 20). Main Outcome Measures Time awake after sleep onset and sleep efficiency as measured by sleep diaries and polysomnography; clinical ratings from subjects, significant others, and clinicians. Results The 3 active treatments were more effective than placebo at posttreatment assessment; there was a trend for the combined approach to improve sleep more than either of its 2 single components (shorter time awake after sleep onset by sleep diary and polysomnography). For example, the percentage reductions of time awake after sleep onset was highest for the combined condition (63.5 %), followed by cognitive-behavior therapy (55%), pharmacotherapy (46.5%), and placebo (16.9%). Subjects treated with behavior therapy sustained their clinical gains at follow-up, whereas those treated with drug therapy alone did not. Long-term outcome of the combined intervention was more variable. Behavioral treatment, singly or combined, was rated by subjects, significant others, and clinicians as more effective than drug therapy alone. Subjects were also more satisfied with the behavioral approach. Conclusions Behavioral and pharmacological approaches are effective for the shortterm management of insomnia in late life; sleep improvements are better sustained over time with behavioral treatment.	Univ Laval, Ecole Psychol, Ste Foy, PQ G1K 7P4, Canada; Virginia Commonwealth Univ, Med Coll Virginia, Richmond, VA 23298 USA	Laval University; Virginia Commonwealth University	Morin, CM (corresponding author), Univ Laval, Ecole Psychol, Pavillon FAS, Ste Foy, PQ G1K 7P4, Canada.	cmorin@psy.ulaval.ca	Morin, Charles M./A-4700-2008; Morin, Charles/G-1021-2011	Morin, Charles M./0000-0002-8649-8895; 	NIMH NIH HHS [MH47020] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH047020] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALLEN RP, 1987, J CLIN PHARMACOL, V27, P768, DOI 10.1002/j.1552-4604.1987.tb02994.x; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; American Sleep Disorders Association. Diagnostic Classification Steering Committee, 1990, INT CLASS SLEEP DIS, pxii, 396; [Anonymous], 1996, AM FAM PHYSICIAN, V53, P1877; BLIWISE DL, 1993, SLEEP, V16, P40, DOI 10.1093/sleep/16.1.40; Bootzin R.R., 1991, STIMULUS CONTROL INS, P19, DOI [10.1007/978-1-4757-9586-8_2, DOI 10.1007/978-1-4757-9586-8_2]; COATES TJ, 1982, J CONSULT CLIN PSYCH, V50, P345, DOI 10.1037/0022-006X.50.3.345; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; ENGLEFRIEDMAN M, 1992, J CLIN PSYCHOL, V48, P77, DOI 10.1002/1097-4679(199201)48:1<77::AID-JCLP2270480112>3.0.CO;2-J; FILLINGIM JM, 1982, CLIN THER, V4, P369; FOLEY DJ, 1995, SLEEP, V18, P425, DOI 10.1093/sleep/18.6.425; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; FRIEDMAN L, 1991, J GERONTOL, V46, pP1, DOI 10.1093/geronj/46.1.P1; Hauri PJ, 1997, SLEEP, V20, P1111, DOI 10.1093/sleep/20.12.1111; HOHAGEN F, 1994, ACTA PSYCHIAT SCAND, V90, P102, DOI 10.1111/j.1600-0447.1994.tb01563.x; Kupfer DJ, 1997, NEW ENGL J MED, V336, P341, DOI 10.1056/NEJM199701303360506; LADER MH, 1983, J CLIN PSYCHIAT, V44, P47; LICHSTEIN KL, 1993, PSYCHOL AGING, V8, P103, DOI 10.1037/0882-7974.8.1.103; MCCLUSKY HY, 1991, AM J PSYCHIAT, V148, P121; MELLINGER GD, 1985, ARCH GEN PSYCHIAT, V42, P225, DOI 10.1001/archpsyc.1985.01790260019002; MILBY JB, 1993, AM J PSYCHIAT, V150, P1259; MORGAN K, 1988, BRIT MED J, V296, P601, DOI 10.1136/bmj.296.6622.601; Morgan K, 1997, BRIT J GEN PRACT, V47, P166; MORIN CM, 1988, J CONSULT CLIN PSYCH, V56, P748, DOI 10.1037/0022-006X.56.5.748; MORIN CM, 1993, J CONSULT CLIN PSYCH, V61, P137, DOI 10.1037/0022-006X.61.1.137; MORIN CM, 1989, PSYCHOL AGING, V4, P290, DOI 10.1037/0882-7974.4.3.290; MORIN CM, 1994, AM J PSYCHIAT, V151, P1172; Morin CM, 1996, CLIN PSYCHOL REV, V16, P521, DOI 10.1016/0272-7358(96)00027-X; Morin CM., 1993, INSOMNIA PSYCHOL ASS; MURTAGH DRR, 1995, J CONSULT CLIN PSYCH, V63, P79, DOI 10.1037/0022-006X.63.1.79; *NIH, 1984, JAMA-J AM MED ASSOC, V18, P2410; *NIH, 1991, SLEEP, V14, P169; Nowell PD, 1997, JAMA-J AM MED ASSOC, V278, P2170; Pollak C P, 1990, J Community Health, V15, P123, DOI 10.1007/BF01321316; PRINZ PN, 1990, NEW ENGL J MED, V323, P520; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Simon GE, 1997, AM J PSYCHIAT, V154, P1417; SPIELMAN AJ, 1987, SLEEP, V10, P45; Spitzer RL, 1990, STRUCTURED CLIN INTE; STOLLER MK, 1994, CLIN THER, V16, P873; VOLLRATH M, 1989, EUR ARCH PSY CLIN N, V239, P113, DOI 10.1007/BF01759584	42	695	717	3	60	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	1999	281	11					991	999		10.1001/jama.281.11.991	http://dx.doi.org/10.1001/jama.281.11.991			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	175EE	10086433	Bronze			2022-12-28	WOS:000079079400025
J	Gulick, RM; McAuliffe, V; Holden-Wiltse, J; Crumpacker, C; Liebes, L; Stein, DS; Meehan, P; Hussey, S; Forcht, J; Valentine, FT				Gulick, RM; McAuliffe, V; Holden-Wiltse, J; Crumpacker, C; Liebes, L; Stein, DS; Meehan, P; Hussey, S; Forcht, J; Valentine, FT		AIDS Clin Trials Grp 150 258 Protocol	Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults - AIDS clinical trials group protocols 150 and 258	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PSEUDOHYPERICIN; INACTIVATION	Background: Hypericin, the active compound in St. John's Wort, has antiretroviral activity in vitro. Many HIV-infected persons use St. John's wort. Objective: To evaluate the safety and antiretroviral activity of hypericin in HIV-infected patients. Design: Phase I study. Setting: Four clinical research units. Patients: 30 HIV-infected patients with CD4 counts less than 350 cells/mm(3). Intervention: Intravenous hypericin, 0.25 or 0.5 mg/kg of body weight twice weekly or 0.25 mg/kg three times weekly, or oral hypericin, 0.5 mg/kg daily. Measurements: Safety was assessed at weekly visits. Antiretroviral activity was assessed by changes in HIV p24 antigen level, HIV titer, HIV RNA copies, and CD4 cell counts. Results: Of the 30 patients who were enrolled, 16 discontinued treatment early because of toxic effects. Severe cutaneous phototoxicity was observed in 11 of 23 (48% [95% CI, 27% to 69%]) evaluable patients, and dose escalation could not be completed. Virologic markers and CD4 cell count did not significantly change. Conclusions: Hypericin caused significant phototoxicity and had no antiretroviral activity in the limited number of patients studied.	NYU, Sch Med, Med Ctr, New York, NY 10016 USA; Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA; Beth Israel Hosp, AIDS Clin Trial Unit, Boston, MA 02215 USA; NIH, Rockville, MD USA	New York University; Boston University; Harvard University; Beth Israel Deaconess Medical Center; National Institutes of Health (NIH) - USA	Gulick, RM (corresponding author), Cornell Clin Trials Unit, Box 566,525 E 68th St, New York, NY 10011 USA.			Valentine, Fred/0000-0002-6046-5913	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027742, U01AI027665] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR 0096] Funding Source: Medline; NIAID NIH HHS [U01-AI 27665, P30-AI 27742] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		COOPER WC, 1990, INT C AIDS, V6, P369; DEGAR S, 1992, AIDS RES HUM RETROV, V8, P1929, DOI 10.1089/aid.1992.8.1929; DURAN N, 1986, PHOTOCHEM PHOTOBIOL, V43, P677, DOI 10.1111/j.1751-1097.1986.tb05646.x; FURNER V, 1991, INT C AIDS, V7, P199; Giese A.C., 1980, PHOTOCHEMICAL AND PHOTOBIOLOGICAL REVIEWS, V5, P229; HUDSON JB, 1991, ANTIVIR RES, V15, P101, DOI 10.1016/0166-3542(91)90028-P; KASSLER WJ, 1991, ARCH INTERN MED, V151, P2281, DOI 10.1001/archinte.151.11.2281; Kerb R, 1996, ANTIMICROB AGENTS CH, V40, P2087, DOI 10.1128/AAC.40.9.2087; LAVIE G, 1995, TRANSFUSION, V35, P392, DOI 10.1046/j.1537-2995.1995.35595259149.x; LAVIE G, 1989, P NATL ACAD SCI USA, V86, P5963, DOI 10.1073/pnas.86.15.5963; LENARD J, 1993, P NATL ACAD SCI USA, V90, P158, DOI 10.1073/pnas.90.1.158; Linde K, 1996, BRIT MED J, V313, P253, DOI 10.1136/bmj.313.7052.253; MILLER S, 1997, NEWSWEEK        0505, P74; RODEWALD G, 1977, ANGEW CHEM INT EDIT, V16, P46, DOI 10.1002/anie.197700462; SCHINAZI RF, 1990, ANTIVIR RES, V13, P265, DOI 10.1016/0166-3542(90)90071-E; STEINBECKKLOSE A, 1993, INT C AIDS, V9, P470; TANG J, 1990, ANTIVIR RES, V13, P313, DOI 10.1016/0166-3542(90)90015-Y; *WH, 1980, 23 REP JOINT FAO WHO; Woelk H, 1994, J Geriatr Psychiatry Neurol, V7 Suppl 1, pS34, DOI 10.1177/089198879400700110; 1997, MED LETT DRUGS THER, V39, P107	20	72	76	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	1999	130	6					510	514		10.7326/0003-4819-130-6-199903160-00015	http://dx.doi.org/10.7326/0003-4819-130-6-199903160-00015			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	176RL	10075619				2022-12-28	WOS:000079165500007
J	Farooque, P; Barthes-Wilson, E				Farooque, P; Barthes-Wilson, E			Martin Kwame Kari Kari Frimpong - Obituary	BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 13	1999	318	7185					739	739						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182JK	10074043				2022-12-28	WOS:000079495700061
J	Martin, EL; Brandner, W; Basri, G				Martin, EL; Brandner, W; Basri, G			A search for companions to nearby brown dwarfs: The binary DENIS-PJ1228.2-1547	SCIENCE			English	Article							CLUSTER; SPECTROSCOPY; DISCOVERY; LITHIUM; PLANETS; STARS; DENIS	Hubble Space Telescope imaging observations of two nearby brown dwarfs, DENIS-P J1228.2-1547 and Kelu 1, made with the near-infrared camera and multiobject spectrometer (NICMOS), show that the DENIS object is resolved into two components of nearly equal brightness with a projected separation of 0.275 are second (5 astronomical units for a distance of 18 parsecs), This binary system will be able to provide the first dynamical measurement of the masses of two brown dwarfs in only a few years. Upper Limits to the mass of any unseen companion in Kelu 1 yield a planer of 7 Jupiter masses aged 0.5 x 10(9) years, which would have been detected at a separation Larger than about 4 astronomical units. This example demonstrates that giant planets could be detected by direct imaging if they exist in Jupiter-like orbits around nearby young brown dwarfs.	Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; CALTECH, Jet Prop Lab, Ctr Infrared Proc & Anal, Pasadena, CA 91125 USA	University of California System; University of California Berkeley; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Martin, EL (corresponding author), Univ Calif Berkeley, Dept Astron, 601 Campbell Hall, Berkeley, CA 94720 USA.		Basri, Gibor B/Y-4048-2018; Brandner, Wolfgang/AFR-1606-2022	Brandner, Wolfgang/0000-0003-1939-6351				Baraffe I, 1998, ASTRON ASTROPHYS, V337, P403; Basri G, 1996, ASTROPHYS J, V458, P600, DOI 10.1086/176842; Basri G, 1997, AIP CONF PROC, P228, DOI 10.1063/1.52787; BASRI G, 1998, 10 CAMBR WORKSH COOL, V154, P1819; BECKLIN EE, 1988, NATURE, V336, P658; Briceno C, 1998, ASTRON J, V115, P2074, DOI 10.1086/300338; Burrows A, 1997, ASTROPHYS J, V491, P856, DOI 10.1086/305002; BURROWS A, 1995, NATURE, V375, P299, DOI 10.1038/375299a0; Delfosse X, 1997, ASTRON ASTROPHYS, V327, pL25; GARZON F, 1997, ASTROPHYSICS SPACE S, V210; Golimowski DA, 1998, ASTRON J, V115, P2579, DOI 10.1086/300370; Harris HC, 1997, ESA SP PUBL, V402, P105; Kulkami SR, 1997, SCIENCE, V276, P1350, DOI 10.1126/science.276.5317.1350; Luhman KL, 1997, ASTROPHYS J, V489, pL165, DOI 10.1086/316784; MAGAZZU A, 1993, ASTROPHYS J, V404, pL17, DOI 10.1086/186733; Malkov O, 1998, ASTRON ASTROPHYS, V338, P452; MARCY GW, IN PRESS PROTOSTARS, V4; Martin EL, 1998, ASTROPHYS J, V509, pL113, DOI 10.1086/311775; Martin EL, 1997, ASTRON ASTROPHYS, V327, pL29; NAKAJIMA T, 1995, NATURE, V378, P463, DOI 10.1038/378463a0; OPPENHEIMER B, IN PRESS PROTOSTARS, V4; OPPENHEIMER BR, 1995, SCIENCE, V270, P1478, DOI 10.1126/science.270.5241.1478; POUND MW, 1995, ASTROPHYS J, V444, P270, DOI 10.1086/175602; REBOLO R, 1995, NATURE, V377, P129, DOI 10.1038/377129a0; Rebolo R, 1998, SCIENCE, V282, P1309, DOI 10.1126/science.282.5392.1309; Rebolo R, 1996, ASTROPHYS J, V469, pL53, DOI 10.1086/310263; REBOLO R, 1992, ASTROPHYS J, V389, pL83, DOI 10.1086/186354; Ruiz MT, 1997, ASTROPHYS J, V491, pL107, DOI 10.1086/311070; Tamura M, 1998, SCIENCE, V282, P1095, DOI 10.1126/science.282.5391.1095; Thompson RI, 1998, ASTROPHYS J, V492, pL95, DOI 10.1086/311095; Tinney CG, 1998, ASTRON ASTROPHYS, V338, P1066; VOIT M, 1997, HST DATA HDB, V1; WILKING BA, IN PRESS ASTROPHYS J	33	117	117	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	1999	283	5408					1718	1720		10.1126/science.283.5408.1718	http://dx.doi.org/10.1126/science.283.5408.1718			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175PF	10073933				2022-12-28	WOS:000079102800046
J	Hofmann, RM; Pickart, CM				Hofmann, RM; Pickart, CM			Noncanonical MMS2-encoded ubiquitin-conjugating enzyme functions in assembly of novel polyubiquitin chains for DNA repair	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; MULTIUBIQUITIN CHAINS; PROTEASOME PATHWAY; PROTEIN LIGASE; GENE-PRODUCT; KAPPA-B; YEAST; ENCODES; RAD6; EXPRESSION	Ubiquitin-conjugating enzyme variant (UEV) proteins resemble ubiquitin-conjugating enzymes (E2s) but lack the defining E2 active-site residue. The MMS2-encoded UEV protein has been genetically implicated in error-free postreplicative DNA repair in Saccharomyces cerevisiae. We show that Mms2p forms a specific heteromeric complex with the UBC13-encoded E2 and is required for the Ubc13p-dependent assembly of polyubiquitin chains linked through lysine 63. A ubc13 yeast strain is UV sensitive, and single, double, and triple mutants of the UBC13, MMS2, and ubiquitin (ubiK63R) genes display a comparable phenotype. These findings support a model in which an Mms2p/Ubc13p complex assembles novel polyubiquitin chains for signaling in DNA repair, and they suggest that UEV proteins may act to increase diversity and selectivity in ubiquitin conjugation.	Johns Hopkins Univ, Sch Publ Hlth, Dept Biochem, Baltimore, MD 21205 USA	Johns Hopkins University	Pickart, CM (corresponding author), Johns Hopkins Univ, Sch Publ Hlth, Dept Biochem, Baltimore, MD 21205 USA.	cpickart@welchlink.welch.jhu.edu			NIDDK NIH HHS [DK46984] Funding Source: Medline; NIEHS NIH HHS [T32 ES07141] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007141] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; BAILLY V, 1994, GENE DEV, V8, P811, DOI 10.1101/gad.8.7.811; Bailly V, 1997, J BIOL CHEM, V272, P23360, DOI 10.1074/jbc.272.37.23360; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Beal RE, 1998, BIOCHEMISTRY-US, V37, P2925, DOI 10.1021/bi972514p; Broomfield S, 1998, P NATL ACAD SCI USA, V95, P5678, DOI 10.1073/pnas.95.10.5678; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; CHEN ZJ, 1990, J BIOL CHEM, V265, P21835; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; COOK WJ, 1994, J MOL BIOL, V236, P601, DOI 10.1006/jmbi.1994.1169; COOK WJ, 1993, BIOCHEMISTRY-US, V32, P13809, DOI 10.1021/bi00213a009; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Haas AL, 1997, FASEB J, V11, P1257; Haldeman MT, 1997, BIOCHEMISTRY-US, V36, P10526, DOI 10.1021/bi970750u; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hodgins R, 1996, J BIOL CHEM, V271, P28766, DOI 10.1074/jbc.271.46.28766; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Koonin EV, 1997, NAT GENET, V16, P330, DOI 10.1038/ng0897-330; Kumar S, 1997, J BIOL CHEM, V272, P13548, DOI 10.1074/jbc.272.21.13548; Li LM, 1996, CELL, V85, P319, DOI 10.1016/S0092-8674(00)81111-3; LIU HP, 1992, GENETICS, V132, P665; Ma L, 1998, ONCOGENE, V17, P1321, DOI 10.1038/sj.onc.1202058; MURALIDHAR MG, 1993, NEURON, V11, P253, DOI 10.1016/0896-6273(93)90182-Q; Nuber U, 1996, J BIOL CHEM, V271, P2795, DOI 10.1074/jbc.271.5.2795; OH CE, 1994, J NEUROSCI, V14, P3166; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; PETERS JM, 1998, UBIQUITIN BIOL CELL, P345; Pickart CM, 1997, FASEB J, V11, P1055, DOI 10.1096/fasebj.11.13.9367341; PICKART CM, 1988, J BIOL CHEM, V263, P12028; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Ponting CP, 1997, J MOL MED-JMM, V75, P467; PRAKASH L, 1977, GENETICS, V86, P33; PRAKASH S, 1993, ANNU REV GENET, V27, P33, DOI 10.1146/annurev.ge.27.120193.000341; REYNOLDS P, 1985, P NATL ACAD SCI USA, V82, P168, DOI 10.1073/pnas.82.1.168; Sancho E, 1998, MOL CELL BIOL, V18, P576, DOI 10.1128/MCB.18.1.576; SAXENA P, 1992, J BACTERIOL, V174, P1956, DOI 10.1128/jb.174.6.1956-1964.1992; Siede W, 1998, CONT CANC RES, P307; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Thomson TM, 1998, FEBS LETT, V423, P49, DOI 10.1016/S0014-5793(98)00060-X; TorresRamos CA, 1996, P NATL ACAD SCI USA, V93, P9676, DOI 10.1073/pnas.93.18.9676; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; WILKINSON KD, 1981, J BIOL CHEM, V256, P9235; Xiao W, 1998, NUCLEIC ACIDS RES, V26, P3908, DOI 10.1093/nar/26.17.3908; Xie WQ, 1998, P NATL ACAD SCI USA, V95, P1595, DOI 10.1073/pnas.95.4.1595; Yamaguchi T, 1996, J BIOCHEM-TOKYO, V120, P494	54	647	681	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	1999	96	5					645	653		10.1016/S0092-8674(00)80575-9	http://dx.doi.org/10.1016/S0092-8674(00)80575-9			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	174TB	10089880	hybrid			2022-12-28	WOS:000079050100008
J	Forman, D				Forman, D			Meat and cancer: a relation in search of a mechanism	LANCET			English	Editorial Material							HETEROCYCLIC AMINES; COLORECTAL-CANCER; COOKED FOODS; RISK; DIET		Univ Leeds, Cookridge Hosp, Ctr Canc Res, Leeds LS16 6QB, W Yorkshire, England	Cookridge Hospital; University of Leeds	Forman, D (corresponding author), Univ Leeds, Cookridge Hosp, Ctr Canc Res, Leeds LS16 6QB, W Yorkshire, England.							Chen J, 1998, CANCER RES, V58, P3307; Department of Health, 1998, REP HLTH SOC SUBJ 48; FELTON JS, 1994, FOOD CHEM TOXICOL, V32, P897, DOI 10.1016/0278-6915(94)90087-6; LANG NP, 1994, CANCER EPIDEM BIOMAR, V3, P675; RobertsThomson IC, 1996, LANCET, V347, P1372, DOI 10.1016/S0140-6736(96)91012-0; SUGIMURA T, 1986, ENVIRON HEALTH PERSP, V67, P5, DOI 10.2307/3430310; WEISBURGER JH, 1993, CANCER RES, V53, P2422; Welfare MR, 1997, CARCINOGENESIS, V18, P1351, DOI 10.1093/carcin/18.7.1351; WILLETT WC, 1990, NEW ENGL J MED, V323, P1664, DOI 10.1056/NEJM199012133232404; [World Cancer Research Fund American Institute for Cancer Research], 1997, FOOD NUTR PREV CANC	10	8	9	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 27	1999	353	9154					686	687		10.1016/S0140-6736(98)00377-8	http://dx.doi.org/10.1016/S0140-6736(98)00377-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173DR	10073504				2022-12-28	WOS:000078966400002
J	Talley, NJ; Janssens, J; Lauritsen, K; Racz, I; Bolling-Sternevald, E				Talley, NJ; Janssens, J; Lauritsen, K; Racz, I; Bolling-Sternevald, E		Optimal Regimen Cures Helicobacter Induced Dysp	Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COLLOIDAL BISMUTH SUBCITRATE; GASTROESOPHAGEAL REFLUX DISEASE; NON-ULCER DYSPEPSIA; NONULCER DYSPEPSIA; GASTROINTESTINAL SYMPTOMS; INFECTION; GASTRITIS; MULTICENTER; ENDOSCOPY	Objectives To determine whether eradication of Helicobacter pylori relieves the symptoms of functional dyspepsia. Design Multicentre randomised double blind placebo controlled trial. Subjects 278 patients infected with H pylori who had functional dyspepsia. Setting Predominantly secondary care centres in Australia, New Zealand, and Europe. Intervention Patients randomised to receive omeprazole 20 mg twice daily, amoxicillin 1000 mg twice daily, and clarithromycin 500 mg twice daily or placebo for 7 days. Patients were followed up for 12 months. Main outcome measures Symptom status (assessed by diary cards) and presence of H pylori (assessed by gastric biopsies and C-13-urea breath testing using urea labelled with carbon-13). Results H pylori was eradicated in 113 patients (85%) in the treatment group and 6 patients (4%) in the placebo group. At 12 months follow up there was no significant difference between the proportion of patients treated successfully by intention to treat in the eradication arm (24%, 95% confidence interval 17% to 32%) and the proportion of patients treated successfully by intention to treat in the placebo group (22%, 15% to 30%). Changes in symptom scores and quality of life did not significantly differ between the treatment and placebo groups. When the groups were combined, there was a significant association between treatment success and chronic gastritis score at 12 months; 41/127 (32%) patients with no or mild gastritis were successfully treated compared with 21/123 (17%) patients with persistent gastritis (P = 0.008). Conclusion No convincing evidence was found that eradication of H pylori relieves the symptoms of functional dyspepsia 12 months after treatment.	Univ Sydney, Nepean Hosp, Dept Med, Penrith, NSW 2751, Australia; KUL Gasthuisberg, Dienst Maag & Darmziekten, B-3000 Louvain, Belgium; Odense Univ, Dept Med Gastroenterol, DK-5000 Odense, Denmark; Teaching & Cty Hosp, H-9002 Eyor, Hungary; Linkoping Univ, Dept Biomed & Surg, S-58185 Molndal, Sweden	Nepean Hospital; University of Sydney; KU Leuven; University of Southern Denmark; Linkoping University	Talley, NJ (corresponding author), Univ Sydney, Nepean Hosp, Dept Med, Penrith, NSW 2751, Australia.	talley@pnc.com.au	Talley, Nicholas J/D-5399-2013	Talley, Nicholas J/0000-0003-2537-3092; Prof. Dr. Racz, Istvan/0000-0001-9740-6995				Armstrong D, 1996, SCAND J GASTROENTERO, V31, P38, DOI 10.3109/00365529609094532; Axon A, 1997, BRIT MED J, V314, P1430, DOI 10.1136/bmj.314.7092.1430; BERNERSEN B, 1992, BRIT MED J, V304, P1276, DOI 10.1136/bmj.304.6837.1276; Blum AL, 1998, NEW ENGL J MED, V339, P1875, DOI 10.1056/NEJM199812243392602; Bytzer P, 1996, GASTROENTEROLOGY, V110, P302, DOI 10.1053/gast.1996.v110.agast960302; DIMENAS E, 1995, SCAND J GASTROENTERO, V30, P1046, DOI 10.3109/00365529509101605; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; DominguezMunoz JE, 1997, GUT, V40, P459, DOI 10.1136/gut.40.4.459; Gilvarry J, 1997, SCAND J GASTROENTERO, V32, P535, DOI 10.3109/00365529709025095; GOH KL, 1991, SCAND J GASTROENTERO, V26, P1123, DOI 10.3109/00365529108998603; Goves J, 1998, ALIMENT PHARM THERAP, V12, P147; Junghard O, 1998, EUR J SURG, V164, P106; KANG JY, 1990, GUT, V31, P476, DOI 10.1136/gut.31.4.476; Laheij RJF, 1996, ALIMENT PHARM THER, V10, P843, DOI 10.1046/j.1365-2036.1996.86258000.x; LAMBERT JR, 1989, SCAND J GASTROENTERO, V24, P7, DOI 10.3109/00365528909091728; LOFFELD RJLF, 1989, GUT, V30, P1206, DOI 10.1136/gut.30.9.1206; MARSHALL BJ, 1993, DIGEST DIS SCI, V38, P1674, DOI 10.1007/BF01303177; MCCARTHY C, 1995, DIGEST DIS SCI, V40, P114, DOI 10.1007/BF02063953; McColl K, 1998, NEW ENGL J MED, V339, P1869, DOI 10.1056/NEJM199812243392601; MCNULTY CAM, 1986, BRIT MED J, V293, P645, DOI 10.1136/bmj.293.6548.645; Nandurkar S, 1998, ARCH INTERN MED, V158, P1427, DOI 10.1001/archinte.158.13.1427; Revicki DA, 1998, QUAL LIFE RES, V7, P75; ROKKAS T, 1988, GUT, V29, P1386, DOI 10.1136/gut.29.10.1386; SCHUBERT TT, 1992, GASTROINTEST ENDOSC, V38, P357, DOI 10.1016/S0016-5107(92)70432-5; STRAUSS RM, 1990, AM J MED, V89, P464, DOI 10.1016/0002-9343(90)90377-P; Talley N, 1991, GASTROENTEROL INT, V4, P145; TALLEY NJ, 1994, GASTROENTEROLOGY, V106, P1174, DOI 10.1016/0016-5085(94)90007-8; TALLEY NJ, 1992, AM J EPIDEMIOL, V136, P165, DOI 10.1093/oxfordjournals.aje.a116483; Talley NJ, 1998, GASTROENTEROLOGY, V114, P582, DOI 10.1016/S0016-5085(98)70542-6; Talley NJ, 1997, GASTROENTEROLOGY, V113, pS67, DOI 10.1016/S0016-5085(97)80016-9; TRESPI E, 1994, SCAND J GASTROENTERO, V29, P884, DOI 10.3109/00365529409094858; vanZanten SJOV, 1996, AM J GASTROENTEROL, V91, P660; Wiklund I, 1998, ITAL J GASTROENTEROL, V30, P19	33	250	259	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	1999	318	7187					833	837		10.1136/bmj.318.7187.833	http://dx.doi.org/10.1136/bmj.318.7187.833			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185DM	10092259	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000079652900022
J	Ng, T; Squire, A; Hansra, G; Bornancin, F; Prevostel, C; Hanby, A; Harris, W; Barnes, D; Schmidt, S; Mellor, H; Bastiaens, PIH; Parker, PJ				Ng, T; Squire, A; Hansra, G; Bornancin, F; Prevostel, C; Hanby, A; Harris, W; Barnes, D; Schmidt, S; Mellor, H; Bastiaens, PIH; Parker, PJ			Imaging protein kinase C alpha activation in cells	SCIENCE			English	Article							MICROSCOPY; ASSOCIATION	Spatially resolved fluorescence resonance energy transfer (FRET) measured by fluorescence lifetime imaging microscopy (FLIM), provides a method for tracing the catalytic activity of fluorescently tagged proteins inside live cell cultures and enables determination of the functional state of proteins in fixed cells and tissues. Here, a dynamic marker of protein kinase C alpha (PKC alpha) activation is identified and exploited. Activation of PKC alpha is detected through the binding of fluorescently tagged phosphorylation site-specific antibodies; the consequent FRET is measured through the donor fluorophore on PKC alpha by FLIM. This approach enabled the imaging of PKC alpha activation in live and fixed cultured cells and was also applied to pathological samples.	Imperial Canc Res Fund, Cell Biophys Lab, London WC2A 3PX, England; Imperial Canc Res Fund, Prot Phosphorylat Lab, London WC2A 3PX, England; Guys Hosp, Imperial Canc Res Fund, Hedley Atkins Lab, London SE1 9RT, England	Cancer Research UK; Cancer Research UK; Cancer Research UK; Guy's & St Thomas' NHS Foundation Trust	Bastiaens, PIH (corresponding author), Imperial Canc Res Fund, Cell Biophys Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	bastiaen@icrf.icnet.uk; parkerp@icrf.icnet.uk	Bornancin, Frederic/AAA-2888-2021; Prevostel, Corinne/AAO-1433-2020; Parker, Peter j/D-5192-2013	Bornancin, Frederic/0000-0002-0152-6720; Ng, Tony/0000-0003-3894-5619; parker, peter/0000-0002-6218-2933; Mellor, Harry/0000-0003-3894-0623; PREVOSTEL, Corinne/0000-0002-7553-087X				Bastiaens PIH, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 3, P136; Bornancin F, 1996, CURR BIOL, V6, P1114, DOI 10.1016/S0960-9822(02)70678-7; Carlsson K, 1997, J MICROSC-OXFORD, V185, P37, DOI 10.1046/j.1365-2818.1997.1450705.x; Cooke FT, 1998, CURR BIOL, V8, P1219, DOI 10.1016/S0960-9822(07)00513-1; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; Dong CY, 1995, BIOPHYS J, V69, P2234, DOI 10.1016/S0006-3495(95)80148-7; Gadella T. W. J.  Jr., 1994, Bioimaging, V2, P139, DOI 10.1002/1361-6374(199409)2:3<139::AID-BIO4>3.3.CO;2-K; GADELLA TWJ, 1993, BIOPHYS CHEM, V48, P221, DOI 10.1016/0301-4622(93)85012-7; Gillett C, 1996, INT J CANCER, V69, P92, DOI 10.1002/(SICI)1097-0215(19960422)69:2<92::AID-IJC4>3.3.CO;2-I; GOODNIGHT J, 1995, J BIOL CHEM, V270, P9991, DOI 10.1074/jbc.270.17.9991; HUG H, 1993, BIOCHEM J, V291, P329, DOI 10.1042/bj2910329; Kiley SC, 1997, CELL GROWTH DIFFER, V8, P221; KRAFT AS, 1983, NATURE, V301, P621, DOI 10.1038/301621a0; LAKOWICZ JR, 1991, REV SCI INSTRUM, V62, P1727, DOI 10.1063/1.1142413; NG TK, UNPUB; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; OLIVIER AR, 1994, J BIOL CHEM, V269, P2758; SANDERS R, 1995, ANAL BIOCHEM, V227, P302, DOI 10.1006/abio.1995.1285; Schneider PC, 1997, REV SCI INSTRUM, V68, P4107, DOI 10.1063/1.1148354; SO PTC, 1995, BIOIMAGING, V3, P1; Squire A, 1999, J MICROSC-OXFORD, V193, P36, DOI 10.1046/j.1365-2818.1999.00427.x	21	256	267	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	1999	283	5410					2085	2089		10.1126/science.283.5410.2085	http://dx.doi.org/10.1126/science.283.5410.2085			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180DH	10092232				2022-12-28	WOS:000079369800047
J	Ji, Q; Luo, ZX; Ji, SA				Ji, Q; Luo, ZX; Ji, SA			A Chinese triconodont mammal and mosaic evolution of the mammalian skeleton	NATURE			English	Article							SHOULDER	Here we describe a new triconodont mammal from the Late Jurassic/Early Cretaceous period of Liaoning, China. This new mammal is represented by the best-preserved skeleton known so far for triconodonts which form one of the earliest Mesozoic mammalian groups with high diversity. The postcranial skeleton of this new triconodont shows a mosaic of characters, including a primitive pelvic girdle and hindlimb but a very derived pectoral girdle that is closely comparable to those of derived therians. Given the basal position of this taxon in mammalian phylogeny, its derived pectoral girdle indicates that homoplasies (similarities resulting from independent evolution among unrelated lineages) are as common in the postcranial skeleton as they are in the skull and dentition in the evolution of Mesozoic mammals. Limb structures of the new triconodont indicate that it was probably a ground-dwelling animal.	Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA 15213 USA; China Univ Geosci, Beijing 100083, Peoples R China; Natl Geol Museum China, Beijing 100034, Peoples R China	China University of Geosciences	Luo, ZX (corresponding author), Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA 15213 USA.	louz@clpgh.org	Luo, Zhe-XI/AAU-2263-2021					Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Cifelli RL, 1998, J VERTEBR PALEONTOL, V18, P237, DOI 10.1080/02724634.1998.10011048; Crompton A.W., 1974, Bulletin Br Mus nat Hist (Geol), V24, P399; FOX RC, 1976, CAN J EARTH SCI, V13, P1105, DOI 10.1139/e76-113; Hopson James A., 1994, Short Courses in Paleontology, V7, P190; Hou LH, 1996, SCIENCE, V274, P1164, DOI 10.1126/science.274.5290.1164; Hu YM, 1997, NATURE, V390, P137, DOI 10.1038/36505; Jenkins F.A., 1971, B PEABODY MUS NAT HI, V36, P1, DOI DOI 10.1671/0272-4634(2008)28[445:NMOMBC]2.0CO;2; Jenkins F.A. Jr, 1979, P74; JENKINS FA, 1976, PHILOS T ROY SOC B, V273, P387, DOI 10.1098/rstb.1976.0022; JENKINS FA, 1979, J ZOOL, V188, P379; JENKINS FA, 1988, J VERTEBR PALEONTOL, V6, P1; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Ji Q., 1996, CHINESE GEOL, V233, P30; KEMP TS, 1983, ZOOL J LINN SOC-LOND, V77, P353, DOI 10.1111/j.1096-3642.1983.tb00859.x; KERMACK KA, 1973, ZOOL J LINN SOC-LOND, V53, P87, DOI 10.1111/j.1096-3642.1973.tb00786.x; Kielan-Jaworowska Z, 1998, ACTA PALAEONTOL POL, V43, P413; Kielan-Jaworowska Zofia, 1994, Fossils and Strata, V36, P1; KIELANJAWOROWSK.Z, 1997, LETHAIA, V29, P249; Klima M., 1973, Advances Anat Embryol Cell Biol, V47, P1; KRAUSE D W, 1983, Bulletin of the Museum of Comparative Zoology, V150, P199; LUO Z, 1994, SHADOW DINOSAURS EAR, P980; MCLEOD N, 1993, AM J SCI, V293, P300; Rougier Guillermo W., 1996, American Museum Novitates, V3183, P1; ROUGIER GW, 1993, THESIS U NACIONAL BU; ROUGLER GW, 1993, THESIS U NACIONAL BU; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; SERENO PC, 1995, NATURE, V377, P144, DOI 10.1038/377144a0; Sigogneau-Russell Denise, 1995, Acta Palaeontologica Polonica, V40, P149; SIMPSON G. G., 1928, CATALOGUE MESOZOIC M; SUN A, 1985, VERTEBRAT PALASIATIC, V23, P136	31	153	182	7	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	1999	398	6725					326	330						5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180DF	10192332				2022-12-28	WOS:000079369600049
J	Smetana, GW				Smetana, GW			Current concepts - Preoperative pulmonary evaluation	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							DEEP BREATHING EXERCISES; OBSTRUCTIVE LUNG-DISEASE; ARTERY BYPASS PATIENTS; ABDOMINAL-SURGERY; RISK-FACTORS; INCENTIVE SPIROMETRY; RESPIRATORY-FAILURE; SURGICAL-PROCEDURES; THORACIC-SURGERY; PREDICTIVE VALUE		Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; Harvard Med Sch, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Smetana, GW (corresponding author), Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, 330 Brookline Ave, Boston, MA 02215 USA.							*AM COLL PHYS, 1990, ANN INTERN MED, V112, P793; APPLEBERG M, 1974, BRIT J SURG, V61, P57, DOI 10.1002/bjs.1800610114; Ballantyne JC, 1998, ANESTH ANALG, V86, P598, DOI 10.1097/00000539-199803000-00032; Bando K, 1997, ANN THORAC SURG, V63, P1026, DOI 10.1016/S0003-4975(96)01279-9; Berg H, 1997, ACTA ANAESTH SCAND, V41, P1095, DOI 10.1111/j.1399-6576.1997.tb04851.x; BONE R, 1994, CHEST, V105, P1411; BROOKSBRUNN JA, 1995, HEART LUNG, V24, P94, DOI 10.1016/S0147-9563(05)80004-4; BrooksBrunn JA, 1997, CHEST, V111, P564, DOI 10.1378/chest.111.3.564; CAIN HD, 1979, CHEST, V76, P130, DOI 10.1378/chest.76.2.130; CALLIGARO KD, 1993, J VASC SURG, V18, P914, DOI 10.1016/0741-5214(93)90545-W; CASTILLO R, 1985, ARCH PHYS MED REHAB, V66, P376; CELLI BR, 1984, AM REV RESPIR DIS, V130, P12; COLLINS CD, 1968, BMJ-BRIT MED J, V1, P401, DOI 10.1136/bmj.1.5589.401; CRISTOPHERSON R, 1993, ANESTHESIOLOGY, V79, P422; CUSCHIERI RJ, 1985, BRIT J SURG, V72, P495, DOI 10.1002/bjs.1800720631; DALES RE, 1993, CHEST, V104, P155, DOI 10.1378/chest.104.1.155; DJOKOVIC JL, 1979, JAMA-J AM MED ASSOC, V242, P2301, DOI 10.1001/jama.242.21.2301; EPSTEIN SK, 1993, CHEST, V104, P694, DOI 10.1378/chest.104.3.694; FOGH J, 1987, ACTA ANAESTH SCAND, V31, P717, DOI 10.1111/j.1399-6576.1987.tb02651.x; FRAGOSO CAV, 1993, AM REV RESPIR DIS, V147, pS40, DOI 10.1164/ajrccm/147.6_Pt_2.S40; GARIBALDI RA, 1981, AM J MED, V70, P677, DOI 10.1016/0002-9343(81)90595-7; GASS GD, 1986, CHEST, V89, P127, DOI 10.1378/chest.89.1.127; GERSON MC, 1990, AM J MED, V88, P101, DOI 10.1016/0002-9343(90)90456-N; GOLD M I, 1963, Anesth Analg, V42, P238; GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601; GRACEY DR, 1979, CHEST, V76, P123, DOI 10.1378/chest.76.2.123; HALL JC, 1991, CHEST, V99, P923, DOI 10.1378/chest.99.4.923; Jacob B, 1997, Conn Med, V61, P327; KABALIN CS, 1995, ARCH INTERN MED, V155, P1379, DOI 10.1001/archinte.155.13.1379; KEARNEY DJ, 1994, CHEST, V105, P753, DOI 10.1378/chest.105.3.753; KISPERT JF, 1992, AM SURGEON, V58, P491; Kocabas A, 1996, RESP MED, V90, P25, DOI 10.1016/S0954-6111(96)90241-3; KROENKE K, 1993, CHEST, V104, P1445, DOI 10.1378/chest.104.5.1445; KROENKE K, 1992, ARCH INTERN MED, V152, P967, DOI 10.1001/archinte.152.5.967; Lawrence VA, 1995, J GEN INTERN MED, V10, P671, DOI 10.1007/BF02602761; Lawrence VA, 1996, CHEST, V110, P744, DOI 10.1378/chest.110.3.744; LAWRENCE VA, 1989, ARCH INTERN MED, V149, P280, DOI 10.1001/archinte.149.2.280; LAZLO G, 1973, BRIT J SURG, V60, P129; MARX GF, 1973, ANESTHESIOLOGY, V39, P54, DOI 10.1097/00000542-197307000-00010; MENDELLA LA, 1982, ANN INTERN MED, V96, P17, DOI 10.7326/0003-4819-96-1-17; MEYERS WC, 1991, NEW ENGL J MED, V324, P1073; MILLEDGE JS, 1975, BRIT MED J, V3, P670, DOI 10.1136/bmj.3.5985.670; Morton HJV, 1944, LANCET, V1, P368; Moulton MJ, 1996, CIRCULATION, V94, P87; *NAT HEART LUNG BL, 1991, J ALLERGY CLIN IMM S, V88, P523; PASULKA PS, 1986, ANN INTERN MED, V104, P540, DOI 10.7326/0003-4819-104-4-540; PEDERSEN T, 1994, DAN MED BULL, V41, P319; PEDERSEN T, 1990, ACTA ANAESTH SCAND, V34, P144, DOI 10.1111/j.1399-6576.1990.tb03059.x; PENNOCK BE, 1991, CHEST, V100, P1371, DOI 10.1378/chest.100.5.1371; PHILLIPS EH, 1994, AM SURGEON, V60, P316; PIEN LC, 1988, J ALLERGY CLIN IMMUN, V82, P696, DOI 10.1016/0091-6749(88)90985-2; POE RH, 1988, AM J MED SCI, V295, P29, DOI 10.1097/00000441-198801000-00007; READY LB, 1991, ANESTHESIOLOGY, V75, P452, DOI 10.1097/00000542-199109000-00012; RPOOLER HE, 1949, BRIT MED J, V9, P1200; *SO SURG CLUB, 1991, NEW ENGL J MED, V325, P1517; STEIN M, 1970, J AMER MED ASSOC, V211, P787, DOI 10.1001/jama.211.5.787; STEIN M, 1962, JAMA-J AM MED ASSOC, V181, P765, DOI 10.1001/jama.1962.03050350027006; STOCK MC, 1985, CHEST, V87, P151, DOI 10.1378/chest.87.2.151; SVENSSON LG, 1991, J VASC SURG, V14, P271; TARHAN S, 1973, SURGERY, V74, P720; THOMAS JA, 1994, PHYS THER, V74, P3, DOI 10.1093/ptj/74.1.3; Thomas P, 1996, EUR J CARDIO-THORAC, V10, P941, DOI 10.1016/S1010-7940(96)80394-0; Warner DO, 1996, ANESTHESIOLOGY, V85, P460, DOI 10.1097/00000542-199609000-00003; WARNER MA, 1989, MAYO CLIN PROC, V64, P609, DOI 10.1016/S0025-6196(12)65337-3; WARNER MA, 1984, ANESTHESIOLOGY, V60, P380, DOI 10.1097/00000542-198404000-00022; WIGHTMAN JA, 1968, BRIT J SURG, V55, P85, DOI 10.1002/bjs.1800550202; WILLIAMSRUSSO P, 1992, ARCH INTERN MED, V152, P1209, DOI 10.1001/archinte.152.6.1209; Wolters U, 1996, BRIT J ANAESTH, V77, P217, DOI 10.1093/bja/77.2.217; WONG DH, 1995, ANESTH ANALG, V80, P276, DOI 10.1097/00000539-199502000-00013; YEAGER MP, 1987, ANESTHESIOLOGY, V66, P729, DOI 10.1097/00000542-198706000-00004	70	285	305	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 25	1999	340	12					937	944		10.1056/NEJM199903253401207	http://dx.doi.org/10.1056/NEJM199903253401207			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180AM	10089188				2022-12-28	WOS:000079362600007
J	Fox, N				Fox, N			A communication headache	BRITISH MEDICAL JOURNAL			English	Article																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 20	1999	318	7186					802	802		10.1136/bmj.318.7186.802	http://dx.doi.org/10.1136/bmj.318.7186.802			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BX	10082713	Green Published			2022-12-28	WOS:000079421700039
J	Liaudet, L; Buclin, T; Jaccard, C; Eckert, P				Liaudet, L; Buclin, T; Jaccard, C; Eckert, P			Severe ergotism associated with interaction between ritonavir and ergotamine	BRITISH MEDICAL JOURNAL			English	Letter									Univ Lausanne Hosp, Dept Internal Med, Serv B, Div Crit Care, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Liaudet, L (corresponding author), Univ Lausanne Hosp, Dept Internal Med, Serv B, Div Crit Care, CH-1011 Lausanne, Switzerland.		Liaudet, Lucas/E-1322-2017; Buclin, Thierry/P-1640-2014	Liaudet, Lucas/0000-0003-2670-4930; Buclin, Thierry/0000-0003-0639-5536				*ABB LAB, 1997, NORV TECHN INF; BONGARD O, 1991, VASA-J VASCULAR DIS, V20, P153; CaballeroGranado FJ, 1997, ANTIMICROB AGENTS CH, V41, P1207, DOI 10.1128/AAC.41.5.1207; Heylen R, 1997, GENITOURIN MED, V73, P5; Horowitz RS, 1996, ARCH INTERN MED, V156, P456, DOI 10.1001/archinte.156.4.456	5	30	30	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 20	1999	318	7186					771	771		10.1136/bmj.318.7186.771	http://dx.doi.org/10.1136/bmj.318.7186.771			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BX	10082701	Green Published			2022-12-28	WOS:000079421700026
J	Smith, PC				Smith, PC			Setting budgets for general practice in the new NHS	BRITISH MEDICAL JOURNAL			English	Article							PERFORMANCE EVALUATION; RATES		Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England	University of York - UK	Smith, PC (corresponding author), Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England.	pcs1@york.ac.uk		Smith, Peter/0000-0003-0058-7588				Argyris C., 1952, IMPACT BUDGETS PEOPL; *AUD COMM, 1996, WHAT DOCT ORD STUD G; Bachmann MO, 1996, BRIT MED J, V313, P1054; BAINES D, 1997, PRESCRIBING BUDGETS; BEVAN G, 1998, SURVEY BUDGETARY RIS; BRIERS M, 1990, ACCOUNT ORG SOC, V15, P373, DOI 10.1016/0361-3682(90)90024-O; Buckley A., 1972, ACCOUNTING BUSINESS, V32, P137; CRUMP BJ, 1991, BRIT MED J, V302, P1582, DOI 10.1136/bmj.302.6792.1582; DIXON J, 1995, BRIT MED J, V311, P727, DOI 10.1136/bmj.311.7007.727; DIXON J, 1994, BRIT MED J, V309, P304; Ellwood S.M., 1996, FINANCIAL ACCOUNTABI, V12, P281; Emmanuel CR, 1990, ACCOUNTING MANAGEMEN; GLAZER J, 1995, EUR ECON REV, V39, P781, DOI 10.1016/0014-2921(94)00085-E; Glennerster H., 1992, IMPLEMENTING GP FUND; GOODWIN N, 1996, HLTH CARE UK 1995 96; GOVINDARAJAN V, 1984, ACCOUNT ORG SOC, V9, P125, DOI 10.1016/0361-3682(84)90002-3; Hofstede G.H., 1968, GAME BUDGET CONTROL; HOPWOOD AG, 1972, J ACCOUNT RES, V10, P156; Macintosh N. B, 1985, SOCIAL SOFTWARE ACCO; MARTIN S, 1997, 153 U YORK CTR HLTH; MATSAGANIS M, 1994, J HEALTH ECON, V13, P31, DOI 10.1016/0167-6296(94)90003-5; MAYS N, 1997, TOTAL PURCHASING PRO; National Audit Office, 1994, GEN PRACT FUNDH ENGL; Newhouse J P, 1989, Health Care Financ Rev, V10, P41; *NHS EX, 1997, HCHS REV RES ALL HLT; *NHS EX RES ALL FU, 1988, 1988 89 HLTH AUTH RE; NOVE A, 1980, SOVIET EC SYSTEM; OTLEY DT, 1978, J ACCOUNTING RES, V16, P122, DOI 10.2307/2490414; PETCHEY R, 1995, LANCET, V346, P1139, DOI 10.1016/S0140-6736(95)91805-1; Pollack H, 1996, MANAGE SCI, V42, P642, DOI 10.1287/mnsc.42.5.642; ROLAND MO, 1990, BRIT MED J, V301, P98, DOI 10.1136/bmj.301.6743.98; SMITH P, 1997, HLTH EC SERIES; *UK DEP HLTH, 1997, NEW NHS; WALLEY T, 1995, PHARMACOECONOMICS, V7, P320, DOI 10.2165/00019053-199507040-00006	34	12	12	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 20	1999	318	7186					776	779		10.1136/bmj.318.7186.776	http://dx.doi.org/10.1136/bmj.318.7186.776			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	181BX	10082704	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000079421700028
J	Supattapone, S; Bosque, P; Muramoto, T; Wille, H; Aagaard, C; Peretz, D; Nguyen, HOB; Heinrich, C; Torchia, M; Safar, J; Cohen, FE; DeArmond, SJ; Prusiner, SB; Scott, M				Supattapone, S; Bosque, P; Muramoto, T; Wille, H; Aagaard, C; Peretz, D; Nguyen, HOB; Heinrich, C; Torchia, M; Safar, J; Cohen, FE; DeArmond, SJ; Prusiner, SB; Scott, M			Prion protein of 106 residues creates an artificial transmission barrier for prion replication in transgenic mice	CELL			English	Article							SCRAPIE ISOFORM; CULTURED-CELLS; BIOCHEMICAL-PROPERTIES; SECONDARY STRUCTURE; CELLULAR PRP; N-TERMINUS; PROPAGATION; INFECTIVITY; DISEASE; MUTANT	A redacted prion protein (PrP) of 106 amino acids with two large deletions was expressed in transgenic (Tg) mice deficient for wild-type (wt) PrP (Prnp(0/0)) and supported prion propagation. RML prions containing full-length PrPSc produced disease in Tg(PrP106)Prnp(0/0) mice after similar to 300 days, while transmission of RML106 prions containing PrP(Sc)106 created disease in Tg(PrP106) Prnp(0/0) mice after only similar to 65 days on repeated passage. This artificial transmission barrier for the passage of RML prions was diminished by the coexpression of wt MoPrPC in Tg(PrP106)Prnp(+/0) mice that developed scrapie in similar to 165 days, suggesting that wt MoPrP acts in trans to accelerate replication of RML106 prions. Purified PrP(Sc)106 was protease resistant, formed filaments, and was insoluble in nondenaturing detergents. The unique features of RML106 prions offer insights into the mechanism of prion replication, and the small size of PrP(Sc)106 should facilitate structural analysis.	Univ Calif San Francisco, Inst Neurodegenerat Dis, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Scott, M (corresponding author), Univ Calif San Francisco, Inst Neurodegenerat Dis, Dept Neurol, San Francisco, CA 94143 USA.		Safar, Jiri G/G-6512-2013; Wille, Holger/C-2280-2008	Wille, Holger/0000-0001-5102-8706				BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BUELER H, 1994, MOL MED, V1, P19; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; CARLSON GA, 1986, CELL, V46, P503, DOI 10.1016/0092-8674(86)90875-5; CARLSON GA, 1994, P NATL ACAD SCI USA, V91, P5690, DOI 10.1073/pnas.91.12.5690; CHANDLER RL, 1961, LANCET, V1, P1378; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; GASSET M, 1993, P NATL ACAD SCI USA, V90, P1, DOI 10.1073/pnas.90.1.1; HUANG ZW, 1994, P NATL ACAD SCI USA, V91, P7139, DOI 10.1073/pnas.91.15.7139; James TL, 1997, P NATL ACAD SCI USA, V94, P10086, DOI 10.1073/pnas.94.19.10086; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Lehmann S, 1996, P NATL ACAD SCI USA, V93, P5610, DOI 10.1073/pnas.93.11.5610; Lehmann S, 1996, J BIOL CHEM, V271, P1633, DOI 10.1074/jbc.271.3.1633; MASTERS CL, 1978, BRAIN, V101, P333, DOI 10.1093/brain/101.2.333; Mehlhorn I, 1996, BIOCHEMISTRY-US, V35, P5528, DOI 10.1021/bi952965e; Muramoto T, 1997, NAT MED, V3, P750, DOI 10.1038/nm0797-750; Muramoto T, 1996, P NATL ACAD SCI USA, V93, P15457, DOI 10.1073/pnas.93.26.15457; Pattison I. H., 1965, NINDB MONOGRAPH, V2, P249; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; PRUSINER SB, 1982, BIOCHEMISTRY-US, V21, P6942, DOI 10.1021/bi00269a050; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Riesner D, 1996, J VIROL, V70, P1714, DOI 10.1128/JVI.70.3.1714-1722.1996; ROGERS M, 1993, P NATL ACAD SCI USA, V90, P3182, DOI 10.1073/pnas.90.8.3182; SCOTT M, 1993, CELL, V73, P979, DOI 10.1016/0092-8674(93)90275-U; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; Scott MR, 1997, J VIROL, V71, P9032, DOI 10.1128/JVI.71.12.9032-9044.1997; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; TARABOULOS A, 1992, P NATL ACAD SCI USA, V89, P7620, DOI 10.1073/pnas.89.16.7620; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Telling GC, 1996, GENE DEV, V10, P1736, DOI 10.1101/gad.10.14.1736; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Wille H, 1999, BIOPHYS J, V76, P1048, DOI 10.1016/S0006-3495(99)77270-X; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998	39	181	185	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 19	1999	96	6					869	878		10.1016/S0092-8674(00)80596-6	http://dx.doi.org/10.1016/S0092-8674(00)80596-6			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	178ZY	10102274	Bronze			2022-12-28	WOS:000079300100013
J	Aitken, RJ; Thompson, MR; Smith, JAE; Radcliffe, AG; Stamatakis, JD; Steele, RJC				Aitken, RJ; Thompson, MR; Smith, JAE; Radcliffe, AG; Stamatakis, JD; Steele, RJC			Training in large bowel cancer surgery: observations from three prospective regional United Kingdom audits	BRITISH MEDICAL JOURNAL			English	Article									Eastern Gen Hosp, Edinburgh EH6 7LN, Midlothian, Scotland; Queen Alexandra Hosp, Portsmouth PO6 3LY, Hants, England; Wessex Canc Intelligence Unit, Winchester SO22 5DH, Hants, England; Llandough Hosp, Penarth CF64 2XX, S Glam, Wales; Prince Wales Hosp, Bridgend CF31 1RQ, Wales; Queens Med Ctr, Nottingham NG1 2UH, England	Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital; University of Nottingham	Aitken, RJ (corresponding author), Queen Elizabeth II Med Ctr, Dept Surg, 2nd Floor,M Block, Nedlands, WA 6009, Australia.			Steele, Robert JC/0000-0003-4248-6785				*AM SOC COL RECT S, 1996, DIR RES TRAIN PROGR; CALMAN R, 1993, REPORT WORKING GROUP; GRAY AJ, 1997, REPORT NATL CONFIDEN; *JOINT COMM HIGH S, 1998, CURR ORG SYLL HIGH S; MCARDLE CS, 1991, BRIT MED J, V302, P1501, DOI 10.1136/bmj.302.6791.1501	5	23	23	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 13	1999	318	7185					702	703						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182JK	10074013				2022-12-28	WOS:000079495700023
J	Jolly, K; Bradley, F; Sharp, S; Smith, H; Thompson, S; Kinmonth, AL; Mant, D				Jolly, K; Bradley, F; Sharp, S; Smith, H; Thompson, S; Kinmonth, AL; Mant, D		SHIP Collaborative Grp	Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of the Southampton heart integrated care project (SHIP)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DISEASE	Objective To assess the effectiveness of a programme to coordinate and support follow up care in general practice after a hospital diagnosis of myocardial infarction or angina. Design Randomised controlled trial; stratified random allocation of practices to intervention and control groups. Setting All 67 practices in Southampton and south west Hampshire, England. Subjects 597 adult patients (422 with myocardial infarction and 175 with a new diagnosis of angina) who were recruited during hospital admission or attendance at a chest pain clinic between April 1995 and September 1996. Intervention Programme to coordinate preventive care led by specialist liaison nurses which sought to improve communication between hospital and general practice and to encourage general practice nurses to provide structured follow up. Main outcome measures Serum total cholesterol concentration, blood pressure, distance walked in 6 minutes, confirmed smoking cessation, and body mass index measured at 1 year follow up. Results Of 559 surviving patients at 1 year, 502 (90%) were followed up. There was no significant difference between the intervention and control groups in smoking (cotinine validated quit rate 19% v 20%), lipid concentrations (serum total cholesterol 5.80 v 5.93 mmol/l), blood pressure (diastolic pressure 84 v 85 mm Hg), or fitness (distance walked in 6 minutes 443 v 433 m). Body mass index was slightly lower in the intervention group (27.4 v 28.2; P = 0.08). Conclusions Although the programme was effective in promoting follow up in general practice, it did not improve health outcome. Simply coordinating and supporting existing NHS care is insufficient. Ischaemic heart disease is a chronic condition which requires the same systematic approach to secondary prevention applied in other chronic conditions such as diabetes mellitus.	Univ Southampton, Aldermoor Hlth Ctr, Southampton SO16 5ST, Hants, England; London Sch Hyg & Trop Med, Med Stat Unit, London WC1E 7HT, England; Hammersmith Hosp, Imperial Coll, Sch Med, Dept Med Stat & Evaluat, London W12 0NN, England; Univ Cambridge, Inst Publ Hlth, Gen Practice & Primary Care Res Unit, Cambridge CB2 2SR, England	University of Southampton; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; University of Cambridge	Jolly, K (corresponding author), Univ Southampton, Aldermoor Hlth Ctr, Southampton SO16 5ST, Hants, England.		Mant, David CA/C-7763-2009; Jolly, Kate/AAA-1341-2019; Smith, Helen E/M-2449-2016	Jolly, Kate/0000-0002-6224-2115; Smith, Helen E/0000-0003-1883-6124				ADDINGTONHALL JM, 1992, BRIT MED J, V305, P1317, DOI 10.1136/bmj.305.6865.1317; APFEL J, 1996, DIABET MED S4, V13, P65; *AUD COMM, 1995, DEAR OUR HEARTS COMM; Bowker TJ, 1996, HEART, V75, P334, DOI 10.1136/hrt.75.4.334; Bradley F, 1997, FAM PRACT, V14, P220, DOI 10.1093/fampra/14.3.220; Campbell NC, 1998, BMJ-BRIT MED J, V316, P1434, DOI 10.1136/bmj.316.7142.1434; Carney AJ, 1996, BRIT MED J, V312, P846; CUPPLES ME, 1994, BRIT MED J, V309, P993, DOI 10.1136/bmj.309.6960.993; DONNER A, 1988, APPL STAT, V47, P95; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; Kerry SM, 1998, BMJ-BRIT MED J, V316, P54, DOI 10.1136/bmj.316.7124.54; MARKS L, 1996, COUNTING COST REAL I, P25; MASON P, 1994, HELPING PEOPLE CHANG; Moher M, 1997, BMJ-BRIT MED J, V315, P69, DOI 10.1136/bmj.315.7100.69; *SHIP COLL GROUP, IN PRESS FAM PRACT; van der Weijden T, 1998, BMJ-BRIT MED J, V316, P1400, DOI 10.1136/bmj.316.7142.1400; Wiles R, 1998, SOC SCI MED, V46, P1477, DOI 10.1016/S0277-9536(97)10140-X; Wiles R, 1997, J ADV NURS, V26, P729, DOI 10.1046/j.1365-2648.1997.00409.x; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; WRIGHT L, 1998, BR J COMM NURS, V3, P118; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	21	158	158	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	1999	318	7185					706	711						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182JK	10074017				2022-12-28	WOS:000079495700026
J	Hamada, F; Tomoyasu, Y; Takatsu, Y; Nakamura, M; Nagai, S; Suzuki, A; Fujita, F; Shibuya, H; Toyoshima, K; Ueno, N; Akiyama, T				Hamada, F; Tomoyasu, Y; Takatsu, Y; Nakamura, M; Nagai, S; Suzuki, A; Fujita, F; Shibuya, H; Toyoshima, K; Ueno, N; Akiyama, T			Negative regulation of Wingless signaling by D-axin, a Drosophila homolog of axin	SCIENCE			English	Article							BETA-CATENIN; LIMB DEVELOPMENT; CELL FATES; EXPRESSION; MELANOGASTER; ARMADILLO; PROTEIN; MOSAICS; ABDOMEN; CANCER	Wnt/Wingless directs many cell fates during development. Wnt/Wingless signaling increases the amount of beta-catenin/Armadillo, which in turn activates gene transcription. Here the Drosophila protein D-Axin was shown to interact with Armadillo and D-APC. Mutation of d-axin resulted in the accumulation of cytoplasmic Armadillo and one of the Wingless target gene products, Distal-less. Ectopic expression of d-axin inhibited Wingless signaling. Hence, D-Axin negatively regulates Wingless signaling by down-regulating the Level of Armadillo. These results establish the importance of the Axin family of proteins in Wnt/Wingless signaling in Drosophila.	Osaka Univ, Res Inst Microbial Dis, Dept Oncogene Res, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, PRESTO, Inheritance & Variat Precursory Res Embryon Sci &, Kyoto, Japan; Natl Inst Basic Biol, Dept Dev Biol, Okazaki, Aichi 4448585, Japan; Osaka Med Ctr Canc & Cardiovasc Dis, Higashinari Ku, Osaka 5378511, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Dept Mol & Genet Informat, Bunkyo Ku, Tokyo 1130032, Japan	Osaka University; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Osaka Medical Center for Cancer & Cardiovascular Diseases; University of Tokyo	Akiyama, T (corresponding author), Osaka Univ, Res Inst Microbial Dis, Dept Oncogene Res, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.		Tomoyasu, Yoshinori/D-3061-2017	Tomoyasu, Yoshinori/0000-0001-9824-3454; Ueno, Naoto/0000-0002-8375-2317				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Chou TB, 1996, GENETICS, V144, P1673; HAMADA F, UNPUB; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Hayashi S, 1997, P NATL ACAD SCI USA, V94, P242, DOI 10.1073/pnas.94.1.242; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Irvine KD, 1997, CURR OPIN CELL BIOL, V9, P867, DOI 10.1016/S0955-0674(97)80090-7; Itoh K, 1998, CURR BIOL, V8, P591, DOI 10.1016/S0960-9822(98)70229-5; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Jiang J, 1996, CELL, V86, P401, DOI 10.1016/S0092-8674(00)80113-0; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nakamura T, 1998, GENES CELLS, V3, P395, DOI 10.1046/j.1365-2443.1998.00198.x; Neumann CJ, 1997, DEVELOPMENT, V124, P871; PEIFER M, 1994, DEVELOPMENT, V120, P369; Penton A, 1996, NATURE, V382, P162, DOI 10.1038/382162a0; ROBERTSON HM, 1988, GENETICS, V118, P461; Rulifson EJ, 1996, NATURE, V384, P72, DOI 10.1038/384072a0; Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; Shirras AD, 1996, DEV BIOL, V175, P24, DOI 10.1006/dbio.1996.0092; SIEGFRIED E, 1994, BIOESSAYS, V16, P395, DOI 10.1002/bies.950160607; SIEGFRIED E, 1994, NATURE, V367, P76, DOI 10.1038/367076a0; VACHON G, 1992, CELL, V71, P437, DOI 10.1016/0092-8674(92)90513-C; Van der Meer JM., 1977, DROS INFORM SERV, V52, P160; XU T, 1993, DEVELOPMENT, V117, P1223; Yamamoto H, 1998, MOL CELL BIOL, V18, P2867, DOI 10.1128/MCB.18.5.2867; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	34	168	173	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	1999	283	5408					1739	1742		10.1126/science.283.5408.1739	http://dx.doi.org/10.1126/science.283.5408.1739			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175PF	10073940				2022-12-28	WOS:000079102800053
J	Vosshall, LB; Amrein, H; Morozov, PS; Rzhetsky, A; Axel, R				Vosshall, LB; Amrein, H; Morozov, PS; Rzhetsky, A; Axel, R			A spatial map of olfactory receptor expression in the Drosophila antenna	CELL			English	Article							PUTATIVE PHEROMONE RECEPTORS; MELANOGASTER MEIGEN DIPTERA; ODORANT-BINDING PROTEINS; MITRAL TUFTED CELLS; C-ELEGANS; SENSORY PROJECTIONS; MULTIGENE FAMILY; GENE-EXPRESSION; PHYSICAL MAP; BULB	Insects provide an attractive system for the study of olfactory sensory perception. We have identified a novel family of seven transmembrane domain proteins, encoded by 100 to 200 genes, that is likely to represent the family of Drosophila odorant receptors. Members of this gene family are expressed in topographically defined subpopulations of olfactory sensory neurons in either the antenna or the maxillary palp. Sensory neurons express different complements of receptor genes, such that individual neurons are functionally distinct. The isolation of candidate odorant receptor genes along with a genetic analysis of olfactory-driven behavior in insects may ultimately afford a system to understand the mechanistic link between odor recognition and behavior.	Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Columbia Genome Ctr, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University	Axel, R (corresponding author), Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	ra27@columbia.edu	rzhetsky, andrey/B-6118-2012; Amrein, Hubert/AAG-9480-2021	rzhetsky, andrey/0000-0001-6959-7405; Amrein, Hubert/0000-0001-8799-7250; Vosshall, Leslie/0000-0002-6060-8099; Axel, Richard/0000-0002-3141-4076	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH050733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS029832] Funding Source: NIH RePORTER; NIMH NIH HHS [5P50 MH50733-05] Funding Source: Medline; NINDS NIH HHS [NS29832-07] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AMREIN H, 1988, CELL, V55, P1025, DOI 10.1016/0092-8674(88)90247-4; AMREIN H, 1988, CELL, V58, P1989; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; Bargmann CI, 1998, ANNU REV NEUROSCI, V21, P279, DOI 10.1146/annurev.neuro.21.1.279; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; BENARIE N, 1994, HUM MOL GENET, V3, P229, DOI 10.1093/hmg/3.2.229; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Carlson JR, 1996, TRENDS GENET, V12, P175, DOI 10.1016/0168-9525(96)10015-9; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Doe CQ, 1996, CURR OPIN NEUROBIOL, V6, P18, DOI 10.1016/S0959-4388(96)80004-3; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Grillenzoni N, 1998, DEVELOPMENT, V125, P3563; HARTL DL, 1994, P NATL ACAD SCI USA, V91, P6824, DOI 10.1073/pnas.91.15.6824; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; IMAMURA K, 1992, J NEUROPHYSIOL, V68, P1986, DOI 10.1152/jn.1992.68.6.1986; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; KATOH K, 1993, J NEUROPHYSIOL, V70, P2161, DOI 10.1152/jn.1993.70.5.2161; KAUER JS, 1987, BRAIN RES, V418, P255, DOI 10.1016/0006-8993(87)90093-X; Kim MS, 1998, GENETICS, V150, P711; Kimmerly W, 1996, GENOME RES, V6, P414, DOI 10.1101/gr.6.5.414; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANCET D, 1982, P NATL ACAD SCI-BIOL, V79, P670, DOI 10.1073/pnas.79.2.670; LEVY NS, 1991, J STEROID BIOCHEM, V39, P633, DOI 10.1016/0960-0760(91)90262-4; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; MERRITT DJ, 1995, J NEUROSCI, V15, P1755, DOI 10.1523/JNEUROSCI.15-03-01755.1995; Mitchell R, 1998, NATURE, V392, P411, DOI 10.1038/32937; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MORI K, 1992, J NEUROPHYSIOL, V67, P786, DOI 10.1152/jn.1992.67.3.786; NGAI J, 1993, CELL, V72, P667, DOI 10.1016/0092-8674(93)90396-8; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; PELOSI P, 1994, CRIT REV BIOCHEM MOL, V29, P199, DOI 10.3109/10409239409086801; PERSSON B, 1994, J MOL BIOL, V237, P182, DOI 10.1006/jmbi.1994.1220; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; Reddy GV, 1997, DEVELOPMENT, V124, P703; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Robertson HM, 1998, GENOME RES, V8, P449, DOI 10.1101/gr.8.5.449; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; RODRIGUES V, 1988, BRAIN RES, V453, P299, DOI 10.1016/0006-8993(88)90170-9; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; SIDDIQI O, 1987, TRENDS GENET, V3, P137, DOI 10.1016/0168-9525(87)90204-6; SIDENKIAMOS I, 1990, NUCLEIC ACIDS RES, V18, P6261, DOI 10.1093/nar/18.21.6261; SINGH RN, 1985, INT J INSECT MORPHOL, V14, P291; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; VENKATESH S, 1984, INT J INSECT MORPHOL, V13, P51, DOI 10.1016/0020-7322(84)90032-1; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9	63	843	930	11	139	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	1999	96	5					725	736		10.1016/S0092-8674(00)80582-6	http://dx.doi.org/10.1016/S0092-8674(00)80582-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	174TB	10089887	Bronze			2022-12-28	WOS:000079050100015
J	Aithal, GP; Day, CP; Kesteven, PJL; Daly, AK				Aithal, GP; Day, CP; Kesteven, PJL; Daly, AK			Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications	LANCET			English	Article							(S)-WARFARIN; EXPRESSION; METABOLISM	Background The cytochrome P450 CYP2C9 is responsible for the metabolism of S-warfarin. Two known allelic variants CYP2C9*2 and CYP2C9*3 differ from the wild type CYP2C9*1 by a single aminoacid substitution in each case. The allelic variants are associated with impaired hydroxylation of S-warfarin in in-vitro expression systems. We have studied the effect of CYP2C9 polymorphism on the in-vivo warfarin dose requirement. Methods Patients with a daily warfarin dose requirement of 1.5 mg or less (low-dose group, n=36), randomly selected patients with a wide range of dose requirements from an anticoagulant clinic in north-east England (clinic control group, n=52), and 100 healthy controls from the community in the same region were studied. Genotyping for the CYP2C9*2 and CYP2C9*3 alleles was done by PCR analysis. Case notes were reviewed to assess the difficulties encountered during the induction of warfarin therapy and bleeding complications in the low-dose and clinic control groups. Findings The odds ratio for individuals with a low warfarin dose requirement having one or more CYP2C9 variant alleles compared with the normal population was 6.21 (95% CI 2.48-15.6). Patients in the low-dose group were more likely to have difficulties at the time of induction of warfarin therapy (5.97 [2.26-15.82]) and have increased risk of major bleeding complications (rate ratio 3.68 [1.43-9.50]) when compared with randomly selected clinic controls. Interpretation We have shown that there is a strong association between CYP2C9 variant alleles and low warfarin dose requirement. CYP2C9 genotyping may identify a subgroup of patients who have difficulty at induction of warfarin therapy and are potentially at a higher risk of bleeding complications.	Univ Newcastle Upon Tyne, Sch Med, Dept Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle Upon Tyne, Sch Med, Dept Pharmacol Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Daly, AK (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Dept Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	a.k.daly@newcastle.ac.uk	Day, Christopher/Z-3305-2019; Daly, Ann/H-3144-2011	Daly, Ann/0000-0002-7321-0629; Aithal, Guruprasad/0000-0003-3924-4830				Chesebro JH, 1996, ARCH INTERN MED, V156, P409; CHOONARA IA, 1986, BRIT J CLIN PHARMACO, V21, P271, DOI 10.1111/j.1365-2125.1986.tb05190.x; Crespi CL, 1997, PHARMACOGENETICS, V7, P203, DOI 10.1097/00008571-199706000-00005; Daly AK, 1996, METHOD ENZYMOL, V272, P199, DOI 10.1016/S0076-6879(96)72024-4; DOECKE CJ, 1991, AUST NZ J MED, V21, P319, DOI 10.1111/j.1445-5994.1991.tb04697.x; FINN SD, 1996, ANN INTERN MED, V124, P970; Furuya H, 1995, PHARMACOGENETICS, V5, P389, DOI 10.1097/00008571-199512000-00008; Haining RL, 1996, ARCH BIOCHEM BIOPHYS, V333, P447, DOI 10.1006/abbi.1996.0414; HALLAK HO, 1993, BRIT J CLIN PHARMACO, V35, P327, DOI 10.1111/j.1365-2125.1993.tb05703.x; JAMES AH, 1992, J CLIN PATHOL, V45, P704, DOI 10.1136/jcp.45.8.704; Kaminsky LS, 1997, PHARMACOL THERAPEUT, V73, P67, DOI 10.1016/S0163-7258(96)00140-4; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; RETTIE AE, 1994, PHARMACOGENETICS, V4, P39, DOI 10.1097/00008571-199402000-00005; Steward DJ, 1997, PHARMACOGENETICS, V7, P361, DOI 10.1097/00008571-199710000-00004; Stubbins MJ, 1996, PHARMACOGENETICS, V6, P429, DOI 10.1097/00008571-199610000-00007; WANG SL, 1995, PHARMACOGENETICS, V5, P37, DOI 10.1097/00008571-199502000-00004; 1992, DRUG THER B, V30, P77	17	980	1042	0	54	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 27	1999	353	9154					717	719		10.1016/S0140-6736(98)04474-2	http://dx.doi.org/10.1016/S0140-6736(98)04474-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173DR	10073515				2022-12-28	WOS:000078966400013
J	Ehrenfreund, P				Ehrenfreund, P			Astrophysical chemistry: Molecules on a space odyssey	SCIENCE			English	Editorial Material							EMISSION; BANDS		Austrian Acad Sci, NL-2300 RA Leiden, Netherlands; Leiden Observ, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Ehrenfreund, P (corresponding author), Austrian Acad Sci, NL-2300 RA Leiden, Netherlands.	pascale@strw.leidenuniv.nl						Bauschlicher CW, 1998, ASTROPHYS J, V509, pL125, DOI 10.1086/311782; Bernstein MP, 1999, SCIENCE, V283, P1135, DOI 10.1126/science.283.5405.1135; Boulanger F, 1998, ASTRON ASTROPHYS, V339, P194; CHYBA C, 1992, NATURE, V355, P125, DOI 10.1038/355125a0; Dwek E, 1997, ASTROPHYS J, V475, P565, DOI 10.1086/303568; Ehrenfreund P, 1996, ASTRON ASTROPHYS, V307, pL25; FinlaysonPitts BJ, 1997, SCIENCE, V276, P1045, DOI 10.1126/science.276.5315.1045; HENDECOURT L, 1996, ASTRON ASTROPHYS, V315, pL365; Kaiser RI, 1998, ASTROPHYS J, V503, P959, DOI 10.1086/306001; Mattila K, 1996, ASTRON ASTROPHYS, V315, pL353; TIELENS AGG, IN PRESS EUROPEAN SP	12	37	38	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	1999	283	5405					1123	1124		10.1126/science.283.5405.1123	http://dx.doi.org/10.1126/science.283.5405.1123			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169GD	10075570				2022-12-28	WOS:000078738400032
J	Geddes, J				Geddes, J			Prenatal and perinatal risk factors for early onset schizophrenia, affective psychosis, and reactive psychosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England	University of Oxford	Geddes, J (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England.			Geddes, John/0000-0002-5281-5960				Geddes JR, 1995, BRIT J PSYCHIAT, V167, P786, DOI 10.1192/bjp.167.6.786; Jones P, 1998, PSYCHIAT CLIN N AM, V21, P1, DOI 10.1016/S0193-953X(05)70358-0; Jones PB, 1998, AM J PSYCHIAT, V155, P355, DOI 10.1176/ajp.155.3.355; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Verdoux H, 1997, AM J PSYCHIAT, V154, P1220	6	10	10	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 13	1999	318	7181					426	426						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	168BF	10084831				2022-12-28	WOS:000078670100023
J	Whitehead, M; Drever, F				Whitehead, M; Drever, F			Short version 2 - Narrowing social inequalities in health? Analysis of trends in mortality among babies of lone mothers	BRITISH MEDICAL JOURNAL			English	Article							ACCIDENTS; CHILDREN	Objectives To examine trends in mortality among babies registered solely by their mother (lone mothers) and to compare these with trends in infant mortality for couple registrations overall and couple registrations subdivided by social class of father. Design Analysis of trends in infant death rates from 1975 to 1996 for the three groups. The data source was the national linked infant mortality file. containing all records of infant death in England and Wales linked to the respective birth records. Setting England and Wales. Participants All live births (n = 14.3 million) from 1975 to 1996; all deaths of infants from birth to 12 months of age over the same period (n = 135 800). Main outcome measures Death rates in the perinatal, neonatal, and postneonatal periods and for infancy overall. Results For the babies of lone mothers infant mortality has fallen to less than a third of the 1975 level, with a clear reduction in the gap between the mortality in these babies compared with all couple registrations: the excess mortality in solely register ed births was 79% in 1975 reducing to 33% in 1996. Most of the narrowing of the sole-couple differential was associated with the neonatal period, for which there is now no appreciable gap. For couple registrations analysed by social class of father infant death rates have more than halved in each social class from 1975 to 1996. The reductions in mortality were greater in the late 1970s and early 1990s, infant death rates in classes IV-V remained between 50% and 65% higher than in classes I-II. Differentials between social classes were largest in the postneonatal period and smallest hi the perinatal and neonatal periods. The gap in perinatal and neonatal mortality between the babies of lone mothers and couple parents in social classes IV-V has disappeared. Conclusions The differential in infant mortality between social classes still exists, whereas the differential between sole and couple registrations has decreased, showing positive progress in the reduction of inequalities. As the reduction in the differential was confined to the neonatal period these improvements may be more a reflection of healthcare factors than of factors associated with lone mothers' social and economic circumstances.	Kings Fund, Policy & Dev Div, London W1M 0AN, England; Off Natl Stat, Social & Reg Div, London SW1V 2QQ, England		Whitehead, M (corresponding author), Old Sch, Ash Magna, Whitchurch SY13 4DR, Shrops, England.							BRADSHAW J, 1998, PRIVATE LIVES PUBLIC; BRESLOW NE, 1985, BIOSTATISTICS STAT B; LEON DA, 1992, BMJ-BRIT MED J, V305, P687, DOI 10.1136/bmj.305.6855.687; MACFARLANE A, 1980, BIRTH COUNTS STAT PR; ROBERTS I, 1995, BRIT MED J, V311, P925; Shouls S., 1999, POPUL TRENDS, V95, P5; WADSWORTH J, 1983, J EPIDEMIOL COMMUN H, V37, P100, DOI 10.1136/jech.37.2.100	7	2	2	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 3	1999	318	7188					912	914						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185GV	10102854				2022-12-28	WOS:000079660500026
J	Timmermans, MCP; Hudson, A; Becraft, PW; Nelson, T				Timmermans, MCP; Hudson, A; Becraft, PW; Nelson, T			ROUGH SHEATH2: A Myb protein that represses knox homeobox genes in maize lateral organ primordia	SCIENCE			English	Article							ECTOPIC EXPRESSION; CELL FATES; BOX GENE; LEAF; KNOTTED-1; MUTATION; IDENTITY; LEAVES; BARLEY; MUTANT	The regulation of members of the knotted1-like homeobox (knox) gene family is required for the normal initiation and development of lateral organs. The maize rough sheath2 (rs2) gene, which encodes a Myb-domain protein, is expressed in Lateral organ primordia and their initials. Mutations in the rs2 gene permit ectopic expression of knox genes in leaf and floral primordia, causing a variety of developmental defects. Ectopic KNOX protein accumulation in rs2 mutants occurs in a subset of the normal rs2-expressing cells. This variegated accumulation of KNOX proteins in rs2 mutants suggests that rs2 represses knox expression through epigenetic means.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JH, Midlothian, Scotland; Iowa State Univ, Dept Zool & Genet, Ames, IA 50011 USA	Yale University; Cold Spring Harbor Laboratory; University of Edinburgh; Iowa State University	Nelson, T (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA.	timothy.nelson@yale.edu		Becraft, Philip/0000-0002-3299-2126				Brun C, 1997, TRENDS CELL BIOL, V7, P317, DOI 10.1016/S0962-8924(97)01092-1; BURR B, 1988, GENETICS, V118, P519; Chuck G, 1996, PLANT CELL, V8, P1277, DOI 10.1105/tpc.8.8.1277; Fowler JE, 1996, DEV GENET, V18, P198, DOI 10.1002/(SICI)1520-6408(1996)18:3&lt;198::AID-DVG2&gt;3.0.CO;2-4; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; Grunstein M, 1997, CURR OPIN CELL BIOL, V9, P383, DOI 10.1016/S0955-0674(97)80011-7; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; Hareven D, 1996, CELL, V84, P735, DOI 10.1016/S0092-8674(00)81051-X; JACKSON D, 1994, DEVELOPMENT, V120, P405; Jackson DP, 1991, MOL PLANT PATHOL, P163; KERSTETTER R, 1994, PLANT CELL, V6, P1877, DOI 10.1105/tpc.6.12.1877; Martin C, 1997, TRENDS GENET, V13, P67, DOI 10.1016/S0168-9525(96)10049-4; Muehlbauer GJ, 1997, DEVELOPMENT, V124, P5097; MULLER KJ, 1995, NATURE, V374, P727, DOI 10.1038/374727a0; Poethig RS., 1984, CONT PROBLEMS PLANT, P235; Scanlon MJ, 1996, DEVELOPMENT, V122, P1683; Schneeberger R, 1998, DEVELOPMENT, V125, P2857; SCHNEEBERGER RG, 1995, GENE DEV, V9, P2292, DOI 10.1101/gad.9.18.2292; Sharman BC, 1942, ANN BOT-LONDON, V6, P245, DOI 10.1093/oxfordjournals.aob.a088407; SINHA NR, 1993, GENE DEV, V7, P787, DOI 10.1101/gad.7.5.787; SMITH LG, 1992, DEVELOPMENT, V116, P21; Sommer A, 1997, CURR BIOL, V7, P357, DOI 10.1016/S0960-9822(06)00183-7; Sylvester AW, 1996, ANNU REV CELL DEV BI, V12, P257, DOI 10.1146/annurev.cellbio.12.1.257; Timmermans MCP, 1998, DEVELOPMENT, V125, P2813; WAITES R, 1995, DEVELOPMENT, V121, P2143; Waites R, 1998, CELL, V93, P779, DOI 10.1016/S0092-8674(00)81439-7; WilliamsCarrier RE, 1997, DEVELOPMENT, V124, P3737	27	256	285	4	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	1999	284	5411					151	153		10.1126/science.284.5411.151	http://dx.doi.org/10.1126/science.284.5411.151			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182QE	10102816				2022-12-28	WOS:000079509000055
J	Andiman, W; Boucher, M; Burns, D; Bryson, Y; Farley, J; Fowler, H; Gabiano, C; Galli, L; Hutto, C; Kind, C; Korber, B; Kovacs, A; Krogstad, P; Landesman, S; Lapointe, N; Lemay, M; Lew, J; Mandelbrot, L; Mayaux, MJ; Mellins, R; Minkoff, H; Mofenson, L; Nielsen, K; Newell, ML; Pardi, G; Peavy, H; Peckham, C; Read, J; Rother, C; Rudin, C; Scott, G; Semprini, A; Shearer, W; Simonds, R; Simpson, B; Stek, A; Tovo, PA; Tuomala, R; Van Dyke, R; Weedon, J; de Martino, M; Lindsay, M; Belair, S; Chan, L; Harris, D; Kalish, L; Muenz, L; Nugent, R; Schluchter, M; Durako, S; Goodwin, S; Mitchell, R; Nourjah, P; Owen, W; Widmayer, S; Bardeguez, A; Hanson, C; Wiznia, A; Luzuriaga, K; Viscarello, R; Ho, D; Koup, R; Chen, I; Mullins, J; Wolinsky, S; Walker, B; Ammann, A; Clapp, S; McDonald, D; Fauvel, M; Hankins, C; Samson, J; Bailey, A; Giaquinto, C; Ruga, E; De Rossi, A; Truscia, D; Grosch-Worner, I; Schafer, A; Mok, J; Johnstone, F; Jiminez, J; de Alba, C; Garcia-Rodriguez, M; Bates, I; de Jose, I; Hawkins, F; Zapico, RM; Asensi-Botet, F; Otero, M; Perez-Tamarit, D; Moya, A; Galbis, M; Scherpbier, H; Boer, K; Bohlin, A; Lindgren, S; Ehrnst, A; Anzen, B; Belfrage, E; Levy, J; Alimenti, A; Barlow, P; Ferrazin, A; De Maria, A; Gotta, C; Maritati, V; Mur, A; Rovira, M; Paya, A; Coll, O; Fortuny, C; Boguna, J; Caro, MC; Canet, Y; Pardi, G; Ravizza, M; Castagna, C; Fiore, S; Guerra, B; Lanari, M; Bianchi, S; Bovicelli, L; Prati, E; Duse, M; Soresina, A; Scaravelli, G; De Santis, M; Muggiasca, M; Vigano, A; Marchisio, P; Iasci, A; Spinillo, A; Bucceri, A; Grossi, E; Rancilio, L; Della Torre, M; Dallacasa, P; Soresina, A; Pachi, A; Principi, N; Muggiasca, M; Marchisio, P; Zara, C; Vignali, M; Rossi, G; Rancilio, L; Selvaggi, L; Greco, P; Vimercati, A; Massi, G; Innocenti, T; Fiscella, A; Sansone, M; Benedetto, C; Tibaldi, C; Ziarati, N; Tadrist, B; Thevenicau, D; Gondry, J; Paulard, B; Alisy, C; Brault, D; Tordjeman, P; Mamou, J; Rozan, M; Colombani, D; Pincemaille, O; Salvetti, A; Chabanier, C; Hernandorena, X; Leroy, J; Schaal, J; Balde, P; Faucher, P; Lachassinne, E; Benoit, S; Douard, D; Hocke, C; Barjot, P; Brouard, J; Delattre, P; Stien, L; Audibert, F; Labrune, P; Vial, M; Mazy, F; Sitbon, D; Crenn-Hebert, C; Floch-Tudal, C; Akakpo, R; Daveau, C; Leblanc, A; Cesbron, P; Duval-Arnould, H; Huraux-Rendu, C; Lemerle, S; Touboul, C; Guerin, M; Maingueneau, C; Reynaud, I; Rousseau, T; Ercoil, V; Lanza, M; Denavit, M; Garnier, J; Lahsinat, K; Pia, R; Allouche, C; Nardou, M; Grall, F; May, A; Dallot, M; Lhuillier, P; Cecile, W; Mezin, R; Balde, P; Bech, A; Lobut, J; Algava, G; Dermesay, AC; Busuttil, R; Jacquemot, M; Bader-Meunier, B; Fridman, S; Codaccioni, X; Maxingue, F; Thomas, D; Alain, J; De Lumley, L; Tabaste, J; Salin, PB; Seaume, H; Guichard, A; Kebaili, K; Roussouly, C; Botto, C; De Lanete, A; Wipff, P; Cravello, L; De Boisse, P; Leclaire, M; Michel, G; Crumiere, C; Lefevre, V; Le Lorier, B; Pauly, I; Robichez, B; Seguy, D; Dehlinger, M; Rideau, F; Talon, P; Benos, P; Huret, C; Nicolas, J; Heller-Roussin, B; Saint-Leger, S; Delaporte, M; Hubert, C; De Sarcus, B; Karoubi, P; Mechinaud, F; Bertcrottiere, D; Bongain, A; Monpoux, F; De Gennes, C; Devianne, F; Nisand, I; Rousset, M; Karoubi, P; Mouchnino, G; Muray, J; Munzer, M; Quereux, C; Brossard, V; Clavier, B; Allemon, M; Rotten, D; Stephan, J; Varlet, M; Guyot, B; Narey, P; Bardinet, F; De Caunes, F; Jeny, R; Robin, M; Bouley, AR; Savey, L; Berrebi, A; Tricoire, J; Borderon, J; Fignon, A; Guillot, F; Maria, B; Broyard, A; Chitrit, Y; Firtion, G; Mandelbrot, L; Pillet, ML; Parat, S; Boissinot, C; Garec, N; Levine, M; Ottenwalter, A; Schaller, F; Vilmer, B; Courpotin, C; Brunner, C; Ciraru-Vigneron, N; Hatem-Gantzer, G; Heller-Roussin, B; Fritel, X; Wallet, A; Bouille, J; Milliez, J; Mrejen, DB; Dermer, E; Noseda, G; Bardou, D; Cressaty, J; Francoual, C; Moncomble, CC; Cohen, H; Blanche, S; Bastion, H; Benifla, J; Benkhatar, F; Berkane, N; Herve, F; Ronzier, M; Mayaux, MJ; de Martino, M; Tovo, PA; Galli, L; Gabiano, C; Ferraris, G; Rancillo, L; Bucceri, A; Tulisso, S; Scolfaro, C; Riva, C; Vierucci, A; de Luca, M; Farina, S; Fundaro, C; Genovese, O; Mercu, G; Forni, G; Stegagno, M; Falconieri, P; Zuccotti, G; Riva, E; Cellini, M; Baraldi, C; Consolini, R; Palla, G; Ruggeri, M; Pignata, C; Guarino, A; Osimani, P; Metri, A; Antonellini, A; Benaglia, G; Romano, A; Dallacasa, P; De Mattia, D; Caselli, D; Boni, S; Dell'Erba, G; Bassanetti, F; Sticca, M; Timpano, C; Magnani, C; Salvatore, C; Gambaretto, G; Lipreri, R; Tornaghi, R; Pinzani, R; Cecchi, M; Bezzi, T; Battisti, L; Bresciani, E; Gattinara, G; Berrino, R; Pellegatta, A; Mazza, A; Baldi, F; Micheletti, E; Ruga, E; Altobelli, R; Deiana, M; Colnaghi, C; Tarallo, L; Tondo, U; Anastasio, E; Duse, M; Chiriaco, P; Contardi, I; Ruggeri, C; Ibba, P; Scott, G; Hutto, C; O'Sullivan, M; Malmsberry, A; Willoughby, A; Burns, D; Goedert, J; Landesman, S; Minkoff, H; Mendez, H; Holman, S; Rubinstein, A; Durako, S; Muenz, L; Goodwin, S; Nesheim, S; Lindsay, M; Clark, S; Lee, F; Nahmias, A; Sawyer, M; Vink, P; Farley, J; Alger, L; Abrams, E; Bamji, M; Lambert, G; Schoenbaum, E; Thea, D; Thomas, P; Weedon, J; Palumbo, P; Bardeguez, A; Denny, T; Oleske, J; Simonds, R; Orloff, S; Ethier-Ives, J; Rogers, M; Schluchter, M; Kutner, M; Kaplan, S; Kattan, M; Lipshultz, S; Mellins, R; Shearer, W; Peavy, H; Sopko, G; Sloand, E; Wu, M; Kind, C; Nadal, D; Rudin, C; Siegrist, CA; Wyler, CA; Cheseaux, JJ; Aebi, C; Gnehm, H; Schubiger, G; Klingler, J; Hunziker, U; Kuchler, H; Gianinazzi, M; Buhlmann, U; Rudin, C; Biedermann, K; Lauper, U; Irion, O; Brunelli, A; Spoletini, G; Schreyer, A; Kind, C; Hosli, I; Saurenmann, E; Drack, G; Isenschmid, M; Poorbeik, M; Schupbach, J; Perrin, L; Erb, P; Joller, H; Bryson, Y; Dillon, M; Nielsen, R; Boyer, P; Liao, D; Keller, M; Deveikis, A; Kovacs, A; Stek, A; Chan, L; Rother, C; Khoury, M; Diaz, C; Pacheco-Acosta, E; Tuomala, R; Cooper, E; Mesthene, D; Pitt, J; Higgins, A; Mendez, H; Moroso, G; Rich, K; Turpin, D; Cooper, N; Fowler, M; Nugent, R; Smeriglio, V; McKinlay, S; Kalish, L; Ellis, S; Andiman, W; Simpson, B				Andiman, W; Boucher, M; Burns, D; Bryson, Y; Farley, J; Fowler, H; Gabiano, C; Galli, L; Hutto, C; Kind, C; Korber, B; Kovacs, A; Krogstad, P; Landesman, S; Lapointe, N; Lemay, M; Lew, J; Mandelbrot, L; Mayaux, MJ; Mellins, R; Minkoff, H; Mofenson, L; Nielsen, K; Newell, ML; Pardi, G; Peavy, H; Peckham, C; Read, J; Rother, C; Rudin, C; Scott, G; Semprini, A; Shearer, W; Simonds, R; Simpson, B; Stek, A; Tovo, PA; Tuomala, R; Van Dyke, R; Weedon, J; de Martino, M; Lindsay, M; Belair, S; Chan, L; Harris, D; Kalish, L; Muenz, L; Nugent, R; Schluchter, M; Durako, S; Goodwin, S; Mitchell, R; Nourjah, P; Owen, W; Widmayer, S; Bardeguez, A; Hanson, C; Wiznia, A; Luzuriaga, K; Viscarello, R; Ho, D; Koup, R; Chen, I; Mullins, J; Wolinsky, S; Walker, B; Ammann, A; Clapp, S; McDonald, D; Fauvel, M; Hankins, C; Samson, J; Bailey, A; Giaquinto, C; Ruga, E; De Rossi, A; Truscia, D; Grosch-Worner, I; Schafer, A; Mok, J; Johnstone, F; Jiminez, J; de Alba, C; Garcia-Rodriguez, M; Bates, I; de Jose, I; Hawkins, F; Zapico, RM; Asensi-Botet, F; Otero, M; Perez-Tamarit, D; Moya, A; Galbis, M; Scherpbier, H; Boer, K; Bohlin, A; Lindgren, S; Ehrnst, A; Anzen, B; Belfrage, E; Levy, J; Alimenti, A; Barlow, P; Ferrazin, A; De Maria, A; Gotta, C; Maritati, V; Mur, A; Rovira, M; Paya, A; Coll, O; Fortuny, C; Boguna, J; Caro, MC; Canet, Y; Pardi, G; Ravizza, M; Castagna, C; Fiore, S; Guerra, B; Lanari, M; Bianchi, S; Bovicelli, L; Prati, E; Duse, M; Soresina, A; Scaravelli, G; De Santis, M; Muggiasca, M; Vigano, A; Marchisio, P; Iasci, A; Spinillo, A; Bucceri, A; Grossi, E; Rancilio, L; Della Torre, M; Dallacasa, P; Soresina, A; Pachi, A; Principi, N; Muggiasca, M; Marchisio, P; Zara, C; Vignali, M; Rossi, G; Rancilio, L; Selvaggi, L; Greco, P; Vimercati, A; Massi, G; Innocenti, T; Fiscella, A; Sansone, M; Benedetto, C; Tibaldi, C; Ziarati, N; Tadrist, B; Thevenicau, D; Gondry, J; Paulard, B; Alisy, C; Brault, D; Tordjeman, P; Mamou, J; Rozan, M; Colombani, D; Pincemaille, O; Salvetti, A; Chabanier, C; Hernandorena, X; Leroy, J; Schaal, J; Balde, P; Faucher, P; Lachassinne, E; Benoit, S; Douard, D; Hocke, C; Barjot, P; Brouard, J; Delattre, P; Stien, L; Audibert, F; Labrune, P; Vial, M; Mazy, F; Sitbon, D; Crenn-Hebert, C; Floch-Tudal, C; Akakpo, R; Daveau, C; Leblanc, A; Cesbron, P; Duval-Arnould, H; Huraux-Rendu, C; Lemerle, S; Touboul, C; Guerin, M; Maingueneau, C; Reynaud, I; Rousseau, T; Ercoil, V; Lanza, M; Denavit, M; Garnier, J; Lahsinat, K; Pia, R; Allouche, C; Nardou, M; Grall, F; May, A; Dallot, M; Lhuillier, P; Cecile, W; Mezin, R; Balde, P; Bech, A; Lobut, J; Algava, G; Dermesay, AC; Busuttil, R; Jacquemot, M; Bader-Meunier, B; Fridman, S; Codaccioni, X; Maxingue, F; Thomas, D; Alain, J; De Lumley, L; Tabaste, J; Salin, PB; Seaume, H; Guichard, A; Kebaili, K; Roussouly, C; Botto, C; De Lanete, A; Wipff, P; Cravello, L; De Boisse, P; Leclaire, M; Michel, G; Crumiere, C; Lefevre, V; Le Lorier, B; Pauly, I; Robichez, B; Seguy, D; Dehlinger, M; Rideau, F; Talon, P; Benos, P; Huret, C; Nicolas, J; Heller-Roussin, B; Saint-Leger, S; Delaporte, M; Hubert, C; De Sarcus, B; Karoubi, P; Mechinaud, F; Bertcrottiere, D; Bongain, A; Monpoux, F; De Gennes, C; Devianne, F; Nisand, I; Rousset, M; Karoubi, P; Mouchnino, G; Muray, J; Munzer, M; Quereux, C; Brossard, V; Clavier, B; Allemon, M; Rotten, D; Stephan, J; Varlet, M; Guyot, B; Narey, P; Bardinet, F; De Caunes, F; Jeny, R; Robin, M; Bouley, AR; Savey, L; Berrebi, A; Tricoire, J; Borderon, J; Fignon, A; Guillot, F; Maria, B; Broyard, A; Chitrit, Y; Firtion, G; Mandelbrot, L; Pillet, ML; Parat, S; Boissinot, C; Garec, N; Levine, M; Ottenwalter, A; Schaller, F; Vilmer, B; Courpotin, C; Brunner, C; Ciraru-Vigneron, N; Hatem-Gantzer, G; Heller-Roussin, B; Fritel, X; Wallet, A; Bouille, J; Milliez, J; Mrejen, DB; Dermer, E; Noseda, G; Bardou, D; Cressaty, J; Francoual, C; Moncomble, CC; Cohen, H; Blanche, S; Bastion, H; Benifla, J; Benkhatar, F; Berkane, N; Herve, F; Ronzier, M; Mayaux, MJ; de Martino, M; Tovo, PA; Galli, L; Gabiano, C; Ferraris, G; Rancillo, L; Bucceri, A; Tulisso, S; Scolfaro, C; Riva, C; Vierucci, A; de Luca, M; Farina, S; Fundaro, C; Genovese, O; Mercu, G; Forni, G; Stegagno, M; Falconieri, P; Zuccotti, G; Riva, E; Cellini, M; Baraldi, C; Consolini, R; Palla, G; Ruggeri, M; Pignata, C; Guarino, A; Osimani, P; Metri, A; Antonellini, A; Benaglia, G; Romano, A; Dallacasa, P; De Mattia, D; Caselli, D; Boni, S; Dell'Erba, G; Bassanetti, F; Sticca, M; Timpano, C; Magnani, C; Salvatore, C; Gambaretto, G; Lipreri, R; Tornaghi, R; Pinzani, R; Cecchi, M; Bezzi, T; Battisti, L; Bresciani, E; Gattinara, G; Berrino, R; Pellegatta, A; Mazza, A; Baldi, F; Micheletti, E; Ruga, E; Altobelli, R; Deiana, M; Colnaghi, C; Tarallo, L; Tondo, U; Anastasio, E; Duse, M; Chiriaco, P; Contardi, I; Ruggeri, C; Ibba, P; Scott, G; Hutto, C; O'Sullivan, M; Malmsberry, A; Willoughby, A; Burns, D; Goedert, J; Landesman, S; Minkoff, H; Mendez, H; Holman, S; Rubinstein, A; Durako, S; Muenz, L; Goodwin, S; Nesheim, S; Lindsay, M; Clark, S; Lee, F; Nahmias, A; Sawyer, M; Vink, P; Farley, J; Alger, L; Abrams, E; Bamji, M; Lambert, G; Schoenbaum, E; Thea, D; Thomas, P; Weedon, J; Palumbo, P; Bardeguez, A; Denny, T; Oleske, J; Simonds, R; Orloff, S; Ethier-Ives, J; Rogers, M; Schluchter, M; Kutner, M; Kaplan, S; Kattan, M; Lipshultz, S; Mellins, R; Shearer, W; Peavy, H; Sopko, G; Sloand, E; Wu, M; Kind, C; Nadal, D; Rudin, C; Siegrist, CA; Wyler, CA; Cheseaux, JJ; Aebi, C; Gnehm, H; Schubiger, G; Klingler, J; Hunziker, U; Kuchler, H; Gianinazzi, M; Buhlmann, U; Rudin, C; Biedermann, K; Lauper, U; Irion, O; Brunelli, A; Spoletini, G; Schreyer, A; Kind, C; Hosli, I; Saurenmann, E; Drack, G; Isenschmid, M; Poorbeik, M; Schupbach, J; Perrin, L; Erb, P; Joller, H; Bryson, Y; Dillon, M; Nielsen, R; Boyer, P; Liao, D; Keller, M; Deveikis, A; Kovacs, A; Stek, A; Chan, L; Rother, C; Khoury, M; Diaz, C; Pacheco-Acosta, E; Tuomala, R; Cooper, E; Mesthene, D; Pitt, J; Higgins, A; Mendez, H; Moroso, G; Rich, K; Turpin, D; Cooper, N; Fowler, M; Nugent, R; Smeriglio, V; McKinlay, S; Kalish, L; Ellis, S; Andiman, W; Simpson, B		Int Perinatal HIV Grp	The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 - A meta-analysis of 15 prospective cohort studies	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	12th International Conference on AIDS	JUN-JUL -, 1998	GENEVA, SWITZERLAND				MOTHER-TO-CHILD; INFANT HIV TRANSMISSION; CESAREAN-SECTION; ZIDOVUDINE PROPHYLAXIS; OBSTETRIC FACTORS; INFECTION; WOMEN; COMPLICATIONS; PREVENTION; REDUCTION	Background To evaluate the relation between elective cesarean section and vertical transmission of human immunodeficiency virus type 1 (HIV-1), we performed a meta-analysis using data on individual patients from 15 prospective cohort studies. Methods North American and European studies of at least 100 mother-child pairs were included in the meta-analysis. Uniform definitions of modes of delivery were used. Elective cesarean sections were defined as those performed before onset of labor and rupture of membranes. Multivariate logistic-regression analysis was used to adjust for other factors known to be associated with vertical transmission. Results The primary analysis included data on 8533 mother-child pairs. After adjustment for receipt of antiretroviral therapy, maternal stage of disease, and infant birth weight, the likelihood of vertical transmission of HIV-1 was decreased by approximately 50 percent with elective cesarean section, as compared with other modes of delivery (adjusted odds ratio, 0.43; 95 percent confidence interval, 0.33 to 0.56). The results were similar when the study population was limited to those with rupture of membranes shortly before delivery. The likelihood of transmission was reduced by approximately 87 percent with both elective cesarean section and receipt of antiretroviral therapy during the prenatal, intrapartum, and neonatal periods, as compared with other modes of delivery and the absence of therapy (adjusted odds ratio, 0.13; 95 percent confidence interval, 0.09 to 0.19), Among mother-child pairs receiving antiretroviral therapy during the prenatal, intrapartum, and neonatal periods, rates of vertical transmission were 2.0 percent among the 196 mothers who underwent elective cesarean section and 7.3 percent among the 1255 mothers with other modes of delivery. Conclusions The results of this meta-analysis suggest that elective cesarean section reduces the risk of transmission of HIV-1 from mother to child independently of the effects of treatment with zidovudine. (N Engl J Med 1999;340:977-87.) (C)1999, Massachusetts Medical Society.	NICHHD, Pediat Adolescent & Maternal AIDS Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Read, J (corresponding author), NICHHD, Pediat Adolescent & Maternal AIDS Branch, NIH, Execut Bldg,Rm 4B11F,6100 Execut Blvd,MSC 7510, Bethesda, MD 20892 USA.		Manzotti, Grazia/C-5985-2008; vimercati, antonella/I-8114-2012; Brouard, Jacques/AAH-3387-2020; Pignata, Claudio/O-2466-2013; Audibert, François/AAL-1265-2020; Krogstad, Paul/AAQ-8495-2020; Newell, Marie-Louise/AAE-8222-2019; Greco, Pantaleo/AAC-5173-2022; Giaquinto, Carlo/AAB-5016-2020; FRITEL, Xavier/K-8566-2012; de maria, andrea/F-7116-2016; Kind, Christian/AAJ-1103-2020; SHCS, MoCHIV/G-4081-2011; Mofenson, Lynne/P-9631-2019; Wolinsky, Steven/B-2893-2012; De Rossi, Anita/Q-4845-2019; peckham, catherine s/I-6300-2013; De Rossi, A./L-3128-2015; Spinillo, Arsenio/AAB-9315-2022; Guarino, Alfredo/AAC-4812-2022; Mandelbrot, Laurent/AAD-3554-2019; Oleske, James/C-1951-2016	vimercati, antonella/0000-0002-9862-1619; Pignata, Claudio/0000-0003-1568-9843; Newell, Marie-Louise/0000-0002-1074-7699; FRITEL, Xavier/0000-0002-4987-8127; de maria, andrea/0000-0001-5782-333X; Mofenson, Lynne/0000-0002-2818-9808; De Rossi, Anita/0000-0001-6435-7509; De Rossi, A./0000-0001-6435-7509; Spinillo, Arsenio/0000-0002-7755-1084; Guarino, Alfredo/0000-0003-0199-0336; Mandelbrot, Laurent/0000-0002-5883-7597; GIAQUINTO, CARLO/0000-0001-9365-0413; Rossi, Gabriele/0000-0003-4350-720X; Oleske, James/0000-0003-2305-5605; Villa, Paola/0000-0002-4501-3038; GRECO, Pantaleo/0000-0003-2461-6777; Alimenti, Ariane/0000-0003-4999-8230; Thea, Donald/0000-0002-6933-1030	NICHD NIH HHS [N01 HD 43208] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD043208] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AGRESTI A, 1990, CATEGORICAL DATA ANA, P66; BECKERMAN K, 1998, 12 WORLD AIDS C GEN, P41; BOYER PJ, 1994, JAMA-J AM MED ASSOC, V271, P1925, DOI 10.1001/jama.271.24.1925; Breslow NE, 1980, IARC SCI PUBL, V1, P142; Bulterys M, 1996, AIDS, V10, P923, DOI 10.1097/00002030-199607000-00019; BURNS DN, 1994, J ACQ IMMUN DEF SYND, V7, P718; Cao YZ, 1997, NAT MED, V3, P549, DOI 10.1038/nm0597-549; Centers for Disease Control (CDC), 1985, MMWR Morb Mortal Wkly Rep, V34, P721; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; CONTOPOLOSIOANN.DG, 1998, 5 C RETR OPP INF CHI, P124; DEMARTINO M, 1992, AIDS, V6, P991, DOI 10.1097/00002030-199209000-00013; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DULIEGE AM, 1995, J PEDIATR-US, V126, P625, DOI 10.1016/S0022-3476(95)70365-9; DUNN DT, 1994, J ACQ IMMUN DEF SYND, V7, P1064; *EUR MOD DEL COLL, IN PRESS LANCET; GALLI L, 1997, INT J IMMUNOPATHOL S, V10, P236; HOSMER DW, 1989, APPL LOGISTIC REGRES, P135; HUTTO C, 1991, J PEDIATR-US, V118, P347, DOI 10.1016/S0022-3476(05)82145-6; Kaneda T, 1997, J PEDIATR-US, V130, P730, DOI 10.1016/S0022-3476(97)80014-5; Kattan M, 1996, J CLIN EPIDEMIOL, V49, P1285; Kind C, 1998, AIDS, V12, P205, DOI 10.1097/00002030-199802000-00011; KIND C, 1992, EUR J PEDIATR, V151, P442, DOI 10.1007/BF01959360; KOVACS A, 1995, PEDIATR INFECT DIS J, V14, P948, DOI 10.1097/00006454-199511000-00005; Kuhn L, 1996, J ACQ IMMUN DEF SYND, V11, P478, DOI 10.1097/00042560-199604150-00008; KUHN L, 1995, PAEDIATR PERINAT EP, V9, P1, DOI 10.1111/j.1365-3016.1995.tb00113.x; Landesman SH, 1996, NEW ENGL J MED, V334, P1617, DOI 10.1056/NEJM199606203342501; Maguire A, 1997, AIDS, V11, P1851, DOI 10.1097/00002030-199715000-00010; Mandelbrot L, 1996, AM J OBSTET GYNECOL, V175, P661; Mandelbrot L, 1998, JAMA-J AM MED ASSOC, V280, P55, DOI 10.1001/jama.280.1.55; MAYAUX MJ, 1995, J ACQ IMMUN DEF SYND, V8, P188; MILLER JM, 1988, OBSTET GYN CLIN N AM, V15, P629; Mofenson LM, 1997, OBSTET GYN CLIN N AM, V24, P759, DOI 10.1016/S0889-8545(05)70343-0; *NAT I CHILD HLTH, 1982, NIH PUBL; NEWELL ML, 1994, LANCET, V343, P1464; Newell ML, 1996, AIDS, V10, P1675; Newell ML, 1998, BRIT J OBSTET GYNAEC, V105, P281, DOI 10.1111/j.1471-0528.1998.tb10087.x; PETITTI DB, 1985, CLIN OBSTET GYNECOL, V28, P763, DOI 10.1097/00003081-198528040-00009; *PHS TASK FORC, 1998, MMWR-MORBID MORTAL W, V47, P1; *PHS TASK FORC, 1998, MMWR-MORBID MORTAL W, V47, P287; *PHS TASK FORC, 1998, MMWR-MORBID MORTAL W, V47, P315; Rouzioux C, 1995, AM J EPIDEMIOL, V142, P1330, DOI 10.1093/oxfordjournals.aje.a117601; SCOTT GB, 1995, PEDIATRICS, V96, P977; SEMPRINI AE, 1995, AIDS, V9, P913, DOI 10.1097/00002030-199508000-00013; Shaffer N, 1999, J INFECT DIS, V179, P590, DOI 10.1086/314641; SHEON AR, 1996, J WOMENS HEALTH, V5, P69, DOI DOI 10.1089/JWH.1996.5.69; Silvestri G, 1996, AIDS, V10, P549, DOI 10.1097/00002030-199605000-00018; Simonds RJ, 1998, AIDS, V12, P301, DOI 10.1097/00002030-199803000-00008; Simpson BJ, 1997, J ACQ IMMUN DEF SYND, V14, P145, DOI 10.1097/00042560-199702010-00007; TOVO PA, 1988, LANCET, V2, P1043; Tovo PA, 1996, J ACQ IMMUN DEF SYND, V11, P88, DOI 10.1097/00042560-199601010-00012; Tuomala R., 1993, American Journal of Obstetrics and Gynecology, V168, P419; vanHam MAPC, 1997, EUR J OBSTET GYN R B, V74, P1, DOI 10.1016/S0301-2115(97)02725-5; VILLARI P, 1993, J CURR CLIN TRIALS; Weisser M, 1998, J ACQ IMMUN DEF SYND, V17, P404, DOI 10.1097/00042560-199804150-00004	54	511	539	1	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 1	1999	340	13					977	987		10.1056/NEJM199904013401301	http://dx.doi.org/10.1056/NEJM199904013401301			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	182GA	10099139				2022-12-28	WOS:000079489800001
J	Kaneshima, S; Helffrich, G				Kaneshima, S; Helffrich, G			Dipping low-velocity layer in the mid-lower mantle: Evidence for geochemical heterogeneity	SCIENCE			English	Article							SEISMIC EVIDENCE; EARTH; VOLCANISM; BASALTS; MODEL	Data from western United States short-period seismic networks reveal a conversion from an S to a P wave within a low seismic velocity layer (greater than or equal to the 4 percent velocity difference compared to the surrounding mantle) in the mid-lower mantle (1400 to 1600 kilometers deep) east of the Mariana and Izu-Bonin subduction zones. The low-velocity layer (about 8 kilometers thick) dips 30 degrees to 40 degrees southward and is at least 500 kilometers by 300 kilometers. Its steep dip, large velocity contrast, and sharpness imply a chemical rather than a thermal origin, Ancient oceanic crust subducted into the lower mantle is a plausible candidate for the low-velocity layer because of its broad thin extent.	Tokyo Inst Technol, Fac Sci, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 152, Japan; Univ Bristol, Dept Geol, Bristol, Avon, England	Tokyo Institute of Technology; University of Bristol	Kaneshima, S (corresponding author), Tokyo Inst Technol, Fac Sci, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 152, Japan.			Helffrich, George/0000-0002-7363-4552				Aki K., 1980, QUANTITATIVE SEISMOL; ANDERSON DL, 1982, J GEOPHYS RES, V87, P3893, DOI 10.1029/JB087iB05p03893; CHAPMAN CH, 1985, J GEOPHYS-Z GEOPHYS, V58, P27; CHRISTENSEN UR, 1994, J GEOPHYS RES-SOL EA, V99, P19867, DOI 10.1029/93JB03403; DAVIES GF, 1992, J GEOL, V100, P151, DOI 10.1086/629582; DZIEWONSKI AM, 1984, J GEOPHYS RES, V89, P5929, DOI 10.1029/JB089iB07p05929; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Engebretson D.C., 1985, GEOLOGICAL SOC AM SP, V206, P59, DOI [10.1130/SPE206, DOI 10.1130/SPE206]; GAHERTY JB, 1994, GEOPHYS RES LETT, V21, P141, DOI 10.1029/93GL03466; Grand SP., 1997, GSA TODAY, V7, P1; Hanyu T, 1997, NATURE, V390, P273, DOI 10.1038/36835; Hedlin MAH, 1997, NATURE, V387, P145, DOI 10.1038/387145a0; Helffrich GR, 1997, GEOPHYS J INT, V131, P741, DOI 10.1111/j.1365-246X.1997.tb06609.x; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; Kaneshima S, 1998, J GEOPHYS RES-SOL EA, V103, P4825, DOI 10.1029/97JB02565; KAWAKATSU H, 1994, NATURE, V371, P301, DOI 10.1038/371301a0; KELLOGG LH, 1992, ANNU REV EARTH PL SC, V20, P365; LESTUNFF Y, 1995, SCIENCE, V270, P74, DOI 10.1126/science.270.5233.74; NOLET G, 1993, GEOPHYS J INT, V114, P185, DOI 10.1111/j.1365-246X.1993.tb01478.x; RICHARDS MA, 1989, SCIENCE, V246, P103, DOI 10.1126/science.246.4926.103; SAKURAI T, 1996, THESIS U TOKYO; vanderHilst RD, 1997, NATURE, V386, P578, DOI 10.1038/386578a0; VOGT PR, 1981, J GEOPHYS RES, V86, P950, DOI 10.1029/JB086iB02p00950	23	119	120	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 19	1999	283	5409					1888	1891		10.1126/science.283.5409.1888	http://dx.doi.org/10.1126/science.283.5409.1888			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177UC	10082456				2022-12-28	WOS:000079228600039
J	Lagergren, J; Bergstrom, R; Lindgren, A; Nyren, O				Lagergren, J; Bergstrom, R; Lindgren, A; Nyren, O			Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLUMNAR-LINED ESOPHAGUS; BARRETTS-ESOPHAGUS; GASTRIC CARDIA; INCREASING INCIDENCE; OVERRATED RISK; DISEASE; METAPLASIA; CARCINOMAS; TOBACCO; ALCOHOL	Background The causes of adenocarcinomas of the esophagus and gastric cardia are poorly understood. We conducted an epidemiologic investigation of the possible association between gastroesophageal reflux and these tumors. Methods We performed a nationwide, population-based, case-control study in Sweden. Case ascertainment was rapid, and all cases were classified uniformly. information on the subjects' history of gastroesophageal reflux was collected in personal interviews. The odds ratios were calculated by logistic regression, with multivariate adjustment for potentially confounding variables. Results Of the patients interviewed, the 189 with esophageal adenocarcinoma and the 262 with adenocarcinoma of the cardia constituted 85 percent of the 529 patients in Sweden who were eligible for the study during the period from 1995 through 1997. For comparison, we interviewed 820 control subjects from the general population and 167 patients with esophageal squamous-cell carcinoma. Among persons with recurrent symptoms of reflux, as compared with persons without such symptoms, the odds ratios were 7.7 (95 percent confidence interval, 5.3 to 11.4) for esophageal adenocarcinoma and 2.0 (95 percent confidence interval, 1.4 to 2.9) for adenocarcinoma of the cardia. The more frequent, more severe, and longer-lasting the symptoms of reflux, the greater the risk. Among persons with long-standing and severe symptoms of reflux, the odds ratios were 43.5 (95 percent confidence interval, 18.3 to 103.5) for esophageal adenocarcinoma and 4.4 (95 percent confidence interval, 1.7 to 11.0) for adenocarcinoma of the cardia. The risk of esophageal squamous-cell carcinoma was not associated with reflux (odds ratio, 1.1; 95 percent confidence interval, 0.7 to 1.9). Conclusions There is a strong and probably causal relation between gastroesophageal reflux and esophageal adenocarcinoma. The relation between reflux and adenocarcinoma of the gastric cardia is relatively weak. (N Engl J Med 1999; 340:825-31.) (C) 1999, Massachusetts Medical Society.	Karolinska Inst, Dept Med Epidemiol, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Surg, Stockholm, Sweden; Danderyd Hosp, Stockholm, Sweden; Uppsala Univ, Dept Stat, Uppsala, Sweden; Falun Cent Hosp, Dept Pathol, Falun, Sweden	Karolinska Institutet; Karolinska Institutet; Danderyds Hospital; Uppsala University; Falun Hospital	Lagergren, J (corresponding author), Karolinska Inst, Dept Med Epidemiol, Box 281, S-17177 Stockholm, Sweden.	jesper.lagergren@mep.ki.se		Lagergren, Jesper/0000-0002-5143-5448	NATIONAL CANCER INSTITUTE [R01CA057947] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA57947-03] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTORKI NK, 1990, SEMIN SURG ONCOL, V6, P274, DOI 10.1002/ssu.2980060509; BLOT WJ, 1991, JAMA-J AM MED ASSOC, V265, P1287, DOI 10.1001/jama.265.10.1287; Breslow NE, 1980, IARC SCI PUBL, V32; CAMERON AJ, 1985, NEW ENGL J MED, V313, P857, DOI 10.1056/NEJM198510033131404; Cameron AJ, 1997, GASTROENTEROL CLIN N, V26, P487, DOI 10.1016/S0889-8553(05)70308-3; CHOW WH, 1995, JAMA-J AM MED ASSOC, V274, P474, DOI 10.1001/jama.274.6.474; Chow WH, 1998, JNCI-J NATL CANCER I, V90, P150, DOI 10.1093/jnci/90.2.150; CLARK GWB, 1994, ARCH SURG-CHICAGO, V129, P609; Correa P, 1998, BRIT MED BULL, V54, P151; Drewitz DJ, 1997, AM J GASTROENTEROL, V92, P212; Gammon MD, 1997, J NATL CANCER I, V89, P1277, DOI 10.1093/jnci/89.17.1277; HAMEETEMAN W, 1989, GASTROENTEROLOGY, V96, P1249, DOI 10.1016/S0016-5085(89)80011-3; HANSSON LE, 1993, BRIT J SURG, V80, P374, DOI 10.1002/bjs.1800800338; HANSSON LE, 1993, INT J CANCER, V54, P402, DOI 10.1002/ijc.2910540309; Kim R, 1997, CANCER EPIDEM BIOMAR, V6, P369; KLAUSER AG, 1990, LANCET, V335, P205, DOI 10.1016/0140-6736(90)90287-F; LOCKE GR, 1994, MAYO CLIN PROC, V69, P539, DOI 10.1016/S0025-6196(12)62245-9; Marshall REK, 1997, BRIT J SURG, V84, P21; MIWA K, 1994, BRIT J CANCER, V70, P185, DOI 10.1038/bjc.1994.277; Morales TG, 1997, DIGEST DIS, V15, P346, DOI 10.1159/000171610; OVASKA J, 1989, DIGEST DIS SCI, V34, P1336, DOI 10.1007/BF01538065; PERA M, 1993, GASTROENTEROLOGY, V104, P510, DOI 10.1016/0016-5085(93)90420-H; Powell J, 1992, Eur J Cancer Prev, V1, P265, DOI 10.1097/00008469-199204000-00008; Revicki DA, 1998, QUAL LIFE RES, V7, P75; ROBERTSON CS, 1988, BRIT J SURG, V75, P760, DOI 10.1002/bjs.1800750813; Rothman KJ, 1998, MODERN EPIDEMIOLOGY, P53; SCHLESSELMAN JJ, 1982, CASE CONTROL STUDIES, P43; SPECHLER SJ, 1984, GASTROENTEROLOGY, V87, P927; SPECHLER SJ, 1986, NEW ENGL J MED, V315, P362, DOI 10.1056/NEJM198608073150605; Streitz JM, 1998, AM J GASTROENTEROL, V93, P911; Ter RB, 1997, GASTROENTEROL CLIN N, V26, P549, DOI 10.1016/S0889-8553(05)70313-7; VANDERVEEN AH, 1989, GUT, V30, P14, DOI 10.1136/gut.30.1.14; WILLIFORD WO, 1994, CONTROL CLIN TRIALS, V15, P335, DOI 10.1016/0197-2456(94)90031-0; Wink DA, 1998, CARCINOGENESIS, V19, P711, DOI 10.1093/carcin/19.5.711; Winters C, 1987, GASTROENTEROLOGY, V92, P118, DOI 10.1016/0016-5085(87)90847-X; Wright TA, 1996, GUT, V39, P574, DOI 10.1136/gut.39.4.574; Zhang ZF, 1996, CANCER EPIDEM BIOMAR, V5, P761	37	2188	2238	0	65	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 18	1999	340	11					825	831		10.1056/NEJM199903183401101	http://dx.doi.org/10.1056/NEJM199903183401101			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	176ZW	10080844				2022-12-28	WOS:000079183200001
J	Malmstrom, K; Rodriguez-Gomez, G; Guerra, J; Villaran, C; Pineiro, A; Wei, LX; Seidenberg, BC; Reiss, TF				Malmstrom, K; Rodriguez-Gomez, G; Guerra, J; Villaran, C; Pineiro, A; Wei, LX; Seidenberg, BC; Reiss, TF		Montelukast Beclomethasone Study Grp	Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma - A randomized, controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article						placebos; asthma beclomethasone; montelukast; forced expiratory volume	LEUKOTRIENE-RECEPTOR ANTAGONIST; QUALITY-OF-LIFE; CLINICAL-TRIALS; CORTICOSTEROIDS; THERAPY; POTENT; RISK	Background: Oral leukotriene receptor antagonists have been shown to have efficacy in chronic asthma. Objective: To compare the clinical benefit of montelukast, a once-daily oral leukotriene receptor antagonist; placebo; and inhaled beclomethasone. Design: Randomized, double-blind, double-dummy, placebo-controlled, parallel-group, 12-week study. Setting: 36 sites worldwide. Patients: 895 patients 15 to 85 years of age with chronic asthma and an FEV, 50% to 85% of predicted. Interventions: Montelukast, 10 mg once daily at bedtime; inhaled beclomethasone, 200 mu g twice daily, administered with a spacer device; or placebo. Measurements: Primary end points were daytime asthma symptom score and FEV1. Secondary end points were peak expiratory flow rates in the morning and evening, as-needed beta-agonist use, nocturnal awakenings, asthma-specific quality of life, and worsening asthma episodes. Results: Over the 12-week treatment period, the average percentage change from baseline in FEV1 was 13.1% with beclomethasone, 7.4% with montelukast, and 0.7% with placebo (P < 0.001 for each active treatment compared with placebo; P < 0.01 for beclomethasone compared with montelukast). The average change from baseline in daytime symptom score was -0.62 for beclomethasone, -0.41 for montelukast, and -0.17 for placebo (P < 0.001 for each active treatment compared with placebo; P < 0.01 for beclomethasone compared with montelukast). Each agent improved peak expiratory flow rates and quality of life, reduced nocturnal awakenings and asthma attacks, increased the number of asthma-control days, and decreased the number of days with asthma exacerbations (P < 0.001 for each active treatment compared with placebo for each end point; P < 0.01 for beclomethasone compared with montelukast for each end point). Although beclomethasone had a greater mean clinical benefit than montelukast, montelukast had a faster onset of action and a greater initial effect. The two agents caused similar decreases in peripheral blood eosinophil counts (P < 0.05 for each agent compared with placebo). Both agents had tolerability profiles similar to that of placebo over the 12-week study. Conclusions: Although beclomethasone had a larger mean effect than montelukast, both drugs provided clinical benefit to patients with chronic asthma. This finding is consistent with the use of these agents as controller medications for chronic asthma.	Merck Res Labs, Dept Pulm Immunol, Rahway, NJ 07065 USA; Inst Costarricense Invest Clin, San Jose, Costa Rica; Social Secur Gen Hosp, Guatemala City, Guatemala; Clin Ricardo Palma, Lima, Peru	Merck & Company	Reiss, TF (corresponding author), Merck Res Labs, Dept Pulm Immunol, RY 33-648,POB 2000, Rahway, NJ 07065 USA.	theodore_reiss@merck.com						AGERTOFT L, 1994, RESP MED, V88, P373, DOI 10.1016/0954-6111(94)90044-2; ALDERMAN MH, 1993, ANN INTERN MED, V119, P329, DOI 10.7326/0003-4819-119-4-199308150-00013; Altman LC, 1998, J ALLERGY CLIN IMMUN, V102, P50, DOI 10.1016/S0091-6749(98)70054-5; BOTTO A, 1997, AM J RESP CRIT CARE, V155, pA893; BOUSQUET J, 1994, AM J RESP CRIT CARE, V150, pS33, DOI 10.1164/ajrccm/150.5_Pt_2.S33; Bronsky EA, 1997, CLIN PHARMACOL THER, V62, P556, DOI 10.1016/S0009-9236(97)90051-5; Cumming RG, 1997, NEW ENGL J MED, V337, P8, DOI 10.1056/NEJM199707033370102; DOLOVICH M, 1995, EUR RESPIR REV, V5, P166; DUNNETT CW, 1992, STAT MED, V11, P1057, DOI 10.1002/sim.4780110807; Grossman J, 1997, J ASTHMA, V34, P321, DOI 10.3109/02770909709067222; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; HAAHTELA T, 1994, NEW ENGL J MED, V331, P700, DOI 10.1056/NEJM199409153311103; In KH, 1997, J CLIN INVEST, V99, P1130, DOI 10.1172/JCI119241; Israel E, 1996, JAMA-J AM MED ASSOC, V275, P931, DOI 10.1001/jama.275.12.931; JONES TR, 1995, CAN J PHYSIOL PHARM, V73, P191, DOI 10.1139/y95-028; JUNIPER EF, 1992, THORAX, V47, P76, DOI 10.1136/thx.47.2.76; Kamada AK, 1996, AM J RESP CRIT CARE, V153, P1739, DOI 10.1164/ajrccm.153.6.8665030; KELLOWAY JS, 1994, ARCH INTERN MED, V154, P1349, DOI 10.1001/archinte.154.12.1349; Knorr B, 1998, JAMA-J AM MED ASSOC, V279, P1181, DOI 10.1001/jama.279.15.1181; Laitinen L. A., 1997, European Respiratory Journal Supplement, V10, p419S; LEFF JA, 1997, AM J RESP CRIT CARE, V155, pA977; LEWIS RA, 1990, NEW ENGL J MED, V323, P645; *NAT ASTHM ED PREV, 1997, 2 US DEP HLTH HUM SE; NATTEL S, 1979, CIRCULATION, V59, P1158, DOI 10.1161/01.CIR.59.6.1158; Newhouse M. T., 1994, Atemwegs- und Lungenkrankheiten, V20, P268; Noonan MJ, 1998, EUR RESPIR J, V11, P1232, DOI 10.1183/09031936.98.11061232; Reiss T. F., 1997, European Respiratory Journal Supplement, V10, p437S; Reiss TF, 1998, ARCH INTERN MED, V158, P1213, DOI 10.1001/archinte.158.11.1213; Reiss TF, 1996, J ALLERGY CLIN IMMUN, V98, P528, DOI 10.1016/S0091-6749(96)70086-6; Santanello NC, 1997, EUR RESPIR J, V10, P646; SCULPHER MJ, 1993, PHARMACOECONOMICS, V4, P345, DOI 10.2165/00019053-199304050-00005; SPECTOR SL, 1994, AM J RESP CRIT CARE, V150, P618, DOI 10.1164/ajrccm.150.3.8087328; TRIGG CJ, 1994, AM J RESP CRIT CARE, V150, P17, DOI 10.1164/ajrccm.150.1.8025745	33	471	487	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	1999	130	6					487	+		10.7326/0003-4819-130-6-199903160-00005	http://dx.doi.org/10.7326/0003-4819-130-6-199903160-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	176RL	10075616				2022-12-28	WOS:000079165500004
J	Kandela, P				Kandela, P			Antisepsis	LANCET			English	Editorial Material											Kandela, P (corresponding author), 29 Greenlands Rd, Staines TW18 4LR, Middx, England.								0	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 13	1999	353	9156					937	937		10.1016/S0140-6736(05)75056-X	http://dx.doi.org/10.1016/S0140-6736(05)75056-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BU	10094027				2022-12-28	WOS:000079421400074
J	Dobroszycki, J; Herwaldt, BL; Boctor, F; Miller, JR; Linden, J; Eberhard, ML; Yoon, JJ; Ali, NM; Tanowitz, HB; Graham, F; Weiss, LM; Wittner, M				Dobroszycki, J; Herwaldt, BL; Boctor, F; Miller, JR; Linden, J; Eberhard, ML; Yoon, JJ; Ali, NM; Tanowitz, HB; Graham, F; Weiss, LM; Wittner, M			A cluster of transfusion-associated babesiosis cases traced to a single asymptomatic donor	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LYME-DISEASE; INFECTIONS; MICROTI; ATOVAQUONE	Context The risk of acquiring babesiosis by blood transfusion is largely unknown since in areas where it is endemic it is often an asymptomatic infection. Objective To investigate and treat a duster of blood transfusion-associated babesiosis cases, Design Case series and epidemiologic investigation. Setting Urban inner-city hospital. Patients Six persons who received Babesia microti-infected blood components from a donor, Main Outcome Measure Diagnosis and successful therapy of babesiosis following transfusion. Results Six individuals (1 adult, 1 child, and 4 neonates) were exposed to products from a single blood donation by an asymptomatic Babesia-infected donor. Three of the 6 exposed patients became parasitemic, Polymerase chain reaction testing, animal inoculation studies, and indirect immunofluorescent antibody testing were used to confirm the presence of Babesia microti in the donor's blood and to establish the presence of infection in 3 of the 6 recipients, The 3 infected recipients and 1 additional recipient were treated without incident. Conclusion Physicians should consider babesiosis in the differential diagnosis of a febrile hemolytic disorder after blood transfusion. Prompt diagnosis is important since babesiosis is responsive to antibiotic therapy and, untreated, can be a fatal disease in certain risk groups.	Bronx Lebanon Hosp Ctr, Dept Pediat, Bronx, NY 10456 USA; Bronx Lebanon Hosp Ctr, Dept Pathol, Bronx, NY 10456 USA; Ctr Dis Control & Prevent, Div Parasit Dis, Atlanta, GA USA; New York City Dept Hlth, Parasit Dis Surveillance Unit, New York, NY 10013 USA; New York State Dept Hlth, Albany, NY USA; Albert Einstein Coll Med, Dept Pathol, Div Parasitol & Trop Med, New York, NY USA; Albert Einstein Coll Med, Dept Med, New York, NY USA; Jacobi Med Ctr, Dept Pathol Parasitol, Bronx, NY USA	BronxCare Health System; BronxCare Health System; Centers for Disease Control & Prevention - USA; New York City Department of Health & Mental Hygiene; State University of New York (SUNY) System; Yeshiva University; Yeshiva University; Jacobi Medical Center	Wittner, M (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Div Parasitol & Trop Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	Wittner@aecom.yu.edu						CHUNG APS, 1998, AM SOC PAR LAWR KAN, P63; CLARK IA, 1974, NATURE, V252, P328, DOI 10.1038/252328a0; DAMMIN GJ, 1981, HUM PATHOL, V12, P398, DOI 10.1016/S0046-8177(81)80020-2; EBERHARD ML, 1995, J PARASITOL, V81, P790, DOI 10.2307/3283978; Falagas ME, 1996, CLIN INFECT DIS, V22, P809, DOI 10.1093/clinids/22.5.809; GERBER MA, 1994, J INFECT DIS, V170, P231, DOI 10.1093/infdis/170.1.231; HUGHES WT, 1995, J INFECT DIS, V172, P1042, DOI 10.1093/infdis/172.4.1042; Krause PJ, 1998, NEW ENGL J MED, V339, P160, DOI 10.1056/NEJM199807163390304; KRAUSE PJ, 1991, J CLIN MICROBIOL, V29, P1; KRAUSE PJ, 1997, 46 ANN M AM SOC TROP, P247; LYKINS JD, 1975, EXP PARASITOL, V377, P388; OZSOYLU S, 1977, J PEDIATR-US, V90, P560, DOI 10.1016/S0022-3476(77)80366-1; PADMANABHAN J, 1973, JOHNS HOPKINS MED J, V132, P146; PERSING DH, 1992, J CLIN MICROBIOL, V30, P2097, DOI 10.1128/JCM.30.8.2097-2103.1992; POPOVSKY MA, 1991, TRANSFUSION, V31, P296, DOI 10.1046/j.1537-2995.1991.31491213290.x; ROSNER F, 1984, AM J MED, V76, P696, DOI 10.1016/0002-9343(84)90298-5; ROWIN KS, 1984, T ROY SOC TROP MED H, V78, P442, DOI 10.1016/0035-9203(84)90054-3; SHULMAN IA, 1994, ARCH PATHOL LAB MED, V118, P366; SPIELMAN A, 1985, ANNU REV ENTOMOL, V30, P439, DOI 10.1146/annurev.en.30.010185.002255; *US GEN ACC OFF, 1997, PUBL; WESTPHAL R, 1991, TRANSFUSION TRANSMIT, P181; WILSON CB, 1986, J PEDIATR-US, V108, P1, DOI 10.1016/S0022-3476(86)80761-2; Wittner M, 1996, AM J TROP MED HYG, V55, P219, DOI 10.4269/ajtmh.1996.55.219; WITTNER M, 1982, ANN INTERN MED, V96, P601, DOI 10.7326/0003-4819-96-5-601; WITTNER M, 1997, TXB INTERNAL MED, P1808	25	68	70	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	1999	281	10					927	930		10.1001/jama.281.10.927	http://dx.doi.org/10.1001/jama.281.10.927			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172XH	10078490	Bronze			2022-12-28	WOS:000078950600038
J	Rudolph, KL; Chang, S; Lee, HW; Blasco, M; Gottlieb, GJ; Greider, C; DePinho, RA				Rudolph, KL; Chang, S; Lee, HW; Blasco, M; Gottlieb, GJ; Greider, C; DePinho, RA			Longevity, stress response, and cancer in aging telomerase-deficient mice	CELL			English	Article							LIFE-SPAN; CELLULAR SENESCENCE; SACCHAROMYCES-CEREVISIAE; REPLICATIVE SENESCENCE; HUMAN FIBROBLASTS; HUMAN-LYMPHOCYTES; MOUSE CELLS; LENGTH; AGE; MORPHOLOGY	Telomere maintenance is thought to play a role in signaling cellular senescence; however, a link with organismal aging processes has not been established. The telomerase null mouse provides an opportunity to understand the effects associated with critical telomere shortening at the organismal level. We studied a variety of physiological processes in an aging cohort of mTR(-/-) mice. Loss of telomere function did not elicit a full spectrum of classical pathophysiological symptoms of aging. However, age-dependent telomere shortening and accompanying genetic instability were associated with shortened life span as well as a reduced capacity to respond to stresses such as wound healing and hematopoietic ablation. In addition, we found an increased incidence of spontaneous malignancies. These findings demonstrate a critical role for telomere length in the overall fitness, reserve, and well being of the aging organism.	Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med & Genet, Boston, MA 02110 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02110 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02110 USA; Quest diagnost Inc, Anat Pathol, Teterboro, NJ 07608 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Sungkyunkwan Univ, Sch Med, Ctr Mol Med, Samsung Biomed Res Inst, Seoul 135230, South Korea; Natl Biotechnol Ctr, Dept Immunol & Oncol, E-28049 Madrid, Spain	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Johns Hopkins University; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center	DePinho, RA (corresponding author), Dana Farber Canc Inst, Dept Adult Oncol, 44 Binney St,M413, Boston, MA 02115 USA.	ron_depinho@dfci.harvard.edu	Blasco, Maria A./M-1694-2014	Blasco, Maria A./0000-0002-4211-233X; DePinho, Ronald/0000-0002-5625-577X; Rudolph, Karl Lenhard/0000-0002-4839-2862; Greider, Carol/0000-0002-5494-8126	NIA NIH HHS [K08 AG001019] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K08AG001019] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Ashcroft GS, 1997, J ANAT, V190, P351, DOI 10.1046/j.1469-7580.1997.19030351.x; Ashcroft GS, 1997, J INVEST DERMATOL, V108, P430, DOI 10.1111/1523-1747.ep12289705; Austriaco NR, 1997, P NATL ACAD SCI USA, V94, P9768, DOI 10.1073/pnas.94.18.9768; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Campisi J, 1997, EUR J CANCER, V33, P703, DOI 10.1016/S0959-8049(96)00058-5; Campisi J, 1998, J Investig Dermatol Symp Proc, V3, P1; CHANG E, 1995, P NATL ACAD SCI USA, V92, P11190, DOI 10.1073/pnas.92.24.11190; CHEN TS, 1990, J GERONTOL, V45, pB129, DOI 10.1093/geronj/45.4.B129; COOKE HJ, 1986, COLD SPRING HARB SYM, V51, P213, DOI 10.1101/SQB.1986.051.01.026; Counter CM, 1996, MUTAT RES-REV GENET, V366, P45, DOI 10.1016/S0165-1110(96)90006-8; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; COURTOIS M, 1994, SKIN PHARMACOL, V7, P84; COURTOIS M, 1995, BRIT J DERMATOL, V132, P86, DOI 10.1111/j.1365-2133.1995.tb08630.x; DELANGE T, 1994, P NATL ACAD SCI USA, V91, P2882, DOI 10.1073/pnas.91.8.2882; DELANGE T, 1995, TELOMERES, P265; DMELLO NP, 1991, J BACTERIOL, V173, P6709, DOI 10.1128/jb.173.21.6709-6713.1991; DORMAN JB, 1995, GENETICS, V141, P1399; Effros RB, 1996, AIDS, V10, pF17, DOI 10.1097/00002030-199607000-00001; ELANGE T, 1998, SCIENCE, V27, P334; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; GOODRICK CL, 1977, GERONTOLOGY, V23, P405, DOI 10.1159/000212216; Greenberg RA, 1998, ONCOGENE, V16, P1723, DOI 10.1038/sj.onc.1201933; Greider CW, 1998, CURR BIOL, V8, pR178, DOI 10.1016/S0960-9822(98)70105-8; GREIDER CW, 1996, NAN REV BIOCH, V65, P337; Guarente L, 1996, CELL, V86, P9, DOI 10.1016/S0092-8674(00)80072-0; HAENEY M, 1994, J ANTIMICROB CHEMOTH, V34, P1; HANDE P, 1999, IN PRESS J CELL BIOL; Harley CB, 1997, CANCER SURV, V29, P263; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Harley CB, 1997, CIBA F SYMP, V211, P139; Harley CB, 1997, CIBA F SYMP, V211, P129; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; HERRERA E, 1999, IN PRESS EMBO J; HOLT DR, 1992, SURGERY, V112, P293; Hultdin M, 1998, NUCLEIC ACIDS RES, V26, P3651, DOI 10.1093/nar/26.16.3651; Ingram D K, 1987, Basic Life Sci, V42, P247; Jazwinski SM, 1996, SCIENCE, V273, P54, DOI 10.1126/science.273.5271.54; Johnson FB, 1998, CURR OPIN CELL BIOL, V10, P332, DOI 10.1016/S0955-0674(98)80008-2; Jurivich DA, 1997, MECH AGEING DEV, V94, P233, DOI 10.1016/S0047-6374(96)01856-8; KEELAN M, 1985, MECH AGEING DEV, V31, P49, DOI 10.1016/0047-6374(85)90026-0; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; LINDSEY J, 1991, MUTAT RES, V256, P45, DOI 10.1016/0921-8734(91)90032-7; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; Pathak S., 1994, In Vivo (Attiki), V8, P843; PRETLOW TP, 1991, CANCER RES, V51, P1564; PROWSE KR, 1993, P NATL ACAD SCI USA, V90, P1493, DOI 10.1073/pnas.90.4.1493; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; Rufer N, 1998, NAT BIOTECHNOL, V16, P743, DOI 10.1038/nbt0898-743; SALK D, 1982, J AM GERIATR SOC, V30, P334, DOI 10.1111/j.1532-5415.1982.tb05624.x; Shay JW, 1997, J CELL PHYSIOL, V173, P266, DOI 10.1002/(SICI)1097-4652(199711)173:2<266::AID-JCP33>3.0.CO;2-B; Sinclair DA, 1998, TRENDS BIOCHEM SCI, V23, P131, DOI 10.1016/S0968-0004(98)01188-8; Smeal T, 1997, CURR OPIN GENET DEV, V7, P281, DOI 10.1016/S0959-437X(97)80139-6; STANULISPRAEGER BM, 1987, MECH AGEING DEV, V38, P1, DOI 10.1016/0047-6374(87)90109-6; VAZIRI H, 1993, AM J HUM GENET, V52, P661; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Weinberg RA, 1998, NATURE, V396, P23, DOI 10.1038/23825; WRIGHT WE, 1992, EXP GERONTOL, V27, P383, DOI 10.1016/0531-5565(92)90069-C; Wright WE, 1996, DEV GENET, V18, P173; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423; Zivicnjak M, 1997, COLLEGIUM ANTROPOL, V21, P117	65	1049	1099	8	109	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	1999	96	5					701	712		10.1016/S0092-8674(00)80580-2	http://dx.doi.org/10.1016/S0092-8674(00)80580-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	174TB	10089885	Green Published, Bronze			2022-12-28	WOS:000079050100013
J	Peters, R; Sikorski, R				Peters, R; Sikorski, R			Difference mapping Cryo-EM	SCIENCE			English	Article																		Conway JF, 1998, P NATL ACAD SCI USA, V95, P14622, DOI 10.1073/pnas.95.25.14622	1	2	2	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 19	1999	283	5405					1133	1133						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169GD	10075576				2022-12-28	WOS:000078738400040
J	Arcasoy, SM; Kotloff, RM				Arcasoy, SM; Kotloff, RM			Medical progress - Lung transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BRONCHIOLITIS OBLITERANS SYNDROME; MUSCLE MITOCHONDRIAL RESPIRATION; MECHANICALLY VENTILATED PATIENTS; PRIMARY GRAFT FAILURE; HIGH-RESOLUTION CT; QUALITY-OF-LIFE; HEART-LUNG; CYSTIC-FIBROSIS; PULMONARY-HYPERTENSION; INFECTIOUS COMPLICATIONS		Univ Penn, Med Ctr, Div Pulm & Crit Care, Program Adv Lung Dis & Lung Transplantat, Philadelphia, PA 19104 USA	University of Pennsylvania	Kotloff, RM (corresponding author), Univ Penn, Med Ctr, Div Pulm & Crit Care, Program Adv Lung Dis & Lung Transplantat, 3400 Spruce St, Philadelphia, PA 19104 USA.	kotloff@mail.med.upenn.edu	Arcasoy, Selim M/AAR-6637-2020; Kotloff, Robert/R-2579-2019					Anderson MB, 1997, J HEART LUNG TRANSPL, V16, P752; Aris RM, 1997, AM J RESP CRIT CARE, V155, P1699, DOI 10.1164/ajrccm.155.5.9154879; Azuma H, 1996, P NATL ACAD SCI USA, V93, P12439, DOI 10.1073/pnas.93.22.12439; BANDO K, 1995, J THORAC CARDIOV SUR, V110, P4, DOI 10.1016/S0022-5223(05)80003-0; BANDO K, 1995, J THORAC CARDIOV SUR, V109, P49, DOI 10.1016/S0022-5223(95)70419-1; Barr M. L., 1998, Transplantation Proceedings, V30, P2261, DOI 10.1016/S0041-1345(98)00612-5; Bavaria JE, 1997, J THORAC CARDIOV SUR, V113, P520, DOI 10.1016/S0022-5223(97)70365-9; BECKER FS, 1994, AM J RESP CRIT CARE, V150, P159, DOI 10.1164/ajrccm.150.1.8025743; Birsan T, 1998, J HEART LUNG TRANSPL, V17, P437; Cahill BC, 1997, CHEST, V112, P1160, DOI 10.1378/chest.112.5.1160; Caine N, 1996, J HEART LUNG TRANSPL, V15, P1047; Chacon RA, 1998, THORAX, V53, P43, DOI 10.1136/thx.53.1.43; CHAMBERLAIN D, 1994, J HEART LUNG TRANSPL, V13, P963; Christie JD, 1998, CHEST, V114, P51, DOI 10.1378/chest.114.1.51; COOPER JD, 1993, J HEART LUNG TRANSPL, V12, P713; Date H, 1998, J HEART LUNG TRANSPL, V17, P869; DATE H, 1995, J THORAC CARDIOV SUR, V110, P1424, DOI 10.1016/S0022-5223(95)70065-X; Date H, 1996, J THORAC CARDIOV SUR, V111, P913, DOI 10.1016/S0022-5223(96)70364-1; DENNIS C, 1993, J HEART LUNG TRANSPL, V12, P893; DETTERBECK FC, 1995, ANN THORAC SURG, V60, P139; Dorling A, 1997, LANCET, V349, P867, DOI 10.1016/S0140-6736(96)09404-4; DUNCAN SR, 1992, AM REV RESPIR DIS, V146, P1419, DOI 10.1164/ajrccm/146.6.1419; DUNCAN SR, 1994, AM J RESP CRIT CARE, V150, P146, DOI 10.1164/ajrccm.150.1.8025741; Dusmet M, 1996, J HEART LUNG TRANSPL, V15, P948; Dusmet M, 1996, J HEART LUNG TRANSPL, V15, P249; Etienne B, 1997, CHEST, V112, P1423, DOI 10.1378/chest.112.5.1423; ETTINGER NA, 1993, AM REV RESPIR DIS, V147, P1017, DOI 10.1164/ajrccm/147.4.1017; Evans AB, 1997, AM J RESP CRIT CARE, V155, P615, DOI 10.1164/ajrccm.155.2.9032203; FLUME PA, 1994, AM J RESP CRIT CARE, V149, P1601, DOI 10.1164/ajrccm.149.6.7516251; FLUME PA, 1994, J HEART LUNG TRANSPL, V13, P15; Gammie, 1998, J THORAC CARDIOV SUR, V115, P731; Gammie JS, 1998, J THORAC CARDIOV SUR, V115, P397, DOI 10.1016/S0022-5223(98)70284-3; Girgis RE, 1996, J HEART LUNG TRANSPL, V15, P1200; GLASSMAN LR, 1995, J THORAC CARDIOV SUR, V110, P723, DOI 10.1016/S0022-5223(95)70104-4; GOLDBERG M, 1983, J THORAC CARDIOV SUR, V85, P821; GROSS CR, 1995, CHEST, V108, P1587, DOI 10.1378/chest.108.6.1587; GROSSMAN RF, 1990, NEW ENGL J MED, V322, P727, DOI 10.1056/NEJM199003153221104; GUILINGER RA, 1995, AM J RESP CRIT CARE, V152, P2037, DOI 10.1164/ajrccm.152.6.8520773; Hauptman PJ, 1997, NEW ENGL J MED, V336, P422, DOI 10.1056/NEJM199702063360607; Hausen B, 1997, CLIN CHEST MED, V18, P353, DOI 10.1016/S0272-5231(05)70384-1; HAYDEN AM, 1993, TRANSPLANTATION, V55, P1048, DOI 10.1097/00007890-199305000-00019; HAYDOCK DA, 1992, ANN THORAC SURG, V53, P635, DOI 10.1016/0003-4975(92)90324-W; Heng D, 1998, J HEART LUNG TRANSPL, V17, P1255; HOKANSON JF, 1995, AM J RESP CRIT CARE, V151, P1848, DOI 10.1164/ajrccm.151.6.7767529; Hosenpud JD, 1998, LANCET, V351, P24, DOI 10.1016/S0140-6736(97)06405-2; Hosenpud JD, 1998, J HEART LUNG TRANSPL, V17, P656; Iacono AT, 1996, AM J RESP CRIT CARE, V153, P1451, DOI 10.1164/ajrccm.153.4.8616581; Ikonen T, 1997, CHEST, V111, P370, DOI 10.1378/chest.111.2.370; KEENAN RJ, 1995, ANN THORAC SURG, V60, P580, DOI 10.1016/0003-4975(95)00407-C; KESTEN S, 1995, AM J RESP CRIT CARE, V152, P1321, DOI 10.1164/ajrccm.152.4.7551389; Kesten S, 1997, J HEART LUNG TRANSPL, V16, P905; KRAMER MR, 1991, AM REV RESPIR DIS, V144, P552, DOI 10.1164/ajrccm/144.3_Pt_1.552; KRAMER MR, 1993, ARCH INTERN MED, V153, P2010, DOI 10.1001/archinte.153.17.2010; KRAMER MR, 1994, AM J CARDIOL, V73, P494, DOI 10.1016/0002-9149(94)90681-5; KRIETT JM, 1993, J HEART LUNG TRANSPL, V12, P915; Kshettry VR, 1997, ANN THORAC SURG, V63, P1576, DOI 10.1016/S0003-4975(97)83852-0; LEVINE SM, 1994, CHEST, V105, P837, DOI 10.1378/chest.105.3.837; LEVY RD, 1993, J HEART LUNG TRANSPL, V12, P27; LOW DE, 1992, CHEST, V101, P8, DOI 10.1378/chest.101.1.8; MASSARD G, 1993, ANN THORAC SURG, V55, P1087, DOI 10.1016/0003-4975(93)90012-7; MAURER JR, 1992, CHEST, V101, P1056, DOI 10.1378/chest.101.4.1056; Maurer JR, 1998, J HEART LUNG TRANSPL, V17, P703; Maziak DE, 1996, ANN THORAC SURG, V61, P170, DOI 10.1016/0003-4975(95)00823-3; MERCIER JG, 1995, AM J RESP CRIT CARE, V151, P1532, DOI 10.1164/ajrccm.151.5.7735611; MILLET B, 1989, AM REV RESPIR DIS, V140, P62, DOI 10.1164/ajrccm/140.1.62; MORRISH WF, 1991, RADIOLOGY, V179, P487, DOI 10.1148/radiology.179.2.2014297; NATHAN SD, 1995, CHEST, V107, P967, DOI 10.1378/chest.107.4.967; Novick RJ, 1998, ANN THORAC SURG, V65, P227, DOI 10.1016/S0003-4975(97)01191-0; NOVICK RJ, 1993, J HEART LUNG TRANSPL, V12, P5; OTULANA BA, 1990, CHEST, V97, P353, DOI 10.1378/chest.97.2.353; Paradowski LJ, 1997, J HEART LUNG TRANSPL, V16, P524; Paris W, 1998, J HEART LUNG TRANSPL, V17, P430; PASQUE MK, 1995, CIRCULATION, V92, P2252, DOI 10.1161/01.CIR.92.8.2252; Pham SM, 1999, AM J RESP CRIT CARE, V159, P199, DOI 10.1164/ajrccm.159.1.9712041; Pigula FA, 1997, ANN THORAC SURG, V64, P1630, DOI 10.1016/S0003-4975(97)00930-2; Rao AS, 1997, TRANSPL P, V29, P1184, DOI 10.1016/S0041-1345(96)00536-2; Reichenspurner H, 1996, ANN THORAC SURG, V62, P1467, DOI 10.1016/0003-4975(96)00776-X; RITCHIE M, 1993, J AM COLL CARDIOL, V22, P1170, DOI 10.1016/0735-1097(93)90433-2; Sayegh MH, 1998, NEW ENGL J MED, V338, P1813, DOI 10.1056/NEJM199806183382506; SCHAFERS HJ, 1992, CHEST, V102, P1522, DOI 10.1378/chest.102.5.1522; Schulman LL, 1998, AM J RESP CRIT CARE, V157, P1833, DOI 10.1164/ajrccm.157.6.9707007; SHERIDAN PH, 1995, J HEART LUNG TRANSPL, V14, P684; SIBLEY RK, 1993, J HEART LUNG TRANSPL, V12, P308; SMILEY RM, 1991, ANESTHESIOLOGY, V74, P1144, DOI 10.1097/00000542-199106000-00026; SNELL GI, 1993, CHEST, V103, P466, DOI 10.1378/chest.103.2.466; Soghikian MV, 1996, J HEART LUNG TRANSPL, V15, P881; Starnes VA, 1997, J THORAC CARDIOV SUR, V114, P917, DOI 10.1016/S0022-5223(97)70005-9; Sundaresan RS, 1996, J THORAC CARDIOV SUR, V112, P1485, DOI 10.1016/S0022-5223(96)70007-7; Susanto I, 1998, CHEST, V114, P1330, DOI 10.1378/chest.114.5.1330; Systrom DM, 1998, J HEART LUNG TRANSPL, V17, P1220; Tamm M, 1997, AM J RESP CRIT CARE, V155, P1705, DOI 10.1164/ajrccm.155.5.9154880; Tirdel GB, 1998, J HEART LUNG TRANSPL, V17, P1231; TRACHIOTIS GD, 1994, ANN THORAC SURG, V58, P1709, DOI 10.1016/0003-4975(94)91667-5; TRULOCK EP, 1992, CHEST, V102, P1049, DOI 10.1378/chest.102.4.1049; *UN NETW ORG SHAR, 1997, 1997 ANN REP US SCI; Venuta F, 1998, AM J RESP CRIT CARE, V157, P292, DOI 10.1164/ajrccm.157.1.96-09068; Westney GE, 1996, TRANSPLANTATION, V61, P915, DOI 10.1097/00007890-199603270-00013; WILLIAMS TJ, 1992, AM REV RESPIR DIS, V145, P101, DOI 10.1164/ajrccm/145.1.101; Wisser W, 1996, J HEART LUNG TRANSPL, V15, P1209; Yeatman M, 1996, J HEART LUNG TRANSPL, V15, P144; Yousem SA, 1996, J HEART LUNG TRANSPL, V15, P1	101	355	363	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 8	1999	340	14					1081	1091		10.1056/NEJM199904083401406	http://dx.doi.org/10.1056/NEJM199904083401406			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	184AK	10194239				2022-12-28	WOS:000079587000006
J	Beecham, L				Beecham, L			Health service in Ulster will be less bureaucratic	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 3	1999	318	7188					947	947						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185GV	10102886				2022-12-28	WOS:000079660500069
J	Dolan, P; Cookson, R; Ferguson, B				Dolan, P; Cookson, R; Ferguson, B			Effect of discussion and deliberation on the public's views of priority setting in health care: focus group study	BRITISH MEDICAL JOURNAL			English	Article							CITIZENS JURIES	Objective To investigate the extent to which people change their views about priority setting in health care as a result of discussion and deliberation. Design A random sample of patients from two urban general practices was invited to attend two focus group meetings, a fortnight apart. Setting North Yorkshire Health Authority. Subjects 60 randomly chosen patients meeting in 10 groups of five to seven people. Main outcome measures Differences between people's views at the start of the first meeting and at the end of the second meeting, after they have had an opportunity for discussion and deliberation, measured by questionnaires at the start of the first meeting and the end of the second meeting. Results Respondents became more reticent about the role that their views should play in determining priorities and more sympathetic to the role that healthcare managers play. About a half of respondents initially wanted to give lower priority to smokers, heavy drinkers, and illegal drug users, but after discussion many no longer wished to discriminate against these people. Conclusion The public's views about setting priorities in health care are systematically different when they have been given an opportunity to discuss the issues. If the considered opinions of the general public are required, surveys that do not allow respondents time or opportunity for reflection may be of doubtful value.	Univ York, Ctr Hlth Econ, York YO1 5DD, N Yorkshire, England	University of York - UK	Dolan, P (corresponding author), Univ Sheffield, Sheffield Hlth Econ Grp, Sheffield S1 4DA, S Yorkshire, England.							Bowling A, 1996, BRIT MED J, V312, P670; BOWLING A, 1993, SOC SCI MED, V37, P851, DOI 10.1016/0277-9536(93)90138-T; Bryan J, 1997, BRIT MED J, V314, P773; DICKER A, 1995, BRIT MED J, V311, P1137, DOI 10.1136/bmj.311.7013.1137; FISCHHOFF B, 1991, AM PSYCHOL, V46, P835, DOI 10.1037/0003-066X.46.8.835; HEGINBOTHAM C, 1993, RATIONING ACTION; Jordan J, 1998, BRIT MED J, V316, P1668, DOI 10.1136/bmj.316.7145.1668; Lenaghan J, 1996, BRIT MED J, V312, P1591, DOI 10.1136/bmj.312.7046.1591; LEWIS PA, 1989, J MED ETHICS, V15, P28, DOI 10.1136/jme.15.1.28; NHS Management Executive, 1992, LOC VOIC VIEWS LOC P; RICHARDSON A, 1992, BRIT MED J, V304, P680, DOI 10.1136/bmj.304.6828.680	11	159	161	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 3	1999	318	7188					916	919		10.1136/bmj.318.7188.916	http://dx.doi.org/10.1136/bmj.318.7188.916			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	185GV	10102858	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000079660500028
J	Koch, C; Laurent, G				Koch, C; Laurent, G			Complexity and the nervous system	SCIENCE			English	Editorial Material							NEURAL ASSEMBLIES; NEURONS; NETWORKS; BRAIN	Advances in the neurosciences have revealed the staggering complexity of even "simple" nervous systems. This is reflected in their function, their evolutionary history, their structure, and the coding schemes they use to represent information. These four viewpoints need all play a role in any future science of "brain complexity."	CALTECH, Div Biol, Computat & Neural Syst Program, Pasadena, CA 91125 USA; CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Koch, C (corresponding author), CALTECH, Div Biol, Computat & Neural Syst Program, Pasadena, CA 91125 USA.	koch@klab.caltech.edu	Laurent, Gilles/A-4583-2012	Laurent, Gilles/0000-0002-2296-114X; Koch, Christof/0000-0001-6482-8067				ABBOTT LF, 1994, Q REV BIOPHYS, V27, P291, DOI 10.1017/S0033583500003024; Allman J. M., 1998, EVOLVING BRAINS; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Bennett C. H., 1987, EMERGING SYNTHESIS S; Bialek W., 1996, SPIKES EXPLORING NEU; CONRAD M, 1990, BIOSYSTEMS, V24, P61, DOI 10.1016/0303-2647(90)90030-5; Crick F, 1998, CEREB CORTEX, V8, P97, DOI 10.1093/cercor/8.2.97; DALE N, 1993, P NATL ACAD SCI USA, V90, P7163, DOI 10.1073/pnas.90.15.7163; DURBIN R, 1987, THESIS CAMBRIDGE U; GELLMAN M, 1994, QUARK JAGUAR; Gerhart J., 1997, EMBRYOS EVOLUTION; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; HARRISWARRICK RM, 1991, ANNU REV NEUROSCI, V14, P39, DOI 10.1146/annurev.ne.14.030191.000351; HAWKINS RD, 1993, ANNU REV NEUROSCI, V16, P625, DOI 10.1146/annurev.ne.16.030193.003205; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Koch Christof, 1999, P1; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; MCCANN K, 1972, NATURE, V238, P413; MOBBS PG, 1982, PHILOS T ROY SOC B, V298, P309, DOI 10.1098/rstb.1982.0086; Murphy GG, 1997, SCIENCE, V278, P467, DOI 10.1126/science.278.5337.467; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Stavenga D.G., 1989, FACETS VISION; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Strausfeld N.J., 1980, HDB SENSORY PHYSL, P1; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; Tononi G, 1998, TRENDS COGN SCI, V2, P474, DOI 10.1016/S1364-6613(98)01259-5; Tononi G, 1996, P NATL ACAD SCI USA, V93, P3422, DOI 10.1073/pnas.93.8.3422; Tononi G, 1998, SCIENCE, V282, P1846, DOI 10.1126/science.282.5395.1846; TURRIGIANO G, 1995, J NEUROSCI, V15, P3640; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; von Frisch K, 1969, DANCE LANGUAGE ORIEN; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	37	217	228	2	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	1999	284	5411					96	98		10.1126/science.284.5411.96	http://dx.doi.org/10.1126/science.284.5411.96			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182QE	10102826				2022-12-28	WOS:000079509000039
J	Khattak, S; Moghtader, GK; McMartin, K; Barrera, M; Kennedy, D; Koren, G				Khattak, S; Moghtader, GK; McMartin, K; Barrera, M; Kennedy, D; Koren, G			Pregnancy outcome following gestational exposure to organic solvents - A prospective controlled study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR MALFORMATIONS; SPONTANEOUS-ABORTIONS; FINLAND; WOMEN	Context Numerous women of childbearing age are exposed occupationally to organic solvents. Previous retrospective studies have reported conflicting results regarding teratogenic risk. Objective To evaluate pregnancy and fetal outcome following maternal occupational exposure to organic solvents. Design A prospective, observational, controlled study, Setting An antenatal counseling service in Toronto, Ontario. Patients One hundred twenty-five pregnant women who were exposed occupationally to organic solvents and seen during the first trimester between 1987 and 1996. Each pregnant woman who was exposed to organic solvents was matched to a pregnant woman who was exposed to a nonteratogenic agent on age (+/-4 years), gravidity (+/-1), and smoking and drinking status. Main Outcome Measure Occurrence of major congenital malformations. Results Significantly more major malformations occurred among fetuses of women exposed to organic solvents than controls (13 vs 1; relative risk, 13.0; 95% confidence interval, 1.8-99.5). Twelve malformations occurred among the 75 women who had symptoms temporally associated with their exposure, while none occurred among 43 asymptomatic exposed women (P<.001), (One malformation occurred in a woman for whom such information was missing.) More of these exposed women had previous miscarriage while working with organic solvents than controls (54/117 [46.2%] vs 24/125 [19.2%]; P < .001). However, exposed women who had a previous miscarriage had rates of major malformation that were similar to exposed women who had no previous miscarriage. Conclusions Occupational exposure to organic solvents during pregnancy is associated with an increased risk of major fetal malformations, This risk appears to be increased among women who report symptoms associated with organic solvent exposure. Women's exposure to organic solvents should be minimized during pregnancy. Symptomatic exposure appears to predict higher fetal risk for malformations.	Hosp Sick Children, Div Clin Pharmacol & Toxicol, Motherisk Program, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Dept Psychol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Koren, G (corresponding author), Hosp Sick Children, Div Clin Pharmacol & Toxicol, Motherisk Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.		Koren, Gideon/AAG-7726-2019	Koren, Gideon/0000-0002-9234-0875				ANDREW FD, 1979, TOXICOL APPL PHARM, V48, pA27; ANDREW FD, 1981, TOXICOLOGIST, V1, P30; DOE J, 1983, TOXICOL APPL PHARM, V3, P70; GREEN JD, 1978, TOXICOL APPL PHARM, V46, P9, DOI 10.1016/0041-008X(78)90132-1; HANSON JW, 1976, JAMA-J AM MED ASSOC, V236, P1010; HEMMINKI K, 1983, AM J IND MED, V4, P293, DOI 10.1002/ajim.4700040122; HEMSWORTH BN, 1968, J REPROD FERTIL, V17, P325; HOLMBERG PC, 1979, LANCET, V2, P177; HUDAK A, 1978, TOXICOLOGY, V11, P55, DOI 10.1016/S0300-483X(78)90439-0; JOHN JA, 1980, TOXICOL APPL PHARM, V49, pA88; Koren G, 1998, NEW ENGL J MED, V338, P1128, DOI 10.1056/NEJM199804163381607; LINDBOHM ML, 1990, AM J IND MED, V17, P449, DOI 10.1002/ajim.4700170404; McMartin KI, 1998, AM J IND MED, V34, P288, DOI 10.1002/(SICI)1097-0274(199809)34:3<288::AID-AJIM12>3.0.CO;2-Q; Schardein J., 1993, CHEM INDUCED BIRTH D, V2nd, P751; SILBERG SL, 1979, SOUTHERN MED J, V72, P1170, DOI 10.1097/00007611-197909000-00027; TIKKANEN J, 1988, AM J IND MED, V14, P197, DOI 10.1002/ajim.4700140210; TIKKANEN J, 1988, AM J IND MED, V14, P1, DOI 10.1002/ajim.4700140102; VALCIUKAS JA, 1994, DEV CONSEQUENCES, P213	18	113	118	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	1999	281	12					1106	1109		10.1001/jama.281.12.1106	http://dx.doi.org/10.1001/jama.281.12.1106			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177EP	10188661				2022-12-28	WOS:000079197100032
J	Hicks, NR; Dawes, M; Fleminger, M; Goldman, D; Hamling, J; Hicks, LJ				Hicks, NR; Dawes, M; Fleminger, M; Goldman, D; Hamling, J; Hicks, LJ			Evidence based case report - Chlamydia infection in general practice	BRITISH MEDICAL JOURNAL			English	Review									Oxfordshire Hlth Author, Directorate Publ Hlth & Hlth Policy, Oxford OX3 7LG, England; Hollow Way Med Ctr, Oxford OX4 2NJ, England	University of Oxford	Hicks, NR (corresponding author), Oxfordshire Hlth Author, Directorate Publ Hlth & Hlth Policy, Oxford OX3 7LG, England.		dawes, martin/B-1750-2013	Hicks, Nicholas/0000-0002-7214-9678				*AM COLL PHYS, 1997, BEST EV LINK MED RES; ANTMAN EM, 1992, JAMA-J AM MED ASSOC, V268, P240, DOI 10.1001/jama.268.2.240; *COCHR COLL, 1997, COCHR LIB; Davies HD, 1996, CAN MED ASSOC J, V154, P1631; LEVINE WC, 1994, SEX TRANSM DIS S, V21, P96; MCPHERSON A, 1992, OXFORD GEN PRACTICE, V24; Sackett D. L., 1997, EVIDENCE BASED MED P; Scholes D, 1996, NEW ENGL J MED, V334, P1362, DOI 10.1056/NEJM199605233342103; Stokes T, 1997, J PUBLIC HEALTH MED, V19, P222, DOI 10.1093/oxfordjournals.pubmed.a024614; 1996, BANDOLIER, V3, P4	10	8	9	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 20	1999	318	7186					790	792		10.1136/bmj.318.7186.790	http://dx.doi.org/10.1136/bmj.318.7186.790			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BX	10082708	Green Published			2022-12-28	WOS:000079421700032
J	Jawad, ASM				Jawad, ASM			Kamal Al-Samarraie - Obituary	BRITISH MEDICAL JOURNAL			English	Biographical-Item													Jawad, Ali/I-3226-2019	Jawad, Ali/0000-0002-8949-2608					0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 20	1999	318	7186					813	813		10.1136/bmj.318.7186.813	http://dx.doi.org/10.1136/bmj.318.7186.813			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BX	10082728	Green Published			2022-12-28	WOS:000079421700071
J	Taylor, P				Taylor, P			Publication time for letters - Letters are not published fast enough in the BMJ	BRITISH MEDICAL JOURNAL			English	Letter									Postgrad Med Ctr, Exeter, Devon, England	University of Exeter	Taylor, P (corresponding author), Postgrad Med Ctr, Exeter, Devon, England.								0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 20	1999	318	7186					812	812		10.1136/bmj.318.7186.812	http://dx.doi.org/10.1136/bmj.318.7186.812			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BX	10082727	Green Published			2022-12-28	WOS:000079421700069
J	Aziz, H; Popovic, ZD; Hu, NX; Hor, AM; Xu, G				Aziz, H; Popovic, ZD; Hu, NX; Hor, AM; Xu, G			Degradation mechanism of small molecule-based organic light-emitting devices	SCIENCE			English	Article							ELECTROLUMINESCENT DEVICES; IMPROVED STABILITY; DIODES	Studies on the long-term degradation of organic light-emitting devices (OLEDs) based on tris(8-hydroxyquinoline) aluminum (AlQ(3)) the most widely used electroluminescent molecule, reveal that injection of holes in AlQ(3) is the main cause of device degradation. The transport of holes into AlQ(3) caused a decrease in its fluorescence quantum efficiency, thus showing that cationic AlQ(3) species are unstable and that their degradation products are fluorescence quenchers. These findings explain the success of different approaches to stabilizing OLEDs, such as doping of the hole transport layer, introducing a buffer layer at the hole-injecting contact, and using mixed emitting layers of hole and electron transporting molecules.	Xerox Res Ctr Canada Ltd, Mississauga, ON L5K 2L1, Canada; McMaster Univ, Dept Mat Sci & Engn, Hamilton, ON, Canada	Xerox; McMaster University	Popovic, ZD (corresponding author), Xerox Res Ctr Canada Ltd, 2660 Speakman Dr, Mississauga, ON L5K 2L1, Canada.							ADACHI C, 1995, APPL PHYS LETT, V66, P2679, DOI 10.1063/1.113123; Anderson JD, 1998, J AM CHEM SOC, V120, P9646, DOI 10.1021/ja980707+; Aziz H, 1998, APPL PHYS LETT, V72, P756, DOI 10.1063/1.120867; Aziz H, 1998, APPL PHYS LETT, V72, P2642, DOI 10.1063/1.121442; BIN LB, 1997, APPL PHYS LETT, V70, P2052; BURROWS PE, 1994, APPL PHYS LETT, V65, P2922, DOI 10.1063/1.112532; HAMADA Y, 1995, JPN J APPL PHYS, V34, P824; Kido J, 1998, APPL PHYS LETT, V73, P2721, DOI 10.1063/1.122570; Malliaras GG, 1998, J APPL PHYS, V83, P5399, DOI 10.1063/1.367369; Matsumura M, 1997, SYNTHETIC MET, V91, P197, DOI 10.1016/S0379-6779(97)04009-5; McElvain J, 1996, J APPL PHYS, V80, P6002, DOI 10.1063/1.363598; Papadimitrakopoulos F, 1996, CHEM MATER, V8, P1363, DOI 10.1021/cm960152m; Popovic ZD, 1998, PROC SPIE, V3476, P68, DOI 10.1117/12.332630; Sheats JR, 1996, SCIENCE, V273, P884, DOI 10.1126/science.273.5277.884; Shen ZL, 1997, SCIENCE, V276, P2009, DOI 10.1126/science.276.5321.2009; Shi JM, 1997, APPL PHYS LETT, V70, P1665, DOI 10.1063/1.118664; TANG CW, 1989, J APPL PHYS, V65, P3610, DOI 10.1063/1.343409; VanSlyke SA, 1996, APPL PHYS LETT, V69, P2160, DOI 10.1063/1.117151; Vestweber H, 1997, SYNTHETIC MET, V91, P181, DOI 10.1016/S0379-6779(97)04014-9; Yang J, 1998, J APPL PHYS, V84, P2105, DOI 10.1063/1.368271	20	797	856	6	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 19	1999	283	5409					1900	1902		10.1126/science.283.5409.1900	http://dx.doi.org/10.1126/science.283.5409.1900			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177UC	10082460				2022-12-28	WOS:000079228600043
J	Warzecha, AK; Egelhaaf, M				Warzecha, AK; Egelhaaf, M			Variability in spike trains during constant and dynamic stimulation	SCIENCE			English	Article							VISUAL CORTICAL-NEURONS; RESPONSE VARIABILITY; INFORMATION; RELIABILITY; SYSTEM; FLY; MONKEYS; INPUTS	In a recent study, it was concluded that natural time-varying stimuli are represented more reliably in the brain than constant stimuli are. The results presented here disagree with this conclusion, although they were obtained from the same identified neuron (H1) in the fly's visual system. For large parts of the neuron's activity range, the variability of the responses was very similar for constant and time-varying stimuli and was considerably smaller than that in many visual interneurons of vertebrates.	Univ Bielefeld, Fak Biol, Lehrstuhl Neurobiol, D-33501 Bielefeld, Germany	University of Bielefeld	Warzecha, AK (corresponding author), Univ Bielefeld, Fak Biol, Lehrstuhl Neurobiol, Postfach 10 01 31, D-33501 Bielefeld, Germany.		Egelhaaf, Martin/A-9824-2010	Egelhaaf, Martin/0000-0002-9336-4270				Berry MJ, 1998, J NEUROSCI, V18, P2200; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; ECKERT H, 1980, J COMP PHYSIOL, V135, P29, DOI 10.1007/BF00660179; EGELHAAF M, 1987, BIOL CYBERN, V56, P69, DOI 10.1007/BF00317982; EGELHAAF M, 1989, J OPT SOC AM A, V6, P1070, DOI 10.1364/JOSAA.6.001070; EGELHAAF M, 1993, J NEUROSCI, V13, P4563; Geisler WS, 1997, VISUAL NEUROSCI, V14, P897, DOI 10.1017/S0952523800011627; Gershon ED, 1998, J NEUROPHYSIOL, V79, P1135, DOI 10.1152/jn.1998.79.3.1135; Gur M, 1997, J NEUROSCI, V17, P2914; Haag J, 1997, J NEUROSCI, V17, P4809; Haag J, 1996, NATURE, V379, P639, DOI 10.1038/379639a0; Hausen K., 1981, Verhandlungen der Deutschen Zoologischen Gesellschaft, V74, P49; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; MILLER JP, 1991, J NEUROPHYSIOL, V66, P1680, DOI 10.1152/jn.1991.66.5.1680; Nowak LG, 1997, CEREB CORTEX, V7, P487, DOI 10.1093/cercor/7.6.487; Shadlen MN, 1998, J NEUROSCI, V18, P3870; TOLHURST DJ, 1981, EXP BRAIN RES, V41, P414; VANSTEVENINCK RD, 1995, PHILOS T R SOC B, V348, P321; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; VOGELS R, 1989, EXP BRAIN RES, V77, P432, DOI 10.1007/BF00275002; Warzecha AK, 1997, EUR J NEUROSCI, V9, P1365, DOI 10.1111/j.1460-9568.1997.tb01491.x; Warzecha AK, 1998, CURR BIOL, V8, P359, DOI 10.1016/S0960-9822(98)70154-X	25	55	55	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 19	1999	283	5409					1927	1930		10.1126/science.283.5409.1927	http://dx.doi.org/10.1126/science.283.5409.1927			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177UC	10082467	Green Submitted			2022-12-28	WOS:000079228600051
J	Ninomiya-Tsuji, J; Kishimoto, K; Hiyama, A; Inoue, J; Cao, ZD; Matsumoto, K				Ninomiya-Tsuji, J; Kishimoto, K; Hiyama, A; Inoue, J; Cao, ZD; Matsumoto, K			The kinase TAK1 can activate the NIK-I kappa B as well as the MAP kinase cascade in the IL-1 signalling pathway	NATURE			English	Article							BETA; FAMILY; IDENTIFICATION; TRANSDUCTION; ALPHA; TNF	Interleukin-1 (IL-1) is a proinflammatory cytokine that has several effects in the inflammation profess. When it binds to its cell-surface receptor, H-l initiates a signalling cascade that leads to activation of the transcription factor NF-kappa B and is relayed through the protein TRAF6 and a succession of kinase enzymes, including NF-kappa B-inducing kinase (NIK) and I kappa B kinases (IKKs)(1-7). However, the molecular mechanism by which NIK is activated is not understood. Here we show that the MAPKK kinase TAK1 (ref. 8) acts upstream of NIK in the IL-1-activated signalling pathway and that TAK1 associates with TRAF6 during IL-1 signalling. Stimulation of TAK1 causes activation of NF-kappa B, which is blocked by dominant-negative mutants of NIK, and an inactive TAK1 mutant prevents activation of NF-kappa B that is mediated by IL-1 but not by NIK Activated TAK1 phosphorylates NIK, which stimulates IKK-alpha activity. Our results indicate that TAK1 links TRAF6 to the MIK-IKK cascade in the IL-1 signalling pathway.	Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Chikusa Ku, Nagoya, Aichi 46401, Japan; Japan Sci & Technol Corp, CREST, Chikusa Ku, Nagoya, Aichi 46401, Japan; Univ Tokyo, Inst Med Sci, Dept Oncol, Minato Ku, Tokyo 108, Japan; Tularik Inc, S San Francisco, CA 94080 USA	Nagoya University; Japan Science & Technology Agency (JST); University of Tokyo	Matsumoto, K (corresponding author), Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Chikusa Ku, Nagoya, Aichi 46401, Japan.	g44177a@nucc.cc.na-goya-u.ac.jp		Ninomiya-Tsuji, Jun/0000-0002-5584-0176				Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Karin M, 1998, P NATL ACAD SCI USA, V95, P9067, DOI 10.1073/pnas.95.16.9067; Lin X, 1998, MOL CELL BIOL, V18, P5899, DOI 10.1128/MCB.18.10.5899; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Moriguchi T, 1996, J BIOL CHEM, V271, P13675, DOI 10.1074/jbc.271.23.13675; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Sakurai H, 1998, BIOCHEM BIOPH RES CO, V243, P545, DOI 10.1006/bbrc.1998.8124; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Shirakabe K, 1997, J BIOL CHEM, V272, P8141, DOI 10.1074/jbc.272.13.8141; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; TAKAKAWA M, 1997, EMBO J, V16, P4973; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	25	964	1012	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	1999	398	6724					252	256		10.1038/18465	http://dx.doi.org/10.1038/18465			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177UA	10094049				2022-12-28	WOS:000079228400056
J	Bogardus, ST; Holmboe, E; Jekel, JF				Bogardus, ST; Holmboe, E; Jekel, JF			Perils, pitfalls, and possibilities in talking about medical risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TREATMENT DECISIONS; PROBABILITY TERMS; COMMUNICATION; PREFERENCES; PERCEPTION; PHYSICIANS; NUMBERS; CANCER; LIFE	Virtually every course of medical action is associated with some adverse risk to the patient. Discussing these risks with patients is a fundamental duty of physicians both to fulfill a role as trusted adviser and to promote the ethical principle of autonomy (particularly as embodied in the doctrine of informed consent). Discussing medical risk is a difficult task to accomplish appropriately. Challenges stem from gaps in the physician's knowledge about pertinent risks, uncertainty about how much and what kind of information to communicate, and difficulties in communicating risk information in a format that is clearly understood by most patients. For example, a discussion of the risk of undergoing a procedure should be accompanied by a discussion of the risk of not undergoing a procedure. This article describes basic characteristics of risk information, outlines major challenges in communicating risk information, and suggests several ways to communicate risk information to patients in an understandable format. Ultimately, a combination of formats (eg, qualitative, quantitative, and graphic) may best accommodate the widely varying needs, preferences, and abilities of patients. Such communication will help the physician accomplish the fundamental duty of teaching the patient the information necessary to make an informed and appropriate decision.	Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA	Yale University; Yale University	Bogardus, ST (corresponding author), Yale Univ, Sch Med, Yale New Haven Hosp, 20 York St,TMP 15, New Haven, CT 06504 USA.	bogardus@gwpo.ynhh.com						BERGER ES, 1989, ARCH INTERN MED, V149, P1507, DOI 10.1001/archinte.149.7.1507; Calman KC, 1996, BRIT MED J, V313, P799; COHEN BL, 1979, HEALTH PHYS, V36, P707, DOI 10.1097/00004032-197906000-00007; COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; FEINSTEIN AR, 1992, AM J MED, V92, P117, DOI 10.1016/0002-9343(92)90099-W; FEINSTEIN AR, 1988, SCIENCE, V242, P1257, DOI 10.1126/science.3057627; FISCHHOFF B, 1993, ANNU REV PUBL HEALTH, V14, P183, DOI 10.1146/annurev.pu.14.050193.001151; FISCHHOFF B, 1995, RISK ANAL, V15, P137, DOI 10.1111/j.1539-6924.1995.tb00308.x; FORROW L, 1992, AM J MED, V92, P121, DOI 10.1016/0002-9343(92)90100-P; KALET A, 1994, J GEN INTERN MED, V9, P402, DOI 10.1007/BF02629523; KONG A, 1986, NEW ENGL J MED, V315, P740, DOI 10.1056/NEJM198609183151206; LITTENBERG B, 1994, J GEN INTERN MED, V9, P295, DOI 10.1007/BF02599661; LLEWELLYNTHOMAS HA, 1995, MED DECIS MAKING, V15, P101, DOI 10.1177/0272989X9501500201; MALENKA DJ, 1993, J GEN INTERN MED, V8, P543, DOI 10.1007/BF02599636; MAZUR DJ, 1991, J GEN INTERN MED, V6, P237, DOI 10.1007/BF02598968; MAZUR DJ, 1990, MED DECIS MAKING, V10, P2, DOI 10.1177/0272989X9001000102; Mazur DJ, 1997, J GEN INTERN MED, V12, P114, DOI 10.1046/j.1525-1497.1997.00016.x; MAZUR DJ, 1993, J GEN INTERN MED, V8, P374, DOI 10.1007/BF02600076; MAZUR DJ, 1994, J GEN INTERN MED, V9, P268, DOI 10.1007/BF02599654; MAZUR DJ, 1993, MED DECIS MAKING, V13, P59, DOI 10.1177/0272989X9301300108; MAZUR DJ, 1998, MED RISK RIGHT INFOR; Merriam-Webster Inc, 1996, MERR WEBST COLL DICT; NAKAO MA, 1983, AM J MED, V74, P1061, DOI 10.1016/0002-9343(83)90819-7; PAUKER SG, 1981, J CHRON DIS, V34, P77, DOI 10.1016/0021-9681(81)90053-9; SACKETT DL, 1989, J CLIN EPIDEMIOL, V42, P309, DOI 10.1016/0895-4356(89)90035-8; SANDMAN PM, 1994, RISK ANAL, V14, P35, DOI 10.1111/j.1539-6924.1994.tb00026.x; SIMINOFF LA, 1989, MED DECIS MAKING, V9, P262, DOI 10.1177/0272989X8900900406; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; URQUHART J, 1988, NEW ENGL J MED, V318, P1728; Wachbroit R., 1991, Risk assessment in genetic engineering., P368; Weinstein ND, 1996, RISK ANAL, V16, P305, DOI 10.1111/j.1539-6924.1996.tb01464.x; Weiss BD, 1998, J FAM PRACTICE, V46, P168; WILSON R, 1987, SCIENCE, V236, P267, DOI 10.1126/science.3563505; WU WC, 1988, J GEN INTERN MED, V3, P9, DOI 10.1007/BF02595749	36	157	158	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	1999	281	11					1037	1041		10.1001/jama.281.11.1037	http://dx.doi.org/10.1001/jama.281.11.1037			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	175EE	10086441				2022-12-28	WOS:000079079400033
J	Hoeper, MM; Niedermeyer, J; Hoffmeyer, F; Flemming, P; Fabel, H				Hoeper, MM; Niedermeyer, J; Hoffmeyer, F; Flemming, P; Fabel, H			Pulmonary hypertension after splenectomy?	ANNALS OF INTERNAL MEDICINE			English	Article								Background: A high prevalence of asplenia has been observed in patients with unexplained pulmonary hypertension. Objective: To describe the clinical and histopathologic characteristics of patients with postsplenectomy pulmonary hypertension and to compare the prevalence of surgical asplenia in patients with idiopathic pulmonary hypertension and patients with other pulmonary diseases. Design: Case series and case-control study. Setting: University hospital in Hannover, Germany. Patients: 61 patients with pulmonary hypertension and 151 lung transplant recipients. Results: The prevalence of asplenia in patients with pulmonary hypertension was 11.5% (95% CI, 4.7% to 22.2%) compared with 0% (CI, 0% to 3.2%) in those without pulmonary hypertension (P < 0.001). Histopathologic examination of lung specimens from patients with postsplenectomy pulmonary hypertension showed intimal fibrosis, plexiform lesions, and abundant thrombotic lesions. Conclusion: Patients who have had splenectomy may be at increased risk for developing pulmonary hypertension.	Hannover Med Sch, Dept Resp Med, D-30623 Hannover, Germany	Hannover Medical School	Hoeper, MM (corresponding author), Hannover Med Sch, Dept Resp Med, D-30623 Hannover, Germany.		Hoeper, Marius C/Z-1546-2019	Hoeper, Marius C/0000-0001-9086-2293; Hoffmeyer, Frank/0000-0002-0870-4171				Abenhaim L, 1996, NEW ENGL J MED, V335, P609, DOI 10.1056/NEJM199608293350901; AESSOPOS A, 1995, CHEST, V107, P50, DOI 10.1378/chest.107.1.50; Kisanuki A, 1997, THROMB RES, V85, P95, DOI 10.1016/S0049-3848(96)00226-5; MCDONNELL PJ, 1983, AM REV RESPIR DIS, V127, P437, DOI 10.1164/arrd.1983.127.4.437; PHILPOTT GW, 1981, TXB SURG BIOL BASIS, P1311; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; Rosner B., 2011, FUNDAMENTALS BIOSTAT, V7th; Rubin LJ, 1997, NEW ENGL J MED, V336, P111, DOI 10.1056/NEJM199701093360207; Sonakul D, 1992, Southeast Asian J Trop Med Public Health, V23 Suppl 2, P25; SPEICH R, 1991, CHEST, V100, P1268, DOI 10.1378/chest.100.5.1268; Stewart GW, 1996, BRIT J HAEMATOL, V93, P303, DOI 10.1046/j.1365-2141.1996.4881033.x; Sumiyoshi A, 1992, Southeast Asian J Trop Med Public Health, V23 Suppl 2, P29	12	124	131	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	1999	130	6					506	509		10.7326/0003-4819-130-6-199903160-00014	http://dx.doi.org/10.7326/0003-4819-130-6-199903160-00014			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	176RL	10075618				2022-12-28	WOS:000079165500006
J	Marques, L; Mezouar, M; Hodeau, JL; Nunez-Regueiro, M; Serebryanaya, NR; Ivdenko, VA; Blank, VD; Dubitsky, GA				Marques, L; Mezouar, M; Hodeau, JL; Nunez-Regueiro, M; Serebryanaya, NR; Ivdenko, VA; Blank, VD; Dubitsky, GA			"Debye-Scherrer ellipses" from 3D fullerene polymers: An anisotropic pressure memory signature	SCIENCE			English	Article							STRUCTURAL PHASE-TRANSITIONS; C-60; DIAMOND; TRANSFORMATIONS; TEMPERATURE; COMPRESSION; C60; GPA	High-pressure studies on fullerenes have previously shown the existence of one- and two-dimensional (2D) polymerized C-60 structures. Synchrotron radiation measurements, performed on C-60 samples quenched from 13 gigapascals and 820 kelvin, yield unambiguous proof for the existence of a three-dimensional (3D) polymerized C-60 derivative. Moreover, unusual ellipsoidal Debye-Scherrer diffraction patterns are observed, which shows that the giant anisotropic deformation induced by the nonhydrostatic compression is retained in the quenched samples. The multiple bonding possibilities of the highly symmetrical C-60 allow the retention (down to ambient pressure) of the deformation, a phenomenon reported previously only under high pressure.	CNRS, Cristallog Lab, F-38042 Grenoble 09, France; Univ Aveiro, Dept Fis, P-3800 Aveiro, Portugal; European Synchrotron Radiat Facil, F-38041 Grenoble, France; CNRS, Ctr Rech Tres Basses Temp, F-38042 Grenoble 09, France; Russian Acad Sci, Inst Spect, Troitsk 142092, Moscow Region, Russia; Res Ctr Superhard Mat, Troitsk 142092, Moscow Region, Russia	Centre National de la Recherche Scientifique (CNRS); Universidade de Aveiro; European Synchrotron Radiation Facility (ESRF); Centre National de la Recherche Scientifique (CNRS); Russian Academy of Sciences; Institute of Spectroscopy	Hodeau, JL (corresponding author), CNRS, Cristallog Lab, Boite Postale 166, F-38042 Grenoble 09, France.	hodeau@polycnrs-gre.fr	Blank, Vladimir/A-5577-2014	Marques, Leonel/0000-0001-6809-3811				AGOFONOV V, 1997, CHEM PHYS LETT, V267, P193; BLANK VD, 1995, PHYS LETT A, V205, P208, DOI 10.1016/0375-9601(95)00564-J; BLANK VD, 1997, I PHYS C SER, V153, P593; DAVID WIF, 1993, J PHYS-CONDENS MAT, V5, P7923, DOI 10.1088/0953-8984/5/43/005; DAVID WIF, 1992, EUROPHYS LETT, V18, P735, DOI 10.1209/0295-5075/18/8/012; DAVID WIF, 1992, EUROPHYS LETT, V18, P219, DOI 10.1209/0295-5075/18/3/006; FISCHER JE, 1991, SCIENCE, V252, P1288, DOI 10.1126/science.252.5010.1288; FUNAMORI N, 1994, J APPL PHYS, V75, P4327, DOI 10.1063/1.355975; Hammersley AP, 1996, HIGH PRESSURE RES, V14, P235, DOI 10.1080/08957959608201408; HAUSERMANN D, 1998, ESRF NEWSLETTERS, V30, P25; HIRAI H, 1993, CARBON, V31, P1095, DOI 10.1016/0008-6223(93)90061-E; HIRAI H, 1995, PHYS REV B, V51, P15555, DOI 10.1103/PhysRevB.51.15555; HODEAU JL, 1994, PHYS REV B, V50, P10311, DOI 10.1103/PhysRevB.50.10311; IWASA Y, 1994, SCIENCE, V264, P1570, DOI 10.1126/science.264.5165.1570; KINSLAND GL, 1976, REV SCI INSTRUM, V47, P130, DOI 10.1063/1.1134460; MARQUES L, 1996, PHYS REV B, V54, P12663; Moret R, 1997, EUROPHYS LETT, V40, P55, DOI 10.1209/epl/i1997-00424-4; NICOL M, 1984, J PHYS-PARIS, V45, P163, DOI 10.1051/jphyscol:1984830; NUNEZREGUEIRO M, 1995, PHYS REV LETT, V74, P278, DOI 10.1103/PhysRevLett.74.278; NUNEZREGUEIRO M, 1992, NATURE, V355, P237; NUNEZREGUEIRO M, IN PRESS FULLERENE P, pCH7; OKEEFFE M, 1991, NATURE, V352, P674, DOI 10.1038/352674a0; SINGH AK, 1993, J APPL PHYS, V73, P4278, DOI 10.1063/1.352809; STROUT DL, 1993, CHEM PHYS LETT, V214, P576, DOI 10.1016/0009-2614(93)85686-I; SUNDQVIST B, 1995, SOLID STATE COMMUN, V93, P109, DOI 10.1016/0038-1098(94)00750-0; Thoms M, 1998, NUCL INSTRUM METH A, V413, P175, DOI 10.1016/S0168-9002(98)00199-5; WOLK JA, 1995, PHYS REV LETT, V74, P3483, DOI 10.1103/PhysRevLett.74.3483; YOO CS, 1991, SCIENCE, V254, P1489, DOI 10.1126/science.254.5037.1489	28	128	129	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	1999	283	5408					1720	1723		10.1126/science.283.5408.1720	http://dx.doi.org/10.1126/science.283.5408.1720			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175PF	10073934				2022-12-28	WOS:000079102800047
J	Henderson, DK				Henderson, DK			Postexposure chemoprophylaxis for occupational exposures to the human immunodeficiency virus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-CARE WORKERS; DENDRITIC CELLS; ZIDOVUDINE TREATMENT; HIV-INFECTION; LANGERHANS CELLS; RHESUS MACAQUES; SIV INFECTION; 3'-AZIDO-3'-DEOXYTHYMIDINE; TRANSMISSION; PROPHYLAXIS		NIH, Off Deputy Director Clin Care, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Henderson, DK (corresponding author), NIH, Off Deputy Director Clin Care, Warren G Magnuson Clin Ctr, Bldg 10,Room 2C146,10 Ctr Dr,MSC-1504, Bethesda, MD 20892 USA.	dkh@nih.gov						[Anonymous], 1998, MMWR Recomm Rep, V47, P1; AYEHUNIE S, 1995, AIDS RES HUM RETROV, V11, P877, DOI 10.1089/aid.1995.11.877; BLAUVELT A, 1995, J INVEST DERMATOL, V105, pS122, DOI 10.1111/1523-1747.ep12316662; Blauvelt A, 1997, J CLIN INVEST, V100, P2043, DOI 10.1172/JCI119737; Blauvelt Andrew, 1997, American Journal of Medicine, V102, P16, DOI 10.1016/S0002-9343(97)00055-7; Bottiger D, 1997, AIDS, V11, P157, DOI 10.1097/00002030-199702000-00004; BOTTIGER D, 1992, AIDS RES HUM RETROV, V8, P1235, DOI 10.1089/aid.1992.8.1235; Burke S, 1997, OCCUP MED-OXFORD, V47, P357, DOI 10.1093/occmed/47.6.357; Cameron P, 1996, J LEUKOCYTE BIOL, V59, P158, DOI 10.1002/jlb.59.2.158; Cardo DM, 1997, NEW ENGL J MED, V337, P1485, DOI 10.1056/NEJM199711203372101; *CDC, 1983, MMWR-MORBID MORTAL W, V32, P450; *CDCP, 1998, MMWR-MORBID MORTAL W, V47, P151; Centers for Disease Control (CDC), 1982, MMWR Morb Mortal Wkly Rep, V31, P577; Centers for Disease Control (CDC), 1987, MMWR Suppl, V36, p1S; Clark EA, 1996, CURR BIOL, V6, P655, DOI 10.1016/S0960-9822(09)00441-2; CLERICI M, 1994, JAMA-J AM MED ASSOC, V271, P42, DOI 10.1001/jama.271.1.42; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Garner Julia S., 1996, Infection Control and Hospital Epidemiology, V17, P53; Gerberding JL, 1996, ANN INTERN MED, V125, P497, DOI 10.7326/0003-4819-125-6-199609150-00011; GERBERDING JL, 1995, NEW ENGL J MED, V332, P444, DOI 10.1056/NEJM199502163320707; Gerberding JL, 1998, 12 INT C AIDS JUN 28; GERBERDING JL, 1991, 31ST INT C ANT AG CH, P261; HENDERSON DK, 1991, AM J MED, V91, pS312, DOI 10.1016/0002-9343(91)90388-E; HENDERSON DK, 1989, J INFECT DIS, V160, P321, DOI 10.1093/infdis/160.2.321; HENDERSON DK, 1990, AIDS UPDATES AIDS ET, P1; Henry K, 1995, Minn Med, V78, P41; HO DD, 1995, NEW ENGL J MED, V333, P450, DOI 10.1056/NEJM199508173330710; Katz MH, 1998, ANN INTERN MED, V128, P306, DOI 10.7326/0003-4819-128-4-199802150-00012; Katz MH, 1997, NEW ENGL J MED, V336, P1097, DOI 10.1056/NEJM199704103361512; LAFON SW, 1988, J INFECT DIS, V158, P503, DOI 10.1093/infdis/158.2.503; LAFON SW, 1990, 30TH INT C ANT AG CH, P167; LUNDGREN B, 1991, J ACQ IMMUN DEF SYND, V4, P489; MANGIONE CM, 1991, AM J MED, V90, P85, DOI 10.1016/0002-9343(91)90510-5; MCCLURE HM, 1990, ANN NY ACAD SCI, V616, P287; MCCRAY E, 1986, NEW ENGL J MED, V314, P1127, DOI 10.1056/NEJM198604243141729; MCCUNE JM, 1990, SCIENCE, V247, P564, DOI 10.1126/science.2300816; MITSUYA H, 1985, P NATL ACAD SCI USA, V82, P7096, DOI 10.1073/pnas.82.20.7096; PARA MF, 1992, CLIN INFECT DIS, V15, P884, DOI 10.1093/clind/15.5.884; PINTO LA, 1995, J CLIN INVEST, V96, P867, DOI 10.1172/JCI118133; POPE M, 1995, J EXP MED, V182, P2045, DOI 10.1084/jem.182.6.2045; Puro V, 1997, J BIOL REG HOMEOS AG, V11, P11; Putkonen P, 1997, J VIROL, V71, P4981, DOI 10.1128/JVI.71.7.4981-4984.1997; ROBINSON EN, 1993, CLIN INFECT DIS, V16, P357, DOI 10.1093/clind/16.3.357; RUPRECHT RM, 1986, NATURE, V323, P467, DOI 10.1038/323467a0; RUPRECHT RM, 1994, DNA CELL BIOL, V13, P59, DOI 10.1089/dna.1994.13.59; SotoRamirez LE, 1996, SCIENCE, V271, P1291, DOI 10.1126/science.271.5253.1291; Sperling RS, 1996, NEW ENGL J MED, V335, P1621, DOI 10.1056/NEJM199611283352201; Spira AI, 1996, J EXP MED, V183, P215, DOI 10.1084/jem.183.1.215; STEGER KA, 1997, 35 ANN M INF DIS SOC, P161; Tacchetti C, 1997, AM J PATHOL, V150, P533; TAMIN J, 1991, BMJ-BRIT MED J, P303; TAVARES L, 1987, CANCER RES, V47, P3190; TOKARS JI, 1993, ANN INTERN MED, V118, P913, DOI 10.7326/0003-4819-118-12-199306150-00001; TSAI CC, 1995, J INFECT DIS, V171, P1338, DOI 10.1093/infdis/171.5.1338; TSAI CC, 1995, SCIENCE, V270, P1197, DOI 10.1126/science.270.5239.1197; Tsai CC, 1998, J VIROL, V72, P4265, DOI 10.1128/JVI.72.5.4265-4273.1998; VANROMPAY KKA, 1995, ANTIMICROB AGENTS CH, V39, P125, DOI 10.1128/AAC.39.1.125; VANROMPAY KKA, 1992, ANTIMICROB AGENTS CH, V36, P2381, DOI 10.1128/AAC.36.11.2381; Wade NA, 1998, NEW ENGL J MED, V339, P1409, DOI 10.1056/NEJM199811123392001; WEISS SH, 1985, JAMA-J AM MED ASSOC, V254, P2089, DOI 10.1001/jama.254.15.2089; Wharton M, 1990, MMWR Recomm Rep, V39, P1; Zaitseva M, 1997, NAT MED, V3, P1369, DOI 10.1038/nm1297-1369; ZAMBRUNO G, 1995, IMMUNOL TODAY, V16, P520, DOI 10.1016/0167-5699(95)80044-1	63	33	33	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	1999	281	10					931	936		10.1001/jama.281.10.931	http://dx.doi.org/10.1001/jama.281.10.931			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172XH	10078491				2022-12-28	WOS:000078950600039
J	Robertson, RG				Robertson, RG			Sherry and Richard	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	1999	281	10					874	874		10.1001/jama.281.10.874-a	http://dx.doi.org/10.1001/jama.281.10.874-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172XH	10078463				2022-12-28	WOS:000078950600001
J	Mant, D				Mant, D			Can randomised trials inform clinical decisions about individual patients?	LANCET			English	Article							EVIDENCE-BASED MEDICINE; ACUTE OTITIS-MEDIA; PRIMARY-CARE		Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England	University of Oxford	Mant, D (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England.		Mant, David CA/C-7763-2009					ASHER R, 1961, LANCET, V2, P1403; Bell J, 1998, BMJ-BRIT MED J, V316, P618, DOI 10.1136/bmj.316.7131.618; BRADLEY F, IN PRESS BMJ; BREWIN CR, 1989, BRIT MED J, V299, P313, DOI 10.1136/bmj.299.6694.313; BURKE P, 1997, BRIT MED J, V303, P558; Charlton BG, 1996, J CLIN EPIDEMIOL, V49, P623, DOI 10.1016/0895-4356(96)00038-8; DelMar C, 1997, BRIT MED J, V314, P1526, DOI 10.1136/bmj.314.7093.1526; Dowie J, 1996, J Health Serv Res Policy, V1, P104; Fahey T, 1998, BRIT J GEN PRACT, V48, P1173; Fihn SD, 1996, ANN INTERN MED, V124, P970, DOI 10.7326/0003-4819-124-11-199606010-00004; FROOM J, 1990, BRIT MED J, V300, P582, DOI 10.1136/bmj.300.6724.582; GLASZIOU PP, 1995, BMJ-BRIT MED J, V311, P1356, DOI 10.1136/bmj.311.7016.1356; Guyatt GH, 1998, BRIT MED J, V316, P690, DOI 10.1136/bmj.316.7132.690; Hart JT, 1997, J EPIDEMIOL COMMUN H, V51, P623, DOI 10.1136/jech.51.6.623; Kerridge I, 1998, BMJ-BRIT MED J, V316, P1151, DOI 10.1136/bmj.316.7138.1151; Lilford RJ, 1995, J ROY SOC MED, V88, P552; McPherson K, 1997, J ROY SOC MED, V90, P652, DOI 10.1177/014107689709001205; NAYLOR CD, 1995, LANCET, V345, P840, DOI 10.1016/S0140-6736(95)92969-X; OBOYLE CA, 1993, LANCET, V342, P1126, DOI 10.1016/0140-6736(93)92116-B; OXMAN AD, 1992, ANN INTERN MED, V116, P78, DOI 10.7326/0003-4819-116-1-78; ROTHWELL PM, 1995, LANCET, V345, P1616, DOI 10.1016/S0140-6736(95)90120-5; RUCKER G, 1989, STAT MED, V8, P477, DOI 10.1002/sim.4780080411; Sackett D., 1996, EVIDENCE BASED MED P; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Senn S, 1998, BRIT MED J, V317, P537; SILAGY C, 1993, BMJ-BRIT MED J, V306, P897, DOI 10.1136/bmj.306.6882.897; Sullivan FM, 1996, LANCET, V348, P941, DOI 10.1016/S0140-6736(96)05219-1; SWEENEY KG, 1995, BRIT J GEN PRACT, V45, P153; Sweeney KG, 1998, LANCET, V351, P134, DOI 10.1016/S0140-6736(97)06316-2; vanWeel C, 1996, LANCET, V348, P1431, DOI 10.1016/S0140-6736(96)08116-0; VANWEEL C, 1996, EUR J GEN PRACT, V2, P17	31	145	151	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	1999	353	9154					743	746		10.1016/S0140-6736(98)09102-8	http://dx.doi.org/10.1016/S0140-6736(98)09102-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173DR	10073531				2022-12-28	WOS:000078966400045
J	Kleypas, JA; Buddemeier, RW; Archer, D; Gattuso, JP; Langdon, C; Opdyke, BN				Kleypas, JA; Buddemeier, RW; Archer, D; Gattuso, JP; Langdon, C; Opdyke, BN			Geochemical consequences of increased atmospheric carbon dioxide on coral reefs	SCIENCE			English	Article							SEAWATER; CO2; PRESSURE; PACIFIC; PCO(2); OCEANS; FLUX	A coral reef represents the net accumulation of calcium carbonate (CaCO3) produced by corals and other calcifying organisms. If calcification declines, then reef-building capacity also declines. Coral reef calcification depends on the saturation state of the carbonate mineral aragonite of surface waters. By the middle of the next century, an increased concentration of carbon dioxide will decrease the aragonite saturation state in the tropics by 30 percent and biogenic aragonite precipitation by 14 to 30 percent. Coral reefs are particularly threatened, because reef-building organisms secrete metastable forms of CaCO3, but the biogeochemical consequences on other calcifying marine ecosystems may be equally severe.	Natl Ctr Atmospher Res, Boulder, CO 80307 USA; Univ Kansas, Kansas Geol Survey, Lawrence, KS 66047 USA; Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; UPMC, ESA 7076 CNRS, Observ Oceanol, F-06234 Villefranche Sur Mer, France; Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Australian Natl Univ, Dept Geol, Canberra, ACT 0200, Australia	National Center Atmospheric Research (NCAR) - USA; University of Kansas; University of Chicago; UDICE-French Research Universities; Sorbonne Universite; Columbia University; Australian National University	Kleypas, JA (corresponding author), Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA.		Gattuso, Jean-Pierre/E-6631-2010; Langdon, Chris/A-1543-2016; Gattuso, Jean-Pierre/AAG-8643-2019; Archer, David/K-7371-2012	Gattuso, Jean-Pierre/0000-0002-4533-4114; Langdon, Chris/0000-0002-3043-3806; Gattuso, Jean-Pierre/0000-0002-4533-4114; Archer, David/0000-0002-4523-7912				ACEGIAN C.R., 1985, THESIS U HAWAII; Arrow Kenneth J., 1996, CLIMATE CHANGE 1995; BEHAIRY AKA, 1984, MAR GEOL, V58, P443, DOI 10.1016/0025-3227(84)90214-7; BOROWITZKA MA, 1981, MAR BIOL, V62, P17, DOI 10.1007/BF00396947; BROECKER W. S., 1985, AM GEOPHYSICAL UNION, V32, P585; Broecker WS, 1989, GLOBAL BIOGEOCHEM CY, V3, P215, DOI 10.1029/GB003i003p00215; BROECKER WS, 1966, J GEOPHYS RES, V71, P1575, DOI 10.1029/JZ071i006p01575; Buddemeier Robert W., 1994, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V13, P119; Cortes J, 1997, CORAL REEFS, V16, pS39, DOI 10.1007/s003380050240; CROSSLAND CJ, 1988, 6TH P INT COR REEF S, V1, P221; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; FAAUTIN DG, 1996, B I OCEANOGR MONACO, V14, P23; FAUTIN DG, 1996, B I OCEANOGR MONACO, V14, P33; GAO K, 1973, MAR BIOL, V177, P129; Gattuso JP, 1999, AM ZOOL, V39, P160; Gattuso JP, 1998, GLOBAL PLANET CHANGE, V18, P37, DOI 10.1016/S0921-8181(98)00035-6; Gruber N, 1998, GLOBAL BIOGEOCHEM CY, V12, P165, DOI 10.1029/97GB03658; Inoue HY, 1996, GEOPHYS RES LETT, V23, P1781, DOI 10.1029/96GL01674; Kheshgi HS, 1996, CLIMATIC CHANGE, V33, P31, DOI 10.1007/BF00140512; Kleypas JA, 1999, AM ZOOL, V39, P146; LANGDON C, 1998, SOC INT COMP BIOL AN; LEVITUS S, 1993, PROG OCEANOGR, V31, P245, DOI 10.1016/0079-6611(93)90003-V; LEVITUS S, 1994, NOAA PROFESSOINAL PA, V13; MAIERREIMER E, 1987, CLIM DYNAM, V2, P63, DOI 10.1007/BF01054491; MARUBINI F, COMMUNICATION; MILLERO FJ, 1995, GEOCHIM COSMOCHIM AC, V59, P661, DOI 10.1016/0016-7037(94)00354-O; MUCCI A, 1983, AM J SCI, V283, P780, DOI 10.2475/ajs.283.7.780; OPDYKE BN, 1993, AM J SCI, V293, P217, DOI 10.2475/ajs.293.3.217; SABINE CL, 1997, EOS, V78, P49; Sandberg P.A., 1985, SEPM SPEC PUBL, V36, P33; SMITH AD, 1979, MAR BIOL, V52, P217, DOI 10.1007/BF00398135; SMITH SV, 1992, ANNU REV ECOL SYST, V23, P89, DOI 10.1146/annurev.es.23.110192.000513; SMITH SV, 1974, PAC SCI, V28, P225; Spero HJ, 1997, NATURE, V390, P497, DOI 10.1038/37333; Takahashi T, 1997, P NATL ACAD SCI USA, V94, P8292, DOI 10.1073/pnas.94.16.8292; Veron J.E.N., 1993, AUSTR I MARINE SCI M, V10; WARE JR, 1992, CORAL REEFS, V11, P127, DOI 10.1007/BF00255465; Weiss R.F., 1974, MAR CHEM, V2, P203, DOI DOI 10.1016/0304-4203(74)90015-2	38	927	973	8	390	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 2	1999	284	5411					118	120		10.1126/science.284.5411.118	http://dx.doi.org/10.1126/science.284.5411.118			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182QE	10102806				2022-12-28	WOS:000079509000045
J	White, ET; Tang, J; Oka, T				White, ET; Tang, J; Oka, T			CH5+: The infrared spectrum observed	SCIENCE			English	Article							MOLECULAR-IONS; CARBO-IONS; PROTONATED ACETYLENE; ELECTRONIC-STRUCTURE; SPECTROSCOPY; QUANTUM; H-3(+); BAND; VIBRATION; C2H3+	Protonated methane, CH5+, has unusual vibrational and rotational behavior because its three nonequivalent equilibrium structures have nearly identical energies and its five protons scramble freely. Although many theoretical papers have been published on the quantum mechanics of the system, a better understanding requires spectral data. A complex, high-resolution infrared spectrum of CH5+ corresponding to the C-H stretching band in the 3.4-micrometer region is reported. Although no detailed assignment of the individual Lines was made, comparison with other carbocation spectra strongly, suggests that the transitions are due to CH5+.	Univ Chicago, Dept Chem, Chicago, IL 60637 USA; Univ Chicago, Dept Astron & Astrophys, Chicago, IL 60637 USA; Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Oka, T (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.		TANG, Jian/B-2574-2011	TANG, Jian/0000-0003-1488-2385				BAWENDI MG, 1990, J CHEM PHYS, V93, P6200, DOI 10.1063/1.458989; BOO DW, 1995, J CHEM PHYS, V103, P520, DOI 10.1063/1.470138; Bunker PR, 1996, J MOL SPECTROSC, V176, P297, DOI 10.1006/jmsp.1996.0090; CROFTON MW, 1983, J CHEM PHYS, V79, P3157, DOI 10.1063/1.446147; CROFTON MW, 1989, J CHEM PHYS, V91, P5139, DOI 10.1063/1.457612; CROFTON MW, 1988, J CHEM PHYS, V88, P666, DOI 10.1063/1.454194; DEFREES DJ, 1985, J CHEM PHYS, V82, P333, DOI 10.1063/1.448805; Dyczmons V, 1970, CHEM PHYS LETT, V5, P361, DOI 10.1016/0009-2614(70)85167-3; DYCZMONS V, 1974, THEOR CHIM ACTA, V33, P239, DOI 10.1007/BF00551258; East ALL, 1997, J PHYS CHEM A, V101, P6746, DOI 10.1021/jp9704628; East ALL, 1997, J MOL SPECTROSC, V183, P157, DOI 10.1006/jmsp.1997.7268; ELTENTON GC, 1940, UNPUB REPORT; GABRYS CM, 1995, J PHYS CHEM-US, V99, P15611, DOI 10.1021/j100042a042; Gamba A, 1969, CHEM PHYS LETT, V3, P20, DOI 10.1016/0009-2614(69)80007-2; GUDEMAN CS, 1983, PHYS REV LETT, V50, P727, DOI 10.1103/PhysRevLett.50.727; JAGOD MF, 1994, CAN J PHYS, V72, P1192, DOI 10.1139/p94-153; JAGOD MF, 1992, J CHEM PHYS, V97, P7111, DOI 10.1063/1.463536; Jaquet R, 1998, J CHEM PHYS, V108, P2837, DOI 10.1063/1.475703; Kolbuszewski M, 1996, J CHEM PHYS, V105, P3649, DOI 10.1063/1.472210; LATHAN WA, 1971, J AM CHEM SOC, V93, P808, DOI 10.1021/ja00753a007; LIU DJ, 1985, PHYS REV LETT, V54, P1787, DOI 10.1103/PhysRevLett.54.1787; Marx D, 1996, SCIENCE, V271, P179, DOI 10.1126/science.271.5246.179; MARX D, 1995, NATURE, V375, P216, DOI 10.1038/375216a0; Marx D, 1997, ANGEW CHEM INT EDIT, V36, P2077, DOI 10.1002/anie.199720771; MILLER S, 1990, J MOL SPECTROSC, V141, P104, DOI 10.1016/0022-2852(90)90281-T; Muller H, 1997, J CHEM PHYS, V106, P1863, DOI 10.1063/1.473340; OLAH GA, 1969, J AM CHEM SOC, V91, P3261, DOI 10.1021/ja01040a029; POPLE A, 1973, P RA WELSH FDN C CHE, P10; ROSSLEIN M, 1992, J MOL SPECTROSC, V153, P1; SCHLEYER PV, 1992, J COMPUT CHEM, V13, P997, DOI 10.1002/jcc.540130810; SCHREINER PR, 1993, J CHEM PHYS, V99, P3716, DOI 10.1063/1.466147; SCUSERIA GE, 1993, NATURE, V366, P512, DOI 10.1038/366512a0; STEVENSON DP, 1955, J CHEM PHYS, V23, P1353, DOI 10.1063/1.1742283; SUTCLIFFE BT, 1988, MOL PHYSICS CHEM BIO, V2, P313; Tal'roze V. L., 1952, DOKL AKAD NAUK SSSR, V86, P909; Van der Lugt WTAM, 1969, CHEM PHYS LETT, V4, P389, DOI 10.1016/0009-2614(69)80271-X; WATSON JKG, 1995, CHEM PHYS, V190, P291, DOI 10.1016/0301-0104(94)00293-J; WOLNIEWICZ L, 1994, J CHEM PHYS, V101, P9817, DOI 10.1063/1.467947; 1995, J CHEM PHYS, V103, P520	39	169	170	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	1999	284	5411					135	137		10.1126/science.284.5411.135	http://dx.doi.org/10.1126/science.284.5411.135			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182QE	10102811				2022-12-28	WOS:000079509000050
J	Wood, B; Collard, M				Wood, B; Collard, M			Anthropology - The human genus	SCIENCE			English	Review							BODY-MASS; AUSTRALOPITHECUS-AFRICANUS; MIDDLE PLEISTOCENE; FOSSIL HOMINIDS; HUMAN-EVOLUTION; OLDUVAI-GORGE; SOUTH-AFRICA; BRAIN-SIZE; EARLY HOMO; HYPOTHESIS		George Washington Univ, Dept Anthropol, Washington, DC 20052 USA; Smithsonian Inst, Natl Museum Amer Hist, Human Origins Program, Washington, DC 20560 USA; UCL, Dept Anthropol, London WC1E 6BT, England	George Washington University; Smithsonian Institution; Smithsonian National Museum of Natural History; University of London; University College London	Wood, B (corresponding author), George Washington Univ, Dept Anthropol, 2110 G St NW, Washington, DC 20052 USA.	bwood@gwu.edu		Collard, Mark/0000-0002-2725-4989	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABITBOL MM, 1995, AM J PHYS ANTHROPOL, V96, P143, DOI 10.1002/ajpa.1330960204; ABITBOL MM, 1994, J HUM EVOL, V28, P211; Aiello L, 1990, INTRO HUMAN EVOLUTIO; AIELLO LC, 1994, AM J PHYS ANTHROPOL, V95, P409, DOI 10.1002/ajpa.1330950405; AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Behrensmeyer AK, 1997, SCIENCE, V278, P1589, DOI 10.1126/science.278.5343.1589; Berger LR, 1996, J HUM EVOL, V30, P343, DOI 10.1006/jhev.1996.0027; Chamberlain A.T., 1987, THESIS U LIVERPOOL; CHAMBERLAIN AT, 1987, J HUM EVOL, V16, P118; CLARKE RJ, 1995, SCIENCE, V269, P521, DOI 10.1126/science.7624772; CLAYTON W D, 1983, Kew Bulletin, V38, P149, DOI 10.2307/4108098; Corruccini R.S., 1994, INTEGRATIVE PATHS PA, P167; DEACON TW, 1990, INT J PRIMATOL, V11, P237, DOI 10.1007/BF02192870; DEAN MC, 1986, AM J PHYS ANTHROPOL, V70, P301, DOI 10.1002/ajpa.1330700305; DEAN MC, 1982, AM J PHYS ANTHROPOL, V59, P157, DOI 10.1002/ajpa.1330590206; DEAN MC, 1995, ASPECTS DENT BIOL PA, P239; DEQUEIROZ K, 1994, TRENDS ECOL EVOL, V9, P27, DOI 10.1016/0169-5347(94)90231-3; DUNBAR RIM, 1995, J HUM EVOL, V28, P287, DOI 10.1006/jhev.1995.1021; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Galaburda A.M., 1982, P203; Gannon PJ, 1998, SCIENCE, V279, P220, DOI 10.1126/science.279.5348.220; Grausz H.M., 1988, P127; Groves C., 1989, THEORY HUMAN PRIMATE; HARTWIGSCHERER S, 1993, AM J PHYS ANTHROPOL, V92, P17, DOI 10.1002/ajpa.1330920103; Henneberg M., 1995, Evolutionary Theory, V11, P31; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Howell F.C., 1978, P154; HOWELL FC, 1965, CURR ANTHROPOL, V6, P399; Hunt KD, 1996, S AFR J SCI, V92, P77; JOHANSON DC, 1987, NATURE, V327, P205, DOI 10.1038/327205a0; Kappelman J, 1996, J HUM EVOL, V30, P243, DOI 10.1006/jhev.1996.0021; KIBUNJIA M, 1994, J HUM EVOL, V27, P159, DOI 10.1006/jhev.1994.1040; Knox EB, 1998, BIOL J LINN SOC, V63, P1; LATIMER B, ORIGINES BIPEDIE CHE, V169, P91; LEAKEY LSB, 1964, NATURE, V202, P7, DOI 10.1038/202007a0; Lieberman DE, 1996, J HUM EVOL, V30, P97, DOI 10.1006/jhev.1996.0008; MacLatchy LM, 1996, J HUM EVOL, V31, P455, DOI 10.1006/jhev.1996.0071; MADDISON WP, 1992, MACCLADE ANAL PHYLOG; Martin R.D., 1983, HUMAN BRAIN EVOLUTIO; MAYR E, 1950, COLD SPRING HARB SYM, V15, P109, DOI 10.1101/SQB.1950.015.01.013; MCHENRY HM, 1994, J HUM EVOL, V27, P77, DOI 10.1006/jhev.1994.1036; MCHENRY HM, 1991, AM J PHYS ANTHROPOL, V86, P445, DOI 10.1002/ajpa.1330860402; Moggi-Cecchi J, 1998, AM J PHYS ANTHROPOL, V106, P425, DOI 10.1002/(SICI)1096-8644(199808)106:4<425::AID-AJPA2>3.0.CO;2-I; MOGGICECCHI J, I VENETO SCI LETT AR, V2; Ohman JC, 1997, AM J PHYS ANTHROPOL, V104, P117, DOI 10.1002/(SICI)1096-8644(199709)104:1<117::AID-AJPA8>3.0.CO;2-O; Passingham R.E., 1974, International Rev Neurobiol, V16, P233, DOI 10.1016/S0074-7742(08)60198-1; Preuschoft H., 1991, P59; Reed KE, 1997, J HUM EVOL, V32, P289, DOI 10.1006/jhev.1996.0106; Rightmire GP, 1996, J HUM EVOL, V31, P21; ROBERTS MB, 1994, NATURE, V369, P311, DOI 10.1038/369311a0; ROBINSON JT, 1965, NATURE, V205, P121, DOI 10.1038/205121a0; ROCHE H, 1989, OSSA, V14, P97; ROCHE H, 1996, 1 HUMANS THEIR CULTU, P55; Ruff CB, 1997, NATURE, V387, P173, DOI 10.1038/387173a0; Ruff Christopher B., 1993, P234; Ruff Christopher B., 1994, Yearbook of Physical Anthropology, V37, P65; Schmid P., 1991, P225; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; SMITH BH, 1994, AM J PHYS ANTHROPOL, V94, P307, DOI 10.1002/ajpa.1330940303; Smith RJ, 1996, CURR ANTHROPOL, V37, P309, DOI [DOI 10.1086/204505, 10.1086/204505]; SPOOR F, 1994, NATURE, V369, P645, DOI 10.1038/369645a0; STEVENS PF, 1984, KEW B, V40, P457; Strait DS, 1997, J HUM EVOL, V32, P17, DOI 10.1006/jhev.1996.0097; STRINGER CB, 1987, J HUM EVOL, V16, P135, DOI 10.1016/0047-2484(87)90064-9; SUSMAN RL, 1994, SCIENCE, V265, P1570, DOI 10.1126/science.8079169; Susman RL, 1998, J HUM EVOL, V35, P23, DOI 10.1006/jhev.1998.0220; SUSMAN RL, 1979, AM J PHYS ANTHROPOL, V51, P311, DOI 10.1002/ajpa.1330510303; Tardieu C, 1998, AM J PHYS ANTHROPOL, V107, P163; TATTERSALL I, 1992, J HUM EVOL, V22, P341, DOI 10.1016/0047-2484(92)90064-G; TATTERSALL I, 1986, J HUM EVOL, V15, P165, DOI 10.1016/S0047-2484(86)80043-4; TATTERSALL I, 1994, EVOL ANTHROPOL, V3, P114; TATTERSALL I, 1992, J HUM EVOL, V22, P351; Tobias P. V., 1991, SKULLS ENDOCASTS TEE, VIV; TOBIAS PV, CLASSIFICATION HUMAN, P196; Trinkaus E, 1998, NEANDERTALS AND MODERN HUMANS IN WESTERN ASIA, P391; Valentine JW, 1996, PALEOBIOLOGY, V22, P23, DOI 10.1017/S0094837300015992; Vrba ES, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P24; WALKER A, 1976, EARLIEST MAN ENV LAK, P484; WHEELER PE, 1993, J HUM EVOL, V24, P13, DOI 10.1006/jhev.1993.1003; Wolpoff Milford H., 1994, Courier Forschungsinstitut Senckenberg, V171, P341; WOOD B, 1994, AM J PHYS ANTHROPOL, V95, P117, DOI 10.1002/ajpa.1330950202; WOOD B, 1992, NATURE, V355, P783, DOI 10.1038/355783a0; Wood B, 1998, AM J PHYS ANTHROPOL, V105, P523, DOI 10.1002/(SICI)1096-8644(199804)105:4<523::AID-AJPA9>3.0.CO;2-O; Wood B, 1996, BIOESSAYS, V18, P945, DOI 10.1002/bies.950181204; Wood B., 1991, HOMINID CRANIAL REMA, V4; Wood BA, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P438; [No title captured]; [No title captured]	88	445	462	0	215	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	1999	284	5411					65	+		10.1126/science.284.5411.65	http://dx.doi.org/10.1126/science.284.5411.65			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182QE	10102822				2022-12-28	WOS:000079509000030
J	D'Onofrio, G; Rathlev, NK; Ulrich, AS; Fish, SS; Freedland, ES				D'Onofrio, G; Rathlev, NK; Ulrich, AS; Fish, SS; Freedland, ES			Lorazepam for the prevention of recurrent seizures related to alcohol	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WITHDRAWAL SEIZURES; STATUS EPILEPTICUS; LIVER-DISEASE; RISK FACTOR; DIAZEPAM; MANAGEMENT; PHARMACOKINETICS; BENZODIAZEPINES; INTOXICATION; CONSUMPTION	Background and Methods Alcohol abuse is one of the most common causes of seizures in adults. In a randomized, double-blind study, we compared lorazepam with placebo for the prevention of recurrent seizures related to alcohol. Over a 21-month period, we studied consecutive patients with chronic alcohol abuse who were at least 21 years of age and who presented to the emergency departments of two hospitals in Boston after a witnessed, generalized seizure. The patients were randomly assigned to receive either 2 mg of lorazepam in 2 ml of normal saline or 4 ml of normal saline intravenously and then observed for six hours. The primary end point was the occurrence of a second seizure during the observation period. Results Of the 229 patients who were initially evaluated, 186 met the entry criteria. In the lorazepam group, 3 of 100 patients (3 percent) had a second seizure, as compared with 21 of 86 patients (24 percent) in the placebo group (odds ratio for seizure with the use of placebo, 10.4; 95 percent confidence interval, 3.6 to 30.2; P<0.001). Forty-two percent of the placebo group were admitted to the hospital, as compared with 29 percent of the lorazepam group (odds ratio for admission, 2.1; 95 percent confidence interval, 1.1 to 4.0; P=0.02). Seven patients in the placebo group and one in the lorazepam group were transported to an emergency department in Boston with a second seizure within 48 hours after hospital discharge. Conclusions Treatment with intravenous lorazepam is associated with a significant reduction in the risk of recurrent seizures related to alcohol. (N Engl J Med 1999;340:915-9.) (C) 1999, Massachusetts Medical Society.	Boston Med Ctr, Dept Emergency Med, Boston, MA USA; Boston Univ, Sch Med, Boston, MA 02118 USA; Carney Hosp, Dept Emergency Med, Boston, MA USA	Boston Medical Center; Boston University	D'Onofrio, G (corresponding author), Yale Univ, 464 Congress Ave, New Haven, CT 06519 USA.			Ulrich, Andrew/0000-0001-8319-7643; Fish, Susan/0000-0001-6309-0558; D'Onofrio, Gail/0000-0002-3833-1871				ALLDREDGE BK, 1989, AM J MED, V87, P645, DOI 10.1016/S0002-9343(89)80397-3; BROWNE TR, 1973, EPILEPSIA, V14, P277, DOI 10.1111/j.1528-1157.1973.tb03965.x; BROWNE TR, 1990, NEUROLOGY, V40, P28; BROWNE TR, 1983, EPILEPSY DIAGNOSIS M, P235; CHAN AWK, 1985, EPILEPSIA, V26, P323, DOI 10.1111/j.1528-1157.1985.tb05658.x; CHANCE JF, 1991, ANN EMERG MED, V20, P520, DOI 10.1016/S0196-0644(05)81606-3; DEVENYI P, 1985, CAN MED ASSOC J, V132, P798; EARNEST MP, 1976, EPILEPSIA, V17, P387, DOI 10.1111/j.1528-1157.1976.tb04450.x; ELLIOTT HW, 1971, CLIN PHARMACOL THER, V12, P468; GILL JS, 1991, AM J MED, V90, P489, DOI 10.1016/0002-9343(91)80090-9; Greenblatt D. J., 1974, BENZODIAZEPINES CLIN; GREENBLATT DJ, 1978, NEW ENGL J MED, V299, P1342; GREENBLATT DJ, 1977, J CLIN PHARMACOL, V17, P490, DOI 10.1002/j.1552-4604.1977.tb05641.x; GREENBLATT DJ, 1978, SOUTHERN MED J, V71, P2, DOI 10.1097/00007611-197808001-00002; HADDOX VG, 1987, WESTERN J MED, V146, P695; HILLBOM M, 1982, NEUROLOGY, V32, P706, DOI 10.1212/WNL.32.7.706; HOYUMPA AM, 1978, SOUTHERN MED J, V71, P23, DOI 10.1097/00007611-197808001-00006; JELLINEK EM, 1943, Q J STUD ALCOHOL, V4, P85; KAIM SC, 1969, AM J PSYCHIAT, V125, P1640, DOI 10.1176/ajp.125.12.1640; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR; KRAUS JW, 1978, CLIN PHARMACOL THER, V24, P411; KRAUS JW, 1977, GASTROENTEROLOGY, V73, P1228; Lennox WG, 1941, Q J STUD ALCOHOL, V2, P1; LEPPIK IE, 1983, JAMA-J AM MED ASSOC, V249, P1452, DOI 10.1001/jama.249.11.1452; LITTEN RZ, 1991, ALCOHOL CLIN EXP RES, V15, P620, DOI 10.1111/j.1530-0277.1991.tb00570.x; MayoSmith MF, 1997, JAMA-J AM MED ASSOC, V278, P144, DOI 10.1001/jama.278.2.144; McMicken David B., 1994, Emergency Medicine Clinics of North America, V12, P1057; MILLER WC, 1984, CLIN THER, V6, P364; NARANJO CA, 1983, CLIN PHARMACOL THER, V34, P214, DOI 10.1038/clpt.1983.155; NG SKC, 1988, NEW ENGL J MED, V319, P666; OBRIEN JE, 1983, CURR THER RES CLIN E, V34, P825; PINEL JPJ, 1980, PHARMACOL BIOCHEM BE, V13, P225, DOI 10.1016/S0091-3057(80)80034-7; RATHLEV NK, 1994, ANN EMERG MED, V23, P513, DOI 10.1016/S0196-0644(94)70070-2; SELLERS EM, 1976, NEW ENGL J MED, V294, P757; SELLERS EM, 1988, CAN MED ASSOC J, V139, P113; SELLERS EM, 1986, PSYCHOPHARMACOL BULL, V22, P88; SELLERS EM, 1983, CLIN PHARMACOL THER, V34, P822, DOI 10.1038/clpt.1983.256; TREIMAN DM, 1990, NEUROLOGY, V40, P32; VICTOR M., 1967, EPILEPSIA, V8, P1; WEISBERG LA, 1988, STROKE, V19, P1565, DOI 10.1161/01.STR.19.12.1565	40	68	70	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 25	1999	340	12					915	919		10.1056/NEJM199903253401203	http://dx.doi.org/10.1056/NEJM199903253401203			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180AM	10094637				2022-12-28	WOS:000079362600003
J	Leonhard, K; Stiegler, A; Neupert, W; Langer, T				Leonhard, K; Stiegler, A; Neupert, W; Langer, T			Chaperone-like activity of the AAA domain of the yeast Yme1 AAA protease	NATURE			English	Article							ATP-DEPENDENT DEGRADATION; PRECURSOR PROTEIN; MEMBRANE-FUSION; INNER MEMBRANE; MITOCHONDRIA; BIOGENESIS; FAMILY; IMPORT	The AAA domain, a conserved Walker-type ATPase module, is a feature of members of the AAA family of proteins(1,2), which are involved in many cellular processes, including vesicular transport(3-7), organelle biogenesis(8), microtubule rearrangement(9) and protein degradation(10-12), The function of the AAA domain, however, has not been explained. Membrane-anchored AAA proteases of prokaryotic and eukaryotic cells comprise a subfamily of AAA proteins(13-15) that have metal-dependent peptidase activity and mediate the degradation of non-assembled membrane proteins. Inactivation of an orthologue of this protease family in humans causes neurodegeneration in hereditary spastic paraplegia(16). Here we investigate the AAA domain of the yeast protein Yme1, a subunit of the i-AAA protease located in the inner membrane of mitochondria(17,18). We show that Yme1 senses the folding state of solvent-exposed domains and specifically degrades unfolded membrane proteins. Substrate recognition and binding are mediated by the amino-terminal region of the AAA domain. The purified AAA. domain of Yme1 binds unfolded polypeptides and suppresses their aggregation. Our results indicate that the AAA domain of Yme1 has a chaperone-like activity and suggest that the AAA domains of other AAA proteins may have a similar function.	Univ Munich, Inst Physiol Chem, D-80336 Munich, Germany	University of Munich	Langer, T (corresponding author), Univ Munich, Inst Physiol Chem, Goethestr 33, D-80336 Munich, Germany.	langer@bio-med.uni-muenchen.de		Langer, Thomas/0000-0003-1250-1462				Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Beyer A, 1997, PROTEIN SCI, V6, P2043; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; Erdmann R, 1997, TRENDS CELL BIOL, V7, P400, DOI 10.1016/S0962-8924(97)01126-4; Gottesman S, 1997, CELL, V91, P435, DOI 10.1016/S0092-8674(00)80428-6; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; HUANG SM, 1989, BIOCHEMISTRY-US, V28, P471, DOI 10.1021/bi00428a010; Langer T, 1996, EXPERIENTIA, V52, P1069, DOI 10.1007/BF01952104; Larsen CN, 1997, CELL, V91, P431, DOI 10.1016/S0092-8674(00)80427-4; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Leonhard K, 1996, EMBO J, V15, P4218, DOI 10.1002/j.1460-2075.1996.tb00796.x; Lupas A, 1997, TRENDS BIOCHEM SCI, V22, P399, DOI 10.1016/S0968-0004(97)01117-1; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; NAKAI T, 1995, MOL CELL BIOL, V15, P4441; PAJIC A, 1994, FEBS LETT, V353, P201, DOI 10.1016/0014-5793(94)01046-3; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; PEARCE DA, 1995, J BIOL CHEM, V270, P1; Rep M, 1996, CURR GENET, V30, P367, DOI 10.1007/s002940050145; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Schumann W, 1999, FEMS MICROBIOL REV, V23, P1; Suzuki CK, 1997, TRENDS BIOCHEM SCI, V22, P118, DOI 10.1016/S0968-0004(97)01020-7; TANDON S, 1989, J BIOL CHEM, V264, P9859; VESTWEBER D, 1988, EMBO J, V7, P1147, DOI 10.1002/j.1460-2075.1988.tb02924.x; WAGNER I, 1994, EMBO J, V13, P5135, DOI 10.1002/j.1460-2075.1994.tb06843.x; Weber ER, 1996, MOL BIOL CELL, V7, P307, DOI 10.1091/mbc.7.2.307; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945	29	172	175	1	8	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 25	1999	398	6725					348	351		10.1038/18704	http://dx.doi.org/10.1038/18704			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180DF	10192337				2022-12-28	WOS:000079369600055
J	Simon, SR; Pan, RJD; Sullivan, AM; Clark-Chiarelli, N; Connelly, MT; Peters, AS; Singer, JD; Inui, TS; Block, SD				Simon, SR; Pan, RJD; Sullivan, AM; Clark-Chiarelli, N; Connelly, MT; Peters, AS; Singer, JD; Inui, TS; Block, SD			Views of managed care - A survey of students, residents, faculty, and deans at medical schools in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EDUCATION; ATTITUDES; SYSTEM; FUTURE	Background and Methods Views of managed care among academic physicians and medical students in the United States are not well known. In 1997 we conducted a telephone survey of a national sample of medical students (506 respondents), residents (494), faculty members (728), department chairs (186), directors of residency training in internal medicine and pediatrics (143), and deans (105) at U.S. medical schools to determine their experiences in and perspectives on managed care. The overall rate of response was 80.1 percent. Results Respondents rated their attitudes toward managed care on a 0-to-10 scale, with 0 defined as "as negative as possible" and 10 as "as positive as possible." The expressed attitudes toward managed care were negative, ranging from a low mean (+/-SD) score of 3.9+/-1.7 for residents to a high of 5.0+/-1.3 for deans. When asked about specific aspects of care, fee-for-service medicine was rated better than managed care in terms of access (by 80.2 percent of respondents), minimizing ethical conflicts (74.8 percent), and the quality of the doctor-patient relationship (70.6 percent). With respect to the continuity of care, 52.0 percent of respondents preferred fee-for-service medicine, and 29.3 percent preferred managed care. For care at the end of life, 49.1 percent preferred fee-for-service medicine, and 20.5 percent preferred managed care. With respect to care for patients with chronic illness, 41.8 percent preferred fee-for-service care, and 30.8 percent preferred managed care. Faculty members, residency-training directors, and department chairs responded that managed care had reduced the time they had available for research (63.1 percent agreed) and teaching (58.9 percent) and had reduced their income (55.8 percent). Overall, 46.6 percent of faculty members, 26.7 percent of residency-training directors, and 42.7 percent of department chairs reported that the message they delivered to students about managed care was negative. Conclusions Negative views of managed care are widespread among medical students, residents, faculty members, and medical school deans. (N Engl J Med 1999;340:928-36.) (C) 1999, Massachusetts Medical Society.	Harvard Univ, Sch Med, Dept Ambulatory Care & Preven, Boston, MA 02215 USA; Harvard Pilgrim Hlth Care, Boston, MA 02215 USA; Childrens Hosp, Div Gen Pediat, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Psychiat, Boston, MA 02115 USA; Harvard Univ, Grad Sch Educ, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University	Simon, SR (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Preven, 126 Brookline Ave,Suite 200, Boston, MA 02215 USA.		Singer, Judith D/B-6846-2008	Singer, Judith D/0000-0002-5828-4961; Sullivan, Amy/0000-0003-1020-3197	BHP HRSA HHS [T32 PE11001-10, T32 PE10018] Funding Source: Medline	BHP HRSA HHS		*AM ASS HLTH, 1998, MAN CAR FACTS; BOURNE S, 1997, 1997 MARKET CLASSIFI; Campbell EG, 1997, JAMA-J AM MED ASSOC, V278, P222, DOI 10.1001/jama.278.3.222; Clogg C. C., 1994, ADV QUANTITATIVE TEC; Council on Graduate Medical Education, 1997, PREP LEARN PRACT MAN; Culbertson RA, 1996, ACAD MED, V71, P858, DOI 10.1097/00001888-199608000-00013; GOLDMAN L, 1995, JAMA-J AM MED ASSOC, V273, P1549, DOI 10.1001/jama.273.19.1549; GRAUBARD BI, 1993, J AM STAT ASSOC, V88, P629, DOI 10.2307/2290345; HAFFERTY FW, 1994, ACAD MED, V69, P861, DOI 10.1097/00001888-199411000-00001; Iglehart J, 1997, ACAD MED, V72, P754, DOI 10.1097/00001888-199709000-00008; IGLEHART JK, 1992, NEW ENGL J MED, V327, P742, DOI 10.1056/NEJM199209033271029; IGLEHART JK, 1994, NEW ENGL J MED, V330, P1167, DOI 10.1056/NEJM199404213301628; Lee E.S., 1989, QUANTITATIVE APPL SO; Long J.Scott., 1997, REGRESSION MODELS CA; Menard Scott W., 1995, QUANTITATIVE APPL SO, P07; Nelson HD, 1998, J GEN INTERN MED, V13, P39, DOI 10.1046/j.1525-1497.1998.00006.x; Neter J., 1996, APPL LINEAR STAT MOD; Pardes H, 1997, ACAD MED, V72, P97, DOI 10.1097/00001888-199702000-00009; *RES TRIANGL I, 1998, SUDAAN SOFTW STAT AN; Simon CJ, 1998, HEALTH SERV RES, V33, P549; Veloski J, 1996, JAMA-J AM MED ASSOC, V276, P667, DOI 10.1001/jama.276.9.667; WARTMAN SA, 1994, ARCH INTERN MED, V154, P2539, DOI 10.1001/archinte.154.22.2539; WILKES MS, 1994, ACAD MED, V69, P307, DOI 10.1097/00001888-199404000-00016	23	94	95	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 25	1999	340	12					928	936		10.1056/NEJM199903253401206	http://dx.doi.org/10.1056/NEJM199903253401206			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180AM	10089187				2022-12-28	WOS:000079362600006
J	Gorelick, PB; Sacco, RL; Smith, DB; Alberts, M; Mustone-Alexander, L; Rader, D; Ross, JL; Raps, E; Ozer, MN; Brass, LM; Malone, ME; Goldberg, S; Booss, J; Hanley, DF; Toole, JF; Greewold, NL; Rhew, DC				Gorelick, PB; Sacco, RL; Smith, DB; Alberts, M; Mustone-Alexander, L; Rader, D; Ross, JL; Raps, E; Ozer, MN; Brass, LM; Malone, ME; Goldberg, S; Booss, J; Hanley, DF; Toole, JF; Greewold, NL; Rhew, DC			Prevention of a first stroke - A review of guidelines and a multidisciplinary consensus statement from the National Stroke Association	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							NONVALVULAR ATRIAL-FIBRILLATION; AMERICAN-HEART-ASSOCIATION; HEALTH-CARE PROFESSIONALS; CAROTID-ARTERY STENOSIS; ACUTE MYOCARDIAL-INFARCTION; CIGARETTE-SMOKING; RISK FACTOR; PHYSICAL-ACTIVITY; CARDIORESPIRATORY FITNESS; REDUCTASE INHIBITORS	Objective To establish, in a single resource, up-to-date recommendations for primary care physicians regarding prevention strategies for a first stroke. Participants Members of the National Stroke Association's (NSA's) Stroke Prevention Advisory Board and Cedars-Sinai Health System Department of Health Services Research convened on April 9, 1998, in an open meeting. The conference attendees, selected to participate by the NSA, were recognized experts in neurology (9), cardiology (2), family practice (1), nursing (1), physician assistant practices (1), and health services research (2). Evidence A literature review was carried out by the Department of Health Services Research, Cedars-Sinai Health System, Los Angeles, Calif, using the MEDLINE database search for 1990 through April 1998 and updated in November 1998. English-language guidelines, statements, meta-analyses, and overviews on prevention of a first stroke were reviewed. Consensus Process At the meeting, members of the advisory board identified 6 important stroke risk factors (hypertension, myocardial infarction [MI], atrial fibrillation, diabetes mellitus, blood lipids, asymptomatic carotid artery stenosis), and 4 lifestyle factors (cigarette smoking, alcohol use, physical activity, diet). Conclusions Several interventions that modify well-documented and treatable cardiovascular and cerebrovascular risk factors can reduce the risk of a first stroke. Good evidence for direct stroke reduction exists for hypertension treatment; using warfarin for patients after MI who have atrial fibrillation, decreased left ventricular ejection fraction, or left ventricular thrombus; using 3-hydroxy3 methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors for patients after MI; using warfarin for patients with atrial fibrillation and specific risk factors; and performing carotid endarterectomy for patients with stenosis of at least 60%. Observational studies support the role of modifying lifestyle-related risk factors leg, smoking, alcohol use, physical activity, diet) in stroke prevention. Measures to help patients improve adherence are an important component of-a stroke prevention plan.	NPS, Salt Lake City, UT USA; Searle & Lorex Pharmaceut, Skokie, IL USA; Cedars Sinai Hlth Syst, Zynx Hlth, Beverly Hills, CA USA	Cedars Sinai Medical Center	Gorelick, PB (corresponding author), Rush Med Coll, Ctr Stroke Res, 1645 W Jackson Blvd,Suite 400, Chicago, IL 60612 USA.		Sacco, Ralph/Y-9278-2019	Hanley, Daniel/0000-0002-9536-4258				*4 AM COLL CHEST P, 1995, CHEST S, V108, pS225; ABBOTT RD, 1986, NEW ENGL J MED, V315, P717, DOI 10.1056/NEJM198609183151201; Albers GW, 1998, CHEST, V114, p683S, DOI 10.1378/chest.114.5_Supplement.683S; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; *AM DIAB ASS, 1998, DIABETES CARE, V21, pS1; [Anonymous], 1996, JAMA, V276, P241; [Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 1997, Arch Intern Med, V157, P1237; [Anonymous], 1996, SHAP FUT; [Anonymous], 1997, FACT BOOK FISC YEAR; [Anonymous], 1994, CANADIAN GUIDE CLIN; [Anonymous], 1997, ARCH INTERN MED, V157, P2413; BARNETT HJM, 1995, ARCH NEUROL-CHICAGO, V52, P827, DOI 10.1001/archneur.1995.00540320111019; Biller J, 1998, CIRCULATION, V97, P501; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; Blauw GJ, 1997, STROKE, V28, P946, DOI 10.1161/01.STR.28.5.946; BONITA R, 1986, BRIT MED J, V293, P6, DOI 10.1136/bmj.293.6538.6; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Broderick J, 1998, STROKE, V29, P415, DOI 10.1161/01.STR.29.2.415; Brown RD, 1996, STROKE, V27, P373; Bucher HC, 1998, ANN INTERN MED, V128, P89, DOI 10.7326/0003-4819-128-2-199801150-00002; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Cairns JA, 1998, CHEST, V114, p611S, DOI 10.1378/chest.114.5_Supplement.611S; COLDITZ GA, 1988, NEW ENGL J MED, V318, P937, DOI 10.1056/NEJM198804143181501; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Cromwell J, 1997, JAMA-J AM MED ASSOC, V278, P1759, DOI 10.1001/jama.278.21.1759; *CTR ADV HLTH, 1996, IND BIBL SELF MAN PE; DAGOSTINO RB, 1994, STROKE, V25, P40, DOI 10.1161/01.STR.25.1.40; DAVIS PH, 1987, ANN NEUROL, V22, P319, DOI 10.1002/ana.410220307; Delanty N, 1997, STROKE, V28, P2315, DOI 10.1161/01.STR.28.11.2315; Devine EC, 1995, NURS RES, V44, P237; Diabet Control Complications Trial DCCT Res Grp, 1995, AM J CARDIOL, V75, P894; DONAHUE RP, 1986, JAMA-J AM MED ASSOC, V255, P2311, DOI 10.1001/jama.255.17.2311; Eccles M, 1998, BMJ-BRIT MED J, V316, P1303, DOI 10.1136/bmj.316.7140.1303; Findlay JM, 1997, CAN MED ASSOC J, V157, P653; Fletcher G F, 1994, Health Rep, V6, P106; Gavin JR, 1997, DIABETES CARE, V20, P1183; GEY KF, 1993, CLIN INVESTIGATOR, V71, P3, DOI 10.1007/BF00210955; GILL JS, 1986, NEW ENGL J MED, V315, P1041, DOI 10.1056/NEJM198610233151701; GILLMAN MW, 1995, JAMA-J AM MED ASSOC, V273, P1113, DOI 10.1001/jama.273.14.1113; GORELICK PB, 1995, ARCH NEUROL-CHICAGO, V52, P347, DOI 10.1001/archneur.1995.00540280029015; GORELICK PB, 1994, STROKE, V25, P220, DOI 10.1161/01.STR.25.1.220; Gorelick PB, 1997, NEUROEPIDEMIOLOGY, V16, P107, DOI 10.1159/000109679; GORELICK PB, 1989, STROKE, V20, P1607, DOI 10.1161/01.STR.20.12.1607; GORELICK PB, 1989, NEUROLOGY, V39, P339, DOI 10.1212/WNL.39.3.339; GORELICK PB, IN PRESS J CARDIOVAS; GOULD AL, 1995, CIRCULATION, V91, P2274, DOI 10.1161/01.CIR.91.8.2274; Greenberg MK, 1998, NEUROLOGY, V51, P671; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032; Hall WD, 1997, AM J MED SCI, V313, P195, DOI 10.1097/00000441-199704000-00002; Hart RG, 1998, NEUROLOGY, V51, P674, DOI 10.1212/WNL.51.3.674; Haynes RB, 1996, LANCET, V348, P383; Hebert PR, 1997, JAMA-J AM MED ASSOC, V278, P313, DOI 10.1001/jama.278.4.313; HEISS G, 1991, AM J EPIDEMIOL, V134, P250, DOI 10.1093/oxfordjournals.aje.a116078; Howard G, 1998, JAMA-J AM MED ASSOC, V279, P119, DOI 10.1001/jama.279.2.119; Howard G, 1996, STROKE, V27, P1951, DOI 10.1161/01.STR.27.11.1951; Howard PA, 1997, ANN PHARMACOTHER, V31, P1187, DOI 10.1177/106002809703101012; Hurt RD, 1997, NEW ENGL J MED, V337, P1195, DOI 10.1056/NEJM199710233371703; JONKER JJC, 1994, LANCET, V343, P499; KAREM JH, 1996, CURRENT MED DIAGNOSI; KAWACHI I, 1993, JAMA-J AM MED ASSOC, V269, P232, DOI 10.1001/jama.269.2.232; KHAW KT, 1987, NEW ENGL J MED, V316, P235, DOI 10.1056/NEJM198701293160502; KOKKINOS PF, 1995, NEW ENGL J MED, V333, P1462, DOI 10.1056/NEJM199511303332204; KOUDSTAAL PJ, 1995, NEW ENGL J MED, V333, P5; KULLER LH, 1985, DIABETES AM DIABETES, P1; LAKKA TA, 1993, J CLIN EPIDEMIOL, V46, P1119, DOI 10.1016/0895-4356(93)90111-D; Laupacis A, 1998, CHEST, V114, p579S, DOI 10.1378/chest.114.5_Supplement.579S; LAUPACIS A, 1995, CHEST, V108, pS352, DOI 10.1378/chest.108.4_Supplement.352S; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; Loh E, 1997, NEW ENGL J MED, V336, P251, DOI 10.1056/NEJM199701233360403; Lorenz R, 1998, DIABETES CARE, V21, P2021, DOI 10.2337/diacare.21.11.2021; MACHARIA WM, 1992, JAMA-J AM MED ASSOC, V267, P1813, DOI 10.1001/jama.267.13.1813; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; Mast H, 1998, STROKE, V29, P908, DOI 10.1161/01.STR.29.5.908; MATCHAR DB, 1994, ANN INTERN MED, V121, P41, DOI 10.7326/0003-4819-121-1-199407010-00008; MATCHAR DB, 1994, ANN INTERN MED, V121, P54; MCCRORY DC, 1995, ARCH INTERN MED, V155, P277, DOI 10.1001/archinte.155.3.277; Messerli FH, 1998, JAMA-J AM MED ASSOC, V279, P1903, DOI 10.1001/jama.279.23.1903; Miller NH, 1997, CIRCULATION, V95, P1085; Monette J, 1997, J AM GERIATR SOC, V45, P1060, DOI 10.1111/j.1532-5415.1997.tb05967.x; Mullen PD, 1997, PATIENT EDUC COUNS, V32, P157; NORRIS JW, 1991, STROKE, V22, P1485, DOI 10.1161/01.STR.22.12.1485; OLEARY DH, 1992, STROKE, V23, P1752, DOI 10.1161/01.STR.23.12.1752; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; PEDERSEN TR, 1994, LANCET, V344, P1383; Pellegrini N, 1996, EUR J CLIN NUTR, V50, P209; Perry JR, 1997, ARCH NEUROL-CHICAGO, V54, P25, DOI 10.1001/archneur.1997.00550130015009; *PREV SERV TASK FO, 1996, GUID CLIN PREV SERV, V92, P953; Prystowsky EN, 1996, CIRCULATION, V93, P1262, DOI 10.1161/01.CIR.93.6.1262; RANGEMARK C, 1995, SLEEP, V18, P188, DOI 10.1093/sleep/18.3.188; ROOS J, 1980, LANCET, V2, P989; Rosenson RS, 1998, JAMA-J AM MED ASSOC, V279, P1643, DOI 10.1001/jama.279.20.1643; ROTH HP, 1971, AM J MED SCI, V262, P269, DOI 10.1097/00000441-197111000-00004; RUDD P, 1995, AM HEART J, V130, P572, DOI 10.1016/0002-8703(95)90368-2; Ryan TJ, 1996, J AM COLL CARDIOL, V28, P1328; Sacco RL, 1997, STROKE, V28, P1507, DOI 10.1161/01.STR.28.7.1507; Sacco RL, 1997, STROKE, V28, P929, DOI 10.1161/01.STR.28.5.929; SACKETT DL, 1989, CHEST, V95, pS2, DOI 10.1378/chest.95.2.2S; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; *SCOTT INT GUID NE, 1998, MAN DIAB CARD DIS NA; *SCOTT INT GUID NE, 1998, MAN PAT STROK MAN CA; SELHUB J, 1995, NEW ENGL J MED, V332, P286, DOI 10.1056/NEJM199502023320502; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SHINTON R, 1989, BMJ-BRIT MED J, V298, P789, DOI 10.1136/bmj.298.6676.789; Singer DE, 1998, AM J CARDIOL, V81, p35C, DOI 10.1016/S0002-9149(98)00185-4; SMITH P, 1990, NEW ENGL J MED, V323, P147, DOI 10.1056/NEJM199007193230302; STAMLER J, 1989, HYPERTENSION, V14, P570, DOI 10.1161/01.HYP.14.5.570; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; STRANDNESS DE, 1995, ARCH NEUROL-CHICAGO, V52, P832, DOI 10.1001/archneur.1995.00540320116020; TANNE D, 1993, STROKE, V24, P1490, DOI 10.1161/01.STR.24.10.1490; Taylor TN, 1996, STROKE, V27, P1459, DOI 10.1161/01.STR.27.9.1459; THORNTON J, 1983, LANCET, V2, P819; TONKIN A, 1995, AM J CARDIOL, V76, P474; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; UELAND PM, 1998, ATHEROSCLEROTIC CARD, P183; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; WANG JS, 1995, ARTERIOSCL THROM VAS, V15, P1668, DOI 10.1161/01.ATV.15.10.1668; Wheeldon NM, 1998, HEART, V79, P50, DOI 10.1136/hrt.79.1.50; Williams PT, 1996, NEW ENGL J MED, V334, P1298, DOI 10.1056/NEJM199605163342004; WOLF PA, 1986, NEW ENGL J MED, V315, P1087, DOI 10.1056/NEJM198610233151709; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; WOLF PA, 1978, NEUROLOGY, V28, P973, DOI 10.1212/WNL.28.10.973; WOLF PA, 1988, JAMA-J AM MED ASSOC, V259, P1025, DOI 10.1001/jama.259.7.1025; WOOLF SH, 1990, ARCH INTERN MED, V150, P1811, DOI 10.1001/archinte.150.9.1811; 1979, CAN MED ASS J, V121, P1193	127	345	356	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	1999	281	12					1112	1120		10.1001/jama.281.12.1112	http://dx.doi.org/10.1001/jama.281.12.1112			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	177EP	10188663				2022-12-28	WOS:000079197100034
J	Valeur-Jensen, AK; Pedersen, CB; Westergaard, T; Jensen, IP; Lebech, M; Andersen, PK; Aaby, P; Pedersen, BN; Melbye, M				Valeur-Jensen, AK; Pedersen, CB; Westergaard, T; Jensen, IP; Lebech, M; Andersen, PK; Aaby, P; Pedersen, BN; Melbye, M			Risk factors for parvovirus B19 infection in pregnancy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ERYTHEMA-INFECTIOSUM; OCCUPATIONAL RISK; HUMAN-DISEASE; 5TH DISEASE; OUTBREAK; WOMEN; ANTIBODIES; SCHOOL; CARE	Context Parvovirus B19 infection during pregnancy has been associated with fetal death. However, the incidence of and risk factors for infection in pregnant women have not been well studied. Objectives To estimate a pregnant woman's risk of infection with parvovirus B19 in epidemic and endemic situations and to study risk factors for infection. Design Population-based cohort study conducted between November 1992 and June 1994. Setting Three regions in Denmark. Participants A total of 30 946 pregnant women from a consecutive and population-based screening. Main Outcome Measures Specific IgG antibodies in serum samples obtained in the first trimester of pregnancy and from the newborn infant to assess past infection and seroconversion. Information on family structure, educational background, socioeconomic status, and pregnancy outcome was obtained from national registers. Results Based on 30 946 serum samples, 65.0% of pregnant women had evidence of past infection. Annual seroconversion rates among susceptible women during endemic and epidemic periods were 1.5% (95% confidence interval [CI], 0.2%-1.9%) and 13.0% (95% CI, 8.7%-23.1%), respectively. Baseline seropositivity was significantly correlated with increasing number of siblings, having a sibling of the same age, number of own children, and occupational exposure to children. Risk of acute infection increased with the number of children in the household as follows: 0 children odds ratio (OR), 1 (reference); 1 child OR, 3.17 (95% CI, 2.24-4.49); 2 children OR, 5.47 (95% CI, 3.55-8.45); 3 or more children OR, 7.54 (95% CI, 3.80-14.94). Having children aged 6 to 7 years resulted in the highest rate of seroconversion among mothers (6.8%; OR, 4.07; 95% CI, 1.89-8.73). Compared with other pregnant women, nursery school teachers had a 3-fold increased risk of acute infection (OR, 3.09; 95% CI, 1.62-5.89). Population-attributable risk of seroconversion was 55.4% for number of own children and 6.0% for occupational exposure. Conclusions The risk of infection is high for susceptible pregnant women during epidemics and associated with the level of contact with children. Nursery school teachers have the highest occupational risk, but most infections seem to be the result of exposure to the woman's own children.	Danish Epidemiol Sci Ctr, Dept Epidemiol Res, Copenhagen, Denmark; State Serum Inst, Dept Virol, Copenhagen, Denmark; State Serum Inst, Dept Clin Biochem, Copenhagen, Denmark	Aarhus University; Statens Serum Institut; Statens Serum Institut	Melbye, M (corresponding author), State Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	mme@ssi.dk	Pedersen, Carsten Bøcker/B-8441-2013	Pedersen, Carsten Bøcker/0000-0003-2077-8533; Aaby, Peter/0000-0001-8331-1389; melbye, mads/0000-0001-8264-6785				ANDERSON LJ, 1986, J CLIN MICROBIOL, V24, P522, DOI 10.1128/JCM.24.4.522-526.1986; ANDERSON MJ, 1983, LANCET, V1, P1378; Azzi A, 1996, EPIDEMIOL INFECT, V117, P401, DOI 10.1017/S095026880000159X; BELL LM, 1989, NEW ENGL J MED, V321, P485, DOI 10.1056/NEJM198908243210801; Brown KE, 1997, ANNU REV MED, V48, P59; BROWN T, 1984, LANCET, V2, P1033; Carstensen B, 1996, STAT MED, V15, P2177, DOI 10.1002/(SICI)1097-0258(19961030)15:20&lt;2177::AID-SIM345&gt;3.0.CO;2-7; CARTTER ML, 1991, J INFECT DIS, V163, P282, DOI 10.1093/infdis/163.2.282; CHORBA T, 1986, J INFECT DIS, V154, P383, DOI 10.1093/infdis/154.3.383; COHEN B, 1995, BMJ-BRIT MED J, V311, P1549, DOI 10.1136/bmj.311.7019.1549; COHEN BJ, 1988, J MED MICROBIOL, V25, P151, DOI 10.1099/00222615-25-2-151; COHEN BJ, 1993, J PUBLIC HEALTH MED, V15, P281; ELSHUBINGER AM, 1996, ZENTRALBL BAKTERIOL, V284, P232; GILLESPIE SM, 1990, JAMA-J AM MED ASSOC, V263, P2061, DOI 10.1001/jama.263.15.2061; GRATACOS E, 1995, J INFECT DIS, V171, P1360, DOI 10.1093/infdis/171.5.1360; HALL SM, 1990, BMJ-BRIT MED J, V300, P1166; Harger JH, 1998, OBSTET GYNECOL, V91, P413, DOI 10.1016/S0029-7844(97)00701-1; KNUDSEN LB, 1986, COMMUNITY MED, V8, P29; KOCH WC, 1989, PEDIATR INFECT DIS J, V8, P83; Melbye M, 1997, NEW ENGL J MED, V336, P81, DOI 10.1056/NEJM199701093360201; PILLAY D, 1992, LANCET, V339, P107, DOI 10.1016/0140-6736(92)91009-W; Rice PS, 1996, EPIDEMIOL INFECT, V116, P331, DOI 10.1017/S0950268800052651; RODIS JF, 1990, AM J OBSTET GYNECOL, V163, P1168, DOI 10.1016/0002-9378(90)90681-V; SkjoldebrandSparre L, 1996, ACTA OBSTET GYN SCAN, V75, P336, DOI 10.3109/00016349609033326; TOROK TJ, 1992, ADV INTERNAL MED, V37, P431; Westergaard T, 1997, J NATL CANCER I, V89, P939, DOI 10.1093/jnci/89.13.939; WOOLF AD, 1989, ARCH INTERN MED, V149, P1153, DOI 10.1001/archinte.149.5.1153	27	118	127	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	1999	281	12					1099	1105		10.1001/jama.281.12.1099	http://dx.doi.org/10.1001/jama.281.12.1099			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177EP	10188660				2022-12-28	WOS:000079197100031
J	Chapman, R				Chapman, R			Should we fight to preserve the independent status of general practitioners? For	BRITISH MEDICAL JOURNAL			English	Article											Chapman, R (corresponding author), 29 Bassett Rd, Leighton Buzzard LU7 7AR, Beds, England.							*HLTH POL EC RES U, 1998, BMA COH STUD 1995 ME; MILBURN A, 1998, COMMUNICATION   0617; *SECR STAT HLTH, 1997, CM3807; Taylor DH, 1999, BRIT MED J, V318, P306, DOI 10.1136/bmj.318.7179.306	4	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 20	1999	318	7186					797	798		10.1136/bmj.318.7186.797	http://dx.doi.org/10.1136/bmj.318.7186.797			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BX	10082710	Green Published			2022-12-28	WOS:000079421700034
J	Nolan, CM; Goldberg, SV; Buskin, SE				Nolan, CM; Goldberg, SV; Buskin, SE			Hepatotoxicity associated with isoniazid preventive therapy - A 7-year survey from a public health tuberculosis clinic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; DECISION-ANALYSIS; HEPATITIS; RISK; CHEMOPROPHYLAXIS; LIVER; REACTORS; DEATHS; ADULTS; AGE	Context Isoniazid preventive therapy for latent tuberculosis (TB) infection has been debated because of the risk of hepatotoxicity. The frequency of hepatotoxicity was 0.5% to 2.0% in early studies but may have changed with new criteria for diagnosis and patient selection. Objective To determine the rate of isoniazid hepatotoxicity in patients managed according to current guidelines and practice standards. Design Prospective cohort study. Setting A public health clinic operated by the TB control program of a city-county public health agency. Patients A total of 11 141 consecutive patients who started a regimen of isoniazid preventive therapy for latent TB infection from January 1989 through December 1995, Main Outcome Measures The rate of developing symptoms and signs of hepatotoxicity among all persons starting isoniazid preventive therapy, among all those completing therapy, and by age, sex, and race. Results Eleven patients (0.10% of those starting, and 0.15% of those completing treatment) had hepatotoxic reactions to isoniazid during preventive treatment. The rate of hepatotoxicity in persons receiving preventive therapy increased with increasing age (chi(2) for linear trend = 5.22, P = .02) and there were trends toward increased rates in women (odds ratio [OR], 3.30; 95% confidence interval [CI], 0.87-12.45; chi(2) = 3.28; P = .07) and in whites (OR, 2.60; 95% CI, 0.75-8.95; chi(2) = 3.08; P = .08). Conclusions The rate of isoniazid hepatotoxicity during clinically monitored preventive therapy was lower than has been reported previously. Clinicians should have greater confidence in the safety of isoniazid preventive therapy.	Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Nolan, CM (corresponding author), Harborview Med Ctr, Seattle King Cty Dept Publ Hlth, TB Control Program, 325 9th Ave, Seattle, WA 98104 USA.	charles.nolan@metrokc.gov						American Thoracic Society, 1965, AM REV RESPIR DIS, V96, P558; BASS JB, 1994, AM J RESP CRIT CARE, V149, P1359, DOI 10.1164/ajrccm.149.5.8173779; BLACK M, 1975, GASTROENTEROLOGY, V69, P289; *CDC, 1989, MMWR-MORBID M      S, V3, P1; COLICE GL, 1990, ARCH INTERN MED, V150, P2517, DOI 10.1001/archinte.150.12.2517; COMSTOCK GW, 1981, ANN INTERN MED, V94, P817, DOI 10.7326/0003-4819-94-6-817; DICKINSON DS, 1981, J CLIN GASTROENTEROL, V3, P271, DOI 10.1097/00004836-198109000-00012; FRANKS AL, 1989, PUBLIC HEALTH REP, V104, P151; GARABALDI RA, 1972, AM REV RESPIR DIS, V106, P357; GORDIN F, 1998, 5 C RETR OPP INF FEB; Halsey NA, 1998, LANCET, V351, P786, DOI 10.1016/S0140-6736(97)06532-X; ISEMAN MD, 1989, AM REV RESPIR DIS, V140, P575, DOI 10.1164/ajrccm/140.3.575; ISRAEL HL, 1992, CHEST, V101, P1298, DOI 10.1378/chest.101.5.1298; JORDAN TJ, 1991, AM REV RESPIR DIS, V144, P1357, DOI 10.1164/ajrccm/144.6.1357; KOPANOFF DE, 1978, AM REV RESPIR DIS, V117, P991; LEE WM, 1995, NEW ENGL J MED, V333, P1118, DOI 10.1056/NEJM199510263331706; Leff DR, 1997, AM J RESP CRIT CARE, V156, P1487, DOI 10.1164/ajrccm.156.5.9704105; McCray E, 1997, CLIN CHEST MED, V18, P99, DOI 10.1016/S0272-5231(05)70359-2; Millard PS, 1996, WESTERN J MED, V164, P486; Miller B, 1996, JAMA-J AM MED ASSOC, V276, P1916; MITCHELL JR, 1976, ANN INTERN MED, V84, P181, DOI 10.7326/0003-4819-84-2-181; MOULDING TS, 1989, AM REV RESPIR DIS, V140, P700, DOI 10.1164/ajrccm/140.3.700; MWINGA AG, 1997, INT J TUBERC LUNG S1, V1, pS164; RISKA N, 1976, Bulletin of the International Union Against Tuberculosis, V51, P203; ROSE DN, 1986, JAMA-J AM MED ASSOC, V256, P2709, DOI 10.1001/jama.256.19.2709; SALPETER SR, 1993, WESTERN J MED, V159, P560; Salpeter SR, 1997, ANN INTERN MED, V127, P1051, DOI 10.7326/0003-4819-127-12-199712150-00001; SARASIN FP, 1995, TUBERCLE LUNG DIS, V76, P394, DOI 10.1016/0962-8479(95)90004-7; SNIDER DE, 1992, AM REV RESPIR DIS, V145, P494, DOI 10.1164/ajrccm/145.2_Pt_1.494; STEELE MA, 1991, CHEST, V99, P465, DOI 10.1378/chest.99.2.465; TAYLOR WC, 1981, ANN INTERN MED, V94, P808, DOI 10.7326/0003-4819-94-6-808; TSEVAT J, 1988, AM REV RESPIR DIS, V137, P215, DOI 10.1164/ajrccm/137.1.215; Whalen CC, 1997, NEW ENGL J MED, V337, P801, DOI 10.1056/NEJM199709183371201; Zuber PLF, 1997, JAMA-J AM MED ASSOC, V278, P304, DOI 10.1001/jama.278.4.304	34	346	356	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	1999	281	11					1014	1018		10.1001/jama.281.11.1014	http://dx.doi.org/10.1001/jama.281.11.1014			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175EE	10086436	Bronze			2022-12-28	WOS:000079079400028
J	Justice, AC; Covinsky, KE; Berlin, JA				Justice, AC; Covinsky, KE; Berlin, JA			Assessing the generalizability of prognostic information	ANNALS OF INTERNAL MEDICINE			English	Article							ARTIFICIAL NEURAL NETWORKS; CLINICAL-PREDICTION RULES; COLORECTAL-CANCER; RECTAL-CANCER; STAGING SYSTEM; DIAGNOSTIC PROBABILITIES; METHODOLOGICAL STANDARDS; AIDS PATIENTS; BAD-NEWS; JASS	Physicians are often asked to make prognostic assessments but often worry that their assessments will prove inaccurate. Prognostic systems were developed to enhance the accuracy of such assessments. This paper describes an approach for evaluating prognostic systems based on the accuracy (calibration and discrimination) and generalizability (reproducibility and transportability) of the system's predictions. Reproducibility is the ability to produce accurate predictions among patients not included in the development of the system but from the same population. Transportability is the ability to produce accurate predictions among patients drawn from a different but plausibly related population. On the basis of the observation that the generalizability of a prognostic system is commonly limited to a single historical period, geographic location, methodologic approach, disease spectrum, or follow-up interval, we describe a working hierarchy of the cumulative generalizability of prognostic systems. This approach is illustrated in a structured review of the Dukes and Jass staging systems for colon and rectal cancer and applied to a young man with colon cancer. Because it treats the development of the system as a "black box" and evaluates only the performance of the predictions, the approach can be applied to any system that generates predicted probabilities. Although the Dukes and Jass staging systems are discrete, the approach can also be applied to systems that generate continuous predictions and, with some modification, to systems that predict over multiple time periods. Like any scientific hypothesis, the generalizability of a prognostic system is established by being tested and being found accurate across increasingly diverse settings. The more numerous and diverse the settings in which the system is tested and found accurate, the more likely it will generalize to an untested setting.	Pittsburgh Vet Affairs Hlth Care Syst, Sect Gen Internal Med 11E, Pittsburgh, PA 15240 USA; Univ Pittsburgh, Pittsburgh, PA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Vet Affairs Med Ctr, San Francisco, CA 94121 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Justice, AC (corresponding author), Pittsburgh Vet Affairs Hlth Care Syst, Sect Gen Internal Med 11E, Univ Dr C, Pittsburgh, PA 15240 USA.				AHRQ HHS [5 T32 HS00009] Funding Source: Medline	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		ALEMI F, 1990, MED CARE, V28, P762, DOI 10.1097/00005650-199009000-00006; ANNAS GJ, 1994, NEW ENGL J MED, V330, P223, DOI 10.1056/NEJM199401203300324; Ash A, 1994, RISK ADJUSTMENT MEAS, P313; BAXT WG, 1995, LANCET, V346, P1135, DOI 10.1016/S0140-6736(95)91804-3; Braitman LE, 1996, ANN INTERN MED, V125, P406, DOI 10.7326/0003-4819-125-5-199609010-00008; BRELMAN L, 1984, CLASSIFICATION REGRE; BREWIN TB, 1991, LANCET, V337, P1207, DOI 10.1016/0140-6736(91)92870-8; BREWSTER AC, 1985, INQUIRY-J HEALTH CAR, V22, P377; Buckman R., 1992, BREAK BAD NEWS GUIDE; Centor R M, 1985, Med Decis Making, V5, P139, DOI 10.1177/0272989X8500500203; CHARLSON ME, 1987, ARCH INTERN MED, V147, P2155, DOI 10.1001/archinte.147.12.2155; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Christakis NA, 1998, ARCH INTERN MED, V158, P2389, DOI 10.1001/archinte.158.21.2389; CHRISTAKIS NA, 1995, PROGNOSTICATION DEAT; Concato J, 1995, J CLIN EPIDEMIOL, V48, P1495, DOI 10.1016/0895-4356(95)00510-2; DARZI A, 1995, SURG ENDOSC-ULTRAS, V9, P414; DEANS GT, 1994, J AM COLL SURGEONS, V179, P11; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; DIAMOND GA, 1992, J CLIN EPIDEMIOL, V45, P85, DOI 10.1016/0895-4356(92)90192-P; DUKES CE, 1958, BRIT J CANCER, V12, P309, DOI 10.1038/bjc.1958.37; FEINSTEIN AR, 1972, CLIN PHARMACOL THER, V13, P285; Feinstein AR., 1967, CLIN JUDGMENT; FISHER ER, 1989, DIS COLON RECTUM, V32, P944, DOI 10.1007/BF02552270; FLETCHER R.H., 1998, CLIN EPIDEMIOLOGY; Fucci L., 1994, Pathologica (Genoa), V86, P371; GAGLIARDI G, 1995, BRIT J SURG, V82, P599, DOI 10.1002/bjs.1800820508; GAGLIARDI G, 1995, VIRCHOWS ARCH, V426, P149; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; HARRISON JC, 1994, HUM PATHOL, V25, P498, DOI 10.1016/0046-8177(94)90122-8; HART A, 1990, MED INFORM, V15, P229, DOI 10.3109/14639239009025270; HECKERLING PS, 1992, MED DECIS MAKING, V12, P280, DOI 10.1177/0272989X9201200406; HILDEN J, 1978, METHOD INFORM MED, V17, P238; HILDEN J, 1978, METHOD INFORM MED, V17, P227; IEZZONI LI, 1988, JAMA-J AM MED ASSOC, V260, P3159, DOI 10.1001/jama.260.21.3159; JASS JR, 1990, DIS COLON RECTUM, V33, P721, DOI 10.1007/BF02150754; Jass JR, 1996, HISTOPATHOLOGY, V28, P543, DOI 10.1046/j.1365-2559.1996.d01-467.x; JASS JR, 1987, LANCET, V1, P1303; JUSTICE AC, 1989, NEW ENGL J MED, V320, P1388, DOI 10.1056/NEJM198905253202106; Justice AC, 1996, J CLIN EPIDEMIOL, V49, P193, DOI 10.1016/0895-4356(95)00546-3; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LACHS MS, 1992, ANN INTERN MED, V117, P135, DOI 10.7326/0003-4819-117-2-135; Lang T.A., 1997, REPORT STAT MED ANNO, P137; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; LAUPACIS A, 1994, JAMA-J AM MED ASSOC, V272, P234, DOI 10.1001/jama.272.3.234; LEPRI AC, 1995, LANCET, V346, P1103, DOI 10.1016/S0140-6736(95)91778-0; Liabakk NB, 1996, CANCER RES, V56, P190; LINDSAY RM, 1993, AM STAT, V47, P217, DOI 10.2307/2684982; MAZUR DJ, 1993, J AM GERIATR SOC, V41, P223, DOI 10.1111/j.1532-5415.1993.tb06696.x; MOCROFT AJ, 1995, LANCET, V346, P12, DOI 10.1016/S0140-6736(95)92649-6; Mosteller F., 1968, HDB SOC PSYCHOL, V2, P80; NEOPTOLEMOS JP, 1995, BRIT J SURG, V82, P184, DOI 10.1002/bjs.1800820214; OConnor AM, 1996, J CLIN EPIDEMIOL, V49, P1271, DOI 10.1016/S0895-4356(96)00177-1; OCONNOR AM, 1989, J CLIN EPIDEMIOL, V42, P119, DOI 10.1016/0895-4356(89)90085-1; OFNER D, 1995, BRIT J CANCER, V72, P981, DOI 10.1038/bjc.1995.446; OFNER D, 1990, J PATHOL, V162, P43, DOI 10.1002/path.1711620109; Poller DN, 1997, BRIT J CANCER, V75, P87, DOI 10.1038/bjc.1997.14; POSES RM, 1988, MED DECIS MAKING, V8, P233, DOI 10.1177/0272989X8800800403; Ptacek JT, 1996, JAMA-J AM MED ASSOC, V276, P496; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; Rothman K, 1986, MODERN EPIDEMIOLOGY; Secco G B, 1990, Minerva Chir, V45, P1347; Secco GB, 1996, TUMORI, V82, P390, DOI 10.1177/030089169608200419; SECCO GB, 1990, DIGESTION, V47, P71, DOI 10.1159/000200479; SENN SJ, 1989, STAT MED, V8, P467, DOI 10.1002/sim.4780080410; SHEA JA, 1994, ARCH INTERN MED, V154, P2573, DOI 10.1001/archinte.154.22.2573; Smith TJ, 1998, JAMA-J AM MED ASSOC, V279, P1746, DOI 10.1001/jama.279.21.1746; STAHLE E, 1989, APMIS, V97, P513, DOI 10.1111/j.1699-0463.1989.tb00824.x; STONE VE, 1992, JAMA-J AM MED ASSOC, V268, P2655, DOI 10.1001/jama.268.19.2655; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Vecchio Fabio Maria, 1995, Rays (Rome), V20, P15; WAGNER DP, 1994, CRIT CARE MED, V22, P1359, DOI 10.1097/00003246-199409000-00004; WASSON JH, 1985, NEW ENGL J MED, V313, P793, DOI 10.1056/NEJM198509263131306; WYATT J, 1995, LANCET, V346, P1175, DOI 10.1016/S0140-6736(95)92893-6; YATES JF, 1982, ORGAN BEHAV HUM PERF, V30, P132, DOI 10.1016/0030-5073(82)90237-9	76	815	825	0	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	1999	130	6					515	524		10.7326/0003-4819-130-6-199903160-00016	http://dx.doi.org/10.7326/0003-4819-130-6-199903160-00016			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	176RL	10075620				2022-12-28	WOS:000079165500008
J	Moerner, WE; Orrit, M				Moerner, WE; Orrit, M			Illuminating single molecules in condensed matter	SCIENCE			English	Review							PARA-TERPHENYL CRYSTAL; TIME-RESOLVED SPECTROSCOPY; GREEN FLUORESCENT PROTEIN; NEAR-FIELD; PENTACENE MOLECULES; MAGNETIC-RESONANCE; OPTICAL MICROSCOPY; ROOM-TEMPERATURE; SPECTRAL DIFFUSION; IMPURITY MOLECULES	Efficient collection and detection of fluorescence coupled with careful minimization of background from impurities and Raman scattering now enable routine optical microscopy and study of single molecules in complex condensed matter environments. This ultimate method for unraveling ensemble averages Leads to the observation of new effects and to direct measurements of stochastic fluctuations, Experiments at cryogenic temperatures open new directions in molecular spectroscopy, quantum optics, and solid-state dynamics. Room-temperature investigations apply several techniques (polarization microscopy, single-molecule imaging, emission time dependence, energy transfer, Lifetime studies, and the Like) to a growing array of biophysical problems where new insight may be gained from direct observations of hidden static and dynamic inhomogeneity.	Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Univ Bordeaux 1, Ctr Phys Mol Opt & Hertzienne, CNRS, UMR 5798, F-33405 Talence, France	Stanford University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite de Bordeaux	Moerner, WE (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.		ORRIT, Michel/I-2426-2013; ORRIT, Michel/ABC-1795-2020; Moerner, William E/C-3260-2008	ORRIT, Michel/0000-0002-3607-3426; Moerner, William E/0000-0002-2830-209X				AMBROSE WP, 1991, NATURE, V349, P225, DOI 10.1038/349225a0; AMBROSE WP, 1991, J CHEM PHYS, V95, P7150, DOI 10.1063/1.461392; AMBROSE WP, 1994, SCIENCE, V265, P364, DOI 10.1126/science.265.5170.364; BARNES MD, 1995, ANAL CHEM, V67, pA418, DOI 10.1021/ac00109a001; BASCHE T, 1995, NATURE, V373, P132, DOI 10.1038/373132a0; BASCHE T, 1992, PHYS REV LETT, V69, P1516, DOI 10.1103/PhysRevLett.69.1516; Basche T., 1997, SINGLE MOL OPTICAL D; BERNARD J, 1993, J CHEM PHYS, V98, P850, DOI 10.1063/1.464249; BETZIG E, 1993, SCIENCE, V262, P1422, DOI 10.1126/science.262.5138.1422; Bian RX, 1995, PHYS REV LETT, V75, P4772, DOI 10.1103/PhysRevLett.75.4772; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BINNIG G, 1987, REV MOD PHYS, V59, P615, DOI 10.1103/RevModPhys.59.615; Bopp MA, 1997, P NATL ACAD SCI USA, V94, P10630, DOI 10.1073/pnas.94.20.10630; Brouwer ACJ, 1998, PHYS REV LETT, V80, P3944, DOI 10.1103/PhysRevLett.80.3944; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; DEHMELT H, 1990, REV MOD PHYS, V62, P525, DOI 10.1103/RevModPhys.62.525; Dickson RM, 1996, SCIENCE, V274, P966, DOI 10.1126/science.274.5289.966; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; DIEDRICH F, 1988, IEEE J QUANTUM ELECT, V24, P1314, DOI 10.1109/3.968; Edman L, 1996, P NATL ACAD SCI USA, V93, P6710, DOI 10.1073/pnas.93.13.6710; EGGELING C, 1998, SCIENCE, V95, P1556; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Empedocles SA, 1997, SCIENCE, V278, P2114, DOI 10.1126/science.278.5346.2114; Feynman RP, 1961, MINIATURIZATION; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Gammon D, 1997, SCIENCE, V277, P85, DOI 10.1126/science.277.5322.85; Geva E, 1997, J PHYS CHEM B, V101, P8920, DOI 10.1021/jp971722o; Goodwin PM, 1997, NUCLEOS NUCLEOT, V16, P543, DOI 10.1080/07328319708002914; Gruber A, 1997, SCIENCE, V276, P2012, DOI 10.1126/science.276.5321.2012; GUTTLER F, 1994, CHEM PHYS LETT, V217, P393, DOI 10.1016/0009-2614(94)87003-9; Ha T, 1998, PHYS REV LETT, V80, P2093, DOI 10.1103/PhysRevLett.80.2093; Ha T, 1996, PHYS REV LETT, V77, P3979, DOI 10.1103/PhysRevLett.77.3979; ITANO WM, 1987, SCIENCE, V237, P612, DOI 10.1126/science.237.4815.612; Jia YW, 1997, P NATL ACAD SCI USA, V94, P7932, DOI 10.1073/pnas.94.15.7932; Keller RA, 1996, APPL SPECTROSC, V50, pA12, DOI 10.1366/0003702963905600; KOHLER J, 1993, NATURE, V363, P242, DOI 10.1038/363242a0; KOZANKIEWICZ B, 1994, J CHEM PHYS, V101, P9377, DOI 10.1063/1.467968; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Lu HP, 1997, NATURE, V385, P143, DOI 10.1038/385143a0; Macklin JJ, 1996, SCIENCE, V272, P255, DOI 10.1126/science.272.5259.255; Mehta AD, 1999, SCIENCE, V283, P1689, DOI 10.1126/science.283.5408.1689; Mets U, 1994, J Fluoresc, V4, P259, DOI 10.1007/BF01878461; Moerner WE, 1997, SCIENCE, V277, P1059, DOI 10.1126/science.277.5329.1059; MOERNER WE, 1991, PHYS REV LETT, V66, P1376, DOI 10.1103/PhysRevLett.66.1376; MOERNER WE, 1989, PHYS REV LETT, V62, P2535, DOI 10.1103/PhysRevLett.62.2535; MOERNER WE, 1993, ANGEW CHEM INT EDIT, V32, P457, DOI 10.1002/anie.199304573; NIE SM, 1994, SCIENCE, V266, P1018, DOI 10.1126/science.7973650; Nie SM, 1997, ANNU REV BIOPH BIOM, V26, P567, DOI 10.1146/annurev.biophys.26.1.567; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; ORRIT M, 1990, PHYS REV LETT, V65, P2716, DOI 10.1103/PhysRevLett.65.2716; Orrit M, 1996, PROG OPTICS, V35, P61, DOI 10.1016/S0079-6638(08)70528-6; Phillips W.A., 1981, AMORPHOUS SOLIDS LOW; Pierce DW, 1997, NATURE, V388, P338, DOI 10.1038/41009; Plakhotnik T, 1996, SCIENCE, V271, P1703, DOI 10.1126/science.271.5256.1703; Plakhotnik T, 1997, ANNU REV PHYS CHEM, V48, P181, DOI 10.1146/annurev.physchem.48.1.181; REBANE KK, 1994, CHEM PHYS, V189, P139, DOI 10.1016/0301-0104(94)00298-3; REILLY PD, 1995, J CHEM PHYS, V102, P1540, DOI 10.1063/1.468886; Schmidt T, 1996, P NATL ACAD SCI USA, V93, P2926, DOI 10.1073/pnas.93.7.2926; SHERA EB, 1990, CHEM PHYS LETT, V174, P553, DOI 10.1016/0009-2614(90)85485-U; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; TAMARAT P, 1995, PHYS REV LETT, V75, P1514, DOI 10.1103/PhysRevLett.75.1514; TCHENIO P, 1993, CHEM PHYS LETT, V213, P325, DOI 10.1016/0009-2614(93)85140-J; Trautman JK, 1996, CHEM PHYS, V205, P221, DOI 10.1016/0301-0104(95)00391-6; TRAUTMAN JK, 1994, NATURE, V369, P40, DOI 10.1038/369040a0; Tsien Roger Y., 1995, P267; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; Van Der Meer B. W., 1994, RESONANCE ENERGY TRA; VandenBout DA, 1997, SCIENCE, V277, P1074, DOI 10.1126/science.277.5329.1074; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Wennmalm S, 1997, P NATL ACAD SCI USA, V94, P10641, DOI 10.1073/pnas.94.20.10641; WILD UP, 1992, CHEM PHYS LETT, V193, P451, DOI 10.1016/0009-2614(92)85830-4; Wrachtrup J, 1997, CHEM PHYS LETT, V267, P179, DOI 10.1016/S0009-2614(97)00073-0; Xie XS, 1996, ACCOUNTS CHEM RES, V29, P598, DOI 10.1021/ar950246m; XIE XS, 1994, SCIENCE, V265, P361, DOI 10.1126/science.265.5170.361; Xie XS, 1998, ANNU REV PHYS CHEM, V49, P441, DOI 10.1146/annurev.physchem.49.1.441; ZUMBUSCH A, 1993, PHYS REV LETT, V70, P3584, DOI 10.1103/PhysRevLett.70.3584	80	917	952	11	443	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	1999	283	5408					1670	+		10.1126/science.283.5408.1670	http://dx.doi.org/10.1126/science.283.5408.1670			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175PF	10073924				2022-12-28	WOS:000079102800037
J	Nagle, DL; McGrail, SH; Vitale, J; Woolf', EA; Dussault, BJ; DiRocco, L; Holmgren, L; Montagno, J; Bork, P; Huszar, D; Fairchild-Huntress, V; Ge, P; Keilty, J; Ebeling, C; Baldini, L; Gilchrist, J; Burn, P; Carlson, GA; Moore, KJ				Nagle, DL; McGrail, SH; Vitale, J; Woolf', EA; Dussault, BJ; DiRocco, L; Holmgren, L; Montagno, J; Bork, P; Huszar, D; Fairchild-Huntress, V; Ge, P; Keilty, J; Ebeling, C; Baldini, L; Gilchrist, J; Burn, P; Carlson, GA; Moore, KJ			The mahogany protein is a receptor involved in suppression of obesity	NATURE			English	Article							AGOUTI; TOOL; GENE; IDENTIFICATION; ALIGNMENT; MUTATIONS; FAMILY; MOTIF; MICE; MAP	Genetic studies have shown that mutations within the mahogany locus(1) suppress the pleiotropic phenotypes, including obesity, of the agouti-lethal-yellow mutant(2,3). Here we identify the mahogany gene and its product; this study, to our knowledge, represents the first positional cloning of a suppressor gene in the mouse. Expression of the mahogany gene is broad; however, in situ hybridization analysis emphasizes the importance of its expression in the ventromedial hypothalamic nucleus, a region that is intimately involved in the regulation of body weight and feeding. We present new genetic studies that indicate that the mahogany locus does not suppress the obese phenotype of the melanocortin-4-receptor null allele(4) or those of the monogenic obese models (Lep(db), tub and Cpe(fat)). However, mahogany can suppress diet-induced obesity, the mechanism of which is likely to have implications for therapeutic intervention in common human obesity. The amino-acid sequence of the mahogany protein suggests that it is a large, single-transmembrane-domain receptor-like molecule, with a short cytoplasmic tail containing a site that is conserved between Caenorhabditis elegans and mammals. We propose two potential, alternative modes of action for mahogany: one draws parallels with the mechanism of action of low-affinity proteoglycan receptors such as fibroblast growth factor and transforming growth factor-beta, and the other suggests that mahogany itself is a signalling receptor.	Millennium Pharmaceut Inc, Cambridge, MA 02139 USA; European Mol Biol Lab, D-69012 Heidelberg, Germany; Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; McLaughlin Res Inst Biomed Sci, Great Falls, MT 59405 USA; Hoffmann La Roche Inc, Dept Metab Dis, Nutley, NJ 07110 USA	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Max Delbruck Center for Molecular Medicine; McLaughlin Research Institute for Biomedical Sciences, Inc.; Roche Holding	Moore, KJ (corresponding author), Millennium Pharmaceut Inc, 640 Mem Dr, Cambridge, MA 02139 USA.	moore@mpi.com	Bork, Peer/F-1813-2013	Bork, Peer/0000-0002-2627-833X				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; BORK P, 1994, J MOL BIOL, V236, P1277, DOI 10.1016/0022-2836(94)90056-6; DEITRICH WF, 1996, NATURE, V380, P149; Dinulescu DM, 1998, P NATL ACAD SCI USA, V95, P12707, DOI 10.1073/pnas.95.21.12707; DRICKAMER K, 1995, NAT STRUCT BIOL, V2, P437, DOI 10.1038/nsb0695-437; Duke-Cohan JS, 1998, P NATL ACAD SCI USA, V95, P11336, DOI 10.1073/pnas.95.19.11336; Duncan LM, 1998, CANCER RES, V58, P1515; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gyapay G, 1996, HUM MOL GENET, V5, P339, DOI 10.1093/hmg/5.3.339; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; LANE PRISCILLA W., 1960, JOUR HEREDITY, V51, P228; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Maestrini E, 1996, P NATL ACAD SCI USA, V93, P674, DOI 10.1073/pnas.93.2.674; Miller KA, 1997, GENETICS, V146, P1407; Misumi DJ, 1997, GENOMICS, V40, P147, DOI 10.1006/geno.1996.4549; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Nakayama M, 1998, GENOMICS, V51, P27, DOI 10.1006/geno.1998.5341; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SCLESSINGER J, 1995, CELL, V88, P357; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; SING CF, 1998, GENOME RES, V8, P175; Stewart EA, 1997, GENOME RES, V7, P422, DOI 10.1101/gr.7.5.422; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Yang YK, 1997, MOL ENDOCRINOL, V11, P274, DOI 10.1210/me.11.3.274	30	141	154	0	3	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 11	1999	398	6723					148	152		10.1038/18210	http://dx.doi.org/10.1038/18210			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176DG	10086355				2022-12-28	WOS:000079135200044
J	Brewer, TF				Brewer, TF			Preventive therapy for tuberculosis in HIV infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; HIGH-RISK; ANERGY		Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Brewer, TF (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	timothy.brewer@channing.harvard.edu						*CDCP, 1990, MMWR-MORBID MORTAL W, V39, P9; Gordin FM, 1997, NEW ENGL J MED, V337, P315, DOI 10.1056/NEJM199707313370505; *INT UN TUB LUNG D, 1994, TUBERCLE LUNG DIS, V75, P96; Msamanga GI, 1997, NEW ENGL J MED, V337, P849, DOI 10.1056/NEJM199709183371210; NUNN PP, 1994, THORAX, V49, P511, DOI 10.1136/thx.49.5.511; PANICH V, 1994, 10 WORLD AIDS C AUG; SACKS H, 1998, 12 WORLD AIDS C JUN; SELWYN PA, 1992, JAMA-J AM MED ASSOC, V268, P504, DOI 10.1001/jama.268.4.504; Wilkinson D, 1998, BRIT MED J, V317, P625, DOI 10.1136/bmj.317.7159.625; Yanai H, 1996, AIDS, V10, P527, DOI 10.1097/00002030-199605000-00012	10	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	1999	281	10					881	882		10.1001/jama.281.10.881	http://dx.doi.org/10.1001/jama.281.10.881			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172XH	10078465				2022-12-28	WOS:000078950600003
J	Wilde, JA; McMillan, JA; Serwint, J; Butta, J; O'Riordan, MA; Steinhoff, MC				Wilde, JA; McMillan, JA; Serwint, J; Butta, J; O'Riordan, MA; Steinhoff, MC			Effectiveness of influenza vaccine in health care professionals - A randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Annual Meeting of the Society-for-Pediatric-Research	MAY 01-05, 1998	NEW ORLEANS, LA	Soc Pediat Res			NOSOCOMIAL INFLUENZA; ELDERLY PERSONS; COST-EFFECTIVENESS; UNITED-STATES; OTITIS-MEDIA; INFECTION; EFFICACY; PREVENTION; MORTALITY; CHILDREN	Context Data are limited and conflicting regarding the effectiveness of influenza vaccine in health care professionals. Objective To determine the effectiveness of trivalent influenza vaccine in reducing infection, illness, and absence from work in young, healthy health care professionals. Design Randomized, prospective, double-blind, controlled trial over 3 consecutive years, from 1992-1993 to 1994-1995, Setting Two large teaching hospitals in Baltimore, Md, Participants Two hundred sixty-four hospital-based health care professionals without chronic medical problems were recruited; 49 participated for 2 seasons; 24 participated for 3 seasons. The mean age was 28.4 years, 75 % were resident physicians, and 57% were women. Intervention Participants were randomly assigned to receive either an influenza vaccine or a control (meningococcal vaccine, pneumococcal vaccine, or placebo). Serum samples for antibody assays were collected at the time of vaccination, 1 month after vaccination, and at the end of the influenza season. Active weekly surveillance for illness was conducted during each influenza epidemic period. Main Outcome Measures Serologically defined influenza infection (4-fold increase in hemagglutination-inhibiting antibodies), days of febrile respiratory illness, and days absent from work. Results We conducted 359 person-winters of serologic surveillance (99.4% followup) and 4746 person-weeks of illness surveillance (100% follow-up). Twenty-four (13.4%) of 179 control subjects and 3 (1.7%) of 180 influenza vaccine recipients had serologic evidence of influenza type A or B infection during the study period. Vaccine efficacy against serologically defined infection was 88% for influenza A (95% confidence interval [CI], 47%-97%; P = .001) and 89% for influenza B (95% CI, 14% -99%; P = .03). Among influenza vaccinees, cumulative days of reported febrile respiratory illness were 28.7 per 100 subjects compared with 40.6 per 100 subjects in controls (P = .57) and days of absence were 9.9 per 100 subjects vs 21.1 per 100 subjects in controls (P = .41). Conclusions Influenza vaccine is effective in preventing infection by influenza A and B in health care professionals and may reduce reported days of work absence and febrile respiratory illness. These data support a policy of annual influenza vaccination of health care professionals.	Case Western Reserve Univ, Sch Med, Dept Pediat, Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Div Clin Epidemiol, Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Baltimore, MD 21205 USA; Med Coll Georgia, Dept Emergency Med, Augusta, GA 30912 USA; Med Coll Georgia, Dept Pediat, Augusta, GA 30912 USA	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Johns Hopkins University; Johns Hopkins University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Wilde, JA (corresponding author), Med Coll Georgia, Dept Emergency Med, 1120 15th St, Rm AF 2021, Augusta, GA 30912 USA.	jwilde@mail.mcg.edu			NCRR NIH HHS [M01RR00052] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AHMED AEH, 1995, LANCET, V346, P591, DOI 10.1016/S0140-6736(95)91434-X; [Anonymous], MMWR MORB MORTAL WKL; BARKER WH, 1986, AM J PUBLIC HEALTH, V76, P761, DOI 10.2105/AJPH.76.7.761; Carrat F, 1996, NEW ENGL J MED, V334, P403; CLEMENTS DA, 1995, ARCH PEDIAT ADOL MED, V149, P1113, DOI 10.1001/archpedi.1995.02170230067009; EDWARDS KM, 1994, J INFECT DIS, V169, P68, DOI 10.1093/infdis/169.1.68; FEDSON DS, 1993, JAMA-J AM MED ASSOC, V270, P1956, DOI 10.1001/jama.270.16.1956; FEERY BJ, 1979, J INFECT DIS, V139, P237, DOI 10.1093/infdis/139.2.237; FOX JP, 1982, AM J EPIDEMIOL, V116, P228, DOI 10.1093/oxfordjournals.aje.a113408; GARDNER PS, 1973, BMJ-BRIT MED J, V2, P571, DOI 10.1136/bmj.2.5866.571; George W K, 1965, J Am Coll Health Assoc, V14, P97; GILL PW, 1985, MED J AUSTRALIA, V142, P94, DOI 10.5694/j.1326-5377.1985.tb133042.x; GLEZEN WP, 1980, JAMA-J AM MED ASSOC, V243, P1345; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; HALL CB, 1975, PEDIATRICS, V55, P673; HAMMOND ML, 1978, MED J AUSTRALIA, V1, P301, DOI 10.5694/j.1326-5377.1978.tb107862.x; HEIKKINEN T, 1991, AM J DIS CHILD, V145, P445, DOI 10.1001/archpedi.1991.02160040103017; HOSKINS TW, 1979, LANCET, V1, P33; KAPILA R, 1977, CHEST, V71, P576, DOI 10.1378/chest.71.5.576; KEITEL WA, 1988, AM J EPIDEMIOL, V127, P353, DOI 10.1093/oxfordjournals.aje.a114809; KNIGHT V, 1970, Infection and Immunity, V1, P200; MCDOUGAL BA, 1977, SOUTHERN MED J, V70, P1023, DOI 10.1097/00007611-197708000-00044; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; MULLOOLY JP, 1994, ANN INTERN MED, V121, P947, DOI 10.7326/0003-4819-121-12-199412150-00008; NICHOL KL, 1995, NEW ENGL J MED, V333, P889, DOI 10.1056/NEJM199510053331401; NICHOL KL, 1994, NEW ENGL J MED, V331, P778, DOI 10.1056/NEJM199409223311206; PACHUCKI CT, 1989, ARCH INTERN MED, V149, P77, DOI 10.1001/archinte.149.1.77; PACHUCKI CT, 1985, J INFECT DIS, V151, P1170, DOI 10.1093/infdis/151.6.1170; PALMER DF, 1980, IMMUNOLOGY SERIES, V6, P25; PATRIARCA PA, 1995, NEW ENGL J MED, V333, P933, DOI 10.1056/NEJM199510053331410; Potter J, 1997, J INFECT DIS, V175, P1, DOI 10.1093/infdis/175.1.1; Rothman KJ., 1998, MODEM EPIDEMIOLOGY, V2, P269; RUBEN FL, 1987, AM J MED, V82, P31, DOI 10.1016/0002-9343(87)90558-4; SCRAGG R, 1985, MED J AUSTRALIA, V142, P98, DOI 10.5694/j.1326-5377.1985.tb133043.x; SERWINT J, 1993, PEDIATR INFECT DIS J, V12, P956, DOI 10.1097/00006454-199311000-00014; SMITH JWG, 1979, J HYG-CAMBRIDGE, V83, P157, DOI 10.1017/S0022172400025936; SULLIVAN KM, 1993, AM J PUBLIC HEALTH, V83, P1712, DOI 10.2105/AJPH.83.12.1712; VANVORIS LP, 1982, ANN INTERN MED, V96, P153, DOI 10.7326/0003-4819-96-2-153; WEINGARTEN S, 1988, J GEN INTERN MED, V3, P32, DOI 10.1007/BF02595754; Yassi A, 1991, Can J Infect Dis, V2, P101	41	465	483	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	1999	281	10					908	913		10.1001/jama.281.10.908	http://dx.doi.org/10.1001/jama.281.10.908			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	172XH	10078487	Bronze			2022-12-28	WOS:000078950600035
J	Kandela, P				Kandela, P			Hospital food	LANCET			English	Editorial Material											Kandela, P (corresponding author), 29 Greenlands Rd, Staines TW18 4LR, Middx, England.								0	3	6	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 27	1999	353	9154					763	763		10.1016/S0140-6736(05)76144-4	http://dx.doi.org/10.1016/S0140-6736(05)76144-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173DR	10073555				2022-12-28	WOS:000078966400074
J	Rieppel, O				Rieppel, O			Evolution - Turtle origins	SCIENCE			English	Editorial Material							PHYLOGENY		Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA	Field Museum of Natural History (Chicago)	Rieppel, O (corresponding author), Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA.	rieppel@fmppr.fmnh.org						Broom R, 1924, B AM MUS NAT HIST, V51, P39; de Beer G., 1937, DEV VERTEBRATE SKULL; deBraga M, 1997, ZOOL J LINN SOC-LOND, V120, P281, DOI 10.1111/j.1096-3642.1997.tb01280.x; Gaffney E. S., 1990, B AM MUS NAT HIST, V194, P1; Goodrich ES, 1930, STRUCTURE DEV VERTEB; Gregory William King, 1946, BULL AMER MUS NAT HIST, V86, P275; Hedges SB, 1999, SCIENCE, V283, P998, DOI 10.1126/science.283.5404.998; HOFSTEN NV, 1941, ZOOL BIDR UPPS, V20, P501; Kirsch JAW, 1998, PHILOS T R SOC B, V353, P1221, DOI 10.1098/rstb.1998.0278; Lee MSY, 1997, ZOOL J LINN SOC-LOND, V120, P197; Lovtrup S., 1977, PHYLOGENY VERTEBRATA; Merck J. W. Jr., 1997, Journal of Vertebrate Paleontology, V17, p65A; Platz JE, 1997, NATURE, V389, P246, DOI 10.1038/38425; RIEPPEL O, IN PRESS ANN REV ECO; Rieppel Olivier, 1993, Journal of Vertebrate Paleontology, V13, P31; Romer A, 1956, OSTEOLOGY REPTILES; Zardoya R, 1998, P NATL ACAD SCI USA, V95, P14226, DOI 10.1073/pnas.95.24.14226	17	20	21	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 12	1999	283	5404					945	946		10.1126/science.283.5404.945	http://dx.doi.org/10.1126/science.283.5404.945			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166KM	10075558				2022-12-28	WOS:000078574800034
J	Rait, G				Rait, G			Counting heads may mask cultural and social factors - Commentary	BRITISH MEDICAL JOURNAL			English	Editorial Material							ETHNICITY		Royal Free Med Sch, Dept Primary Care & Populat Sci, Archway Resource Ctr, London N19 5NF, England; UCL, Sch Med, Archway Resource Ctr, London N19 5NF, England	University of London; University College London; University of London; University College London; UCL Medical School	Rait, G (corresponding author), Royal Free Med Sch, Dept Primary Care & Populat Sci, Archway Resource Ctr, Whittington Campus, London N19 5NF, England.	g.rait@ucl.ac.uk	Rait, Greta/C-5577-2009	Rait, Greta/0000-0002-7216-7294				Abas M, 1996, INT J GERIATR PSYCH, V11, P1097, DOI 10.1002/(SICI)1099-1166(199612)11:12<1097::AID-GPS496>3.0.CO;2-8; Bracken PJ, 1998, BRIT J PSYCHIAT, V172, P103, DOI 10.1192/bjp.172.2.103; Jacob KS, 1997, PSYCHOL MED, V27, P1215, DOI 10.1017/S0033291796004436; KLEINMAN A, 1987, BRIT J PSYCHIAT, V151, P447, DOI 10.1192/bjp.151.4.447; MARSELLA A J, 1978, Culture Medicine and Psychiatry, V2, P343; McKenzie K, 1996, BRIT MED J, V312, P1054; *OFF POP CENS SURV, 1992, 1991 CONS LOC BAS ST; SENIOR PA, 1994, BRIT MED J, V309, P327, DOI 10.1136/bmj.309.6950.327; SMAJE C, 1995, HLTH RACE ETHNICITY	9	8	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 30	1999	318	7179					305	306						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	163ZH	10075461				2022-12-28	WOS:000078436700025
J	Proctor, SR; Campbell, JL				Proctor, SR; Campbell, JL			Towards primary care groups - Managing the future in Bradford	BRITISH MEDICAL JOURNAL			English	Article									Guys Kings & St Thomass Sch Med, Dept Gen Practice & Primary Care, London SE11 6SP, England	University of London; King's College London	Proctor, SR (corresponding author), Guys Kings & St Thomass Sch Med, Dept Gen Practice & Primary Care, London SE11 6SP, England.		Campbell, John/A-5792-2011	Campbell, John/0000-0002-6752-3493				*SECR STAT HLTH, 1997, CM3807	1	2	2	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 20	1999	318	7186					783	785		10.1136/bmj.318.7186.783	http://dx.doi.org/10.1136/bmj.318.7186.783			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BX	10082706	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000079421700030
J	Bradke, F; Dotti, CG				Bradke, F; Dotti, CG			The role of local actin instability in axon formation	SCIENCE			English	Article							GROWTH CONE; HIPPOCAMPAL-NEURONS; STRESS FIBERS; RHO-PROTEINS; CELL-GROWTH; ORGANIZATION; FILOPODIA; POLARITY; CULTURE; CDC42	The role of localized instability of the actin network in specifying axonal fate was examined with the use of rat hippocampal neurons in culture. During normal neuronal development, actin dynamics and instability polarized to a single growth cone before axon formation. Consistently, global application of actin-depolymerizing drugs and of the Rho-signaling inactivator toxin B to nonpolarized cells produced neurons with multiple axons. Moreover, disruption of the actin network in one individual growth cone induced its neurite to become the axon. Thus, local instability of the actin network restricted to a single growth cone is a physiological signal specifying neuronal polarization.	European Mol Biol Lab, Cell Biol Programme, D-69012 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Dotti, CG (corresponding author), European Mol Biol Lab, Cell Biol Programme, Meyerhofstr 1, D-69012 Heidelberg, Germany.	dotti@embl-heidelberg.de	Dotti, Carlos G/I-5533-2015	Dotti, Carlos G/0000-0003-4052-1719; Bradke, Frank/0000-0002-0345-3772				ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; Aktories K, 1997, TRENDS MICROBIOL, V5, P282, DOI 10.1016/S0966-842X(97)01067-6; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; Bradke F, 1997, NEURON, V19, P1175, DOI 10.1016/S0896-6273(00)80410-9; BRADKE F, 1997, MICROINJECTION TRANS, P81; BRIDGMAN PC, 1989, J CELL BIOL, V108, P95, DOI 10.1083/jcb.108.1.95; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; CHIEN CB, 1993, NEURON, V11, P237, DOI 10.1016/0896-6273(93)90181-P; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; de Hoop MJ, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 1, P154; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DOTTI CG, 1991, J CELL SCI, P75; EDSON K, 1993, DEVELOPMENT, V117, P689; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; HEIDEMANN SR, 1990, J CELL BIOL, V111, P1949, DOI 10.1083/jcb.111.5.1949; Jareb M, 1997, J NEUROSCI, V17, P8955; JOSHI HC, 1985, J CELL BIOL, V101, P697, DOI 10.1083/jcb.101.3.697; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; LAMOUREUX P, 1989, NATURE, V340, P156, DOI 10.1038/340159a0; Lin CH, 1996, NEURON, V16, P769, DOI 10.1016/S0896-6273(00)80097-5; LIN CH, 1995, NEURON, V14, P763, DOI 10.1016/0896-6273(95)90220-1; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Mandell JW, 1996, J NEUROSCI, V16, P5727; MARSH L, 1984, J CELL BIOL, V99, P2041, DOI 10.1083/jcb.99.6.2041; MILLER PJ, 1994, MOL CELL BIOL, V14, P1075, DOI 10.1128/MCB.14.2.1075; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; Suter DM, 1998, J CELL BIOL, V141, P227, DOI 10.1083/jcb.141.1.227; Suter DM, 1998, CURR OPIN NEUROBIOL, V8, P106, DOI 10.1016/S0959-4388(98)80014-7; TANAKA E, 1995, J CELL BIOL, V128, P139, DOI 10.1083/jcb.128.1.139; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; ZHENG J, 1994, J CELL BIOL, V127, P2049, DOI 10.1083/jcb.127.6.2049	36	412	421	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	1999	283	5409					1931	1934		10.1126/science.283.5409.1931	http://dx.doi.org/10.1126/science.283.5409.1931			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177UC	10082468				2022-12-28	WOS:000079228600052
J	Brunet, A; Bonni, A; Zigmond, MJ; Lin, MZ; Juo, P; Hu, LS; Anderson, MJ; Arden, KC; Blenis, J; Greenberg, ME				Brunet, A; Bonni, A; Zigmond, MJ; Lin, MZ; Juo, P; Hu, LS; Anderson, MJ; Arden, KC; Blenis, J; Greenberg, ME			Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor	CELL			English	Article							PROTEIN-KINASE AKT; CAENORHABDITIS-ELEGANS; INDUCED APOPTOSIS; GENE; BINDING; DEATH; SITE; SPECIFICITY; EXPRESSION; CLONING	Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase Akt, which then phosphorylates and inactivates components of the apoptotic machinery, including BAD and Caspase 9. In this study, we demonstrate that Akt also regulates the activity of FKHRL1, a member of the Forkhead family of transcription factors. In the presence of survival factors, Akt phosphorylates FKHRL1, leading to FKHRL1's association with 14-3-3 proteins and FKHRL1's retention in the cytoplasm. Survival factor withdrawal leads to FKHRL1 dephosphorylation, nuclear translocation, and target gene activation. Within the nucleus, FKHRL1 triggers apoptosis most likely by inducing the expression of genes that are critical for cell death, such as the Fas ligand gene.	Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ Calif San Diego, Ludwig Inst Canc Res, San Diego, CA 92093 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Greenberg, ME (corresponding author), Childrens Hosp, Div Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.	greenberg@a1.tch.harvard.edu	Roszak, Joanna/F-4003-2010; Li, Chia Cheng/D-9906-2015; Juo, Peter/CJY-3695-2022	Juo, Peter/0000-0002-3039-2266; Lin, Michael/0000-0002-0492-1961	NCI NIH HHS [CA43855, CA46595] Funding Source: Medline; NICHD NIH HHS [HD 18655] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA046595, R01CA043855, R37CA046595] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Borkhardt A, 1997, ONCOGENE, V14, P195, DOI 10.1038/sj.onc.1200814; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Cichy SB, 1998, J BIOL CHEM, V273, P6482, DOI 10.1074/jbc.273.11.6482; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Datta SR, 1998, HORM SIGNALING, V1, P257; delPeso L, 1997, SCIENCE, V278, P687; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; Faris M, 1998, J IMMUNOL, V160, P134; Friesen C, 1996, NAT MED, V2, P574, DOI 10.1038/nm0596-574; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; Hillion J, 1997, BLOOD, V90, P3714, DOI 10.1182/blood.V90.9.3714; Holtz-Heppelmann CJ, 1998, J BIOL CHEM, V273, P4416, DOI 10.1074/jbc.273.8.4416; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; KAUFMANN E, 1995, J MOL BIOL, V248, P239, DOI 10.1006/jmbi.1995.0218; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; KHANNA KK, 1993, ONCOGENE, V8, P3307; Latinis KM, 1997, J BIOL CHEM, V272, P31427, DOI 10.1074/jbc.272.50.31427; Le-Niculescu H, 1999, MOL CELL BIOL, V19, P751; Liao JF, 1998, J BIOL CHEM, V273, P27320, DOI 10.1074/jbc.273.42.27320; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Mittelstadt PR, 1998, MOL CELL BIOL, V18, P3744, DOI 10.1128/MCB.18.7.3744; MIYASHITA T, 1995, CELL, V80, P293; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; OBRIEN RM, 1995, MOL CELL BIOL, V15, P1747; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; PAGES G, 1994, EMBO J, V13, P3003, DOI 10.1002/j.1460-2075.1994.tb06599.x; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; Sakamaki K, 1998, EUR J BIOCHEM, V253, P399, DOI 10.1046/j.1432-1327.1998.2530399.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; SUNG SSJ, 1991, J IMMUNOL, V147, P2047; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345	44	5216	5392	8	247	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	1999	96	6					857	868		10.1016/S0092-8674(00)80595-4	http://dx.doi.org/10.1016/S0092-8674(00)80595-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	178ZY	10102273	Bronze			2022-12-28	WOS:000079300100012
J	Seelos, C				Seelos, C			Lessons from Iraq on bioweapons	NATURE			English	Editorial Material									UN Special Commiss, New York, NY 10017 USA		Seelos, C (corresponding author), UN Special Commiss, S-3027, New York, NY 10017 USA.								0	7	7	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 18	1999	398	6724					187	188		10.1038/18292	http://dx.doi.org/10.1038/18292			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177UA	10094038				2022-12-28	WOS:000079228400020
J	Harper, L; Savage, COS				Harper, L; Savage, COS			Treatment of IgA nephropathy	LANCET			English	Editorial Material							ANGIOTENSIN-CONVERTING ENZYME; CONTROLLED TRIAL; STEROID-THERAPY; PROGRESSION; INHIBITION; PREDNISONE		Univ Birmingham, Div Med Sci, MRC, Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Harper, L (corresponding author), Univ Birmingham, Div Med Sci, MRC, Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England.							ALLEN AC, 1995, CLIN EXP IMMUNOL, V100, P470; BANNISTER KM, 1995, CONTRIB NEPHROL, V111, P184; DAMICO G, 1987, QJM, V53, P227; FEEHALLY J, 1988, NEPHROL DIAL TRANSPL, V3, P361, DOI 10.1093/oxfordjournals.ndt.a091683; GALLO GR, 1988, AM J KIDNEY DIS, V12, P362, DOI 10.1016/S0272-6386(88)80025-8; GATTRAN D, 1996, AM J KIDNEY DIS, V23, P247; GOUMENOS D, 1995, NEPHROL DIAL TRANSPL, V10, P1173, DOI 10.1093/ndt/10.7.1173; Hiki Y, 1996, J AM SOC NEPHROL, V7, P955; KOBAYASHI Y, 1988, NEPHRON, V48, P12, DOI 10.1159/000184861; KOBAYASHI Y, 1989, NEPHRON, V53, P250, DOI 10.1159/000185753; LAI KN, 1987, CLIN NEPHROL, V28, P281; LAI KN, 1986, CLIN NEPHROL, V26, P174; REMUZZI A, 1991, KIDNEY INT, V39, P1267, DOI 10.1038/ki.1991.160; SCHENA FP, 1990, NEPHROL DIAL TRANSPL, V5, P47; WALDO FB, 1993, PEDIATR NEPHROL, V7, P529; WELCH TR, 1992, J PEDIATR-US, V121, P474, DOI 10.1016/S0022-3476(05)81808-6; Yoshikawa N, 1999, J AM SOC NEPHROL, V10, P101	17	5	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 13	1999	353	9156					860	862		10.1016/S0140-6736(98)00395-X	http://dx.doi.org/10.1016/S0140-6736(98)00395-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BU	10093975				2022-12-28	WOS:000079421400005
J	McDonnell, JM; Fushman, D; Milliman, CL; Korsmeyer, SJ; Cowburn, D				McDonnell, JM; Fushman, D; Milliman, CL; Korsmeyer, SJ; Cowburn, D			Solution structure of the proapoptotic molecule BID: A structural basis for apoptotic agonists and antagonists	CELL			English	Article							PROTEIN SECONDARY STRUCTURE; SURVIVAL-PROMOTING PROTEINS; PROGRAMMED CELL-DEATH; BCL-X-L; NMR-SPECTROSCOPY; STRUCTURE PREDICTION; N-15 RELAXATION; BH3 DOMAIN; BAX; RESONANCE	Members of the BCL2 family of proteins are key regulators of programmed cell death, acting either as apoptotic agonists or antagonists. Here we describe the solution structure of BID, presenting the structure of a proapoptotic BCL2 family member. An analysis of sequence/structure of BCL2 family members allows us to define a structural superfamily, which has implications for general mechanisms for regulating proapoptotic activity. It appears two criteria must be met for proapoptotic function within the BCL2 family: targeting of molecules to intracellular membranes, and exposure of the BH3 death domain. BID's activity is regulated by a Caspase 8-mediated cleavage event, exposing the BH3 domain and significantly changing the surface charge and hydrophobicity, resulting in a change of cellular localization.	Rockefeller Univ, New York, NY 10021 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Rockefeller University; Howard Hughes Medical Institute; Washington University (WUSTL)	Cowburn, D (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	cowburn@rockvax.rockefeller.edu	Cowburn, David/A-8448-2008	McDonnell, James/0000-0001-9037-2980; Cowburn, David/0000-0001-6770-7172	NCI NIH HHS [CA-50239] Funding Source: Medline; NIGMS NIH HHS [GM-47021] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA050239, R37CA050239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047021] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; BAGBY S, 1994, BIOCHEMISTRY-US, V33, P2409, DOI 10.1021/bi00175a009; BOYD JM, 1995, ONCOGENE, V11, P1921; Broadhurst RW, 1995, BIOCHEMISTRY-US, V34, P16608, DOI 10.1021/bi00051a008; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Chinnaiyan AM, 1997, SCIENCE, V275, P1122, DOI 10.1126/science.275.5303.1122; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Clem RJ, 1998, P NATL ACAD SCI USA, V95, P554, DOI 10.1073/pnas.95.2.554; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P8172, DOI 10.1021/bi00487a027; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Copie V, 1998, J MOL BIOL, V277, P663; Darnell J., 1990, MOL CELL BIOL; DELATORRE JG, 1994, BIOPHYS J, V67, P530, DOI 10.1016/S0006-3495(94)80512-0; DINGLEY AJ, 1995, J BIOMOL NMR, V6, P321; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; Frishman D, 1996, PROTEIN ENG, V9, P133, DOI 10.1093/protein/9.2.133; Fushman D, 1998, J AM CHEM SOC, V120, P7109, DOI 10.1021/ja980565j; Fushman D, 1997, J MOL BIOL, V266, P173, DOI 10.1006/jmbi.1996.0771; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; GRZESIEK S, 1992, BIOCHEMISTRY-US, V31, P8180, DOI 10.1021/bi00150a009; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; HEDGE R, 1998, J BIOL CHEM, V273, P7783; Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686; King RD, 1996, PROTEIN SCI, V5, P2298, DOI 10.1002/pro.5560051116; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee WPA, 1996, HAND CLIN, V12, P271; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; McDonnell JM, 1997, J AM CHEM SOC, V119, P5321, DOI 10.1021/ja963884o; McDonnell JM, 1998, J MOL BIOL, V279, P921, DOI 10.1006/jmbi.1998.1788; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schlesinger PH, 1997, P NATL ACAD SCI USA, V94, P11357, DOI 10.1073/pnas.94.21.11357; SOLOVYEV VV, 1994, COMPUT APPL BIOSCI, V10, P661; Strasser A, 1997, BBA-REV CANCER, V1333, pF151, DOI 10.1016/S0304-419X(97)00019-X; STULTZ CM, 1993, PROTEIN SCI, V2, P305; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tjandra N, 1997, NAT STRUCT BIOL, V4, P443, DOI 10.1038/nsb0697-443; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wang K, 1998, MOL CELL BIOL, V18, P6083, DOI 10.1128/MCB.18.10.6083; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Wood DE, 1998, ONCOGENE, V17, P1069, DOI 10.1038/sj.onc.1202034; Wuthrich K, 1986, NMR PROTEINS NUCL AC; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zha JP, 1997, J BIOL CHEM, V272, P24101, DOI 10.1074/jbc.272.39.24101	66	322	329	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 5	1999	96	5					625	634		10.1016/S0092-8674(00)80573-5	http://dx.doi.org/10.1016/S0092-8674(00)80573-5			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	174TB	10089878	Bronze			2022-12-28	WOS:000079050100006
J	Vetter, IR; Nowak, C; Nishimoto, T; Kuhlmann, J; Wittinghofer, A				Vetter, IR; Nowak, C; Nishimoto, T; Kuhlmann, J; Wittinghofer, A			Structure of a Ran-binding domain complexed with Ran bound to a GTP analogue: implications for nuclear transport	NATURE			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; PROTEIN IMPORT; PORE COMPLEX; RAN/TC4 GTPASE; CRYSTAL-STRUCTURE; PH DOMAIN; EF-TU; GDP; MOTIF; IDENTIFICATION	The protein Ran is a small GTP-binding protein that binds to two types of effector inside the cell: Ran-binding proteins, which have a role in terminating export processes from the nucleus to the cytoplasm, and importin-beta-like molecules that bind cargo proteins during nuclear transport. The Ran-binding domain is a conserved sequence motif found in several proteins that participate in these transport processes. The Ran-binding protein RanBP2 contains four of these domains and constitutes a large part of the cytoplasmic fibrils that extend from the nuclear-pore complex. The structure of Ran bound to a non-hydrolysable GTP analogue (Ran.GppNHp) in oomplex with the first Ran-binding domain (RanBD1) of human RanRP2 reveals not only that RanBD1 has a pleckstrin-homology domain fold, but also that the switch-I region of Ran.GppNHp resembles the canonical Ras.GppNHp structure and that the carboxy terminus of Ran is wrapped around RanBD1, contacting a basic patch on RanBD1 through its acidic end. This molecular 'embrace' enables RanBDs to sequester the Ran carboxy terminus, triggering the dissociation of Ran.GTP from importin-beta-related transport factors and facilitating GTP hydrolysis by the GTPase-activating protein ranGAP. Such a mechanism represents a new type of switch mechanism and regulatory protein-protein interaction for a Ras-related protein.	Max Planck Inst Mol Physiol, Abt Strukturelle Biol, D-44026 Dortmund, Germany; Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Higashi Ku, Fukuoka 81282, Japan	Max Planck Society; Kyushu University	Wittinghofer, A (corresponding author), Max Planck Inst Mol Physiol, Abt Strukturelle Biol, Postfach 102664, D-44026 Dortmund, Germany.	alfred.wittinghofer@mpi-dortmund.mpg.de						Abel K, 1996, STRUCTURE, V4, P1153, DOI 10.1016/S0969-2126(96)00123-2; AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEDDOW AL, 1995, P NATL ACAD SCI USA, V92, P3328, DOI 10.1073/pnas.92.8.3328; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; Bischoff FR, 1997, FEBS LETT, V419, P249, DOI 10.1016/S0014-5793(97)01467-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chi NC, 1996, J CELL BIOL, V135, P559, DOI 10.1083/jcb.135.3.559; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; Delphin C, 1997, MOL BIOL CELL, V8, P2379, DOI 10.1091/mbc.8.12.2379; DINGWALL C, 1995, P NATL ACAD SCI USA, V92, P7525, DOI 10.1073/pnas.92.16.7525; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Floer M, 1996, J BIOL CHEM, V271, P5313, DOI 10.1074/jbc.271.10.5313; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Gorlich D, 1998, EMBO J, V17, P2721, DOI 10.1093/emboj/17.10.2721; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; GREASLEY SE, 1995, NAT STRUCT BIOL, V2, P797, DOI 10.1038/nsb0995-797; HARTMANN E, 1995, TRENDS CELL BIOL, V5, P192, DOI 10.1016/S0962-8924(00)88992-8; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; HYVONEN M, 1995, EMBO J, V14, P4676, DOI 10.1002/j.1460-2075.1995.tb00149.x; Hyvonen M, 1997, EMBO J, V16, P3396, DOI 10.1093/emboj/16.12.3396; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuhlmann J, 1997, BIOCHEMISTRY-US, V36, P12027, DOI 10.1021/bi970524k; Lounsbury KM, 1996, J BIOL CHEM, V271, P32834, DOI 10.1074/jbc.271.51.32834; MELCHIOR F, 1995, J CELL BIOL, V131, P571, DOI 10.1083/jcb.131.3.571; Melchior F, 1998, TRENDS CELL BIOL, V8, P175, DOI 10.1016/S0962-8924(98)01252-5; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Polekhina G, 1996, STRUCTURE, V4, P1141, DOI 10.1016/S0969-2126(96)00122-0; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; RICHARDS SA, 1995, J BIOL CHEM, V270, P14405, DOI 10.1074/jbc.270.24.14405; SARASTE M, 1995, CURR OPIN STRUC BIOL, V5, P403, DOI 10.1016/0959-440X(95)80104-9; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SCHEFFZEK K, 1995, NATURE, V374, P378, DOI 10.1038/374378a0; SCHLENSTEDT G, 1995, EMBO J, V14, P5367, DOI 10.1002/j.1460-2075.1995.tb00221.x; Stewart M, 1998, J MOL BIOL, V277, P635, DOI 10.1006/jmbi.1997.1602; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; WILKEN N, 1995, EUR J CELL BIOL, V68, P211; WITTINGHOFER A, 1991, TRENDS BIOCHEM SCI, V16, P382, DOI 10.1016/0968-0004(91)90156-P; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0	50	242	246	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	1999	398	6722					39	46		10.1038/17969	http://dx.doi.org/10.1038/17969			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174KG	10078529				2022-12-28	WOS:000079033900044
J	Heaney, AP; Laing, I; Walton, L; Seif, MW; Beardwell, CG; Davis, JRE				Heaney, AP; Laing, I; Walton, L; Seif, MW; Beardwell, CG; Davis, JRE			Misleading hyperprolactinaemia in pregnancy	LANCET			English	Article							PROLACTIN		Withington Hosp, Dept Endocrinol, Manchester M20 8LR, Lancs, England; Cent Manchester Healthcare Trust, Dept Epidemiol, Manchester, Lancs, England; Cent Manchester Healthcare Trust, Dept Clin Biochem, Manchester, Lancs, England; Cent Manchester Healthcare Trust, Dept Obstet & Gynaecol, Manchester, Lancs, England		Davis, JRE (corresponding author), Manchester Royal Infirm, Dept Endocrinol, Oxford Rd, Manchester M13 9WL, Lancs, England.		Davis, Julian R/G-8943-2014	Davis, Julian R/0000-0003-0838-0557				BJORO T, 1995, SCAND J CLIN LAB INV, V55, P139, DOI 10.3109/00365519509089606; JACKSON RD, 1989, J CLIN ENDOCR METAB, V68, P1046, DOI 10.1210/jcem-68-6-1046; MIYAI K, 1986, CLIN ENDOCRINOL, V25, P549, DOI 10.1111/j.1365-2265.1986.tb03608.x; OLUKOGA AO, 1995, EUR J ENDOCRINOL, V133, P463, DOI 10.1530/eje.0.1330463; SUH HK, 1974, J CLIN ENDOCR METAB, V39, P928, DOI 10.1210/jcem-39-5-928	5	17	17	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 27	1999	353	9154					720	720		10.1016/S0140-6736(98)10183-6	http://dx.doi.org/10.1016/S0140-6736(98)10183-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173DR	10073516				2022-12-28	WOS:000078966400014
J	Beecham, L				Beecham, L			Passive smoking affects babies' and children's health	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 3	1999	318	7188					947	947						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185GV	10102886				2022-12-28	WOS:000079660500071
J	Arthur, WB				Arthur, WB			Complexity and the economy	SCIENCE			English	Editorial Material							INCREASING RETURNS; EXCHANGE	After two centuries of studying equilibria-static patterns that call for no further behavioral adjustments-economists are beginning to study the general emergence of structures and the unfolding of patterns in the economy. When viewed in out-of-equilibrium formation, economic patterns sometimes simplify into the simple static equilibria of standard economics. More often they are ever changing, showing perpetually novel behavior and emergent phenomena. Complexity portrays the economy not as deterministic, predictable, and mechanistic, but as process dependent, organic, and always evolving.	Santa Fe Inst, Santa Fe, NM 87501 USA	The Santa Fe Institute	Arthur, WB (corresponding author), Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA.							Anderson P., 1988, EC EVOLVING COMPLEX; Arthur W. B., 1995, Complexity, V1, P20; Arthur W. Brian, 1997, EC EVOLVING COMPLEX; Arthur W.Brian., 1994, INCREASING RETURNS P; ARTHUR WB, 1989, ECON J, V99, P116, DOI 10.2307/2234208; ARTHUR WB, 1990, MATH SOC SCI, V19, P235, DOI 10.1016/0165-4896(90)90064-E; ARTHUR WB, 1990, SCI AM, V262, P92, DOI 10.1038/scientificamerican0290-92; ARTHUR WB, 1994, AM ECON REV, V84, P406; AXELROD R, 1986, AM POLIT SCI REV, V80, P1095, DOI 10.2307/1960858; Bak P., 1993, RICERCHE EC, V47, P3, DOI [DOI 10.1016/0035-5054(93)90023-V, 10.1016/0035-5054(93)90023-V]; Blume LE, 1997, EC EVOLVING COMPLEX, P425; BROCK WA, 1995, HDB STAT, V12; Casti J. L., 1995, COMPLEXITY, V1, P7; Challet D, 1998, PHYSICA A, V256, P514, DOI 10.1016/S0378-4371(98)00260-X; Challet D, 1997, PHYSICA A, V246, P407, DOI 10.1016/S0378-4371(97)00419-6; Darley V.M., 1997, EC EVOLVING COMPLEX, P45; DURLAUF S, 1996, J ECON GROWTH, V1, P75, DOI DOI 10.1007/BF00163343); Durlauf Steven N., 1997, EC EVOLVING COMPLEX, P81; Helpman E., 1987, MARKET STRUCTURE FOR; HUBERMAN BA, 1993, P NATL ACAD SCI USA, V90, P7716, DOI 10.1073/pnas.90.16.7716; Ioannides Yannis M., 1997, EC EVOLVING COMPLEX, P129; Johnson NF, 1998, PHYSICA A, V258, P230, DOI 10.1016/S0378-4371(98)00227-1; KAUFFMAN SA, 1997, EC EVOLVING COMPLEX, V2, P45; Kollman K., 1997, EC EVOLVING COMPLEX, P461; KRUGMAN P, 1991, J POLIT ECON, V99, P483, DOI 10.1086/261763; KRUGMAN PR, 1991, GEOGRAPHY TRADE, P239; LANE DA, 1997, EC EVOLVING COMPLEX, V2, P169; LEIJONHUFVUD A, 1997, EC EVOLVING COMPLEX, V2, P321; Lindgren K., 1991, ARTIF LIFE, VX, P295; LUCAS RE, 1978, ECONOMETRICA, V46, P1429, DOI 10.2307/1913837; MARIMOM R, 1990, J ECON DYN CONTROL, V14, P329, DOI 10.1016/0165-1889(90)90025-C; MARSHALL A, 1920, PRINCIPLES EC, P459; North D. C., 1997, EC EVOLVING COMPLEX, P223; SARGENT TJ, 1993, BOUNDED RATIONALITY; SHUBIK M, 1997, EC EVOLVING COMPLEX, V2, P263; Tesfatsion Leigh, 1997, EC EVOLVING COMPLEX, P533; YOUNG HP, 1993, ECONOMETRICA, V61, P57, DOI 10.2307/2951778; [No title captured]	38	506	537	7	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	1999	284	5411					107	109		10.1126/science.284.5411.107	http://dx.doi.org/10.1126/science.284.5411.107			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182QE	10103172				2022-12-28	WOS:000079509000043
J	Werner, BT				Werner, BT			Complexity in natural landform patterns	SCIENCE			English	Editorial Material							BEACH CUSPS; EDGE WAVES; RIPPLES	Patterns in nature, such as meandering rivers and sand dunes, display complex behavior seemingly at odds with their simplicity of form. Existing approaches to modeling natural Landform patterns, reductionism and universality, are incompatible with the nonlinear, open nature of natural systems. An alternative modeling methodology based on the tendency of natural systems to self-organize in temporal hierarchies is described.	Univ Calif San Diego, Complex Syst Lab, Cecil & Ida Green Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Werner, BT (corresponding author), Univ Calif San Diego, Complex Syst Lab, Cecil & Ida Green Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA.							Ahl V., 1996, HIERARCHY THEORY; Allen TFH, 1992, UNIFIED ECOLOGY; ANDERSON RS, 1993, NATURE, V365, P740, DOI 10.1038/365740a0; BLONDEAUX P, 1990, J FLUID MECH, V218, P1, DOI 10.1017/S0022112090000908; BOWEN AJ, 1971, J GEOPHYS RES, V76, P8662, DOI 10.1029/JC076i036p08662; CHASE CG, 1992, GEOMORPHOLOGY, V5, P39, DOI 10.1016/0169-555X(92)90057-U; CLARKE LB, 1997, EOS, V78, P352; Clifton HE, 1976, SPECIAL PUBLICATION, V24, P126; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; GLEASON KJ, 1986, SCIENCE, V232, P216, DOI 10.1126/science.232.4747.216; GUZA RT, 1975, J GEOPHYS RES-OC ATM, V80, P2997, DOI 10.1029/JC080i021p02997; Haken H., 1983, SYNERGETICS, P191; KESSLER MA, 1997, EOS, V78, P270; KOCUREK G, 1992, J SEDIMENT PETROL, V62, P622; LIPPMANN TC, 1990, J GEOPHYS RES-OCEANS, V95, P11575, DOI 10.1029/JC095iC07p11575; MURRAY AB, 1994, NATURE, V371, P54, DOI 10.1038/371054a0; Nicolis G, 1977, SELF ORG NONEQUILIBR; PEARSON JE, 1993, SCIENCE, V261, P189, DOI 10.1126/science.261.5118.189; Popper K., 1989, CONJECTURES REFUTATI; POPPER KR, 1977, SELF ITS BRAIN, P14; RIGNON R, 1994, J GEOPHYS RES, V99, P11971; RUBIN DM, 1987, SCIENCE, V237, P276, DOI 10.1126/science.237.4812.276; SHARP RP, 1963, J GEOL, V71, P617, DOI 10.1086/626936; STIVE MJF, P 20 COAST ENG C AM, P1550; Stolum HH, 1996, SCIENCE, V271, P1710, DOI 10.1126/science.271.5256.1710; WERNER BT, 1993, SCIENCE, V260, P968, DOI 10.1126/science.260.5110.968; WERNER BT, 1995, GEOLOGY, V23, P1107, DOI 10.1130/0091-7613(1995)023<1107:EDCSAA>2.3.CO;2; WERNER BT, 1993, NATURE, V361, P142, DOI 10.1038/361142a0; Werner BT, 1997, GEOLOGY, V25, P771, DOI 10.1130/0091-7613(1997)025<0771:BFDDTT>2.3.CO;2; WERNER BT, UNPUB	30	214	230	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 2	1999	284	5411					102	104		10.1126/science.284.5411.102	http://dx.doi.org/10.1126/science.284.5411.102			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182QE	10102803				2022-12-28	WOS:000079509000041
J	Beecham, L				Beecham, L			GPC concludes negotiations on 60m pound fund	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 27	1999	318	7187					879	879						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185DM	10092285				2022-12-28	WOS:000079652900071
J	Gottlieb, S				Gottlieb, S			Reflux "increases risk of adenocarcinoma of oesophagus"	BRITISH MEDICAL JOURNAL			English	News Item																		COHEN S, 1999, BRIT MED J, V340, P878; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101	2	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 27	1999	318	7187					827	827		10.1136/bmj.318.7187.827	http://dx.doi.org/10.1136/bmj.318.7187.827			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185DM	10092242	Green Published			2022-12-28	WOS:000079652900006
J	Kearon, C; Gent, M; Hirsh, J; Weitz, J; Kovacs, MJ; Anderson, DR; Turpie, AG; Green, D; Ginsberg, JS; Wells, P; MacKinnon, B; Julian, JA				Kearon, C; Gent, M; Hirsh, J; Weitz, J; Kovacs, MJ; Anderson, DR; Turpie, AG; Green, D; Ginsberg, JS; Wells, P; MacKinnon, B; Julian, JA			A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEEP-VEIN THROMBOSIS; LUPUS ANTICOAGULANT; RANDOMIZED TRIAL; WARFARIN; THERAPY; ANTIBODIES; DIAGNOSIS; DURATION; CANCER; ASSAY	Background Patients who have a first episode of venous thromboembolism in the absence of known risk factors for thrombosis (idiopathic thrombosis) are often treated with anticoagulant therapy for three months. Such patients may benefit from longer treatment, however, because they appear to have an increased risk of recurrence after anticoagulant therapy is stopped. Methods In this double-blind study, we randomly assigned patients who had completed 3 months of anticoagulant therapy for a first episode of idiopathic venous thromboembolism to continue receiving warfarin, with the dose adjusted to achieve an international normalized ratio of 2.0 to 3.0, or to receive placebo for a further 24 months. Our goal was to determine the effects of extended anticoagulant therapy on rates of recurrent symptomatic venous thromboembolism and bleeding. Results A prespecified interim analysis of efficacy led to the early termination of the trial after 162 patients had been enrolled and followed for an average of 10 months. Of 83 patients assigned to continue to receive placebo, 17 had a recurrent episode of venous thromboembolism (27.4 percent per patient-year), as compared with 1 of 79 patients assigned to receive warfarin (1.3 percent per patient-year, P<0.001). Warfarin resulted in a 95 percent reduction in the risk of recurrent venous thromboembolism (95 percent confidence interval, 63 to 99 percent). Three patients assigned to the warfarin group had nonfatal major bleeding (two had gastrointestinal bleeding and one genitourinary bleeding), as compared with none of those assigned to the placebo group (3.8 percent vs. 0 percent per patient-year, P=0.09). Conclusions Patients with a first episode of idiopathic venous thromboembolism should be treated with anticoagulant agents for longer than three months. (N Engl J Med 1999;340:901-7.) (C) 1999, Massachusetts Medical Society.	McMaster Univ, Hamilton, ON, Canada; Hamilton Civ Hosp, Res Ctr, Hamilton, ON, Canada; Univ Western Ontario, London, ON, Canada; Dalhousie Univ, Halifax, NS, Canada; Northwestern Univ, Sch Med, Chicago, IL USA; Univ Ottawa, Ottawa, ON, Canada; Univ Montreal, Montreal, PQ, Canada; Univ New Brunswick, St John, NB E2L 4L5, Canada; Univ Laval, Quebec City, PQ, Canada; McGill Univ, Montreal, PQ, Canada; Texas A&M Univ, Temple, TX USA	McMaster University; McMaster University; Western University (University of Western Ontario); Dalhousie University; Northwestern University; University of Ottawa; Universite de Montreal; University of New Brunswick; Laval University; McGill University; Texas A&M University System	Kearon, C (corresponding author), Hamilton Hlth Sci Corp, Henderson Div, 711 Concess St, Hamilton, ON L8V 1C3, Canada.		Weitz, Jeffrey/AAD-1929-2019; Kovacs, Michael/G-3315-2011; ginsberg, jeffrey s/ABC-1065-2020	Weitz, Jeffrey/0000-0002-1092-7550; Anderson, David/0000-0003-0845-1722				BERN MM, 1990, ANN INTERN MED, V112, P423, DOI 10.7326/0003-4819-76-3-112-6-423; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; HOSMER DW, 1989, APPL LOGISTIC REGRES; HULL R, 1979, NEW ENGL J MED, V301, P855, DOI 10.1056/NEJM197910183011602; HYERS TM, 1995, CHEST, V108, pS335, DOI 10.1378/chest.108.4_Supplement.335S; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kearon C, 1998, ANN INTERN MED, V128, P663, DOI 10.7326/0003-4819-128-8-199804150-00011; KEARON C, 1995, HAEMOSTASIS, V25, P72; LEVINE M, 1994, LANCET, V343, P886, DOI 10.1016/S0140-6736(94)90008-6; LEVINE MN, 1995, THROMB HAEMOSTASIS, V74, P606; LOIZOU S, 1985, CLIN EXP IMMUNOL, V62, P738; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; PIANTADOSI S, 1997, CLIN TRIALS METHODOL, P250; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; PRANDONI P, 1992, NEW ENGL J MED, V327, P1128, DOI 10.1056/NEJM199210153271604; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; PROCTOR RR, 1961, AM J CLIN PATHOL, V36, P212; Rance A, 1997, THROMB HAEMOSTASIS, V77, P221; Schulman S, 1998, AM J MED, V104, P332, DOI 10.1016/S0002-9343(98)00060-6; Schulman S, 1997, NEW ENGL J MED, V336, P393, DOI 10.1056/NEJM199702063360601; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; Simioni P, 1996, THROMB HAEMOSTASIS, V76, P187; SUDLOW MF, 1992, LANCET, V340, P873; THIAGARAJAN P, 1986, BLOOD, V68, P869; TRIPLETT DA, 1993, THROMB HAEMOSTASIS, V70, P787	25	853	873	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 25	1999	340	12					901	907		10.1056/NEJM199903253401201	http://dx.doi.org/10.1056/NEJM199903253401201			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180AM	10089183				2022-12-28	WOS:000079362600001
J	Fletcher, LC; Brand, U; Running, MP; Simon, R; Meyerowitz, EM				Fletcher, LC; Brand, U; Running, MP; Simon, R; Meyerowitz, EM			Signaling of cell fate decisions by CLAVATA3 in Arabidopsis shoot meristems	SCIENCE			English	Article							FLOWER DEVELOPMENT; APICAL MERISTEM; THALIANA; REGULATOR; SITES	In higher plants, organogenesis occurs continuously from self-renewing apical meristems. Arabidopsis thaliana plants with loss-of-function mutations in the CLAVATA (CLV1, 2, and 3) genes have enlarged meristems and generate extra floral organs. Genetic analysis indicates that CLV1, which encodes a receptor kinase, acts with CLV3 to control the balance between meristem cell proliferation and differentiation. CLV3 encodes a small, predicted extracellular protein. CLV3 ads nonautonomously in meristems and is expressed at the meristem surface overlying the CLV1 domain. These proteins may act as a ligand-receptor pair in a signal transduction pathway, coordinating growth between adjacent meristematic regions.	CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA; Univ Cologne, Inst Entwicklungsbiol, D-50923 Cologne, Germany	California Institute of Technology; University of Cologne	Meyerowitz, EM (corresponding author), CALTECH, Div Biol 156 29, 1200 E Calif Blvd, Pasadena, CA 91125 USA.		Running, Mark P./R-8950-2019; Meyerowitz, Elliot M/A-7118-2009					ALVAREZ J, 1994, ARABIDOPSIS ATLAS MO; [Anonymous], COMMUNICATION; BARTON MK, 1993, DEVELOPMENT, V119, P823; Becraft PW, 1998, TRENDS PLANT SCI, V3, P384, DOI 10.1016/S1360-1385(98)01301-6; BRADLEY D, 1993, CELL, V72, P85, DOI 10.1016/0092-8674(93)90052-R; CLARK SE, 1993, DEVELOPMENT, V119, P397; CLARK SE, 1995, DEVELOPMENT, V121, P2057; Clark SE, 1996, SEMIN CELL DEV BIOL, V7, P873, DOI 10.1006/scdb.1996.0107; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; FELDMANN KA, 1987, MOL GEN GENET, V208, P1, DOI 10.1007/BF00330414; Kayes JM, 1998, DEVELOPMENT, V125, P3843; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Laufs P, 1998, PLANT CELL, V10, P1375, DOI 10.1105/tpc.10.8.1375; LEYSER HMO, 1992, DEVELOPMENT, V116, P397; Long JA, 1998, DEVELOPMENT, V125, P3027; Meyerowitz EM, 1997, CELL, V88, P299, DOI 10.1016/S0092-8674(00)81868-1; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; SAKAI H, 1995, NATURE, V378, P199, DOI 10.1038/378199a0; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Steeves T.A., 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; STEWART RN, 1978, CLONAL BASIS DEV; Tilney-Bassett RA., 1986, PLANT CHIMERAS; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; Wisman E, 1998, PLANT MOL BIOL, V37, P989, DOI 10.1023/A:1006082009151	24	949	1005	2	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 19	1999	283	5409					1911	1914		10.1126/science.283.5409.1911	http://dx.doi.org/10.1126/science.283.5409.1911			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177UC	10082464				2022-12-28	WOS:000079228600047
J	Levey, AS; Bosch, JP; Lewis, JB; Greene, T; Rogers, N; Roth, D				Levey, AS; Bosch, JP; Lewis, JB; Greene, T; Rogers, N; Roth, D		Modification Diet Renal Dis Study Grp	A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	30th Annual Meeting of the American-Society-of-Nephrology	NOV 02-06, 1997	SAN ANTONIO, TX	Amer Soc Nephrol		glomerular filtration rate; creatinine; kidney failure, chronic; diet, protein-restricted; blood pressure	CHRONIC RENAL-DISEASE; DIETARY-PROTEIN RESTRICTION; BLOOD-PRESSURE CONTROL; LEAN BODY-MASS; DIABETIC NEPHROPATHY; CLEARANCE; PROGRESSION; FAILURE; HUMANS; WEIGHT	Background: Serum creatinine concentration is widely used as an index of renal function, but this concentration is affected by factors other than glomerular filtration rate (GFR). Objective: To develop an equation to predict GFR from serum creatinine concentration and other factors. Design: Cross-sectional study of GFR, creatinine clearance, serum creatinine concentration, and demographic and clinical characteristics in patients with chronic renal disease. Patients: 1628 patients enrolled in the baseline period of the Modification of Diet in Renal Disease (MDRD) Study, of whom 1070 were randomly selected as the training sample; the remaining 558 patients constituted the validation sample. Methods: The prediction equation was developed by stepwise regression applied to the training sample. The equation was then tested and compared with other prediction equations in the validation sample. Results: To simplify prediction of GFR, the equation included only demographic and serum variables. Independent factors associated with a lower GFR included a higher serum creatinine concentration, older age, female sex, nonblack ethnicity, higher serum urea nitrogen levels, and lower serum albumin levels (P < 0.002 for all factors). The multiple regression model explained 90.3% of the variance in the logarithm of GFR in the validation sample. Measured creatinine clearance overestimated GFR by 19%, and creatinine clearance predicted by the Cockcroft-Gault formula overestimated GFR by 16%. After adjustment for this overestimation, the percentage of variance of the logarithm of GFR predicted by measured creatinine clearance or the Cockcroft-Gault formula was 86.6% and 84.2%, respectively. Conclusion: The equation developed from the MDRD Study provided a more accurate estimate of GFR in our study group than measured creatinine clearance or other commonly used equations.	Tufts Univ New England Med Ctr, Boston, MA 02111 USA	Tufts Medical Center	Levey, AS (corresponding author), Tufts Univ New England Med Ctr, 750 Washington St,Box 391, Boston, MA 02111 USA.	Andrew.Levey@es.nemc.org						*AM SOC TRANSPL PH, 1997, SCI S LIST CRIT KIDN; BAUER JH, 1982, AM J KIDNEY DIS, V2, P30, DOI 10.1016/S0272-6386(82)80040-1; BECK GJ, 1991, CONTROL CLIN TRIALS, V12, P566, DOI 10.1016/0197-2456(91)90069-X; Bedros Fadi V., 1998, Journal of the American Society of Nephrology, V9, p666A; BJORNSSON TD, 1983, CLIN PHARMACOKINET, V8, P365, DOI 10.2165/00003088-198308040-00007; BREYERLEWIS J, 1998, J AM SOC NEPHROL, V9, pA153; BROCHNERMORTENSEN J, 1976, SCAND J CLIN LAB INV, V36, P35, DOI 10.3109/00365517609068016; Buckalew VM, 1996, AM J KIDNEY DIS, V28, P811, DOI 10.1016/S0272-6386(96)90380-7; COCHRAN M, 1993, AUST NZ J MED, V23, P494, DOI 10.1111/j.1445-5994.1993.tb01836.x; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; COHN SH, 1977, AM J PHYSIOL, V232, pE419, DOI 10.1152/ajpendo.1977.232.4.E419; DESANTO NG, 1991, AM J NEPHROL, V11, P181, DOI 10.1159/000168300; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Frisancho AR, 1990, ANTHROPOMETRIC STAND; GATES GF, 1985, AM J KIDNEY DIS, V5, P199, DOI 10.1016/S0272-6386(85)80051-2; GROTH S, 1989, SCAND J CLIN LAB INV, V49, P707, DOI 10.3109/00365518909091548; HALLYNCK T, 1981, CLIN PHARMACOL THER, V30, P414, DOI 10.1038/clpt.1981.181; HARSHA DW, 1978, HUM BIOL, V50, P261; HARTMANN AE, 1985, ARCH PATHOL LAB MED, V109, P1068; HEYMSFIELD SB, 1983, AM J CLIN NUTR, V37, P478, DOI 10.1093/ajcn/37.3.478; JELLIFFE RW, 1973, ANN INTERN MED, V79, P604, DOI 10.7326/0003-4819-79-4-604; KAMPMANN J, 1974, ACTA MED SCAND, V196, P517; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; KUSEK JW, 1993, CONTROL CLIN TRIALS, V14, P538, DOI 10.1016/0197-2456(93)90033-A; LEMANN J, 1990, AM J KIDNEY DIS, V16, P236, DOI 10.1016/S0272-6386(12)81023-7; Levey A. S., 1998, Journal of the American Society of Nephrology, V9, p153A; Levey AS, 1996, J AM SOC NEPHROL, V7, P556; Levey AS, 1996, AM J KIDNEY DIS, V27, P652, DOI 10.1016/S0272-6386(96)90099-2; Levey AS, 1996, J AM SOC NEPHROL, V7, P2616; LEVEY AS, 1993, J AM SOC NEPHROL, V4, P1159; Levey AS, 1996, J AM SOC NEPHROL, V7, P2097; LEVEY AS, 1990, KIDNEY INT, V38, P167, DOI 10.1038/ki.1990.182; MARONI BJ, 1985, KIDNEY INT, V27, P58, DOI 10.1038/ki.1985.10; PARKER RA, 1980, DIALYSIS TRANSPLANT, V9, P251; PERRONE RD, 1990, AM J KIDNEY DIS, V16, P224, DOI 10.1016/S0272-6386(12)81022-5; PERRONE RD, 1992, CLIN CHEM, V38, P1933; PETERSON JC, 1995, ANN INTERN MED, V123, P754, DOI 10.7326/0003-4819-123-10-199511150-00003; POLLOCK C, 1995, AM J NEPHROL, V15, P277, DOI 10.1159/000168849; SAMPSON MJ, 1992, DIABETES CARE, V15, P609, DOI 10.2337/diacare.15.5.609; SAWYER WT, 1983, AM J HOSP PHARM, V40, P2175, DOI 10.1093/ajhp/40.12.2175; Smith HW, 1951, KIDNEY STRUCTURE FUN, P836; TAYALOR GO, 1982, AFR J MED MED SCI, V11, P175; TESSITORE N, 1979, NEPHRON, V24, P41, DOI 10.1159/000181681; TROLLFORS B, 1987, ACTA MED SCAND, V221, P495; *US DEPT HHS, 09380046 OMB US DEP; VANLENTE F, 1989, CLIN CHEM, V35, P2326; WALSER M, 1993, KIDNEY INT, V44, P1145, DOI 10.1038/ki.1993.361; WORRALL JG, 1990, BRIT J RHEUMATOL, V29, P371	48	12379	12780	11	454	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	1999	130	6					461	+		10.7326/0003-4819-130-6-199903160-00002	http://dx.doi.org/10.7326/0003-4819-130-6-199903160-00002			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	176RL	10075613				2022-12-28	WOS:000079165500001
J	Cates, C				Cates, C			An evidence based approach to reducing antibiotic use in children with acute otitis media: controlled before and after study	BRITISH MEDICAL JOURNAL			English	Article									Bushey Hlth Ctr, Manor View Practice, Bushey WD2 2NN, Herts, England		Cates, C (corresponding author), Bushey Hlth Ctr, Manor View Practice, Bushey WD2 2NN, Herts, England.			Cates, Christopher/0000-0002-7056-9433				Cucherat M, 1997, COMPUT METH PROG BIO, V53, P187, DOI 10.1016/S0169-2607(97)00016-3; *DEP HLTH, 1997, PRESCR COST AN ENGL; Froom J, 1997, BRIT MED J, V315, P98, DOI 10.1136/bmj.315.7100.98; GLASZIOU PP, 1995, COCHRANE COLLABORATI; Majeed A, 1997, BRIT MED J, V315, P321	5	82	81	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 13	1999	318	7185					715	716						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182JK	10074019	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000079495700028
J	Cox, JT				Cox, JT			Management of cervical intraepithelial neoplasia	LANCET			English	Editorial Material							CARBON-DIOXIDE LASER; ELECTROSURGICAL EXCISION PROCEDURE; INTRA-EPITHELIAL NEOPLASIA; RANDOMIZED TRIAL; CRYOTHERAPY; THERAPY; FERTILITY; LLETZ		Univ Calif Santa Barbara, Hlth Serv, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Cox, JT (corresponding author), Univ Calif Santa Barbara, Hlth Serv, Santa Barbara, CA 93106 USA.							ALVAREZ RD, 1994, GYNECOL ONCOL, V52, P175, DOI 10.1006/gyno.1994.1027; BERGET A, 1987, ACTA OBSTET GYN SCAN, V66, P531, DOI 10.3109/00016348709015730; Berget A, 1991, ACTA OBSTET GYN SCAN, V70, P231, DOI 10.3109/00016349109006215; Ferenczy A, 1996, OBSTET GYNECOL, V87, P332, DOI 10.1016/0029-7844(95)00453-X; FERENCZY A, 1985, OBSTET GYNECOL, V66, P793; GUNASEKERA PC, 1990, BRIT J OBSTET GYNAEC, V97, P995, DOI 10.1111/j.1471-0528.1990.tb02470.x; HAMMOND RH, 1990, BRIT MED J, V301, P1344, DOI 10.1136/bmj.301.6765.1344; KIRWANPH, 1985, GYNECOL ONCOL, V22, P195; KWIKKEL HJ, 1985, GYNECOL ONCOL, V22, P23, DOI 10.1016/0090-8258(85)90003-4; Mitchell MF, 1998, OBSTET GYNECOL, V92, P737, DOI 10.1097/00006250-199811000-00001; Montz FJ, 1996, AM J OBSTET GYNECOL, V175, P1129, DOI 10.1016/S0002-9378(96)70016-9; NASIELL K, 1986, OBSTET GYNECOL, V67, P665, DOI 10.1097/00006250-198605000-00012; NUOVO GJ, 1991, MODERN PATHOL, V4, P632; Soutter WP, 1997, LANCET, V349, P978, DOI 10.1016/S0140-6736(96)08295-5; TOWNSEND DE, 1983, OBSTET GYNECOL, V61, P75; WRIGHT TC, 1992, OBSTET GYNECOL, V79, P173; WRIGHT VC, 1981, BRIT J OBSTET GYNAEC, V88, P663, DOI 10.1111/j.1471-0528.1981.tb01227.x	17	40	43	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 13	1999	353	9156					857	859		10.1016/S0140-6736(98)00392-4	http://dx.doi.org/10.1016/S0140-6736(98)00392-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BU	10093973				2022-12-28	WOS:000079421400003
J	Logan, M; Tabin, CJ				Logan, M; Tabin, CJ			Role of Pitx1 upstream of Tbx4 in specification of hindlimb identity	SCIENCE			English	Article							T-BOX GENES; LIMB DEVELOPMENT; ADDITIONAL LIMB; CHICK-EMBRYOS; EXPRESSION; INITIATION; PATTERN; FLANK; PTX1; BUD	In spite of recent breakthroughs in understanding Limb patterning, the genetic factors determining the differences between the forelimb and the hindlimb have not been understood. The genes Pitx1 and Tbx4 encode transcription factors that are expressed throughout the developing hindlimb but not forelimb buds. Misexpression of Pitx1 in the chick wing bud induced distal expression of Tbx4, as well as HoxC10 and HoxC11, which are normally restricted to hindlimb expression domains. Wing buds in which Pitx1 was misexpressed developed into Limbs with some morphological characteristics of hindlimbs: the flexure was altered to that normally observed in legs, the digits were more toe-like in their relative size and shape, and the muscle pattern was transformed to that of a Leg.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, 200 Longwood Ave, Boston, MA 02115 USA.							Bao ZZ, 1997, J NEUROSCI, V17, P1425; COHN MJ, 1995, CELL, V80, P739, DOI 10.1016/0092-8674(95)90352-6; Crossley PH, 1996, CELL, V84, P127, DOI 10.1016/S0092-8674(00)80999-X; Gibson-Brown JJ, 1998, DEVELOPMENT, V125, P2499; GibsonBrown JJ, 1996, MECH DEVELOP, V56, P93, DOI 10.1016/0925-4773(96)00514-X; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Isaac A, 1998, DEVELOPMENT, V125, P1867; Kardon G, 1998, DEVELOPMENT, V125, P4019; Klymkowsky M. W., 1991, WHOLE MOUNT STAINING; Lamonerie T, 1996, GENE DEV, V10, P1284, DOI 10.1101/gad.10.10.1284; Lanctot C, 1997, DEVELOPMENT, V124, P2807; LANSER ME, 1987, ANAT RECORD, V217, P61, DOI 10.1002/ar.1092170110; Logan M, 1998, METHODS, V14, P407, DOI 10.1006/meth.1998.0595; Logan M, 1998, DEVELOPMENT, V125, P2825; Logan M, 1998, CELL, V94, P307, DOI 10.1016/S0092-8674(00)81474-9; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Ohuchi H, 1998, DEVELOPMENT, V125, P51; OHUCHI H, 1995, BIOCHEM BIOPH RES CO, V209, P809, DOI 10.1006/bbrc.1995.1572; PAUTOU MP, 1982, ARCH ANAT MICROSC MO, V71, P193; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Shang J, 1997, GENOMICS, V40, P108, DOI 10.1006/geno.1996.4558; SHELLSWELL GB, 1977, PATTERN MUSCLE TENDO; Simon HG, 1997, DEVELOPMENT, V124, P1355; Szeto DP, 1996, P NATL ACAD SCI USA, V93, P7706, DOI 10.1073/pnas.93.15.7706; Vogel A, 1996, DEVELOPMENT, V122, P1737; WORTHAM RA, 1948, J MORPHOL, V83, P105, DOI 10.1002/jmor.1050830106	26	223	231	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	1999	283	5408					1736	1739		10.1126/science.283.5408.1736	http://dx.doi.org/10.1126/science.283.5408.1736			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175PF	10073939				2022-12-28	WOS:000079102800052
J	Thatcher, W; Foulger, GR; Julian, BR; Svarc, J; Quilty, E; Bawden, GW				Thatcher, W; Foulger, GR; Julian, BR; Svarc, J; Quilty, E; Bawden, GW			Present-day deformation across the basin and range province, western United States	SCIENCE			English	Article							STRAIN ACCUMULATION; MOJAVE-DESERT; CALIFORNIA; WASATCH; MOTION; STRESS; FAULT; ZONE	The distribution of deformation within the Basin and Range province was determined from 1992, 1996, and 1998 surveys of a dense, 800-kilometer-aperture, Global Positioning System network. Internal deformation generally follows the pattern of Holocene fault distribution and is concentrated near the western extremity of the province, with Lesser amounts focused near the eastern boundary. Little net deformation occurs across the central 500 kilometers of the network in western Utah and eastern Nevada. Concentration of deformation adjacent to the rigid Sierra Nevada block indicates that external plate-driving forces play an important role in driving deformation, modulating the extensional stress field generated by internal buoyancy forces that are due to Lateral density gradients and topography near the province boundaries.	US Geol Survey, Menlo Park, CA 94025 USA; Univ Durham, Sci Labs, Dept Geol Sci, Durham DH1 3LE, England	United States Department of the Interior; United States Geological Survey; Durham University	Thatcher, W (corresponding author), US Geol Survey, MS-977, Menlo Park, CA 94025 USA.							ARGUS DF, 1991, GEOLOGY, V19, P1085, DOI 10.1130/0091-7613(1991)019<1085:CSNNAM>2.3.CO;2; Bennett RA, 1998, GEOPHYS RES LETT, V25, P563, DOI 10.1029/98GL00128; BRACE WF, 1980, J GEOPHYS RES, V85, P6248, DOI 10.1029/JB085iB11p06248; DEPOLO DM, 1998, EARTHQUAKES NEVADA 1; DIXON TH, 1995, TECTONICS, V14, P755, DOI 10.1029/95TC00931; DOHRENWEND JC, 1996, 962 NEV BUR MIN GEOL; DOKKA RK, 1990, TECTONICS, V9, P311, DOI 10.1029/TC009i002p00311; FREUND LB, 1976, B SEISMOL SOC AM, V66, P667; HAMILTON W, 1987, GEOLOGICAL SOC SPECI, V28, P155; HECKER S, 1993, B UTAH GEOLOGICAL SU, V127; Jones CH, 1996, NATURE, V381, P37, DOI 10.1038/381037a0; LACHENBRUCH AH, 1990, TECTONOPHYSICS, V174, P39, DOI 10.1016/0040-1951(90)90383-J; Langbein J, 1997, J GEOPHYS RES-SOL EA, V102, P591, DOI 10.1029/96JB02945; Martinez LJ, 1998, GEOPHYS RES LETT, V25, P567, DOI 10.1029/98GL00090; PEZZOPANE SK, 1993, TECTONICS, V12, P1140, DOI 10.1029/92TC02950; SAUBER J, 1986, J GEOPHYS RES-SOLID, V91, P2683, DOI 10.1029/JB091iB12p12683; SAVAGE JC, 1990, GEOPHYS RES LETT, V17, P2113, DOI 10.1029/GL017i012p02113; SAVAGE JC, 1973, J GEOPHYS RES, V78, P832, DOI 10.1029/JB078i005p00832; SAVAGE JC, 1995, J GEOPHYS RES-SOL EA, V100, P20257, DOI 10.1029/95JB01872; SAVAGE JC, 1992, J GEOPHYS RES-SOL EA, V97, P2071, DOI 10.1029/91JB02798; SCHWARTZ DP, 1984, J GEOPHYS RES, V89, P5681, DOI 10.1029/JB089iB07p05681; SONDER LJ, 1986, EARTH PLANET SC LETT, V77, P81, DOI 10.1016/0012-821X(86)90134-2; TURCOTTE DL, 1982, MOUNTAIN BUILDING PR, P141; Wernicke B., 1992, GEOLOGICAL SOC AM GE, VG3, P553; ZOBACK ML, 1989, J GEOPHYS RES-SOLID, V94, P7105, DOI 10.1029/JB094iB06p07105	25	215	215	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	1999	283	5408					1714	1718		10.1126/science.283.5408.1714	http://dx.doi.org/10.1126/science.283.5408.1714			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175PF	10073932	Green Submitted			2022-12-28	WOS:000079102800045
J	Garris, PA; Kilpatrick, M; Bunin, MA; Michael, D; Walker, QD; Wightman, RM				Garris, PA; Kilpatrick, M; Bunin, MA; Michael, D; Walker, QD; Wightman, RM			Dissociation of dopamine release in the nucleus accumbens from intracranial self-stimulation	NATURE			English	Article							INVIVO MICRODIALYSIS; BRAIN-STIMULATION; RAT-BRAIN; REWARD; STRIATUM; RECOVERY	Mesolimbic dopamine-releasing neurons appear to be important in the brain reward system(1,2). One behavioural paradigm that supports this hypothesis is intracranial self-stimulation (ICS), during which animals repeatedly press a lever to stimulate their own dopamine-releasing neurons electrically(3-6). Here we study dopamine release from dopamine terminals in the nucleus accumbens core and shell in the brain by using rapid-responding voltammetric microsensors(7) during electrical stimulation of dopamine cell bodies in the ventral tegmental area/substantia nigra brain regions. In rats in which stimulating electrode placement failed to elicit dopamine release in the nucleus accumbens, ICS behaviour was not learned In contrast, ICS was acquired when stimulus trains evoked extracellular dopamine in either the core or the shell of the nucleus accumbens. In animals that could learn ICS, experimenter-delivered stimulation always elicited dopamine release. In contrast, extracellular dopamine was rarely observed during ICS itself. Thus, although activation of mesolimbic dopamine-releasing neurons seems to be a necessary condition for ICS, evoked dopamine release is actually diminished during ICS. Dopamine may therefore be a neural substrate for novelty(8) or reward expectation(9) rather than reward itself.	Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC 27599 USA; Illinois State Univ, Dept Biol Sci, Normal, IL 61790 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Illinois State University	Wightman, RM (corresponding author), Univ N Carolina, Dept Chem, CB 3290,Venable Hall, Chapel Hill, NC 27599 USA.							BLAHA CD, 1990, J NEUROSCI METH, V34, P125, DOI 10.1016/0165-0270(90)90050-P; Cahill PS, 1996, ANAL CHEM, V68, P3180, DOI 10.1021/ac960347d; DIORINO DF, 1993, BEHAV BRAIN RES, V55, P131; FIBIGER HC, 1987, J NEUROSCI, V7, P3888; GALLISTEL CR, 1987, PHARMACOL BIOCHEM BE, V26, P731, DOI 10.1016/0091-3057(87)90605-8; GARRIS PA, 1994, J NEUROSCI, V14, P6084; Garris PA, 1997, J NEUROCHEM, V68, P152; Jones SR, 1996, SYNAPSE, V23, P224, DOI 10.1002/(SICI)1098-2396(199607)23:3<224::AID-SYN12>3.3.CO;2-6; Kruk ZL, 1998, J NEUROSCI METH, V79, P9, DOI 10.1016/S0165-0270(97)00156-8; MARSDEN CA, 1988, NEUROSCIENCE, V25, P389, DOI 10.1016/0306-4522(88)90247-3; MICHAEL AC, 1987, BRAIN RES, V421, P325, DOI 10.1016/0006-8993(87)91302-3; Michael D, 1998, ANAL CHEM, V70, p586A, DOI 10.1021/ac9819640; MILIARESSIS E, 1991, BEHAV BRAIN RES, V46, P43, DOI 10.1016/S0166-4328(05)80095-6; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; MURRAY B, 1994, BEHAV BRAIN RES, V63, P47, DOI 10.1016/0166-4328(94)90050-7; NAKAHARA D, 1992, BRAIN RES, V574, P164, DOI 10.1016/0006-8993(92)90813-O; Nirenberg MJ, 1997, J NEUROSCI, V17, P6899; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; PARSONS LH, 1992, J NEUROCHEM, V58, P212, DOI 10.1111/j.1471-4159.1992.tb09298.x; Phillips AG, 1989, NEUROPHARMACOLOGICAL, P66; Pich EM, 1997, SCIENCE, V275, P83; REVEC GV, 1997, NEUROSCIENCE, V76, P707; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rocha BA, 1998, NAT NEUROSCI, V1, P132, DOI 10.1038/381; SCHULTEIS G, 1995, P NATL ACAD SCI USA, V92, P5880, DOI 10.1073/pnas.92.13.5880; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shizgal P., 1989, NEUROPHARMACOLOGICAL, P106; STELLAR JR, 1989, NEUROPHARMACOLOGICAL, P14; Wise RA, 1996, ANNU REV NEUROSCI, V19, P319, DOI 10.1146/annurev.ne.19.030196.001535; WISE RA, 1983, NEUROBIOLOGY OPIATE, P405	30	257	265	0	18	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 4	1999	398	6722					67	69		10.1038/18019	http://dx.doi.org/10.1038/18019			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174KG	10078530				2022-12-28	WOS:000079033900052
J	Collins, S; Law, MG; Fletcher, A; Boyd, A; Kaldor, J; Masters, CL				Collins, S; Law, MG; Fletcher, A; Boyd, A; Kaldor, J; Masters, CL			Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study	LANCET			English	Article							EMBOLIZATION; TRANSMISSION; AGENT	Background Apart from the small number of iatrogenic and familial cases, the cause of most cases of Creutzfeldt-Jakob disease (CJD) is not known. We aimed to identify risk factors for sporadic CJD. Methods In a case-control study, we compared the medical history and selected demographic characteristics of 241 definite (neuropathologically confirmed) and probable (clinically likely) patients with CJD, ascertained from the Australian National Creutzfeldt-Jakob Disease Registry between Jan 1, 1970, and October 31, 1997, and of 784 controls, recruited from the community by random telephone interview in August; 1997. Standard logistic regression was used for the comparisons. Findings Surgical procedures were significantly associated with the development of sporadic CJD. This risk progressively increased with the number of surgical treatments to a maximum for three procedures (odds ratio 2.13 [95% CI 1.34-3.41], p=0.002). There was also a significant association between risk of CJD and residence or employment on a farm (p<0.001) or market garden (p=0.002) for longer than 10 years. We found no significant risk associated with a history of blood transfusion, organ transplantation, major dental work, or occupation. Interpretation Our findings accord with the hypothesis that a range of surgical treatments may serve as unrecognised contamination events and account for a proportion of cases of sporadic CJD. Possible biases in different methods and times for the acquisition of data on cases and controls suggest our findings need to be replicated in independent studies with community controls.	Univ Melbourne, Dept Pathol, Australian Natl Creutzfeldt Jakob Dis Registry, Parkville, Vic 3052, Australia; Univ New S Wales, St Vincents Hosp Med Ctr, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia	University of Melbourne; St Vincents Hospital Sydney; University of New South Wales Sydney; Kirby Institute	Collins, S (corresponding author), Univ Melbourne, Dept Pathol, Australian Natl Creutzfeldt Jakob Dis Registry, Parkville, Vic 3052, Australia.	s.collins@pathology.unimelb.edu.au	Kaldor, John M/D-4545-2011	Law, Matthew/0000-0002-3540-8837				Antoine JC, 1997, NEUROLOGY, V48, P1451, DOI 10.1212/WNL.48.5.1451; *AUSTR BUR STAT, 1996, 1216 ABS; BOBOWICK AR, 1973, AM J EPIDEMIOL, V98, P381, DOI 10.1093/oxfordjournals.aje.a121567; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; BROWN P, 1992, LANCET, V340, P24, DOI 10.1016/0140-6736(92)92431-E; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; COLLINGE J, 1991, LANCET, V337, P1441, DOI 10.1016/0140-6736(91)93128-V; Collins S, 1996, TRANSMISSIBLE SUBACUTE SPONGIFORM ENCEPHALOPATHIES: PRION DISEASES, P405; Collins S, 1996, MED J AUSTRALIA, V164, P598, DOI 10.5694/j.1326-5377.1996.tb122202.x; Cousens SN, 1997, BRIT MED J, V315, P389, DOI 10.1136/bmj.315.7105.389; DAVANIPOUR Z, 1985, NEUROLOGY, V35, P1483, DOI 10.1212/WNL.35.10.1483; DAVANIPOUR Z, 1985, AM J EPIDEMIOL, V122, P443, DOI 10.1093/oxfordjournals.aje.a114125; DAVANIPOUR Z, 1986, Neuroepidemiology, V5, P194, DOI 10.1159/000110829; Defebvre L, 1997, NEUROLOGY, V48, P1470, DOI 10.1212/WNL.48.5.1470; HARRIESJONES R, 1988, J NEUROL NEUROSUR PS, V51, P1113, DOI 10.1136/jnnp.51.9.1113; KLEIN R, 1993, LANCET, V341, P768, DOI 10.1016/0140-6736(93)90549-V; KONDO K, 1982, ANN NEUROL, V11, P377, DOI 10.1002/ana.410110410; MASTERS CL, 1979, ANN NEUROL, V5, P177, DOI 10.1002/ana.410050212; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; van Duijn CM, 1998, LANCET, V351, P1081, DOI 10.1016/S0140-6736(97)09468-3; Wientjens DPWM, 1996, NEUROLOGY, V46, P1287, DOI 10.1212/WNL.46.5.1287	22	172	174	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	1999	353	9154					693	697		10.1016/S0140-6736(98)08138-0	http://dx.doi.org/10.1016/S0140-6736(98)08138-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173DR	10073510				2022-12-28	WOS:000078966400008
J	Skjaerven, R; Wilcox, AJ; Lie, RT				Skjaerven, R; Wilcox, AJ; Lie, RT			A population-based study of survival and childbearing among female subjects with birth defects and the risk of recurrence in their children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONGENITAL-MALFORMATIONS; MATERNAL AGE; CLEFT-LIP	Background and Methods Persons with birth defects are at high risk for death during the perinatal period and infancy. Less is known about the rater survival or reproduction of such persons. We studied a cohort that comprised 8192 women and adolescent girls with registered birth defects and 451,241 women and adolescent girls with no birth defects, all of whom were born in Norway from 1967 through 1982. The rate of survival was determined through 1992, and the rate of childbearing was determined through October 1997. We also estimated the risk of birth defects in the children of these subjects. Results Among the subjects with birth defects, 80 percent survived to 15 years of age, as compared with 98 percent of those with no birth defects. Among the surviving subjects, 53 percent of those with birth defects gave birth to at least one infant by the age of 30 years, as compared with 67 percent of those with no birth defects. The subjects with birth defects were one third less likely to give birth by the age of 30 than those with no birth defects. The children of the subjects with birth defects had a significantly higher risk of birth defects than the children of those with no birth defects (relative risk, 1.6; 95 percent confidence interval, 1.3 to 2.1). This increased risk was confined entirely to the specific defect carried by the mother, with the relative risk of recurrence varying from 5.5 to 82 according to the defect. In contrast, there was no increase in the risk of having an infant with a different type of defect. Conclusions Women and girls with birth defects have decreased survival as compared with those with no birth defects, especially in the first years of life, and are less likely to have children. in addition, they have an increased risk of having children with the same defect. (N Engl J Med 1999;340:1057-62.) (C) 1999, Massachusetts Medical Society.	Univ Bergen, Sect Med Stat, N-5021 Bergen, Norway; Univ Bergen, Med Birth Registry Norway, Bergen, Norway; NIEHS, Res Triangle Pk, NC 27709 USA	University of Bergen; University of Bergen; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Skjaerven, R (corresponding author), Univ Bergen, Sect Med Stat, Armauer Hansens Bldg, N-5021 Bergen, Norway.		Wilcox, Allen J/C-7723-2019	Wilcox, Allen J/0000-0002-3376-1311	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES049027, ZIAES049027] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ADAMS MM, 1985, AM J DIS CHILD, V139, P518, DOI 10.1001/archpedi.1985.02140070092045; BAIRD PA, 1991, LANCET, V337, P527, DOI 10.1016/0140-6736(91)91306-F; Burn J, 1998, LANCET, V351, P311, DOI 10.1016/S0140-6736(97)06486-6; CARTER CO, 1982, J MED GENET, V19, P246, DOI 10.1136/jmg.19.4.246; CROEN LA, 1995, AM J PUBLIC HEALTH, V85, P710, DOI 10.2105/AJPH.85.5.710; CZEIZEL A, 1984, MUTAT RES, V128, P73, DOI 10.1016/0027-5107(84)90049-6; LIE RT, 1994, NEW ENGL J MED, V331, P1, DOI 10.1056/NEJM199407073310101; LIE RT, 1994, BIOMETRICS, V50, P433, DOI 10.2307/2533386; MASTROIACOVO P, 1992, AM J MED GENET, V42, P208, DOI 10.1002/ajmg.1320420214; MEHTA C, 1999, STATXACT WINDOWS; Mitchell LE, 1997, EPIDEMIOL REV, V19, P61, DOI 10.1093/oxfordjournals.epirev.a017947; Norusis M J, 1993, SPSS WINDOWS ADV STA; Rothman K, 1986, MODERN EPIDEMIOLOGY	13	47	48	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 8	1999	340	14					1057	1062		10.1056/NEJM199904083401401	http://dx.doi.org/10.1056/NEJM199904083401401			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	184AK	10194234				2022-12-28	WOS:000079587000001
J	Bredin, M; Corner, J; Krishnasamy, M; Plant, H; Bailey, C; A'Hern, R				Bredin, M; Corner, J; Krishnasamy, M; Plant, H; Bailey, C; A'Hern, R			Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SYMPTOMS; DYSPNEA	Objective To evaluate the effectiveness of nursing intervention for breathlessness in patients with lung cancer Design Patients diagnosed with lung cancer participated in a multicentre randomised controlled trial where they either attended a nursing clinic offering intervention for their breathlessness or received rest supportive care. The intervention consisted of a range of strategies combining breathing control, activity pacing, relaxation techniques, and psychosocial support Best supportive care involved receiving standard management and treatment available for breathlessness, and breathing assessments. Participants completed a range of self assessment questionnaires at baseline, 4 weeks, and 8 weeks. Setting Nursing clinics within 6 hospital settings in the United Kingdom. Participants 119 patients diagnosed with small cell or non-small cell lung cancer or with mesothelioma who had completed first line treatment for their disease and reported breathlessness. Outcome measures Visual analogue scales measuring distress due to breathlessness, breathlessness at best and worst, WHO performance status scale, hospital anxiety and depression scale, and Rotterdam symptom checklist. Results The intervention group improved significantly at 8 weeks in 5 of the 11 items assessed: breathlessness at best, WHO performance status, levels of depression and two Rotterdam symptom checklist measures (physical symptom distress and breathlessness) and showed slight improvement in 3 of the remaining 6 items. Conclusion Most patients who completed the study had a pool prognosis, and breathlessness was typically a symptom of their deteriorating condition. Patients who attended nursing clinics and received the breathlessness intervention experienced improvements in breathlessness, performance status, and physical and emotional states relative to control patients.	Royal Marsden NHS Trust, Inst Canc Res, Macmillan Practice Dev Unit, Ctr Canc & Palliat Care Studies, London SW3 6JJ, England; Royal Marsden NHS Trust, Dept Comp & Informat, London SW3 6JJ, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust	Corner, J (corresponding author), Royal Marsden NHS Trust, Inst Canc Res, Macmillan Practice Dev Unit, Ctr Canc & Palliat Care Studies, London SW3 6JJ, England.	jessica@icr.ac.uk		A'Hern, Roger/0000-0003-0593-8391; Corner, Jessica/0000-0002-2240-8133				Corner J, 1996, PALLIATIVE MED, V10, P299, DOI 10.1177/026921639601000405; Corner Jessica, 1995, Int J Palliat Nurs, V1, P5, DOI 10.12968/ijpn.1995.1.1.5; De Haes J, 1996, ROTTERDAM SYMPTOM CH; GOULD AL, 1980, BIOMETRICS, V36, P721, DOI 10.2307/2556126; HIGGINSON I, 1989, J ROY SOC MED, V82, P264, DOI 10.1177/014107688908200507; MUERS MF, 1993, THORAX, V48, P339, DOI 10.1136/thx.48.4.339; ODRISCOLL M, IN PRESS EUR J CANC; ROBERTS DK, 1993, CANCER NURS, V16, P310; TWYCROSS RG, 1986, THERAPEUTICS TERMINA; World Health Organization, 1979, WHO OFFSET PUBLICATI, V48; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	11	192	193	1	99	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	1999	318	7188					901	904		10.1136/bmj.318.7188.901	http://dx.doi.org/10.1136/bmj.318.7188.901			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185GV	10102851	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000079660500023
J	Duncan, B; Hart, G				Duncan, B; Hart, G			Sexuality and health: the hidden costs of screening for Chlamydia trachomatis	BRITISH MEDICAL JOURNAL			English	Article							PREVENTION		Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow	Duncan, B (corresponding author), Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland.		Hart, Graham J/C-1591-2008	Hart, Graham/0000-0001-9676-6577				Boag F, 1998, BMJ-BRIT MED J, V316, P1474, DOI 10.1136/bmj.316.7143.1474; Bower H, 1998, BRIT MED J, V316, P1479; Cameron E, 1998, SOCIOL HEALTH ILL, V20, P673, DOI 10.1111/1467-9566.00124; CAMPION MJ, 1988, BRIT J OBSTET GYNAEC, V95, P175, DOI 10.1111/j.1471-0528.1988.tb06848.x; CATES W, 1991, AM J OBSTET GYNECOL, V164, P1771, DOI 10.1016/0002-9378(91)90559-A; *CDC, 1997, JAMA-J AM MED ASSOC, V277, P952; CHILMAN CS, 1985, CHILD WELFARE, V64, P225; *DEP HLTH, 1998, MAIN REP CHIEF MED O; DUNCAN B, 1998, PREVENIR S, V24, P229; HYNIE M, 1995, PSYCHOL WOMEN QUART, V19, P563, DOI 10.1111/j.1471-6402.1995.tb00093.x; Lakhani B, 1993, Health Visit, V66, P102; Luker K., 1978, TAKING CHANCES ABORT; LUPTON D, 1992, AUST J SOC ISSUES, V27, P112, DOI 10.1002/j.1839-4655.1992.tb01281.x; MCKIE L, 1995, SOCIOL HEALTH ILL, V17, P441, DOI 10.1111/1467-9566.ep10932225; MCKIE L, 1993, MED SOCIOL NEWS, V18, P15; Milburn K, 1994, HLTH ED J, V53, P201; Posner T, 1988, PREVENTION CERVICAL; Scholes D, 1996, NEW ENGL J MED, V334, P1362, DOI 10.1056/NEJM199605233342103	18	43	43	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 3	1999	318	7188					931	+		10.1136/bmj.318.7188.931	http://dx.doi.org/10.1136/bmj.318.7188.931			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	185GV	10102865	Green Published			2022-12-28	WOS:000079660500033
J	Wysession, ME; Langenhorst, A; Fouch, MJ; Fischer, KM; Al-Eqabi, GI; Shore, PJ; Clarke, TJ				Wysession, ME; Langenhorst, A; Fouch, MJ; Fischer, KM; Al-Eqabi, GI; Shore, PJ; Clarke, TJ			Lateral variations in compressional/shear velocities at the base of the mantle	SCIENCE			English	Article							DIFFERENTIAL TRAVEL-TIMES; SEISMIC ANISOTROPY; LOWERMOST MANTLE; D'' LAYER; DIFFRACTED WAVES; P-VELOCITY; CORE; HETEROGENEITY; BOUNDARY; MODEL	Observations of core-diffracted P (P-diff) and SH (SHdiff) waves recorded by the Missouri-to-Massachusetts (MOMA) seismic array show that the ratio of compressional (P) seismic velocities to horizontal shear (SH) velocities at the base of the mantle changes abruptly from beneath the mid-Pacific (V-p/V-s = 1.88, also the value predicted by reference Earth models) to beneath Alaska (V-p/V-s = 1.83). This change signifies a sudden Lateral variation in material properties that may have a mineralogical or textural origin. A textural change could be a result of shear stresses induced during the arrival at the core of ancient lithosphere from the northern Pacific paleotrench.	Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Northwestern Univ, Dept Geol Sci, Evanston, IL 60208 USA; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; New Mexico Inst Min & Technol, Dept Earth & Environm Sci, Socorro, NM 87801 USA	Washington University (WUSTL); Northwestern University; Brown University; New Mexico Institute of Mining Technology	Wysession, ME (corresponding author), Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA.	michael@wucore.wustl.edu	Fouch, Matthew/F-6507-2010					BOLTON H, 1996, EOS T AGU S, V77, pF697; DAVIES GF, 1986, GEOPHYS RES LETT, V13, P1517, DOI 10.1029/GL013i013p01517; DOORNBOS DJ, 1979, GEOPHYS J ROY ASTR S, V57, P353, DOI 10.1111/j.1365-246X.1979.tb04783.x; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Dziewonski AM, 1996, NATO ADV SCI INST SE, V303, P521; FOUCH MJ, UNPUB; FOUCH MJ, 1998, EOS, V79, pF617; Garnero EJ, 1998, GEODYNAMICS-US, V28, P319; Garnero EJ, 1997, J GEOPHYS RES-SOL EA, V102, P8121, DOI 10.1029/96JB03830; Grand SP., 1997, GSA TODAY, V7, P1; INOUE H, 1990, PHYS EARTH PLANET IN, V59, P294, DOI 10.1016/0031-9201(90)90236-Q; JORDAN TH, 1979, P NATL ACAD SCI USA, V76, P4192, DOI 10.1073/pnas.76.9.4192; KARATO S, 1995, SCIENCE, V270, P458, DOI 10.1126/science.270.5235.458; KARATO S, 1998, EOS, V79, pF607; Kendall JM, 1996, NATURE, V381, P409, DOI 10.1038/381409a0; Kendall JM, 1998, GEODYNAMICS, V28, P97; KENNETT BLN, 1991, GEOPHYS J INT, V105, P429, DOI 10.1111/j.1365-246X.1991.tb06724.x; Kuo BY, 1997, J GEOPHYS RES-SOL EA, V102, P11775, DOI 10.1029/97JB00305; Lay T, 1998, GEODYNAMICS, V28, P299; Lay T, 1998, NATURE, V392, P461, DOI 10.1038/33083; LAY T, 1998, EOS, V79, pF607; Li XD, 1996, J GEOPHYS RES-SOL EA, V101, P22245, DOI 10.1029/96JB01306; Lithgow-Bertelloni C, 1998, REV GEOPHYS, V36, P27, DOI 10.1029/97RG02282; Masters G, 1996, PHILOS T R SOC A, V354, P1385, DOI 10.1098/rsta.1996.0054; Matzel E, 1996, GEOPHYS RES LETT, V23, P2417, DOI 10.1029/96GL02186; MCFARLANE EA, 1994, GEOCHIM COSMOCHIM AC, V58, P5161, DOI 10.1016/0016-7037(94)90301-8; MONDT JC, 1977, PHYS EARTH PLANET IN, V15, P46, DOI 10.1016/0031-9201(77)90009-7; MULA AH, 1980, PURE APPL GEOPHYS, V118, P1272, DOI 10.1007/BF01593067; OHTANI E, 1991, GEOPHYS RES LETT, V18, P85, DOI 10.1029/90GL02717; OKAL EA, 1979, B SEISMOL SOC AM, V69, P1039; Pulliam J, 1998, GEOPHYS J INT, V135, P113, DOI 10.1046/j.1365-246X.1998.00612.x; PULLIAM RJ, 1993, J GEOPHYS RES-SOL EA, V98, P699, DOI 10.1029/92JB01053; RICARD Y, 1993, J GEOPHYS RES-SOL EA, V98, P21895, DOI 10.1029/93JB02216; RIGDEN SM, 1989, J GEOPHYS RES-SOLID, V94, P9508, DOI 10.1029/JB094iB07p09508; Robertson GS, 1996, J GEOPHYS RES-SOL EA, V101, P20041, DOI 10.1029/96JB01905; Russell SA, 1998, NATURE, V396, P255, DOI 10.1038/24364; SOURIAU A, 1994, PHYS EARTH PLANET IN, V84, P227, DOI 10.1016/0031-9201(94)90043-4; Stixrude L, 1998, GEODYNAMICS, V28, P83; SU WJ, 1994, J GEOPHYS RES-SOL EA, V99, P6945, DOI 10.1029/93JB03408; Sylvander M, 1996, PHYS EARTH PLANET IN, V94, P1, DOI 10.1016/0031-9201(95)03093-X; TANDON GP, 1984, POLYM COMPOSITE, V5, P327, DOI 10.1002/pc.750050413; TANIMOTO T, 1990, GEOPHYS J INT, V100, P327, DOI 10.1111/j.1365-246X.1990.tb00688.x; Valenzuela PW, 1998, GEODYNAMICS, V28, P57; vanderHilst RD, 1997, NATURE, V386, P578, DOI 10.1038/386578a0; Vinnik L, 1998, NATURE, V393, P564, DOI 10.1038/31208; VINNIK L, 1995, GEOPHYS RES LETT, V22, P1657, DOI 10.1029/95GL01327; VINNIK LP, 1989, B SEISMOL SOC AM, V79, P1542; WYSESSION ME, 1994, J GEOPHYS RES-SOL EA, V99, P13667, DOI 10.1029/94JB00691; Wysession ME, 1996, NATURE, V382, P244, DOI 10.1038/382244a0; Wysession ME, 1998, GEODYNAMICS, V28, P273; WYSESSION ME, 1992, J GEOPHYS RES-SOL EA, V97, P8749, DOI 10.1029/92JB00511; WYSESSION ME, 1989, GEOPHYS RES LETT, V16, P1417, DOI 10.1029/GL016i012p01417; WYSESSION ME, 1993, GEOPH MONOG SERIES, V72, P181; WYSESSION ME, 1995, EOS, V77, P477	54	56	56	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	1999	284	5411					120	125		10.1126/science.284.5411.120	http://dx.doi.org/10.1126/science.284.5411.120			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182QE	10102807				2022-12-28	WOS:000079509000046
J	Forster, A; Young, J; Langhorne, P				Forster, A; Young, J; Langhorne, P		Day Hosp Grp	Systematic review of day hospital care for elderly people	BRITISH MEDICAL JOURNAL			English	Review							COMPREHENSIVE GERIATRIC ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; LONG-TERM CARE; STROKE PATIENTS; COST-EFFECTIVENESS; REHABILITATION; DOMICILIARY; METAANALYSIS; OUTCOMES; HOME	Objective To examine the effectiveness of day hospital attendance in prolonging independent living for elderly people. Design Systematic review of 12 controlled clinical trials (available by January 1997) comparing day hospital care with comprehensive care (five trials), domiciliary care (four trials), or no comprehensive care (three trials). Subjects 2867 elderly people. Main outcome measures Death, institutionalisation, disability, global "poor outcome," and use of resources. Results Overall, there was no significant difference between day hospitals and alternative services for death, disability, or use of resources. However, compared with subjects receiving no comprehensive care, patients attending day hospitals had a lower odds of death or "poor" outcome (0.72, 95% confidence interval 0.53 to 0.99; P < 0.05) and functional deterioration (0.61, 0.38 to 0.97; P < 0.05). The day hospital group showed trends towards reductions in hospital bed use and placement in institutional care. Eight trials reported treatment costs, six of which reported that day hospital attendance was more expensive than other care, although only two analyses took into account cost of long term care. Conclusions Day hospital care seems to be an effective service for elderly people who need rehabilitation but may have no clear advantage over other comprehensive care. Methodological problems limit these conclusions, and further randomised trials are justifiable.	St Lukes Hosp, Dept Hlth Care Elderly, Bradford BD5 0NA, W Yorkshire, England; Glasgow Royal Infirm, Acad Sect Geriatr Med, Glasgow G4 0SF, Lanark, Scotland	University of Glasgow	Forster, A (corresponding author), St Lukes Hosp, Dept Hlth Care Elderly, Bradford BD5 0NA, W Yorkshire, England.			young, john/0000-0003-4085-9306; Forster, Anne/0000-0001-7466-4414				BURCH S, IN PRESS CLIN REHAB; CUMMINGS V, 1985, ARCH PHYS MED REHAB, V66, P86; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DONALDSON C, 1987, COMMUNITY MED, V9, P55; EAGLE DJ, 1991, CAN MED ASSOC J, V144, P699; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; GLADMAN J, 1994, AGE AGEING, V23, P241, DOI 10.1093/ageing/23.3.241; GLADMAN JRF, 1993, J NEUROL NEUROSUR PS, V56, P960, DOI 10.1136/jnnp.56.9.960; HEDRICK SC, 1993, MED CARE, V31, pSS1; HUI E, 1995, STROKE, V26, P1616, DOI 10.1161/01.STR.26.9.1616; *NAT AUD OFF, 1994, NAT HLTH SERV DAY HO; PARKER SG, 1994, J ROY COLL PHYS LOND, V28, P428; PETO R, 1987, STAT MED, V6, P233, DOI 10.1002/sim.4780060306; PITKALA K, 1991, ARCH GERONTOL GERI S, V2, P51; *RES UN ROYAL COLL, 1994, GER HOSP THEIR ROL G; SHERWOOD S, 1986, AM J PUBLIC HEALTH, V76, P38, DOI 10.2105/AJPH.76.1.38; SIU AL, 1994, J AM GERIATR SOC, V42, P1094, DOI 10.1111/j.1532-5415.1994.tb06215.x; SKELLIE FA, 1982, AM J PUBLIC HEALTH, V72, P353, DOI 10.2105/AJPH.72.4.353; STUCK AE, 1993, LANCET, V342, P1032, DOI 10.1016/0140-6736(93)92884-V; TUCKER MA, 1984, BRIT MED J, V289, P1209, DOI 10.1136/bmj.289.6453.1209; Vetter N, 1989, DAY HOSP PILOT STUDY; WEILER PG, 1976, MED CARE, V14, P700, DOI 10.1097/00005650-197608000-00007; WEISSERT W, 1980, MED CARE, V18, P567, DOI 10.1097/00005650-198006000-00001; WOODFORDWILLIAM.E, 1962, GERONTOL CLIN, V4, P241, DOI 10.1159/000244750; YOUNG J, 1993, J ROY COLL PHYS LOND, V27, P252; YOUNG JB, 1992, BRIT MED J, V304, P1085, DOI 10.1136/bmj.304.6834.1085	26	59	62	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 27	1999	318	7187					837	+		10.1136/bmj.318.7187.837	http://dx.doi.org/10.1136/bmj.318.7187.837			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185DM	10092260	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000079652900023
J	Llewellyn, D; Stott, N				Llewellyn, D; Stott, N			Robert Harvard Davis - Obituary	BRITISH MEDICAL JOURNAL			English	Biographical-Item																		DAVIS RV, PUBLICATION LIST	1	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 27	1999	318	7187					878	878		10.1136/bmj.318.7187.878	http://dx.doi.org/10.1136/bmj.318.7187.878			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185DM	10092284	Green Published			2022-12-28	WOS:000079652900066
J	Salzman, C; Parker				Salzman, C; Parker			An 87-year-old woman taking a benzodiazepine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ANXIETY DISORDERS; RESIDENTS; ABUSE; PRESCRIPTIONS; DEPRESSION; IMPAIRMENT; WITHDRAWAL; EXPERIENCE; MEMORY; OLDER		Harvard Univ, Sch Med, Cambridge, MA 02138 USA; Massachusetts Mental Hlth Ctr, Boston, MA 02115 USA	Harvard University	Salzman, C (corresponding author), Beth Israel Deaconess Med Ctr, Div Gen Med, 330 Brookline Ave,LY318, Boston, MA 02215 USA.							*AM PSYCH ASS TASK, 1990, REP BENZ DEP TOX AB; Aparasu RR, 1998, CLIN THER, V20, P603, DOI 10.1016/S0149-2918(98)80069-6; BALTER MB, 1993, HUM PSYCHOPHARM CLIN, V8, P253, DOI 10.1002/hup.470080404; Banazak D A, 1997, J Am Board Fam Pract, V10, P280; BLAZER D, 1991, ANXIETY IN THE ELDERLY, P17; Blazer DG, 1997, HARVARD REV PSYCHIAT, V5, P18, DOI 10.3109/10673229709034721; COWLEY DS, 1993, PSYCHIAT RES, V47, P151, DOI 10.1016/0165-1781(93)90045-I; Dealberto MJ, 1997, INT J GERIATR PSYCH, V12, P567, DOI 10.1002/(SICI)1099-1166(199705)12:5<567::AID-GPS552>3.0.CO;2-V; Fava M, 1997, PSYCHIAT CLIN N AM, V20, P427, DOI 10.1016/S0193-953X(05)70321-X; Flint AJ, 1996, J AFFECT DISORDERS, V36, P95, DOI 10.1016/0165-0327(95)00063-1; Forsell Y, 1997, INT J GERIATR PSYCH, V12, P533, DOI 10.1002/(SICI)1099-1166(199705)12:5<533::AID-GPS537>3.0.CO;2-X; FOY A, 1995, J GERONTOL, V50, P99; Gleason PP, 1998, J GEN INTERN MED, V13, P243, DOI 10.1046/j.1525-1497.1998.00074.x; GOLOMBOK S, 1988, PSYCHOL MED, V18, P365, DOI 10.1017/S0033291700007911; Greenblatt DJ, 1998, J CLIN PSYCHIAT, V59, P19; GREENBLATT DJ, 1991, ANXIETY IN THE ELDERLY, P131; Griffiths RR, 1997, PSYCHOPHARMACOLOGY, V134, P1, DOI 10.1007/s002130050422; Habraken H, 1997, EUR J CLIN PHARMACOL, V51, P355, DOI 10.1007/s002280050213; Hemmelgarn B, 1997, JAMA-J AM MED ASSOC, V278, P27, DOI 10.1001/jama.278.1.27; HERINGS RM, 1995, ARCH INTERN MED, V155, P1081; HILTUNEN TU, 1995, ACTA PSYCHIAT SCAND, V91, P299; KROBOTH PD, 1990, PSYCHOPHARMACOLOGY, V100, P477, DOI 10.1007/BF02243999; LISTER RG, 1985, NEUROSCI BIOBEHAV R, V9, P87, DOI 10.1016/0149-7634(85)90034-X; LUCKI I, 1986, PSYCHOPHARMACOLOGY, V88, P426; MANTOVANI G, 1995, P ANN M AM SOC CLIN, V14, pA1652; MORTON S, 1992, PHARMACOPSYCHIATRY, V25, P177, DOI 10.1055/s-2007-1014402; Palmer BW, 1997, J AFFECT DISORDERS, V46, P183, DOI 10.1016/S0165-0327(97)00146-8; PINSKER H, 1984, J AM GERIATR SOC, V32, P595, DOI 10.1111/j.1532-5415.1984.tb06139.x; POMARA N, 1989, PSYCHOPHARMACOL BULL, V25, P144; Regestein Q, 1998, CLIN GERIATRIC PSYCH, P395; RUMMANS TA, 1993, MAYO CLIN PROC, V68, P731, DOI 10.1016/S0025-6196(12)60628-4; Salzman C, 1997, HARVARD REV PSYCHIAT, V4, P279, DOI 10.3109/10673229709030554; SALZMAN C, 1992, INT J GERIATR PSYCH, V7, P89, DOI 10.1002/gps.930070205; Salzman C, 1998, PSYCHIAT QUART, V69, P251, DOI 10.1023/A:1022125929946; Salzman C, 1993, NIDA Res Monogr, V131, P68; SALZMAN C, 1991, ANXIETY IN THE ELDERLY, P149; SALZMAN C, 1995, PSYCHIATRY, P1; Salzman C, 1998, CLIN GERIATRIC PSYCH, P333; SALZMAN C, 1998, CLIN GERIATRIC PSYCH, P343; SHADER RI, 1993, NEW ENGL J MED, V328, P1398; Small GW, 1997, J CLIN PSYCHIAT, V58, P41; SMITH BD, 1991, HOSP COMMUNITY PSYCH, V42, P1101; Spore DL, 1997, AM J PUBLIC HEALTH, V87, P404, DOI 10.2105/AJPH.87.3.404; VERMEEREN A, 1995, PSYCHOPHARMACOLOGY, V118, P1, DOI 10.1007/BF02245243; WEINTRAUB M, 1993, CLIN PHARMACOL THER, V54, P252, DOI 10.1038/clpt.1993.145; WOODS JH, 1987, PHARMACOL REV, V39, P251; WOODS JH, 1992, PHARMACOL REV, V44, P151; WOODS JH, 1995, PSYCHOPHARMACOLOGY, V118, P107, DOI 10.1007/BF02245824; Zisselman MH, 1997, AM J GERIAT PSYCHIAT, V5, P167	49	11	11	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	1999	281	12					1121	1125		10.1001/jama.281.12.1121	http://dx.doi.org/10.1001/jama.281.12.1121			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	177EP	10188664				2022-12-28	WOS:000079197100035
J	Tookey, PA; Peckham, CS				Tookey, PA; Peckham, CS			Surveillance of congenital rubella in Great Britain, 1971-96	BRITISH MEDICAL JOURNAL			English	Article									Inst Child Hlth, Dept Epidemiol & Publ Hlth, London WC1N 1EH, England	University of London; University College London	Tookey, PA (corresponding author), Inst Child Hlth, Dept Epidemiol & Publ Hlth, 30 Guilford St, London WC1N 1EH, England.		peckham, catherine s/I-6300-2013; Tookey, Pat A/G-2732-2010	Tookey, Pat A/0000-0001-6258-0387				Hall SM, 1998, CHILD CARE HLTH DEV, V24, P129; HMSO, 1996, IMM INF DIS; THOMAS HIJ, 1995, PHLS MICROBIOLOGY DI, V12, P97; 1998, COMMUN DIS REP CDR W, V8, P320; 1998, COMMUN DIS REP CDR W, V8, P317	5	47	47	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 20	1999	318	7186					769	770		10.1136/bmj.318.7186.769	http://dx.doi.org/10.1136/bmj.318.7186.769			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BX	10082699	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000079421700024
J	Jackson, GS; Hosszu, LLP; Power, A; Hill, AF; Kenney, J; Saibil, H; Craven, CJ; Waltho, JP; Clarke, AR; Collinge, J				Jackson, GS; Hosszu, LLP; Power, A; Hill, AF; Kenney, J; Saibil, H; Craven, CJ; Waltho, JP; Clarke, AR; Collinge, J			Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations	SCIENCE			English	Article							CREUTZFELDT-JAKOB DISEASE; MOLTEN GLOBULE STATE; ALPHA-LACTALBUMIN; SCRAPIE; ORGANELLES; STABILITY; LYSOSOMES; ISOFORM; DOMAIN; CELLS	Prion propagation involves the conversion of cellular prion protein (PrPc) into a disease-specific isomer, PrPSc, shifting from a predominantly alpha-helical to beta-sheet structure. Here, conditions were established in which recombinant human PrP could switch between the native a conformation, characteristic of PrPc, and a compact, highly soluble, monomeric form rich in beta structure. The soluble beta form (beta-PrP) exhibited partial resistance to proteinase kappa digestion, characteristic of PrPSc, and was a direct precursor of fibrillar structures closely similar to those isolated from diseased brains. The conversion of PrPc to beta-PrP in suitable cellular compartments, and its subsequent stabilization by intermolecular association, provide a molecular mechanism for prion propagation.	Univ London Imperial Coll Sci Technol & Med, St Marys, Sch Med, Dept Neurogenet,Prion Dis Grp, London W2 1NY, England; Univ Sheffield, Krebs Inst Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; Univ London Birkbeck Coll, Dept Crystallog, London WC1E 7HX, England; Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England	Imperial College London; University of Sheffield; University of London; Birkbeck University London; University of Bristol	Collinge, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, St Marys, Sch Med, Dept Neurogenet,Prion Dis Grp, London W2 1NY, England.		Hill, Andrew F./GZL-4124-2022; Hill, Andrew F/B-4527-2009; Hill, Andrew F./AAH-2854-2020	Hill, Andrew F./0000-0001-5581-2354; Hill, Andrew F/0000-0001-5581-2354; Jackson, Graham/0000-0002-3125-2011	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALEXANDRESCU AT, 1993, BIOCHEMISTRY-US, V32, P1707, DOI 10.1021/bi00058a003; ARNOLD JE, 1995, J PATHOL, V176, P403, DOI 10.1002/path.1711760412; CHYAN CL, 1993, BIOCHEMISTRY-US, V32, P5681, DOI 10.1021/bi00072a025; COLLINGE J, 1991, LANCET, V337, P1441, DOI 10.1016/0140-6736(91)93128-V; Collinge J, 1997, HUM MOL GENET, V6, P1699, DOI 10.1093/hmg/6.10.1699; Eliezer D, 1998, NAT STRUCT BIOL, V5, P148; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Hornemann S, 1998, P NATL ACAD SCI USA, V95, P6010, DOI 10.1073/pnas.95.11.6010; JACKSON GL, UNPUB; JACKSON GS, IN PRESS BIOCH BIOPH; James TL, 1997, P NATL ACAD SCI USA, V94, P10086, DOI 10.1073/pnas.94.19.10086; LASZLO L, 1992, J PATHOL, V166, P333, DOI 10.1002/path.1711660404; LIBERSKI PP, 1991, J COMP PATHOL, V105, P377, DOI 10.1016/S0021-9975(08)80107-7; MAYER RJ, 1992, LANCET, V340, P156, DOI 10.1016/0140-6736(92)93224-B; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; SHYNG SL, 1993, J BIOL CHEM, V268, P15922; Swietnicki W, 1997, J BIOL CHEM, V272, P27517, DOI 10.1074/jbc.272.44.27517; TARABOULOS A, 1992, MOL BIOL CELL, V3, P851, DOI 10.1091/mbc.3.8.851; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6; ZHAN HJ, 1994, BIOCHEMISTRY-US, V33, P11254, DOI 10.1021/bi00203a022; Zhang H, 1997, BIOCHEMISTRY-US, V36, P3543, DOI 10.1021/bi961965r	23	346	357	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 19	1999	283	5409					1935	1937		10.1126/science.283.5409.1935	http://dx.doi.org/10.1126/science.283.5409.1935			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177UC	10082469				2022-12-28	WOS:000079228600053
J	Li, SJ; Hochstrasser, M				Li, SJ; Hochstrasser, M			A new protease required for cell-cycle progression in yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; UBIQUITIN; GENE; DEGRADATION; PROTEINS; ENCODES; SUMO-1; ENZYME	In eukaryotes, protein function can be modulated by ligation to ubiquitin or to ubiquitin-like proteins (Ub1 proteins)(1-3). The vertebrate Ub1 protein SUMO-1 is only 18% identical to ubiquitin but is 48% identical to the yeast protein Smt3. Both SUMO-1 and Smt3 are ligated to cellular proteins, and protein conjugation to SUMO-1/Smt3 is involved in many physiological processes(3-10). It remained unknown, however, whether deconjugation of SUMO1/Smt3 from proteins is also essential. Here we describe a yeast Ub1-specific protease, Ulp1,which cleaves proteins from Smt3 and SUMO-1 but not from ubiquitin. Ulp1 is unrelated to any known deubiquitinating enzyme but shows distant similarity to certain viral proteases, indicating the existence of a widely conserved protease fold. Proteins related to Ulp1 are present in many organisms, including several human pathogens, The pattern of Smt3-coupled proteins in yeast changes markedly throughout the cell cycle, and specific conjugates accumulate in ulp1 mutants. Ulp1 has several functions, including an essential role in the G2/M phase of the fell cycle.	Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago	Hochstrasser, M (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58th St, Chicago, IL 60637 USA.	hoc1@midway.uchicago.edu		Hochstrasser, Mark/0000-0002-1131-5484				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ausubel FM, 1988, MOL REPROD DEV; Deshaies RJ, 1997, CURR OPIN GENET DEV, V7, P7, DOI 10.1016/S0959-437X(97)80103-7; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Ding JZ, 1996, EMBO J, V15, P1778, DOI 10.1002/j.1460-2075.1996.tb00526.x; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Johnson PR, 1997, TRENDS CELL BIOL, V7, P408, DOI 10.1016/S0962-8924(97)01132-X; Kamitani T, 1998, J BIOL CHEM, V273, P26675, DOI 10.1074/jbc.273.41.26675; LEE PY, 1994, J BIOL CHEM, V269, P8616; LOPEZOTIN C, 1989, J BIOL CHEM, V264, P9107; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; MELUH PB, 1995, MOL BIOL CELL, V6, P793, DOI 10.1091/mbc.6.7.793; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Muller S, 1998, BLOOD, V92, P4308, DOI 10.1182/blood.V92.11.4308.423k36_4308_4316; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Pickart CM, 1997, FASEB J, V11, P1055, DOI 10.1096/fasebj.11.13.9367341; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; Saitoh H, 1998, CURR BIOL, V8, P121, DOI 10.1016/S0960-9822(98)70044-2; Saitoh H, 1997, TRENDS BIOCHEM SCI, V22, P374, DOI 10.1016/S0968-0004(97)01102-X; Schwarz SE, 1998, P NATL ACAD SCI USA, V95, P560, DOI 10.1073/pnas.95.2.560; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; TOBIAS JW, 1991, J BIOL CHEM, V266, P12021; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Wilkinson KD, 1998, UBIQUITIN BIOL CELL, P99	26	591	621	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	1999	398	6724					246	251		10.1038/18457	http://dx.doi.org/10.1038/18457			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177UA	10094048				2022-12-28	WOS:000079228400055
J	Zhu, JY; McKeon, F				Zhu, JY; McKeon, F			NF-AT activation requires suppression of Crm1-dependent export by calcineurin	NATURE			English	Article							NUCLEAR EXPORT; FUNCTIONAL-CHARACTERIZATION; LEPTOMYCIN-B; CRM1; PROTEIN; SIGNAL; TRANSLOCATION; LOCALIZATION; MUTAGENESIS; DOMAIN	Nuclear import of the NF-AT transcription factors during T-cell activation requires the calcium-activated phosphatase calcineurin, which unmasks nuclear-location signals on NF-AT (refs 1-5), We show here that the nuclear import of NF-ATs is not sufficient to activate NF-AT target genes, as NF-ATs are subject to a futile cycling across the nuclear em elope owing to engagement with the exportin protein Crm1 (refs 6-8), Calcineurin suppresses this futile cycling by a non-catalytic mechanism involving the masking of nuclear export signals on NF-AT targeted by Crm1, This clustering of binding sites for calcineurin and Crm1 on NF-AT establishes an inherent competition between these molecules that imparts exquisite calcium sensitivity to the shuttling dynamics of the NF-AT transcription factors. Such a balance between nuclear import and export may regulate the action of other transcription factors.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	McKeon, F (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	frank_mckeon@hms.harvard.edu						Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Costa G L, 1996, Methods Mol Biol, V57, P239; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Liu J, 1997, MOL BIOL CELL, V8, P157, DOI 10.1091/mbc.8.1.157; Loh C, 1996, J BIOL CHEM, V271, P10884, DOI 10.1074/jbc.271.18.10884; Luo C, 1996, P NATL ACAD SCI USA, V93, P8907, DOI 10.1073/pnas.93.17.8907; Masuda ES, 1997, MOL CELL BIOL, V17, P2066, DOI 10.1128/MCB.17.4.2066; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; MILAN D, 1994, CELL, V79, P437, DOI 10.1016/0092-8674(94)90253-4; NISHI K, 1994, J BIOL CHEM, V269, P6320; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Tessier D C, 1996, Methods Mol Biol, V57, P229; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Zhu JY, 1998, CELL, V93, P851, DOI 10.1016/S0092-8674(00)81445-2	23	159	167	0	3	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 18	1999	398	6724					256	260		10.1038/18473	http://dx.doi.org/10.1038/18473			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177UA	10094050				2022-12-28	WOS:000079228400057
J	Fielder, AR; Bentley, C; Moseley, MJ				Fielder, AR; Bentley, C; Moseley, MJ			Ophthalmology	BMJ-BRITISH MEDICAL JOURNAL			English	Review							QUALITY-OF-LIFE; EXTERNAL DACRYOCYSTORHINOSTOMY; CATARACT-EXTRACTION; VISUAL FUNCTION; SURGERY; GLAUCOMA; RETINOPATHY; PREMATURITY; AMBLYOPIA; VISION		Univ London Imperial Coll Sci Technol & Med, Western Eye Hosp, Sch Med, London NW1 5YE, England	Imperial College London	Fielder, AR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Western Eye Hosp, Sch Med, London NW1 5YE, England.	a.fielder@ic.ac.uk						Bagdoniene R, 1997, PROGR RETINOPATHY PR, P31; Baker M, 1998, LOST VISION OLDER VI; Booth A, 1997, BRIT J OPHTHALMOL, V81, P409, DOI 10.1136/bjo.81.5.409; BRUCE I, 1991, BLIND PARTIALLY SIGH, V1; Bullough J., 1996, Lighting Research and Technology, V28, P189; CAMPOS E, 1995, SURV OPHTHALMOL, V40, P23, DOI 10.1016/S0039-6257(95)80044-1; CUNNINGHAM S, 1995, LANCET, V346, P1464, DOI 10.1016/S0140-6736(95)92475-2; Desai P, 1996, BRIT J OPHTHALMOL, V80, P868, DOI 10.1136/bjo.80.10.868; FIELDER AR, 1995, BRIT J OPHTHALMOL, V79, P585, DOI 10.1136/bjo.79.6.585; Fitzgerald RG, 1998, BRIT MED J, V316, P1160, DOI 10.1136/bmj.316.7138.1160; FITZPATRICK RE, 1995, CLIN DERMATOL, V13, P35, DOI 10.1016/0738-081X(94)00025-W; FROST NA, IN PRESS OPHTHALMIC; Gilbert C, 1997, LANCET, V350, P12, DOI 10.1016/S0140-6736(97)01107-0; Hart PM, 1998, EYE, V12, P124, DOI 10.1038/eye.1998.20; Hoyng PFJ, 1997, SURV OPHTHALMOL, V41, pS93, DOI 10.1016/S0039-6257(97)80014-8; Javitt JC, 1997, OPHTHALMOLOGY, V104, P589, DOI 10.1016/S0161-6420(97)30265-6; Jones HS, 1996, BRIT J OPHTHALMOL, V80, P784, DOI 10.1136/bjo.80.9.784; KATZ GJ, 1995, OPHTHALMOLOGY, V102, P1263, DOI 10.1016/S0161-6420(95)30875-5; KHAW PT, 1994, EYE, V8, P188, DOI 10.1038/eye.1994.44; Laidlaw DAH, 1998, LANCET, V352, P925, DOI 10.1016/S0140-6736(97)12536-3; Lee PP, 1997, OPHTHALMOLOGY, V104, P390, DOI 10.1016/S0161-6420(97)30303-0; Lim JI, 1996, OPHTHALMOLOGY, V103, P1041, DOI 10.1016/S0161-6420(96)30569-1; MANGIONE CM, 1994, ARCH OPHTHALMOL-CHIC, V112, P1419, DOI 10.1001/archopht.1994.01090230033017; Moseley MJ, 1998, BRIT J OPHTHALMOL, V82, P722, DOI 10.1136/bjo.82.7.722; Reidy A, 1998, BRIT MED J, V316, P1643, DOI 10.1136/bmj.316.7145.1643; Reynolds JD, 1998, NEW ENGL J MED, V338, P1572, DOI 10.1056/NEJM199805283382202; *ROYAL NAT I BLIND, 1996, TK TIM TELL PAR THEI; SALIVE ME, 1994, J AM GERIATR SOC, V42, P287, DOI 10.1111/j.1532-5415.1994.tb01753.x; Shastry BS, 1997, ARCH OPHTHALMOL-CHIC, V115, P651, DOI 10.1001/archopht.1997.01100150653015; ShunShin GA, 1997, BRIT J OPHTHALMOL, V81, P716, DOI 10.1136/bjo.81.9.716; SHUTTLEWORTH GN, 1995, BRIT J OPHTHALMOL, V79, P719, DOI 10.1136/bjo.79.8.719; Smeeth L, 1998, BRIT MED J, V316, P660, DOI 10.1136/bmj.316.7132.660; SNOWDON SK, 1997, 9 NHS CTR REV DISS; STRAHLMAN E, 1995, ARCH OPHTHALMOL-CHIC, V113, P1009, DOI 10.1001/archopht.1995.01100080061030; TARBET KJ, 1995, OPHTHALMOLOGY, V102, P1065; Walters TR, 1996, SURV OPHTHALMOL, V41, pS19, DOI 10.1016/S0039-6257(96)82028-5; Wilkinson AR, 1996, EARLY HUM DEV, V46, P239	37	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	1999	318	7185					717	720						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182JK	10074021				2022-12-28	WOS:000079495700030
J	Merrill, C; Bayraktaroglu, L; Kusano, A; Ganetzky, B				Merrill, C; Bayraktaroglu, L; Kusano, A; Ganetzky, B			Truncated RanGAP encoded by the Segregation Distorter locus of Drosophila	SCIENCE			English	Article							NUCLEOCYTOPLASMIC TRANSPORT; SD LOCUS; MELANOGASTER; COMPONENTS; RESPONDER	Segregation Distorter (SD) in Drosophila melanogaster is a naturally occurring meiotic drive system in which the SD chromosome is transmitted from SD/SD+ males in vast: excess over its homolog owing to the induced dysfunction of SD+-bearing spermatids. The Sd Locus is the key distorting gene responsible for this phenotype. A genomic fragment from the Sd region conferred full distorting activity when introduced into the appropriate genetic background by germline transformation. The only functional product encoded by this fragment is a truncated version of the RanGAP nuclear transport protein. These results demonstrate that this mutant RanGAP is the functional Sd product.	Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Bayraktaroglu, L (corresponding author), Univ Wisconsin, Genet Lab, 445 Henry Mall, Madison, WI 53706 USA.							Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BRITTNACHER JG, 1983, GENETICS, V103, P659; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Dasso M, 1998, AM J HUM GENET, V63, P311, DOI 10.1086/301990; GANETZKY B, 1977, GENETICS, V86, P321; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; HARTL DL, 1974, GENETICS, V76, P477; HIRAIZUMI Y, 1980, GENETICS, V95, P693; Kobayashi M, 1997, J BIOL CHEM, V272, P13980, DOI 10.1074/jbc.272.21.13980; LYTTLE TW, 1993, TRENDS GENET, V9, P205, DOI 10.1016/0168-9525(93)90120-7; LYTTLE TW, 1991, ANNU REV GENET, V25, P511, DOI 10.1146/annurev.ge.25.120191.002455; Mahajan R, 1998, J CELL BIOL, V140, P259, DOI 10.1083/jcb.140.2.259; MCLEAN JR, 1994, GENETICS, V137, P201; MOORE MS, 1994, TRENDS BIOCHEM SCI, V19, P211, DOI 10.1016/0968-0004(94)90024-8; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; PIMPINELLI S, 1989, GENETICS, V121, P765; POWERS PA, 1991, GENETICS, V129, P133; Rush MG, 1996, BIOESSAYS, V18, P103, DOI 10.1002/bies.950180206; Saitoh H, 1997, TRENDS BIOCHEM SCI, V22, P374, DOI 10.1016/S0968-0004(97)01102-X; SANDLER L, 1960, GENETICS, V45, P1269; TEMIN RG, 1991, AM NAT, V137, P287, DOI 10.1086/285164; TOKUYASU KT, 1977, J ULTRA MOL STRUCT R, V58, P96, DOI 10.1016/S0022-5320(77)80011-7; WU CI, 1988, CELL, V54, P179, DOI 10.1016/0092-8674(88)90550-8	23	110	113	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	1999	283	5408					1742	1745		10.1126/science.283.5408.1742	http://dx.doi.org/10.1126/science.283.5408.1742			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175PF	10073941				2022-12-28	WOS:000079102800054
J	Cash, J; Boyd, K				Cash, J; Boyd, K			Blood transfusion: Bayer's initiative	LANCET			English	Editorial Material									Univ Edinburgh, Royal Infirm, Dept Med, Edinburgh EH3 9YW, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh	Cash, J (corresponding author), Otterburn Pk, Edinburgh EH14 1JX, Midlothian, Scotland.							AACH RD, 1980, ANN INTERN MED, V92, P539, DOI 10.7326/0003-4819-92-4-539; ALTER HJ, 1988, VIRAL HEPATITIS LIVE, P537; Busch M P, 1994, Curr Opin Hematol, V1, P438; *DAN COUNC ETH, 1998, 1977 ANN REP; *NUFF COUNC BIOETH, 1998, MENT DIS ETH ETH CON	5	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 27	1999	353	9154					691	692		10.1016/S0140-6736(98)90048-4	http://dx.doi.org/10.1016/S0140-6736(98)90048-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173DR	10073509				2022-12-28	WOS:000078966400007
J	Gottlieb, S				Gottlieb, S			Scientists develop vaccine strategy for peanut allergy	BRITISH MEDICAL JOURNAL			English	News Item																		Moffatt MF, 1999, NAT MED, V5, P380, DOI 10.1038/7374; Roy K, 1999, NAT MED, V5, P387, DOI 10.1038/7385	2	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 3	1999	318	7188					894	894		10.1136/bmj.318.7188.894	http://dx.doi.org/10.1136/bmj.318.7188.894			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185GV	10102841	Green Published			2022-12-28	WOS:000079660500013
J	Kosslyn, SM; Pascual-Leone, A; Felician, O; Camposano, S; Keenan, JP; Thompson, WL; Ganis, G; Sukel, KE; Alpert, NM				Kosslyn, SM; Pascual-Leone, A; Felician, O; Camposano, S; Keenan, JP; Thompson, WL; Ganis, G; Sukel, KE; Alpert, NM			The role of Area 17 in visual imagery: Convergent evidence from PET and rTMS	SCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; POSITRON EMISSION TOMOGRAPHY; OCCIPITAL CORTEX; PERCEPTION; CONNECTIVITY	Visual imagery is used in a wide range of mental activities, ranging from memory to reasoning, and also plays a role in perception proper. The contribution of early visual cortex, specifically Area 17, to Visual mental imagery was examined by the use of two convergent techniques. In one, subjects closed their eyes during positron emission tomography (PET) while they visualized and compared properties (for example, relative length) of sets of stripes. The results showed that when people perform this task, Area 17 is activated. In the other, repetitive transcranial magnetic stimulation (rTMS) was applied to medial occipital cortex before presentation of the same task. Performance was impaired after rTMS compared with a sham control condition; similar results were obtained when the subjects performed the task by actually Looking at the stimuli. In sum, the PET results showed that when patterns of stripes are visualized, Area 17 is activated, and the rTMS results showed that such activation underlies information processing.	Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Lab Magnet Brain Stimulat,Behav Neurol Unit, Boston, MA 02215 USA	Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kosslyn, SM (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	smk@wjh.harvard.edu	Pascual-Leone, Alvaro/G-6566-2011; Pascual-Leone, Alvaro/AAC-5101-2019; Felician, Olivier/F-1212-2011	Pascual-Leone, Alvaro/0000-0001-8975-0382; Felician, Olivier/0000-0002-1481-1846; Ganis, Giorgio/0000-0001-6175-2618	NEI NIH HHS [R01 EY12091] Funding Source: Medline; NIMH NIH HHS [R01 MH57980] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057980] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AMASSIAN VE, 1989, ELECTROEN CLIN NEURO, V74, P458, DOI 10.1016/0168-5597(89)90036-1; ARNASSIAN VE, 1998, J CLIN NEUROPHYSIOL, V15, P288; BECKERS G, 1995, BRAIN, V118, P49, DOI 10.1093/brain/118.1.49; BECKERS G, 1991, EXP BRAIN RES, V87, P421; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; DEsposito M, 1997, NEUROPSYCHOLOGIA, V35, P725, DOI 10.1016/S0028-3932(96)00121-2; FOX PT, 1986, NATURE, V323, P806, DOI 10.1038/323806a0; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; Ilmoniemi RJ, 1997, NEUROREPORT, V8, P3537, DOI 10.1097/00001756-199711100-00024; Kosslyn S.M., 1994, IMAGE BRAIN RESOLUTI; Kosslyn S. M., 1980, IMAGE MIND; Kosslyn SM, 1998, PSYCHOPHYSIOLOGY, V35, P151, DOI 10.1017/S0048577298001516; KOSSLYN SM, IN PRESS MEM COGNIT; MARSOLEK CJ, 1997, CERBRAL ASYMMETRIES; Mellet E, 1998, NEUROIMAGE, V8, P129, DOI 10.1006/nimg.1998.0355; MELLET E, 1995, J COGNITIVE NEUROSCI, V7, P433, DOI 10.1162/jocn.1995.7.4.433; MELLET E, IN PRESS NEUROIMAGE; PASCUALLEONE A, 1994, NEW HORIZONS COGNITI; PASCUALLEONE A, 1996, HDB NEUROPSYCHOLOGY, V11; Paus T, 1997, J NEUROSCI, V17, P3178; Potts GF, 1998, J CLIN NEUROPHYSIOL, V15, P344, DOI 10.1097/00004691-199807000-00006; Talairach J., 1988, COPLANAR STEREOTAXIC; THOMPSON WL, IN PRESS BRAIN MAPPI; TOOTELL RBH, 1982, SCIENCE, V218, P902, DOI 10.1126/science.7134981; Tye M., 1991, THE IMAGERY DEBATE; Walsh V, 1998, TRENDS COGN SCI, V2, P103, DOI 10.1016/S1364-6613(98)01134-6; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127	29	508	526	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	1999	284	5411					167	170		10.1126/science.284.5411.167	http://dx.doi.org/10.1126/science.284.5411.167			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182QE	10102821				2022-12-28	WOS:000079509000060
J	Steinberg, MH				Steinberg, MH			Management of sickle cell disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BONE-MARROW TRANSPLANTATION; FETAL HEMOGLOBIN PRODUCTION; RED-BLOOD-CELLS; GLOBIN GENE-EXPRESSION; K-CL COTRANSPORT; NEUROLOGIC COMPLICATIONS; ERYTHROCYTE DEHYDRATION; HYDROXYUREA THERAPY; ENDOTHELIAL-CELLS; PENICILLIN PROPHYLAXIS		Vet Adm Med Ctr, Jackson, MS 39216 USA; Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Mississippi; University of Mississippi Medical Center	Steinberg, MH (corresponding author), Vet Adm Med Ctr, 1500 E Woodrow Wilson Dr, Jackson, MS 39216 USA.			Steinberg, Martin/0000-0001-8800-8020				Abboud MR, 1996, BONE MARROW TRANSPL, V17, P405; ADAMS R, 1992, NEW ENGL J MED, V326, P605, DOI 10.1056/NEJM199202273260905; Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; AdamsGraves P, 1997, BLOOD, V90, P2041, DOI 10.1182/blood.V90.5.2041; ADRAGNA NC, 1994, BLOOD, V83, P553; Ahman H, 1996, PEDIATR INFECT DIS J, V15, P134, DOI 10.1097/00006454-199602000-00009; Atweh G. F., 1996, Blood, V88, p652A; Ballas Samir K., 1994, P745; BERKOWITZ LR, 1981, J CLIN INVEST, V68, P1215, DOI 10.1172/JCI110367; BERNAUDIN F, 1993, BONE MARROW TRANSPL, V12, P118; BERTLES JF, 1968, J CLIN INVEST, V47, P1731, DOI 10.1172/JCI105863; BLAU CA, 1993, BLOOD, V81, P529; Brichard B, 1996, J PEDIATR-US, V128, P241, DOI 10.1016/S0022-3476(96)70398-0; Bridges KR, 1996, BLOOD, V88, P4701, DOI 10.1182/blood.V88.12.4701.bloodjournal88124701; BRITTAIN HA, 1993, BLOOD, V81, P2137; BRUGNARA C, 1986, SCIENCE, V232, P388, DOI 10.1126/science.3961486; Brugnara C, 1996, J CLIN INVEST, V97, P1227, DOI 10.1172/JCI118537; BRUGNARA C, 1993, J CLIN INVEST, V92, P520, DOI 10.1172/JCI116597; BUCHANAN GR, 1986, AM J DIS CHILD, V140, P428, DOI 10.1001/archpedi.1986.02140190038020; Bunn HF, 1997, NEW ENGL J MED, V337, P762, DOI 10.1056/NEJM199709113371107; Campbell PJ, 1997, BRIT J HAEMATOL, V96, P77, DOI 10.1046/j.1365-2141.1997.d01-1974.x; Cao ZQ, 1996, J MOL BIOL, V256, P219, DOI 10.1006/jmbi.1996.0079; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Charache S, 1996, MEDICINE, V75, P300, DOI 10.1097/00005792-199611000-00002; Charache S, 1996, HEMATOL ONCOL CLIN N, V10, P1357, DOI 10.1016/S0889-8588(05)70406-8; CHESNEY PJ, 1995, J PEDIATR-US, V127, P526, DOI 10.1016/S0022-3476(95)70107-9; CLARK MR, 1982, J CLIN INVEST, V70, P1074, DOI 10.1172/JCI110695; Claster S, 1996, BLOOD, V88, P1951, DOI 10.1182/blood.V88.6.1951.bloodjournal8861951; COHEN AR, 1992, BLOOD, V79, P1657; DeFranceschi L, 1996, BLOOD, V87, P1188, DOI 10.1182/blood.V87.3.1188.bloodjournal8731188; DeFranceschi L, 1997, J CLIN INVEST, V100, P1847, DOI 10.1172/JCI119713; DEFRANCESCHI L, 1994, J CLIN INVEST, V93, P1670, DOI 10.1172/JCI117149; DEMONTALEMBERT M, 1994, BLOOD, V84, pA219; DESIMONE J, 1982, P NATL ACAD SCI-BIOL, V79, P4428, DOI 10.1073/pnas.79.14.4428; DiasDaMotta PM, 1996, BRIT J HAEMATOL, V93, P333, DOI 10.1046/j.1365-2141.1996.4951036.x; *DIV BLOOD DIS RES, 1995, NIH PUBL; DOVER GJ, 1994, BLOOD, V84, P339; ElHazmi MAF, 1995, ACTA HAEMATOL-BASEL, V94, P128; ELHAZMI MAF, 1992, ACTA HAEMATOL-BASEL, V88, P170; Embury SH, 1994, SICKLE CELL DIS BASI; FABRY ME, 1991, BLOOD, V78, P217; FALLETTA JM, 1995, J PEDIATR-US, V127, P685, DOI 10.1016/S0022-3476(95)70154-0; Ferster A, 1996, BLOOD, V88, P1960, DOI 10.1182/blood.V88.6.1960.bloodjournal8861960; FERSTER A, 1995, BLOOD, V86, P408, DOI 10.1182/blood.V86.1.408.bloodjournal861408; FERSTER A, 1993, BLOOD, V81, P1102; GASTON MH, 1986, NEW ENGL J MED, V314, P1593, DOI 10.1056/NEJM198606193142501; GEE BE, 1995, BLOOD, V85, P268, DOI 10.1182/blood.V85.1.268.bloodjournal851268; GLAUBER JG, 1991, MOL CELL BIOL, V11, P4690, DOI 10.1128/MCB.11.9.4690; GOLDBERG MA, 1990, NEW ENGL J MED, V323, P366, DOI 10.1056/NEJM199008093230602; Hackney AC, 1997, CLIN SCI, V92, P481, DOI 10.1042/cs0920481; Head CA, 1997, J CLIN INVEST, V100, P1193, DOI 10.1172/JCI119631; HEBBEL RP, 1980, J CLIN INVEST, V65, P154, DOI 10.1172/JCI109646; HELLER P, 1979, NEW ENGL J MED, V300, P1001, DOI 10.1056/NEJM197905033001801; Hofstra TC, 1996, BLOOD, V87, P4440, DOI 10.1182/blood.V87.10.4440.bloodjournal87104440; Jayabose S, 1996, J PEDIATR-US, V129, P559, DOI 10.1016/S0022-3476(96)70121-X; JOINER CH, 1993, AM J PHYSIOL, V264, pC251, DOI 10.1152/ajpcell.1993.264.2.C251; KARK JA, 1994, SEMIN HEMATOL, V31, P181; KIRKPATRICK DV, 1991, SEMIN HEMATOL, V28, P240; KOSHY M, 1988, NEW ENGL J MED, V319, P1447, DOI 10.1056/NEJM198812013192204; LEY TJ, 1983, BLOOD, V62, P370; Loukopoulos D, 1996, SEMIN HEMATOL, V33, P76; Najean Y, 1997, BLOOD, V89, P2319, DOI 10.1182/blood.V89.7.2319; Nand S, 1996, AM J HEMATOL, V52, P42, DOI 10.1002/(SICI)1096-8652(199605)52:1<42::AID-AJH7>3.0.CO;2-6; OBRIEN KL, 1996, PEDIATR RES 2, V39, pA160; Ohene-Frempong Kwaku, 1994, P423; ORRINGER EP, 1991, AM J PHYSIOL, V261, pC591, DOI 10.1152/ajpcell.1991.261.4.C591; Pegelow CH, 1997, AM J MED, V102, P171; PERRINE SP, 1993, NEW ENGL J MED, V328, P81, DOI 10.1056/NEJM199301143280202; PIOMELLI S, 1992, BONE MARROW TRANSPL, V10, P58; PLATT OS, 1984, J CLIN INVEST, V74, P652, DOI 10.1172/JCI111464; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; RODGERS GP, 1993, NEW ENGL J MED, V328, P73, DOI 10.1056/NEJM199301143280201; RODGERS GP, 1990, NEW ENGL J MED, V322, P1037, DOI 10.1056/NEJM199004123221504; Scott JP, 1996, J PEDIATR-US, V128, P820, DOI 10.1016/S0022-3476(96)70335-9; SEARS DA, 1978, AM J MED, V64, P1021, DOI 10.1016/0002-9343(78)90458-8; SETTY BNY, 1995, PEDIATR RES, V38, P95; SHER GD, 1995, NEW ENGL J MED, V332, P1606, DOI 10.1056/NEJM199506153322404; Steinberg MH, 1996, HEMOGLOBIN, V20, P1, DOI 10.3109/03630269609027906; Steinberg MH, 1997, BLOOD, V89, P1078, DOI 10.1182/blood.V89.3.1078; STEINBERG MH, 1991, NEW ENGL J MED, V324, P1369; Steinberg MH, 1997, BRIT J HAEMATOL, V98, P838, DOI 10.1046/j.1365-2141.1997.3173132.x; Styles LA, 1997, BLOOD, V89, P2554, DOI 10.1182/blood.V89.7.2554; SUGIHARA K, 1992, BLOOD, V80, P2634; SUGIHARA T, 1992, BLOOD, V80, P2374; THOMAS ED, 1991, SEMIN HEMATOL, V28, P260; Thomas PW, 1997, J CLIN EPIDEMIOL, V50, P121, DOI 10.1016/S0895-4356(96)00320-4; TRIADOU P, 1994, NOUV REV FR HEMATOL, V36, P367; VERMYLEN C, 1993, BONE MARROW TRANSPL, V12, P116; VERMYLEN C, 1988, LANCET, V1, P1427; VERMYLEN C, 1993, BLOOD REV, V7, P1, DOI 10.1016/0268-960X(93)90017-X; VICHINSKY E, 1988, PEDIATRICS, V81, P749; VICHINSKY EP, 1995, NEW ENGL J MED, V333, P206, DOI 10.1056/NEJM199507273330402; Vichinsky EP, 1997, BLOOD, V89, P1787, DOI 10.1182/blood.V89.5.1787.1787_1787_1792; VICHINSKY EP, 1990, NEW ENGL J MED, V322, P1617, DOI 10.1056/NEJM199006073222301; VOSKARIDOU E, 1995, BRIT J HAEMATOL, V89, P479, DOI 10.1111/j.1365-2141.1995.tb08352.x; Walters M C, 1996, Biol Blood Marrow Transplant, V2, P100; WALTERS MC, 1995, BLOOD, V85, P879, DOI 10.1182/blood.V85.4.879.bloodjournal854879; WEATHERALL D, 1992, BLOOD, V80, P1379; WICK TM, 1993, AM J HEMATOL, V42, P284, DOI 10.1002/ajh.2830420308; WOLFF D, 1988, J MEMBRANE BIOL, V106, P243, DOI 10.1007/BF01872162	101	399	421	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 1	1999	340	13					1021	1030		10.1056/NEJM199904013401307	http://dx.doi.org/10.1056/NEJM199904013401307			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182GA	10099145				2022-12-28	WOS:000079489800007
J	Abbasi, K				Abbasi, K			The World Bank and world health - Changing sides	BRITISH MEDICAL JOURNAL			English	Article									BMJ, London WC1H 9JR, England		Abbasi, K (corresponding author), BMJ, London WC1H 9JR, England.							BOORMAN J, 1998, GUARDIAN        1109; CAULFIELD C, 1997, MASTERS ILLUSION WOR, P311; GODLEE F, 1994, BRIT MED J, V309, P1424, DOI 10.1136/bmj.309.6966.1424; Logie D, 1997, BRIT MED J, V314, P1556, DOI 10.1136/bmj.314.7093.1556a; *WORLD BANK, 1997, SECT STRAT HLTH NUTR; *WORLD BANK, 1993, WORLD DEV REP 1993 I; *WORLD BANK, 1998, WORLD BANK ACT FISC; 1998, WORLD BANK       SPR, P1	8	36	37	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 27	1999	318	7187					865	869		10.1136/bmj.318.7187.865	http://dx.doi.org/10.1136/bmj.318.7187.865			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185DM	10092271	Green Published			2022-12-28	WOS:000079652900040
J	Bhat, MA; Izaddoost, S; Lu, Y; Cho, KO; Choi, KW; Bellen, HJ				Bhat, MA; Izaddoost, S; Lu, Y; Cho, KO; Choi, KW; Bellen, HJ			Discs lost, a novel multi-PDZ domain protein, establishes and maintains epithelial polarity	CELL			English	Article							DROSOPHILA-MELANOGASTER; CELL POLARITY; ZONULA ADHERENS; MUTATIONS; JUNCTIONS; CRUMBS; EXPRESSION; ARMADILLO; ADHESION; SEPTATE	Polarization of epithelial cells depends on a hierarchical process whereby specific membrane-associated proteins become targeted to specialized membrane domains. Here, we describe a novel Drosophila protein, Discs Lost (DLT), that plays a crucial role in the polarization of embryonic epithelia during cellular blastoderm formation. At subsequent stages of development, DLT interacts with the apical determinant Crumbs (CRB) and the laterally localized protein Neurexin IV (NRX IV). Mutations in dlt or double-stranded RNA interference lead to aberrant localization of CRB and NRX IV and cause a concomitant loss of epithelial cell polarity. Hence, DLT is required to establish and maintain cell polarity and participates in different molecular complexes that define apical and lateral membrane domains.	Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA	Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Bellen, HJ (corresponding author), Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA.	hbellen@bcm.tmc.edu	Choi, Kwang-Wook/C-1707-2011; Cho, Kyung-Ok/C-1705-2011; BHAT, MANZOOR/S-9273-2018	Choi, Kwang-Wook/0000-0002-8997-3065; Cho, Kyung-Ok/0000-0002-0760-2560; Bellen, Hugo/0000-0001-5992-5989; BHAT, MANZOOR/0000-0003-0989-1498				Anderson JM, 1996, CURR BIOL, V6, P382, DOI 10.1016/S0960-9822(02)00501-8; Balda MS, 1998, J CELL SCI, V111, P541; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; Bellen HJ, 1998, TRENDS NEUROSCI, V21, P444, DOI 10.1016/S0166-2236(98)01267-3; Bhat MA, 1996, CELL, V87, P1103, DOI 10.1016/S0092-8674(00)81804-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROWN NH, 1993, BIOESSAYS, V15, P383, DOI 10.1002/bies.950150604; CHOU TB, 1992, GENETICS, V131, P643; Cox RT, 1996, J CELL BIOL, V134, P133, DOI 10.1083/jcb.134.1.133; CUTFORTH T, 1994, CELL, V77, P1027, DOI 10.1016/0092-8674(94)90442-1; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hynes RO, 1996, DEV BIOL, V180, P402, DOI 10.1006/dbio.1996.0314; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; LEE JK, 1993, J CELL BIOL, V123, P1797, DOI 10.1083/jcb.123.6.1797; Littleton JT, 1997, J CELL BIOL, V137, P793, DOI 10.1083/jcb.137.4.793; Marfatia SM, 1997, J BIOL CHEM, V272, P24191, DOI 10.1074/jbc.272.39.24191; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Salzberg A, 1997, GENETICS, V147, P1723; SCHEJTER ED, 1993, ANNU REV CELL BIOL, V9, P67, DOI 10.1146/annurev.cellbio.9.1.67; SLITER TJ, 1989, GENETICS, V123, P327; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; TEPASS U, 1994, DEV BIOL, V161, P563, DOI 10.1006/dbio.1994.1054; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; Tepass U, 1997, BIOESSAYS, V19, P673, DOI 10.1002/bies.950190807; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; WANG M, 1994, MOL GEN GENET, V245, P598, DOI 10.1007/BF00282222; Ward RE, 1998, J CELL BIOL, V140, P1463, DOI 10.1083/jcb.140.6.1463; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; WODARZ A, 1993, MECH DEVELOP, V44, P175, DOI 10.1016/0925-4773(93)90066-7; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; WOODS DF, 1993, MECH DEVELOP, V44, P85, DOI 10.1016/0925-4773(93)90059-7; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; [No title captured]	43	232	238	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 19	1999	96	6					833	845		10.1016/S0092-8674(00)80593-0	http://dx.doi.org/10.1016/S0092-8674(00)80593-0			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	178ZY	10102271	Bronze			2022-12-28	WOS:000079300100010
J	Ruiz-Trillo, I; Riutort, M; Littlewood, DTJ; Herniou, EA; Baguna, J				Ruiz-Trillo, I; Riutort, M; Littlewood, DTJ; Herniou, EA; Baguna, J			Acoel flatworms: Earliest extant bilaterian metazoans, not members of Platyhelminthes	SCIENCE			English	Article							18S RDNA SEQUENCES; MAXIMUM-LIKELIHOOD; MOLECULAR CLOCK; RIBOSOMAL-RNA; DNA-SEQUENCES; EVOLUTION; PHYLA; LIFE; TREE	Because of their simple organization the Acoela have been considered to be either primitive bilaterians or descendants of coelomates through secondary loss of derived features. Sequence data of 18S ribosomal DNA genes from non-fast evolving species of acoels and other metazoans reveal that this group does not belong to the Platyhelminthes but represents the extant members of the earliest divergent Bilateria, an interpretation that is supported by recent studies on the embryonic cleavage pattern and nervous system of acoels. This study has implications for understanding the evolution of major body plans, and for perceptions of the Cambrian evolutionary explosion.	Nat Hist Museum, Dept Zool, London SW7 5BD, England; Univ Barcelona, Fac Biol, Dept Genet, E-08028 Barcelona, Spain	Natural History Museum London; University of Barcelona	Baguna, J (corresponding author), Nat Hist Museum, Dept Zool, Cromwell Rd, London SW7 5BD, England.	bagunya@porthos.bio.ub.es	Herniou, Elisabeth/B-3786-2016; Riutort, Marta/B-6441-2009; Littlewood, Tim/B-5230-2008; Ruiz-Trillo, Iñaki/H-3217-2019; Ruiz-Trillo, Iñaki/C-1360-2008	Herniou, Elisabeth/0000-0001-5362-6056; Riutort, Marta/0000-0002-2134-7674; Littlewood, Tim/0000-0002-2718-4001; Ruiz-Trillo, Iñaki/0000-0001-6547-5304; Ruiz-Trillo, Iñaki/0000-0001-6547-5304	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Ax P, 1996, MULTICELLULAR ANIMAL; AX P, 1963, LOWER METAZOA, P191; Ax P., 1987, PHYLOGENETIC SYSTEM; Ayala FJ, 1998, P NATL ACAD SCI USA, V95, P606, DOI 10.1073/pnas.95.2.606; Boyer BC, 1998, AM ZOOL, V38, P621; BOYER BC, 1971, J EXP ZOOL, V176, P97, DOI 10.1002/jez.1401760110; BRORNHARN L, 1998, P NATL ACAD SCI USA, V95, P12386; Brusca R.C., 1990, INVERTEBRATES; Carranza S, 1997, MOL BIOL EVOL, V14, P485, DOI 10.1093/oxfordjournals.molbev.a025785; Carranza S, 1996, MOL BIOL EVOL, V13, P824, DOI 10.1093/oxfordjournals.molbev.a025643; Conway-Morris S., 1998, CRUCIBLE CREATION; Ehlers U, 1985, PHYLOGENETISCHE SYST; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; GUTELL RR, 1985, PROG NUCLEIC ACID RE, V32, P155, DOI 10.1016/S0079-6603(08)60348-7; Hadzi J., 1963, EVOLUTION METAZOA; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Haszprunar G, 1996, J ZOOL SYST EVOL RES, V34, P41; HENRY JE, COMMUNICATION; Hyman L., 1951, INVERTEBRATES, VII; Jagersten G, 1972, EVOLUTION METAZOAN L; Karling T.G., 1974, P1; KATAYAMA T, 1993, ZOOL SCI, V10, P529; LI WH, 1987, NATURE, V326, P93, DOI 10.1038/326093a0; Littlewood DTJ, 1999, BIOL J LINN SOC, V66, P75, DOI 10.1111/j.1095-8312.1999.tb01918.x; Morris SC, 1998, BIOESSAYS, V20, P676, DOI 10.1002/(SICI)1521-1878(199808)20:8<676::AID-BIES11>3.0.CO;2-W; MORRIS SC, 1993, NATURE, V361, P219, DOI 10.1038/361219a0; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; OLSEN GJ, 1994, COMPUT APPL BIOSCI, V10, P41; PHILIPPE H, 1994, DEVELOPMENT, P15; RAFF RA, 1994, ANNU REV ECOL SYST, V25, P351, DOI 10.1146/annurev.es.25.110194.002031; Raikova OI, 1998, ZOOMORPHOLOGY, V118, P69, DOI 10.1007/s004350050058; REISINGER E, 1972, Zeitschrift fuer Zoologische Systematik und Evolutionsforschung, V10, P1; Reuter M, 1998, TISSUE CELL, V30, P57, DOI 10.1016/S0040-8166(98)80006-2; Rieger R, 1985, ORIGINS RELATIONSHIP, P101; RIEGER RM, 1994, AM ZOOL, V34, P484; Rieger RM, 1991, MICROSCOPIC ANATOMY, V3, P7; SALVINIPLAWEN LV, 1978, Z ZOOL SYST EVOL, V16, P40; Siewing R., 1980, Zoologische Jahrbuecher Abteilung fuer Anatomie und Ontogenie der Tiere, V103, P439; SMITH MR, 1986, IEEE T MED IMAGING, V5, P132, DOI 10.1109/TMI.1986.4307762; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Tyler S, 1985, ORIGINS RELATIONSHIP, P123; Valentine JW, 1997, P NATL ACAD SCI USA, V94, P8001, DOI 10.1073/pnas.94.15.8001; WILSON AC, 1977, ANNU REV BIOCHEM, V46, P573, DOI 10.1146/annurev.bi.46.070177.003041; WINNEPENNINCKX B, 1995, MOL BIOL EVOL, V12, P641; Wray GA, 1996, SCIENCE, V274, P568, DOI 10.1126/science.274.5287.568; Zrzavy J, 1998, CLADISTICS, V14, P249, DOI 10.1111/j.1096-0031.1998.tb00338.x	48	354	367	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	1999	283	5409					1919	1923		10.1126/science.283.5409.1919	http://dx.doi.org/10.1126/science.283.5409.1919			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177UC	10082465				2022-12-28	WOS:000079228600049
J	Winkleby, MA; Robinson, TN; Sundquist, J; Kraemer, HC				Winkleby, MA; Robinson, TN; Sundquist, J; Kraemer, HC			Ethnic variation in cardiovascular disease risk factors among children and young adults - Findings from the Third National Health and Nutrition Examination Survey, 1988-1994	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HISPANIC WHITE-CHILDREN; BODY-MASS INDEX; SOCIOECONOMIC-STATUS; DIABETES-MELLITUS; RACIAL-DIFFERENCES; MEXICAN-AMERICANS; BLOOD-PRESSURE; INSULIN; ADOLESCENTS; GROWTH	Context Knowledge about ethnic differences in cardiovascular disease (CVD) risk factors among children and young adults from national samples is limited. Objective To evaluate ethnic differences in CVD risk factors, the age at which differences were first apparent, and whether differences remained after accounting for socioeconomic status (SES). Design Third National Health and Nutrition Examination Survey, 1988-1994, Setting Eighty-nine mobile examination centers, Participants A total of 2769 black, 2854 Mexican American, and 2063 white (non-Hispanic) children and young adults aged 6 to 24 years. Main Outcome Measures Ethnicity and household level of education (SES) in relation to body mass index (BMI), percentage of energy from dietary fat, cigarette smoking, systolic blood pressure, glycosylated hemoglobin (HbA(1c)), and non-high-density lipoprotein cholesterol (non-HDL-C [the difference between total cholesterol and HDL-C]). Results The BMI levels were significantly higher for black and Mexican American girls than for white girls, with ethnic differences evident by the age of 6 to 9 years (a difference of approximately 0.5 BMI units) and widening thereafter (a difference of >2 BMI units among 18- to 24-year-olds). Percentages of energy from dietary fat paralleled these findings and were also significantly higher for black than for white boys. Blood pressure levels were higher for black girls than for white girls in every age group, and glycosylated hemoglobin levels were highest for black and Mexican American girls and boys in every age group. In contrast, smoking prevalence was highest for white girls and boys, especially for those from low-SES homes (77% of young men and 61% of young women, aged 18-24 years, from low-SES homes were current smokers). All ethnic differences remained significant after accounting for SES and age. Conclusion These findings show strong ethnic differences in CVD risk factors among youths of comparable age and SES from a large national sample. The differences highlight the need for heart disease prevention programs to begin early in childhood and continue throughout young adulthood to reduce the risk of atherosclerosis.	Stanford Univ, Sch Med, Stanford Ctr Res Dis Prevent, Dept Med, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Dept Pediat, Palo Alto, CA 94304 USA	Stanford University; Stanford University	Winkleby, MA (corresponding author), Stanford Univ, Sch Med, Stanford Ctr Res Dis Prevent, Dept Med, 1000 Welch Rd, Palo Alto, CA 94304 USA.	Marilyn_Winkleby@SCRDP.Stanford.edu			NHLBI NIH HHS [1-RO3-HL-57100] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL057100] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADLER NE, 1993, JAMA-J AM MED ASSOC, V269, P3140, DOI 10.1001/jama.269.24.3140; Andersen RE, 1998, JAMA-J AM MED ASSOC, V279, P938, DOI 10.1001/jama.279.12.938; [Anonymous], 1994, VITAL HLTH STAT, V1, P1; Bao WH, 1997, JAMA-J AM MED ASSOC, V278, P1749, DOI 10.1001/jama.278.21.1749; Batey LS, 1997, CIRCULATION, V96, P4319; BELCHER JD, 1993, PREV MED, V22, P143, DOI 10.1006/pmed.1993.1012; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; *BOG HEART STUD, 1995, AM J MED SCI, V310, pS1; BOYKO EJ, 1991, DIABETES, V40, P509, DOI 10.2337/diabetes.40.4.509; CUMMINGS SR, 1988, AM J PUBLIC HEALTH, V78, P574, DOI 10.2105/AJPH.78.5.574; Daniels SR, 1996, J PEDIATR-US, V129, P208, DOI 10.1016/S0022-3476(96)70244-5; Dietz WH, 1998, J PEDIATR-US, V132, P191; Dwyer JT, 1998, AM J CLIN NUTR, V67, P602, DOI 10.1093/ajcn/67.4.602; Ezzati T M, 1992, Vital Health Stat 2, P1; FOLSOM AR, 1989, AM J EPIDEMIOL, V130, P911, DOI 10.1093/oxfordjournals.aje.a115424; FORREST RD, 1987, DIABETIC MED, V4, P254, DOI 10.1111/j.1464-5491.1987.tb00875.x; GOFF DC, 1994, AM J EPIDEMIOL, V139, P474; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; HAFFNER SM, 1986, INT J OBESITY, V10, P493; HAVEL RJ, 1995, NEW ENGL J MED, V332, P1491, DOI 10.1056/NEJM199506013322207; HENDEE WR, 1991, JAMA-J AM MED ASSOC, V265, P248; JIANG XZ, 1995, ARCH INTERN MED, V155, P190, DOI 10.1001/archinte.155.2.190; JUDSON JJ, 1971, J AMER MED ASSOC, V216, P1185; Kaufman JS, 1997, EPIDEMIOLOGY, V8, P621, DOI 10.1097/00001648-199710000-00002; Kington RS, 1997, AM J PUBLIC HEALTH, V87, P805, DOI 10.2105/AJPH.87.5.805; KRIEGER N, 1993, AM J PUBLIC HEALTH, V83, P1086, DOI 10.2105/AJPH.83.8.1086; Liu K, 1996, CIRCULATION, V93, P60, DOI 10.1161/01.CIR.93.1.60; Lowry R, 1996, JAMA-J AM MED ASSOC, V276, P792, DOI 10.1001/jama.276.10.792; LYNCH J, 1995, CIRCULATION, V92, P1786, DOI 10.1161/01.CIR.92.7.1786; McNutt SW, 1997, J ADOLESCENT HEALTH, V20, P27, DOI 10.1016/S1054-139X(96)00176-0; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; NIETO FJ, 1992, AM J EPIDEMIOL, V136, P201, DOI 10.1093/oxfordjournals.aje.a116486; Peters AL, 1996, JAMA-J AM MED ASSOC, V276, P1246, DOI 10.1001/jama.276.15.1246; PinhasHamiel O, 1996, J PEDIATR-US, V128, P608, DOI 10.1016/S0022-3476(96)80124-7; RESNICOW K, 1990, AM J EPIDEMIOL, V132, P1083, DOI 10.1093/oxfordjournals.aje.a115751; Rockett HRH, 1997, AM J CLIN NUTR, V65, P1116; SHEA S, 1991, AM J EPIDEMIOL, V134, P567, DOI 10.1093/oxfordjournals.aje.a116130; Smith GD, 1998, BMJ-BRIT MED J, V316, P1631, DOI 10.1136/bmj.316.7145.1631; Srinivasan SR, 1996, METABOLISM, V45, P235, DOI 10.1016/S0026-0495(96)90060-8; STRONG JP, 1995, CLIN CHEM, V41, P134; Tortolero SR, 1997, CIRCULATION, V96, P418; TYROLER HA, 1984, AM HEART J, V108, P738, DOI 10.1016/0002-8703(84)90667-7; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; *US PHS, 1994, HLTH US; Wagenknecht LE, 1998, ANN EPIDEMIOL, V8, P301, DOI 10.1016/S1047-2797(97)00211-1; Webber LS, 1996, PREV MED, V25, P432, DOI 10.1006/pmed.1996.0075; WILLIAMS DR, 1995, ANNU REV SOCIOL, V21, P349, DOI 10.1146/annurev.so.21.080195.002025; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816; Winkleby MA, 1998, JAMA-J AM MED ASSOC, V280, P356, DOI 10.1001/jama.280.4.356; WINKLEBY MA, 1998, BIOMEDICINA, V1, P321	50	227	229	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	1999	281	11					1006	1013		10.1001/jama.281.11.1006	http://dx.doi.org/10.1001/jama.281.11.1006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	175EE	10086435	Bronze			2022-12-28	WOS:000079079400027
J	Black, D; Morris, JN; Smith, C; Townsend, P				Black, D; Morris, JN; Smith, C; Townsend, P			Better benefits for health: plan to implement the central recommendation of the Acheson report	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ London London Sch Econ & Polit Sci, Houghton St, London WC2A 2AE, England; Univ London London Sch Hyg & Trop Med, Hlth Promot Res Unit, London WC1E 7HT, England; Cornwall Gardens, London SW7 4AE, England	University of London; London School Economics & Political Science; University of London; London School of Hygiene & Tropical Medicine	Townsend, P (corresponding author), Univ London London Sch Econ & Polit Sci, Houghton St, London WC2A 2AE, England.							Acheson D., 1998, INDEPENDENT INQUIRY; Black D, 1980, INEQUALITIES HLTH RE; BRADSHAW J, 1997, BENEFITS, V18, P13; BRADSHAW J, 1996, BUDGET STANDARDS UK; CLARK T, 1998, TAXING CHILD BENEFIT; Cohen R., 1992, HARDSHIP BRITAIN BEI; *DEP SOC SERV, 1994, HOUS BEL AV INC; DILNOT A, 1998, EVIDENCE SOCIAL SECU; Gordon D., 1997, BREADLINE BRITAIN 19, DOI DOI 10.1080/09638280701602418; Haines A, 1997, BRIT MED J, V314, P529, DOI 10.1136/bmj.314.7080.529; HILLS J, 1998, INCOME WEALTH LATEST; JOWELL R, 1991, BRIT SOCIAL ATTITUDE; KEMPSON E, 1996, LIFE LOW INCOME; *NAT CHILDR HOM AC, 1998, FACTF 99; *NAT CHILDR HOM AC, 1995, FACTF 95; *OFF NAT STAT, 1998, FAM SPEND REP FAM EX; PARKER H, 1998, LOW COST ACCPTABLE M; Smith GD, 1998, BMJ-BRIT MED J, V317, P1465, DOI 10.1136/bmj.317.7171.1465; Smith GD, 1997, BMJ-BRIT MED J, V314, P547, DOI 10.1136/bmj.314.7080.547; SMITH GD, 1989, WIDENING HLTH GAP WH; *SOC EXCL UN, 1998, CM4045; TOWNSEND P, 1997, ABSOLUTE OVERALL POV; United Nations, 1995, COP DECL PROGR ACT W; WILKINSON RG, 1995, UNFAIR SHARES EFFECT	24	15	15	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	1999	318	7185					724	727		10.1136/bmj.318.7185.724	http://dx.doi.org/10.1136/bmj.318.7185.724			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182JK	10074023	Green Published			2022-12-28	WOS:000079495700032
J	Powell, CJ				Powell, CJ			Colonic toxicity from pancreatins: a contemporary safety issue	LANCET			English	Review							INDUCED GASTRIC TOXICITY; CYSTIC-FIBROSIS; ENZYME SUPPLEMENTS; ETHYL ACRYLATE; COLONOPATHY; STRICTURES; CHILDREN		St Bartholomews & Royal London Hosp, Sch Med & Dent, Dept Toxicol, London EC1M 6BQ, England	Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London	Powell, CJ (corresponding author), St Bartholomews & Royal London Hosp, Sch Med & Dent, Dept Toxicol, Charterhouse Sq, London EC1M 6BQ, England.							Bakowski MT, 1997, PHARMACOEPIDEM DR S, V6, P347, DOI 10.1002/(SICI)1099-1557(199709/10)6:5<347::AID-PDS305>3.0.CO;2-2; CAMPBELL CA, 1994, LANCET, V343, P109; FitzSimmons SC, 1997, NEW ENGL J MED, V336, P1283, DOI 10.1056/NEJM199705013361803; FREDERICK CB, 1990, TOXICOL PATHOL, V18, P247, DOI 10.1177/019262339001800203; Freiman JP, 1996, J PEDIATR GASTR NUTR, V22, P153, DOI 10.1097/00005176-199602000-00005; GHANAYEM BI, 1986, TOXICOL APPL PHARM, V83, P576, DOI 10.1016/0041-008X(86)90240-1; GHANAYEM BI, 1985, TOXICOL APPL PHARM, V80, P323, DOI 10.1016/0041-008X(85)90090-0; GHANAYEM BI, 1985, TOXICOL APPL PHARM, V80, P336, DOI 10.1016/0041-008X(85)90091-2; GOPINATH C, 1987, ATLAS EXPT PATHOLOGY, V13; HARRISON PTC, 1992, FOOD CHEM TOXICOL, V30, P333, DOI 10.1016/0278-6915(92)90012-A; Hausler M, 1998, AM J GASTROENTEROL, V93, P1171, DOI 10.1111/j.1572-0241.1998.00355.x; JONES R, 1995, LANCET, V346, P499, DOI 10.1016/S0140-6736(95)91346-7; KNABE N, 1994, LANCET, V343, P1230, DOI 10.1016/S0140-6736(94)92443-0; LEBENTHAL E, 1994, J PEDIATR GASTR NUTR, V18, P423, DOI 10.1097/00005176-199405000-00002; Lee J, 1997, ARCH DIS CHILD, V77, P66, DOI 10.1136/adc.77.1.66; Littlewood JM, 1996, POSTGRAD MED J, V72, pS2; *MCA, 1994, CURR PROBL PHARMACOV, V20, P13; *MCA, 1995, CURR PROBL PHARMACOV, V21, P11; Moss RL, 1998, PEDIATR SURG INT, V13, P168, DOI 10.1007/s003830050278; MURPHY JL, 1991, ARCH DIS CHILD, V66, P495, DOI 10.1136/adc.66.4.495; OADES PJ, 1994, LANCET, V343, P109, DOI 10.1016/S0140-6736(94)90836-2; OHARE MMT, 1995, J PEDIATR GASTR NUTR, V21, P59, DOI 10.1097/00005176-199507000-00010; ONG PS, 1995, POST GRAD MED J, V345, P752; Pawel BR, 1997, HUM PATHOL, V28, P395, DOI 10.1016/S0046-8177(97)90025-3; Pohl M, 1997, J PEDIATR GASTR NUTR, V25, P317, DOI 10.1097/00005176-199709000-00014; POSSELT HG, 1995, CONS C MAN CYST FIBR, P3; SCHWARZENBERG SJ, 1995, J PEDIATR-US, V127, P565, DOI 10.1016/S0022-3476(95)70113-3; SHUKLA AJ, 1994, HDB PHARM EXCIPIENTS; SMYTH RL, 1995, LANCET, V346, P1247, DOI 10.1016/S0140-6736(95)91860-4; SMYTH RL, 1994, LANCET, V343, P85, DOI 10.1016/S0140-6736(94)90817-6; Stevens JC, 1998, J PEDIATR GASTR NUTR, V26, P80, DOI 10.1097/00005176-199801000-00014; TAYLOR CJ, 1994, LANCET, V343, P615, DOI 10.1016/S0140-6736(94)92629-8; TAYLOR CJ, 1995, LANCET, V346, P1106, DOI 10.1016/S0140-6736(95)91783-7; TRECHOT PA, 1990, AM J GASTROENTEROL, V55, P330; vanVelzen D, 1996, POSTGRAD MED J, V72, pS39; VANVELZEN D, 1995, LANCET, V346, P499; 1997, PHARM TOXICOL S3, V80, P63; 1997, PHARM TOXICOL S3, V80, P70; 1997, PHARM TOXICOL S3, V80, P62	39	16	17	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 13	1999	353	9156					911	915		10.1016/S0140-6736(98)02023-6	http://dx.doi.org/10.1016/S0140-6736(98)02023-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BU	10093998				2022-12-28	WOS:000079421400043
J	Gimzewski, JK; Joachim, C				Gimzewski, JK; Joachim, C			Nanoscale science of single molecules using local probes	SCIENCE			English	Review							SCANNING-TUNNELING-MICROSCOPE; ATOMIC-FORCE MICROSCOPY; INDIVIDUAL MOLECULES; PHOTON-EMISSION; TIP; SPECTROSCOPY; SURFACE; IMAGES; WIRES; STM	Experiments on individual molecules using scanning probe microscopies have demonstrated an exciting diversity of physical, chemical, mechanical, and electronic phenomena. They have permitted deeper insight into the quantum electronics of molecular systems and have provided unique information on their conformational and mechanical properties. Concomitant developments in experimentation and theory have allowed a diverse range of molecules to be studied, varying in complexity from simple diatomics to biomolecular systems. At the Level of an individual molecule, the interplays of mechanical and electronical behavior and chemical properties manifest themselves in an unusually clear manner. In revealing the crucial role of thermal, stochastic, and quantum-tunneling processes, they suggest that dynamics is inescapable and may play a decisive role in the evolution of nanotechnology.	IBM Corp, Div Res, Zurich Res Lab, CH-8803 Ruschlikon, Switzerland; CNRS, Ctr Elaborat Mat & Etud Struct, F-31055 Toulouse, France	International Business Machines (IBM); Centre National de la Recherche Scientifique (CNRS)	Gimzewski, JK (corresponding author), IBM Corp, Div Res, Zurich Res Lab, CH-8803 Ruschlikon, Switzerland.			gimzewski, james/0000-0003-4333-6957				Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; Bartels L, 1997, PHYS REV LETT, V79, P697, DOI 10.1103/PhysRevLett.79.697; Bartels L, 1998, PHYS REV LETT, V80, P2004, DOI 10.1103/PhysRevLett.80.2004; Baselt DR, 1997, P IEEE, V85, P672, DOI 10.1109/5.573755; BERNDT R, 1993, SCIENCE, V262, P1425, DOI 10.1126/science.262.5138.1425; BINNIG G, 1987, REV MOD PHYS, V59, P615, DOI 10.1103/RevModPhys.59.615; BINNIG G, 1984, TRENDS PHYSICS, V1, P38; BINNING G, 1982, PHYS REV LETT, V49, P57, DOI 10.1103/PhysRevLett.49.57; Bouju X, 1997, PHYS REV B, V55, P16498, DOI 10.1103/PhysRevB.55.16498; Charra F, 1998, PHYS REV LETT, V80, P1682, DOI 10.1103/PhysRevLett.80.1682; CROMMIE MF, 1993, SCIENCE, V262, P219; Cuberes MT, 1997, SURF SCI, V383, P37, DOI 10.1016/S0039-6028(97)00156-8; CUBERES MT, 1997, SURF SCI, V371, P1231; Dujardin G, 1998, PHYS REV LETT, V80, P3085, DOI 10.1103/PhysRevLett.80.3085; DUJARDIN G, 1992, SCIENCE, V255, P1232, DOI 10.1126/science.255.5049.1232; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Feynman R.P., 1992, J MICROELECTROMECH S, V1, P60, DOI 10.1109/84.128057; FLORIN EL, 1994, SCIENCE, V264, P45; Fritz J, 1998, P NATL ACAD SCI USA, V95, P12283, DOI 10.1073/pnas.95.21.12283; GIMZEWSKI JK, 1987, SURF SCI, V181, P267, DOI 10.1016/0039-6028(87)90167-1; Gimzewski JK, 1998, SCIENCE, V281, P531, DOI 10.1126/science.281.5376.531; GIMZEWSKI JK, 1989, EUROPHYS LETT, V8, P435, DOI 10.1209/0295-5075/8/5/007; Gimzewski JK, 1997, SURF SCI, V386, P101, DOI 10.1016/S0039-6028(97)00301-4; GIMZEWSKI JK, 1989, MOL ELECT, P87; Hertel T, 1998, J PHYS CHEM B, V102, P910, DOI 10.1021/jp9734686; Hertel T, 1998, PHYS REV B, V58, P13870, DOI 10.1103/PhysRevB.58.13870; JAKLEVIC RC, 1966, PHYS REV LETT, V17, P1139, DOI 10.1103/PhysRevLett.17.1139; JOACHIM C, 1995, EUROPHYS LETT, V30, P409, DOI 10.1209/0295-5075/30/7/006; JOACHIM C, 1995, PHYS REV LETT, V74, P2102, DOI 10.1103/PhysRevLett.74.2102; Joachim C, 1998, P IEEE, V86, P184, DOI 10.1109/5.658770; Jung TA, 1996, SCIENCE, V271, P181, DOI 10.1126/science.271.5246.181; Jung TA, 1997, NATURE, V386, P696, DOI 10.1038/386696a0; JUNGE W, 1997, TRENDS BIOCHEM SCI, V22, P411; Kelly KF, 1996, SCIENCE, V273, P1371, DOI 10.1126/science.273.5280.1371; KHANNA SK, 1983, SCIENCE, V220, P1345, DOI 10.1126/science.220.4604.1345; Kolb DM, 1997, SCIENCE, V275, P1097, DOI 10.1126/science.275.5303.1097; Krishnan A, 1997, NATURE, V388, P451, DOI 10.1038/41284; LEE GU, 1994, LANGMUIR, V10, P354, DOI 10.1021/la00014a003; LEE GU, 1994, SCIENCE, V266, P771, DOI 10.1126/science.7973628; Magoga M, 1997, PHYS REV B, V56, P4722, DOI 10.1103/PhysRevB.56.4722; Marszalek PE, 1998, NATURE, V396, P661, DOI 10.1038/25322; Martel R, 1998, APPL PHYS LETT, V73, P2447, DOI 10.1063/1.122477; MCINTYRE BJ, 1994, SCIENCE, V265, P1415, DOI 10.1126/science.265.5177.1415; Moriarty P, 1998, SURF SCI, V407, P27, DOI 10.1016/S0039-6028(98)00082-X; OHTANI H, 1988, PHYS REV LETT, V60, P2398, DOI 10.1103/PhysRevLett.60.2398; PERSSON BNJ, 1987, PHYS REV LETT, V59, P339, DOI 10.1103/PhysRevLett.59.339; Porath D, 1997, J APPL PHYS, V81, P2241, DOI 10.1063/1.364275; Reed MA, 1997, SCIENCE, V278, P252, DOI 10.1126/science.278.5336.252; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1997, SCIENCE, V275, P1295, DOI 10.1126/science.275.5304.1295; Rief M, 1998, PHYS REV LETT, V81, P4764, DOI 10.1103/PhysRevLett.81.4764; Rochefort A, 1998, CHEM PHYS LETT, V297, P45, DOI 10.1016/S0009-2614(98)01105-1; SAUTET P, 1991, CHEM PHYS LETT, V185, P23, DOI 10.1016/0009-2614(91)80133-I; SHRODLINGER E, 1952, BR J PHILOS, P233; SMITH DPE, 1987, P NATL ACAD SCI USA, V84, P969, DOI 10.1073/pnas.84.4.969; SMITH DPE, 1987, J CHEM PHYS, V86, P6034, DOI 10.1063/1.452491; Stipe BC, 1998, SCIENCE, V279, P1907, DOI 10.1126/science.279.5358.1907; Stipe BC, 1998, PHYS REV LETT, V81, P1263, DOI 10.1103/PhysRevLett.81.1263; Stipe BC, 1998, SCIENCE, V280, P1732, DOI 10.1126/science.280.5370.1732; Stipe BC, 1997, PHYS REV LETT, V78, P4410, DOI 10.1103/PhysRevLett.78.4410; STROSCIO JA, 1991, SCIENCE, V254, P1319, DOI 10.1126/science.254.5036.1319; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Watanabe S, 1996, PHYS REV B, V54, P17308, DOI 10.1103/PhysRevB.54.R17308; Wildoer JWG, 1998, NATURE, V391, P59, DOI 10.1038/34139; Wintterlin J, 1997, SCIENCE, V278, P1931, DOI 10.1126/science.278.5345.1931; Wong SS, 1998, NATURE, V394, P52, DOI 10.1038/27873; Yazdani A, 1996, SCIENCE, V272, P1921, DOI 10.1126/science.272.5270.1921; Zambelli T, 1997, NATURE, V390, P495, DOI 10.1038/37329	68	551	569	3	209	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	1999	283	5408					1683	1688		10.1126/science.283.5408.1683	http://dx.doi.org/10.1126/science.283.5408.1683			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175PF	10073926				2022-12-28	WOS:000079102800039
J	Kampf, JP; Frank, CW; Malmstrom, EE; Hawker, CJ				Kampf, JP; Frank, CW; Malmstrom, EE; Hawker, CJ			Adaptation of bulk constitutive equations to insoluble monolayer collapse at the air-water interface	SCIENCE			English	Article							DENDRITIC MACROMOLECULES; ORIENTED POLYETHYLENE; PHASE-TRANSITIONS; LIGHT-SCATTERING; BEHAVIOR; CREEP; RELAXATION; NUCLEATION; POLYMER; SURFACE	A constitutive equation based on stress-strain models of bulk solids was adapted to relate the surface pressure, compression rate, and temperature of an insoluble monolayer of monodendrons during collapse at the air-water interface. power Law relation between compression rate and surface pressure and an Arrhenius temperature dependence of the steady-state creep rate were observed in data from compression rate and creep experiments in the collapse region. These relations were combined into a single constitutive equation to calculate the temperature dependence of the collapse pressure with a maximum error of 5 percent for temperatures ranging from 10 degrees to 25 degrees C.	Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; IBM Corp, Almaden Res Ctr, San Jose, CA 95120 USA	Stanford University; International Business Machines (IBM)	Frank, CW (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.		Hawker, Craig J/G-4971-2011; Malmström, Eva E/G-3026-2010	Hawker, Craig J/0000-0001-9951-851X; Malmström, Eva E/0000-0002-8348-2273; Kampf, James/0000-0003-3050-3998				ADAMS J, 1993, MACROMOLECULES, V26, P2871, DOI 10.1021/ma00063a036; BAGLIONI P, 1980, J COLLOID INTERF SCI, V78, P347, DOI 10.1016/0021-9797(80)90573-1; CARDENASVALERA AE, 1993, COLLOID SURFACE A, V79, P115, DOI 10.1016/0927-7757(93)80166-C; Cheung CY, 1997, J RHEOL, V41, P45, DOI 10.1122/1.550858; Copeland LE, 1942, J CHEM PHYS, V10, P357, DOI 10.1063/1.1723735; EARNSHAW JC, 1993, J PHYS-CONDENS MAT, V5, P1769, DOI 10.1088/0953-8984/5/12/005; EARNSHAW JC, 1990, J PHYS-CONDENS MAT, V2, P8499, DOI 10.1088/0953-8984/2/42/026; Edwards D.A., 1991, INTERFACIAL TRANSPOR; EVANS WJ, 1983, J MATER SCI, V18, P3449, DOI 10.1007/BF00544173; FINDLEY WN, 1989, CREE RELAXATION NONL; Forrest JA, 1997, PHYS REV E, V56, P5705, DOI 10.1103/PhysRevE.56.5705; Fried J.R., 1995, POLYM SCI TECHNOLOGY, P4; Friedenberg MC, 1996, MACROMOLECULES, V29, P705, DOI 10.1021/ma9507812; Frost H.J., 1982, DEFORMATION MECH MAP; Gaines GL, 1966, INSOLUBLE MONOLAYERS; GOVAERT LE, 1995, POLYMER, V36, P4425, DOI 10.1016/0032-3861(95)96848-3; GOVAERT LE, 1993, POLYMER, V34, P534, DOI 10.1016/0032-3861(93)90546-M; HALPERIN K, 1989, LANGMUIR, V5, P161, DOI 10.1021/la00085a030; HAWKER CJ, 1995, J AM CHEM SOC, V117, P4409, DOI 10.1021/ja00120a028; Hawker CJ, 1997, J AM CHEM SOC, V119, P9903, DOI 10.1021/ja972027x; HAWKER CJ, 1990, J AM CHEM SOC, V112, P7638, DOI 10.1021/ja00177a027; Kampf JP, 1999, LANGMUIR, V15, P227, DOI 10.1021/la980808l; KATO T, 1990, LANGMUIR, V6, P870, DOI 10.1021/la00094a027; KEDDIE JL, 1994, FARADAY DISCUSS, V98, P219, DOI 10.1039/fd9949800219; Kosterlitz JM, 1973, J PHYS C SOLID STATE, V6, P1181, DOI 10.1088/0022-3719/6/7/010; Krasowsky AJ, 1997, METALL MATER TRANS A, V28, P1831, DOI 10.1007/s11661-997-0113-7; KURI T, 1994, B CHEM SOC JPN, V67, P942, DOI 10.1246/bcsj.67.942; LEE WK, 1995, COLLOID SURFACE A, V102, P191, DOI 10.1016/0927-7757(95)03255-C; Maruyama T, 1998, LANGMUIR, V14, P1836, DOI 10.1021/la971047+; Maruyama T, 1996, SCIENCE, V274, P233, DOI 10.1126/science.274.5285.233; MEAGHER S, 1992, ACTA METALL MATER, V40, P159, DOI 10.1016/0956-7151(92)90209-W; NELSON DR, 1979, PHYS REV B, V19, P2457, DOI 10.1103/PhysRevB.19.2457; OBRIEN KC, 1985, LANGMUIR, V1, P453, DOI 10.1021/la00064a009; OIKAWA H, 1992, MAT SCI ENG A-STRUCT, V153, P427, DOI 10.1016/0921-5093(92)90232-P; PRAKASH O, 1992, ACTA METALL MATER, V40, P3443, DOI 10.1016/0956-7151(92)90058-M; Prucker O, 1998, MACROMOL CHEM PHYSIC, V199, P1435, DOI 10.1002/macp.1998.021990723; RAPP B, 1990, PHYS REV A, V42, P2215, DOI 10.1103/PhysRevA.42.2215; RETTER U, 1992, LANGMUIR, V8, P1693, DOI 10.1021/la00043a001; SEITZ M, 1996, THIN SOLID FILMS, V285, P304; Skarlupka R, 1998, POLYMER, V39, P387, DOI 10.1016/S0032-3861(97)00275-9; SPERLING LH, 1992, INTRO PHYSICALA POLY; TOMALIA DA, 1994, ADV MATER, V6, P529, DOI 10.1002/adma.19940060703; TOMOAIACOTISEL M, 1983, J COLLOID INTERF SCI, V94, P390, DOI 10.1016/0021-9797(83)90278-3; Uppuluri S, 1998, MACROMOLECULES, V31, P4498, DOI 10.1021/ma971199b; VOLLHARDT D, 1991, J PHYS CHEM-US, V95, P3723, DOI 10.1021/j100162a052; VOLLHARDT D, 1991, THIN SOLID FILMS, V199, P189, DOI 10.1016/0040-6090(91)90065-6; VOLLHARDT D, 1992, LANGMUIR, V8, P309, DOI 10.1021/la00037a056; Wagner J, 1996, LANGMUIR, V12, P2807, DOI 10.1021/la950962x; WANG LF, 1995, MATER CHEM PHYS, V40, P197, DOI 10.1016/0254-0584(94)01469-W; YOUNG AP, 1979, PHYS REV B, V19, P1855, DOI 10.1103/PhysRevB.19.1855	50	32	33	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	1999	283	5408					1730	1733		10.1126/science.283.5408.1730	http://dx.doi.org/10.1126/science.283.5408.1730			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175PF	10073937				2022-12-28	WOS:000079102800050
J	Tomoda, K; Kubota, Y; Kato, J				Tomoda, K; Kubota, Y; Kato, J			Degradation of the cyclin-dependent-kinase inhibitor p27(Kip1) is instigated by Jab1	NATURE			English	Article							CELL-CYCLE; CDK INHIBITOR; PROTEIN; PHOSPHORYLATION; GENE; BINDING; ARREST; CRM1; BETA; P27	The proliferation of mammalian cells is under strict control, and the cyclin-dependent-kinase inhibitory protein p27(Kip1) is an essential participant in this regulation both in vitro and in vivo(1). Although mutations in p27(Kip1) are rarely found in human tumours, reduced expression of the protein correlates well with poor survival among patients with breast or colorectal carcinomas(2), suggesting that disruption of the p27(Kip1) regulatory mechanisms contributes to neoplasia. The abundance of p27(Kip1) in the cell is determined either at or after translation(3), for example as a result of phosphorylation by cyclinE/Cdk2 complexes(4,5), degradation by the ubiquitin/proteasome pathway(6), sequestration by unknown Myc-inducible proteins(7), binding to cyclinD/Cdk4 complexes(8), or inactivation by the viral ElA oncoprotein(9). We have found that a mouse 38K protein (p38) encoded by the Jab1 gene(10) interacts specifically with p27(Kip1) and show here that ol overexpression of p38 in mammalian cells causes the translocation of p27(Kip1) from the nucleus to the cytoplasm, decreasing the amount of p27(Kip1) in the cell by accelerating its degradation. Ectopic expression of p38 in mouse fibroblasts partially overcomes p27(Kip1)-mediated arrest in the G1 phase of the cell cycle and markedly reduces their dependence on serum. Our findings indicate that p38 functions as a negative regulator of p27(Kip1) by promoting its degradation.	Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan	Nara Institute of Science & Technology	Kato, J (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Nara 6300101, Japan.	jkata@bs.aist-nara.ac.jp						Akamatsu E, 1998, J BIOL CHEM, V273, P16494, DOI 10.1074/jbc.273.26.16494; Asano K, 1997, J BIOL CHEM, V272, P27042, DOI 10.1074/jbc.272.43.27042; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Fukuda M, 1997, J BIOL CHEM, V272, P32642, DOI 10.1074/jbc.272.51.32642; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; HARPER JW, 1993, CELL, V75, P805; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; HIRAI H, 1995, MOL CELL BIOL, V15, P2672; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; KATO J, 1993, GENE DEV, V7, P331; Mal A, 1996, NATURE, V380, P262, DOI 10.1038/380262a0; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; NISHI K, 1994, J BIOL CHEM, V269, P6320; OGAWA H, 1995, P NATL ACAD SCI USA, V92, P11899, DOI 10.1073/pnas.92.25.11899; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Seeger M, 1998, FASEB J, V12, P469, DOI 10.1096/fasebj.12.6.469; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Steeg PS, 1997, NAT MED, V3, P152, DOI 10.1038/nm0297-152; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Vlach J, 1996, EMBO J, V15, P6595, DOI 10.1002/j.1460-2075.1996.tb01050.x; Wei N, 1998, CURR BIOL, V8, P919, DOI 10.1016/S0960-9822(07)00372-7	30	550	584	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	1999	398	6723					160	165		10.1038/18230	http://dx.doi.org/10.1038/18230			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176DG	10086358				2022-12-28	WOS:000079135200047
J	Murray, HL; Jarrell, KA				Murray, HL; Jarrell, KA			Flipping the switch to an active spliceosome	CELL			English	Review							U5 SNRNP; PROTEIN FAMILY; RNA		Boston Univ, Med Ctr, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA	Boston University	Jarrell, KA (corresponding author), Boston Univ, Med Ctr, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA.	jarrell@bu.edu						Achsel T, 1998, MOL CELL BIOL, V18, P6756, DOI 10.1128/MCB.18.11.6756; Auble DT, 1997, MOL CELL BIOL, V17, P4842, DOI 10.1128/MCB.17.8.4842; Burge CB, 1999, RNA WORLD, P525; HEINRICHS V, 1990, SCIENCE, V247, P69, DOI 10.1126/science.2136774; Kuhn AN, 1999, MOL CELL, V3, P65, DOI 10.1016/S1097-2765(00)80175-6; Lauber J, 1996, EMBO J, V15, P4001, DOI 10.1002/j.1460-2075.1996.tb00774.x; Li ZR, 1996, RNA, V2, P879; LOSSKY M, 1987, CELL, V51, P1019, DOI 10.1016/0092-8674(87)90588-5; Reyes J, 1996, RNA, V2, P213; Staley JP, 1999, MOL CELL, V3, P55, DOI 10.1016/S1097-2765(00)80174-4; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Teigelkamp S, 1997, RNA, V3, P1313; West SC, 1998, CELL, V94, P699, DOI 10.1016/S0092-8674(00)81729-8; Xie J, 1998, EMBO J, V17, P2938, DOI 10.1093/emboj/17.10.2938	14	30	30	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	1999	96	5					599	602		10.1016/S0092-8674(00)80568-1	http://dx.doi.org/10.1016/S0092-8674(00)80568-1			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	174TB	10089873	hybrid			2022-12-28	WOS:000079050100001
J	Jordan, J; Shannon, JR; Grogan, E; Biaggioni, T; Robertson, D				Jordan, J; Shannon, JR; Grogan, E; Biaggioni, T; Robertson, D			A potent pressor response elicited by drinking water	LANCET			English	Article									Vanderbilt Univ, Autonom Dysfunct Ctr, Nathan Blaser Shy Drager Res Program, Nashville, TN 37232 USA; Franz Volhard Clin, Clin Res Ctr, Berlin, Germany	Vanderbilt University; Franz-Volhard Clinical Research Center	Robertson, D (corresponding author), Vanderbilt Univ, Autonom Dysfunct Ctr, Nathan Blaser Shy Drager Res Program, Nashville, TN 37232 USA.	david.robertson@mcmail.vanderbilt.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS033460] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00095] Funding Source: Medline; NHLBI NIH HHS [P01 HL 56693] Funding Source: Medline; NINDS NIH HHS [1U01NS33460] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CRYER PE, 1976, NEW ENGL J MED, V295, P573, DOI 10.1056/NEJM197609092951101; HOFFMAN WE, 1977, P SOC EXP BIOL MED, V154, P121, DOI 10.3181/00379727-154-39617a; ROBERTSON D, 1978, NEW ENGL J MED, V298, P181, DOI 10.1056/NEJM197801262980403; Schatz IJ, 1996, J AUTONOM NERV SYST, V58, P123	4	151	158	1	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 27	1999	353	9154					723	723		10.1016/S0140-6736(99)99015-3	http://dx.doi.org/10.1016/S0140-6736(99)99015-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173DR	10073520				2022-12-28	WOS:000078966400018
J	Raju, TNK				Raju, TNK			The Nobel chronicles - 1943: Henrik Carl Peter Dam (1895-1976); and Edward Adelbert Doisy (1893-1986)	LANCET			English	Article									Univ Illinois, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Raju, TNK (corresponding author), Univ Illinois, Chicago, IL 60680 USA.								0	3	3	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 27	1999	353	9154					761	761		10.1016/S0140-6736(05)76139-0	http://dx.doi.org/10.1016/S0140-6736(05)76139-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173DR	10073554				2022-12-28	WOS:000078966400072
J	Pittenger, MF; Mackay, AM; Beck, SC; Jaiswal, RK; Douglas, R; Mosca, JD; Moorman, MA; Simonetti, DW; Craig, S; Marshak, DR				Pittenger, MF; Mackay, AM; Beck, SC; Jaiswal, RK; Douglas, R; Mosca, JD; Moorman, MA; Simonetti, DW; Craig, S; Marshak, DR			Multilineage potential of adult human mesenchymal stem cells	SCIENCE			English	Article							HUMAN MARROW; IN-VIVO; PRECURSOR CELLS; STROMAL CELLS; BONE; DIFFERENTIATION; TRANSPLANTATION; DEXAMETHASONE; CARTILAGE; INVITRO	Human mesenchymal stem cells are thought to be multipotent cells, which are present in adult marrow, that can replicate as undifferentiated cells and that have the potential to differentiate to Lineages of mesenchymal tissues, including bone; cartilage, fat, tendon, muscle, and marrow stroma. Cells that have the characteristics of human mesenchymal stem cells were isolated from marrow aspirates of volunteer donors. These cells displayed a stable phenotype and remained as a monolayer in vitro. These adult stem cells could be induced to differentiate exclusively into the adipocytic, chondrocytic, or osteocytic Lineages. Individual stem cells were identified that, when expanded to colonies, retained their multilineage potential.	Osiris Therapeut, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA	Osiris Therapeutics; Johns Hopkins University	Pittenger, MF (corresponding author), Osiris Therapeut, 2001 Aliceanna St, Baltimore, MD 21231 USA.	mpittenger@osiristx.com						ASHTON BA, 1980, CLIN ORTHOP RELAT R, P294; BAB I, 1984, CLIN ORTHOP RELAT R, P243; BELLOWS CG, 1989, DEV BIOL, V133, P8, DOI 10.1016/0012-1606(89)90291-1; Bergman RJ, 1996, J BONE MINER RES, V11, P568; Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F; Bruder SP, 1998, CLIN ORTHOP RELAT R, pS247; Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Cassiede P, 1996, J BONE MINER RES, V11, P1264; CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277; CIVIN CI, 1984, J IMMUNOL, V133, P157; Cui Q, 1997, J BONE JOINT SURG AM, V79A, P1054, DOI 10.2106/00004623-199707000-00012; Dennis JE, 1996, CONNECT TISSUE RES, V35, P93, DOI 10.3109/03008209609029179; FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x; FRIEDENSTEIN AJ, 1976, INT REV CYTOL, V47, P327, DOI 10.1016/S0074-7696(08)60092-3; GRIGORIADIS AE, 1988, J CELL BIOL, V106, P2139, DOI 10.1083/jcb.106.6.2139; HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3; HAYNESWORTH SE, 1992, BONE, V13, P69, DOI 10.1016/8756-3282(92)90363-2; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kadiyala S, 1997, CELL TRANSPLANT, V6, P125, DOI 10.1016/S0963-6897(96)00279-5; Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335; LEBOY PS, 1991, J CELL PHYSIOL, V146, P370, DOI 10.1002/jcp.1041460306; Lennon DP, 1996, IN VITRO CELL DEV-AN, V32, P602; LORD BI, 1996, STEM CELLS, P401; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; MAUJUDAR MK, 1998, J CELL PHYSL, V176, P57; OWEN M, 1988, CIBA F SYMP, V136, P42, DOI 10.1002/9780470513637.ch4; PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857; Pittenger M.F., 1998, U.S. Patent, Patent No. [5,827,740, 5827740]; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; SRINIVAS GR, 1993, J IMMUNOL METHODS, V159, P53, DOI 10.1016/0022-1759(93)90141-S; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; WAKITANI S, 1995, MUSCLE NERVE, V18, P1417, DOI 10.1002/mus.880181212; WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013; Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004; Young RG, 1998, J ORTHOPAED RES, V16, P406, DOI 10.1002/jor.1100160403	39	16061	18546	51	2598	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	1999	284	5411					143	147		10.1126/science.284.5411.143	http://dx.doi.org/10.1126/science.284.5411.143			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182QE	10102814				2022-12-28	WOS:000079509000053
J	Tsiantis, M; Schneeberger, R; Golz, JF; Freeling, M; Langdale, JA				Tsiantis, M; Schneeberger, R; Golz, JF; Freeling, M; Langdale, JA			The maize rough sheath2 gene and leaf development programs in monocot and dicot plants	SCIENCE			English	Article							HOMEO BOX GENE; ECTOPIC EXPRESSION; ARABIDOPSIS; KNOTTED-1; MERISTEM; MUTATION; LEAVES; BARLEY; MUTANT; FATES	Leaves of higher plants develop in a sequential manner from the shoot apical meristem. previously it was determined that perturbed Leaf development in maize rough sheath2 (rs2) mutant plants results from ectopic expression of knotted1-like (knox) homeobox genes. Here, the rs2 gene sequence was found to be similar to the Antirrhinum PHANTASTICA (PHAN) gene sequence, which encodes a Myb-Like transcription factor. RS2 and PHAN are both required to prevent the accumulation of knox gene products in maize and Antirrhinum leaves, respectively. However, rs2 and phan mutant phenotypes differ, highlighting fundamental differences in monocot and dicot leaf development programs.	Univ Oxford, Dept Plant Sci, Oxford OX1 3BR, England; Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JH, Midlothian, Scotland	University of Oxford; University of California System; University of California Berkeley; University of Edinburgh	Langdale, JA (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3BR, England.		Langdale, Jane A./AAE-8343-2019; Golz, John F./H-4290-2019	Golz, John F./0000-0001-9478-5459; Langdale, Jane/0000-0001-7648-3924	NIGMS NIH HHS [GM14578, GM42610] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM014578] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chuck G, 1996, PLANT CELL, V8, P1277, DOI 10.1105/tpc.8.8.1277; Eichler A. W., 1861, ENTWICKELUNGSGESCHIC; FREELING M, 1992, DEV BIOL, V153, P44, DOI 10.1016/0012-1606(92)90090-4; HARAVEN D, 1996, CELL, V84, P735; JACKSON D, 1994, DEVELOPMENT, V120, P404; KAPLAN DR, 1973, Q REV BIOL, V48, P437, DOI 10.1086/407703; Kerstetter RA, 1997, DEVELOPMENT, V124, P3045; LINCOLN C, 1994, PLANT CELL, V6, P1859, DOI 10.1105/tpc.6.12.1859; Muehlbauer GJ, 1997, DEVELOPMENT, V124, P5097; MULLER KJ, 1995, NATURE, V374, P727, DOI 10.1038/374727a0; POETHIG S, 1984, CONT PROBLEMS PLANT, P235; Scanlon MJ, 1996, DEVELOPMENT, V122, P1683; Schneeberger R, 1998, DEVELOPMENT, V125, P2857; SCHNEEBERGER RG, 1995, GENE DEV, V9, P2292, DOI 10.1101/gad.9.18.2292; SINHA NR, 1993, GENE DEV, V7, P787, DOI 10.1101/gad.7.5.787; SMITH LG, 1992, DEVELOPMENT, V116, P21; TSIANTIS M, UNPUB; WAITES R, 1995, DEVELOPMENT, V121, P2143; Waites R, 1998, CELL, V93, P779, DOI 10.1016/S0092-8674(00)81439-7; WAITES R, UNPUB; WilliamsCarrier RE, 1997, DEVELOPMENT, V124, P3737	21	243	256	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 2	1999	284	5411					154	156		10.1126/science.284.5411.154	http://dx.doi.org/10.1126/science.284.5411.154			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182QE	10102817				2022-12-28	WOS:000079509000056
J	Whitesides, GM; Ismagilov, RF				Whitesides, GM; Ismagilov, RF			Complexity in chemistry	SCIENCE			English	Editorial Material							OSCILLATORY KINETICS; MOLECULES; DYNAMICS; SHAPE	"Complexity" is a subject that is beginning to be important in chemistry. Historically, chemistry has emphasized the approximation of complex nonlinear processes by simpler Linear ones. Complexity is becoming a profitable approach to a wide range of problems, especially the understanding of Life.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University	Whitesides, GM (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	gwhitesides@gmwgroup.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030367, R37GM030367] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM30367] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alberts B, 1995, MOL BIOL CELL; Alivisatos AP, 1998, ADV MATER, V10, P1297; Arkin A, 1997, SCIENCE, V277, P1275, DOI 10.1126/science.277.5330.1275; BAK P, 1995, P NATL ACAD SCI USA, V92, P6689, DOI 10.1073/pnas.92.15.6689; Beale R, 1991, NEURAL COMPUTING INT; Blankenstein G, 1998, BIOSENS BIOELECTRON, V13, P427, DOI 10.1016/S0956-5663(97)00109-7; Bramwell ST, 1998, NATURE, V396, P552, DOI 10.1038/25083; CARROLL FA, 1998, PERSPECTIVES STRUCTU; Ehrfeld W, 1998, TOP CURR CHEM, V194, P233; Epstein IR, 1996, J PHYS CHEM-US, V100, P13132, DOI 10.1021/jp953547m; ERTL G, 1991, SCIENCE, V254, P1750, DOI 10.1126/science.254.5039.1750; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Goldbeter A., 1996, BIOCH OSCILLATIONS C; GRAHAM MD, 1994, SCIENCE, V264, P80, DOI 10.1126/science.264.5155.80; Hendrickson J B, 1976, Top Curr Chem, V62, P49; HOFFMANN RW, 1992, ANGEW CHEM INT EDIT, V31, P1124, DOI 10.1002/anie.199211241; IMBIHL R, 1995, CHEM REV, V95, P697, DOI 10.1021/cr00035a012; L'vov VS, 1998, NATURE, V396, P519, DOI 10.1038/24998; Lu HP, 1997, NATURE, V385, P143, DOI 10.1038/385143a0; Mainzer K., 1997, THINKING COMPLEXITY; Mezey PG, 1997, INT REV PHYS CHEM, V16, P361, DOI 10.1080/014423597230226; Nie SM, 1997, ANNU REV BIOPH BIOM, V26, P567, DOI 10.1146/annurev.biophys.26.1.567; Schreiber I, 1996, J PHYS CHEM-US, V100, P8556, DOI 10.1021/jp952853x; Steinfeld J.I., 1999, CHEM KINETICS DYNAMI; Stryer L., 1995, BIOCHEMISTRY-US, V4th ed.; Sussman JL, 1998, ACTA CRYSTALLOGR D, V54, P1078, DOI 10.1107/S0907444998009378; Thompson LA, 1996, CHEM REV, V96, P555, DOI 10.1021/cr9402081; Whitlock HW, 1998, J ORG CHEM, V63, P7982, DOI 10.1021/jo9814546; WOLYNES PG, 1992, ACCOUNTS CHEM RES, V25, P513, DOI 10.1021/ar00023a005; XIE XS, 1994, SCIENCE, V265, P361, DOI 10.1126/science.265.5170.361; ZAIKIN AN, 1970, NATURE, V225, P535, DOI 10.1038/225535b0; ZOMETZER SF, 1990, INTRO NEURAL ELECT N; Zykov VS, 1998, PHYS REV LETT, V81, P2811, DOI 10.1103/PhysRevLett.81.2811	33	257	268	0	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	1999	284	5411					89	92		10.1126/science.284.5411.89	http://dx.doi.org/10.1126/science.284.5411.89			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182QE	10102824	Green Accepted			2022-12-28	WOS:000079509000037
J	Chitsike, I; van Furth, R				Chitsike, I; van Furth, R			Paralytic poliomyelitis associated with live oral poliomyelitis vaccine in child with HIV infection in Zimbabwe: case report	BRITISH MEDICAL JOURNAL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIBODY-RESPONSE; TETANUS; DIPHTHERIA	Objective To describe a complication of oral vaccination with live, attenuated poliomyelitis virus in a child infected with HIV. Design Case report. Setting Teaching hospital in Harare, Zimbabwe. Subjects A boy of 41/2 years and his mother. Main outcome measures. Results of clinical and laboratory investigations. Results Two weeks after receiving the second dose of oral poliomyelitis vaccine during national immunisation days the child developed paralysis of the right leg. He had a high titre of antibodies against poliovirus type 2, as well as antibodies against HIV-1, a low CD4 count, a ratio of CD4 to CD8 count of 0.47, and hypergammaglobulinaemia. He did not have any antibodies against diphtheria, tetanus, or poliovirus types 1 and 3, although he had been given diphtheria, tetanus, and pertussis and oral polio vaccines during his first year and a booster of the diphtheria, tetanus, and pertussis vaccine at 24 months. He had no clinical symptoms of AIDS, but his mother had AIDS and tuberculosis. Conclusion Paralytic poliomyelitis in this child with HIV infection was caused by poliovirus type 2 after oral poliomyelitis vaccine.	Univ Zimbabwe, Sch Med, Dept Paediat, Harare, Zimbabwe; Univ Zimbabwe, Sch Med, Dept Immunol, Harare, Zimbabwe	University of Zimbabwe; University of Zimbabwe	van Furth, R (corresponding author), Oud Poelgeest 44, NL-2341 NL Oegstgeest, Netherlands.	RvanFurth@thuisnet.leidenuniv.nl						[Anonymous], 1994, WKLY EPIDEMIOL REC, V69, P273; BARBI M, 1992, AIDS, V6, P1465, DOI 10.1097/00002030-199212000-00007; GOMO ZAR, 1992, CENT AFR J MED, V38, P281; IONNEDELCU N, 1994, LANCET, V343, P51, DOI 10.1016/S0140-6736(94)90903-2; KROON FP, 1995, CLIN INFECT DIS, V21, P1197, DOI 10.1093/clinids/21.5.1197; MCLAUGHLIN M, 1988, PEDIATRICS, V82, P229; NIKOWANE BM, 1987, JAMA-J AM MED ASSOC, V257, P1335; ROBERTSON SE, 1993, POLIOMYELITIS, V16, P1; RYDER RW, 1993, J PEDIATR-US, V122, P697, DOI 10.1016/S0022-3476(06)80007-7; STREBEL PM, 1992, CLIN INFECT DIS, V14, P568, DOI 10.1093/clinids/14.2.568; VANNIEKERK ABW, 1994, LANCET, V343, P51, DOI 10.1016/S0140-6736(94)90902-4; WRIGHT PF, 1991, NEW ENGL J MED, V325, P1774, DOI 10.1056/NEJM199112193252504; 1993, WKLY EPIDEMIOL REC, V68, P264	13	28	31	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 27	1999	318	7187					841	843		10.1136/bmj.318.7187.841	http://dx.doi.org/10.1136/bmj.318.7187.841			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185DM	10092261	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000079652900024
J	Stephen, LJ; Maxwell, JE; Brodie, MJ				Stephen, LJ; Maxwell, JE; Brodie, MJ			Transient hemiparesis with topiramate	BRITISH MEDICAL JOURNAL			English	Letter									Univ Glasgow, Western Infirm, Dept Med & Therapeut, Epilepsy Unit, Glasgow G11 6NT, Lanark, Scotland	University of Glasgow	Stephen, LJ (corresponding author), Univ Glasgow, Western Infirm, Dept Med & Therapeut, Epilepsy Unit, Glasgow G11 6NT, Lanark, Scotland.							Dichter MA, 1996, NEW ENGL J MED, V334, P1583, DOI 10.1056/NEJM199606133342407; WILSON EA, 1996, MODERN MANAGEMENT EP, P723	2	7	8	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 27	1999	318	7187					845	845		10.1136/bmj.318.7187.845	http://dx.doi.org/10.1136/bmj.318.7187.845			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185DM	10092263	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000079652900027
J	Wilkin, TJ				Wilkin, TJ			Changing perceptions in osteoporosis	BRITISH MEDICAL JOURNAL			English	Article							BONE-MINERAL DENSITY; BIOCHEMICAL MARKERS; HIP FRACTURE; WOMEN; RISK; ALENDRONATE; TURNOVER; CALCIUM		Univ Plymouth, Plymouth Postgrad Med Sch, Plymouth PL4 8AA, Devon, England	University of Plymouth	Wilkin, TJ (corresponding author), Univ Plymouth, Plymouth Postgrad Med Sch, Plymouth PL4 8AA, Devon, England.	twilkin@plymouth.ac.uk						Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; CHRISTIANSEN C, 1993, J BONE MINER RES, V8, pS475; Cumming RG, 1997, AM J EPIDEMIOL, V145, P926, DOI 10.1093/oxfordjournals.aje.a009052; DeLaet CEDH, 1997, BRIT MED J, V315, P221, DOI 10.1136/bmj.315.7102.221; *DEP HLTH, 1998, CLIN GUID STRAT PREV; Eastell R, 1997, J RHEUMATOL, V24, P1215; GARNERO P, 1994, J CLIN ENDOCR METAB, V79, P1693, DOI 10.1210/jc.79.6.1693; HEANEY RP, 1992, J INTERN MED, V231, P169, DOI 10.1111/j.1365-2796.1992.tb00520.x; HUI SL, 1988, J CLIN INVEST, V81, P1804, DOI 10.1172/JCI113523; KANIS JA, 1984, LANCET, V1, P27; KREIGER N, 1992, INT J EPIDEMIOL, V21, P953, DOI 10.1093/ije/21.5.953; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Michaelsson K, 1998, BMJ-BRIT MED J, V316, P1858; NORDIN BEC, 1979, CLIN ORTHOP RELAT R, P216; PEEL N, 1995, BRIT MED J, V310, P989, DOI 10.1136/bmj.310.6985.989; WILKIN TJ, 1997, ACTA OBSTET GYN S167, V76, P61	17	33	34	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 27	1999	318	7187					862	864		10.1136/bmj.318.7187.862	http://dx.doi.org/10.1136/bmj.318.7187.862			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185DM	10092270	Green Published			2022-12-28	WOS:000079652900038
J	Guan, ZB; Cotts, PM; McCord, EF; McLain, SJ				Guan, ZB; Cotts, PM; McCord, EF; McLain, SJ			Chain walking: A new strategy to control polymer topology	SCIENCE			English	Article							DYNAMIC LIGHT-SCATTERING; ALPHA-OLEFINS	Ethylene pressure has been used to control the competition between isomerization (chain walking) and monomer insertion processes for ethylene coordination polymerization catalyzed by a palladium-alpha-diimine catalyst. The topology of the polyethylene varies from linear with moderate branching to "hyperbranched" structures. Although the overall branching number and the distribution of short-chain branching change very slightly, the architecture or topology of the polyethylene changes from linear polyethylene with moderate branches at high ethylene pressures to a hyperbranched polyethylene at low pressures.	DuPont Cent Res, Expt Stn, Wilmington, DE 19880 USA	DuPont	Guan, ZB (corresponding author), DuPont Cent Res, Expt Stn, Wilmington, DE 19880 USA.							BAUER BJ, 1989, MACROMOLECULES, V22, P2337, DOI 10.1021/ma00195a058; BROOKHART M, UNPUB; BURCHARD W, 1983, ADV POLYM SCI, V48, P1; Collman J.P., 1987, PRINCIPLES APPL ORGA; Flory PJ., 1953, PRINCIPLES POLYM CHE, V672; FRECHET JMJ, 1995, SCIENCE, V269, P1080, DOI 10.1126/science.269.5227.1080; HAWKER CJ, 1991, J AM CHEM SOC, V113, P4583, DOI 10.1021/ja00012a030; HAWKER CJ, 1995, J AM CHEM SOC, V117, P10763, DOI 10.1021/ja00148a027; HAWKER CJ, 1992, J CHEM SOC P1, V19, P2459; JOHNSON LK, 1995, J AM CHEM SOC, V117, P6414, DOI 10.1021/ja00128a054; KIM YH, 1992, MACROMOLECULES, V25, P5561, DOI 10.1021/ma00047a001; KIM YH, 1990, J AM CHEM SOC, V112, P4592, DOI 10.1021/ja00167a094; KUNZ D, 1983, COLLOID POLYM SCI, V261, P635, DOI 10.1007/BF01415033; MCLAIN SJ, 1997, POLYM PREPR AM CHEM, V38, P772; MOHRING VM, 1985, ANGEW CHEM INT EDIT, V24, P1001, DOI 10.1002/anie.198510011; NEWKOME GR, 1986, J AM CHEM SOC, V108, P849, DOI 10.1021/ja00264a054; Odian G., 1991, PRINCIPLES POLYM, V3; Scherrenberg R, 1998, MACROMOLECULES, V31, P456, DOI 10.1021/ma9618181; Tomalia D.a., 1990, ANGEW CHEM-GER EDIT, V102, P119, DOI DOI 10.1002/ANIE.199001381; TOMALIA DA, 1986, MACROMOLECULES, V19, P2466, DOI 10.1021/ma00163a029; Ulrich H, 1993, INTRO IND POLYM; USAMI T, 1984, MACROMOLECULES, V17, P1756, DOI 10.1021/ma00139a022; WEBSTER OW, 1991, SCIENCE, V251, P887, DOI 10.1126/science.251.4996.887; XU ZD, 1985, MACROMOLECULES, V18, P2560, DOI 10.1021/ma00154a034	24	652	672	5	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	1999	283	5410					2059	2062		10.1126/science.283.5410.2059	http://dx.doi.org/10.1126/science.283.5410.2059			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180DH	10092223				2022-12-28	WOS:000079369800038
J	Nauta, K; Miller, RE				Nauta, K; Miller, RE			Nonequilibrium self-assembly of long chains of polar molecules in superfluid helium	SCIENCE			English	Article							HYDROGEN-CYANIDE; VIBRATIONAL SPECTROSCOPY; INFRARED-SPECTROSCOPY; CLUSTERS; ABINITIO; COMPLEXES; DYNAMICS; ISOMERS; DIMER; SF6	It is shown that in the low-temperature (0.37 kelvin) environment of superfluid helium droplets, long-range dipole-dipole forces acting between two polar molecules can result in the self-assembly of noncovalently bonded linear chains, At this temperature the effective range of these forces is on the nanometer scale, making them important in the growth of nanoscale structures. In particular, the self-assembly of exclusively linear hydrogen cyanide chains is observed, even when the folded structures are energetically favored. This suggests a design strategy for the growth of new nanoscale oligomers composed of monomers with defined dipole (or higher order) moment directions.	Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Miller, RE (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.							ANEX DS, 1988, J PHYS CHEM-US, V92, P2913, DOI 10.1021/j100321a041; [Anonymous], 1992, INTERMOLECULAR SURFA; BLOCK PA, 1989, CHEM PHYS, V139, P15, DOI 10.1016/0301-0104(89)90002-5; BLOCK PA, 1992, PHYS REV LETT, V68, P1303, DOI 10.1103/PhysRevLett.68.1303; BUXTON LW, 1981, CHEM PHYS, V56, P399, DOI 10.1016/0301-0104(81)80161-9; DULMAGE WJ, 1951, ACTA CRYSTALLOGR, V4, P330, DOI 10.1107/S0365110X51001070; GOUGH TE, 1985, J CHEM PHYS, V83, P4958, DOI 10.1063/1.449757; GOYAL S, 1992, PHYS REV LETT, V69, P933, DOI 10.1103/PhysRevLett.69.933; Grebenev S, 1998, SCIENCE, V279, P2083, DOI 10.1126/science.279.5359.2083; Hartmann M, 1996, SCIENCE, V272, P1631, DOI 10.1126/science.272.5268.1631; HARTMANN M, 1995, PHYS REV LETT, V75, P1566, DOI 10.1103/PhysRevLett.75.1566; HIRSCHFELDER JO, 1965, MOL THEORY GASSES LI; JUCKS KW, 1988, J CHEM PHYS, V88, P2196, DOI 10.1063/1.454052; JUCKS KW, 1988, J CHEM PHYS, V88, P6059, DOI 10.1063/1.454498; Karpfen A, 1996, J PHYS CHEM-US, V100, P13474, DOI 10.1021/jp960599i; KOFRANEK M, 1987, CHEM PHYS, V113, P53, DOI 10.1016/0301-0104(87)80219-7; KURNIG IJ, 1990, J CHEM PHYS, V92, P2469, DOI 10.1063/1.457990; Lehmann KK, 1998, SCIENCE, V279, P2065, DOI 10.1126/science.279.5359.2065; LEWERENZ M, 1995, J CHEM PHYS, V102, P8191, DOI 10.1063/1.469231; LOVEJOY CM, 1987, J CHEM PHYS, V87, P1450, DOI 10.1063/1.453279; Miller R, UNPUB; MILLER RE, 1988, SCIENCE, V240, P447, DOI 10.1126/science.240.4851.447	22	281	281	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 19	1999	283	5409					1895	1897		10.1126/science.283.5409.1895	http://dx.doi.org/10.1126/science.283.5409.1895			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177UC	10082458				2022-12-28	WOS:000079228600041
J	Plows, CW; Tenery, RM; Hartford, A; Miller, D; Morse, L; Rakatansky, H; Riddick, FA; Ruff, V; Wilkins, G; Ile, M; Munson, J; Emanuel, LL				Plows, CW; Tenery, RM; Hartford, A; Miller, D; Morse, L; Rakatansky, H; Riddick, FA; Ruff, V; Wilkins, G; Ile, M; Munson, J; Emanuel, LL		Council Ethical Judicial Affairs	Medical futility in end-of-life care - Report of the Council on Ethical and Judicial Affairs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DEBATE	Use of life-sustaining or invasive interventions in patients in a persistent vegetative state or who are terminally ill may only prolong the dying process. What constitutes futile intervention remains a point of controversy in the medical literature and in clinical practice. In clinical practice, controversy arises when the patient or proxy and the physician have discrepant values or goals of care. Since definitions of futile care are value laden, universal consensus on futile care is unlikely to be achieved. Rather, the American Medical Association Council on Ethical and Judicial Affairs recommends a process-based approach to futility determinations. The process includes at least 4 steps aimed at deliberation and resolution including all involved parties, 2 steps aimed at securing alternatives in the case of irreconcilable differences, and a final step aimed at closure when all alternatives have been exhausted. The approach is placed in the context of the circumstances in which futility claims are made, the difficulties of defining medical futility, and a discussion of how best to implement a policy on futility.	Amer Med Assoc, Council Eth & Judicial Affairs, Chicago, IL 60610 USA	American Medical Association	Emanuel, LL (corresponding author), Amer Med Assoc, Council Eth & Judicial Affairs, 515 N State St, Chicago, IL 60610 USA.	Linda_Emanuel@ama-assn.org						*AM MED ASS BOARD, AM MED ASS 144 ANN M; *AM MED ASS COUNC, 1997, P HOUS DEL AM MED AS; Angell M, 1993, Trends Health Care Law Ethics, V8, P17; APPELBAUM P, 1986, INFORMED CONSENT; BLACKHALL LJ, 1987, NEW ENGL J MED, V317, P1281, DOI 10.1056/NEJM198711123172009; BRODY BA, 1995, J MED PHILOS, V20, P123, DOI 10.1093/jmp/20.2.123; CALLAHAN D, 1991, HASTINGS CENT REP, V21, P30, DOI 10.2307/3562999; CARPRON AM, 1995, HASTINGS CENT REP, V24, P6; EMANUEL EJ, 1992, JAMA-J AM MED ASSOC, V267, P2221, DOI 10.1001/jama.267.16.2221; EMANUEL L, 1995, JAMA-J AM MED ASSOC, V274, P501, DOI 10.1001/jama.274.6.501; EMANUEL L, 1995, HASTINGS CENT REP S, V6, pS14; EMANUEL LL, 1993, HASTINGS CENT REP, V23, P6, DOI 10.2307/3562059; Fletcher JC, 1996, J CLIN ETHIC, V7, P122; GRAY WA, 1991, NEW ENGL J MED, V325, P1393, DOI 10.1056/NEJM199111143252001; Halevy A, 1996, JAMA-J AM MED ASSOC, V276, P571, DOI 10.1001/jama.276.7.571; JECKER NS, 1992, AM J MED, V92, P189, DOI 10.1016/0002-9343(92)90111-N; KELLY B, 1995, N C MED J, V56, P427; LANTOS JD, 1989, AM J MED, V87, P81; LUNDBERG GD, 1992, JAMA-J AM MED ASSOC, V267, P2521; MILES SH, 1991, NEW ENGL J MED, V325, P512, DOI 10.1056/NEJM199108153250713; Murphy D J, 1995, N C Med J, V56, P428; MURPHY DJ, 1993, ARCH INTERN MED, V153, P1641, DOI 10.1001/archinte.153.14.1641; ORENTLICHER D, 1992, JAMA-J AM MED ASSOC, V267, P2229; PARIS JJ, 1990, NEW ENGL J MED, V322, P1012, DOI 10.1056/NEJM199004053221420; SCHNEIDERMAN LJ, 1994, AM J MED, V96, P110, DOI 10.1016/0002-9343(94)90130-9; SCHNEIDERMAN LJ, 1990, ANN INTERN MED, V112, P949, DOI 10.7326/0003-4819-112-12-949; SCHNEIDERMAN LJ, 1994, J AM GERIATR SOC, V42, P883, DOI 10.1111/j.1532-5415.1994.tb06564.x; Sugarman J, 1995, N C Med J, V56, P415; TENO JM, 1994, J AM GERIATR SOC, V42, P1202, DOI 10.1111/j.1532-5415.1994.tb06990.x; TOMLINSON T, 1995, HASTINGS CENT REP, V25, P28, DOI 10.2307/3562112; TROUG RD, 1992, NEW ENGL J MED, V326, P1560; ZAWACKI BE, 1995, J CLIN ETHIC, V6, P112; 1995, N C MED J, V56, P412	33	215	219	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	1999	281	10					937	941						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	172XH	10078492				2022-12-28	WOS:000078950600040
J	Augustsson, K; Skog, K; Jagerstad, M; Dickman, PW; Steineck, G				Augustsson, K; Skog, K; Jagerstad, M; Dickman, PW; Steineck, G			Dietary heterocyclic amines and cancer of the colon, rectum, bladder, and kidney: a population-based study	LANCET			English	Article							MEAT-PRODUCTS; HUMAN TISSUES; PAN RESIDUES; RISK; FISH	Background Heterocyclic amines formed in cooked meat and fish are carcinogenic in animal models and form DNA adducts in human beings. We undertook a study to assess whether these substances are related to the risks of cancer in the large bowel and urinary tract. Methods In a population-based case-control study, cases were identified from the Swedish cancer registry. Controls were randomly selected from the population register. Information on intake of various foods and was assessed by questionnaire, with photographs of foods cooked at various temperatures. We measured the content of heterocyclic amines in foods cooked under these conditions. Findings Information was retrieved from 553 controls, 352 cases of colon cancer, 249 cases of rectal cancer, 273 cases of bladder cancer, and 138 cases of kidney cancer. The response rate was 80% for controls and 70% for cases. The estimated daily median intake of heterocyclic amines was 77 ng for controls, and 66 ng, 63 ng, 96 ng, and 84 ng for cases with cancer of the colon, rectum, bladder, and kidney, respectively. The relative risk for the intake of heterocyclic amines (highest vs lowest quintile) was 0.6 (95% CI 0.4-1.0) for colon cancer, 0.7 (0.4-1.1) for rectal cancer, 1.2 (0.7-2.1) for bladder cancer, and 1.0 (0.5-1.9) for kidney cancer. Seven cases, but no controls, had an estimated daily intake of heterocyclic amines above 1900 ng. Interpretation Intake of heterocyclic amines, within the usual dietary range in this study population, is unlikely to increase the incidence of cancer in the colon, rectum, bladder, or kidney. For daily intakes above 1900 ng, our data are consistent with human carcinogenicity, but the precision was extremely low.	Karolinska Inst, Stockholm, Sweden; Swedish Univ Agr Sci, Dept Food Sci, Uppsala, Sweden; Swedish Univ Agr Sci, Ctr Chem & Chem Engn, Dept Appl Nutr & Food Chem, Uppsala, Sweden	Karolinska Institutet; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Augustsson, K (corresponding author), Karolinska Univ Hosp, Norrbacka 5 Tr, SE-17176 Stockholm, Sweden.	Gunnar.Steineck@onkpat.ki.se	Steineck, Gunnar/W-1515-2019; Dickman, Paul W/B-4572-2013	Steineck, Gunnar/0000-0002-0787-3969; Dickman, Paul W/0000-0002-5788-3380				Augustsson K, 1997, CARCINOGENESIS, V18, P1931, DOI 10.1093/carcin/18.10.1931; AUGUSTSSON K, IN PRESS FOOD ADDIT; Becker W., 1994, FOOD HABITS NUTR INT; BENITO E, 1990, INT J CANCER, V45, P69, DOI 10.1002/ijc.2910450114; DEVERDIER MG, 1991, INT J CANCER, V49, P520, DOI 10.1002/ijc.2910490408; FRIESEN MD, 1994, CHEM RES TOXICOL, V7, P733, DOI 10.1021/tx00042a004; Gaard M, 1996, EUR J CANCER PREV, V5, P445; Hsing AW, 1998, INT J CANCER, V77, P549, DOI 10.1002/(SICI)1097-0215(19980812)77:4&lt;549::AID-IJC13&gt;3.0.CO;2-1; International Agency for Research on Cancer, 1993, IARC MON EV CARC RIS, V56, P165; JAGERSTAD M, 1983, ACS SYM SER, V215, P507; JAGERSTAD M, 1991, ADV EXP MED BIOL, V289, P83; MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9; MAUGH TH, 1978, SCIENCE, V202, P37, DOI 10.1126/science.694517; NAGAO M, 1977, CANCER LETT, V2, P221, DOI 10.1016/S0304-3835(77)80025-6; NORELL SE, 1986, AM J EPIDEMIOL, V124, P894, DOI 10.1093/oxfordjournals.aje.a114479; OVERVIK E, 1984, MUTAT RES, V135, P149, DOI 10.1016/0165-1218(84)90115-0; REUTERSWARD AL, 1987, FOOD CHEM TOXICOL, V25, P755, DOI 10.1016/0278-6915(87)90230-4; RobertsThomson IC, 1996, LANCET, V347, P1372, DOI 10.1016/S0140-6736(96)91012-0; SADRIEH N, 1995, CARCINOGENESIS, V16, P1549, DOI 10.1093/carcin/16.7.1549; SKOG K, 1995, CARCINOGENESIS, V16, P861, DOI 10.1093/carcin/16.4.861; Skog K, 1997, FOOD CHEM TOXICOL, V35, P555, DOI 10.1016/S0278-6915(97)00021-5; SKOG K, 1993, FOOD CHEM TOXICOL, V31, P655, DOI 10.1016/0278-6915(93)90049-5; STEINECK G, 1990, INT J CANCER, V45, P1006, DOI 10.1002/ijc.2910450604; Sugimura T, 1997, MUTAT RES-FUND MOL M, V376, P211, DOI 10.1016/S0027-5107(97)00045-6; Sugimura T., 1977, ORIGINS HUMAN CANC, P1561; Totsuka Y, 1996, CARCINOGENESIS, V17, P1029, DOI 10.1093/carcin/17.5.1029; *WHO, 1977, INT CLASS DIS INJ CA; WILLETT W, 1990, MONOGRAPHS EPIDEMIOL; WILLETT WC, 1990, NEW ENGL J MED, V323, P1664, DOI 10.1056/NEJM199012133232404; YOUNG TB, 1988, INT J CANCER, V42, P167, DOI 10.1002/ijc.2910420205	30	207	212	1	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	1999	353	9154					703	707		10.1016/S0140-6736(98)06099-1	http://dx.doi.org/10.1016/S0140-6736(98)06099-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173DR	10073512				2022-12-28	WOS:000078966400010
J	Barnett, AG; Underwood, MR; Vickers, MR				Barnett, AG; Underwood, MR; Vickers, MR			Effect of UK national guidelines on services to treat patients with acute low back pain: follow up questionnaire survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article; Proceedings Paper	Conference of the World Organisation of National Colleges, Academies and Academic Associations of General Practioners/Family Physicians	JUN, 1998	DUBLIN, IRELAND	World Org Natl Coll Acad & Acad Assoc Gen Practitioners Family Physicians					Queen Mary Univ London, St Bartholomews & Royal London Sch Med & Dent, Wolfson Inst Prevent Med, MRC,Epidemiol & Med Care Unit, London EC1M 6BQ, England	University of London; Queen Mary University London	Underwood, MR (corresponding author), Queen Mary Univ London, St Bartholomews & Royal London Sch Med & Dent, Wolfson Inst Prevent Med, MRC,Epidemiol & Med Care Unit, London EC1M 6BQ, England.	M.Underwood@mds.qmw.ac.uk	Underwood, Martin/D-6364-2015; Barnett, Adrian/I-9850-2012	Underwood, Martin/0000-0002-0309-1708; Barnett, Adrian/0000-0001-6339-0374				*CLIN STAND ADV GR, 1994, BACK PAIN REP CSAG B; DENNIS SM, 1997, THORAX S6, V52, pA18; Jones E, 1996, BMJ-BRIT MED J, V313, P36, DOI 10.1136/bmj.313.7048.36; Moser CA, 1971, SURVEY METHODS SOCIA, P137; Underwood MR, 1997, BRIT J GEN PRACT, V47, P501	5	18	18	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	1999	318	7188					919	920		10.1136/bmj.318.7188.919	http://dx.doi.org/10.1136/bmj.318.7188.919			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	185GV	10102859	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000079660500029
J	Sarin, SK; Lamba, GS; Kumar, M; Misra, A; Murthy, NS				Sarin, SK; Lamba, GS; Kumar, M; Misra, A; Murthy, NS			Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROSPECTIVE RANDOMIZED TRIAL; ESOPHAGEAL-VARICES; PORTAL-HYPERTENSION; BAND LIGATION; INJECTION SCLEROTHERAPY; PRIMARY PROPHYLAXIS; CIRRHOTIC-PATIENTS; NATURAL-HISTORY; CLINICAL-TRIALS; GASTRIC VARICES	Background and Methods We compared propranolol therapy and endoscopic ligation for the primary prevention of bleeding from esophageal varices. This prospective, controlled trial included consecutive eligible patients who had large varices (>5 mm in diameter) that were at high risk for bleeding. The patients were assigned to either propranolol therapy, at a dose sufficient to decrease the base-line heart rate by 25 percent, or variceal ligation, to be performed weekly until the varices were obliterated or so reduced in size that it was not possible to continue treatment. Results Of the 89 patients, 82 of whom had cirrhosis of the liver, 44 received propranolol and 45 underwent variceal ligation. The mean (+/-SD) duration of follow-up in each group was 14+/-9 and 13+/-10 months, respectively. The mean time required to achieve an adequate reduction in the heart rate was 2.5+/-1.7 days; the mean number of sessions needed to complete variceal ligation was 3.2+/-1.1. After 18 months, the actuarial probability of bleeding was 43 percent in the propranolol group and 15 percent in the ligation group (P = 0.04). Twelve patients in the propranolol group and four in the ligation group had bleeding. Three of the four in the ligation group had bleeding before their varices had been obliterated. Nine patients in the ligation group had recurrent varices, a mean of 3.7 months after the initial treatment. Five patients in each group died; bleeding from the varices was the cause of death of four patients in the propranolol group and of three in the ligation group. There were no serious complications of variceal ligation; in the propranolol group, treatment was stopped in two patients because of side effects. Conclusions In patients with high-risk esophageal varices, endoscopic ligation of the varices is safe and more effective than propranolol for the primary prevention of variceal bleeding. (N Engl J Med 1999;340: 988-93.) (C)1999, Massachusetts Medical Society.	GB Pant Hosp, Dept Gastroenterol, New Delhi 110002, India; Inst Cytol & Prevent Oncol, Dept Biostat, New Delhi, India	Govind Ballabh Pant Institute of Postgraduate Medical Education & Research; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cancer Prevention & Research (NICPR)	Sarin, SK (corresponding author), GB Pant Hosp, Dept Gastroenterol, New Delhi 110002, India.	skrarin@nda.vsnl.net.in						Altman DG, 1991, PRATICAL STAT MED RE; Angelico M, 1997, GASTROENTEROLOGY, V113, P1632, DOI 10.1053/gast.1997.v113.pm9352866; Banares R., 1997, Hepatology, V26, p133A; CHRISTENSEN E, 1981, GASTROENTEROLOGY, V81, P944; CONN HO, 1967, J LAB CLIN MED, V70, P442; CONN HO, 1972, MEDICINE, V51, P27, DOI 10.1097/00005792-197201000-00002; COX DR, 1972, J R STAT SOC B, V34, P187; DAMICO G, 1995, HEPATOLOGY, V22, P332, DOI 10.1002/hep.1840220145; FARDY JM, 1994, AM J GASTROENTEROL, V89, P1938; FEU F, 1995, LANCET, V346, P1056, DOI 10.1016/S0140-6736(95)91740-3; GARCIAPAGAN JC, 1991, ANN INTERN MED, V114, P869, DOI 10.7326/0003-4819-114-10-869; GIMSON A, 1990, GASTROENTEROLOGY, V99, P1829, DOI 10.1016/0016-5085(90)90495-M; GREGORY PB, 1991, NEW ENGL J MED, V324, P1779; Groszmann RJ, 1997, GASTROENTEROLOGY, V113, P1794, DOI 10.1053/gast.1997.v113.agast971131794; GROSZMANN RJ, 1990, GASTROENTEROLOGY, V99, P1401, DOI 10.1016/0016-5085(90)91168-6; LAINE L, 1995, ANN INTERN MED, V123, P280, DOI 10.7326/0003-4819-123-4-199508150-00007; Lay CS, 1997, HEPATOLOGY, V25, P1346, DOI 10.1002/hep.510250608; LEBREC D, 1982, NEW ENGL J MED, V307, P560; Merkel C, 1996, LANCET, V348, P1677, DOI 10.1016/S0140-6736(96)05406-2; PAQUET KJ, 1994, ENDOSCOPY, V26, P734, DOI 10.1055/s-2007-1009085; PAQUET KJ, 1982, ENDOSCOPY, V14, P4, DOI 10.1055/s-2007-1021560; PASCAL JP, 1987, NEW ENGL J MED, V317, P856, DOI 10.1056/NEJM198710013171403; PASCAL JP, 1988, NEW ENGL J MED, V318, P994; PASTA L, 1988, HEPATOLOGY, V8, P1; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; POLSON RJ, 1989, HEPATOLOGY, V10, P279, DOI 10.1002/hep.1840100304; POYNARD T, 1991, NEW ENGL J MED, V324, P1532, DOI 10.1056/NEJM199105303242202; SAKAI P, 1994, ENDOSCOPY, V26, P511, DOI 10.1055/s-2007-1009021; Sarin S K, 1992, Drugs, V44 Suppl 2, P56, DOI 10.2165/00003495-199200442-00007; SARIN SK, 1992, GASTROENTEROLOGY, V102, P994, DOI 10.1016/0016-5085(92)90188-5; SARIN SK, 1989, GUT, V30, P406, DOI 10.1136/gut.30.3.406; Sarin SK, 1997, J HEPATOL, V26, P826, DOI 10.1016/S0168-8278(97)80248-6; Sarin SK, 1996, EUR J GASTROEN HEPAT, V8, P337, DOI 10.1097/00042737-199604000-00010; SARIN SK, 1992, HEPATOLOGY, V16, P1343, DOI 10.1002/hep.1840160607; SARIN SK, 1989, GUT, V30, P1757, DOI 10.1136/gut.30.12.1757; Shahi HM, 1998, AM J GASTROENTEROL, V93, P2348, DOI 10.1016/S0002-9270(98)00470-5; SILVAIN C, 1985, GASTROEN CLIN BIOL, V9, P670; SMITH JL, 1982, GASTROENTEROLOGY, V82, P968; STIEGMANN GV, 1992, NEW ENGL J MED, V326, P1527, DOI 10.1056/NEJM199206043262304	39	263	274	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 1	1999	340	13					988	993		10.1056/NEJM199904013401302	http://dx.doi.org/10.1056/NEJM199904013401302			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182GA	10099140				2022-12-28	WOS:000079489800002
J	Wolpert, L				Wolpert, L			Is science dangerous?	NATURE			English	Editorial Material									UCL, Dept Anat & Dev Biol, London WC1E 6BT, England	University of London; University College London	Wolpert, L (corresponding author), UCL, Dept Anat & Dev Biol, Gower St, London WC1E 6BT, England.	l.wolpert@ucl.ac.uk						KENNEDY I, 1993, PREDICTING FUTURE, P96; Kevles D., 1985, NAME EUGENICS; Rhodes R., 1986, MAKING ATOMIC BOMB; Wolpert L., 1992, UNNATURAL NATURE SCI	4	16	16	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 25	1999	398	6725					281	282		10.1038/18543	http://dx.doi.org/10.1038/18543			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180DF	10192325				2022-12-28	WOS:000079369600020
J	Strode, SW; Gustke, S; Allen, A				Strode, SW; Gustke, S; Allen, A			Technical and clinical progress in telemedicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Arkansas Med Sci, Telemed Program, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Reg Programs, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Dept Family & Community Med, Little Rock, AR 72205 USA; Eastern Carolina Sch Med, Eastern Area Hlth Educ Ctr, Greenville, NC USA; Univ Kansas, Sch Med, Dept Med, Kansas City, KS USA; Univ Kansas, Sch Med, Telemed Serv, Kansas City, KS USA; Telemed Today Magazine, Kansas City, KS USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of North Carolina; East Carolina University; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Strode, SW (corresponding author), Univ Arkansas Med Sci, Telemed Program, Slot 599A, Little Rock, AR 72205 USA.							Allen A, 1998, Telemed Today, V6, P18; Allen A, 1997, Telemed Today, V5, P24; Borowitz SM, 1998, JAMA-J AM MED ASSOC, V280, P1321, DOI 10.1001/jama.280.15.1321; ESSEX D, 1998, HEALTHCARE INFOR NOV, P44; Eysenbach G, 1998, JAMA-J AM MED ASSOC, V280, P1333, DOI 10.1001/jama.280.15.1333; GILBERT SW, 1998, 190 AAHESGIT; Glowniak J, 1998, SEMIN NUCL MED, V28, P135, DOI 10.1016/S0001-2998(98)80003-2; GOLDBERG MA, 1993, RADIOLOGY, V186, P429, DOI 10.1148/radiology.186.2.8421746; Harris ED, 1997, WESTERN J MED, V166, P123; Hersh WR, 1998, JAMA-J AM MED ASSOC, V280, P1307, DOI 10.1001/jama.280.15.1307; *HLTH CAR ADV BOAR, 1998, AMI004003 HLTH CAR A; *HLTH CAR FIN ADM, 1997, DISC HCFA TEL DEM; Hubbs PR, 1998, JAMA-J AM MED ASSOC, V280, P1363, DOI 10.1001/jama.280.15.1363; Izenberg N, 1998, CLIN PEDIATR, V37, P275, DOI 10.1177/000992289803700501; KEWSLER D, 1995, J TELEMED TELECARE, V1, P179; KIM H, 1998, AM MED NEWS     0504, P7; Mandl KD, 1998, ANN INTERN MED, V129, P495, DOI 10.7326/0003-4819-129-6-199809150-00012; MURPHY K, 1998, NY TIMES        0608, pD5; Neill R A, 1994, Arch Fam Med, V3, P268, DOI 10.1001/archfami.3.3.268; *OFF RUR HLTH POL, 1997, EXPL EV RUR APPL TEL; Pies R, 1998, NEW ENGL J MED, V339, P638, DOI 10.1056/NEJM199808273390920; Schanz S J, 1998, Telemed Today, V6, P13; SIWICKI B, 1998, HLTH DATA MANAGE APR, P85; Swartz D, 1998, Telemed Today, V6, P27; Thrall JH, 1998, SEMIN NUCL MED, V28, P145, DOI 10.1016/S0001-2998(98)80004-4; Wheeler T, 1998, Telemed Today, V6, P37	26	96	96	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	1999	281	12					1066	1068		10.1001/jama.281.12.1066	http://dx.doi.org/10.1001/jama.281.12.1066			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177EP	10188642				2022-12-28	WOS:000079197100002
J	[Anonymous]				[Anonymous]			BMA calls for renewed action on debt relief	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	1999	318	7186					815	815						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BX	10082729				2022-12-28	WOS:000079421700084
J	Ghiglione, C; Carraway, KL; Amundadottir, LT; Boswell, RE; Perrimon, N; Duffy, JB				Ghiglione, C; Carraway, KL; Amundadottir, LT; Boswell, RE; Perrimon, N; Duffy, JB			The transmembrane molecule kekkon 1 acts in a feedback loop to negatively regulate the activity of the Drosophila EGF receptor during oogenesis	CELL			English	Article							DORSAL-VENTRAL AXIS; TYROSINE KINASE; SIGNALING PATHWAYS; SPEMANN ORGANIZER; NUCLEAR-LOCALIZATION; DORSOVENTRAL PATTERN; GENE GURKEN; PDZ DOMAINS; PROTEIN; MELANOGASTER	We have identified the Drosophila transmembrane molecule kekkon 1 (kek1) as an inhibitor of the epidermal growth factor receptor (EGFR) and demonstrate that it acts in a negative feedback loop to modulate the activity of the EGFR tyrosine kinase. During oogenesis, kek1 is expressed in response to the Gurken/EGFR signaling pathway, and loss of kek1 activity is associated with an increase in EGFR signaling. Consistent with our loss-of-function studies, we demonstrate that ectopic overexpression of kek1 mimics a loss of EGFR activity. We show that the extracellular and transmembrane domains of Kek1 can inhibit and physically associate with the EGFR, suggesting potential models for this inhibitory mechanism.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Beth Israel Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; Univ Colorado, Howard Hughes Med Inst, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Beth Israel Deaconess Medical Center; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Perrimon, N (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.		Amundadottir, Laufey T/L-7656-2016	Amundadottir, Laufey T/0000-0003-1859-8971; Perrimon, Norbert/0000-0001-7542-472X	NCI NIH HHS [CA71702] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA071702] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ASHBURNER M, 1990, GENETICS, V126, P679; BRAND AH, 1994, GENE DEV, V8, P629, DOI 10.1101/gad.8.5.629; BRAND AH, 1993, DEVELOPMENT, V118, P401; CLIFFORD RJ, 1989, GENETICS, V123, P771; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Golembo M, 1996, DEVELOPMENT, V122, P3363; Golembo M, 1996, DEVELOPMENT, V122, P223; Greenwood S, 1997, DEVELOPMENT, V124, P4879; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; HSU JC, 1994, GENE DEV, V8, P2176, DOI 10.1101/gad.8.18.2176; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kim SK, 1997, CURR OPIN CELL BIOL, V9, P853, DOI 10.1016/S0955-0674(97)80088-9; Kokel M, 1998, GENE DEV, V12, P1425, DOI 10.1101/gad.12.10.1425; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Li W, 1997, Genet Eng (N Y), V19, P167; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; MELNICK MB, 1993, DEVELOPMENT, V118, P127; Morisato D, 1995, ANNU REV GENET, V29, P371, DOI 10.1146/annurev.genet.29.1.371; Musacchio M, 1996, DEV BIOL, V178, P63, DOI 10.1006/dbio.1996.0198; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; NEUMANSILBERBERG FS, 1994, DEVELOPMENT, V120, P2457; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; Perrimon N, 1997, CELL, V89, P13, DOI 10.1016/S0092-8674(00)80177-4; PERRIMON N, 1991, DEV GENET, V12, P238, DOI 10.1002/dvg.1020120309; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; PRICE JV, 1989, CELL, V56, P1085, DOI 10.1016/0092-8674(89)90641-7; Queenan AM, 1997, DEVELOPMENT, V124, P3871; Ray RP, 1996, GENE DEV, V10, P1711, DOI 10.1101/gad.10.14.1711; ROBERTSON HM, 1988, GENETICS, V118, P461; ROTH S, 1994, DEVELOPMENT, V120, P2245; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; RUOHOLABAKER H, 1993, CELL, V73, P953, DOI 10.1016/0092-8674(93)90273-S; RUTLEDGE BJ, 1992, GENE DEV, V6, P1503, DOI 10.1101/gad.6.8.1503; Sapir A, 1998, DEVELOPMENT, V125, P191; Schnepp B, 1996, GENE DEV, V10, P2302, DOI 10.1101/gad.10.18.2302; Schnorr JD, 1996, GENETICS, V144, P1545; SCHUPBACH T, 1987, CELL, V49, P699, DOI 10.1016/0092-8674(87)90546-0; SCHWEITZER R, 1995, NATURE, V376, P699, DOI 10.1038/376699a0; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; SMITH D, 1993, GENETICS, V135, P1063; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Speicher S, 1998, NEURON, V20, P221, DOI 10.1016/S0896-6273(00)80451-1; SPRADLING AC, 1995, P NATL ACAD SCI USA, V92, P10824, DOI 10.1073/pnas.92.24.10824; STURTEVANT MA, 1994, DEVELOPMENT, V120, P2593; Suzuki Y, 1996, J BIOL CHEM, V271, P22522, DOI 10.1074/jbc.271.37.22522; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; THEURKAUF WE, 1993, DEVELOPMENT, V118, P1169, DOI 10.1016/0168-9525(93)90134-4; THISSE B, 1988, EMBO J, V7, P2175, DOI 10.1002/j.1460-2075.1988.tb03056.x; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Van der Meer JM., 1977, DROS INFORM SERV, V52, P160; VANDERGEER P, 1994, ANN REV CELL BIOL, V10, P208; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; Wasserman JD, 1998, CELL, V95, P355, DOI 10.1016/S0092-8674(00)81767-5; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	59	176	191	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 19	1999	96	6					847	856		10.1016/S0092-8674(00)80594-2	http://dx.doi.org/10.1016/S0092-8674(00)80594-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	178ZY	10102272	Bronze			2022-12-28	WOS:000079300100011
J	Welsh, J				Welsh, J			Japan: Prisoners wait for rights	LANCET			English	Editorial Material									Amnesty Int, Med Off, London WC1X 8DJ, England		Welsh, J (corresponding author), Amnesty Int, Med Off, 1 Easton St, London WC1X 8DJ, England.							*AMN INT, 1998, JAP AB PUN JAP PRIS; *AMN INT, 1999, ILL TREATM CUST; *AMN INT, 1995, MED DEATH PEN; *HUM RIGHTS WATCH, 1995, PRIS COND JAP; *INT COMM JUR, 1985, HUM RIGHTS MENT PATI, P94	5	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 13	1999	353	9156					922	922		10.1016/S0140-6736(99)90057-0	http://dx.doi.org/10.1016/S0140-6736(99)90057-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BU	10094002				2022-12-28	WOS:000079421400047
J	Smith, DE; Babcock, HP; Chu, S				Smith, DE; Babcock, HP; Chu, S			Single-polymer dynamics in steady shear flow	SCIENCE			English	Article							HYDRODYNAMIC INTERACTION; ELONGATIONAL FLOW; FLEXIBLE POLYMERS; DNA; DEFORMATION; MODEL; SCATTERING	The conformational dynamics of individual, flexible polymers in steady shear flow were directly observed by the use of video fluorescence microscopy. The probability distribution for the molecular extension was determined as a function of shear rate, (gamma)over dot, for two different polymer relaxation times, tau. In contrast to the behavior in pure elongational Flow, the average polymer extension in shear flow does not display a sharp coil-stretch transition. Large, aperiodic temporal fluctuations were observed, consistent with end-over-end tumbling of the molecule. The rate of these fluctuations (relative to the relaxation rate) increased as the Weissenberg number, (gamma)over dot tau, was increased.	Stanford Univ, Dept Phys, Stanford, CA 94305 USA; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Stanford University; Stanford University	Chu, S (corresponding author), Stanford Univ, Dept Phys, Varian Bldg, Stanford, CA 94305 USA.	schu@leland.stanford.edu	Smith, Douglas E/A-3131-2017	Smith, Douglas E/0000-0002-8206-3632; Babcock, Hazen/0000-0003-4835-3692				ATKINS EDT, 1992, BIOPOLYMERS, V32, P911, DOI 10.1002/bip.360320803; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; COTTRELL FR, 1969, J POLYM SCI A2, V7, P1415, DOI 10.1002/pol.1969.160070811; Doyle PS, 1998, J NON-NEWTON FLUID, V76, P79, DOI 10.1016/S0377-0257(97)00113-4; FULLER GG, 1980, RHEOL ACTA, V19, P580, DOI 10.1007/BF01517512; HINCH EJ, 1976, J FLUID MECH, V75, P765, DOI 10.1017/S0022112076000529; Jeffery GB, 1922, P R SOC LOND A-CONTA, V102, P161, DOI 10.1098/rspa.1922.0078; Kuhn W, 1943, HELV CHIM ACTA, V26, P1394, DOI 10.1002/hlca.19430260514; Larson R. G., 1988, CONSTITUTIVE EQUATIO; Lee EC, 1997, MACROMOLECULES, V30, P7313, DOI 10.1021/ma9706945; LINDNER P, 1988, COLLOID POLYM SCI, V266, P886, DOI 10.1007/BF01410843; LIU TW, 1989, J CHEM PHYS, V90, P5826, DOI 10.1063/1.456389; PECORA R, 1991, SCIENCE, V251, P893, DOI 10.1126/science.2000490; Perkins TT, 1997, SCIENCE, V276, P2016, DOI 10.1126/science.276.5321.2016; PERKINS TT, 1995, SCIENCE, V268, P83, DOI 10.1126/science.7701345; PERKINS TT, IN PRESS FLEXIBLE CH; PETERLIN A, 1958, J CHEM PHYS, V28, P470, DOI 10.1063/1.1744160; PRESS WP, 1988, NUMERICAL RECIPES C, P442; ROUSE PE, 1953, J CHEM PHYS, V21, P1272, DOI 10.1063/1.1699180; SHAQFEH E, COMMUNICATION; Smith DE, 1996, MACROMOLECULES, V29, P1372, DOI 10.1021/ma951455p; Smith DE, 1998, SCIENCE, V281, P1335, DOI 10.1126/science.281.5381.1335; WANG MC, 1945, REV MOD PHYS, V17, P323, DOI 10.1103/RevModPhys.17.323; WARNER HR, 1972, IND ENG CHEM FUND, V11, P379, DOI 10.1021/i160043a017; WEDGEWOOD LE, 1988, J NON-NEWTON FLUID, V27, P245, DOI 10.1016/0377-0257(88)85016-X; WEDGEWOOD LE, 1991, J NON-NEWTON FLUID, V40, P119, DOI 10.1016/0377-0257(91)87029-W; ZIMM BH, 1956, J CHEM PHYS, V24, P269, DOI 10.1063/1.1742462	31	640	653	7	177	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	1999	283	5408					1724	1727		10.1126/science.283.5408.1724	http://dx.doi.org/10.1126/science.283.5408.1724			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175PF	10073935	Green Submitted			2022-12-28	WOS:000079102800048
J	Bottomly, K				Bottomly, K			Immunology - T cells and dendritic cells get intimate	SCIENCE			English	Editorial Material							MICE		Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Yale University	Bottomly, K (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.							KIM J, 1985, J EXP MED, V162, P188, DOI 10.1084/jem.162.1.188; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; ROMANI N, 1989, J EXP MED, V169, P1169, DOI 10.1084/jem.169.3.1169; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; STEINMAN RM, 1978, P NATL ACAD SCI USA, V75, P5132, DOI 10.1073/pnas.75.10.5132; Stumbles PA, 1998, J EXP MED, V188, P2019, DOI 10.1084/jem.188.11.2019	7	61	70	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 19	1999	283	5405					1124	1125		10.1126/science.283.5405.1124	http://dx.doi.org/10.1126/science.283.5405.1124			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169GD	10075571				2022-12-28	WOS:000078738400033
J	Ostrom, E; Burger, J; Field, CB; Norgaard, RB; Policansky, D				Ostrom, E; Burger, J; Field, CB; Norgaard, RB; Policansky, D			Sustainability - Revisiting the commons: Local lessons, global challenges	SCIENCE			English	Review							TRAGEDY; INSTITUTIONS; PERFORMANCE; GOVERNANCE; BEHAVIOR	In a seminal paper, Garrett Hardin argued in 1968 that users of a commons are caught in an inevitable process that leads to the destruction of the resources on which they depend. This article discusses new insights about such problems and the conditions most likely to favor sustainable uses of common-pool resources. Some of the most difficult challenges concern the management of large-scale resources that depend on international cooperation, such as fresh water in international basins or large marine ecosystems. Institutional diversity may be as important as biological diversity for our long-term survival.	Indiana Univ, Ctr Study Inst Populat & Environm Change, Bloomington, IN 47408 USA; Indiana Univ, Workshop Polit Theory & Policy Anal, Bloomington, IN 47408 USA; Rutgers State Univ, Environm & Occupat Hlth Sci Inst, Piscataway, NJ 08854 USA; Carnegie Inst Washington, Stanford, CA 94305 USA; Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA; Natl Res Council, Washington, DC 20418 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Rutgers State University New Brunswick; Carnegie Institution for Science; University of California System; University of California Berkeley; National Academies of Sciences, Engineering & Medicine	Ostrom, E (corresponding author), Indiana Univ, Ctr Study Inst Populat & Environm Change, Bloomington, IN 47408 USA.	ostrom@indiana.edu			NIEHS NIH HHS [ESO 5022] Funding Source: Medline	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Agrawal Arjun, 1999, GREENER PASTURES POL; [Anonymous], 1996, HALTING DEGRADATION; [Anonymous], 1999, POLITICIANS POACHERS; AXELROD R, 1986, AM POLIT SCI REV, V80, P1095, DOI 10.2307/1960858; Berkes F., 1998, LINKING SOCIAL ECOLO, V1st, DOI DOI 10.1017/CBO9780511541957; Berkes F., 1989, COMMON PROPERTY RESO; Blomquist W., 1992, DIVIDING WATERS GOVE; Bowles Samuel, 1997, HOMO RECIPROCANS RES; Broecker WS, 1997, SCIENCE, V278, P1582, DOI 10.1126/science.278.5343.1582; Bromley D. W., 1992, MAKING COMMONS WORK; Buchanan J., 1962, CALCULUS CONSENT; Buck Susan J, 1998, GLOBAL COMMONS INTRO; Burger J, 1998, CONDOR, V100, P528, DOI 10.2307/1369719; CLARK CW, 1994, INVESTING IN NATURAL CAPITAL, P343; COSMIDES L, 1994, AM ECON REV, V84, P327; Cosmides L., 1992, ADAPTED MIND EVOLUTI, P163; Costanza R, 1998, SCIENCE, V281, P198, DOI 10.1126/science.281.5374.198; Demsetz H, 1967, AM ECON REV, V57, P347; Feeny D, 1996, LAND ECON, V72, P187, DOI 10.2307/3146965; FEENY D, 1990, HUM ECOL, V18, P1, DOI 10.1007/BF00889070; FINLAYSON AC, 1998, LINKING SOCIAL ECOLO, P331; Gordon HS, 1954, J POLIT ECON, V62, P124, DOI 10.1086/257497; Haas P.M., 1993, I EARTH SOURCES EFFE; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hardin G, 1998, SCIENCE, V280, P682, DOI 10.1126/science.280.5364.682; HESS C, 1996, COMMON POOL RESOURCE, V3; Hilton R. M., 1992, Journal of Theoretical Politics, V4, P283, DOI 10.1177/0951692892004003003; Hoffman E, 1996, AM ECON REV, V86, P653; Humphrey Caroline, 1996, CULTURE ENV INNER AS, V1; Kagel JH, 1995, HDB EXPT EC; Keohane R. O., 1995, LOCAL COMMONS GLOBAL; KRIER JE, 1992, HARVARD J LAW PUBL P, V15, P325; Lam W. F., 1998, GOVERNING IRRIGATION; Lam WF, 1996, WORLD DEV, V24, P1301, DOI 10.1016/0305-750X(96)00043-5; LIBECAP GD, 1989, J INST THEOR ECON, V145, P6; LUDWIG D, 1993, SCIENCE, V260, P17, DOI 10.1126/science.260.5104.17; McGinnis M., 1996, INT POLITICAL EC INT, V2, P465; McKean M. A., 1992, J THEORETICAL POLITI, V4, P247, DOI DOI 10.1177/0951692892004003002; MICHELMAN F, 1990, LIBERTY PROPERTY FUT; National Research Council, 1999, SUST MAR FISH; NORGAARD RB, 1995, ADV HUMAN ECOLOGY, V4, P141; NORTH DC, 1994, AM ECON REV, V84, P359; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; ORBELL JM, 1988, J PERS SOC PSYCHOL, V54, P811, DOI 10.1037/0022-3514.54.5.811; *ORG EC COOP DEV, 1997, SUST FISH EC ASP MAN; Ostrom E, 1998, AM POLIT SCI REV, V92, P1, DOI 10.2307/2585925; OSTROM E, IN PRESS COMMONS REV; Ostrom E., 1997, PERSPECTIVES PUBLIC, P35; Ostrom E., 1990, GOVERNING COMMONS EV; Ostrom E., 1994, RULES GAMES COMMON P; OSTROM V, 1990, B YOUNG U LAW REV, V3, P857; Pinkerton Evelyn, 1989, COOPERATIVE MANAGEME; PLOTT CR, 1986, SCIENCE, V232, P732, DOI 10.1126/science.232.4751.732; REPETTO R, 1985, 4 WORLD RES I; Rose Carol, 1994, PROPERTY PERSUASION; SAFINA C, 1994, ISSUES SCI TECHNOL, V10, P37; SCHLAGER E, 1994, LAND ECON, V70, P294, DOI 10.2307/3146531; Sneath D, 1998, SCIENCE, V281, P1147, DOI 10.1126/science.281.5380.1147; Speck Frank G., 1946, AM ANTHROPOL, V48, P355; Tang Shui-Yan., 1992, I COLLECTIVE ACTION; Wade R., 1994, VILLAGE REPUBLICS EC; WHITEMAN L, 1997, NATL PARKS, V71, P22; Wiener JB, 1999, YALE LAW J, V108, P677, DOI 10.2307/797394; WIERNER JB, IN PRESS GEORGETOWN; Young O., 1999, SCI PLAN I DIMENSION; YOUNG OR, 1997, GLOBAL GOVERNANCE DR; [No title captured]; [No title captured]	68	1458	1492	26	623	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 9	1999	284	5412					278	282		10.1126/science.284.5412.278	http://dx.doi.org/10.1126/science.284.5412.278			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	184WH	10195886				2022-12-28	WOS:000079636400032
J	Cunningham, PJ; Grossman, JM; St Peter, RF; Lesser, CS				Cunningham, PJ; Grossman, JM; St Peter, RF; Lesser, CS			Managed care and physicians' provision of charity care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICAL-CARE; TRENDS; RACE	Context Health system changes may be affecting the ability of physicians to provide care with little or no compensation from patients who are uninsured and underinsured and may result in decreased access to physicians for uninsured persons. Objective To examine the association between managed care and physicians' provision of charity care. Design The 1996-1997 Community Tracking Study physician survey. Setting and Participants A nationally representative sample of 10 881 physicians from 60 randomly selected communities. Main Outcome Measure The number of hours in the month prior to the interview that the physician provided care for free or at reduced fees because of the financial need of the patient. Results Overall, 77.3 % of respondents provided an average of 10.3 hours of charity care per week. Physicians who derive at least 85% of their practice revenue from managed care plans were considerably less likely to provide charity care and spend fewer hours providing charity care than physicians with little involvement in managed care plans (P = .01). In addition, physicians who practice in areas with high managed care penetration provided fewer hours of charity care than physicians in other areas, regardless of their own level of involvement with managed care (P<.01). Differences in charity care provision were also shown for other important factors, including ownership of the practice and practice arrangements (more charity care occurred in solo and 2-physician practices; P<.01). Conclusion Physicians involved with managed care plans and those who practice in areas with high managed care penetration tend to provide less charity care.	Ctr Studying Hlth Syst Change, Washington, DC 20024 USA; Kansas Hlth Inst, Topeka, KS USA		Cunningham, PJ (corresponding author), Ctr Studying Hlth Syst Change, 600 Maryland Ave,Suite 550, Washington, DC 20024 USA.							*AM HOSP ASS, 1997, 1996 ANN SURV HOSP D; Bindman AB, 1998, JAMA-J AM MED ASSOC, V279, P675, DOI 10.1001/jama.279.9.675; Blumenthal D, 1996, HEALTH AFFAIR, V15, P170, DOI 10.1377/hlthaff.15.2.170; BLUMENTHAL D, 1991, MED CARE, V29, P502, DOI 10.1097/00005650-199106000-00010; Cantor JC, 1996, INQUIRY-J HEALTH CAR, V33, P167; CULLER SD, 1986, J HUM RESOUR, V21, P138, DOI 10.2307/145961; CUNNINGHAM PJ, 1998, 1 CTR STUD HLTH SYST; DUAN H, 1982, RAND HLTH INSURANCE; DUNHAM NC, 1991, JAMA-J AM MED ASSOC, V265, P2982, DOI 10.1001/jama.265.22.2982; EMMONS DW, 1995, UNCOMPENSATED PHYSIC; GAYNOR M, 1996, INT HLTH EC ASS M MA; GONZALEZ M, 1998, PHYSICIAN MARKETPLAC; HOLLEMAN MC, 1991, MED CARE, V29, P654, DOI 10.1097/00005650-199107000-00005; HURDLE S, 1989, INQUIRY-J HEALTH CAR, V26, P100; *INT PUBL, 1997, INT COMP EDG 7 1; Kemper P, 1996, INQUIRY-J HEALTH CAR, V33, P195; Kletke PR, 1996, JAMA-J AM MED ASSOC, V276, P555, DOI 10.1001/jama.276.7.555; Manning WG, 1998, J HEALTH ECON, V17, P283, DOI 10.1016/S0167-6296(98)00025-3; METCALF CE, 1996, SITE DEFINITION SAMP; MOY E, 1995, JAMA-J AM MED ASSOC, V273, P1515, DOI 10.1001/jama.273.19.1515; OHSFELDT RL, 1985, MED CARE, V23, P1338, DOI 10.1097/00005650-198512000-00003; Robinson JC, 1998, JAMA-J AM MED ASSOC, V279, P144, DOI 10.1001/jama.279.2.144; Shah BV, 1996, SUDAAN USERS MANUAL; Simon CJ, 1997, HEALTH AFFAIR, V16, P89, DOI 10.1377/hlthaff.16.6.89; Simon CJ, 1996, HEALTH AFFAIR, V15, P124, DOI 10.1377/hlthaff.15.3.124; Xu G, 1997, AM J PUBLIC HEALTH, V87, P817, DOI 10.2105/AJPH.87.5.817	26	115	115	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	1999	281	12					1087	1092		10.1001/jama.281.12.1087	http://dx.doi.org/10.1001/jama.281.12.1087			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	177EP	10188658	Bronze			2022-12-28	WOS:000079197100029
J	Chiu, DT; Wilson, CF; Ryttsen, F; Stromberg, A; Farre, C; Karlsson, A; Nordholm, S; Gaggar, A; Modi, BP; Moscho, A; Garza-Lopez, RA; Orwar, O; Zare, RN				Chiu, DT; Wilson, CF; Ryttsen, F; Stromberg, A; Farre, C; Karlsson, A; Nordholm, S; Gaggar, A; Modi, BP; Moscho, A; Garza-Lopez, RA; Orwar, O; Zare, RN			Chemical transformations in individual ultrasmall biomimetic containers	SCIENCE			English	Article							ELECTRICAL BREAKDOWN; SINGLE MOLECULES; AQUEOUS CONTENTS; MEMBRANES; KINETICS; FUSION; CELL	Individual phospholipid vesicles, 1 to 5 micrometers in diameter, containing a single reagent or a complete reaction system, were immobilized with an infrared laser optical trap or by adhesion to modified borosilicate glass surfaces. Chemical transformations were initiated either by electroporation or by electrofusion, in each case through application of a short (10-microsecond), intense (20 to 50 kilovolts per centimeter) electric pulse delivered across ultramicroelectrodes. Product formation was monitored by far-field laser fluorescence microscopy. The ultrasmall characteristic of this reaction volume led to rapid diffusional mixing that permits the study of fast chemical kinetics. This technique is also well suited for the study of reaction dynamics of biological molecules within lipid-enclosed nanoenvironments that mimic cell membranes.	Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Univ Gothenburg, Dept Chem, S-41296 Gothenburg, Sweden; Pomona Coll, Dept Chem, Claremont, CA 91711 USA	Stanford University; University of Gothenburg; Claremont Colleges; Pomona College	Zare, RN (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.		Zare, Richard N./A-8410-2009; Nordholm, Sture/A-8506-2010	Zare, Richard/0000-0001-5266-4253	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009873] Funding Source: NIH RePORTER; NIDA NIH HHS [DA09873] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		CHANG DC, 1990, BIOPHYS J, V58, P1, DOI 10.1016/S0006-3495(90)82348-1; CHERNOMORDIK LV, 1987, BIOCHIM BIOPHYS ACTA, V902, P360, DOI 10.1016/0005-2736(87)90204-5; Chiu DT, 1997, ANAL CHEM, V69, P1801, DOI 10.1021/ac961226g; Clark RA, 1997, ANAL CHEM, V69, P259, DOI 10.1021/ac960559a; Drott J, 1998, THIN SOLID FILMS, V330, P161, DOI 10.1016/S0040-6090(98)00543-4; DUZGUNES N, 1993, METHOD ENZYMOL, V220, P3, DOI 10.1016/0076-6879(93)20069-F; ERMAK DL, 1975, J CHEM PHYS, V62, P4189, DOI 10.1063/1.430300; FUNAKURA S, 1994, J PHYS CHEM-US, V98, P3073, DOI 10.1021/j100063a003; Jensen K, 1998, NATURE, V393, P735, DOI 10.1038/31590; Knight JB, 1998, PHYS REV LETT, V80, P3863, DOI 10.1103/PhysRevLett.80.3863; Kovacs GTA, 1996, ANAL CHEM, V68, pA407, DOI 10.1021/ac961977i; Kung CY, 1998, ANAL CHEM, V70, P658, DOI 10.1021/ac971107g; Masuhara H., 1994, MICROCHEMISTRY SPECT; Moscho A, 1996, P NATL ACAD SCI USA, V93, P11443, DOI 10.1073/pnas.93.21.11443; NEEDHAM D, 1993, METHOD ENZYMOL, V220, P111, DOI 10.1016/0076-6879(93)20078-H; Nie SM, 1997, ANNU REV BIOPH BIOM, V26, P567, DOI 10.1146/annurev.biophys.26.1.567; ROTMAN B, 1961, P NATL ACAD SCI USA, V47, P1981, DOI 10.1073/pnas.47.12.1981; STENGER DA, 1988, BIOPHYS J, V53, P833, DOI 10.1016/S0006-3495(88)83162-X; Tan WH, 1997, ANAL CHEM, V69, P4242, DOI 10.1021/ac970631k; TSIEN RY, 1989, ANNU REV NEUROSCI, V12, P227, DOI 10.1146/annurev.neuro.12.1.227; TURQ P, 1977, J CHEM PHYS, V66, P3039, DOI 10.1063/1.434317; WILHELM C, 1993, BIOPHYS J, V64, P121, DOI 10.1016/S0006-3495(93)81346-8; You AJ, 1997, CHEM BIOL, V4, P969, DOI 10.1016/S1074-5521(97)90305-7; ZIMMERMANN U, 1982, BIOCHIM BIOPHYS ACTA, V694, P227, DOI 10.1016/0304-4157(82)90007-7	24	223	257	0	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 19	1999	283	5409					1892	1895		10.1126/science.283.5409.1892	http://dx.doi.org/10.1126/science.283.5409.1892			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177UC	10082457				2022-12-28	WOS:000079228600040
J	Woloshin, S; Schwartz, LM				Woloshin, S; Schwartz, LM			The US Postal Service and cancer screening - Stamps of approval?	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Vet Affairs Med & Reg Off Ctr, Vet Affairs Outcomes Grp 111B, White River Junction, VT 05009 USA		Woloshin, S (corresponding author), Vet Affairs Med & Reg Off Ctr, Vet Affairs Outcomes Grp 111B, N Hartland Rd, White River Junction, VT 05009 USA.							*AM CANC SOC, 1997, CANC FACTS FIG 1997; *AM UR ASS, 1997, EX COM REP EARL DET; American Cancer Society, 1993, GUID CANC REL CHECK; ANGELL M, 1997, NY TIMES        0504, P44; Fletcher SW, 1997, NEW ENGL J MED, V336, P1180, DOI 10.1056/NEJM199704173361612; *POST SERV, 1998, POST SERV GUID US ST; U.S. Preventive Services Task Force, 1996, GUID CLIN PREV SERV	7	23	23	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 18	1999	340	11					884	887		10.1056/NEJM199903183401112	http://dx.doi.org/10.1056/NEJM199903183401112			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	176ZW	10080855				2022-12-28	WOS:000079183200012
J	Feder, G; Eccles, M; Grol, R; Griffiths, C; Grimshaw, J				Feder, G; Eccles, M; Grol, R; Griffiths, C; Grimshaw, J			Using clinical guidelines	BRITISH MEDICAL JOURNAL			English	Article							DEVELOPMENT PROJECT; MANAGEMENT; NORTH; CARE		Univ London Queen Mary & Westfield Coll, St Bartholomews & Royal London Med Coll, Dept Gen Practice & Primary Care, London E1 4NS, England; Catholic Univ Nijmegen, Ctr Qual Care Res, NL-6500 HB Nijmegen, Netherlands; Univ Newcastle Upon Tyne, Ctr Hlth Serv Res, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England; Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB9 2ZD, Scotland	University of London; Queen Mary University London; Radboud University Nijmegen; Newcastle University - UK; University of Aberdeen	Feder, G (corresponding author), Univ London Queen Mary & Westfield Coll, St Bartholomews & Royal London Med Coll, Dept Gen Practice & Primary Care, Mile End Rd, London E1 4NS, England.	g.s.feder@mds.qmw.ac.uk	Grol, Richard/C-8523-2013; Eccles, Martin P/AAD-4029-2020; Grimshaw, Jeremy/D-8726-2013	Grimshaw, Jeremy/0000-0001-8015-8243; Feder, Gene/0000-0002-7890-3926				*AG HLTH CAR POL R, 1995, AHCPR PUBL; BERO L, 1998, COCHRANE EFFECTIVE P; Cluzeau F, 1994, Qual Health Care, V3, P121, DOI 10.1136/qshc.3.3.121; *COCHR COLL, 1998, COCHR LIBR; Eccles M, 1998, BRIT MED J, V316, P1232, DOI 10.1136/bmj.316.7139.1232; Eccles M, 1998, BMJ-BRIT MED J, V316, P1369, DOI 10.1136/bmj.316.7141.1369; Eccles M, 1996, BMJ-BRIT MED J, V312, P760; EMSLIE C, 1993, BRIT MED J, V306, P1728, DOI 10.1136/bmj.306.6894.1728; FEDER G, 1995, BRIT MED J, V311, P1473, DOI 10.1136/bmj.311.7018.1473; FREEMANTLE N, 1996, COCHRANE LIBRARY; GRIFFITHS C, 1998, EVIDENCE BASED PRACT; GRIMSHAW JM, 1998, EVIDENCE BASED PRACT; Grol R, 1997, BRIT MED J, V315, P418, DOI 10.1136/bmj.315.7105.418; HAYWARD RSA, 1995, JAMA-J AM MED ASSOC, V274, P570, DOI 10.1001/jama.274.7.570; LOMAS J, 1994, DISSEMINATING RES CH, V6; *NHS EX, 1998, 1 CLASS SERV QUAL NE; *NHS EX, 1996, CLIN GUID TEST CLIN; OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423; PETRIE JC, 1995, HLTH B, V53, P315; *ROYAL COLL GEN PR, 1996, DEV IMPL CLIN GUID R; Sackett D., 1996, EVIDENCE BASED MED P; Shekelle PG, 1999, BRIT MED J, V318, P593, DOI 10.1136/bmj.318.7183.593; Wensing M, 1994, Int J Qual Health Care, V6, P115; WOOLF SH, 1998, BMJ, V318; 1994, EFFECTIVE HLTH CARE	25	221	225	0	13	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 13	1999	318	7185					728	730						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182JK	10074024				2022-12-28	WOS:000079495700033
J	Ledergerber, B; Egger, M; Opravil, M; Telenti, A; Hirschel, B; Battegay, M; Vernazza, P; Sudre, P; Flepp, M; Furrer, H; Francioli, P; Weber, R				Ledergerber, B; Egger, M; Opravil, M; Telenti, A; Hirschel, B; Battegay, M; Vernazza, P; Sudre, P; Flepp, M; Furrer, H; Francioli, P; Weber, R		Swiss HIV Cohort Study	Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study	LANCET			English	Article							IMMUNODEFICIENCY-VIRUS INFECTION; INDINAVIR; COUNTS	Background The efficacy of highly active antiretroviral therapy (HAART) in suppression of HIV-1 is well documented. We investigated virological and clinical outcomes of HAART in routine practice. Methods We analysed prospective data from the Swiss HIV Cohort Study on suppression of viral load and progression to AIDS or death in 2674 outpatients (median age 36 years, 27.3% women) who started HAART in 1995-98. Viral rebound was defined as two consecutive HIV-1-RNA measurements of more than 400 copies/mL. We analysed separately outcomes in patients with a history of antiretroviral treatment and in treatment-naive patients. Findings An estimated 90.7% of treatment-naive patients reached undetectable viral load (<400 copies/mL) by 12 months. Among pretreated patients, estimates ranged from 70.3% treated with one new drug to 78.7% on three new drugs. 2 years after reaching undetectable concentrations, an estimated 20.1% of treatment-naive patients and 35.7-40.1% of pretreated patients had viral rebound. At 30 months, an estimated 6.6% (95% CI 4.6-8.6) of patients who had maintained undetectable concentrations, 9.0% (5.5-12.5) who had viral rebound, and 20.1% (15.3-24.9) who had never reached undetectable concentrations developed AIDS or died. Compared with patients who maintained undetectable viral load, the adjusted relative hazard of AIDS or death was 1.00 (0.66-1.55) for patients with viral rebound, and 2.40 (1.72-3.33) for patients who failed to reach undetectable concentrations. Interpretation The rate of virological failure of HAART was high among these patients, but the probability of clinical progression was low even in patients with viral rebound.	Univ Zurich, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; Univ Bristol, Dept Social Med, MRC, Hlth Serv Res Collaborat, Bristol, Avon, England; Univ Lausanne, Div Infect Dis, Lausanne, Switzerland; Univ Lausanne, Div Hosp Prevent Med, Lausanne, Switzerland; Univ Geneva, Div Infect Dis, Geneva, Switzerland; Univ Basel, Outpatient Dept Internal Med, Basel, Switzerland; Cantonal Hosp St Gall, Div Internal Med, St Gallen, Switzerland; Univ Bern, Outpatient Dept Internal Med, Bern, Switzerland	University of Zurich; University of Bristol; University of Lausanne; University of Lausanne; University of Geneva; University of Basel; Kantonsspital St. Gallen; University of Bern	Ledergerber, B (corresponding author), Univ Zurich Hosp, Div Infect Dis, U RAE 33, CH-8091 Zurich, Switzerland.	infled@usz.unizh.ch	Weber, Rainer/D-5175-2012; Telenti, Amalio/AAY-1674-2021; Ledergerber, Bruno/B-5656-2009; Furrer, Hansjakob/G-6768-2013	Ledergerber, Bruno/0000-0002-6881-4401; Furrer, Hansjakob/0000-0002-1375-3146; Egger, Matthias/0000-0001-7462-5132				BABIKER A, 1997, 6 EUR C CLIN ASP TRE, P207; Brodt HR, 1997, AIDS, V11, P1731, DOI 10.1097/00002030-199714000-00010; Carpenter CCJ, 1998, JAMA-J AM MED ASSOC, V280, P78, DOI 10.1001/jama.280.1.78; Carr A, 1998, LANCET, V351, P1881, DOI 10.1016/S0140-6736(98)03391-1; Casado JL, 1998, AIDS, V12, pF131, DOI 10.1097/00002030-199811000-00005; CDC (Centers for Disease Control and Prevention), 1993, MMWR RECOMM REP, V41, P1; Egger M, 1997, BMJ-BRIT MED J, V315, P1194, DOI 10.1136/bmj.315.7117.1194; Fatkenheuer G, 1997, AIDS, V11, pF113, DOI 10.1097/00002030-199714000-00001; FEINSTEIN A, 1984, STAT MED, V3, P341, DOI 10.1002/sim.4780030409; FLEMING TR, 1994, STAT MED, V13, P955, DOI 10.1002/sim.4780130906; Gazzard B, 1998, LANCET, V352, P314, DOI 10.1016/S0140-6736(98)04084-7; GREEN SB, 1984, STAT MED, V3, P361, DOI 10.1002/sim.4780030413; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Gulick RM, 1998, JAMA-J AM MED ASSOC, V280, P35, DOI 10.1001/jama.280.1.35; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hirschel B, 1998, NEW ENGL J MED, V338, P906, DOI 10.1056/NEJM199803263381310; Ho DD, 1996, SCIENCE, V272, P1124, DOI 10.1126/science.272.5265.1124; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; Kaufmann D, 1998, LANCET, V351, P723, DOI 10.1016/S0140-6736(98)24010-4; LEDERGERBER B, 1994, SOZ PRAVENTIV MED, V39, P387, DOI 10.1007/BF01299670; Levy JA, 1998, LANCET, V352, P982, DOI 10.1016/S0140-6736(98)05391-4; Lorenzi P, 1999, AIDS, V13, pF17, DOI 10.1097/00002030-199902040-00001; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Mocroft A, 1998, AIDS, V12, P2161, DOI 10.1097/00002030-199816000-00011; Monforte AD, 1998, AIDS, V12, P1631, DOI 10.1097/00002030-199813000-00010; MONTANE RJSG, 1998, JAMA-J AM MED ASSOC, V279, P930; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Perry CM, 1998, DRUGS, V55, P461, DOI 10.2165/00003495-199855030-00014	28	790	803	0	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 13	1999	353	9156					863	868		10.1016/S0140-6736(99)01122-8	http://dx.doi.org/10.1016/S0140-6736(99)01122-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BU	10093977				2022-12-28	WOS:000079421400007
J	Paggel, JJ; Miller, T; Chiang, TC				Paggel, JJ; Miller, T; Chiang, TC			Quantum-well states as Fabry-Perot modes in a thin-film electron interferometer	SCIENCE			English	Article							BAND-STRUCTURE; NOBLE-METALS; PHOTOEMISSION; BULK	Angle-resolved photoemissian from atomically uniform silver films on iron (100) shows quantum-well states for absolutely determined film thicknesses ranging from 1 to similar to 100 monolayers. These states can be understood in terms of Fabry-Perot modes in an electron interferometer. A quantitative Line shape analysis over the entire two orders of magnitude of thickness range yields an accurate measurement of the band structure, quasiparticle Lifetime, electron reflectivity, and phase shift. Effects of confinement energy gap, reflection Loss, and surface scattering caused by controlled roughness are demonstrated.	Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Chiang, TC (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.		Chiang, Tai C/H-5528-2011					BADUREK G, 1988, PHYSICA B, V151, P1; Born M., 1980, PRINCIPLES OPTICS; Cohen-Tannoudji C., 1977, QUANTUM MECH; COLERIDGE PT, 1982, PHYS REV B, V25, P7818, DOI 10.1103/PhysRevB.25.7818; ECKARDT H, 1984, J PHYS F MET PHYS, V14, P97, DOI 10.1088/0305-4608/14/1/013; HALSE MR, 1969, PHILOS T R SOC S-A, V265, P507, DOI 10.1098/rsta.1969.0064; Hansen ED, 1998, PHYS REV LETT, V80, P1766, DOI 10.1103/PhysRevLett.80.1766; HUFNER S, 1996, PHOTOELECTRON SPECTR; JORNSSON C, 1961, Z PHYS, V161, P454; LINDGREN SA, 1988, PHYS REV LETT, V61, P2894, DOI 10.1103/PhysRevLett.61.2894; LOLY PD, 1983, J PHYS C SOLID STATE, V16, P423, DOI 10.1088/0022-3719/16/2/025; Miller T, 1996, PHYS REV LETT, V77, P1167, DOI 10.1103/PhysRevLett.77.1167; MUELLER MA, 1990, PHYS REV B, V41, P5214, DOI 10.1103/PhysRevB.41.5214; Paggel JJ, 1998, PHYS REV LETT, V81, P5632, DOI 10.1103/PhysRevLett.81.5632; Pines D., 1966, THEORY QUANTUM LIQUI; SMITH NV, 1994, PHYS REV B, V49, P332, DOI 10.1103/PhysRevB.49.332; STEELE CA, 1981, PHYS REV B, V24, P6129, DOI 10.1103/PhysRevB.24.6129	17	232	242	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	1999	283	5408					1709	1711		10.1126/science.283.5408.1709	http://dx.doi.org/10.1126/science.283.5408.1709			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175PF	10073930				2022-12-28	WOS:000079102800043
J	Cocks, TM; Fong, B; Chow, JM; Anderson, GP; Frauman, AG; Goldie, RG; Henry, PJ; Carr, MJ; Hamilton, JR; Moffatt, JD				Cocks, TM; Fong, B; Chow, JM; Anderson, GP; Frauman, AG; Goldie, RG; Henry, PJ; Carr, MJ; Hamilton, JR; Moffatt, JD			A protective role for protease-activated receptors in the airways	NATURE			English	Article							THROMBIN RECEPTOR; MOLECULAR-CLONING; NITRIC-OXIDE; EXPRESSION; MECHANISMS; BRADYKININ	The protection of cells in the upper intestine against digestion by pancreatic trypsin depends on the prostanoid prostaglandin E-2 (PGE(2)) and is mediated by protease-activated receptors in the epithelium(1,2). As the airway epithelium is morphologically similar and also expresses one of these receptors, PAR2 (ref. 3), and is a major source of PGE2 (ref. 4), we reasoned that bronchial epithelial PAR2 might also participate in prostanoid-dependent cytoprotection in the airways, Here we show that activation of PAR2, which co-localizes immunohistochemically with trypsin(ogen) in airway epithelium, causes the relaxation of airway preparations from mouse, rat, guinea-pig and humans by the release of a cyclooxygenase product from the epithelium.This physiological protective response in isolated airways also occurred in anaesthetized rats, where activation of PAR2 caused a marked and prolonged inhibition of bronchoconstriction. After desensitization of PAR2, the response to trypsin recovered rapidly by mechanisms dependent on de novo synthesis and trafficking of proteins. Our results indicate that trypsin released from the epithelium can initiate powerful bronchoprotection in the airways by activation of epithelial PAR2.	Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia; Univ Melbourne, Dept Med, Parkville, Vic 3052, Australia; Univ Western Australia, Dept Pharmacol, Perth, WA 6907, Australia	University of Melbourne; University of Melbourne; University of Western Australia	Cocks, TM (corresponding author), Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia.	t.cocks@pharmacology.unimelb.edu.au		Anderson, Gary/0000-0001-6580-3398; Henry, Peter/0000-0002-8213-0508				Blackhart BD, 1996, J BIOL CHEM, V271, P16466, DOI 10.1074/jbc.271.28.16466; Bohm SK, 1996, J BIOL CHEM, V271, P22003; Bohm SK, 1996, BIOCHEM J, V314, P1009; CHOUDRY NB, 1989, AM REV RESPIR DIS, V140, P137, DOI 10.1164/ajrccm/140.1.137; COUGHLIN SR, 1994, TRENDS CARDIOVAS MED, V4, P77, DOI 10.1016/1050-1738(94)90013-2; D'Andrea MR, 1998, J HISTOCHEM CYTOCHEM, V46, P157; Dery O, 1998, AM J PHYSIOL-CELL PH, V274, pC1429, DOI 10.1152/ajpcell.1998.274.6.C1429; Ishihara H, 1997, NATURE, V386, P502, DOI 10.1038/386502a0; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Kawano N, 1997, HUM PATHOL, V28, P613, DOI 10.1016/S0046-8177(97)90085-X; Kemp BK, 1997, BRIT J PHARMACOL, V120, P757, DOI 10.1038/sj.bjp.0700928; Kong WY, 1997, P NATL ACAD SCI USA, V94, P8884, DOI 10.1073/pnas.94.16.8884; MANNING PJ, 1987, J APPL PHYSIOL, V63, P1572, DOI 10.1152/jappl.1987.63.4.1572; Molino M, 1997, J BIOL CHEM, V272, P11133; MONCADA S, 1991, PHARMACOL REV, V43, P109; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P8208; OBYRNE PM, 1986, AM REV RESPIR DIS, V134, P69; PAVORD ID, 1994, LANCET, V344, P436; Szarek JL, 1998, AM J PHYSIOL-LUNG C, V275, pL1006, DOI 10.1152/ajplung.1998.275.5.L1006; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; WEIDEMANN HP, 1996, CURR OPIN PULM MED, V2, P155; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642	22	309	318	0	11	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 11	1999	398	6723					156	160		10.1038/18223	http://dx.doi.org/10.1038/18223			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176DG	10086357				2022-12-28	WOS:000079135200046
J	Guse, AH; da Silva, CP; Berg, I; Skapenko, AL; Weber, K; Heyer, P; Hohenegger, M; Ashamu, GA; Schulze-Koops, H; Potter, BVL; Mayr, GW				Guse, AH; da Silva, CP; Berg, I; Skapenko, AL; Weber, K; Heyer, P; Hohenegger, M; Ashamu, GA; Schulze-Koops, H; Potter, BVL; Mayr, GW			Regulation of calcium signalling in T lymphocytes by the second messenger cyclic ADP-ribose	NATURE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; CA2+-INDUCED CA2+ RELEASE; RYANODINE RECEPTOR; CELL RECEPTOR; ENTRY; CHANNELS; MEMBRANE; MODULATION; HYDROLYSIS; DEPLETION	Cyclic ADP-ribose (cADPR) is a natural compound that mobilizes calcium ions in several eukaryotic cells(1-3). Although it can lead to the release of calcium ions in T lymphocytes(4-7), it has not been firmly established as a second messenger in these cells. Here, using high-performance liquid chromatography analysis(8), we show that stimulation of the T-cell receptor/CD3 (TCR/CD3) complex results in activation of a soluble ADP-ribosyl cyclase and a sustained increase in intracellular levels of cADPR. There is a causal relation between increased cADPR concentrations, sustained calcium signalling and activation of T cells, as shown by inhibition of TCR/CD3-stimulated calcium sig-nailing, cell proliferation and expression of the early- and late-activation markers I CD25 and HLA-DR by using cADPR antagonists(9). The molecular target for cADPR, the type-3 ryanodine receptor/calcium channel, is expressed in T cells. Increased cADPR significantly and specifically stimulates the apparent association of [H-3]ryanodine with the type-3 ryanodine receptor, indicating a direct modulatory effect of cADPR on channel opening. Thus we show the presence, causal relation and biological significance of the major constituents of the cADPR/calcium-signalling pathway in human T cells.	Univ Hamburg, Inst Physiol Chem, Dept Enzyme Chem, D-20146 Hamburg, Germany; Univ Erlangen Nurnberg, Dept Internal Med 3, D-91054 Erlangen, Germany; Univ Vienna, Inst Pharmacol, A-1090 Vienna, Austria; Univ Bath, Dept Pharm & Pharmacol, Wolfson Lab Med Chem, Bath BA2 7AY, Avon, England	University of Hamburg; University of Erlangen Nuremberg; University of Vienna; University of Bath	Guse, AH (corresponding author), Univ Hamburg, Inst Physiol Chem, Dept Enzyme Chem, Grindelallee 117, D-20146 Hamburg, Germany.	guse@uke.uni-hamburg.de	Potter, Barry/AAX-4781-2020; Hohenegger, Martin/AAF-6479-2020; Potter, Barry VL/A-1845-2012	Hohenegger, Martin/0000-0001-6537-9574	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bennett DL, 1996, J BIOL CHEM, V271, P6356, DOI 10.1074/jbc.271.11.6356; BOURGUIGNON LYW, 1995, J BIOL CHEM, V270, P17917, DOI 10.1074/jbc.270.30.17917; Cancela JM, 1998, CURR BIOL, V8, P865, DOI 10.1016/S0960-9822(07)00347-8; da Silva CP, 1998, J CHROMATOGR B, V707, P43, DOI 10.1016/S0378-4347(97)00622-1; FANGER CM, 1995, J CELL BIOL, V131, P655, DOI 10.1083/jcb.131.3.655; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; Guse AH, 1998, CRIT REV IMMUNOL, V18, P419, DOI 10.1615/CritRevImmunol.v18.i5.20; Guse AH, 1997, J BIOL CHEM, V272, P8546, DOI 10.1074/jbc.272.13.8546; GUSE AH, 1995, J IMMUNOL, V155, P3353; Guse AH, 1996, J BIOL CHEM, V271, P23946, DOI 10.1074/jbc.271.39.23946; HAKAMATA Y, 1994, FEBS LETT, V352, P206, DOI 10.1016/0014-5793(94)00955-4; HELLMICH MR, 1991, CELL REGUL, V2, P193, DOI 10.1091/mbc.2.3.193; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; IMOTO M, 1993, J ANTIBIOT, V46, P1342, DOI 10.7164/antibiotics.46.1342; JAYARAMAN T, 1995, P NATL ACAD SCI USA, V92, P6007, DOI 10.1073/pnas.92.13.6007; Lee HC, 1997, PHYSIOL REV, V77, P1133, DOI 10.1152/physrev.1997.77.4.1133; LEE HC, 1989, J BIOL CHEM, V264, P1608; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; MESZAROS LG, 1993, NATURE, V364, P76, DOI 10.1038/364076a0; PARTISETI M, 1994, J BIOL CHEM, V269, P32327; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Ricard I, 1997, CELL SIGNAL, V9, P197, DOI 10.1016/S0898-6568(96)00141-6; Schulze-Koops H, 1998, EUR J IMMUNOL, V28, P2517, DOI 10.1002/(SICI)1521-4141(199808)28:08<2517::AID-IMMU2517>3.0.CO;2-5; SCHULZEKOOPS H, 1995, J IMMUNOL, V155, P5029; Sethi JK, 1997, J BIOL CHEM, V272, P16358, DOI 10.1074/jbc.272.26.16358; Sutko JL, 1996, PHYSIOL REV, V76, P1027, DOI 10.1152/physrev.1996.76.4.1027; Takemura H, 1996, BIOCHEM J, V319, P393, DOI 10.1042/bj3190393; Wu Y, 1997, SCIENCE, V278, P2126, DOI 10.1126/science.278.5346.2126; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	30	257	283	2	11	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 4	1999	398	6722					70	73		10.1038/18024	http://dx.doi.org/10.1038/18024			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174KG	10078531				2022-12-28	WOS:000079033900053
J	James, V; Kearsley, J; Irving, T; Amemiya, Y; Cookson, D				James, V; Kearsley, J; Irving, T; Amemiya, Y; Cookson, D			Using hair to screen for breast cancer	NATURE			English	Letter									Univ New S Wales, Rex Vowels Low Angle Diffract Lab, Sydney, NSW 2052, Australia; St George Hosp, Canc Care Ctr, Kogarah, NSW 2217, Australia; IIT, BCPS Dept, BioCAT, Chicago, IL 60616 USA; Univ Tokyo, Sch Engn, Engn Res Unit, Bunkyo Ku, Tokyo 113, Japan; Australian Nucl Sci & Technol Org, Menai, NSW 2234, Australia	University of New South Wales Sydney; St George Hospital; Illinois Institute of Technology; University of Tokyo; Australian Nuclear Science & Technology Organisation	James, V (corresponding author), Univ New S Wales, Rex Vowels Low Angle Diffract Lab, Sydney, NSW 2052, Australia.		Amemiya, Yoshiyuki/M-7147-2018	Amemiya, Yoshiyuki/0000-0003-3306-3772				James VJ, 1998, TEXT RES J, V68, P167, DOI 10.1177/004051759806800303; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Wilk KE, 1995, BBA-GEN SUBJECTS, V1245, P392, DOI 10.1016/0304-4165(95)00111-5	3	74	76	0	12	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 4	1999	398	6722					33	34		10.1038/17949	http://dx.doi.org/10.1038/17949			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174KG	10078527				2022-12-28	WOS:000079033900037
J	Royston, G				Royston, G			Commentary: trials versus models in appraising screening programmes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									NHS Execut, Leeds LS2 7UE, W Yorkshire, England		Royston, G (corresponding author), NHS Execut, Leeds LS2 7UE, W Yorkshire, England.	groyston@doh.gov.uk		Royston, Geoff/0000-0001-7180-3124				Baker R D, 1998, Health Care Manag Sci, V1, P103, DOI 10.1023/A:1019046619402; Brailsford S C, 1998, Health Care Manag Sci, V1, P115, DOI 10.1023/A:1019086300747; Brandeau M. L., 1990, AIDS and Public Policy Journal, V5, P119; *DEP HLTH, 1995, ASS OPT CANC KEY AR; Lilford R, 1998, J Health Serv Res Policy, V3, P159; PARKIN DM, 1986, J EPIDEMIOL COMMUN H, V40, P143, DOI 10.1136/jech.40.2.143; Royston G, 1998, EUR J OPER RES, V105, P267, DOI 10.1016/S0377-2217(97)00234-8; Sheldon TA, 1996, HEALTH ECON, V5, P1; TAYLOR K, 1998, J HEALTH SERV RES PO, P3226; van Oortmarssen G J, 1995, Stat Methods Med Res, V4, P33; Wildhagen MF, 1998, J EPIDEMIOL COMMUN H, V52, P459, DOI 10.1136/jech.52.7.459	11	24	24	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 6	1999	318	7180					360	361						6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166JN	10075469				2022-12-28	WOS:000078572600024
J	Shen, K; Meyer, T				Shen, K; Meyer, T			Dynamic control of CaMKII translocation and localization in hippocampal neurons by NMDA receptor stimulation	SCIENCE			English	Article							PROTEIN-KINASE-II; LONG-TERM POTENTIATION; POSTSYNAPTIC DENSITY; GLUTAMATE RECEPTORS; SYNAPTIC JUNCTIONS; MUTANT MICE; CALMODULIN; AUTOPHOSPHORYLATION; PHOSPHORYLATION; ACTIVATION	Calcium-calmodulin-dependent protein kinase II (CaMKII) is thought to increase synaptic strength by phosphorylating postsynaptic density (PSD) ion channels and signaling proteins. It is shown that N-methyl-D-aspartate (NMDA) receptor stimulation reversibly translocates green fluorescent protein-tagged CaMKII from an F-actin-bound to a PSD-bound state. The translocation time was controlled by the ratio of expressed beta-CaMKII to alpha-CaMKII isoforms. Although F-actin dissociation into the cytosol required autophosphorylation of or calcium-calmodulin binding to beta-CaMKII, PSD translocation required binding of calcium-calmodulin to either the alpha- or beta-CaMKII subunits. Autophosphorylation of CaMKII indirectly prolongs its PSD localization by increasing the calmodulin-binding affinity.	Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University; Duke University	Meyer, T (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Box 3709, Durham, NC 27710 USA.	tobias@cellbio.duke.edu		Meyer, Tobias/0000-0003-4339-3804	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048113, R55GM048113] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-48113] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; FONG YL, 1989, J BIOL CHEM, V264, P16759; FUKUNAGA K, 1992, J BIOL CHEM, V267, P22527; Gardoni F, 1998, J NEUROCHEM, V71, P1733; Glazewski S, 1996, SCIENCE, V272, P421, DOI 10.1126/science.272.5260.421; GOLDENRING JR, 1984, J NEUROCHEM, V42, P1077, DOI 10.1111/j.1471-4159.1984.tb12713.x; Gordon JA, 1996, NEURON, V17, P491, DOI 10.1016/S0896-6273(00)80181-6; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HU BR, 1995, J NEUROCHEM, V64, P277; LOU LL, 1986, P NATL ACAD SCI USA, V83, P9497, DOI 10.1073/pnas.83.24.9497; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MCGLADEMCCULLOH E, 1993, NATURE, V362, P640, DOI 10.1038/362640a0; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MILLER SG, 1985, J BIOL CHEM, V260, P9039; MUKHERJI S, 1994, J BIOL CHEM, V269, P13744; PETTIT DL, 1994, SCIENCE, V266, P1881, DOI 10.1126/science.7997883; Raman B, 1996, J BIOL CHEM, V271, P17067, DOI 10.1074/jbc.271.29.17067; SCHWORER CM, 1986, J BIOL CHEM, V261, P8581; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; SHIELDS SM, 1984, J NEUROCHEM, V43, P1599, DOI 10.1111/j.1471-4159.1984.tb06084.x; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Strack S, 1997, J BIOL CHEM, V272, P13467, DOI 10.1074/jbc.272.21.13467; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; SUZUKI T, 1994, J NEUROCHEM, V63, P1529, DOI 10.1046/j.1471-4159.1994.63041529.x; Teruel MN, 1997, BIOPHYS J, V73, P1785, DOI 10.1016/S0006-3495(97)78209-2; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Yokoe E, 1996, NAT BIOTECHNOL, V14, P1252, DOI 10.1038/nbt1096-1252; Yoshimura Y, 1997, J BIOL CHEM, V272, P26354, DOI 10.1074/jbc.272.42.26354	31	510	528	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	1999	284	5411					162	166		10.1126/science.284.5411.162	http://dx.doi.org/10.1126/science.284.5411.162			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182QE	10102820				2022-12-28	WOS:000079509000059
J	Jones, J				Jones, J			Deaths from nvCJD rise sharply	BRITISH MEDICAL JOURNAL			English	News Item																		Will RG, 1999, LANCET, V353, P979, DOI 10.1016/S0140-6736(99)01160-5; 1999, LANCET, V353, P939	2	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 27	1999	318	7187					829	829		10.1136/bmj.318.7187.829	http://dx.doi.org/10.1136/bmj.318.7187.829			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185DM	10092247	Green Published			2022-12-28	WOS:000079652900010
J	Seeling, JM; Miller, JR; Gil, R; Moon, RT; White, R; Virshup, DM				Seeling, JM; Miller, JR; Gil, R; Moon, RT; White, R; Virshup, DM			Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A	SCIENCE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; INSULIN; PATHWAY; PHOSPHORYLATION; IDENTIFICATION; SPECIFICITY; INHIBITION; AXIS	Dysregulation of Wnt-beta-catenin signaling disrupts axis formation in vertebrate embryos and underlies multiple human malignancies. The adenomatous polyposis coli (APC) protein, axin, and glycogen synthase kinase 3 beta form a Wnt-regulated signaling complex that mediates the phosphorylation-dependent degradation of beta-catenin. A protein phosphatase 2A (PP2A) regulatory subunit, B56, interacted with APC in the yeast two-hybrid system. Expression of B56 reduced the abundance of beta-catenin and inhibited transcription of beta-catenin target genes in mammalian cells and Xenopus embryo explants. The B56-dependent decrease in beta-catenin was blocked by oncogenic mutations in beta-catenin or APC, and by proteasome inhibitors. B56 may direct PP2A to dephosphorylate specific components of the APC-dependent signaling complex and thereby inhibit Wnt signaling.	Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84132 USA; Univ Utah, Dept Pediat, Salt Lake City, UT 84132 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Virshup, DM (corresponding author), Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84132 USA.	david.virshup@hci.utah.edu	Virshup, David M/C-1449-2009; Moon, Randall/M-5605-2019; Moon, Randall T/B-1743-2014; Gil, Rosario/R-6932-2018	Virshup, David M/0000-0001-6976-850X; Moon, Randall/0000-0002-9352-1408; Moon, Randall T/0000-0002-9352-1408; Gil, Rosario/0000-0002-9397-1003	NATIONAL CANCER INSTITUTE [R01CA071074, T32CA009602, P30CA042014] Funding Source: NIH RePORTER; NCI NIH HHS [3P30CA42014, R01 CA71074, T32CA09602] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AGOSTINIS P, 1992, EUR J BIOCHEM, V205, P241, DOI 10.1111/j.1432-1033.1992.tb16774.x; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CEGIELSKA A, 1994, MOL CELL BIOL, V14, P4616, DOI 10.1128/MCB.14.7.4616; Cook D, 1996, EMBO J, V15, P4526, DOI 10.1002/j.1460-2075.1996.tb00830.x; CROSS DAE, 1994, BIOCHEM J, V303, P21, DOI 10.1042/bj3030021; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Csortos C, 1996, J BIOL CHEM, V271, P2578, DOI 10.1074/jbc.271.5.2578; CUI YZ, 1995, DEVELOPMENT, V121, P2177; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hsu W, 1999, J BIOL CHEM, V274, P3439, DOI 10.1074/jbc.274.6.3439; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; MCCRIGHT B, 1995, J BIOL CHEM, V270, P26123, DOI 10.1074/jbc.270.44.26123; MCCRIGHT B, UNPUB; MCLELLAN T, 1985, CYTOGENET CELL GENET, V39, P224, DOI 10.1159/000132139; Moon RT, 1997, TRENDS GENET, V13, P256, DOI 10.1016/S0168-9525(97)01196-7; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Polakis P, 1997, BBA-REV CANCER, V1332, pF127, DOI 10.1016/S0304-419X(97)00008-5; SEELING JM, UNPUB; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; SUGANUMA M, 1992, CARCINOGENESIS, V13, P1841, DOI 10.1093/carcin/13.10.1841; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Voeller HJ, 1998, CANCER RES, V58, P2520; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; WELSH GI, 1993, BIOCHEM J, V294, P625, DOI 10.1042/bj2940625; WERA S, 1995, BIOCHEM J, V311, P17, DOI 10.1042/bj3110017; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; ZOLNIEROWICZ S, 1994, BIOCHEMISTRY-US, V33, P11858, DOI 10.1021/bi00205a023	30	352	355	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	1999	283	5410					2089	2091		10.1126/science.283.5410.2089	http://dx.doi.org/10.1126/science.283.5410.2089			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180DH	10092233				2022-12-28	WOS:000079369800048
J	Majeed, A; Malcolm, L				Majeed, A; Malcolm, L			Unified budgets for primary care groups	BRITISH MEDICAL JOURNAL			English	Article									UCL, Sch Publ Policy, London WC1H 9EZ, England; Aotearoa Hlth, Lyttelton, New Zealand	University of London; University College London	Majeed, A (corresponding author), UCL, Sch Publ Policy, London WC1H 9EZ, England.	a.majeed@ucl.ac.uk		Majeed, Azeem/0000-0002-2357-9858				Bevan G, 1998, BRIT MED J, V316, P39, DOI 10.1136/bmj.316.7124.39; Coulter A, 1998, BRIT MED J, V316, P1974, DOI 10.1136/bmj.316.7149.1974; Dixon J, 1997, BRIT MED J, V315, P1639, DOI 10.1136/bmj.315.7123.1639; Dixon J, 1998, BRIT MED J, V317, P125, DOI 10.1136/bmj.317.7151.125; Gilley J, 1999, BRIT MED J, V318, P168, DOI 10.1136/bmj.318.7177.168; Goodwin N, 1998, BRIT MED J, V317, P256, DOI 10.1136/bmj.317.7153.256; Greenhalgh T, 1998, BRIT MED J, V316, P750, DOI 10.1136/bmj.316.7133.750; JUDGE K, 1994, BRIT MED J, V308, P1363, DOI 10.1136/bmj.308.6940.1363; Klein R, 1998, BRIT MED J, V317, P5, DOI 10.1136/bmj.317.7150.5; MAJCED A, 1998, BRIT MED J, V316, P748; MAJEED A, 1999, PUBLIC HLTH MED, V1, P6; Malcolm L, 1997, BRIT MED J, V314, P1890, DOI 10.1136/bmj.314.7098.1890; MALCOLM L, 1998, HLTH MANAGER, V5, P7; Malcolm LA, 1998, MED J AUSTRALIA, V169, P147, DOI 10.5694/j.1326-5377.1998.tb116016.x; MAYS N, 1998, TOTAL PURCHASING STE; *NHS EX, 1998, NEW NHS MOD DEP EST; POLLOCK AM, 1998, HLTH SERVICE J  0409, P28; Scally G, 1998, BRIT MED J, V317, P61, DOI 10.1136/bmj.317.7150.61; *SECR STAT HLTH, 1997, NEW NHS; Sims A, 1997, J PUBLIC HEALTH MED, V19, P380, DOI 10.1093/oxfordjournals.pubmed.a024664	20	34	34	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 20	1999	318	7186					772	776		10.1136/bmj.318.7186.772	http://dx.doi.org/10.1136/bmj.318.7186.772			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BX	10082703	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000079421700027
J	Li, HS; Chen, JH; Wu, W; Fagaly, T; Zhou, LJ; Yuan, WL; Dupuis, S; Jiang, ZH; Nash, W; Gick, C; Ornitz, DM; Wu, JY; Rao, Y				Li, HS; Chen, JH; Wu, W; Fagaly, T; Zhou, LJ; Yuan, WL; Dupuis, S; Jiang, ZH; Nash, W; Gick, C; Ornitz, DM; Wu, JY; Rao, Y			Vertebrate slit, a secreted ligand for the transmembrane protein roundabout, is a repellent for olfactory bulb axons	CELL			English	Article							GROWTH CONE GUIDANCE; ODORANT RECEPTOR EXPRESSION; CENTRAL-NERVOUS-SYSTEM; DORSAL-ROOT GANGLIA; MITRAL TUFTED CELLS; EMBRYO SPINAL-CORD; C-ELEGANS; COMMISSURAL AXONS; MOTOR AXONS; FLOOR-PLATE	The olfactory bulb plays a central role in olfactory information processing through its connections with both peripheral and cortical structures. Axons projecting from the olfactory bulb to the telencephalon are guided by a repulsive activity in the septum. The molecular nature of the repellent is not known. We report here the isolation of vertebrate homologs of the Drosophila slit gene and show that Slit protein binds to the transmembrane protein Roundabout (Robo). Slit is expressed in the septum whereas Robe is expressed in the olfactory bulb. Functionally, Slit acts as a chemorepellent for olfactory bulb axons. These results establish a ligand-receptor relationship between two molecules important for neural development, suggest a role for Slit in olfactory bulb axon guidance, and reveal the existence of a new family of axon guidance molecules.	Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurobiol & Anat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Shanghai Res Ctr Life Sci, Mol Neurobiol Lab, Shanghai 200031, Peoples R China; Chinese Acad Sci, Chinese Inst Neurosci, Shanghai 200031, Peoples R China	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Wu, JY (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	jwu@pharmdec.wustl.edu; raoyi@thalamus.wustl.edu	Chen, Jinhui/A-7138-2009	Chen, Jinhui/0000-0002-6864-7121; Ornitz, David/0000-0003-1592-7629	NATIONAL CANCER INSTITUTE [R01CA114197] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070967] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA114197-01A2] Funding Source: Medline; NEI NIH HHS [R01 EY014576-03] Funding Source: Medline; NIGMS NIH HHS [R01 GM070967-02] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; BRUNJES PC, 1986, BRAIN RES REV, V11, P1, DOI 10.1016/0165-0173(86)90008-1; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHENG HJ, 1994, CELL, V79, P157, DOI 10.1016/0092-8674(94)90408-1; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; COLAMARINO SA, 1995, ANNU REV NEUROSCI, V18, P497, DOI 10.1146/annurev.ne.18.030195.002433; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; FITZGERALD M, 1993, DEVELOPMENT, V117, P1377; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Getchell TV., 1991, SMELL TASTE HLTH DIS, P19; Greer C. A., 1991, SMELL TASTE HLTH DIS, P65; GUTHRIE S, 1995, NEURON, V14, P1117, DOI 10.1016/0896-6273(95)90260-0; GUTHRIE S, 1994, NEUROPROTOCOLS, V4, P116; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; HINDS JW, 1972, J COMP NEUROL, V146, P233, DOI 10.1002/cne.901460207; HINDS JW, 1973, J COMP NEUROL, V151, P281, DOI 10.1002/cne.901510305; Hirata T, 1997, J NEUROBIOL, V32, P415, DOI 10.1002/(SICI)1097-4695(199704)32:4<415::AID-NEU5>3.0.CO;2-9; IMAMURA K, 1992, J NEUROPHYSIOL, V68, P1986, DOI 10.1152/jn.1992.68.6.1986; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; Itoh A, 1998, MOL BRAIN RES, V62, P175, DOI 10.1016/S0169-328X(98)00224-1; KATOH K, 1993, J NEUROPHYSIOL, V70, P2161, DOI 10.1152/jn.1993.70.5.2161; KAUER JS, 1987, BRAIN RES, V418, P255, DOI 10.1016/0006-8993(87)90093-X; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Keynes R, 1997, NEURON, V18, P889, DOI 10.1016/S0896-6273(00)80329-3; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Kolodkin AL, 1996, TRENDS CELL BIOL, V6, P15, DOI 10.1016/0962-8924(96)81033-6; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; KOLODZIEJ PA, 1995, NEURON, V15, P273, DOI 10.1016/0896-6273(95)90033-0; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; LANCET D, 1982, P NATL ACAD SCI-BIOL, V79, P670, DOI 10.1073/pnas.79.2.670; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; Li HS, 1997, DEVELOPMENT, V124, P603; LUO YL, 1995, NEURON, V14, P1131, DOI 10.1016/0896-6273(95)90261-9; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MORI K, 1992, J NEUROPHYSIOL, V67, P786, DOI 10.1152/jn.1992.67.3.786; Nakayama M, 1998, GENOMICS, V51, P27, DOI 10.1006/geno.1998.5341; NGAI J, 1993, CELL, V72, P667, DOI 10.1016/0092-8674(93)90396-8; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; OPPENHEIM RW, 1988, J COMP NEUROL, V275, P159, DOI 10.1002/cne.902750202; PINI A, 1993, SCIENCE, V261, P95, DOI 10.1126/science.8316861; Price J.L., 1987, P179; Puschel AW, 1996, EUR J NEUROSCI, V8, P1317, DOI 10.1111/j.1460-9568.1996.tb01593.x; REED RR, 1992, NEURON, V8, P205, DOI 10.1016/0896-6273(92)90287-N; Reed RR, 1996, COLD SPRING HARB SYM, V61, P165; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; ROTHBERG JM, 1992, J MOL BIOL, V227, P367, DOI 10.1016/0022-2836(92)90891-M; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; ROTHBERG JM, 1988, CELL, V55, P1047, DOI 10.1016/0092-8674(88)90249-8; Sato Y, 1998, J NEUROSCI, V18, P7800; SAUCIER D, 1986, BRAIN RES BULL, V16, P455, DOI 10.1016/0361-9230(86)90173-5; SCHOENFELD TA, 1994, BRAIN RES BULL, V34, P183, DOI 10.1016/0361-9230(94)90059-0; SCHWOB JE, 1984, J COMP NEUROL, V223, P177, DOI 10.1002/cne.902230204; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shepherd G. M., 1990, SYNAPTIC ORG BRAIN, P133; Shipley Michael T., 1995, P899; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; Stoeckli ET, 1997, NEURON, V18, P209, DOI 10.1016/S0896-6273(00)80262-7; STROTMANN J, 1994, CELL TISSUE RES, V278, P11, DOI 10.1007/s004410050189; STROTMANN J, 1992, NEUROREPORT, V3, P1053, DOI 10.1097/00001756-199212000-00005; Sugisaki N, 1996, J NEUROBIOL, V29, P127, DOI 10.1002/(SICI)1097-4695(199602)29:2<127::AID-NEU1>3.0.CO;2-C; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; WRIGHT DE, 1995, J COMP NEUROL, V351, P329, DOI 10.1002/cne.903510302; Wu JY, 1996, SCIENCE, V273, P355, DOI 10.1126/science.273.5273.355; YAGINUMA H, 1991, J COMP NEUROL, V304, P78, DOI 10.1002/cne.903040107; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2	84	381	414	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	1999	96	6					807	818		10.1016/S0092-8674(00)80591-7	http://dx.doi.org/10.1016/S0092-8674(00)80591-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	178ZY	10102269	Bronze			2022-12-28	WOS:000079300100008
J	Methot, N; Basler, K				Methot, N; Basler, K			Hedgehog controls limb development by regulating the activities of distinct transcriptional activator and repressor forms of Cubitus interruptus	CELL			English	Article							KINESIN-RELATED PROTEIN; DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; TARGET GENES; PATTERN; SIGNAL; GLI; COMPARTMENTS; RECEPTOR; DOMINANT	Hedgehog (Hh) proteins play diverse organizing roles in development by regulating gene expression in responding cells, The Gli homolog Cubitus interruptus (Ci) is involved in controlling the transcription of Hh target genes, A repressor form of Ci arises in the absence of Hh signaling by proteolytic cleavage of intact Ci. We show that this cleavage is essential for limb patterning and is regulated by Hh in vivo. We provide evidence for the existence of a distinct activator form of Ci, which does not arise by mere prevention of Ci proteolysis, but rather depends on a separate regulatory step subject to Hh control, These different activities of Ci regulate overlapping but distinct subsets of Hh target genes, Thus, limb development is organized by the integration of different transcriptional outputs of Hh signaling.	Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland	University of Zurich	Basler, K (corresponding author), Univ Zurich, Inst Zool, Winterthurerstr 190, CH-8057 Zurich, Switzerland.			Basler, Konrad/0000-0003-3534-1529				Ahmed A, 1997, GENE, V197, P367, DOI 10.1016/S0378-1119(97)00285-0; Alcedo J, 1997, BIOL CHEM, V378, P583; Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Alexandre C, 1996, GENE DEV, V10, P2003, DOI 10.1101/gad.10.16.2003; Alves G, 1998, MECH DEVELOP, V78, P17, DOI 10.1016/S0925-4773(98)00130-0; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; BLACKMAN RK, 1991, DEVELOPMENT, V111, P657; BLAIR SS, 1992, DEVELOPMENT, V115, P21; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chen Y, 1998, P NATL ACAD SCI USA, V95, P2349, DOI 10.1073/pnas.95.5.2349; Dominguez M, 1996, SCIENCE, V272, P1621, DOI 10.1126/science.272.5268.1621; EATON S, 1990, GENE DEV, V4, P1068, DOI 10.1101/gad.4.6.1068; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; Hepker J, 1997, DEVELOPMENT, V124, P549; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; Locke J, 1996, GENOME RES, V6, P155, DOI 10.1101/gr.6.2.155; Marigo V, 1996, DEV BIOL, V180, P273, DOI 10.1006/dbio.1996.0300; Monnier V, 1998, CURR BIOL, V8, P583, DOI 10.1016/S0960-9822(98)70227-1; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Ohlmeyer JT, 1998, NATURE, V396, P749, DOI 10.1038/25533; ORENIC TV, 1990, GENE DEV, V4, P1053, DOI 10.1101/gad.4.6.1053; Pignoni F, 1997, DEVELOPMENT, V124, P271; PREAT T, 1993, GENETICS, V135, P1047; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; SanchezHerrero E, 1996, MECH DEVELOP, V55, P159, DOI 10.1016/0925-4773(96)00498-4; Schweizer L, 1998, MECH DEVELOP, V78, P141, DOI 10.1016/S0925-4773(98)00163-4; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; SLUSARSKI DC, 1995, GENETICS, V139, P229; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; Von Ohlen T, 1997, MECH DEVELOP, V68, P149, DOI 10.1016/S0925-4773(97)00150-0; XU T, 1993, DEVELOPMENT, V117, P1223; ZECCA M, 1995, DEVELOPMENT, V121, P2265	37	313	320	1	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 19	1999	96	6					819	831		10.1016/S0092-8674(00)80592-9	http://dx.doi.org/10.1016/S0092-8674(00)80592-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	178ZY	10102270	Green Accepted, Bronze			2022-12-28	WOS:000079300100009
J	Vorflusev, V; Kumar, S				Vorflusev, V; Kumar, S			Phase-separated composite films for liquid crystal displays	SCIENCE			English	Article								A method of preparing liquid crystal devices by phase separation of liquid crystal from its solution in a prepolymer, which results in adjacent layers of liquid crystal and polymer, is described. Liquid crystals in these phase-separated composite films exhibit electro-optical properties not observed in devices prepared by conventional methods, polymer dispersion, or polymer-stabilization methods. Devices incorporating ferroelectric liquid crystals have gray scale and switch 100 times faster at low fields than conventional surface-stabilized devices. This method makes it possible to prepare devices with liquid crystal film thickness comparable to optical wavelengths.	Kent State Univ, Dept Phys, Kent, OH 44242 USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Kumar, S (corresponding author), Kent State Univ, Dept Phys, Kent, OH 44242 USA.							Blinov L., 1993, ELECTROOPTICAL EFFEC; CLARK NA, 1980, APPL PHYS LETT, V36, P899, DOI 10.1063/1.91359; Clark NA, 1988, FERROELECTRICS, V85, P79, DOI [10.1080/00150198808007647, DOI 10.1080/00150198808007647]; Crawford G. P., 1996, LIQUID CRYSTALS COMP; DOANE JW, 1986, APPL PHYS LETT, V48, P269, DOI 10.1063/1.96577; Drzaic P. S., 1995, LIQUID CRYSTAL DISPE, DOI 10.1142/2337; FUKUDA A, 1994, J MATER CHEM, V4, P997, DOI 10.1039/jm9940400997; KRONGAUZ VV, 1991, POLYMER, V32, P1654, DOI 10.1016/0032-3861(91)90402-5; VORILUSEV V, 1998, FERROELECTRICS, V213, P117	9	147	160	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 19	1999	283	5409					1903	1905		10.1126/science.283.5409.1903	http://dx.doi.org/10.1126/science.283.5409.1903			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177UC	10082461				2022-12-28	WOS:000079228600044
J	Moses, CA; Mishkin, FS				Moses, CA; Mishkin, FS			Right-to-left shunt on a lung scan	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Ventura Radiol Med Grp, Ventura, CA 93003 USA; Harbor UCLA Med Ctr, Torrance, CA 90509 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Moses, CA (corresponding author), Ventura Radiol Med Grp, Ventura, CA 93003 USA.								0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 18	1999	340	11					857	857		10.1056/NEJM199903183401106	http://dx.doi.org/10.1056/NEJM199903183401106			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	176ZW	10080849				2022-12-28	WOS:000079183200006
J	Aronson, J				Aronson, J			Please, please me	BRITISH MEDICAL JOURNAL			English	Article																			0	13	14	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 13	1999	318	7185					716	716						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182JK	10074020				2022-12-28	WOS:000079495700029
J	Pozzi, C; Bolasco, PG; Fogazzi, GB; Andrulli, S; Altieri, P; Ponticelli, C; Locatelli, F				Pozzi, C; Bolasco, PG; Fogazzi, GB; Andrulli, S; Altieri, P; Ponticelli, C; Locatelli, F			Corticosteroids in IgA nephropathy: a randomised controlled trial	LANCET			English	Article							CHRONIC RENAL-INSUFFICIENCY; BLOOD-PRESSURE CONTROL; PROGNOSTIC INDICATORS; PROTEIN RESTRICTION; STEROID-THERAPY; PROGRESSION; GLOMERULONEPHRITIS; PREDNISONE; DISEASE	Background IgA nephropathy is progressive in most cases and has no established therapy, In this randomised trial, we assessed the efficacy and safety of a 6-month course of steroids in this disorder, Methods Between July, 1987, and September, 1995, we enrolled 86 consecutive patients from seven renal units in Italy. Eligible patients had biopsy-proven IgA nephropathy, urine protein excretion of 1.0-3.5 g daily, and plasma creatinine concentrations of 133 mu mol/L (1.5 mg/dL) or less. Patients were randomly assigned either supportive therapy alone or steroid treatment (intravenous methylprednisolone Ig per day for 3 consecutive days at the beginning of months 1, 3, and 5, plus oral prednisone 0.5 mg/kg on alternate days for 6 months). The primary endpoint was deterioration in renal function defined as a 50% or 100% increase in plasma creatinine concentration from baseline. Analyses were by intention to treat. Findings Nine of 43 patients in the steroid group and 14 of 43 in the control group reached the primary endpoint (a 50% increase in plasma creatinine) by year 5 of follow-up (p<0.048). Factors influencing renal survival were vascular sclerosis (relative risk for 1-point increase in score 1.53, p=0.0347), female sex (0.22, p=0.0163), and steroid therapy (0.41, p=0.0439). All 43 patients assigned steroids completed the treatment without experiencing any important side-effects. Interpretation A 6-month course of steroid treatment protected against deterioration in renal function in IgA nephropathy with no notable adverse effects during followup. An increase in urinary protein excretion could be a marker indicating the need for a second course of steroid therapy.	Axienda ospedaliera Lecco, Div Nefrol, I-23900 Lecce, Italy; Axineda Ospedallera G Brotzu, Div Nefrol, Cagliari, Italy; Osped Maggiore, IRCCS, Div Nefrol, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico	Pozzi, C (corresponding author), Axienda ospedaliera Lecco, Div Nefrol & Dialisi, Via Ghislanzoni 22, I-23900 Lecce, Italy.		Andrulli, Simeone/GSD-5643-2022					BERGSTROM J, 1986, CLIN NEPHROL, V25, P1; CHAUVEAU D, 1993, CONTRIB NEPHROL, V104, P1; CHIDA Y, 1985, NEPHRON, V40, P189, DOI 10.1159/000183477; Clarkson A R, 1984, Contrib Nephrol, V40, P187; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; DAMICO G, 1986, Q J MED, V59, P363; DAMICO G, 1987, Q J MED, V64, P709; GALLA JH, 1995, KIDNEY INT, V47, P377, DOI 10.1038/ki.1995.50; IMBASCIATI E, 1985, BMJ-BRIT MED J, V291, P1305, DOI 10.1136/bmj.291.6505.1305; JULIAN BA, 1988, AM J MED, V84, P129, DOI 10.1016/0002-9343(88)90019-8; JULIAN BA, 1993, CONTRIB NEPHROL, V104, P198; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; KOBAYASHI Y, 1988, NEPHRON, V48, P12, DOI 10.1159/000184861; Kobayashi Y, 1996, NEPHRON, V72, P237, DOI 10.1159/000188848; KOBAYASHI Y, 1986, Q J MED, V61, P935; LAI KN, 1986, CLIN NEPHROL, V26, P174; LOCATELLI F, 1991, LANCET, V337, P1299, DOI 10.1016/0140-6736(91)92977-A; LOCATELLI F, 1996, NEPHROL DIAL TRANSPL, V11, P161; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; NEELAKANTAPPA K, 1987, SEMIN NEPHROL, V7, P344; PONTICELLI C, 1984, NEW ENGL J MED, V310, P946, DOI 10.1056/NEJM198404123101503; Rossing P, 1998, NEPHROL DIAL TRANSPL, V13, P244, DOI 10.1093/ndt/13.2.244; WALDO FB, 1993, PEDIATR NEPHROL, V7, P529; WELCH TR, 1992, J PEDIATR-US, V121, P474, DOI 10.1016/S0022-3476(05)81808-6; YOSHIKAWA N, 1992, NEPHRON, V60, P60, DOI 10.1159/000186706	25	376	398	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 13	1999	353	9156					883	887		10.1016/S0140-6736(98)03563-6	http://dx.doi.org/10.1016/S0140-6736(98)03563-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BU	10093981				2022-12-28	WOS:000079421400011
J	Mannucci, PM				Mannucci, PM			Genetic control of anticoagulation	LANCET			English	Editorial Material							WARFARIN; PROPEPTIDE; PREVENTION		IRCCS, Maggiore Hosp, Hemophilia & Thrombosis Ctr, I-920122 Milan, Italy; Univ Milan, I-920122 Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Mannucci, PM (corresponding author), IRCCS, Maggiore Hosp, Hemophilia & Thrombosis Ctr, I-920122 Milan, Italy.							Chu K, 1996, J CLIN INVEST, V98, P1619, DOI 10.1172/JCI118956; HIRSH J, 1995, CHEST S, V108, P231; LANDEFELD CS, 1993, AM J MED, V95, P315, DOI 10.1016/0002-9343(93)90285-W; LEVINE M, 1994, LANCET, V343, P886, DOI 10.1016/S0140-6736(94)90008-6; Meade TW, 1998, LANCET, V351, P233; Oldenburg J, 1997, BRIT J HAEMATOL, V98, P240, DOI 10.1046/j.1365-2141.1997.2213036.x; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; Poller L, 1998, LANCET, V352, P1505, DOI 10.1016/S0140-6736(98)04147-6; POLLER L, 1987, BRIT MED J, V295, P1309, DOI 10.1136/bmj.295.6609.1309	9	31	35	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 27	1999	353	9154					688	689		10.1016/S0140-6736(98)00326-2	http://dx.doi.org/10.1016/S0140-6736(98)00326-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173DR	10073506				2022-12-28	WOS:000078966400004
J	Beecham, L				Beecham, L			Government sets out vision for clinical governance	BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 27	1999	318	7187					832	832		10.1136/bmj.318.7187.832	http://dx.doi.org/10.1136/bmj.318.7187.832			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185DM	10092256	Green Published			2022-12-28	WOS:000079652900019
J	Danesh, J; Gault, S; Semmence, J; Appleby, P; Peto, R				Danesh, J; Gault, S; Semmence, J; Appleby, P; Peto, R			Postcodes as useful markers of social class: population based study in 26,000 British households	BRITISH MEDICAL JOURNAL			English	Article							MORTALITY		Univ Oxford, Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England; Univ Oxford, Radcliffe Infirm, Epidemiol Studies Unit, Oxford OX2 6HE, England; Dept Social Secur, Family Resources Survey, London WC2N 6HT, England; Imperial Canc Res Fund, Canc Epidemiol Unit, Oxford OX2 6HE, England	Radcliffe Infirmary; University of Oxford; Radcliffe Infirmary; University of Oxford; University of Oxford	Danesh, J (corresponding author), Univ Oxford, Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England.							AUSTIN H, 1994, EPIDEMIOL REV, V16, P65, DOI 10.1093/oxfordjournals.epirev.a036146; BenShlomo Y, 1996, BRIT MED J, V312, P1013; Gatrell A. C., 1989, International Journal of Geographical Information Systems, V3, P335, DOI 10.1080/02693798908941520; SEMMENCE J, 1997, FAMILY RESOURCES SUR; Smith GD, 1998, LANCET, V351, P934, DOI 10.1016/S0140-6736(05)60603-4	5	68	68	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 27	1999	318	7187					843	844		10.1136/bmj.318.7187.843	http://dx.doi.org/10.1136/bmj.318.7187.843			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185DM	10092262	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000079652900025
J	Brown, CB; Boyer, AS; Runyan, RB; Barnett, JV				Brown, CB; Boyer, AS; Runyan, RB; Barnett, JV			Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart	SCIENCE			English	Article							GROWTH-FACTOR-BETA; GENE-EXPRESSION; EMBRYONIC HEART; BETAGLYCAN; LIGAND; ANTIBODIES; ACTIVATION; TGF-BETA-2; CLONING; PROTEIN	Transforming growth factor-beta (TGF-beta) signaling is mediated by a complex of type I (TBRI) and type II (TBRII) receptors. The type III receptor (TBRIII) Lacks a recognizable signaling domain and has no clearly defined role in TGF-beta signaling. Cardiac endothelial cells that undergo epithelial-mesenchymal transformation express TBRIII, and here TBRIII-specific antisera were found to inhibit mesenchyme formation and migration in atrioventricular cushion explants. Misexpression of TBRIII in nontransforming ventricular endothelial cells conferred transformation in response to TGF-beta 2. These results support a model where TBRIII localizes transformation in the heart and plays an essential, nonredundant role in TGF-beta signaling.	Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med & Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; Univ Arizona, Univ Heart Ctr, Dept Cell Biol & Anat, Tucson, AZ 85724 USA	Vanderbilt University; Vanderbilt University; University of Arizona	Barnett, JV (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med & Pharmacol, 2200 Pierce Ave, Nashville, TN 37232 USA.	joey.barnett@mcmail.vanderbilt.edu	Runyan, Raymond B/B-6977-2012	Runyan, Raymond B/0000-0002-7410-916X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052922] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL52922, R01 HL052922, R01 HL052922-05] Funding Source: Medline; PHS HHS [42266, 38649] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BARNETT JV, 1994, DEV DYNAM, V199, P12, DOI 10.1002/aja.1001990103; BASSING CH, 1994, SCIENCE, V263, P87, DOI 10.1126/science.8272871; Brown CB, 1996, DEV BIOL, V174, P248, DOI 10.1006/dbio.1996.0070; BROWN CM, UNPUB; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; DICKSON MC, 1993, DEVELOPMENT, V117, P625; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; Fishman MC, 1997, DEVELOPMENT, V124, P2099; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; JOHNSON DW, 1995, GENOMICS, V28, P356, DOI 10.1006/geno.1995.1157; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Lakkis MM, 1998, DEVELOPMENT, V125, P4359; LIN HY, 1995, J BIOL CHEM, V270, P2747, DOI 10.1074/jbc.270.6.2747; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; LOPEZCASILLAS F, 1994, J CELL BIOL, V124, P557, DOI 10.1083/jcb.124.4.557; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; MOUSTAKAS A, 1993, J BIOL CHEM, V268, P22215; POTTS JD, 1989, DEV BIOL, V134, P392, DOI 10.1016/0012-1606(89)90111-5; POTTS WM, 1987, J GEN VIROL, V68, P3177, DOI 10.1099/0022-1317-68-12-3177; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Roberts AB, 1990, PEPTIDE GROWTH FACTO, P419; RUNYAN RB, 1983, DEV BIOL, V95, P108, DOI 10.1016/0012-1606(83)90010-6; Sanford LP, 1997, DEVELOPMENT, V124, P2659; SANKAR S, 1995, J BIOL CHEM, V270, P13567, DOI 10.1074/jbc.270.22.13567; Sheffield VC, 1997, HUM MOL GENET, V6, P117, DOI 10.1093/hmg/6.1.117; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; WANG XF, 1991, CELL, V67, P797, DOI 10.1016/0092-8674(91)90074-9; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0	31	302	312	2	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	1999	283	5410					2080	2082		10.1126/science.283.5410.2080	http://dx.doi.org/10.1126/science.283.5410.2080			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180DH	10092230				2022-12-28	WOS:000079369800045
J	Hopkins, SM				Hopkins, SM			A role for advocacy in general medicine	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 20	1999	318	7186					819	819		10.1136/bmj.318.7186.819	http://dx.doi.org/10.1136/bmj.318.7186.819			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BX	10082736	Green Published			2022-12-28	WOS:000079421700089
J	Simini, B				Simini, B			Preoperative fasting	LANCET			English	Editorial Material									Osped Lucca, Anaesthesia Intens Care & Pain Management Unit, I-55100 Lucca, Italy		Simini, B (corresponding author), Osped Lucca, Anaesthesia Intens Care & Pain Management Unit, I-55100 Lucca, Italy.							Harter RL, 1998, ANESTH ANALG, V86, P147, DOI 10.1097/00000539-199801000-00030; LISTER J, 1993, HOLMES SYSTEM SURG, V3; Lydon A, 1998, BRIT J ANAESTH, V81, P522, DOI 10.1093/bja/81.4.522; MACFIE AG, 1991, BRIT J ANAESTH, V67, P54, DOI 10.1093/bja/67.1.54; SELLICK BA, 1961, LANCET, V2, P404; Smith AF, 1997, BRIT MED J, V314, P1486, DOI 10.1136/bmj.314.7092.1486a; SNOW J, 1847, INHALATION VAPOUR ET, P43; SOREIDE E, 1995, ACTA ANAESTH SCAND, V39, P738, DOI 10.1111/j.1399-6576.1995.tb04162.x; Soreide E, 1996, ACTA ANAESTH SCAND, V40, P549, DOI 10.1111/j.1399-6576.1996.tb04486.x	9	12	12	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 13	1999	353	9156					862	862		10.1016/S0140-6736(99)00081-1	http://dx.doi.org/10.1016/S0140-6736(99)00081-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BU	10093976				2022-12-28	WOS:000079421400006
J	Brouwer, ML; Tolboom, JJM; Hardeman, JHJ				Brouwer, ML; Tolboom, JJM; Hardeman, JHJ			Routine screening of children returning home from the tropics: retrospective study	BRITISH MEDICAL JOURNAL			English	Article									Univ Nijmegen St Radboud Hosp, Dept Paediat, NL-6500 HB Nijmegen, Netherlands; Haskoning BV Consultants, NL-6500 AD Nijmegen, Netherlands	Radboud University Nijmegen	Tolboom, JJM (corresponding author), Univ Nijmegen St Radboud Hosp, Dept Paediat, POB 9101, NL-6500 HB Nijmegen, Netherlands.		Brouwer, Marianne/AAF-3230-2019					*AM AC PED COMM IN, 1997, 1997 RED BOOK REP CO; CARROLL B, 1993, BRIT MED J, V307, P541, DOI 10.1136/bmj.307.6903.541; CARTER JP, 1970, PEDIATR CLIN N AM, V17, P255; ISAACSON M, 1997, TXB TRAVEL MED HLTH; WELLER PF, 1992, MED CLIN N AM, V76, P1413, DOI 10.1016/S0025-7125(16)30294-2	5	11	11	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	FEB 27	1999	318	7183					568	569		10.1136/bmj.318.7183.568	http://dx.doi.org/10.1136/bmj.318.7183.568			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173DQ	10189209	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000078966300028
J	Lowenstein, DH; Parent, JM				Lowenstein, DH; Parent, JM			Neurobiology - Brain, heal thyself	SCIENCE			English	Editorial Material							ADULT-RAT HIPPOCAMPUS; STEM-CELLS; MAMMALIAN BRAIN; NERVOUS-SYSTEM; DENTATE GYRUS; EXPRESSION; NEURONS; CNS; PROLIFERATION; NEUROGENESIS		Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Epilepsy Res Lab, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lowenstein, DH (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.							ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; BONFANTI L, 1994, NEUROSCIENCE, V62, P291, DOI 10.1016/0306-4522(94)90333-6; CAJAL SRY, 1959, DEGENERATION REGENER, V2, P750; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; Giger RJ, 1998, J NEUROSCI RES, V52, P27, DOI 10.1002/(SICI)1097-4547(19980401)52:1<27::AID-JNR4>3.0.CO;2-M; Gould E, 1997, NEUROSCIENCE, V80, P427, DOI 10.1016/S0306-4522(97)00127-9; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Ide CF, 1996, PROG BRAIN RES, V108, P365, DOI 10.1016/S0079-6123(08)62552-2; KAPLAN MS, 1984, J NEUROSCI, V4, P1429; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; KAWAKAMI A, 1995, J NEUROBIOL, V29, P1; Liu JL, 1998, J NEUROSCI, V18, P7768; Livesey FJ, 1997, MOL CELL NEUROSCI, V8, P417, DOI 10.1006/mcne.1997.0598; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; McCormick MB, 1996, MOL CELL BIOL, V16, P5792; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Parent JM, 1997, J NEUROSCI, V17, P3727; Powell EM, 1997, CELL TISSUE RES, V290, P385, DOI 10.1007/s004410050945; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Schwab MH, 1998, J NEUROSCI, V18, P1408; Scott BW, 1998, NEUROSCI LETT, V248, P73, DOI 10.1016/S0304-3940(98)00355-3; Snyder Evan Y., 1994, Current Opinion in Neurobiology, V4, P742, DOI 10.1016/0959-4388(94)90018-3; Snyder EY, 1998, NEUROSCIENTIST, V4, P408, DOI 10.1177/107385849800400613; Weiss S, 1996, J NEUROSCI, V16, P7599	27	34	36	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 19	1999	283	5405					1126	1127		10.1126/science.283.5405.1126	http://dx.doi.org/10.1126/science.283.5405.1126			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169GD	10075572				2022-12-28	WOS:000078738400035
J	de Lange, T; DePinho, RA				de Lange, T; DePinho, RA			Cell proliferation - Unlimited mileage from telomerase?	SCIENCE			English	Editorial Material							IMMORTAL CELLS; FIBROBLASTS; SENESCENCE; RNA; P53; RB		Rockefeller Univ, Cell Biol & Genet Lab, New York, NY 10021 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Rockefeller University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	de Lange, T (corresponding author), Rockefeller Univ, Cell Biol & Genet Lab, 1230 York Ave, New York, NY 10021 USA.		de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X; DePinho, Ronald/0000-0002-5625-577X	NATIONAL CANCER INSTITUTE [R01CA076027] Funding Source: NIH RePORTER; NCI NIH HHS [CA76027] Funding Source: Medline; NICHD NIH HHS [HD 348880] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; COUNTER CM, 1994, J VIROL, V68, P3410, DOI 10.1128/JVI.68.5.3410-3414.1994; de Lange T, 1998, SCIENCE, V279, P334, DOI 10.1126/science.279.5349.334; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; Greider CW, 1998, P NATL ACAD SCI USA, V95, P90, DOI 10.1073/pnas.95.1.90; HARA E, 1991, BIOCHEM BIOPH RES CO, V179, P528, DOI 10.1016/0006-291X(91)91403-Y; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056; KARSLEDER J, IN PRESS SCIENCE; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SERRANO M, 1995, SCIENCE, V267, P249, DOI 10.1126/science.7809631; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	25	52	53	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 12	1999	283	5404					947	949		10.1126/science.283.5404.947	http://dx.doi.org/10.1126/science.283.5404.947			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166KM	10075559				2022-12-28	WOS:000078574800036
J	Beecham, L				Beecham, L			There must be "compelling reasons" for trust mergers	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 3	1999	318	7188					947	947						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185GV	10102886				2022-12-28	WOS:000079660500070
J	Coxell, A; King, M; Mezey, G; Gordon, D				Coxell, A; King, M; Mezey, G; Gordon, D			Lifetime prevalence, characteristics, and associated problems of non-consensual sex in men: cross sectional survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ABUSE; ASSAULT; IMPACT	Objective To identify the lifetime prevalence of non-consensual sexual experiences in men, the relationship between such experiences as a child and as an adult, associated psychological and behavioural problems, and help received. Design Cross sectional survey. Setting England. Subjects 2474 men (mean age 46 years) attending one of 18 general practices. Main outcome measures Experiences of non-consensual and consensual sex before and after the age of 16 years-that is, as a child and adult respectively-psychological problems experienced for more than 2 weeks at any one time, use of alcohol (CAGE questionnaire), self harm, and help received. Results 2474 of 3142 men (79%) agreed to participate; 71/2468 (standardised rate 2.89%, 95% confidence interval 2.21% to 3.56%) reported non-consensual sexual experiences as adults, 128/2423 (5.35%, 4.39% to 6.31%) reported non-consensual sexual experiences as children and 185/2406 (7.66% 6.54% to 8.77%) reported consensual sexual experiences as children that are illegal under English law. Independent predictors of non-consensual sex as adults were reporting male sexual partners (odds ratio 6.0, 2.6 to 13.5), non-consensual sex, in childhood (4.2, 2.1 to 8.6), age (0.98, 0.96 to 0.99), and sex of interviewer (2.0, 1.2 to 3.5). Non-consensual sexual experiences were associated with a greater prevalence of psychological problems, alcohol misuse, and self harm. These sexual experiences were also significant predictors of help received from mental health professionals. Conclusion Almost 3% of men in England report non-consensual sexual experiences as adults. Medical professionals need to be aware of the range of psychological difficulties in men who have had such experiences. They also need to be aware of the relationship between sexual experiences in childhood and adulthood in men.	UCL Royal Free & Univ Coll Med Sch, Dept Psychiat & Behav Sci, London NW3 2PF, England; Univ London St Georges Hosp, Sect Forens Psychiat, Sch Med, London SW17 0RE, England	University of London; University College London; UCL Medical School; St Georges University London	King, M (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Psychiat & Behav Sci, London NW3 2PF, England.	mike@rfhsm.ac.uk	King, Michael B/D-7477-2011	King, Michael B/0000-0003-4715-7171	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARTHOLOW BN, 1994, CHILD ABUSE NEGLECT, V18, P747; Bolton F. G., 1989, MALES RISK; CANTWELL HB, 1988, CHILD ABUSE NEGLECT, V12, P579, DOI 10.1016/0145-2134(88)90075-0; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; FINKLEHOR D, 1986, SOURCE BOOK CHILD SE; Follette VM, 1996, J TRAUMA STRESS, V9, P25, DOI 10.1007/BF02116831; GARDNER MJ, 1989, STAT CONFIDENCE CONF; HICKSON FCI, 1994, ARCH SEX BEHAV, V23, P281, DOI 10.1007/BF01541564; HOBSON WF, 1985, MED ASPECTS HUMAN SE, V19, P104; KENDALLTACKETT KA, 1993, PSYCHOL BULL, V113, P164, DOI 10.1037/0033-2909.113.1.164; King M. B., 1992, MALE VICTIMS SEXUAL; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; Lees S., 1996, CARNAL KNOWLEDGE; MENDEL MP, 1995, MALE SURVIVOR; Messman TL, 1996, CLIN PSYCHOL REV, V16, P397, DOI 10.1016/0272-7358(96)00019-0; MILLSTEIN SG, 1983, J PEDIATR-US, V103, P815, DOI 10.1016/S0022-3476(83)80493-4; SORENSON SB, 1987, AM J EPIDEMIOL, V126, P1154, DOI 10.1093/oxfordjournals.aje.a114753; STRUCKMANJOHNSON C, 1994, ARCH SEX BEHAV, V23, P93, DOI 10.1007/BF01541620; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; WELLINGS K, 1994, SEXUAL BEHAV BRIT; 1996, CRIMINAL STAT	21	114	115	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	1999	318	7187					846	850		10.1136/bmj.318.7187.846	http://dx.doi.org/10.1136/bmj.318.7187.846			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	185DM	10092264	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000079652900028
J	O'Connell, DRH				O'Connell, DRH			Replication of apparent nonlinear seismic response with linear wave propagation models	SCIENCE			English	Article							EMPIRICAL GREENS-FUNCTIONS; WESTERN TRANSVERSE RANGES; STRONG-GROUND-MOTION; SAN-ANDREAS FAULT; 3-DIMENSIONAL SIMULATION; 1994 NORTHRIDGE; EARTHQUAKE; CALIFORNIA; RUPTURE; SCATTERING	It is necessary to understand ground-motion amplification by sediment, defined as the ratio of ground motions at sediment sites to those at rock sites, to predict seismic Loadings for earthquake engineering. At sediment sites, observed weak-motion amplifications from magnitude 3 to 4 aftershocks of the 1994 Northridge earthquake were twice as Large as magnitude 6.7 mainshock amplifications. Amplitude-dependent (nonlinear) amplification by sediment is one explanation. However, earthquake simulations with empirical impulse responses and elastic finite-difference calculations with weakly heterogeneous, random three-dimensional (3D) crustal velocity variations show that Linear wave propagation can explain observed (apparently nonlinear) sediment responses. Random 3D velocity variations also reproduce the observed Log-normal dispersion of peak ground motions. Deterministic wave propagation models are not adequate to quantify the scaling and dispersion of near-source ground motions.	US Bur Reclamat, Lakewood, CO 80225 USA		O'Connell, DRH (corresponding author), US Bur Reclamat, Box 25007 D-8330, Lakewood, CO 80225 USA.							Abrahamson NA., 1997, SEISMOL RES LETT, V68, P9, DOI [10.1785/gssrl.68.1.9, DOI 10.1785/GSSRL.68.1.9]; Abrahamson NA, 1997, SEISMOL RES LETT, V68, P94, DOI [DOI 10.1785/GSSRL.68.1.94, 10.1785/gssrl.68.1.94]; AKI K, 1992, B SEISMOL SOC AM, V82, P1969; Anderson JG, 1996, B SEISMOL SOC AM, V86, pS100; ANDREWS DJ, 1980, J GEOPHYS RES, V85, P3867, DOI 10.1029/JB085iB07p03867; BERNARD P, 1984, B SEISMOL SOC AM, V74, P539; Boore D.M., 1998, SEISMOL RES LETT, V69, P222, DOI [10.1785/gssrl.69.3.222, DOI 10.1785/GSSRL.69.3.222]; Boore D. M., 1997, SEISMOL RES LETT, V68, P128, DOI DOI 10.1785/GSSRL.68.1.128; Campbell K.W., 1997, SEISMOL RES LETT, V68, P154, DOI DOI 10.1785/GSSRL.68.1.154; Field E. H., 1998, SEISMOL RES LETT, V69, P230, DOI DOI 10.1785/GSSR1.69.3.230; Field EH, 1997, NATURE, V390, P599, DOI 10.1038/37586; FRANKEL A, 1993, B SEISMOL SOC AM, V83, P1020; FRANKEL A, 1986, J GEOPHYS RES-SOLID, V91, P6465, DOI 10.1029/JB091iB06p06465; FRANKEL A, 1991, J GEOPHYS RES-SOLID, V96, P6291, DOI 10.1029/91JB00237; FUKUYAMA E, 1993, J GEOPHYS RES-SOL EA, V98, P6529, DOI 10.1029/92JB02451; GRAVES RW, 1993, B SEISMOL SOC AM, V83, P1042; Graves RW, 1996, B SEISMOL SOC AM, V86, P1091; HANKS TC, 1982, B SEISMOL SOC AM, V72, P1867; Hauksson E, 1997, J GEOPHYS RES-SOL EA, V102, P5423, DOI 10.1029/96JB03219; HEATON TH, 1990, PHYS EARTH PLANET IN, V64, P1, DOI 10.1016/0031-9201(90)90002-F; HEATON TH, 1995, SCIENCE, V267, P206, DOI 10.1126/science.267.5195.206; HENRY M, 1980, GEOPHYS RES LETT, V7, P1073, DOI 10.1029/GL007i012p01073; HERRERO A, 1994, B SEISMOL SOC AM, V84, P1216; Horton S, 1996, B SEISMOL SOC AM, V86, P122; HUTCHINGS L, 1994, B SEISMOL SOC AM, V84, P1028; Jarpe SP, 1996, B SEISMOL SOC AM, V86, P1116; KELLER B, 1987, J GEOPHYS RES-SOLID, V92, P7890, DOI 10.1029/JB092iB08p07890; KENNETT BLN, 1985, SEISMIC WAVE PROPAGA, P53; KIND R, 1978, J GEOPHYS-Z GEOPHYS, V44, P603; MCGUIRE RK, 1995, B SEISMOL SOC AM, V85, P1275; MIKUMO T, 1993, GEOPHYS J INT, V112, P481, DOI 10.1111/j.1365-246X.1993.tb01182.x; MIKUMO T, 1987, SEISMIC STRONG MOTIO, P91; NAMSON J, 1988, GEOLOGY, V16, P675, DOI 10.1130/0091-7613(1988)016<0675:STOTWT>2.3.CO;2; OCONNELL DRH, 1998, 986 US BUR RECL SEIS; Oglesby DD, 1998, SCIENCE, V280, P1055, DOI 10.1126/science.280.5366.1055; OLSEN KB, 1995, SCIENCE, V270, P1628, DOI 10.1126/science.270.5242.1628; Olsen KB, 1996, B SEISMOL SOC AM, V86, P575; PRESS WH, 1992, NUMERICAL RECIPES FO, P617; ROTH M, 1993, GEOPHYS J INT, V115, P552, DOI 10.1111/j.1365-246X.1993.tb01206.x; Rubin CM, 1998, SCIENCE, V281, P398, DOI 10.1126/science.281.5375.398; Sadigh K., 1997, SEISMOL RES LETT, V1, P180, DOI DOI 10.1785/GSSRL.68.1.180; Schneider JF, 1993, EARTHQ SPECTRA, V9, p25l, DOI [10.1193/1.1585715, DOI 10.1193/1.1585715]; Sirles P. C., 1990, GEOTECHNICAL ENV GEO, V3, P121; SPUICH P, 1997, SEISMOL RES LETT, V68, P190; Wald DJ, 1996, B SEISMOL SOC AM, V86, pS49; WALDEN AT, 1985, GEOPHYS PROSPECT, V33, P400, DOI 10.1111/j.1365-2478.1985.tb00443.x; Wills CJ., 1998, SEISMOL RES LETT, V69, P216; WONG IG, 1998, PROBABILISTIC SEISMI; Yilmaz O., 1987, SEISMIC DATA PROCESS; YOUNGS RR, 1995, B SEISMOL SOC AM, V85, P1161; YU G, 1995, B SEISMOL SOC AM, V85, P31; ZENG YH, 1993, B SEISMOL SOC AM, V83, P1264	52	40	41	2	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	1999	283	5410					2045	2050		10.1126/science.283.5410.2045	http://dx.doi.org/10.1126/science.283.5410.2045			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180DH	10092220				2022-12-28	WOS:000079369800035
J	Papadakis, SJ; De Poortere, EP; Manoharan, HC; Shayegan, M; Winkler, R				Papadakis, SJ; De Poortere, EP; Manoharan, HC; Shayegan, M; Winkler, R			The effect of spin splitting on the metallic behavior of a two-dimensional system	SCIENCE			English	Article							INSULATOR-TRANSITION; 2 DIMENSIONS; MAGNETIC-FIELD; 2-DIMENSIONAL SYSTEM; INVERSION SYMMETRY; SCALING THEORY; B=0; HETEROSTRUCTURES; HETEROJUNCTIONS; PHASE	Experiments on a constant-density two-dimensional hole system in a gallium arsenide quantum well revealed that the metallic behavior observed in the zero-magnetic-field temperature dependence of the resistivity depends on the symmetry of the confinement potential and the resulting spin splitting of the valence band.	Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA; Univ Erlangen Nurnberg, Inst Tech Phys 3, D-91058 Erlangen, Germany	Princeton University; University of Erlangen Nuremberg	Papadakis, SJ (corresponding author), Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA.	papadaks@el.princeton.edu						Altshuler BL, 1999, PHYS REV LETT, V82, P145, DOI 10.1103/PhysRevLett.82.145; BISHOP DJ, 1980, PHYS REV LETT, V44, P1153, DOI 10.1103/PhysRevLett.44.1153; Coleridge PT, 1997, PHYS REV B, V56, P12764, DOI 10.1103/PhysRevB.56.R12764; DAS B, 1989, PHYS REV B, V39, P1411, DOI 10.1103/PhysRevB.39.1411; Dobrosavljevic V, 1997, PHYS REV LETT, V79, P455, DOI 10.1103/PhysRevLett.79.455; DRESSELHAUS PD, 1992, PHYS REV LETT, V68, P106, DOI 10.1103/PhysRevLett.68.106; EISENSTEIN JP, 1984, PHYS REV LETT, V53, P2579, DOI 10.1103/PhysRevLett.53.2579; Hanein Y, 1998, PHYS REV LETT, V80, P1288, DOI 10.1103/PhysRevLett.80.1288; HEREMANS JJ, 1994, J APPL PHYS, V76, P1980, DOI 10.1063/1.358419; HIRAKAWA K, 1993, PHYS REV B, V47, P4076, DOI 10.1103/PhysRevB.47.4076; JUSSERAND B, 1995, PHYS REV B, V51, P4707, DOI 10.1103/PhysRevB.51.4707; Kravchenko SV, 1998, PHYS REV B, V58, P3553, DOI 10.1103/PhysRevB.58.3553; KRAVCHENKO SV, 1995, PHYS REV B, V51, P7038, DOI 10.1103/PhysRevB.51.7038; Kravchenko SV, 1996, PHYS REV LETT, V77, P4938, DOI 10.1103/PhysRevLett.77.4938; Lam J, 1997, PHYS REV B, V56, P12741, DOI 10.1103/PhysRevB.56.R12741; Lu JP, 1998, PHYS REV LETT, V81, P1282, DOI 10.1103/PhysRevLett.81.1282; Muraki K, 1998, PHYSICA B, V249, P65, DOI 10.1016/S0921-4526(98)00068-4; Nitta J, 1997, PHYS REV LETT, V78, P1335, DOI 10.1103/PhysRevLett.78.1335; Papadakis SJ, 1998, PHYS REV B, V57, P15068, DOI 10.1103/PhysRevB.57.R15068; Popovic D, 1997, PHYS REV LETT, V79, P1543, DOI 10.1103/PhysRevLett.79.1543; Pudalov VM, 1997, JETP LETT+, V65, P932, DOI 10.1134/1.567445; Pudalov VM, 1997, JETP LETT+, V66, P175, DOI 10.1134/1.567498; Schultz M, 1996, SEMICOND SCI TECH, V11, P1168, DOI 10.1088/0268-1242/11/8/009; Simmons MY, 1998, PHYS REV LETT, V80, P1292, DOI 10.1103/PhysRevLett.80.1292; Simonian D, 1997, PHYS REV LETT, V79, P2304, DOI 10.1103/PhysRevLett.79.2304; [No title captured]	29	148	148	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	1999	283	5410					2056	2058		10.1126/science.283.5410.2056	http://dx.doi.org/10.1126/science.283.5410.2056			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180DH	10092222	Green Submitted			2022-12-28	WOS:000079369800037
J	Weissman, JS; Saglam, D; Campbell, EG; Causino, N; Blumenthal, D				Weissman, JS; Saglam, D; Campbell, EG; Causino, N; Blumenthal, D			Market forces and unsponsored research in academic health centers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MANAGED CARE; CLINICAL RESEARCH; LIFE-SCIENCE; FACULTY; MEDICINE; IMPACT	Context Increased competitive pressures on academic health centers may result in reduced discretionary funds from patient care revenues to support the performance of unsponsored research, including institutionally funded and faculty-supported activities. Objective To measure the amount and distribution of unsponsored research activities and their outcomes. Design and Setting Survey conducted in academic year 1996-1997 of 2336 research faculty in 117 medical schools. Responses were weighted to provide national estimates. Main Outcome Measures Institutionally funded research as a proportion of total direct costs of research was compared across stages of market competition. Logistic regression was used to assess the relationship of performing unsponsored research to faculty characteristics and market stage. Results Overall, 43% of faculty received institutional funding for research. Young faculty were more likely than others to receive institutional support (adjusted odds ratio [OR], 1.4; 95% confidence interval [CI], 1.1-1.9; P = .004). The amount of institutional support as a proportion of total funding was more than twice as high in less competitive markets (6.1 %) compared with the most competitive markets (2.5%; P = .05). Most faculty (55%) performed faculty-supported research. Clinical researchers (OR, 1.6; 95% CI, 1.1-2.3), principal investigators (OR, 4.3; 95% CI, 2.8-7.0), faculty with high levels of research effort (OR, 6.2; 95% CI, 4.0-9.5) or institutional funding (OR, 1.9; 95% CI, 1.4-2.6), and faculty in the most competitive markets (OR, 1.9; 95% CI, 1.4-2.5) were more likely than others to conduct faculty-supported research. When undertaken by clinical researchers, these activities were supported by clinical income, extra hours worked, and discretionary funds, and often led to publications (76%) or grant awards (51%). Conclusions Many academic health center faculty receive institutional support to conduct their research or fund the research themselves. Market pressures may be affecting the level of institutional funding available to faculty.	Massachusetts Gen Hosp, Inst Hlth Policy, Dept Med, Partners Healthcare Syst, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Partners Healthcare System; Harvard University; Harvard Medical School	Weissman, JS (corresponding author), Massachusetts Gen Hosp, Inst Hlth Policy, Dept Med, Partners Healthcare Syst, 50 Staniford St,9th Floor, Boston, MA 02114 USA.	weissman@gem.mgh.harvard.edu						*ASS AM MED COLL, 1996, AAMC DAT BOOK; BEATY HN, 1986, ANN INTERN MED, V104, P90, DOI 10.7326/0003-4819-104-1-90; BERMAN JJ, 1995, SOUTHERN MED J, V88, P295, DOI 10.1097/00007611-199503000-00009; BERMAN JJ, 1993, JAMA-J AM MED ASSOC, V270, P44, DOI 10.1001/jama.1993.03510010049020; Blumenthal D, 1996, NEW ENGL J MED, V335, P1734, DOI 10.1056/NEJM199612053352305; Blumenthal D, 1997, NEW ENGL J MED, V337, P1550, DOI 10.1056/NEJM199711203372113; Blumenthal D, 1997, JAMA-J AM MED ASSOC, V277, P1224, DOI 10.1001/jama.277.15.1224; BORKOWSKI A, 1992, MODERN PATHOL, V5, P577; Burns LR, 1997, HEALTH AFFAIR, V16, P204, DOI 10.1377/hlthaff.16.6.204; Campbell EG, 1997, JAMA-J AM MED ASSOC, V278, P222, DOI 10.1001/jama.278.3.222; Cohen J, 1998, SCIENCE, V279, P178, DOI 10.1126/science.279.5348.178; *COMM FUND TASK FO, 1997, LEV PLAYING FIELD FI; Jones RF, 1996, ACAD MED, V71, P300, DOI 10.1097/00001888-199603000-00027; Mechanic RE, 1996, HEALTH AFFAIR, V15, P72, DOI 10.1377/hlthaff.15.3.72; Mood A., 1973, INTRO THEORY STAT; Moy E, 1997, JAMA-J AM MED ASSOC, V278, P217, DOI 10.1001/jama.278.3.217; Shah BV, 1996, SUDAAN USERS MANUAL; Stedman D, 1996, ACAD MED, V71, P1164, DOI 10.1097/00001888-199611000-00014; STEIN MD, 1993, JAMA-J AM MED ASSOC, V269, P781, DOI 10.1001/jama.269.6.781; *U HLTH SYST CONS, 1997, UHC MAN CAR WHIT PAP, V4	20	56	56	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	1999	281	12					1093	1098		10.1001/jama.281.12.1093	http://dx.doi.org/10.1001/jama.281.12.1093			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177EP	10188659	Bronze			2022-12-28	WOS:000079197100030
J	Brose, K; Bland, KS; Wang, KH; Arnott, D; Henzel, W; Goodman, CS; Tessier-Lavigne, M; Kidd, T				Brose, K; Bland, KS; Wang, KH; Arnott, D; Henzel, W; Goodman, CS; Tessier-Lavigne, M; Kidd, T			Slit proteins bind robe receptors and have an evolutionarily conserved role in repulsive axon guidance	CELL			English	Article							GROWTH CONE GUIDANCE; FLOOR-PLATE; IMMUNOGLOBULIN SUPERFAMILY; EXTRACELLULAR PROTEIN; COMMISSURAL AXONS; SPINAL-CORD; ENCODES; MIDLINE; DROSOPHILA; HEDGEHOG	Extending axons in the developing nervous system are guided in part by repulsive cues. Genetic analysis in Drosophila, reported in a companion to this paper, identifies the Slit protein as a candidate ligand for the repulsive guidance receptor Roundabout (Robo). Here we describe the characterization of three mammalian Slit homologs and show that the Drosophila Slit protein and at least one of the mammalian Slit proteins, Slit2, are proteolytically processed and show specific, high-affinity binding to Robe proteins. Furthermore, recombinant Slit2 can repel embryonic spinal motor axons in cell culture. These results support the hypothesis that Slit proteins have an evolutionarily conserved role in axon guidance as repulsive ligands for Robe receptors.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Roche Holding; Genentech	Tessier-Lavigne, M (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA.	marctl@itsa.ucsf.edu	Kidd, Thomas/AAT-9993-2020; Wang, Kuan Hong/J-1150-2016	Wang, Kuan Hong/0000-0002-2249-5417; Kidd, Thomas/0000-0001-7190-4208; Henzel, William/0000-0003-2940-3797; Bland, Kimberly/0000-0003-4863-6772				Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; BACHARVET KTN, 1999, IN PRESS NEURON; BLEBER AJ, 1994, METHOD CELL BIOL, P683; Bumcrot DA, 1996, CHEM BIOL, V3, P13, DOI 10.1016/S1074-5521(96)90077-0; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; COLAMARINO SA, 1995, ANNU REV NEUROSCI, V18, P497, DOI 10.1146/annurev.ne.18.030195.002433; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; GUTHRIE S, 1995, NEURON, V14, P1117, DOI 10.1016/0896-6273(95)90260-0; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Holmes GP, 1998, MECH DEVELOP, V79, P57, DOI 10.1016/S0925-4773(98)00174-9; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Itoh A, 1998, MOL BRAIN RES, V62, P175, DOI 10.1016/S0169-328X(98)00224-1; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; KLAR A, 1992, CELL, V69, P95, DOI 10.1016/0092-8674(92)90121-R; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Lentz SI, 1997, J COMP NEUROL, V378, P547, DOI 10.1002/(SICI)1096-9861(19970224)378:4<547::AID-CNE9>3.0.CO;2-2; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; Nakayama M, 1998, GENOMICS, V51, P27, DOI 10.1006/geno.1998.5341; Qi HL, 1999, SCIENCE, V283, P91, DOI 10.1126/science.283.5398.91; ROTHBERG JM, 1992, J MOL BIOL, V227, P367, DOI 10.1016/0022-2836(92)90891-M; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Stoeckli ET, 1997, NEURON, V18, P209, DOI 10.1016/S0896-6273(00)80262-7; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2	39	930	992	3	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	1999	96	6					795	806		10.1016/S0092-8674(00)80590-5	http://dx.doi.org/10.1016/S0092-8674(00)80590-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	178ZY	10102268	Bronze			2022-12-28	WOS:000079300100007
J	Murray, N; Holman, M				Murray, N; Holman, M			The origin of chaos in the outer solar system	SCIENCE			English	Article							ASTEROID BELT; COMPANION; NEPTUNE; MOTION; PLUTO; ORBIT; STAR	Classical analytic theories of the solar system indicate that it is stable, but numerical integrations suggest that it is chaotic. This disagreement is resolved by a new analytic theory. The theory shows that the chaos among the jovian planets results from the overlap of the components of a mean motion resonance among Jupiter, Saturn, and Uranus, and provides rough estimates of the Lyapunov time (10(7) years) and the dynamical lifetime of Uranus (10(18) years). The jovian planets must have entered the resonance after all the gas and most of the planetesimals in the protoplanetary disk were removed.	Univ Toronto, Canadian Inst Theoret Astrophys, Toronto, ON M5S 3H8, Canada; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	University of Toronto; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Murray, N (corresponding author), Univ Toronto, Canadian Inst Theoret Astrophys, 60 St George St, Toronto, ON M5S 3H8, Canada.			Murray, Norman/0000-0002-8659-3729				Arnold V, 1963, RUSS MATH SURV, V18, P85, DOI DOI 10.1070/RM1963V018N06ABEH001143; BECKWITH SVW, 1990, ASTRON J, V99, P924, DOI 10.1086/115385; Butler RP, 1997, ASTROPHYS J, V474, pL115, DOI 10.1086/310444; CHIRIKOV BV, 1979, PHYS REP, V52, P263, DOI 10.1016/0370-1573(79)90023-1; Dutrey A, 1998, ASTRON ASTROPHYS, V338, pL63; FERNANDEZ JA, 1984, ICARUS, V58, P109, DOI 10.1016/0019-1035(84)90101-5; Holman MJ, 1996, ASTRON J, V112, P1278, DOI 10.1086/118098; Laplace P.S., 1825, TRAITE MECANIQUE CEL; LASKAR J, 1989, NATURE, V338, P237, DOI 10.1038/338237a0; LATHAM DW, 1989, NATURE, V339, P38, DOI 10.1038/339038a0; Le Verrier Urbain, 1855, ANN OBSERV IMP PARIS, V1, P1; MALHOTRA R, 1993, NATURE, V365, P819, DOI 10.1038/365819a0; MALHOTRA R, 1995, ASTRON J, V110, P420, DOI 10.1086/117532; Marcy GW, 1996, ASTROPHYS J, V464, pL147, DOI 10.1086/310096; MOULTON F, 1970, INTRO CELESTIAL MECH, P361; MURRAY CS, 1993, EXPANSION PLANETARY; Murray N, 1998, ASTRON J, V116, P2583, DOI 10.1086/300586; Murray N, 1997, ASTRON J, V114, P1246, DOI 10.1086/118558; Murray N, 1998, SCIENCE, V279, P69, DOI 10.1126/science.279.5347.69; Nesvorny D, 1998, ASTRON J, V116, P3029, DOI 10.1086/300632; Noyes RW, 1997, ASTROPHYS J, V487, pL195; Noyes RW, 1997, ASTROPHYS J, V483, pL111, DOI 10.1086/310754; PEIRCE B, ASTRON J, V1, P1; QUINLAN GD, 1992, IAU S, V152; STANDISH M, COMMUNICATION; Stapelfeldt KR, 1998, ASTROPHYS J, V502, pL65, DOI 10.1086/311479; SUSSMAN GJ, 1988, SCIENCE, V241, P433, DOI 10.1126/science.241.4864.433; SUSSMAN GJ, 1992, SCIENCE, V257, P56, DOI 10.1126/science.257.5066.56; WISDOM J, 1996, FIELDS I COMMUNICATI, V10, P217	32	100	101	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 19	1999	283	5409					1877	1881		10.1126/science.283.5409.1877	http://dx.doi.org/10.1126/science.283.5409.1877			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177UC	10082453	Green Submitted			2022-12-28	WOS:000079228600036
J	Wang, KH; Brose, K; Arnott, D; Kidd, T; Goodman, CS; Henzel, W; Tessier-Lavigne, M				Wang, KH; Brose, K; Arnott, D; Kidd, T; Goodman, CS; Henzel, W; Tessier-Lavigne, M			Biochemical purification of a mammalian slit protein as a positive regulator of sensory axon elongation and branching	CELL			English	Article							NERVE GROWTH-FACTOR; SPINAL-CORD; NEURONS; BRAIN; NEUROTROPHIN-3; PROJECTIONS; INDUCTION; GUIDANCE; CULTURE; SYSTEM	Many neurons in both vertebrates and invertebrates innervate multiple targets by sprouting secondary axon collaterals (or branches) from a primary axon shaft. To begin to identify molecular regulators of axon branch initiation or extension, we studied the growth of single sensory axons in an in vitro collagen assay system and identified an activity in extracts of embryonic spinal cord and of postnatal and adult brain that promotes the elongation and formation of extensive branches by these axons. Biochemical purification of the activity from calf brain extracts led to the identification of an amino-terminal fragment of Slit2 as the main active component and to the discovery of a distinct activity that potentiates its effects. These results indicate that Slit proteins may function as positive regulators of axon collateral formation during the establishment or remodeling of neural circuits.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Genentech Inc, Dept Prot Chem, S San Francisco, CA 94080 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Roche Holding; Genentech	Tessier-Lavigne, M (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA.		Wang, Kuan Hong/J-1150-2016; Kidd, Thomas/AAT-9993-2020	Wang, Kuan Hong/0000-0002-2249-5417; Kidd, Thomas/0000-0001-7190-4208; Henzel, William/0000-0003-2940-3797				ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; Arnott D, 1998, ELECTROPHORESIS, V19, P968, DOI 10.1002/elps.1150190612; Arnott D, 1998, ANAL BIOCHEM, V258, P1, DOI 10.1006/abio.1998.2566; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; CAMPENOT RB, 1982, DEV BIOL, V93, P1, DOI 10.1016/0012-1606(82)90232-9; Castellani V, 1998, J NEUROSCI, V18, P4663; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; DIAMOND J, 1992, J NEUROSCI, V12, P1454; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gallo G, 1998, J NEUROSCI, V18, P5403, DOI 10.1523/JNEUROSCI.18-14-05403.1998; HARRIS WA, 1985, J NEUROSCI RES, V13, P101, DOI 10.1002/jnr.490130108; HEFFNER CD, 1990, SCIENCE, V247, P217, DOI 10.1126/science.2294603; HENZEL WJ, 1987, J CHROMATOGR, V404, P41, DOI 10.1016/S0021-9673(01)86835-7; HENZEL WJ, 1993, P NATL ACAD SCI USA, V90, P5011, DOI 10.1073/pnas.90.11.5011; HENZEL WJ, 1995, CURRENT PROTOCOLS PR, V1; Holmes GP, 1998, MECH DEVELOP, V79, P57, DOI 10.1016/S0925-4773(98)00174-9; HORYLEE F, 1993, P NATL ACAD SCI USA, V90, P2613, DOI 10.1073/pnas.90.7.2613; Itoh A, 1998, MOL BRAIN RES, V62, P175, DOI 10.1016/S0169-328X(98)00224-1; Kennedy Timothy E., 1995, Current Opinion in Neurobiology, V5, P83, DOI 10.1016/0959-4388(95)80091-3; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; KRUTZSCH HC, 1993, ANAL BIOCHEM, V209, P109, DOI 10.1006/abio.1993.1089; Lentz SI, 1999, J NEUROSCI, V19, P1038; LEVIMONTALCINI R, 1964, ANN NY ACAD SCI, V118, P149, DOI 10.1111/j.1749-6632.1964.tb33978.x; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Lui M, 1996, ANAL BIOCHEM, V241, P156, DOI 10.1006/abio.1996.0393; Maina F, 1998, NEURON, V20, P835, DOI 10.1016/S0896-6273(00)80466-3; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Nakayama M, 1998, GENOMICS, V51, P27, DOI 10.1006/geno.1998.5341; O'Leary D D, 1992, Curr Opin Neurobiol, V2, P70, DOI 10.1016/0959-4388(92)90165-H; OAKLEY RA, 1995, DEVELOPMENT, V121, P1341; OLEARY DDM, 1990, COLD SH Q B, V55, P453; Ozaki S, 1997, J COMP NEUROL, V380, P215; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; ROTHBERG JM, 1988, CELL, V55, P1047, DOI 10.1016/0092-8674(88)90249-8; SATO M, 1994, NEURON, V13, P791, DOI 10.1016/0896-6273(94)90246-1; SCOTT SA, 1993, J COMP NEUROL, V337, P277, DOI 10.1002/cne.903370208; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; White FA, 1998, J NEUROSCI, V18, P1428; WINSLOW JW, 1995, NEURON, V14, P973, DOI 10.1016/0896-6273(95)90335-6; Yang XM, 1998, J NEUROSCI, V18, P8369; YU WQ, 1994, J NEUROSCI, V14, P5872; ZHANG L, 1994, J NEUROSCI, V14, P5187	45	396	427	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 19	1999	96	6					771	784		10.1016/S0092-8674(00)80588-7	http://dx.doi.org/10.1016/S0092-8674(00)80588-7			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	178ZY	10102266	Bronze			2022-12-28	WOS:000079300100005
J	Strain, EC; Bigelow, GE; Liebson, IA; Stitzer, ML				Strain, EC; Bigelow, GE; Liebson, IA; Stitzer, ML			Moderate- vs high-dose methadone in the treatment of opioid dependence - A randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BUPRENORPHINE; MAINTENANCE; PREDICTORS; ABUSE	Context Methadone hydrochloride treatment is the most common pharmacological intervention for opioid dependence, and recent interest has focused on expanding methadone treatment availability beyond traditional specially licensed clinics. However, despite recommendations regarding effective dosing of methadone, controlled clinical trials of higher-dose methadone have not been conducted. Objective To compare the relative clinical efficacy of moderate- vs high-dose methadone in the treatment of opioid dependence. Design A 40-week randomized, double-blind clinical trial starting in June 1992 and ending in October 1995. Setting Outpatient substance abuse treatment research clinic at the Johns Hopkins University Bayview Campus, Baltimore, Md. Participants One hundred ninety-two eligible clinic patients. Intervention Daily oral methadone hydrochloride in the dose range of 40 to 50 mg (n = 97) or 80 to 100 mg (n = 95), with concurrent substance abuse counseling. Main Outcome Measures Opioid-positive urinalysis results and retention in treatment. Results By intent-to-treat analysis, through week 30 patients in the high-dose group had significantly lower rates of opioid-positive urine samples compared with patients in the moderate-dose group (53.0% [95 % confidence interval {Cl}, 46.9% -59.2 %] vs 61.9% [95 % CI, 55.9 % -68.0 %]; P = .047). These differences persisted during withdrawal from methadone, Through day 210 no significant difference was evident between dose groups in treatment retention (high-dose group mean retention, 159 days; moderate-dose group mean retention, 157 days), Nineteen (33%) of 57 patients in the high-dose group and 11 (20%) of 54 patients in the moderate-dose group completed detoxification. Conclusions Both moderate- and high-dose methadone treatment resulted in decreased illicit opioid use during methadone maintenance and detoxification, The high-dose group had significantly greater decreases in illicit opiod use.	Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21224 USA	Johns Hopkins University	Strain, EC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, 5510 Nathan Shock Dr, Baltimore, MD 21224 USA.	ecsgss@aol.com			NATIONAL INSTITUTE ON DRUG ABUSE [K02DA000332, R01DA005792, K05DA000050] Funding Source: NIH RePORTER; NIDA NIH HHS [K02 DA00332, K05 DA00050, R01 DA05792] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		[Anonymous], 1995, FEDERAL REGULATION M; Ball J.C., 2012, EFFECTIVENESS METHAD; Bigelow GE., 1998, J MAINTENANCE ADDICT, V1, DOI 10.1300/J126v01n03_05; Diggle P. J., 1996, ANAL LONGITUDINAL DA; DOLE VP, 1965, JAMA-J AM MED ASSOC, V193, P80; FARLEY TA, 1992, AIDS, V6, P115, DOI 10.1097/00002030-199201000-00016; FARRELL M, 1996, REV LEGISLATION REGU; GARBUTT GD, 1972, P 4 NAT C METH TREAT, P411; GIBBONS RD, 1993, ARCH GEN PSYCHIAT, V50, P739; GOLDSTEIN A, 1970, P 3 NAT C METH TREAT, P31; GOLDSTEIN A, 1973, P 5 NAT C METH TREAT, P21; IGUCHI MY, 1991, AM J DRUG ALCOHOL AB, V17, P279, DOI 10.3109/00952999109027552; JOHNSON RE, 1992, JAMA-J AM MED ASSOC, V267, P2750, DOI 10.1001/jama.267.20.2750; Judd LL, 1998, JAMA-J AM MED ASSOC, V280, P1936; KOSTEN TR, 1993, J NERV MENT DIS, V181, P358, DOI 10.1097/00005053-199306000-00004; Kreft I. G., 1998, INTRO MULTILEVEL MOD, DOI DOI 10.4135/9781849209366; Ling W, 1996, ARCH GEN PSYCHIAT, V53, P401; LING W, 1976, ARCH GEN PSYCHIAT, V33, P709; PARRINO MW, 1993, STATE METHADONE TREA, V1; Schottenfeld RS, 1997, ARCH GEN PSYCHIAT, V54, P713; SINGER JD, IN PRESS J ED BEHAV; STRAIN EC, 1993, DRUG ALCOHOL DEPEN, V33, P105, DOI 10.1016/0376-8716(93)90052-R; STRAIN EC, 1993, ANN INTERN MED, V119, P23, DOI 10.7326/0003-4819-119-1-199307010-00004; Strain Eric C., 1999, METHADONE TREATMENT; *SUBST AB MENT HLT, 1996, NAT DRUG ALC TREATM; *US GEN ACC OFF, 1990, METH MAINT SOM TREAT	26	304	315	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	1999	281	11					1000	1005		10.1001/jama.281.11.1000	http://dx.doi.org/10.1001/jama.281.11.1000			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175EE	10086434	Bronze			2022-12-28	WOS:000079079400026
J	Laurance, J				Laurance, J			MONICA did not deliver on task it set out to accomplish	BRITISH MEDICAL JOURNAL			English	Letter									Independent, London E14 5DL, England		Laurance, J (corresponding author), Independent, London E14 5DL, England.							Tunstall-Pedoe, 1998, BMJ, V317, P1023	1	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 13	1999	318	7185					732	733						6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182JK	10074026	Green Published			2022-12-28	WOS:000079495700040
J	Schmid, ML; McKendrick, MW; Lobo, A; Leach, M				Schmid, ML; McKendrick, MW; Lobo, A; Leach, M			A perianal ulcer	LANCET			English	Article							AMPHOTERICIN-B; LEISHMANIASIS		Royal Hallamshire Hosp, N Trent Dept Infect & Trop Med, Sheffield S10 2JF, S Yorkshire, England; Royal Hallamshire Hosp, Dept Gastroenterol, Sheffield S10 2JF, S Yorkshire, England; Royal Hallamshire Hosp, Dept Haematol, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Schmid, ML (corresponding author), Royal Hallamshire Hosp, N Trent Dept Infect & Trop Med, Glossop Rd, Sheffield S10 2JF, S Yorkshire, England.		Schmid, Matthias/B-7750-2008					Berman JD, 1997, CLIN INFECT DIS, V24, P684, DOI 10.1093/clind/24.4.684; DAVIDSON RN, 1991, LANCET, V337, P1061, DOI 10.1016/0140-6736(91)91708-3; LAGUNA F, 1994, CLIN INFECT DIS, V19, P48, DOI 10.1093/clinids/19.1.48; Punda-Polic V, 1998, LANCET, V351, P188, DOI 10.1016/S0140-6736(05)78208-8; Thakur CP, 1996, INDIAN J MED RES, V103, P259	5	6	6	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 13	1999	353	9156					894	894		10.1016/S0140-6736(98)10454-3	http://dx.doi.org/10.1016/S0140-6736(98)10454-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BU	10093983				2022-12-28	WOS:000079421400013
J	Schwab, M; Roder, F; Morike, K; Thon, KP; Klotz, U				Schwab, M; Roder, F; Morike, K; Thon, KP; Klotz, U			Prevention of falls in elderly people	LANCET			English	Letter									Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany; Robert Bosch Hosp, Dept Geriatr Rehabil, Stuttgart, Germany; Robert Bosch Hosp, Dept Gen Abdominal & Traumat Surg, Stuttgart, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Bosch; Robert Bosch Krankenhaus; Bosch; Robert Bosch Krankenhaus	Schwab, M (corresponding author), Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany.							Butler R, 1997, J AFFECT DISORDERS, V46, P303, DOI 10.1016/S0165-0327(97)00154-7; Close J, 1999, LANCET, V353, P93, DOI 10.1016/S0140-6736(98)06119-4; Cumming RG, 1998, DRUG AGING, V12, P43, DOI 10.2165/00002512-199812010-00005; Passare G, 1998, CLIN DRUG INVEST, V15, P497, DOI 10.2165/00044011-199815060-00006; RUBENSTEIN LZ, 1990, ANN INTERN MED, V113, P308, DOI 10.7326/0003-4819-113-4-308	5	3	3	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 13	1999	353	9156					928	928		10.1016/S0140-6736(05)75037-6	http://dx.doi.org/10.1016/S0140-6736(05)75037-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BU	10094011				2022-12-28	WOS:000079421400059
J	Mehta, AD; Rief, M; Spudich, JA; Smith, DA; Simmons, RM				Mehta, AD; Rief, M; Spudich, JA; Smith, DA; Simmons, RM			Single-molecule biomechanics with optical methods	SCIENCE			English	Review							ATOMIC-FORCE MICROSCOPY; KINESIN MOLECULES; ACTIN FILAMENT; SMOOTH-MUSCLE; DNA-MOLECULES; ADP RELEASE; LASER TRAP; MYOSIN; ELASTICITY; MOVEMENT	Single-molecule observation and manipulation have come of age. With the advent of optical tweezers and other methods for probing and imaging single molecules, investigators have circumvented the model-dependent extrapolation from ensemble assays that has been the hallmark of classical biochemistry and biophysics. In recent years, there have been important advances in the understanding of how motor proteins work. The range of these technologies has also started to expand into areas such as DNA transcription and protein folding. Here, recent experiments with rotary motors, Linear motors, RNA polymerase, and titin are described.	Univ London Kings Coll, Randall Inst, London WC2B 5RL, England; Stanford Univ, Dept Biochem B400, Sch Med, Stanford, CA 94305 USA	University of London; King's College London; Stanford University	Spudich, JA (corresponding author), Univ London Kings Coll, Randall Inst, 26-29 Drury Lane, London WC2B 5RL, England.							Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BERLINER E, 1995, NATURE, V373, P718, DOI 10.1038/373718a0; Block SM, 1998, CELL, V93, P5, DOI 10.1016/S0092-8674(00)81138-1; BLOCK SM, 1989, NATURE, V338, P514, DOI 10.1038/338514a0; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Cluzel P, 1996, SCIENCE, V271, P792, DOI 10.1126/science.271.5250.792; Coppin CM, 1997, P NATL ACAD SCI USA, V94, P8539, DOI 10.1073/pnas.94.16.8539; Cremo CR, 1998, BIOCHEMISTRY-US, V37, P1969, DOI 10.1021/bi9722406; Dammer U, 1996, BIOPHYS J, V70, P2437, DOI 10.1016/S0006-3495(96)79814-4; DeSilva TM, 1997, BIOCHEMISTRY-US, V36, P3991, DOI 10.1021/bi962412j; Dupuis DE, 1997, J MUSCLE RES CELL M, V18, P17, DOI 10.1023/A:1018672631256; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Gautel M, 1996, FEBS LETT, V385, P11, DOI 10.1016/0014-5793(96)00338-9; Gelles J, 1998, CELL, V93, P13, DOI 10.1016/S0092-8674(00)81140-X; Guilford WH, 1997, BIOPHYS J, V72, P1006, DOI 10.1016/S0006-3495(97)78753-8; Hancock WO, 1998, J CELL BIOL, V140, P1395, DOI 10.1083/jcb.140.6.1395; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Howard J, 1997, NATURE, V389, P561, DOI 10.1038/39247; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; Inoue Y, 1997, P NATL ACAD SCI USA, V94, P7275, DOI 10.1073/pnas.94.14.7275; Ishijima A, 1998, CELL, V92, P161, DOI 10.1016/S0092-8674(00)80911-3; Ishijima A, 1996, BIOPHYS J, V70, P383, DOI 10.1016/S0006-3495(96)79582-6; JONTES JD, 1995, NATURE, V378, P751, DOI 10.1038/378751a0; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; Kinosita K, 1998, CELL, V93, P21, DOI 10.1016/S0092-8674(00)81142-3; KISHINO A, 1988, NATURE, V334, P74, DOI 10.1038/334074a0; Kitamura K, 1999, NATURE, V397, P129, DOI 10.1038/16403; Kojima H, 1997, BIOPHYS J, V73, P2012, DOI 10.1016/S0006-3495(97)78231-6; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; LEE GU, 1994, LANGMUIR, V10, P354, DOI 10.1021/la00014a003; Lohman TM, 1998, CELL, V93, P9, DOI 10.1016/S0092-8674(00)81139-3; Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3; Marszalek PE, 1998, NATURE, V396, P661, DOI 10.1038/25322; MARUYAMA K, 1977, J BIOCHEM, V82, P317; Mehta AD, 1997, P NATL ACAD SCI USA, V94, P7927, DOI 10.1073/pnas.94.15.7927; MEYHOFER E, 1995, P NATL ACAD SCI USA, V92, P574, DOI 10.1073/pnas.92.2.574; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Politou AS, 1995, BIOPHYS J, V69, P2601, DOI 10.1016/S0006-3495(95)80131-1; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1997, SCIENCE, V275, P1295, DOI 10.1126/science.275.5304.1295; Rief M, 1998, BIOPHYS J, V75, P3008, DOI 10.1016/S0006-3495(98)77741-0; Rief M, 1998, PHYS REV LETT, V81, P4764, DOI 10.1103/PhysRevLett.81.4764; Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466; Romberg L, 1998, J CELL BIOL, V140, P1407, DOI 10.1083/jcb.140.6.1407; SCHAFER DA, 1991, NATURE, V352, P444, DOI 10.1038/352444a0; Schnitzer MJ, 1995, COLD SPRING HARB SYM, V60, P793, DOI 10.1101/SQB.1995.060.01.085; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Sheetz M. P., 1997, METHODS CELL BIOL, V55; Simmons RM, 1996, BIOPHYS J, V70, P1813, DOI 10.1016/S0006-3495(96)79746-1; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; SPUDICH JA, 1989, CELL REGUL, V1, P1; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; Suzuki Y, 1998, NATURE, V396, P380, DOI 10.1038/24640; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; SVOBODA K, 1994, P NATL ACAD SCI USA, V91, P11782, DOI 10.1073/pnas.91.25.11782; Tanaka H, 1998, BIOPHYS J, V75, P1886, DOI 10.1016/S0006-3495(98)77629-5; Tskhovrebova L, 1997, NATURE, V387, P308, DOI 10.1038/387308a0; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; Veigel C, 1998, BIOPHYS J, V75, P1424, DOI 10.1016/S0006-3495(98)74061-5; Visscher K, 1998, METHOD ENZYMOL, V298, P460, DOI 10.1016/S0076-6879(98)98040-5; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0; Warshaw DM, 1998, P NATL ACAD SCI USA, V95, P8034, DOI 10.1073/pnas.95.14.8034; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; WHITTAKER M, 1995, NATURE, V378, P748, DOI 10.1038/378748a0; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; YIN H, 1995, SCIENCE, V270, P1653, DOI 10.1126/science.270.5242.1653; Young EC, 1998, BIOCHEMISTRY-US, V37, P3467, DOI 10.1021/bi972172n	81	568	587	0	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	1999	283	5408					1689	1695		10.1126/science.283.5408.1689	http://dx.doi.org/10.1126/science.283.5408.1689			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175PF	10073927				2022-12-28	WOS:000079102800040
J	Burke, AP; Farb, A; Malcom, GT; Liang, YH; Smialek, JE; Virmani, R				Burke, AP; Farb, A; Malcom, GT; Liang, YH; Smialek, JE; Virmani, R			Plaque rupture and sudden death related to exertion in men with coronary artery disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRIMARY CARDIAC-ARREST; ATHEROSCLEROTIC LESIONS; CIRCUMFERENTIAL STRESS; CARDIOVASCULAR-DISEASE; PHYSICAL-ACTIVITY; MYOCARDIAL-INFARCTION; UNSTABLE ANGINA; FITNESS; MORPHOLOGY; APOPTOSIS	Context Exertion has been reported to acutely increase the risk of sudden coronary death, but the underlying mechanisms are unclear. Objective To determine the frequency of plaque rupture in sudden deaths related to exertion compared with sudden deaths not related to exertion. Design Autopsy survey. Coronary arteries were perfusion fixed and segments with more than 50% luminal narrowing were examined histologically, Ruptured plaques were defined as intraplaque hemorrhage with disruption of the fibrous cap and luminal thrombus. Exertion before death was determined by the investigator of the death. Setting Medical examiner's office. Patients A total of 141 men with severe coronary artery disease who died suddenly, including 116 whose deaths occurred at rest (mean [SD] age, 51 [11] years) and 25 who died during strenuous activity or emotional stress (age, 49 [9] years). Main Outcome Measures The frequency and morphology of plaque rupture was compared in men dying at rest vs those dying during exertion. Independent association of risk factors (total cholesterol, high-density lipoprotein cholesterol, glycosylated hemoglobin, cigarette smoking) in addition to acute exertion with plaque rupture were determined. Results The mean (SD) number of vulnerable plaques in the coronary arteries of men in the exertional-death group was 1.6 (1.5) and in the at-rest group was 0.9 (1.2) (P = .03). The culprit plaque in men dying during exertion was plaque rupture in 17 (68%) of 25 vs 27 (23%) of 116 men dying at rest (P < .001). Hemorrhage into the plaque occurred in 18 (72%) of 25 men in the exertional-death group and 47 (41%) of 116 men in the rest group (P = .007). Histological evidence of acute myocardial infarction was present in 0 of 25 in the exertion group and in 15 (13%) of 116 in the rest group. Men dying during exertion had a significantly higher mean (SD) total cholesterol-high-density lipoprotein cholesterol ratio (8.2 [3.0]) than those dying at rest (6.2 [2.7]; P = .002), and the majority (21/25) were not conditioned. In multivariate analysis, both exertion (P = .002) and total cholesterol-high-density lipoprotein cholesterol ratio (P = .002) were associated with acute plaque rupture, independent of age and other cardiac risk factors. Conclusion In men with severe coronary artery disease, sudden death related to exertion was associated with acute plaque rupture.	Armed Forces Inst Pathol, Dept Cardiovasc Pathol, Washington, DC 20306 USA; Louisiana State Univ, New Orleans, LA USA; Univ Maryland, Baltimore, MD 21201 USA	United States Department of Defense; Louisiana State University System; University System of Maryland; University of Maryland Baltimore	Virmani, R (corresponding author), Armed Forces Inst Pathol, Dept Cardiovasc Pathol, Washington, DC 20306 USA.							BARGER AC, 1984, NEW ENGL J MED, V310, P175, DOI 10.1056/NEJM198401193100307; BARGER AC, 1990, AM J CARDIOL, V66, P41; Bjorkerud S, 1996, AM J PATHOL, V149, P367; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; BROWN DL, 1995, CIRCULATION, V91, P2125, DOI 10.1161/01.CIR.91.8.2125; Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; CHENG GC, 1993, CIRCULATION, V87, P1179, DOI 10.1161/01.CIR.87.4.1179; Crisby M, 1997, ATHEROSCLEROSIS, V130, P17, DOI 10.1016/S0021-9150(96)06037-6; EKELUND LG, 1988, NEW ENGL J MED, V319, P1379, DOI 10.1056/NEJM198811243192104; FALK E, 1992, CIRCULATION, V86, P30; FARB A, 1997, MODERN PATHOL, V9, pA29; Felton CV, 1997, ARTERIOSCL THROM VAS, V17, P1337, DOI 10.1161/01.ATV.17.7.1337; Haft JI, 1997, CLIN CARDIOL, V20, P651, DOI 10.1002/clc.4960200712; Hayashi K, 1997, J BIOMECH, V30, P573, DOI 10.1016/S0021-9290(96)00185-6; Johnstone MT, 1996, AM J HYPERTENS, V9, pS22, DOI 10.1016/0895-7061(95)00403-3; KANNEL WB, 1985, AM HEART J, V109, P876, DOI 10.1016/0002-8703(85)90653-2; Lee RT, 1996, ARTERIOSCL THROM VAS, V16, P1070, DOI 10.1161/01.ATV.16.8.1070; LEON AS, 1987, JAMA-J AM MED ASSOC, V258, P2388, DOI 10.1001/jama.258.17.2388; LOREE HM, 1992, CIRC RES, V71, P850, DOI 10.1161/01.RES.71.4.850; LOREE HM, 1994, ARTERIOSCLER THROMB, V14, P230, DOI 10.1161/01.ATV.14.2.230; Mann JM, 1996, CIRCULATION, V94, P928, DOI 10.1161/01.CIR.94.5.928; MORENO PR, 1994, CIRCULATION, V90, P775, DOI 10.1161/01.CIR.90.2.775; MULLER JE, 1989, CIRCULATION, V79, P733, DOI 10.1161/01.CIR.79.4.733; OBERMAN A, 1985, AM J CARDIOL, V55, pD10, DOI 10.1016/0002-9149(85)91049-5; RICHARDSON PD, 1989, LANCET, V2, P941; SISCOVICK DS, 1984, NEW ENGL J MED, V311, P874, DOI 10.1056/NEJM198410043111402; SISCOVICK DS, 1982, JAMA-J AM MED ASSOC, V248, P3113, DOI 10.1001/jama.248.23.3113; TOFLER GH, 1990, AM J CARDIOL, V66, P22, DOI 10.1016/0002-9149(90)90729-K	28	285	294	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	1999	281	10					921	926		10.1001/jama.281.10.921	http://dx.doi.org/10.1001/jama.281.10.921			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172XH	10078489	Bronze			2022-12-28	WOS:000078950600037
J	Mallick, NP; Gokal, R				Mallick, NP; Gokal, R			Haemodialysis	LANCET			English	Article							CHRONIC-HEMODIALYSIS PATIENTS; BLOOD-PRESSURE CONTROL; CHRONIC-RENAL-FAILURE; DIALYSIS PATIENTS; MEMBRANE BIOCOMPATIBILITY; RISK-FACTORS; POPULATION; MORTALITY; DISEASE; PARAMETERS	This paper charts the development of haemodialysis, the cornerstone of renal replacement therapy (RRT). It has enabled patients with end-stage renal failure to survive for years, in many cases with a surprisingly good quality of life. Through technological advances, RRT can be offered to patients who are older and more frail. Many have intercurrent comorbid illness. Such patients can have good quality of life, but their survival is shorter since they are likely to succumb early to comorbid illnesses. The challenge to nephrologists is to provide treatment based on exacting standards for all those patients who can benefit, yet to maintain cost-effectiveness. There is increasing recognition that, however good the technology underpinning dialysis, what justifies the cost and commitment that dialysis entails is the provision for the patient of a satisfactory quality of life.	Manchester Royal Infirm, Dept Renal Med, Manchester M13 9WL, Lancs, England	University of Manchester	Mallick, NP (corresponding author), Manchester Royal Infirm, Dept Renal Med, Oxford Rd, Manchester M13 9WL, Lancs, England.							Bergstrom J, 1995, BLOOD PURIFICAT, V13, P361, DOI 10.1159/000170222; Bloembergen W E, 1996, Adv Ren Replace Ther, V3, P201; BROWN JH, 1994, NEPHROL DIAL TRANSPL, V9, P1136, DOI 10.1093/ndt/9.8.1136; Buoncristiani U, 1996, CONTRIB NEPHROL, V119, P152; CHARRA B, 1994, CONTRIB NEPHROL, V106, P179; CHARRA B, 1992, KIDNEY INT, V41, P1286, DOI 10.1038/ki.1992.191; CHAZOT C, 1995, NEPHROL DIAL TRANSPL, V10, P831; Cheung AK, 1997, SEMIN NEPHROL, V17, P196; DAVFIRDAS JT, 1997, KIDNEY INT, V52, P1345; *DISN APS, 1995, AUSTR NZ DIAL TRANSP, P135; FEEST TG, 1990, BRIT MED J, V301, P897, DOI 10.1136/bmj.301.6757.897; Foley R N, 1997, Adv Ren Replace Ther, V4, P234; GOKAL R, 1995, J ROY COLL PHYS LOND, V29, P190; Hakim RM, 1996, J AM SOC NEPHROL, V7, P472; HIATT RA, 1982, AM J PUBLIC HEALTH, V72, P829, DOI 10.2105/AJPH.72.8.829; HRUSKA KA, 1995, NEW ENGL J MED, V333, P166, DOI 10.1056/NEJM199507203330307; Khan A, 1996, HEALTH POLICY PLANN, V11, P30, DOI 10.1093/heapol/11.1.30; Kopple JD, 1997, ASAIO J, V43, P246; Locatelli F, 1996, NEPHROL DIAL TRANSPL, V11, P116; MALLICK NP, 1995, NEPHROL DIAL TRANSPL, V10, P2, DOI 10.1093/ndt/10.supp7.2; MCGEOWN MG, 1990, BRIT MED J, V301, P900, DOI 10.1136/bmj.301.6757.900; Owen WF, 1996, BLOOD PURIFICAT, V14, P278; OWEN WF, 1993, NEW ENGL J MED, V329, P1001, DOI 10.1056/NEJM199309303291404; Parfrey PS, 1996, NEPHROL DIAL TRANSPL, V11, P1277; Parker TF, 1996, KIDNEY INT, V49, P551, DOI 10.1038/ki.1996.78; Pereira BJG, 1996, J AM SOC NEPHROL, V7, P861; Pierratos A, 1998, J AM SOC NEPHROL, V9, P859; Rocco MV, 1996, J AM SOC NEPHROL, V7, P889; RODERICK PJ, 1994, BRIT MED J, V309, P1111, DOI 10.1136/bmj.309.6962.1111; Tracy RE, 1996, SEMIN NEPHROL, V16, P126; Twardowski Z J, 1996, Adv Ren Replace Ther, V3, P124; *US DEP HHS, US REN DAT SYST 1993; *US NAT KIDN FDN, 1997, AM J KIDNEY DIS S2, V30; VALDERRABANO F, 1996, NEPHROL DIAL TRANSPL, V11, P125	34	51	56	1	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	1999	353	9154					737	742		10.1016/S0140-6736(97)09411-7	http://dx.doi.org/10.1016/S0140-6736(97)09411-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173DR	10073530				2022-12-28	WOS:000078966400044
J	Parrish, JK; Edelstein-Keshet, L				Parrish, JK; Edelstein-Keshet, L			Complexity, pattern, and evolutionary trade-offs in animal aggregation	SCIENCE			English	Editorial Material							SELFISH HERD; FISH; SCHOOLS; THERMOREGULATION; PREDATION; DOLPHINS; BEHAVIOR; BIRDS	One of the most striking patterns in biology is the formation of animal aggregations. Classically; aggregation has been viewed as an evolutionarily advantageous state, in which members derive the benefits of protection, mate choice, and centralized information, balanced by the costs of Limiting resources. Consisting of individual members, aggregations nevertheless function as an integrated whole, displaying a complex set of behaviors not possible at the Level of the individual organism. Complexity theory indicates that Large populations of units can self-organize into aggregations that generate pattern, store information, and engage in collective decision-making. This begs the question, are all emergent properties of animal aggregations functional or are some simply pattern? Solutions to this dilemma will necessitate a closer marriage of theoretical and modeling studies Linked to empirical work addressing the choices, and trajectories, of individuals constrained by membership in the group.	Univ Washington, Dept Zool, Seattle, WA 98195 USA; Univ British Columbia, Dept Math, Vancouver, BC V6T 1Z2, Canada	University of Washington; University of Washington Seattle; University of British Columbia	Parrish, JK (corresponding author), Univ Washington, Dept Zool, Seattle, WA 98195 USA.	jparrish@u.washington.edu	Fahimifar, Sepideh/M-5303-2019					ABRAHAMS MV, 1985, ENVIRON BIOL FISH, V13, P195, DOI 10.1007/BF00000931; Allee W., 1949, PRINCIPLES ANIMAL EC; Allee W.C, 1931, ANIMAL AGGREGATION S; Belkovich V. M., 1991, DOLPHIN SOC DISCOVER; Ben-Jacob E, 1998, SCI AM, V279, P82, DOI 10.1038/scientificamerican1098-82; Bertram B.C.R., 1978, P64; Bonner JT, 1944, AM J BOT, V31, P175, DOI 10.2307/2437641; CLARK CW, 1986, THEOR POPUL BIOL, V30, P45, DOI 10.1016/0040-5809(86)90024-9; COULSON JC, 1968, NATURE, V217, P478, DOI 10.1038/217478a0; DENEUBOURG JL, 1989, ETHOL ECOL EVOL, V1, P295, DOI 10.1080/08927014.1989.9525500; Diamond J., 2010, RUZHYA MIKROBY STALI; Edelstein-Keshet L, 1998, J MATH BIOL, V36, P515, DOI 10.1007/s002850050112; Edmunds M., 1974, DEFENSE IN ANIMALS; ELLIS PE, 1953, J EXP BIOL, V30, P214; ERMENTROUT GB, 1993, J THEOR BIOL, V160, P97, DOI 10.1006/jtbi.1993.1007; FISH D, 1973, NATURE, V241, P290; Flierl G, 1999, J THEOR BIOL, V196, P397, DOI 10.1006/jtbi.1998.0842; FORCADA J, 1994, MAR MAMMAL SCI, V10, P137, DOI 10.1111/j.1748-7692.1994.tb00256.x; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Giraldeau L.-A., 1988, P33; GRAHAM R, 1987, LAS SYN C COH SELF O; Grunbaum Daniel, 1997, P257; Haken H., 1983, SYNERGETICS INTRO NO; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; HEINRICH B, 1981, SCIENCE, V212, P565, DOI 10.1126/science.212.4494.563; Holldobler B., 1990, pi; HOOGLAND JL, 1979, ANIM BEHAV, V27, P394, DOI 10.1016/0003-3472(79)90174-X; Hunter J. R., 1967, Fishery Bulletin Fish and Wildlife Service US, V66, P13; KERMACK WO, 1922, R STAT SOC J, V115, P700; KRAUSE J, 1994, BIOL REV, V69, P187, DOI 10.1111/j.1469-185X.1994.tb01505.x; Lack D., 1954, P343; LANDEAU L, 1986, ANIM BEHAV, V34, P1372, DOI 10.1016/S0003-3472(86)80208-1; Langton C., 1997, ARTIFICIAL LIFE OVER; LAZARUS J, 1979, ANIM BEHAV, V27, P855, DOI 10.1016/0003-3472(79)90023-X; Levin Simon A., 1997, ANIMAL GROUPS 3 DIME, P245; LISSAMAN PB, 1970, SCIENCE, V168, P1003, DOI 10.1126/science.168.3934.1003; MCFARLAND WN, 1967, SCIENCE, V156, P260, DOI 10.1126/science.156.3772.260; Mech LD., 1970, WOLF ECOLOGY BEHAV E; MIMURA M, 1982, ADV BIOPHYS, V15, P19, DOI 10.1016/0065-227X(82)90004-1; MISUND OA, 1991, BEHAV SCH RELATED FI; MOGILNER A, IN PRESS J MATH BIOL; NORRIS KS, 1988, ETHOL SOCIOBIOL, V9, P149, DOI 10.1016/0162-3095(88)90019-2; Okubo A., 1986, Advances in Biophysics, V22, P1, DOI 10.1016/0065-227X(86)90003-1; Okubo A., 1980, DIFFUSION ECOLOGICAL; PARRISH JK, 1992, NETH J ZOOL, V42, P358, DOI 10.1163/156854291X00388; PARRISH JK, 1989, ANIM BEHAV, V38, P1048, DOI 10.1016/S0003-3472(89)80143-5; PARRISH JK, IN PRESS ENV BIOL FI; PARTRIDGE BL, 1983, ENVIRON BIOL FISH, V9, P253, DOI 10.1007/BF00692374; PEDLEY TJ, 1992, ANNU REV FLUID MECH, V24, P313, DOI 10.1146/annurev.fluid.24.1.313; Pitcher T. J., 1983, PREDATORS PREY FISHE, P193; Pitcher TJ., 1993, Behaviour of teleost fishes, P363, DOI 10.1007/978-94-011-1578-0_12; RETTENMEYER CARL W., 1963, UNIV KANSAS SCI BULL, V44, P281; REYNOLDS CW, 1975, COMPUT GRAPHICS, V21, P75; Romey WL, 1996, ECOL MODEL, V92, P65, DOI 10.1016/0304-3800(95)00202-2; Schilt Carl R., 1997, P225; SCHNEIRLA TC, 1971, STUDY SOCIAL ORG; Smith E. A, 1981, HUNTER GATHERER FORA, P36; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Vabo R, 1997, FISH OCEANOGR, V6, P155, DOI 10.1046/j.1365-2419.1997.00037.x; Wakita J, 1998, J PHYS SOC JPN, V67, P3630, DOI 10.1143/JPSJ.67.3630; WATMOUGH J, 1995, J THEOR BIOL, V176, P391, DOI 10.1006/jtbi.1995.0207; Williams G. C., 1964, PUBLS MUS MICHIGAN S, V2, P349; Wittenberger J.F., 1985, Avian Biology, V8, P1; WURSIG B, 1980, FISH B-NOAA, V77, P871	64	811	844	8	268	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	1999	284	5411					99	101		10.1126/science.284.5411.99	http://dx.doi.org/10.1126/science.284.5411.99			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182QE	10102827	Green Published			2022-12-28	WOS:000079509000040
J	Azcona, C; Bareille, P; Stanhope, L				Azcona, C; Bareille, P; Stanhope, L			Lesson of the week - Turner's syndrome mosaicism in patients with a normal blood lymphocyte karyotype	BRITISH MEDICAL JOURNAL			English	Article									Great Ormond St Hosp Children, Dept Paediat Endocrinol, London WC1N 8AA, England; UCLH, Middlesex Hosp, London WC1N 8AA, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University College London Hospitals NHS Foundation Trust; University of London; University College London	Stanhope, L (corresponding author), Great Ormond St Hosp Children, Dept Paediat Endocrinol, London WC1N 8AA, England.		San Julián, María Cristina Azcona/A-1160-2015	San Julián, María Cristina Azcona/0000-0001-5534-8758				ATKINS LEONARD, 1966, JMED GENET, V3, P134, DOI 10.1136/jmg.3.2.134; BORTER I, 1969, J MED GENET, V6, P310; FERRIER P, 1964, LANCET, V1, P80; GOLDSTEIN DE, 1977, J PEDIATR-US, V90, P604, DOI 10.1016/S0022-3476(77)80378-8; KAVA HW, 1968, FERTIL STERIL, V19, P835; LADDA R, 1973, J GENET HUM, V21, P215; LYON AJ, 1985, ARCH DIS CHILD, V60, P932, DOI 10.1136/adc.60.10.932; PAGON RA, 1979, AM J HUM GENET, V31, P54; RICHARDS BW, 1969, J MENT DEFIC RES, V13, P66; SCHINZEL A, 1974, HELV PAEDIATR ACTA, V29, P531; SMITH DW, 1982, RECOGNIZABLE PATTERN, P46; Turner HH, 1938, ENDOCRINOLOGY, V23, P566, DOI 10.1210/endo-23-5-566; ULRICH O, 1949, AM J HUM GENET, V1, P179	13	9	11	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 27	1999	318	7187					856	857		10.1136/bmj.318.7187.856	http://dx.doi.org/10.1136/bmj.318.7187.856			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185DM	10092267	Green Published			2022-12-28	WOS:000079652900031
J	He, J; Vupputuri, S; Allen, K; Prerost, MR; Hughes, J; Whelton, PK				He, J; Vupputuri, S; Allen, K; Prerost, MR; Hughes, J; Whelton, PK			Passive smoking and the risk of coronary heart disease a meta-analysis of epidemiologic studies	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; CARDIOVASCULAR-DISEASE; MORTALITY; EXPOSURE; HEALTH; NONSMOKERS; POPULATION; CAROTENE; ATTACK; CANCER	Background The effect of passive smoking on the risk of coronary heart disease is controversial. We conducted a meta-analysis of the risk of coronary heart disease associated with passive smoking among nonsmokers. Methods We searched the Medline and Dissertation Abstracts Online data bases and reviewed citations in relevant articles to identify 18 epidemiologic (10 cohort and 8 case-control) studies that met pre-stated inclusion criteria. Information on the designs of the studies, the characteristics of the study subjects, exposure and outcome measures, control for potential confounding factors, and risk estimates was abstracted independently by three investigators using a standardized protocol. Results Overall, nonsmokers exposed to environmental smoke had a relative risk of coronary heart disease of 1.25 (95 percent confidence interval, 1.17 to 1.32) as compared with nonsmokers not exposed to smoke. Passive smoking was consistently associated with an increased relative risk of coronary heart disease in cohort studies (relative risk, 1.21; 95 percent confidence interval, 1.14 to 1.30), in case-control studies (relative risk, 1.51; 95 percent confidence interval, 1.26 to 1.81), in men (relative risk, 1.22; 95 percent confidence interval, 1.10 to 1.35), in women (relative risk, 1.24; 95 percent confidence interval, 1.15 to 1.34), and in those exposed to smoking at home (relative risk, 1.17; 95 percent confidence interval, 1.11 to 1.24) or in the workplace (relative risk, 1.11; 95 percent confidence interval, 1.00 to 1.23). A significant dose-response relation was identified, with respective relative risks of 1.23 and 1.31 for nonsmokers who were exposed to the smoke of 1 to 19 cigarettes per day and those who were exposed to the smoke of 20 or more cigarettes per day, as compared with nonsmokers not exposed to smoke (P=0.006 for linear trend). Conclusions Passive smoking is associated with a small increase in the risk of coronary heart disease. Given the high prevalence of cigarette smoking, the public health consequences of passive smoking with regard to coronary heart disease may be important. (N Engl J Med 1999;340:920-6.) (C) 1999, Massachusetts Medical Society.	Tulane Univ, Sch Publ Hlth & Trop Med, Dept Biostat & Epidemiol, New Orleans, LA 70112 USA; Tulane Univ, Sch Publ Hlth & Trop Med, Prevent Res Ctr, New Orleans, LA 70112 USA	Tulane University; Tulane University	He, J (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Biostat & Epidemiol, 1430 Tulane Ave,SL18, New Orleans, LA 70112 USA.	jhe@mailhost.tcs.tulanc.edu			NHLBI NIH HHS [HL60300] Funding Source: Medline; NIEHS NIH HHS [ES06435] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P20ES006435] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		*AM HEART AWS, 1998, 1998 HEART STROK STA; ANDERSON R, 1991, AM REV RESPIR DIS, V144, P570, DOI 10.1164/ajrccm/144.3_Pt_1.570; ARONOW WS, 1978, NEW ENGL J MED, V299, P21, DOI 10.1056/NEJM197807062990105; BEGG C. B., 1994, HDB RES SYNTHESIS, P400; BUTLER TL, 1988, THESIS U CALIFORNIA; Ciruzzi M, 1998, J AM COLL CARDIOL, V31, P797, DOI 10.1016/S0735-1097(98)00017-5; DAVIS JW, 1989, ARCH INTERN MED, V149, P386, DOI 10.1001/archinte.149.2.386; Denson KWE, 1996, LANCET, V348, P1663, DOI 10.1016/S0140-6736(05)65734-0; *DEP HLTH HUM SERV, 1983, DHHS PUBL; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DOBSON AJ, 1991, MED J AUSTRALIA, V154, P793, DOI 10.5694/j.1326-5377.1991.tb121366.x; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; FELDMAN J, 1991, PEDIATRICS, V88, P259; GARLAND C, 1985, AM J EPIDEMIOL, V121, P645, DOI 10.1093/aje/121.5.645; GLANTZ SA, 1995, JAMA-J AM MED ASSOC, V273, P1047, DOI 10.1001/jama.273.13.1047; GLANTZ SA, 1991, CIRCULATION, V83, P1, DOI 10.1161/01.CIR.83.1.1; HE Y, 1994, BRIT MED J, V308, P380, DOI 10.1136/bmj.308.6925.380; HE Y, 1989, CHIN J PREV MED, V23, P19; HEINONEN OP, 1994, NEW ENGL J MED, V330, P1029; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; HIRAYAMA T, 1990, NEW ZEAL MED J, V103, P54; HIRAYAMA T, 1984, LUNG CANCER CAUSES P, P175; HOLE DJ, 1989, BRIT MED J, V299, P423, DOI 10.1136/bmj.299.6696.423; HUMBLE C, 1990, AM J PUBLIC HEALTH, V80, P599, DOI 10.2105/AJPH.80.5.599; JACKSON RT, 1989, THESIS U AUCKLAND NZ; KAHN HA, 1989, EPIDEMIOLOGY BIOSTAT, V12; Kawachi I, 1997, CIRCULATION, V95, P2374, DOI 10.1161/01.CIR.95.10.2374; KHALFEN ES, 1987, TERAPEVT ARKH, V59, P112; KRITZ H, 1995, ARCH INTERN MED, V155, P1942, DOI 10.1001/archinte.155.18.1942; LABARTHE DR, 1998, EPIDEMIOLOGY PREVENT, P323; LAM JYT, 1994, AM J CARDIOL, V73, P333, DOI 10.1016/0002-9149(94)90004-3; LAVECCHIA C, 1993, LANCET, V341, P505, DOI 10.1016/0140-6736(93)90271-H; Law MR, 1997, BMJ-BRIT MED J, V315, P973, DOI 10.1136/bmj.315.7114.973; LAYARD MW, 1995, REGUL TOXICOL PHARM, V21, P180, DOI 10.1006/rtph.1995.1022; LEE PN, 1986, BRIT J CANCER, V54, P97, DOI 10.1038/bjc.1986.157; LEVOIS ME, 1995, REGUL TOXICOL PHARM, V21, P184, DOI 10.1006/rtph.1995.1023; MATANOSKI G, 1995, AM J EPIDEMIOL, V142, P149, DOI 10.1093/oxfordjournals.aje.a117613; MUSCAT JE, 1995, INT J EPIDEMIOL, V24, P715, DOI 10.1093/ije/24.4.715; Ockene IS, 1997, CIRCULATION, V96, P3243, DOI 10.1161/01.CIR.96.9.3243; Osler M, 1998, PREV MED, V27, P438, DOI 10.1006/pmed.1998.0289; Pirkle JL, 1996, JAMA-J AM MED ASSOC, V275, P1233, DOI 10.1001/jama.275.16.1233; SANDLER DP, 1989, AM J PUBLIC HEALTH, V79, P163, DOI 10.2105/AJPH.79.2.163; SIDNEY S, 1989, AM J EPIDEMIOL, V129, P1305, DOI 10.1093/oxfordjournals.aje.a115250; Steenland K, 1996, CIRCULATION, V94, P622, DOI 10.1161/01.CIR.94.4.622; STEENLAND K, 1992, JAMA-J AM MED ASSOC, V267, P94, DOI 10.1001/jama.267.1.94; SVENDSEN KH, 1987, AM J EPIDEMIOL, V126, P783, DOI 10.1093/oxfordjournals.aje.a114715; THORNTON A, 1994, J CLIN EPIDEMIOL, V47, P1143, DOI 10.1016/0895-4356(94)90101-5; TUNSTALLPEDOE H, 1995, J EPIDEMIOL COMMUN H, V49, P139, DOI 10.1136/jech.49.2.139; WALTER SD, 1991, BIOMETRICS, V47, P795, DOI 10.2307/2532640; Wells AJ, 1998, J AM COLL CARDIOL, V31, P1, DOI 10.1016/S0735-1097(97)00432-4; WELLS AJ, 1994, J AM COLL CARDIOL, V24, P546, DOI 10.1016/0735-1097(94)90315-8; World Health Organization, 1998, WORLD HLTH STAT ANN; 1993, MMWR MORB MORTAL WKL, V42, P645	53	409	427	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 25	1999	340	12					920	926		10.1056/NEJM199903253401204	http://dx.doi.org/10.1056/NEJM199903253401204			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180AM	10089185				2022-12-28	WOS:000079362600004
J	Zalev, AH; Kopplin, PA				Zalev, AH; Kopplin, PA			Gastric tumor discovered by chest radiography	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									St Michaels Hosp, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Zalev, AH (corresponding author), St Michaels Hosp, 30 Bond St, Toronto, ON M5B 1W8, Canada.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 25	1999	340	12					927	927		10.1056/NEJM199903253401205	http://dx.doi.org/10.1056/NEJM199903253401205			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180AM	10089186				2022-12-28	WOS:000079362600005
J	Nenner, F				Nenner, F			A mother's voice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	1999	281	12					1065	1065		10.1001/jama.281.12.1065	http://dx.doi.org/10.1001/jama.281.12.1065			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177EP	10188641				2022-12-28	WOS:000079197100001
J	Kidd, T; Bland, KS; Goodman, CS				Kidd, T; Bland, KS; Goodman, CS			Slit is the midline repellent for the robe receptor in Drosophila	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; GROWTH CONE GUIDANCE; GENETIC-ANALYSIS; CNS MIDLINE; MELANOGASTER; PROTEIN; FASCICULATION; ENCODES; LOCUS; EGF	Previous studies suggested that Roundabout (Robo) is a repulsive guidance receptor on growth cones that binds to an unknown midline ligand. Here we present genetic evidence that Slit is the midline Robe ligand; a companion paper presents biochemical evidence that Slit binds Robe. Slit is a large extracellular matrix protein expressed by midline glia. In slit mutants, growth cones enter the midline but never leave it; they abnormally continue to express high levels of Robe while at the midline. slit and robe display dosage-sensitive genetic interactions, indicating that they function in the same pathway. slit is also required for migration of muscle precursors away from the midline. Slit appears to function as a short-range repellent controlling axon crossing of the midline and as a long-range chemorepellent controlling mesoderm migration away from the midline.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Goodman, CS (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.		Kidd, Thomas/AAT-9993-2020	Kidd, Thomas/0000-0001-7190-4208; Bland, Kimberly/0000-0003-4863-6772	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018366] Funding Source: NIH RePORTER; NINDS NIH HHS [NS18366] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; CREWS ST, 1988, CELL, V52, P143, DOI 10.1016/0092-8674(88)90538-7; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; Hidalgo A, 1997, DEVELOPMENT, V124, P3253; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; KIDD T, 1998, CELL, V20, P25; KIEHART DP, 1986, J CELL BIOL, V103, P1517, DOI 10.1083/jcb.103.4.1517; LEWIS JO, 1994, MECH DEVELOP, V48, P81, DOI 10.1016/0925-4773(94)90018-3; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Noordermeer JN, 1998, NEURON, V21, P991, DOI 10.1016/S0896-6273(00)80618-2; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; ROTHBERG JM, 1988, CELL, V55, P1047, DOI 10.1016/0092-8674(88)90249-8; Scholz H, 1997, MECH DEVELOP, V64, P137; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SONNENFELD MJ, 1994, MECH DEVELOP, V46, P3, DOI 10.1016/0925-4773(94)90033-7; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; THOMAS JB, 1988, CELL, V52, P133, DOI 10.1016/0092-8674(88)90537-5; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2	26	766	789	0	22	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 19	1999	96	6					785	794		10.1016/S0092-8674(00)80589-9	http://dx.doi.org/10.1016/S0092-8674(00)80589-9			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	178ZY	10102267	Bronze			2022-12-28	WOS:000079300100006
J	Crow, JF				Crow, JF			Genetics - Unmasking a cheating gene	SCIENCE			English	Editorial Material							MENDELIAN SEGREGATION; DISTORTION		Univ Wisconsin, Dept Genet, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Crow, JF (corresponding author), Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.							CROW JF, 1991, BIOESSAYS, V13, P305, DOI 10.1002/bies.950130609; LYTTLE TW, 1993, TRENDS GENET, V9, P205, DOI 10.1016/0168-9525(93)90120-7; LYTTLE TW, 1991, ANNU REV GENET, V25, P511, DOI 10.1146/annurev.ge.25.120191.002455; Merrill C, 1999, SCIENCE, V283, P1742, DOI 10.1126/science.283.5408.1742; TEMIN RG, 1991, AM NAT, V137, P287, DOI 10.1086/285164	5	9	9	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	1999	283	5408					1651	1652		10.1126/science.283.5408.1651	http://dx.doi.org/10.1126/science.283.5408.1651			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175PF	10189318				2022-12-28	WOS:000079102800029
J	LaPrade, RF; Swiontkowski, MF				LaPrade, RF; Swiontkowski, MF			New horizons in the treatment of osteoarthritis of the knee	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HYLAN		Univ Minnesota, Dept Orthopaed Surg, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	LaPrade, RF (corresponding author), Univ Minnesota, Dept Orthopaed Surg, 420 Delaware Ave SE,Box 492, Minneapolis, MN 55455 USA.		LaPrade, Robert F./AFA-8673-2022	LaPrade, Robert F./0000-0002-9823-2306; Swiontkowski, Marc/0000-0001-7036-1782				Adams ME, 1995, OSTEOARTHR CARTILAGE, V3, P213, DOI 10.1016/S1063-4584(05)80013-5; BROWNE JE, 1998, T 8 ESSKA C NIC FRAN, P103; GABRIEL SE, 1995, J RHEUMATOL, V22, P23; Hangody L, 1998, ORTHOPEDICS, V21, P751, DOI 10.3928/0147-7447-19980701-04; Hangody L, 1997, Knee Surg Sports Traumatol Arthrosc, V5, P262, DOI 10.1007/s001670050061; Lussier A, 1996, J RHEUMATOL, V23, P1579; Minas T, 1998, J SPORT TRAUMATOL, V20, P90; PETERSON L, 1998, AM AC ORTH SURG 65 A; Simonian PT, 1998, AM J SPORT MED, V26, P491, DOI 10.1177/03635465980260040201	9	24	24	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	1999	281	10					876	878		10.1001/jama.281.10.876	http://dx.doi.org/10.1001/jama.281.10.876			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172XH	10078464				2022-12-28	WOS:000078950600002
J	Casci, T; Vinos, J; Freeman, M				Casci, T; Vinos, J; Freeman, M			Sprouty, an intracellular inhibitor of Ras signaling	CELL			English	Article							DROSOPHILA EGF RECEPTOR; GUANINE-NUCLEOTIDE EXCHANGE; PROTEIN TYROSINE KINASE; VENTRAL ECTODERM; ADAPTER PROTEIN; GENETIC MOSAICS; PLASMA-MEMBRANE; SEVENLESS; ACTIVATION; PATHWAY	Sprouty was identified in a genetic screen as an inhibitor of Drosophila EGF receptor signaling. The Egfr triggers cell recruitment in the eye, and sprouty(-) eyes have excess photoreceptors, cone cells, and pigment cells. Sprouty's function is, however, more widespread. We show that it also interacts genetically with the receptor tyrosine kinases Torso and Sevenless, and it was first discovered through its effect on FGF receptor signaling. In contrast to an earlier proposal that Sprouty is extracellular, we show by biochemical analysis that Sprouty is an intracellular protein, associated with the inner surface of the plasma membrane. Sprouty binds to two intracellular components of the Ras pathway, Drk and Gap1. Our results indicate that Sprouty is a widespread inhibitor of Ras pathway signal transduction.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Freeman, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	mf1@mrc-lmb.cam.ac.uk		Freeman, Matthew/0000-0003-0410-5451; Casci, Tanita/0000-0002-1838-0027				ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; BIER E, 1990, GENE DEV, V4, P190, DOI 10.1101/gad.4.2.190; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; CASANOVA J, 1995, GENE DEV, V9, P2539, DOI 10.1101/gad.9.20.2539; CHERBAS L, 1994, DROSOPHILA MELANOGAS, P161; Chou TB, 1996, GENETICS, V144, P1673; DIAZBENJUMEA FJ, 1994, DEVELOPMENT, V120, P569; DIAZBENJUMEA FJ, 1990, P ROY SOC B-BIOL SCI, V242, P36, DOI 10.1098/rspb.1990.0100; DICKSON B, 1992, NATURE, V360, P600, DOI 10.1038/360600a0; Dominguez M, 1998, CURR BIOL, V8, P1039, DOI 10.1016/S0960-9822(98)70441-5; FORTINI ME, 1992, NATURE, V355, P559, DOI 10.1038/355559a0; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; FREEMAN M, 1992, CELL, V69, P963, DOI 10.1016/0092-8674(92)90615-J; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; GAUL U, 1992, CELL, V68, P1007, DOI 10.1016/0092-8674(92)90073-L; Golembo M, 1996, DEVELOPMENT, V122, P3363; Gonzalez-Reyes A, 1998, DEVELOPMENT, V125, P2837; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Herbst R, 1996, CELL, V85, P899, DOI 10.1016/S0092-8674(00)81273-8; HORTSCH M, 1994, METHOD CELL BIOL, V44, P289, DOI 10.1016/S0091-679X(08)60920-6; Howes R, 1998, J BIOL CHEM, V273, P4275, DOI 10.1074/jbc.273.7.4275; Joneson T, 1997, J MOL MED-JMM, V75, P587, DOI 10.1007/s001090050143; KIMMEL BE, 1990, GENE DEV, V4, P712, DOI 10.1101/gad.4.5.712; LAWRENCE PA, 1985, DROSOPHILA PRACTICAL, P229; Le N, 1998, MOL CELL BIOL, V18, P4844, DOI 10.1128/MCB.18.8.4844; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; LOW SH, 1991, J BIOL CHEM, V266, P13391; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; NEWTON AC, 1995, CURR BIOL, V5, P973, DOI 10.1016/S0960-9822(95)00191-6; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; OLIVIER JP, 1993, CELL, V73, P179, DOI 10.1016/0092-8674(93)90170-U; Perrimon N, 1997, CELL, V89, P13, DOI 10.1016/S0092-8674(00)80177-4; Raabe T, 1996, CELL, V85, P911, DOI 10.1016/S0092-8674(00)81274-X; REICHMANFRIED M, 1994, GENE DEV, V8, P428, DOI 10.1101/gad.8.4.428; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; SCHWEITZER R, 1995, NATURE, V376, P699, DOI 10.1038/376699a0; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; SIMON MA, 1993, CELL, V73, P169, DOI 10.1016/0092-8674(93)90169-Q; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; SPRADLING AC, 1995, P NATL ACAD SCI USA, V92, P10824, DOI 10.1073/pnas.92.24.10824; Sternberg PW, 1998, CELL, V95, P447, DOI 10.1016/S0092-8674(00)81612-8; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; STURTEVANT MA, 1993, GENE DEV, V7, P961, DOI 10.1101/gad.7.6.961; vandeGoor J, 1996, FEBS LETT, V380, P251, DOI 10.1016/0014-5793(96)00026-9; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; Waltzer L, 1998, NATURE, V395, P521, DOI 10.1038/26785; WASSARMAN DA, 1995, CURR OPIN GENET DEV, V5, P44, DOI 10.1016/S0959-437X(95)90052-7; Wasserman JD, 1997, TRENDS CELL BIOL, V7, P431, DOI 10.1016/S0962-8924(97)01143-4; Wasserman JD, 1998, CELL, V95, P355, DOI 10.1016/S0092-8674(00)81767-5; WOLFF T, 1991, DEVELOPMENT, V113, P825; XU T, 1993, DEVELOPMENT, V117, P1223; [No title captured]	56	390	407	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	1999	96	5					655	665		10.1016/S0092-8674(00)80576-0	http://dx.doi.org/10.1016/S0092-8674(00)80576-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	174TB	10089881	Bronze			2022-12-28	WOS:000079050100009
J	Farzan, M; Mirzabekov, T; Kolchinsky, P; Wyatt, R; Cayabyab, M; Gerard, NP; Gerard, C; Sodroski, J; Choe, H				Farzan, M; Mirzabekov, T; Kolchinsky, P; Wyatt, R; Cayabyab, M; Gerard, NP; Gerard, C; Sodroski, J; Choe, H			Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry	CELL			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CHEMOKINE RECEPTOR CCR5; 7-TRANSMEMBRANE SEGMENT RECEPTORS; HEPARAN-SULFATE; MOLECULAR-CLONING; FUSION COFACTOR; TROPIC HIV-1; IDENTIFICATION; MIP-1-ALPHA; MIP-1-BETA	Chemokine receptors and related seven-transmembrane-segment (7TMS) receptors serve as coreceptors for entry of human and simian immunodeficiency viruses (HIV-1, HIV-2, and SIV) into target cells. Each of these otherwise diverse coreceptors contains an N-terminal region that is acidic and tyrosine rich. Here, we show that the chemokine receptor CCR5, a principal HIV-1 coreceptor, is posttranslationally modified by O-linked glycosylation and by sulfation of its N-terminal tyrosines. Sulfated tyrosines contribute to the binding of CCR5 to MIP-1 alpha, MIP-1 beta, and HIV-1 gp120/CD4 complexes and to the ability of HIV-1 to enter cells expressing CCR5 and CD4. CXCR4, another important HIV-1 coreceptor, is also sulfated. Tyrosine sulfation may contribute to the natural function of many 7TMS receptors and may be a modification common to primate immunodeficiency virus coreceptors.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pathol,Div Human Retrovirol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Canc Biol, Boston, MA 02115 USA; Childrens Hosp, Ina Sue Perlmutter Lab, Boston, MA 02115 USA; Beth Israel Hosp, Dept Med, Boston, MA 02115 USA; Beth Israel Hosp, Dept Pediat, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Farzan, M (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pathol,Div Human Retrovirol, 44 Binney St, Boston, MA 02115 USA.	farzan@mbcrr.harvard.edu		Farzan, Michael/0000-0002-2990-5319	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI024755, R01AI024755, P30AI028691, R01AI041851] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 41851, AI 28691, AI 24755] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Bundgaard JR, 1997, J BIOL CHEM, V272, P21700, DOI 10.1074/jbc.272.35.21700; CARLSSON SR, 1986, J BIOL CHEM, V261, P2787; Choe H, 1998, J VIROL, V72, P6113, DOI 10.1128/JVI.72.7.6113-6118.1998; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Choe H, 1998, SEMIN IMMUNOL, V10, P249, DOI 10.1006/smim.1998.0127; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Deng HK, 1997, NATURE, V388, P296, DOI 10.1038/40894; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Doms RW, 1997, VIROLOGY, V235, P179, DOI 10.1006/viro.1997.8703; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Dragic T, 1998, J VIROL, V72, P279, DOI 10.1128/JVI.72.1.279-285.1998; Este JA, 1997, MOL PHARMACOL, V52, P98, DOI 10.1124/mol.52.1.98; Farzan M, 1997, J BIOL CHEM, V272, P6854, DOI 10.1074/jbc.272.11.6854; Farzan M, 1997, J EXP MED, V186, P405, DOI 10.1084/jem.186.3.405; Farzan M, 1998, J VIROL, V72, P1160, DOI 10.1128/JVI.72.2.1160-1164.1998; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; FUKUDA M, 1986, J BIOL CHEM, V261, P2796; GERARD C, 1994, CURR OPIN IMMUNOL, V6, P140, DOI 10.1016/0952-7915(94)90045-0; Gong WH, 1998, J BIOL CHEM, V273, P4289, DOI 10.1074/jbc.273.8.4289; Horuk R, 1998, J BIOL CHEM, V273, P386, DOI 10.1074/jbc.273.1.386; HUTTNER WB, 1984, METHOD ENZYMOL, V107, P200; HUTTNER WB, 1988, ANNU REV PHYSIOL, V50, P363, DOI 10.1146/annurev.ph.50.030188.002051; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Liao F, 1997, J EXP MED, V185, P2015, DOI 10.1084/jem.185.11.2015; Littman DR, 1998, CELL, V93, P677, DOI 10.1016/S0092-8674(00)81429-4; LUSTER AD, 1995, J EXP MED, V182, P219, DOI 10.1084/jem.182.1.219; MINTZ KP, 1994, J BIOL CHEM, V269, P4845; Mondor I, 1998, J VIROL, V72, P3623, DOI 10.1128/JVI.72.5.3623-3634.1998; Monteclaro FS, 1996, J BIOL CHEM, V271, P19084, DOI 10.1074/jbc.271.32.19084; Oravecz T, 1997, J IMMUNOL, V159, P4587; Pleskoff O, 1997, SCIENCE, V276, P1874, DOI 10.1126/science.276.5320.1874; POUYANI T, 1995, CELL, V83, P333, DOI 10.1016/0092-8674(95)90174-4; Premack BA, 1996, NAT MED, V2, P1174, DOI 10.1038/nm1196-1174; Rabut GEE, 1998, J VIROL, V72, P3464, DOI 10.1128/JVI.72.4.3464-3468.1998; Raport CJ, 1996, J BIOL CHEM, V271, P17161, DOI 10.1074/jbc.271.29.17161; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; RODERIQUEZ G, 1995, J VIROL, V69, P2233, DOI 10.1128/JVI.69.4.2233-2239.1995; ROSENQUIST GL, 1993, PROTEIN SCI, V2, P215; Ross TM, 1998, J VIROL, V72, P1918, DOI 10.1128/JVI.72.3.1918-1924.1998; Rucker J, 1997, J VIROL, V71, P8999, DOI 10.1128/JVI.71.12.8999-9007.1997; Rucker J, 1996, CELL, V87, P437, DOI 10.1016/S0092-8674(00)81364-1; Samson M, 1996, BIOCHEMISTRY-US, V35, P3362, DOI 10.1021/bi952950g; Samson M, 1997, J BIOL CHEM, V272, P24934, DOI 10.1074/jbc.272.40.24934; TANAKA H, 1993, TRENDS POLYM SCI, V1, P361; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Wang WK, 1998, P NATL ACAD SCI USA, V95, P5740, DOI 10.1073/pnas.95.10.5740; WEBB LMC, 1993, P NATL ACAD SCI USA, V90, P7158, DOI 10.1073/pnas.90.15.7158; Wu LJ, 1997, J EXP MED, V186, P1373, DOI 10.1084/jem.186.8.1373; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Yang DW, 1996, ANTIVIR RES, V31, P95, DOI 10.1016/0166-3542(96)00957-6; Zhang JL, 1998, VIROLOGY, V244, P530, DOI 10.1006/viro.1998.9115	56	578	619	3	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 5	1999	96	5					667	676		10.1016/S0092-8674(00)80577-2	http://dx.doi.org/10.1016/S0092-8674(00)80577-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	174TB	10089882	Bronze			2022-12-28	WOS:000079050100010
J	Adish, AA; Esrey, SA; Gyorkos, TW; Jean-Baptiste, J; Rojhani, A				Adish, AA; Esrey, SA; Gyorkos, TW; Jean-Baptiste, J; Rojhani, A			Effect of consumption of food cooked in iron pots on iron status and growth of young children: a randomised trial	LANCET			English	Article							SCHOOL-CHILDREN; SUPPLEMENTATION; ABSORPTION; MEALS	Background In less-developed countries, novel strategies are needed to control iron-deficiency anaemia, the most common form of malnutrition. Methods We undertook a community-based randomised controlled trial to assess the effects of iron or aluminium cooking pots in young Ethiopian children. Analysis was by intention-to-treat. The primary outcomes were change in children's haemoglobin concentration, weight, or length over the study period. We also did a laboratory study of total and available iron in traditional Ethiopian foods cooked in iron, aluminium, and clay pots. Findings 407 children, one per household, entered the study. The change in haemoglobin concentration was greater in the iron-pot group than in the aluminium-pot group (mean change to 12 months 1.7 [SD 1.5] vs 0.4 [1.0] g/dL; mean difference between groups 1.3 g/dL [95% CI 1.1-1.6]). The mean differences between the groups in weight and length gain to 12 months (adjusted for baseline weight or length) were 0.6 cm (95% CI 0.1-1.0) and 0.1 kg (-0.1 to 0.3). The laboratory study showed that total and available iron was greatest in foods cooked in iron pots, except for available iron in legumes for which there was no difference between types of pot. Interpretation Ethiopian children fed food from iron pots had lower rates of anaemia and better growth than children whose food was cooked in aluminium pots. Provision of iron cooking pots for households in less-developed countries may be a useful method to prevent iron-deficiency anaemia.	McGill Univ, Sch Dietet & Human Nutr, Ste Anne De Bellevue, PQ, Canada; Jimma Inst Hlth Sci, Jima, Ethiopia; UNICEF, New York, NY USA; McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; Phoenix Int, Pharmacokinet, Montreal, PQ, Canada; Montreal Gen Hosp, Div Clin Epidemiol, Montreal, PQ H3G 1A4, Canada; Western Michigan Univ, Dept Family & Consumer Sci, Kalamazoo, MI 49008 USA	McGill University; Jimma University; UNICEF; McGill University; McGill University; Western Michigan University	Gyorkos, TW (corresponding author), Montreal Gen Hosp, Div Clin Epidemiol, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.							*ASS OFF AN CHEM, 1990, OFF METH AN ASS OFF; AUKETT MA, 1986, ARCH DIS CHILD, V61, P849, DOI 10.1136/adc.61.9.849; BAKER SJ, 1979, AM J CLIN NUTR, V32, P368, DOI 10.1093/ajcn/32.2.368; BERGER J, 1992, NUTR RES, V12, P39, DOI 10.1016/S0271-5317(05)80408-7; Borigato EVM, 1998, J NUTR, V128, P855, DOI 10.1093/jn/128.5.855; BRIEND A, 1990, ARCH DIS CHILD, V65, P224, DOI 10.1136/adc.65.2.224; BRITTIN HC, 1986, J AM DIET ASSOC, V86, P897; BURROUGHS AL, 1972, J AM DIET ASSOC, V60, P123; CHENG YJ, 1991, J FOOD SCI, V56, P584, DOI 10.1111/j.1365-2621.1991.tb05331.x; CHWANG LC, 1988, AM J CLIN NUTR, V47, P496, DOI 10.1093/ajcn/47.3.496; DeMaeyer EM., 1989, PREVENTING CONTROLLI; Drover D P, 1975, P N G Med J, V18, P15; Ethiopian Nutrition Institute, 1980, ETH TRAD REC; FAO & WHO, 1988, REQ VIT A IR FOL VIT; HALLBERG L, 1981, AM J CLIN NUTR, V34, P2808, DOI 10.1093/ajcn/34.12.2808; HURRELL RF, 1988, AM J CLIN NUTR, V47, P102, DOI 10.1093/ajcn/47.1.102; IDJRADINATA P, 1994, LANCET, V343, P1252, DOI 10.1016/S0140-6736(94)92151-2; LATHAM MC, 1990, NUTRITION, V6, P159; LAWLESS JW, 1994, J NUTR, V124, P645, DOI 10.1093/jn/124.5.645; LEVIN HM, 1986, RES OBSERVER, V1, P219; MARSHALL WA, 1971, HUM BIOL, V43, P502; MARTINEZ FE, 1986, NUTR RES, V6, P421, DOI 10.1016/S0271-5317(86)80183-X; MILLER DD, 1981, AM J CLIN NUTR, V34, P2248, DOI 10.1093/ajcn/34.10.2248; STRICKER BR, 1981, AM J CLIN NUTR, V34, P2257; TONKIN S, 1970, New Zealand Medical Journal, V71, P129; United Nations, 1986, WEIGH MEAS CHILDR AS; United Nations, 1990, ASIA-PAC J PUBLIC HE, V4, DOI [10.1177/101053959000400303, DOI 10.1177/101053959000400303]; *WHO, 1993, POP STUD REL EFF WEE; *WHO, 1994, CONS IND STRAT IR DE	29	66	69	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	1999	353	9154					712	716		10.1016/S0140-6736(98)04450-X	http://dx.doi.org/10.1016/S0140-6736(98)04450-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173DR	10073514				2022-12-28	WOS:000078966400012
J	Christoph, J; Strasser, P; Eiswirth, M; Ertl, G				Christoph, J; Strasser, P; Eiswirth, M; Ertl, G			Remote triggering of waves in an electrochemical system	SCIENCE			English	Article							SPATIOTEMPORAL PATTERNS; ELECTRODE	In the potentiostatic electrochemical oxidation of formic acid on a platinum ring electrode under bistable conditions, an appropriate perturbation at one location of the ring can cause the emergence of a wave on the opposite side (remote triggering). These findings can be rationalized in terms of the nonlocal coupling function of the system and are theoretically reproduced by solution of the corresponding reaction-migration equation.	Max Planck Gesell, Fritz Haber Inst, D-14195 Berlin, Germany	Max Planck Society; Fritz Haber Institute of the Max Planck Society	Strasser, P (corresponding author), Max Planck Gesell, Fritz Haber Inst, Faradayweg 4-6, D-14195 Berlin, Germany.		Strasser, Peter/ABE-6795-2020; Strasser, Peter/A-1868-2012	Strasser, Peter/0000-0002-3884-436X; Strasser, Peter/0000-0002-3884-436X				CHRISTOPH J, 1999, THESIS FREIE U BERLI; CHRISTOPH J, IN PRES J CHEM PHYS; Fei Z, 1996, J PHYS CHEM-US, V100, P18986, DOI 10.1021/jp961266o; FLATGEN G, 1995, PHYS REV E, V51, P3997, DOI 10.1103/PhysRevE.51.3997; FLATGEN G, 1995, J CHEM PHYS, V103, P5428, DOI 10.1063/1.470578; Grauel P, 1998, J PHYS CHEM B, V102, P10264, DOI 10.1021/jp982841m; Kapral R., 1995, CHEM WAVES PATTERNS; KRISCHER K, IN PRESS MODERN ASPE, V32; Mazouz N, 1997, PHYS REV E, V55, P2260, DOI 10.1103/PhysRevE.55.2260; Murray J.D., 1990, MATH BIOL; SAYER JC, 1995, IND ENG CHEM RES, V34, P3246, DOI 10.1021/ie00037a010; Strasser P, 1997, J CHEM PHYS, V107, P979, DOI 10.1063/1.474450; SWINNEY HL, 1991, PHYSICA D, V49; WINFREE AT, 1987, TIME BREAKS DOWN	14	53	53	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 9	1999	284	5412					291	293		10.1126/science.284.5412.291	http://dx.doi.org/10.1126/science.284.5412.291			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184WH	10195888				2022-12-28	WOS:000079636400034
J	Becker, AE; Grinspoon, SK; Klibanski, A; Herzog, DB				Becker, AE; Grinspoon, SK; Klibanski, A; Herzog, DB			Current concepts - Eating disorders	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ANOREXIA-NERVOSA; BULIMIA-NERVOSA; FOLLOW-UP; WOMEN; PSYCHOTHERAPY; OSTEOPOROSIS; THERAPY; ANTIDEPRESSANTS; DISTURBANCES; PREGNANCY		Harvard Univ, Sch Med, Harvard Eating Disorders Ctr, Boston, MA 02116 USA; Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Herzog, DB (corresponding author), Harvard Univ, Sch Med, Harvard Eating Disorders Ctr, 356 Boylston St, Boston, MA 02116 USA.	dherzog@partners.org		Becker, Anne/0000-0001-9129-6510	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH038333] Funding Source: NIH RePORTER; NCRR NIH HHS [5M01 RR01066] Funding Source: Medline; NIDDK NIH HHS [R01 DK5265] Funding Source: Medline; NIMH NIH HHS [5R01 MH38333] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AGRAS WS, 1994, J CLIN PSYCHIAT, V55, P179; AGRAS WS, 1991, J CLIN PSYCHIAT, V52, P29; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, P539; Andersen A. E., 1995, EATING DISORDERS OBE, P177; ANDERSEN AE, 1982, INT J EAT DISORDER, V1, P74, DOI 10.1002/1098-108X(198224)1:2<74::AID-EAT2260010205>3.0.CO;2-K; BACHRACH LK, 1990, PEDIATRICS, V86, P440; Beck D, 1996, INT J EAT DISORDER, V20, P389; Becker AE, 1996, HARVARD REV PSYCHIAT, V4, P163, DOI 10.3109/10673229609030540; BECKER AE, 1998, ANN DRUG THERAPY, P17; Beumont PJV, 1997, AUST NZ J PSYCHIAT, V31, P514, DOI 10.3109/00048679709065073; BILLER BMK, 1989, J CLIN ENDOCR METAB, V68, P548, DOI 10.1210/jcem-68-3-548; Bostic JQ, 1997, J DEV BEHAV PEDIATR, V18, P331, DOI 10.1097/00004703-199710000-00008; BREWERTON TD, 1995, PSYCHONEUROENDOCRINO, V20, P561, DOI 10.1016/0306-4530(95)00001-5; Bruce B, 1996, J AM DIET ASSOC, V96, P58, DOI 10.1016/S0002-8223(96)00016-8; BRUCH H, 1982, AM J PSYCHIAT, V139, P1531; Bruch H., 1973, EATING DISORDERS OBE; BRYANTWAUGH RJ, 1992, ARCH DIS CHILD, V67, P103, DOI 10.1136/adc.67.1.103; COOKE RA, 1995, BRIT J HOSP MED, V54, P313; Crago M, 1996, INT J EAT DISORDER, V19, P239, DOI 10.1002/(SICI)1098-108X(199604)19:3&lt;239::AID-EAT2&gt;3.0.CO;2-N; DEVUYST O, 1993, Q J MED, V86, P791; FAIRBURN CG, 1993, ARCH GEN PSYCHIAT, V50, P419; FRANKO DL, 1993, INT J EAT DISORDER, V13, P41, DOI 10.1002/1098-108X(199301)13:1&lt;41::AID-EAT2260130106&gt;3.0.CO;2-L; FRISCH RE, 1973, HUM BIOL, V45, P469; Gard MCE, 1996, INT J EAT DISORDER, V20, P1, DOI 10.1002/(SICI)1098-108X(199607)20:1&lt;1::AID-EAT1&gt;3.0.CO;2-M; GARNER DM, 1980, PSYCHOL REP, V47, P483, DOI 10.2466/pr0.1980.47.2.483; GILLBERG C, 1994, ACTA PAEDIATR, V83, P967, DOI 10.1111/j.1651-2227.1994.tb13183.x; GOLD PW, 1983, NEW ENGL J MED, V308, P1117, DOI 10.1056/NEJM198305123081902; GREENFELD D, 1995, AM J PSYCHIAT, V152, P60; Grinspoon S, 1996, J CLIN ENDOCR METAB, V81, P3861, DOI 10.1210/jc.81.11.3861; Grinspoon S, 1996, J CLIN ENDOCR METAB, V81, P3864, DOI 10.1210/jc.81.11.3864; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Herzog DB, 1996, PSYCHIAT CLIN N AM, V19, P843, DOI 10.1016/S0193-953X(05)70385-3; HERZOG W, 1993, J BONE MINER RES, V8, P597; HOEK HW, 1995, EATING DISORDERS OBE, P207; Hudson JI, 1998, AM J PSYCHIAT, V155, P1756, DOI 10.1176/ajp.155.12.1756; JIMERSON DC, 1993, HARVARD REV PSYCHIAT, V1, P82, DOI 10.3109/10673229309017063; KAYE WH, 1991, J CLIN PSYCHIAT, V52, P41; Keel PK, 1997, AM J PSYCHIAT, V154, P313; KENDLER KS, 1991, AM J PSYCHIAT, V148, P1627; KING MB, 1989, PSYCHOL MED, P1, DOI 10.1017/S0264180100000515; KLIBANSKI A, 1995, J CLIN ENDOCR METAB, V80, P898, DOI 10.1210/jc.80.3.898; MARCUS MD, IN PRESS MANAGEMENT; MEHLER PS, 1993, INT J EAT DISORDER, V14, P297, DOI 10.1002/1098-108X(199311)14:3&lt;297::AID-EAT2260140308&gt;3.0.CO;2-X; MITCHELL JE, 1990, ARCH GEN PSYCHIAT, V47, P149; MITCHELL JE, 1989, J CLIN PSYCHOPHARM, V9, P291; MORTOLA JF, 1989, J CLIN ENDOCR METAB, V68, P517, DOI 10.1210/jcem-68-3-517; MOSHANG T, 1975, J CLIN ENDOCR METAB, V40, P470, DOI 10.1210/jcem-40-3-470; Ogg EC, 1997, INT J EAT DISORDER, V22, P89, DOI 10.1002/(SICI)1098-108X(199707)22:1<89::AID-EAT12>3.0.CO;2-D; Pike KM, 1996, PSYCHOPHARMACOL BULL, V32, P265; PIRKE KM, 1988, CLIN ENDOCRINOL, V29, P265, DOI 10.1111/j.1365-2265.1988.tb01224.x; POPE HG, 1985, J CLIN PSYCHOPHARM, V5, P320, DOI 10.1097/00004714-198505060-00003; RIGOTTI NA, 1984, NEW ENGL J MED, V311, P1601, DOI 10.1056/NEJM198412203112503; RIGOTTI NA, 1986, JAMA-J AM MED ASSOC, V256, P385, DOI 10.1001/jama.256.3.385; RIGOTTI NA, 1991, JAMA-J AM MED ASSOC, V265, P1133, DOI 10.1001/jama.265.9.1133; RIGOTTI NA, 1995, PRIMARY CARE WOMEN, P443; RUSSELL GFM, 1987, ARCH GEN PSYCHIAT, V44, P1047; SHISSLAK CM, 1995, INT J EAT DISORDER, V18, P209, DOI 10.1002/1098-108X(199511)18:3&lt;209::AID-EAT2260180303&gt;3.0.CO;2-E; SPITZER RL, 1993, INT J EAT DISORDER, V13, P137, DOI 10.1002/1098-108X(199303)13:2&lt;161::AID-EAT2260130204&gt;3.0.CO;2-R; STEINHAUSEN HC, 1995, HORM RES, V43, P168, DOI 10.1159/000184270; STEWART DE, 1987, AM J OBSTET GYNECOL, V157, P1194, DOI 10.1016/S0002-9378(87)80293-4; STEWART DE, 1990, AM J OBSTET GYNECOL, V163, P1196, DOI 10.1016/0002-9378(90)90688-4; STROBER M, 1991, J CLIN PSYCHIAT, V52, P9; SULLIVAN PF, 1995, AM J PSYCHIAT, V152, P1073; Tobin David L., 1993, P287; Walsh BT, 1997, AM J PSYCHIAT, V154, P523; WHITEHOUSE AM, 1992, BRIT J GEN PRACT, V42, P57; WILSON GT, 1993, J CONSULT CLIN PSYCH, V61, P261, DOI 10.1037/0022-006X.61.2.261; ZHANG YY, 1995, NATURE, V374, P479, DOI 10.1038/374479a0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; 1993, AM J PSYCHIAT, V152, P212	70	279	293	3	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 8	1999	340	14					1092	1098		10.1056/NEJM199904083401407	http://dx.doi.org/10.1056/NEJM199904083401407			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	184AK	10194240				2022-12-28	WOS:000079587000007
J	Emberton, M; Anson, K				Emberton, M; Anson, K			Fortnightly review - Acute urinary retention in men: an age old problem	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BENIGN PROSTATIC HYPERPLASIA; URODYNAMIC ASSESSMENT; SYMPTOMS; SURGERY; ABSCESS; BLADDER; RISK		Univ London St Georges Hosp, London SW17 0QT, England; UCL, Inst Urol & Nephrol, London W1P 7PN, England	St Georges University London; University of London; University College London	Emberton, M (corresponding author), Univ London St Georges Hosp, London SW17 0QT, England.	memberton@dial.pipex.com						BARONE JG, 1994, AM SURGEON, V60, P210; Barry MJ, 1996, TXB BENIGN PROSTATIC, P125; Benekli M, 1996, ANN HEMATOL, V73, P143, DOI 10.1007/s002770050216; Brown JA, 1997, UROLOGY, V49, P960, DOI 10.1016/S0090-4295(97)00077-0; COHEN LM, 1993, INT J DERMATOL, V32, P24, DOI 10.1111/j.1365-4362.1993.tb00955.x; DEVER DP, 1985, UROLOGY, V25, P289, DOI 10.1016/0090-4295(85)90331-0; Djavan B, 1998, EUR UROL, V33, P261, DOI 10.1159/000019578; Djavan B, 1997, J UROLOGY, V158, P1829, DOI 10.1016/S0022-5347(01)64139-9; Emberton M, 1996, BRIT J UROL, V77, P233, DOI 10.1046/j.1464-410X.1996.88213.x; Flanigan RC, 1998, J UROLOGY, V160, P12, DOI 10.1016/S0022-5347(01)63011-8; GODEC CJ, 1982, ANN EMERG MED, V11, P471, DOI 10.1016/S0196-0644(82)80064-4; GROSE K, 1995, BRIT J UROL, V76, P440, DOI 10.1111/j.1464-410X.1995.tb07741.x; ICHSAN J, 1987, AUST NZ J SURG, V57, P33, DOI 10.1111/j.1445-2197.1987.tb01236.x; Jacobsen SJ, 1997, J UROLOGY, V158, P481, DOI 10.1016/S0022-5347(01)64508-7; KLARSKOV P, 1987, SCAND J UROL NEPHROL, V21, P23, DOI 10.3109/00365598709180285; LASANEN LT, 1992, UROL RES, V20, P259, DOI 10.1007/BF00300255; LI CK, 1995, MED PEDIATR ONCOL, V25, P420, DOI 10.1002/mpo.2950250510; Lieber M, 1998, J UROLOGY, V159, P107; MAKAR A, 1998, EUR UROL SUPPL, V33, P75; McConnell JD, 1998, NEW ENGL J MED, V338, P557, DOI 10.1056/NEJM199802263380901; MCCONNELL JD, 1994, CLIN PRACTICE GUIDEL; McNeill SA, 1998, J UROLOGY, V159, P256; MURRAY K, 1984, BRIT J UROL, V56, P468; OlapadeOlaopa EO, 1997, J DIABETES COMPLICAT, V11, P350, DOI 10.1016/S1056-8727(96)00107-9; OLIVARES JP, 1995, ARCH PHYS MED REHAB, V76, P1171, DOI 10.1016/S0003-9993(95)80128-6; Pickard R, 1998, BRIT J UROL, V81, P712; Saborio DV, 1997, UROL INT, V58, P128, DOI 10.1159/000282968; SAVARIRAYAN S, 1995, UROLOGY, V46, P573, DOI 10.1016/S0090-4295(99)80277-5; Shah B., 1997, International Urology and Nephrology, V29, P173, DOI 10.1007/BF02551338; TINTINALLI JE, 1986, ANN EMERG MED, V15, P1235, DOI 10.1016/S0196-0644(86)80876-9; WASSON JH, 1995, NEW ENGL J MED, V332, P75, DOI 10.1056/NEJM199501123320202; WATERHOUSE N, 1987, J BONE JOINT SURG BR, V69, P64, DOI 10.1302/0301-620X.69B1.2434510; Zhou Y, 1997, J UROLOGY, V158, P916, DOI 10.1016/S0022-5347(01)64364-7	33	73	79	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	1999	318	7188					921	925		10.1136/bmj.318.7188.921	http://dx.doi.org/10.1136/bmj.318.7188.921			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185GV	10102861	Green Published			2022-12-28	WOS:000079660500030
J	[Anonymous]				[Anonymous]			Is it part of the locum's job to whistleblow?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	1999	318	7188					951	951						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185GV	10102893				2022-12-28	WOS:000079660500072
J	Gnanadesikan, A				Gnanadesikan, A			A simple predictive model for the structure of the oceanic pycnocline	SCIENCE			English	Article							CIRCULATION MODELS; WIND-DRIVEN; TRANSPORTS; FLUXES; HEAT	A simple theory for the large-scale oceanic circulation is developed, relating pycnocline depth, Northern Hemisphere sinking, and low-latitude upwelling to pycnocline diffusivity and Southern Ocean winds and eddies. The results show that Southern Ocean processes help maintain the global ocean structure and that pycnocline diffusion controls low-latitude upwelling.	Princeton Univ, NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08544 USA; Princeton Univ, Atmospher & Ocean Sci Program, Princeton, NJ 08544 USA	National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University; National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University	Gnanadesikan, A (corresponding author), Princeton Univ, NOAA, Geophys Fluid Dynam Lab, POB CN710, Princeton, NJ 08544 USA.	gnana@splash.princeton.edu	Gnanadesikan, Anand/A-2397-2008	Gnanadesikan, Anand/0000-0001-5784-1116				BRYAN F, 1987, J PHYS OCEANOGR, V17, P970, DOI 10.1175/1520-0485(1987)017<0970:PSOPEO>2.0.CO;2; DANABASOGLU G, 1994, SCIENCE, V264, P1123, DOI 10.1126/science.264.5162.1123; DESZOEKE RA, 1995, J PHYS OCEANOGR, V25, P918, DOI 10.1175/1520-0485(1995)025<0918:AMOWAB>2.0.CO;2; GATES WL, 1992, B AM METEOROL SOC, V73, P1962, DOI 10.1175/1520-0477(1992)073<1962:ATAMIP>2.0.CO;2; GENT P, 1995, J PHYS OCEANOGR, V26, P463; GENT PR, 1990, J PHYS OCEANOGR, V20, P150, DOI 10.1175/1520-0485(1990)020<0150:IMIOCM>2.0.CO;2; GRIFFIES SM, 1995, J CLIMATE, V8, P2440, DOI 10.1175/1520-0442(1995)008<2440:ALTODB>2.0.CO;2; HELLERMANN S, 1982, J PHYS OCEANOGR, V13, P1093; HOLLOWAY G, 1986, NATURE, V323, P243, DOI 10.1038/323243a0; HUANG RX, 1992, J PHYS OCEANOGR, V22, P231, DOI 10.1175/1520-0485(1992)022<0231:MESICT>2.0.CO;2; HUGHES TMC, 1994, J PHYS OCEANOGR, V24, P619, DOI 10.1175/1520-0485(1994)024<0619:MEOAAT>2.0.CO;2; Ledwell JR, 1998, J GEOPHYS RES-OCEANS, V103, P21499, DOI 10.1029/98JC01738; LEDWELL JR, 1993, NATURE, V364, P701, DOI 10.1038/364701a0; LEVITUS S, 1992, 13 NOAA; Macdonald AM, 1996, NATURE, V382, P436, DOI 10.1038/382436a0; Munk W, 1998, DEEP-SEA RES PT I, V45, P1977, DOI 10.1016/S0967-0637(98)00070-3; MUNK W., 1966, DEEP SEA RES OCEANOG, V13, P707, DOI [10.1016/0011-7471(66)90602-4, DOI 10.1016/0011-7471(66)90602-4]; MUNK WH, 1950, J METEOROL, V7, P79; OLBERS D, 1989, OCEAN CIRCULATION MO, P99; PACANOWSKI RC, 1998, 3 GFDL; PRICE JF, 1987, SCIENCE, V238, P1534, DOI 10.1126/science.238.4833.1534; SCHMITZ WJ, 1995, REV GEOPHYS, V33, P151, DOI 10.1029/95RG00879; STOMMEL H, 1961, TELLUS, V13, P224, DOI 10.1111/j.2153-3490.1961.tb00079.x; Toggweiler J., 1993, GLOBAL CARBON CYCLE, P303; Toggweiler JR, 1998, J PHYS OCEANOGR, V28, P1832, DOI 10.1175/1520-0485(1998)028<1832:OTOSLS>2.0.CO;2; Wright DG, 1998, J PHYS OCEANOGR, V28, P791, DOI 10.1175/1520-0485(1998)028<0791:CUIZAO>2.0.CO;2; WRIGHT DG, 1991, J PHYS OCEANOGR, V21, P1713, DOI 10.1175/1520-0485(1991)021<1713:AZAOMF>2.0.CO;2; WUNSCH C, 1983, J PHYS OCEANOGR, V13, P725, DOI 10.1175/1520-0485(1983)013<0725:MHSANF>2.0.CO;2	28	347	350	6	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	1999	283	5410					2077	2079		10.1126/science.283.5410.2077	http://dx.doi.org/10.1126/science.283.5410.2077			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180DH	10092229				2022-12-28	WOS:000079369800044
J	Brent, J; McMartin, K; Phillips, S; Burkhart, KK; Donovan, JW; Wells, M; Kulig, K				Brent, J; McMartin, K; Phillips, S; Burkhart, KK; Donovan, JW; Wells, M; Kulig, K		Methylpyrazole Toxic Alcohols Study Grp	Fomepizole for the treatment of ethylene glycol poisoning	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							METABOLIC INTERACTIONS; 4-METHYLPYRAZOLE; METHANOL; HEMODIALYSIS; ETHANOL; INTOXICATION; TOXICITY; MONKEY; SERUM; ACID	Background Ethylene glycol poisoning causes metabolic acidosis and renal failure and may cause death. The standard treatment is inhibition of alcohol dehydrogenase with ethanol, given in intoxicating doses, and adjunctive hemodialysis. We studied the efficacy of fomepizole, a new inhibitor of alcohol dehydrogenase, in the treatment of ethylene glycol poisoning. Methods We administered intravenous fomepizole to 19 patients with ethylene glycol poisoning (plasma ethylene glycol concentration, greater than or equal to 20 mg per deciliter [3.2 mmol per liter]). Patients who met specific criteria also underwent hemodialysis. Treatment was continued until plasma ethylene glycol concentrations were less than 20 mg per deciliter. Acid-base status, renal function, the kinetics of fomepizole, and ethylene glycol metabolism were assessed at predetermined intervals. Results Fifteen of the patients initially had acidosis (mean serum bicarbonate concentration, 72.9 mmol per liter). Acid-base status tended to normalize within hours after the initiation of treatment with fomepizole. One patient with extreme acidosis died. In nine patients, renal function decreased during therapy; at enrollment, all nine had high serum creatinine concentrations and markedly elevated plasma glycolate concentrations (greater than or equal to 97.7 mg per deciliter [12.9 mmol per liter]). None of the 10 patients with normal serum creatinine concentrations at enrollment had renal injury during treatment; all 10 had plasma glycolate concentrations at or below 76.8 mg per deciliter (10.1 mmol per liter). Renal injury was independent of the initial plasma ethylene glycol concentration. The plasma concentration of glycolate and the urinary excretion of oxalate, the major metabolites of ethylene glycol, uniformly fell after the initiation of fomepizole therapy. Few adverse effects were attributable to fomepizole. Conclusions In patients with ethylene glycol poisoning, fomepizole administered early in the course of intoxication prevents renal injury by inhibiting the formation of toxic metabolites. (N Engl J Med 1999; 340:832-8.) (C) 1999, Massachusetts Medical Society.	Univ Denver, Hlth Sci Ctr, Toxicol Associates, Denver, CO 80210 USA; Univ Denver, Hlth Sci Ctr, Sect Clin Pharmacol & Toxicol, Denver, CO 80210 USA; Univ Denver, Hlth Sci Ctr, Sect Emergency Med, Denver, CO 80210 USA; Univ Denver, Hlth Sci Ctr, Sect Pediat Pharmacol, Denver, CO 80210 USA; Louisiana State Univ, Med Ctr, Dept Pharmacol, Shreveport, LA USA; Milton S Hershey Penn State Geisinger Hlth Syst, Dept Emergency Med, Hershey, PA USA; Milton S Hershey Penn State Geisinger Hlth Syst, Cent Penn Poison Ctr, Hershey, PA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Denver; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Geisinger Health System; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Geisinger Health System; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Brent, J (corresponding author), Univ Denver, Hlth Sci Ctr, Toxicol Associates, 2555 S Downing St,Suite 260, Denver, CO 80210 USA.				FOOD AND DRUG ADMINISTRATION [R01FD001256] Funding Source: NIH RePORTER; FDA HHS [FDR-001256-01] Funding Source: Medline	FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services); FDA HHS		BAUD FJ, 1988, NEW ENGL J MED, V319, P97, DOI 10.1056/NEJM198807143190206; BAUD FJ, 1986, J TOXICOL-CLIN TOXIC, V24, P463, DOI 10.3109/15563658608995388; BLOMSTRAND R, 1980, ARCH BIOCHEM BIOPHYS, V199, P591, DOI 10.1016/0003-9861(80)90317-3; CHENG JT, 1987, J TOXICOL-CLIN TOXIC, V25, P95, DOI 10.3109/15563658708992616; Diczfalusy U, 1987, Biomed Chromatogr, V2, P226, DOI 10.1002/bmc.1130020511; Faessel H, 1995, EUR J CLIN PHARMACOL, V49, P211; FRASER AD, 1993, J TOXICOL-CLIN TOXIC, V31, P397, DOI 10.3109/15563659309000408; FRY IDR, 1991, ANN CLIN BIOCHEM, V28, P581, DOI 10.1177/000456329102800607; GABOW PA, 1986, ANN INTERN MED, V105, P16, DOI 10.7326/0003-4819-105-1-16; GRAUER GF, 1987, TOXICOL LETT, V35, P307, DOI 10.1016/0378-4274(87)90220-7; HARRY P, 1994, HUM EXP TOXICOL, V13, P61, DOI 10.1177/096032719401300109; JACOBSEN D, 1989, EUR J CLIN PHARMACOL, V37, P599; Jacobsen D, 1997, J TOXICOL-CLIN TOXIC, V35, P127, DOI 10.3109/15563659709001182; JACOBSEN D, 1986, MED TOXICOL ADV DRUG, V1, P309, DOI 10.1007/BF03259846; JACOBSEN D, 1990, Journal of Emergency Medicine, V8, P455, DOI 10.1016/0736-4679(90)90176-V; JACOBSEN D, 1988, ALCOHOL CLIN EXP RES, V12, P516, DOI 10.1111/j.1530-0277.1988.tb00235.x; Jobard E, 1996, J TOXICOL-CLIN TOXIC, V34, P373, DOI 10.3109/15563659609013806; KAGER L, 1974, ACTA PATH MICRO IM A, VA 82, P534; MCMARTIN KE, 1975, BIOCHEM MED METAB B, V13, P319, DOI 10.1016/0006-2944(75)90171-4; MCMARTIN KE, 1980, ARCH BIOCHEM BIOPHYS, V199, P606, DOI 10.1016/0003-9861(80)90318-5; ONEILL B, 1983, J STUD ALCOHOL, V44, P222, DOI 10.15288/jsa.1983.44.222; PARRY MF, 1974, AM J MED, V57, P143, DOI 10.1016/0002-9343(74)90780-3; PORTER WH, 1982, CLIN CHEM, V28, P75; STURTEVANT FM, 1976, N-S ARCH PHARMACOL, V293, P203, DOI 10.1007/BF00507342	24	219	228	1	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 18	1999	340	11					832	838		10.1056/NEJM199903183401102	http://dx.doi.org/10.1056/NEJM199903183401102			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	176ZW	10080845	Bronze			2022-12-28	WOS:000079183200002
J	Ayanian, JZ; Cleary, PD				Ayanian, JZ; Cleary, PD			Perceived risks of heart disease and cancer among cigarette smokers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COST-EFFECTIVENESS; SMOKING RISK; HEALTH; PERCEPTIONS; BELIEFS	Context Cigarette smoking causes more preventable deaths from cardiovascular disease and cancer than any other modifiable risk factor, but smokers may discount the increased personal risk they face from continued smoking. Objective To assess smokers' perceptions of their risks of heart disease and cancer. Design and Setting Telephone and self-administered survey in 1995 of a probability sample of US households with telephones. Participants A total of 3031 adults aged 25 to 74 years, including 737 current smokers (24.3%). Main Outcome Measures Respondents with no history of myocardial infarction (MI) (96.2%) or cancer (92.9%) assessed their risk of these conditions relative to other people of the same age and sex. Among current smokers, perceived risks were analyzed by demographic and clinical factors using logistic regression. Results Only 29% and 40% of current smokers believed they have a higher-than-average risk of MI or cancer, respectively, and only 39% and 49% of heavy smokers (greater than or equal to 40 cigarettes per day) acknowledged these risks. Even among smokers with hypertension, angina, or a family history of MI, 48%, 49%, and 39%, respectively, perceived their risk of MI as higher than average. In multivariate analyses, older (greater than or equal to 65 years), less educated (< high school graduate), and light smokers (1-19 cigarettes per day) were less likely than younger, more educated, and heavy smokers to perceive an increased personal risk of MI or cancer. Conclusions Most smokers do not view themselves at increased risk of heart disease or cancer. As part of multifaceted approaches to smoking cessation, physicians and public health professionals should identify and educate smokers who are not aware of smoking-related health risks.	Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Gen Med, Sect Hlth Serv & Policy Res, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Ayanian, JZ (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	ayanian@hcp.med.harvard.edu	Cleary, Paul/AAF-7048-2019					AVIS NE, 1989, AM J PUBLIC HEALTH, V79, P1608, DOI 10.2105/AJPH.79.12.1608; BROWNSON RC, 1992, AM J PUBLIC HEALTH, V82, P99, DOI 10.2105/AJPH.82.1.99; *CDCP, 1993, MMWR-MORBID MORTAL W, V42, P645; *CDCP, 1993, MMWR-MORBID MORTAL W, V42, P854; Centers for Disease Control and Prevention (CDC), 1996, MMWR-MORBID MORTAL W, V45, P588; Cromwell J, 1997, JAMA-J AM MED ASSOC, V278, P1759, DOI 10.1001/jama.278.21.1759; CUMMINGS SR, 1989, JAMA-J AM MED ASSOC, V261, P75, DOI 10.1001/jama.261.1.75; Fiore MC, 1996, JAMA-J AM MED ASSOC, V275, P1270, DOI 10.1001/jama.1996.03530400058039; Gibbons FX, 1997, J PERS SOC PSYCHOL, V72, P184, DOI 10.1037//0022-3514.72.1.184; GLYNN TJ, 1997, NIH PUBL; LEVENTHAL H, 1980, PSYCHOL BULL, V88, P370, DOI 10.1037/0033-2909.88.2.370; LEVENTHAL H, 1987, JAMA-J AM MED ASSOC, V257, P3373, DOI 10.1001/jama.257.24.3373; Levy P., 1991, SAMPLING POPULATIONS; Marmot MG, 1998, MILBANK Q, V76, P403, DOI 10.1111/1468-0009.00097; MCCOY SB, 1992, J BEHAV MED, V15, P469, DOI 10.1007/BF00844942; National Cancer Institute, 1997, NIH PUBL; Schoenbaum M, 1997, AM J PUBLIC HEALTH, V87, P755, DOI 10.2105/AJPH.87.5.755; STRECHER VJ, 1995, J BEHAV MED, V18, P45, DOI 10.1007/BF01857704; Thorndike AN, 1998, JAMA-J AM MED ASSOC, V279, P604, DOI 10.1001/jama.279.8.604; *US DEP HHS, 1990, HLTH BEN SMOK CESS; *US DEP HHS, 1989, DHHS PUBL CDC; Viscusi WK, 1992, SMOKING MAKING RISKY; Weinstein ND, 1998, ANN BEHAV MED, V20, P135, DOI 10.1007/BF02884459; WEINSTEIN ND, 1987, J BEHAV MED, V10, P481, DOI 10.1007/BF00846146; WEINSTEIN ND, 1988, HEALTH PSYCHOL, V7, P355, DOI 10.1037/0278-6133.7.4.355	25	176	180	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	1999	281	11					1019	1021		10.1001/jama.281.11.1019	http://dx.doi.org/10.1001/jama.281.11.1019			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	175EE	10086437				2022-12-28	WOS:000079079400029
J	Breslow, L				Breslow, L			From disease prevention to health promotion	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Breslow, L (corresponding author), Univ Calif Los Angeles, Sch Publ Hlth, 21-253 CHS, Los Angeles, CA 90095 USA.	breslow@ucla.edu						BERKMAN L, 1983, HLTH WAYS LIVING; BRESLOW L, 1993, PREV MED, V22, P86, DOI 10.1006/pmed.1993.1006; BRESLOW L, 1989, MED CARE, V27, pS205, DOI 10.1097/00005650-198903001-00017; *CDC, 1991, MMWR-MORBID MORTAL W, V39, P1; *COMM CHRON ILLN, 1957, CHRON US, V1; *DEP HLTH ED WELF, 1979, PHS PUBL; FANSHEL S, 1972, INT J EPIDEMIOL, V1, P319, DOI 10.1093/ije/1.4.319; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; GREEN LW, 1990, ANNU REV PUBL HEALTH, V11, P319; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; *NAT CTR HLTH STAT, 1995, HLTH US 1994; NOACK H, 1987, EUROPEAN SERIES, V22; NULAND SB, 1998, NY TIMES        0510; *PRES COMM HLTH NA, 1952, BUILD AM HLTH; REUBEN DB, 1990, J AM GERIATR SOC, V38, P855, DOI 10.1111/j.1532-5415.1990.tb05699.x; Schottenfeld D, 2006, CANC EPIDEMIOLOGY PR; SIGERIST HE, 1946, U CROSSROADS ADDRESS, P127; Sigerist HE, 1941, MED HUMAN WELFARE, P100; SINGH GK, 1995, MONTHLY VITAL STAT R, V43, P13; Terris M, 1985, J Public Health Policy, V6, P15, DOI 10.2307/3342015; *WHO, 1985, BAS DOC; World Health Organization, 1986, OTT CHART GES	23	105	111	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	1999	281	11					1030	1033		10.1001/jama.281.11.1030	http://dx.doi.org/10.1001/jama.281.11.1030			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	175EE	10086439				2022-12-28	WOS:000079079400031
J	Syngal, S; Coakley, EH; Willett, WC; Byers, T; Williamson, DF; Colditz, GA				Syngal, S; Coakley, EH; Willett, WC; Byers, T; Williamson, DF; Colditz, GA			Long-term weight patterns and risk for cholecystectomy in women	ANNALS OF INTERNAL MEDICINE			English	Article						cholelithiasis; weight loss; weight gain; cholecystectomy	GASTRIC BYPASS-SURGERY; GALLSTONE DISEASE; GALLBLADDER-DISEASE; SYMPTOMATIC GALLSTONES; MORBID-OBESITY; URSODEOXYCHOLIC ACID; PHYSICAL-ACTIVITY; RELATIVE WEIGHT; UNITED-STATES; GALL-STONES	Background: Obesity and rapid weight loss in obese persons are known risk factors for gallstones. However, the effect of intentional, long-term, moderate weight changes on the risk for gallstones is unclear. Objective: To study long-term weight patterns in a cohort of women and to examine the relation between weight pattern and risk for cholecystectomy. Design: Prospective cohort study. Setting: 11 U.S. states. Participants: 47 153 female registered nurses who did not undergo cholecystectomy before 1988. Measurements: Cholecystectomy between 1988 and 1994 (ascertained by patient self-report). Results: During the exposure period (1972 to 1988), there was evidence of substantial Variation in weight due to intentional weight loss during adulthood. Among cohort patients, 54.9% reported weight cycling with at least one episode of intentional weight loss associated with regain. Of the total cohort, 20.1% were light cyclers (5 to 9 Ib of weight loss and gain), 18.8% were moderate cyclers(10 to 19 lb of weight loss and gain), and 16.0% were severe cyclers (greater than or equal to 20 lb of weight loss and gain). Net weight gain without cycling occurred in 29.3% of women; net weight loss without cycling was the least common pattern (4.6%). Only 11.1% of the cohort maintained weight within 5 lb over the 16-year period. In the study, 1751 women had undergone cholecystectomy between 1988 and 1994. Compared with weight maintainers, the relative risk for cholecystectomy (adjusted for body mass index, age, alcohol intake, fat intake, and smoking) was 1.20 (95% CI, 0.96 to 1.50) among light cyclers, 1.31 among moderate cyclers (CI, 1.05 to 1.64), and 1.68 among severe cyclers (CI, 1.34 to 2.10). Conclusion: Weight cycling was highly prevalent in this large cohort of middle-aged women. The risk for cholecystectomy associated with weight cycling was substantial, independent of attained relative body weight.	Harvard Univ, Brigham & Womens Hosp, Sch Med,Dana Farber Canc Inst, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Ctr Dis Control & Prevent, Div Diabet Translat K10, Atlanta, GA 30341 USA; Univ Colorado, Sch Med, Dept Prevent Med & Biometr, Denver, CO 80262 USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Centers for Disease Control & Prevention - USA; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Colditz, GA (corresponding author), Channing Labs, 181 Longwood Ave, Boston, MA 02115 USA.		Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291	NATIONAL CANCER INSTITUTE [R01CA040356, R25CA057711, R37CA040356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200] Funding Source: NIH RePORTER; NCI NIH HHS [5R25CA57711, CA 40356] Funding Source: Medline; NIDDK NIH HHS [DK 46200] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMARAL JF, 1985, AM J SURG, V149, P551, DOI 10.1016/S0002-9610(85)80055-6; ANGELICO M, 1988, HEPATOLOGY, V8, P907; ATKINSON RL, 1994, JAMA-J AM MED ASSOC, V272, P1196, DOI 10.1001/jama.272.15.1196; BARBARA L, 1987, HEPATOLOGY, V7, P913, DOI 10.1002/hep.1840070520; BENNION LJ, 1978, NEW ENGL J MED, V299, P1221, DOI 10.1056/NEJM197811302992205; BLACKBURN GL, 1989, AM J CLIN NUTR, V49, P1105, DOI 10.1093/ajcn/49.5.1105; BRAY GA, 1976, ANN INTERN MED, V85, P97, DOI 10.7326/0003-4819-85-1-97; BRAY GA, 1985, ANN INTERN MED, V103, P1052, DOI 10.7326/0003-4819-103-6-1052; BROOMFIELD PH, 1988, NEW ENGL J MED, V319, P1567, DOI 10.1056/NEJM198812153192403; Colditz GA, 1990, CURR PROB OBST GYN F, V13, P129; CUPPLES LA, 1988, STAT MED, V7, P205, DOI 10.1002/sim.4780070122; DEITEL M, 1987, SURG GYNECOL OBSTET, V164, P549; EVERHART JE, 1993, ANN INTERN MED, V119, P1029, DOI 10.7326/0003-4819-119-10-199311150-00010; FRENCH SA, 1995, INT J OBESITY, V19, P22; FRIEDMAN GD, 1966, J CHRON DIS, V19, P273, DOI 10.1016/0021-9681(66)90132-9; Jeffery RW, 1996, AM J CLIN NUTR, V63, P452; JORGENSEN T, 1989, GUT, V30, P528, DOI 10.1136/gut.30.4.528; KAMRATH RO, 1992, AM J CLIN NUTR, V56, P255; KATO I, 1992, DIGEST DIS SCI, V37, P784, DOI 10.1007/BF01296440; KNECHT BH, 1978, AM SURGEON, V44, P496; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; LAYDE PM, 1982, J EPIDEMIOL COMMUN H, V36, P274, DOI 10.1136/jech.36.4.274; LIDDLE RA, 1989, ARCH INTERN MED, V149, P1750, DOI 10.1001/archinte.149.8.1750; MACLURE KM, 1989, NEW ENGL J MED, V321, P563, DOI 10.1056/NEJM198908313210902; MARKS JW, 1992, GASTROENTEROLOGY, V103, P566, DOI 10.1016/0016-5085(92)90848-S; MARZIO L, 1988, DIGEST DIS SCI, V33, P4, DOI 10.1007/BF01536623; MAURER KR, 1990, AM J EPIDEMIOL, V131, P836, DOI 10.1093/oxfordjournals.aje.a115574; RODIN J, 1993, ANN INTERN MED, V119, P643, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00003; SCHLESINGER MH, 1989, GASTROINTESTINAL DIS; SCRAGG RKR, 1984, BRIT MED J, V288, P1113, DOI 10.1136/bmj.288.6424.1113; SHIFFMAN ML, 1991, AM J GASTROENTEROL, V86, P1000; SHIFFMAN ML, 1995, ANN INTERN MED, V122, P899, DOI 10.7326/0003-4819-122-12-199506150-00002; SICHIERI R, 1991, AM J PUBLIC HEALTH, V81, P880, DOI 10.2105/AJPH.81.7.880; SICHIERI R, 1990, AM J EPIDEMIOL, V131, P826, DOI 10.1093/oxfordjournals.aje.a115573; STAMPFER MJ, 1992, AM J CLIN NUTR, V55, P652, DOI 10.1093/ajcn/55.3.652; SUGERMAN HJ, 1989, AM J SURG, V157, P93, DOI 10.1016/0002-9610(89)90427-3; THIJS C, 1992, AM J EPIDEMIOL, V135, P274, DOI 10.1093/oxfordjournals.aje.a116281; *US DEPT HHS, 1987, VIT HLTH STAT, V11; WATTCHOW DA, 1983, BRIT MED J, V286, P763, DOI 10.1136/bmj.286.6367.763; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; Willett W., 1990, NUTR EPIDEMIOLOGY; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; World Health Organization, 1995, PHYS STAT US INT ANT; YANG HY, 1992, DIGEST DIS SCI, V37, P912, DOI 10.1007/BF01300390	44	69	73	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	1999	130	6					471	+		10.7326/0003-4819-130-6-199903160-00003	http://dx.doi.org/10.7326/0003-4819-130-6-199903160-00003			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	176RL	10075614				2022-12-28	WOS:000079165500002
J	Hagley, EW; Deng, L; Kozuma, M; Wen, J; Helmerson, K; Rolston, SL; Phillips, WD				Hagley, EW; Deng, L; Kozuma, M; Wen, J; Helmerson, K; Rolston, SL; Phillips, WD			A well-collimated quasi-continuous atom laser	SCIENCE			English	Article							BOSE-EINSTEIN CONDENSATION	Extraction of sodium atoms from a trapped Bose-Einstein condensate (BEC) by a coherent, stimulated Raman process is demonstrated. Optical Raman pulses drive transitions between trapped and untrapped magnetic sublevels, giving the output-coupled BEC fraction a well-defined momentum. The pulsed output coupling can be run at such a rate that the extracted atomic wave packets strongly overlap, forming a highly directional, quasi-continuous matter wave.	Natl Inst Stand & Technol, Gaithersburg, MD 20899 USA; Georgia So Univ, Statesboro, GA 30460 USA; Univ Tokyo, Inst Phys, Tokyo 1538902, Japan	National Institute of Standards & Technology (NIST) - USA; University System of Georgia; Georgia Southern University; University of Tokyo	Hagley, EW (corresponding author), Natl Inst Stand & Technol, Gaithersburg, MD 20899 USA.		Helmerson, Kristian/E-3683-2013; Hagley, Edward/B-4285-2012; rolston, steven l/L-5175-2013; Deng, Lu/B-3997-2012	rolston, steven l/0000-0003-1671-4190; Helmerson, Kristian/0000-0002-6387-0949				ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; Andrews MR, 1997, SCIENCE, V275, P637, DOI 10.1126/science.275.5300.637; Bradley CC, 1997, PHYS REV LETT, V78, P985, DOI 10.1103/PhysRevLett.78.985; Dalfovo F, 1999, REV MOD PHYS, V71, P463, DOI 10.1103/RevModPhys.71.463; DAVIS KB, 1995, PHYS REV LETT, V75, P3969, DOI 10.1103/PhysRevLett.75.3969; EDWARDS MA, IN PRESS J PHYS B; Einstein A, 1925, SITZBER PREUSS AKAD, P3; Einstein A, 1924, SITZBER PREUSS AKAD, P261; Killian TC, 1998, PHYS REV LETT, V81, P3807, DOI 10.1103/PhysRevLett.81.3807; Kozuma M, 1999, PHYS REV LETT, V82, P871, DOI 10.1103/PhysRevLett.82.871; MARTIN PJ, 1988, PHYS REV LETT, V60, P515, DOI 10.1103/PhysRevLett.60.515; Mewes MO, 1997, PHYS REV LETT, V78, P582, DOI 10.1103/PhysRevLett.78.582; Moy GM, 1997, PHYS REV A, V55, P3631, DOI 10.1103/PhysRevA.55.3631; PETRICH W, 1995, PHYS REV LETT, V74, P3352, DOI 10.1103/PhysRevLett.74.3352; 1994, J PHYSIQUE, V4, P11; 1992, APPL PHYS B, V54, P321; 1994, J PHYS REP, P240	17	420	430	4	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	1999	283	5408					1706	1709		10.1126/science.283.5408.1706	http://dx.doi.org/10.1126/science.283.5408.1706			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175PF	10073929				2022-12-28	WOS:000079102800042
J	Bonifazi, E; Mileti, F				Bonifazi, E; Mileti, F			Congenital hemangioma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Bari, I-70124 Bari, Italy; Osped Fasano, I-72015 Brindisi, Italy	Universita degli Studi di Bari Aldo Moro	Bonifazi, E (corresponding author), Univ Bari, I-70124 Bari, Italy.								0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 8	1999	340	14					1080	1080		10.1056/NEJM199904083401405	http://dx.doi.org/10.1056/NEJM199904083401405			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	184AK	10194238				2022-12-28	WOS:000079587000005
J	Locatelli, ER; Varghese, JP; Shuaib, A; Potolicchio, SJ				Locatelli, ER; Varghese, JP; Shuaib, A; Potolicchio, SJ			Cardiac asystole and bradycardia as a manifestation of left temporal lobe complex partial seizure	ANNALS OF INTERNAL MEDICINE			English	Article							ICTAL BRADYCARDIA; EPILEPTIC SEIZURES; SIMULTANEOUS EEG; ECG; ARRHYTHMIAS		George Washington Univ, Dept Neurol, Washington, DC 20037 USA; George Washington Univ, Dept Med, Div Cardiol, Washington, DC 20037 USA	George Washington University; George Washington University	Locatelli, ER (corresponding author), George Washington Univ, Dept Neurol, 2150 Penn Ave NW,Room 7-404, Washington, DC 20037 USA.	elocat@gwis2.circ.gwu.edu						BERTHOLDS E, 1988, LAKARTIDNINGEN, V85, P24; Devinsky O, 1997, NEUROLOGY, V48, P1712, DOI 10.1212/WNL.48.6.1712; FINCHAM RW, 1992, NEUROLOGY, V42, P2222, DOI 10.1212/WNL.42.11.2222; GILCHRIST JM, 1985, NEUROLOGY, V35, P1503, DOI 10.1212/WNL.35.10.1503; HOWELL SJL, 1989, J NEUROL NEUROSUR PS, V52, P795, DOI 10.1136/jnnp.52.6.795; JACOME DE, 1988, AM J MED SCI, V295, P469, DOI 10.1097/00000441-198805000-00010; LANE RD, 1992, STROKE, V23, P362, DOI 10.1161/01.STR.23.3.362; LEVY MN, 1990, CARDIAC ELECTROPHYSI, P305; LIEDHOLM LJ, 1992, NEUROLOGY, V42, P824, DOI 10.1212/WNL.42.4.824; LOWN B, 1976, NEW ENGL J MED, V294, P1165; Massetani R, 1997, EPILEPSIA, V38, P363, DOI 10.1111/j.1528-1157.1997.tb01129.x; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; Reeves AL, 1996, EPILEPSIA, V37, P983, DOI 10.1111/j.1528-1157.1996.tb00536.x; ROBERTS WC, 1986, AM J CARDIOL, V57, P1410, DOI 10.1016/0002-9149(86)90229-8; SCHWARTZ PJ, 1981, J CARDIOVASC PHARM, V3, P1251, DOI 10.1097/00005344-198111000-00012; SWARTZ CM, 1994, J NEUROL NEUROSUR PS, V57, P97, DOI 10.1136/jnnp.57.1.97; THOMPSON ME, 1987, AM J PHYSIOL, V253, pR150, DOI 10.1152/ajpregu.1987.253.1.R150; VANRIJCKEVORSEL K, 1995, SEIZURE, V4, P237, DOI 10.1016/S1059-1311(05)80067-6; WILDERSMITH E, 1995, SCHWEIZ MED WSCHR, V125, P2237; ZAMRINI EY, 1990, NEUROLOGY, V40, P1408, DOI 10.1212/WNL.40.9.1408	20	30	31	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 6	1999	130	7					581	583		10.7326/0003-4819-130-7-199904060-00018	http://dx.doi.org/10.7326/0003-4819-130-7-199904060-00018			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183BG	10189328				2022-12-28	WOS:000079533300006
J	Beecham, L				Beecham, L			NHSE agrees to negotiate over millennium pay	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 3	1999	318	7188					947	947						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185GV	10102886				2022-12-28	WOS:000079660500068
J	Bozhilov, KN; Green, HW; Dobrzhinetskaya, L				Bozhilov, KN; Green, HW; Dobrzhinetskaya, L			Clinoenstatite in Alpe Arami peridotite: Additional evidence of very high pressure	SCIENCE			English	Article							TRANSMISSION ELECTRON-MICROSCOPY; X-RAY-MICROANALYSIS; HIGH-TEMPERATURE; UPPER-MANTLE; EXSOLUTION LAMELLAE; CRYSTAL-CHEMISTRY; SINGLE-CRYSTALS; PYROXENES; OLIVINE; MICROSTRUCTURES	Observations by transmission electron microscopy show that Lamellae of clinoenstatite are present in diopside grains of the Alpe Arami garnet Iherzolite of the Swiss Alps. The simplest interpretation of the orientation, crystallography, and microstructures of the lamellae and the phase relationships in this system is that the Lamellae originally exsolved as the high-pressure C-centered form of clinoenstatite. These results imply that the rocks were exhumed from a minimum depth of 250 kilometers before or during continental collision.	Univ Calif Riverside, Inst Geophys & Planetary Phys, Riverside, CA 92521 USA; Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Bozhilov, KN (corresponding author), Univ Calif Riverside, Inst Geophys & Planetary Phys, Riverside, CA 92521 USA.							ANGEL RJ, 1994, J GEOPHYS RES-SOL EA, V99, P19777, DOI 10.1029/94JB01750; ANGEL RJ, 1992, NATURE, V358, P322, DOI 10.1038/358322a0; BAILEY JC, 1970, P APOLLO 11 LUNAR SC, V1, P169; BECKER H, 1993, GEOLOGY, V21, P599, DOI 10.1130/0091-7613(1993)021<0599:GPAESN>2.3.CO;2; BOYSEN H, 1991, PHYS CHEM MINER, V17, P629; Brenner S, 1997, CLIN DERMATOL, V15, P1, DOI 10.1016/S0738-081X(96)00142-3; BUISKOOL JMA, 1976, LEIDSE GEOL MEDED, V51, P1; BUISKOOLTOXOPEUS JMA, 1977, TECTONOPHYSICS, V39, P55, DOI 10.1016/0040-1951(77)90088-9; Buseck P. R., 1980, REV MINERAL, V4, P117; CAMERON M, 1981, AM MINERAL, V66, P1; CARPENTER MA, 1979, PHYS CHEM MINER, V5, P119, DOI 10.1007/BF00307548; CARTER NL, 1970, GEOL SOC AM BULL, V81, P2181, DOI 10.1130/0016-7606(1970)81[2181:HTFODA]2.0.CO;2; Champness P. E., 1976, ELECTRON MICROS, P228; COE RS, 1975, CONTRIB MINERAL PETR, V52, P29, DOI 10.1007/BF00378000; DENTEX E, 1971, FORTSCHR MINERAL, V48, P69; Dobrzhinetskaya L, 1996, SCIENCE, V271, P1841, DOI 10.1126/science.271.5257.1841; DOBRZHINETSKAYA L, IN PRESS CHEM GEOL; DRURY MR, 1988, GEOLOGY, V16, P1035, DOI 10.1130/0091-7613(1988)016<1035:MOFFTR>2.3.CO;2; DRURY MR, 1989, GEOLOGY, V17, P676; DURHAM WB, 1977, J GEOPHYS RES, V82, P5755, DOI 10.1029/JB082i036p05755; ERNST WG, 1978, J PETROL, V19, P341, DOI 10.1093/petrology/19.3.341; ERNST WG, 1981, AM MINERAL, V66, P443; FEUER H, 1989, EUR J MINERAL, V1, P507; GASPARIK T, 1990, AM MINERAL, V75, P1080; GBAAUER D, 1994, 1 WORKSH UHP MET TEC; GEBAUER D, 1993, TERR ABSTR, V6, P5; Green H.W., 1972, FLOW FRACTURE ROCKS, P139, DOI [10.1029/GM016p013, DOI 10.1029/GM016P013]; GREEN HW, 1983, TECTONOPHYSICS, V92, P71, DOI 10.1016/0040-1951(83)90085-9; Green HW, 1997, TECTONOPHYSICS, V279, P1, DOI 10.1016/S0040-1951(97)00127-3; Green HW, 1997, SCIENCE, V278, P704; GREEN HW, 1972, EARTH PLANET SC LETT, V15, P239, DOI 10.1016/0012-821X(72)90169-0; GREEN HW, 1976, ELECTRON MICROS, P443; GUEGUEN Y, 1977, TECTONOPHYSICS, V39, P231, DOI 10.1016/0040-1951(77)90098-1; Hacker BR, 1997, SCIENCE, V278, P702, DOI 10.1126/science.278.5338.702; HAGGERTY SE, 1994, EOS, V75, P192; Hervig R.L., 1986, EARTH ENV SCI T R SO, V77, P181, DOI DOI 10.1017/S026359330001083X; HERZBERG C, 1991, J GEOPHYS RES-SOL EA, V96, P16263, DOI 10.1029/91JB01481; HughJones D, 1996, EUR J MINERAL, V8, P1337; HUGHJONES DA, 1994, AM MINERAL, V79, P1032; IIJIMA S, 1975, AM MINERAL, V60, P758; JAFFE HW, 1975, AM MINERAL, V60, P9; JIN ZM, 1989, TECTONOPHYSICS, V169, P23, DOI 10.1016/0040-1951(89)90181-9; KOHLSTEDT DL, 1974, J GEOPHYS RES, V79, P2045, DOI 10.1029/JB079i014p02045; LIVI KJT, 1989, AM MINERAL, V74, P1070; Medaris Jr L.G., 1990, ECLOGITE FACIES ROCK, P260; Mockel J.R., 1969, LEIDSE GEOL MEDED, V42, P61; MORIMOTO N, 1969, AM MINERAL, V54, P725; MOSELEY D, 1981, AM MINERAL, V66, P976; NICOLS A, 1976, CRYSTALLINE PLASTICI; NORD GL, 1992, REV MINERAL, V27, P455; PACALO REG, 1990, J GEOPHYS RES-SOLID, V95, P15853, DOI 10.1029/JB095iB10p15853; RALEIGH CB, 1968, J GEOPHYS RES, V73, P5391, DOI 10.1029/JB073i016p05391; RIETMEIJER FJM, 1982, MINERAL MAG, V45, P11, DOI 10.1180/minmag.1982.045.337.02; RISOLD AC, 1997, EUROP GEOPHYS UNION, V9, P93; RISOLD AC, 1996, T AGU, V77, pF761; ROBINSON P, 1977, AM MINERAL, V62, P857; van Roermund H.L.M., 1998, EOS, V79, pF971; VANCAPPELLEN E, 1990, MICROSC MICROANAL M, V1, P1, DOI 10.1051/mmm:01990001010100; VANCAPPELLEN E, 1994, ULTRAMICROSCOPY, V53, P343, DOI 10.1016/0304-3991(94)90047-7; VANROERMUND HLM, IN PRESS TERRA NOVA; VEBLEN DR, 1988, AM MINERAL, V73, P677; VEBLEN DR, 1980, AM MINERAL, V65, P599; WOODLAND AB, 1995, CONTRIB MINERAL PETR, V121, P87, DOI 10.1007/s004100050091; Woodland AB, 1997, EUR J MINERAL, V9, P245; YAMAGUCHI Y, 1978, CONTRIB MINERAL PETR, V66, P263, DOI 10.1007/BF00373410; ZEUCH DH, 1984, TECTONOPHYSICS, V110, P263, DOI 10.1016/0040-1951(84)90264-6; [No title captured]	67	108	116	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	1999	284	5411					128	132		10.1126/science.284.5411.128	http://dx.doi.org/10.1126/science.284.5411.128			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182QE	10102809				2022-12-28	WOS:000079509000048
J	Steer, P				Steer, P			ABC of labour care - Assessment of mother and fetus in labour	BRITISH MEDICAL JOURNAL			English	Review							ACTIVE MANAGEMENT		Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Sch Med, London, England	Imperial College London	Steer, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Sch Med, London, England.							*DEP HLTH, 1992, CHANG CHILDB; Ingermarsson J, 1993, FETAL HEART RATE MON; Maternal and Child Health Research Consortium, 2000, CONF ENQ STILLB DEAT; ODRISCOLL K, 1984, OBSTET GYNECOL, V63, P485; ODRISCOLL K, 1969, BMJ-BRIT MED J, V2, P477, DOI 10.1136/bmj.2.5655.477; ODRISCOLL K, 1973, BMJ-BRIT MED J, V3, P135, DOI 10.1136/bmj.3.5872.135; Spencer JAD, 1993, INTRAPARTUM FETAL SU; Westgren M, 1998, BRIT J OBSTET GYNAEC, V105, P29, DOI 10.1111/j.1471-0528.1998.tb09346.x	8	2	2	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 27	1999	318	7187					858	+		10.1136/bmj.318.7187.858	http://dx.doi.org/10.1136/bmj.318.7187.858			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185DM	10092268	Green Published			2022-12-28	WOS:000079652900037
J	Andersen, MI; Castro-Tirado, AJ; Hjorth, J; Moller, P; Pedersen, H; Caon, N; Cairos, LM; Korhonen, H; Osorio, MRZ; Perez, E; Frontera, F				Andersen, MI; Castro-Tirado, AJ; Hjorth, J; Moller, P; Pedersen, H; Caon, N; Cairos, LM; Korhonen, H; Osorio, MRZ; Perez, E; Frontera, F			Spectroscopic limits on the distance and energy release of GRB 990123	SCIENCE			English	Article								An optical spectrum of the afterglow from the unusually bright gamma-ray burst GRB 990123 obtained on 24.25 January 1999 universal time showed an absorption system at a redshift of z = 1.600. The absence of a hydrogen Lyman or forest sets an upper limit of z < 2.17, whereas ultraviolet photometry indicates an upper Limit of z < 2.05. The probability of intersecting an absorption system as strong as the one observed along a random line of sight out to this z is at most a few percent, implying that GRB 990123 was probably at z = 1.600. Currently favored cosmological parameters imply that an isotropic energy release equivalent to the rest mass of 1.8 neutron stars (4.5 x 10(54) erg) was emitted in gamma rays. Nonisotropic emission, such as intrinsic beaming, may resolve this energy problem.	Nord Opt Telescope, E-38700 Canarias, Spain; Inst Nacl Tecn Aeroespacial, Lab Astrofis Espacial & Fis Fundamental, E-28080 Madrid, Spain; CSIC, Inst Astrofis Andalucia, E-18080 Granada, Spain; Univ Copenhagen, Astron Observ, DK-2100 Copenhagen O, Denmark; European So Observ, D-85748 Garching, Germany; Inst Astrofis Canarias, E-38200 Tenerife, Spain; Univ Oulu, Astron Div, FIN-90401 Oulu, Finland; Univ Ferrara, Dipartimento Fis, I-44100 Ferrara, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); University of Copenhagen; European Southern Observatory; Instituto de Astrofisica de Canarias; University of Oulu; University of Ferrara	Andersen, MI (corresponding author), Nord Opt Telescope, Apartado 474 St Cruz La Palma, E-38700 Canarias, Spain.	andersen@not.iac.es	Korhonen, Heidi/AAZ-5747-2020; Zapatero Osorio, Maria Rosa/C-2744-2017; Korhonen, Heidi H./E-3065-2016; Andersen, Michael/H-6403-2018; Hjorth, Jens/M-5787-2014; Caon, Nicola/B-5113-2008; Perez, Enrique/A-2217-2009	Korhonen, Heidi/0000-0003-0529-1161; Zapatero Osorio, Maria Rosa/0000-0001-5664-2852; Korhonen, Heidi H./0000-0003-0529-1161; Hjorth, Jens/0000-0002-4571-2306; Caon, Nicola/0000-0002-1653-5806; Perez, Enrique/0000-0001-9737-4559; Castro-Tirado, A. J./0000-0003-2999-3563				AKERLOF CW, IN PRESS NATURE; AKERLOF CW, 1999, 7100 IAU; AKERLOF CW, 1999, 205 GCN; Bloom JS, 1998, ASTROPHYS J, V507, pL25, DOI 10.1086/311682; BLOOM JS, ASTROPH9902182; Castro-Tirado AJ, 1999, SCIENCE, V283, P2069, DOI 10.1126/science.283.5410.2069; DJORGOVSKI SG, 1999, 216 GCN; FISHMAN GJ, 1995, ANNU REV ASTRON ASTR, V33, P415, DOI 10.1146/annurev.astro.33.1.415; FRUCHTER AS, ASTROPH9902236; HEISE J, UNPUB; Hjorth J, 1999, SCIENCE, V283, P2073, DOI 10.1126/science.283.5410.2073; HOLLAND S, ASTROPH9903175; KIPPEN RM, 1999, 224 GCN; Kulkarni SR, 1998, NATURE, V393, P35, DOI 10.1038/29927; KULKARNI SR, IN PRESS NATURE; METZGER MR, 1997, NATURE, V387, P879; MOLLER P, 1990, ASTRON ASTROPHYS, V228, P299; ODEWAHN S, 1999, 201 GCN; ODEWAHN SC, 1999, 7094 IAU; Pettini M, 1997, ASTROPHYS J, V486, P665, DOI 10.1086/304564; RUIZLAPUENTE P, 1997, THERMONUCLEAR SUPERN	21	52	53	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	1999	283	5410					2075	2077		10.1126/science.283.5410.2075	http://dx.doi.org/10.1126/science.283.5410.2075			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180DH	10092228				2022-12-28	WOS:000079369800043
J	Fery, F; Plat, L; van de Borne, P; Cogan, E; Mockel, J				Fery, F; Plat, L; van de Borne, P; Cogan, E; Mockel, J			Impaired counterregulation of glucose in a patient with hypothalamic sarcoidosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INSULIN-INDUCED HYPOGLYCEMIA; DIABETES-MELLITUS; PREVENTION; RESPONSES; GLUCAGON; CATECHOLAMINES; UNAWARENESS; MECHANISMS; NERVES; RATS		Free Univ Brussels, Hop Erasme, Dept Endocrinol, B-1070 Brussels, Belgium; Free Univ Brussels, Hop Erasme, Dept Internal Med, B-1070 Brussels, Belgium; Free Univ Brussels, Hop Erasme, Hypertens Clin, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Fery, F (corresponding author), Free Univ Brussels, Hop Erasme, Dept Endocrinol, 808 Route Lennik, B-1070 Brussels, Belgium.			Cogan, Elie/0000-0003-2890-766X				ADRIAN TE, 1982, RADIOIMMUNOASSAY GUT, P92; AMIEL SA, 1988, DIABETES, V37, P901, DOI 10.2337/diabetes.37.7.901; Borg MA, 1997, J CLIN INVEST, V99, P361, DOI 10.1172/JCI119165; BORG WP, 1994, J CLIN INVEST, V93, P1677, DOI 10.1172/JCI117150; BOYLE PJ, 1994, P NATL ACAD SCI USA, V91, P9352, DOI 10.1073/pnas.91.20.9352; BOYLE PJ, 1989, AM J PHYSIOL, V256, pE651, DOI 10.1152/ajpendo.1989.256.5.E651; Braunstein Glenn D., 1995, P309; CHRISTOFIDES ND, 1982, RADIOIMMUNOASSAY GUT, P74; CRYER PE, 1993, AM J PHYSIOL, V264, pE149, DOI 10.1152/ajpendo.1993.264.2.E149; DAGOGOJACK SE, 1993, J CLIN INVEST, V91, P819, DOI 10.1172/JCI116302; Davis SN, 1997, J CLIN INVEST, V100, P429, DOI 10.1172/JCI119550; FAGIUS J, 1986, DIABETES, V35, P1124, DOI 10.2337/diabetes.35.10.1124; GARBER AJ, 1976, J CLIN INVEST, V58, P7, DOI 10.1172/JCI108460; GARG A, 1994, HORM METAB RES, V26, P276, DOI 10.1055/s-2007-1001683; GERICH JE, 1988, DIABETES, V37, P1608, DOI 10.2337/diabetes.37.12.1608; GERLO EAM, 1994, CLIN CHEM, V40, P250; Havel PJ, 1997, DIABETES, V46, P801, DOI 10.2337/diabetes.46.5.801; HERBERT V, 1965, J CLIN ENDOCR METAB, V25, P1375, DOI 10.1210/jcem-25-10-1375; HILSTED J, 1991, ACTA ENDOCRINOL-COP, V125, P466, DOI 10.1530/acta.0.1250466; MITRAKOU A, 1993, NEW ENGL J MED, V329, P834, DOI 10.1056/NEJM199309163291203; RAVUSSIN E, 1986, J CLIN INVEST, V78, P1568, DOI 10.1172/JCI112749; STUART CA, 1978, ANN INTERN MED, V88, P589, DOI 10.7326/0003-4819-88-5-589; TSE TF, 1983, J CLIN INVEST, V72, P278, DOI 10.1172/JCI110967; VENEMAN T, 1993, DIABETES, V42, P1233, DOI 10.2337/diabetes.42.9.1233	24	25	26	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 18	1999	340	11					852	856		10.1056/NEJM199903183401105	http://dx.doi.org/10.1056/NEJM199903183401105			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	176ZW	10080848				2022-12-28	WOS:000079183200005
J	McGee, S; Abernethy, WB; Simel, DL				McGee, S; Abernethy, WB; Simel, DL			Is this patient hypovolemic?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ORTHOSTATIC VITAL SIGNS; ACUTE BLOOD-LOSS; HEAD-UP TILT; POSTURAL HYPOTENSION; ELDERLY PATIENTS; HEMODYNAMIC-RESPONSE; PRESSURE CHANGES; CLINICAL SIGNS; OLD-AGE; DEHYDRATION	Objective To review, systematically, the physical diagnosis of hypovolemia in adults. Methods We searched MEDLINE (January 1966-November 1997), personal files, and bibliographies of textbooks on physical diagnosis and identified 10 studies investigating postural vital signs or the capillary refill time of healthy volunteers, some of whom underwent phlebotomy of up to 1150 mL of blood, and 4 studies of patients presenting to emergency departments with suspected hypovolemia, usually due to vomiting, diarrhea, or decreased oral intake. Results When clinicians evaluate adults with suspected blood loss, the most helpful physical findings are either severe postural dizziness (preventing measurement of upright vital signs) or a postural pulse increment of 30 beats/min or more. The presence of either finding has a sensitivity for moderate blood loss of only 22% (95% confidence interval [CI], 6%-48%) but a much greater sensitivity for large blood loss of 97% (95% CI, 91%-100%); the corresponding specificity is 98% (95% CI, 97%-99%). Supine hypotension and tachycardia are frequently absent, even after up to 1150 mt of blood loss (sensitivity, 33%; 95% CI, 21%-47%, for supine hypotension). The finding of mild postural dizziness has no proven value. In patients with vomiting, diarrhea, or decreased oral intake, the presence of a dry axilla supports the diagnosis of hypovolemia (positive likelihood ratio, 2.8; 95% CI, 1.4-5.4), and moist mucous membranes and a tongue without furrows argue against it (negative likelihood ratio, 0.3; 95% CI, 0.1-0.6 for both findings). In adults, the capillary refill time and poor skin turgor have no proven diagnostic value. Conclusions A large postural pulse change (greater than or equal to 30 beats/min) or severe postural dizziness is required to clinically diagnose hypovolemia due to blood loss, although these findings are often absent after moderate amounts of blood loss. In patients with vomiting, diarrhea, or decreased oral intake, few findings have proven utility, and clinicians should measure serum electrolytes, serum blood urea nitrogen, and creatinine levels when diagnostic certainty is required.	Univ Washington, Seattle Puget Sound VA Hlth Care Syst 111, Dept Med, Seattle, WA 98108 USA; Massachusetts Gen Hosp, Dept Cardiovasc Med, Boston, MA 02114 USA; Duke Univ, Dept Med Ambulatory Care, Durham, NC USA; Durham Vet Affairs Med Ctr, Durham, NC USA	University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	McGee, S (corresponding author), Univ Washington, Seattle Puget Sound VA Hlth Care Syst 111, Dept Med, 1660 S Columbian Way, Seattle, WA 98108 USA.							ARONOW WS, 1988, AM J CARDIOL, V62, P336, DOI 10.1016/0002-9149(88)90243-3; BARAFF LJ, 1992, AM J EMERG MED, V10, P99, DOI 10.1016/0735-6757(92)90038-Y; Barcroft H, 1944, LANCET, V1, P489; BAYLOR PH, 1967, AM J SURG, V114, P913; Bennett TI, 1938, LANCET, V2, P651; BERGENWALD L, 1977, SCAND J CLIN LAB INV, V37, P209, DOI 10.3109/00365517709091484; Bergman G E, 1983, J Emerg Med, V1, P137, DOI 10.1016/0736-4679(83)90047-1; BORST C, 1982, AM J PHYSIOL, V243, pH676, DOI 10.1152/ajpheart.1982.243.5.H676; CAIRD FI, 1973, BRIT HEART J, V35, P527; Castro W, 1985, Pediatr Emerg Care, V1, P123, DOI 10.1097/00006565-198509000-00004; CURRENS JH, 1948, AM HEART J, V35, P646, DOI 10.1016/0002-8703(48)90650-4; CUTLER JA, 1981, DIG DIS SCI S, V26, P905; DAMBRINK JHA, 1987, CLIN SCI, V72, P335, DOI 10.1042/cs0720335; DORRINGTON KL, 1981, LANCET, V1, P264; Duggan C, 1996, J PEDIATR GASTR NUTR, V22, P56, DOI 10.1097/00005176-199601000-00009; EATEN D, 1994, BRIT MED J, V308, P1271, DOI 10.1136/bmj.308.6939.1271; Ebert RV, 1941, ARCH INTERN MED, V68, P578, DOI 10.1001/archinte.1941.00200090205009; EDDY DM, 1992, FAST PRO V 1 8 SOFTW, P176; EDDY DM, 1992, METAANALYSIS CONFIDE, P93; FUCHS SM, 1987, ANN EMERG MED, V16, P386, DOI 10.1016/S0196-0644(87)80356-6; GREEN DM, 1947, SURG GYNECOL OBSTET, V84, P1045; GROSS C R, 1992, Journal of Emergency Medicine, V10, P267, DOI 10.1016/0736-4679(92)90331-M; HOLLERBACH AD, 1990, HEART LUNG, V19, P258; HONDA H, 1977, JPN CIRC J, V41, P629; HORAM WJ, 1992, AM J DIS CHILD, V146, P848, DOI 10.1001/archpedi.1992.02160190080026; Jansen RWMM, 1996, J AM GERIATR SOC, V44, P383, DOI 10.1111/j.1532-5415.1996.tb06406.x; JANSEN RWMM, 1989, J AM GERIATR SOC, V37, P528, DOI 10.1111/j.1532-5415.1989.tb05684.x; JOHNSON DR, 1995, ACAD EMERG MED, V2, P692, DOI 10.1111/j.1553-2712.1995.tb03620.x; JOHNSON RH, 1965, LANCET, V1, P731; KAIJSER L, 1985, CLIN PHYSIOL, V5, P347, DOI 10.1111/j.1475-097X.1985.tb00755.x; Klockhoff I, 1967, Acta Otolaryngol, V63, P347, DOI 10.3109/00016486709128769; KNOPP R, 1980, ANN EMERG MED, V9, P72, DOI 10.1016/S0196-0644(80)80333-7; KOZIOLMCLAIN J, 1991, ANN EMERG MED, V20, P606, DOI 10.1016/S0196-0644(05)82376-5; LARON Z, 1957, PEDIATRICS, V19, P816; LAVIZZOMOUREY R, 1988, J AM GERIATR SOC, V36, P213, DOI 10.1111/j.1532-5415.1988.tb01803.x; LEVITT MA, 1992, ANN EMERG MED, V21, P713; LIPSITZ LA, 1985, CLIN SCI, V69, P337, DOI 10.1042/cs0690337; MACKENZIE A, 1989, LANCET, V2, P605; MACLENNAN WJ, 1980, AGE AGEING, V9, P25, DOI 10.1093/ageing/9.1.25; MADER SL, 1987, JAMA-J AM MED ASSOC, V258, P1511, DOI 10.1001/jama.258.11.1511; Mange K, 1997, ANN INTERN MED, V127, P848, DOI 10.7326/0003-4819-127-9-199711010-00020; MOORE KI, 1986, HEART LUNG, V15, P611; MYERS MG, 1978, CAN MED ASSOC J, V119, P581; Ooi WL, 1997, JAMA-J AM MED ASSOC, V277, P1299, DOI 10.1001/jama.277.16.1299; Palevsky PM, 1996, ANN INTERN MED, V124, P197, DOI 10.7326/0003-4819-124-2-199601150-00002; PALMER KT, 1983, NEW ZEAL MED J, V96, P43; PATEL A, 1993, AM HEART J, V126, P184, DOI 10.1016/S0002-8703(07)80027-5; Paxton LA, 1996, B WORLD HEALTH ORGAN, V74, P613; RAIHA I, 1995, ARCH INTERN MED, V155, P930, DOI 10.1001/archinte.155.9.930; RALSTON LA, 1961, AM HEART J, V61, P770, DOI 10.1016/0002-8703(61)90461-6; REEVES RA, 1995, JAMA-J AM MED ASSOC, V273, P1211, DOI 10.1001/jama.1995.03520390071036; RODSTEIN M, 1957, J Chronic Dis, V6, P581, DOI 10.1016/0021-9681(57)90012-7; RUETZ PP, 1967, MEDICINE, V46, P363, DOI 10.1097/00005792-196709000-00001; SAAVEDRA JM, 1991, AM J DIS CHILD, V145, P296, DOI 10.1001/archpedi.1991.02160030064022; SANDERJENSEN K, 1986, BMJ-BRIT MED J, V292, P364, DOI 10.1136/bmj.292.6517.364; Schiff L, 1942, AM J MED SCI, V203, P409, DOI 10.1097/00000441-194203000-00016; SCHILLER KF, 1970, BRIT MED J, V2, P7, DOI 10.1136/bmj.2.5700.7; Schneider EC, 1922, AM J PHYSIOL, V61, P429, DOI 10.1152/ajplegacy.1922.61.3.429; SCHRIGER DL, 1988, ANN EMERG MED, V17, P932, DOI 10.1016/S0196-0644(88)80675-9; SCHRIGER DL, 1991, ANN EMERG MED, V20, P601, DOI 10.1016/S0196-0644(05)82375-3; Shenkin HA, 1944, AM J MED SCI, V208, P421, DOI 10.1097/00000441-194410000-00001; SILVERSTEIN FE, 1981, GASTROINTEST ENDOSC, V27, P80, DOI 10.1016/S0016-5107(81)73156-0; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; SKILLMAN JJ, 1967, ANN SURG, V166, P713, DOI 10.1097/00000658-196711000-00001; SMITH JJ, 1994, J CLIN PHARMACOL, V34, P375, DOI 10.1002/j.1552-4604.1994.tb04977.x; SMITH JJ, 1987, J GERONTOL, V42, P406, DOI 10.1093/geronj/42.4.406; SNYDER NA, 1987, ANN INTERN MED, V107, P309, DOI 10.7326/0003-4819-107-2-309; STREETEN DHP, 1988, J LAB CLIN MED, V111, P326; TELL GS, 1988, AM J EPIDEMIOL, V128, P360, DOI 10.1093/oxfordjournals.aje.a114976; TENHARKEL ADJ, 1990, J APPL PHYSIOL, V68, P147, DOI 10.1152/jappl.1990.68.1.147; TIBBS DJ, 1956, LANCET, V2, P266; TRIEDMAN JK, 1993, HYPERTENSION, V21, P236, DOI 10.1161/01.HYP.21.2.236; TUCKMAN J, 1966, BRIT HEART J, V28, P32; VELASQUEZ MT, 1987, HYPERTENSION, V9, P423, DOI 10.1161/01.HYP.9.5.423; Wallace J, 1941, LANCET, V2, P393; WARA P, 1985, SCAND J GASTROENTERO, V20, P72, DOI 10.3109/00365528509089635; Ward C, 1996, AM J MED, V100, P418, DOI 10.1016/S0002-9343(97)89517-4; WARREN JV, 1945, J CLIN INVEST, V24, P337, DOI 10.1172/JCI101611; WITTING MD, 1994, ANN EMERG MED, V23, P1320, DOI 10.1016/S0196-0644(94)70358-2; WONG DH, 1989, CRIT CARE MED, V17, P979, DOI 10.1097/00003246-198910000-00002; Yurdakok K, 1997, ARCH PEDIAT ADOL MED, V151, P208, DOI 10.1001/archpedi.1997.02170390098021	81	345	349	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	1999	281	11					1022	1029		10.1001/jama.281.11.1022	http://dx.doi.org/10.1001/jama.281.11.1022			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175EE	10086438				2022-12-28	WOS:000079079400030
J	Boezen, HM; van der Zee, SC; Postma, DS; Vonk, JM; Gerritsen, J; Hoek, G; Brunekreef, B; Rijcken, B; Schouten, JP				Boezen, HM; van der Zee, SC; Postma, DS; Vonk, JM; Gerritsen, J; Hoek, G; Brunekreef, B; Rijcken, B; Schouten, JP			Effects of ambient air pollution on upper and lower respiratory symptoms and peak expiratory flow in children	LANCET			English	Article							ASTHMATIC-CHILDREN; SERUM IGE; HEALTH; RESPONSIVENESS; ASSOCIATION	Background Previous epidemiological studies have shown acute effects of increased amounts of ambient air pollution on the prevalence of respiratory symptoms in children with respiratory disorders. We investigated whether children with bronchial hyperresponsiveness (BHR) and relatively high serum concentrations of total IgE (>60 kU/L, the median value) are susceptible to air pollution. Methods We collected data from children during three winters (1992-95) in rural and urban areas of the Netherlands. Lower respiratory symptoms (wheeze, attacks of wheezing, shortness of breath), upper respiratory symptoms (sore throat, runny or blocked nose), and peak expiratory flow were recorded daily for 3 months. The acute effects of airborne particulate matter with a diameter of less than 10 mu m, black smoke, sulphur dioxide, and nitrogen dioxide were estimated by logistic regression. Findings 459 (73%) of 632 children had complete data. Of these, 26% had BHR and relatively high (above median) serum total IgE, 36% had no BHR and total IgE of 60 kU/L or less, 15% had BHR and total IgE of 60 kU/L or less, and 23% had a total IgE of more than 60 kU/L but no BHR. In children with BHR and relatively high serum total IgE the prevalence of lower respiratory symptoms increased significantly by between 32% and 139% for each 100 mu m/m(3) increase in particulate matter, and between 16% acid 131% for each 40 mu m/m(3) increase in black smoke, SO2, or NO2. Decrease in peak expiratory flow of more than 10% in that group was more common with increased airborne particulate matter and black smoke. There were no consistent positive or negative associations between increased air pollution and prevalence of respiratory symptoms or decrease in peak expiratory flow in the other three groups of children. Interpretation Children with BHR and relatively high concentrations of serum total IgE are susceptible to air pollution. Although our odds ratios were rather low (range 1.16-2.39) the overall effect of air pollution on public health is likely to be substantial since these odds ratios refer to large numbers of people.	Univ Groningen, Dept Epidemiol & Biostat, NL-9713 AV Groningen, Netherlands; Wageningen Univ Agr, Dept Environm Sci, Environm Hlth Unit, Wageningen, Netherlands; Wageningen Univ Agr, Dept Environm Sci, Occupat Hlth Unit, Wageningen, Netherlands; Univ Groningen Hosp, Dept Pulm, Groningen, Netherlands; Univ Groningen Hosp, Dept Pediat Pulm, Groningen, Netherlands	University of Groningen; Wageningen University & Research; Wageningen University & Research; University of Groningen; University of Groningen	Boezen, HM (corresponding author), Univ Groningen, Dept Epidemiol & Biostat, Ant Deusinglaan 1, NL-9713 AV Groningen, Netherlands.	h.m.boezen@med.rug.nl	Vonk, Judith M/ABA-3009-2020; Vonk, Judith/K-8477-2019	Vonk, Judith M/0000-0001-7531-4547; Vonk, Judith/0000-0001-7531-4547; brunekreef, bert/0000-0001-9908-0060				Boezen HM, 1996, AM J RESP CRIT CARE, V154, P30, DOI 10.1164/ajrccm.154.1.8680695; Brand PLP, 1997, EUR RESPIR J, V10, P1242, DOI 10.1183/09031936.97.10061242; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; DOCKERY DW, 1994, ANNU REV PUBL HEALTH, V15, P107, DOI 10.1146/annurev.pu.15.050194.000543; Doekes G, 1996, OCCUP ENVIRON MED, V53, P63, DOI 10.1136/oem.53.1.63; Gielen MH, 1997, AM J RESP CRIT CARE, V155, P2105, DOI 10.1164/ajrccm.155.6.9196122; Hoek G, 1998, EUR RESPIR J, V11, P1307, DOI 10.1183/09031936.98.11061307; Lebowitz MD, 1996, EUR RESPIR J, V9, P1029, DOI 10.1183/09031936.96.09051029; ROEMER W, 1998, EUR RESPIR REV, V52, P4; Romieu I, 1996, AM J RESP CRIT CARE, V154, P300, DOI 10.1164/ajrccm.154.2.8756798; ROSSI OVJ, 1993, THORAX, V48, P244, DOI 10.1136/thx.48.3.244; Samet JM, 1995, TOXICOLOGY, V105, P307, DOI 10.1016/0300-483X(95)03227-7; Schwartz J B, 1996, PDA J Pharm Sci Technol, V50, P197; SEARS MR, 1991, NEW ENGL J MED, V325, P1067, DOI 10.1056/NEJM199110103251504; SPORIK R, 1995, AM J RESP CRIT CARE, V151, P1388, DOI 10.1164/ajrccm.151.5.7735590	15	131	136	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 13	1999	353	9156					874	878		10.1016/S0140-6736(98)06311-9	http://dx.doi.org/10.1016/S0140-6736(98)06311-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BU	10093979				2022-12-28	WOS:000079421400009
J	Center, JR; Nguyen, TV; Schneider, D; Sambrook, PN; Eisman, JA				Center, JR; Nguyen, TV; Schneider, D; Sambrook, PN; Eisman, JA			Mortality after all major types of osteoporotic fracture in men and women: an observational study	LANCET			English	Article							HIP FRACTURE; SURVIVAL; MORBIDITY; HEALTH; COHORT; SEX; AGE	Background Mortality increases after hip fractures in women and more so in men. Little is known, however, about mortality after other fractures. We investigated the mortality associated with all fracture types in elderly women and men. Methods We did a 5-year prospective cohort study in the semi-urban city of Dubbo, Australia, of all residents aged 60 years and older (2413 women and 1898 men). Low-trauma osteoporotic fractures that occurred between 1989 and 1994, confirmed by radiography and personal interview, were classified as proximal femur, vertebral, and groupings of other major and minor fractures. We calculated standardised mortality rates from death certificates for people with fractures compared with the Dubbo population. Findings 356 women and 137 men had low-trauma fractures. In women and men, mortality was increased in the first year after all major fractures. In women, age-standardised mortality ratios were 2.18(95% CI 2.03-2.32) for proximal femur, 1.66 (1.51-1.80) for vertebral, 1.92 (1.70-2.14) for other major, and 0.75 (0.66-0.84) for minor fractures. In men, these ratios were 3.17 (2.90-3.44) for proximal femur, 2.38 (2.17-2.59) for vertebral, 2.22 (1.91-2.52) for other major, and 1.45 (1.25-1.65) for minor fractures. There were excess deaths (excluding minor fractures in women) in all age-groups. Interpretation All major fractures were associated with increased mortality, especially in men. The loss of potential years of life in the younger age-group shows that preventative strategies for fracture should not focus on older patients at the expense of younger women and of men.	St Vincents Hosp, Garvan Inst Med Res, Bone & Mineral Res Div, Sydney, NSW 2010, Australia; Univ Sydney, Royal N Shore Hosp, Sydney, NSW, Australia; Univ Calif San Diego, La Jolla, CA 92093 USA	Garvan Institute of Medical Research; St Vincents Hospital Sydney; Royal North Shore Hospital; University of Sydney; University of California System; University of California San Diego	Center, JR (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Bone & Mineral Res Div, Sydney, NSW 2010, Australia.	j.center@garvan.unsw.edu.au	Nguyen, Tuan V/B-6147-2008; Nguyen, Tuan V./AAD-9503-2020; Eisman, John A/C-2886-2014; Center, Jacqueline/AAY-8712-2021	Nguyen, Tuan V/0000-0002-3246-6281; Nguyen, Tuan V./0000-0002-3246-6281; Center, Jacqueline/0000-0002-5278-4527				AITKEN JM, 1987, INT S OST DENM OST, P45; *AUSTR BUR STAT, 1994, 33020 AUSTR BUR STAT; BOEREBOOM FTJ, 1992, NETH J MED, V41, P4; Breslow NE, 1980, ANAL CASE CONTROL ST; Browner WS, 1996, ARCH INTERN MED, V156, P1521, DOI 10.1001/archinte.156.14.1521; BROWNER WS, 1991, LANCET, V338, P355, DOI 10.1016/0140-6736(91)90489-C; COLLETT D, 1995, TESTS STAT SCI, P40; COOPER C, 1993, AM J EPIDEMIOL, V137, P1001, DOI 10.1093/oxfordjournals.aje.a116756; DAHL E, 1980, ACTA ORTHOP SCAND, V51, P163, DOI 10.3109/17453678008990781; Fisher E S, 1991, Epidemiology, V2, P116, DOI 10.1097/00001648-199103000-00005; Hennekens CH., 1987, EPIDEMIOLOGY MED, P87; HOLMBERG S, 1986, ACTA ORTHOP SCAND, V57, P8, DOI 10.3109/17453678608993205; JACOBSEN SJ, 1992, AM J PUBLIC HEALTH, V82, P1147, DOI 10.2105/AJPH.82.8.1147; JALOVAARA P, 1991, ACTA ORTHOP SCAND, V62, P208, DOI 10.3109/17453679108993594; Katelaris AG, 1996, AM J PUBLIC HEALTH, V86, P557, DOI 10.2105/AJPH.86.4.557; KEENE GS, 1993, BRIT MED J, V307, P1248, DOI 10.1136/bmj.307.6914.1248; KELSEY JL, 1992, AM J EPIDEMIOL, V135, P477, DOI 10.1093/oxfordjournals.aje.a116314; KENZORA JE, 1984, CLIN ORTHOP RELAT R, P45; LUYAO GL, 1994, AM J PUBLIC HEALTH, V84, P1287, DOI 10.2105/AJPH.84.8.1287; MAGAZINER J, 1989, AM J PUBLIC HEALTH, V79, P274, DOI 10.2105/AJPH.79.3.274; MAROTTOLI RA, 1994, AM J PUBLIC HEALTH, V84, P1807, DOI 10.2105/AJPH.84.11.1807; MULLEN JO, 1992, CLIN ORTHOP RELAT R, V20, P214; OLSSON H, 1992, AM J EPIDEMIOL, V136, P422, DOI 10.1093/oxfordjournals.aje.a116515; PARKER MJ, 1991, PUBLIC HEALTH, V105, P443, DOI 10.1016/S0033-3506(05)80614-6; PETITTI DB, 1989, CLIN ORTHOP RELAT R, P150; Poor G, 1995, OSTEOPOROSIS INT, V5, P419, DOI 10.1007/BF01626602; POOR G, 1995, CLIN ORTHOP RELAT R, P260; SCHRODER HM, 1993, J ORTHOP TRAUMA, V7, P525, DOI 10.1097/00005131-199312000-00007; SIMONS LA, 1990, AUST NZ J MED, V20, P783, DOI 10.1111/j.1445-5994.1990.tb00423.x; WEISS NS, 1983, J CHRON DIS, V36, P879, DOI 10.1016/0021-9681(83)90009-7; WHITE BL, 1987, J BONE JOINT SURG AM, V69A, P1335	31	1369	1419	3	52	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 13	1999	353	9156					878	882		10.1016/S0140-6736(98)09075-8	http://dx.doi.org/10.1016/S0140-6736(98)09075-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	181BU	10093980				2022-12-28	WOS:000079421400010
J	Nilsson, L; Farahmand, BY; Persson, PG; Thiblin, I; Tomson, T				Nilsson, L; Farahmand, BY; Persson, PG; Thiblin, I; Tomson, T			Risk factors for sudden unexpected death in epilepsy: a case-control study	LANCET			English	Article							UNEXPLAINED DEATH; MORTALITY; COHORT; SEIZURES; PROGRAM	Background Sudden unexpected death is substantially more common in people with epilepsy than in the general population. Our objective was to investigate the association between some clinical variables and sudden unexpected death in epilepsy (SUDEP) to identify risk factors. Methods This nested case-control study was based on a Cohort of people aged between 15 and 70 years, who, during 1980-89, had been admitted to and discharged with a diagnosis of epilepsy from any hospital in the county of Stockholm. The study population was followed up through the National Cause of Death Register until Dec 31, 1991. Cases were individuals who had died, with a diagnosis of epilepsy registered on the death certificate, and who after review of medical and necropsy records were found to meet our SUDEP criteria. Three control participants, who were living epilepsy patients matched for age and sex, were selected from the same cohort for each case. All medical records were examined. Clinical data were collected and analysed on a predesigned protocol. Findings 57 SUDEP cases were included, of whom 91% had undergone necropsy. The relative risk of SUDEP increased with number of seizures per year. The estimated relative risk was 10.16 (95% CI 2.94-35.18) in patients with more than 50 seizures per year, compared with those with up to two seizures per year, The risk of SUDEP increased with increasing number of antiepileptic drugs takenconcomitantly-9.89 (3.20-30.60) for three antiepileptic drugs compared with monotherapy. Other major risk factors were early-onset versus late-onset epilepsy (7.72 [2.13-27.96]), and frequent changes of antiepileptic drug dosage compared with unchanged dosage (6.08 [1.99-18.56]). The association between SUDEP risk and early onset, and SUDEP risk and seizure frequency, was weaker for female than for male patients, whereas frequent dose changes showed a stronger association in female patients. Interpretation Our data suggest that SUDEP is a seizure-related event, although the pathophysiological substrate that predisposes individuals to SUDEP may be established at an early age, and there may be some sex differences. Improvement of seizure control and possibly the avoidance of polytherapy may be ways to reduce the risk of SUDEP.	Stora Skondal Hosp, Dept Neurol Rehabil, S-12885 Skondal, Sweden; Karolinska Hosp, Div Neurol, Dept Clin Neurosci, Stockholm, Sweden; Karolinska Inst, Inst Environm Med, Div Epidemiol, Stockholm, Sweden; Karolinska Hosp, Stockholm Cty Council, Div Epidemiol, Stockholm, Sweden; Dept Forens Med, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Stockholm County Council	Nilsson, L (corresponding author), Stora Skondal Hosp, Dept Neurol Rehabil, S-12885 Skondal, Sweden.	lena.weine@swipnet.se						ANNEGERS JF, 1984, EPILEPSIA, V25, P699, DOI 10.1111/j.1528-1157.1984.tb03480.x; [Anonymous], 1993, EPILEPSIA, V34, P592; [Anonymous], 1991, Lancet, V337, P1175; BIRNBACH CD, 1991, J EPILEPSY, V4, P11, DOI 10.1016/0896-6974(91)90116-Z; DASHEIFF RM, 1991, J CLIN NEUROPHYSIOL, V8, P216, DOI 10.1097/00004691-199104000-00010; Derby LE, 1996, EPILEPSIA, V37, P931, DOI 10.1111/j.1528-1157.1996.tb00529.x; EARNEST MP, 1992, EPILEPSIA, V33, P310, DOI 10.1111/j.1528-1157.1992.tb02321.x; Hauser WA, 1997, EPILEPSIA, V38, pS26, DOI 10.1111/j.1528-1157.1997.tb06120.x; JICK SS, 1992, PHARMACOEPIDEM DR S, V1, P59, DOI DOI 10.1002/PDS.2630010203; JOHNSTON SC, 1995, ANN NEUROL, V37, P531, DOI 10.1002/ana.410370416; KLENERMAN P, 1993, J NEUROL NEUROSUR PS, V56, P149, DOI 10.1136/jnnp.56.2.149; LATHERS CM, 1990, EPILEPSY SUDDEN DEAT; Leestma JE, 1997, EPILEPSIA, V38, P47, DOI 10.1111/j.1528-1157.1997.tb01076.x; LEESTMA JE, 1984, EPILEPSIA, V25, P84, DOI 10.1111/j.1528-1157.1984.tb04159.x; LEESTMA JE, 1989, ANN NEUROL, V26, P195, DOI 10.1002/ana.410260203; Leppik Ilo E., 1997, Epilepsia, V38, P49; LIP GYH, 1992, J ROY SOC MED, V85, P609; Nashef L, 1996, J NEUROL NEUROSUR PS, V60, P297, DOI 10.1136/jnnp.60.3.297; Nashef L, 1998, J NEUROL NEUROSUR PS, V64, P349, DOI 10.1136/jnnp.64.3.349; NASHEF L, 1995, J NEUROL NEUROSUR PS, V58, P462, DOI 10.1136/jnnp.58.4.462; NASHEF L, 1995, EPILEPSIA, V36, P1187, DOI 10.1111/j.1528-1157.1995.tb01061.x; Nashef L, 1996, LANCET, V348, P1324, DOI 10.1016/S0140-6736(05)65402-5; Nashef L, 1997, EPILEPSIA, V38, pS6, DOI 10.1111/j.1528-1157.1997.tb06130.x; Nilsson L, 1997, EPILEPSIA, V38, P1062, DOI 10.1111/j.1528-1157.1997.tb01194.x; O'Donoghue MF, 1997, EPILEPSIA, V38, pS15, DOI 10.1111/j.1528-1157.1997.tb06117.x; SCHRAEDER PL, 1989, EPILEPSY RES, V3, P55, DOI 10.1016/0920-1211(89)90068-5; TENNIS P, 1995, EPILEPSIA, V36, P29, DOI 10.1111/j.1528-1157.1995.tb01661.x; TERRENCE CF, 1975, NEUROLOGY, V25, P594, DOI 10.1212/WNL.25.6.594; Timmings PL, 1998, SEIZURE-EUR J EPILEP, V7, P289, DOI 10.1016/S1059-1311(98)80020-4; Tomson T, 1997, EPILEPSIA, V38, pS48, DOI 10.1111/j.1528-1157.1997.tb06128.x	30	349	351	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 13	1999	353	9156					888	893		10.1016/S0140-6736(98)05114-9	http://dx.doi.org/10.1016/S0140-6736(98)05114-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BU	10093982				2022-12-28	WOS:000079421400012
J	Sutcliffe, AG; Taylor, B; Li, J; Thornton, S; Grudzinskas, JG; Lieberman, BA				Sutcliffe, AG; Taylor, B; Li, J; Thornton, S; Grudzinskas, JG; Lieberman, BA			Children born after intracytoplasmic sperm injection: population control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article									UCL Royal Free & Univ Coll Med Sch, Dept Child Hlth, London NW3 2PF, England; Pk Hosp, Ctr Assisted Reprod CARE, Nottingham NG5 8RX, England; Royal London Hosp, St Bartholomews & Royal London Sch Med & Dent, Dept Obstet & Gynaecol, London E1 1BB, England; St Marys Hosp, Dept Reprod Med, Manchester M13 0JH, Lancs, England	University of London; University College London; UCL Medical School; Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London; University of Manchester	Sutcliffe, AG (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Child Hlth, Royal Free Campus, London NW3 2PF, England.	icsi@rthsm.ac.uk		Sutcliffe, Alastair/0000-0001-8542-6155				Bonduelle M, 1998, LANCET, V351, P1553, DOI 10.1016/S0140-6736(98)24021-9; BOTTING B, 1997, HLTH OUR CHILDREN, P148; Bowen JR, 1998, LANCET, V351, P1529, DOI 10.1016/S0140-6736(98)10168-X; DEMOUZON J, 1997, J ASSIST REPROD GE S, V14, P251; Griffiths R., 1996, GRIFFITHS MENTAL DEV	5	65	67	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	1999	318	7185					704	705						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182JK	10074014				2022-12-28	WOS:000079495700024
J	Koegl, M; Hoppe, T; Schlenker, S; Ulrich, HD; Mayer, TU; Jentsch, S				Koegl, M; Hoppe, T; Schlenker, S; Ulrich, HD; Mayer, TU; Jentsch, S			A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN-DEGRADATION; ENZYME; PROTEOLYSIS; PROTEASOME; ENCODES; PATHWAY; SIGNAL; SHOWS; RAD23	Proteins modified by multiubiquitin chains are the preferred substrates of the proteasome. Ubiquitination involves a ubiquitin-activating enzyme, E1, a ubiquitin-conjugating enzyme, E2, and often a substrate-specific ubiquitin-protein ligase, E3. Here we show that efficient multiubiquitination needed for proteasomal targeting of a model substrate requires an additional conjugation factor, named E4. This protein, previously known as UFD2 in yeast, binds to the ubiquitin moieties of preformed conjugates and catalyzes ubiquitin chain assembly in conjunction with E1, E2, and E3. Intriguingly, E4 defines a novel protein family that includes two human members and the regulatory protein NOSA from Dictyostelium required for fruiting body development. In yeast, E4 activity is linked to cell survival under stress conditions, indicating that eukaryotes utilize E4-dependent proteolysis pathways for multiple cellular functions.	Univ Heidelberg, Zentrum Mol Biol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Am Klopferspitz 18A, D-82152 Martinsried, Germany.	jentsch@biochem.mpg.de	Hoppe, Thorsten/AAC-7880-2020	Hoppe, Thorsten/0000-0002-4734-9352; Ulrich, Helle D./0000-0003-0431-2223; Mayer, Thomas/0000-0001-6954-2287				Ausubel FM, 1994, CURRENT PROTOCOLS MO; Biggins S, 1996, J CELL BIOL, V133, P1331, DOI 10.1083/jcb.133.6.1331; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; COOK WJ, 1994, J MOL BIOL, V236, P601, DOI 10.1006/jmbi.1994.1169; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; FROHLICH KU, 1991, J CELL BIOL, V114, P443, DOI 10.1083/jcb.114.3.443; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; JENTSCH S, 1995, CELL, V82, P881, DOI 10.1016/0092-8674(95)90021-7; JOHNSON ES, 1992, EMBO J, V11, P497, DOI 10.1002/j.1460-2075.1992.tb05080.x; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; JUNGMANN J, 1993, NATURE, V361, P369, DOI 10.1038/361369a0; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; MASUTANI C, 1994, EMBO J, V13, P1831, DOI 10.1002/j.1460-2075.1994.tb06452.x; MCGRATH JP, 1991, EMBO J, V10, P227, DOI 10.1002/j.1460-2075.1991.tb07940.x; MORTZ E, 1994, BIOL MASS SPECTROM, V23, P249, DOI 10.1002/bms.1200230503; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Pukatzki S, 1998, J BIOL CHEM, V273, P24131, DOI 10.1074/jbc.273.37.24131; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; SEUFERT W, 1992, EMBO J, V11, P3077, DOI 10.1002/j.1460-2075.1992.tb05379.x; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; SUNG P, 1988, GENE DEV, V2, P1476, DOI 10.1101/gad.2.11.1476; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; WATKINS JF, 1993, MOL CELL BIOL, V13, P7757, DOI 10.1128/MCB.13.12.7757	27	794	830	5	41	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 5	1999	96	5					635	644		10.1016/S0092-8674(00)80574-7	http://dx.doi.org/10.1016/S0092-8674(00)80574-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	174TB	10089879	Green Submitted, hybrid			2022-12-28	WOS:000079050100007
J	Morrison, SJ; White, PM; Zock, C; Anderson, DJ				Morrison, SJ; White, PM; Zock, C; Anderson, DJ			Prospective identification, isolation by flow cytometry, and in vivo self-renewal of multipotent mammalian neural crest stem cells	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; GLIAL GROWTH-FACTOR; HEMATOPOIETIC STEM; CLONAL ANALYSIS; DEVELOPMENTAL SWITCH; EMBRYONIC NERVES; CEREBRAL-CORTEX; SCHWANN-CELLS; QUAIL EMBRYO; DORSAL-ROOT	Multipotent and self-renewing neural stem cells have been isolated in culture, but equivalent cells have not yet been prospectively identified in neural tissue. Using cell surface markers and flow cytometry, we have isolated neural crest stem cells (NCSCs) from mammalian fetal peripheral nerve. These cells are phenotypically and functionally indistinguishable from NCSCs previously isolated by culturing embryonic neural tube explants. Moreover, in vivo BrdU labeling indicates that these stem cells self-renew in vivo. NCSCs freshly isolated from nerve tissue can be directly transplanted in vivo, where they generate both neurons and glia. These data indicate that neural stem cells persist in peripheral nerve into late gestation by undergoing self-renewal. Such persistence may explain the origins of some PNS tumors in humans.	CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Anderson, DJ (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.		Morrison, Sean/ABD-5326-2021	Morrison, Sean/0000-0003-1587-8329				Anderson D J, 1993, Curr Opin Neurobiol, V3, P8, DOI 10.1016/0959-4388(93)90028-W; BARAKATWALTER I, 1994, DEV BIOL, V161, P263; BAROFFIO A, 1988, P NATL ACAD SCI USA, V85, P5325, DOI 10.1073/pnas.85.14.5325; BIRREN SJ, 1993, DEVELOPMENT, V119, P597; BRONNERFRASER M, 1988, NATURE, V335, P161, DOI 10.1038/335161a0; BRONNERFRASER M, 1980, DEV BIOL, V77, P130, DOI 10.1016/0012-1606(80)90461-3; Cai L, 1997, J NEUROSCI, V17, P2079; Cameron HA, 1998, CURR OPIN NEUROBIOL, V8, P677, DOI 10.1016/S0959-4388(98)80099-8; CAVAZZANA AO, 1987, AM J PATHOL, V127, P507; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; DARZYNKIEWICZ Z, 1997, CURRENT PROTOCOLS CY; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; DEVILLE FSSC, 1992, DEV BRAIN RES, V66, P1, DOI 10.1016/0165-3806(92)90134-I; DEVILLE FSSC, 1994, DEV BIOL, V163, P141, DOI 10.1006/dbio.1994.1130; DONG Z, 1995, NEURON, V15, P585, DOI 10.1016/0896-6273(95)90147-7; DUFF RS, 1991, DEV BIOL, V147, P451, DOI 10.1016/0012-1606(91)90303-K; FRANK E, 1991, DEVELOPMENT, V111, P895; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; Gage FH, 1998, CURR OPIN NEUROBIOL, V8, P671, DOI 10.1016/S0959-4388(98)80098-6; Geiger H, 1998, CELL, V93, P1055, DOI 10.1016/S0092-8674(00)81210-6; Gritti A, 1996, J NEUROSCI, V16, P1091; HAIMOTO H, 1987, LAB INVEST, V57, P489; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; Jessen K R, 1992, Curr Opin Neurobiol, V2, P575, DOI 10.1016/0959-4388(92)90021-C; JESSEN KR, 1994, NEURON, V12, P509, DOI 10.1016/0896-6273(94)90209-7; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kalyani A, 1997, DEV BIOL, V186, P202, DOI 10.1006/dbio.1997.8592; KILPATRICK TJ, 1993, NEURON, V10, P255, DOI 10.1016/0896-6273(93)90316-J; Le Douarin N.M., 1982, NEURAL CREST; LEBER SM, 1990, J NEUROSCI, V10, P2451; LEDOUARIN NM, 1980, NATURE, V286, P663, DOI 10.1038/286663a0; LEDOUARIN NM, 1986, SCIENCE, V231, P1515, DOI 10.1126/science.3952494; Lee MJ, 1997, MOL CELL NEUROSCI, V8, P336, DOI 10.1006/mcne.1996.0589; LEMKE GE, 1984, J NEUROSCI, V4, P75; Lo LC, 1997, CURR BIOL, V7, P440, DOI 10.1016/S0960-9822(06)00191-6; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; MATTHEWS W, 1991, CELL, V65, P1143, DOI 10.1016/0092-8674(91)90010-V; MEYER D, 1994, P NATL ACAD SCI USA, V91, P1064, DOI 10.1073/pnas.91.3.1064; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; Morrison SJ, 1996, IMMUNITY, V5, P207, DOI 10.1016/S1074-7613(00)80316-7; Morshead CM, 1998, DEVELOPMENT, V125, P2251; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; PARYSEK LM, 1988, J NEUROSCI, V8, P555; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Riccardi VM., 1993, PLASTIC RECONST SURG, V91, P561, DOI [10.1097/00006534-199303000-00029, DOI 10.1097/00006534-199303000-00029]; RICHARDSON MK, 1993, DEV BIOL, V157, P348, DOI 10.1006/dbio.1993.1140; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; SAPPINO AP, 1990, LAB INVEST, V63, P144; Shah NM, 1997, P NATL ACAD SCI USA, V94, P11369, DOI 10.1073/pnas.94.21.11369; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; SIEBERBLUM M, 1980, DEV BIOL, V80, P96, DOI 10.1016/0012-1606(80)90501-1; Sommer L, 1995, NEURON, V15, P1245, DOI 10.1016/0896-6273(95)90005-5; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Takahashi T, 1996, J NEUROSCI, V16, P6183; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; THIELE CJ, 1991, CANCER METAST REV, V10, P311, DOI 10.1007/BF00554793; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6	69	580	643	0	20	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 5	1999	96	5					737	749		10.1016/S0092-8674(00)80583-8	http://dx.doi.org/10.1016/S0092-8674(00)80583-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	174TB	10089888	Bronze			2022-12-28	WOS:000079050100016
J	Steiner, JF				Steiner, JF			Talking about treatment: The language of populations and the language of individuals	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RANDOMIZED CLINICAL-TRIALS; PHYSICIANS; RISK; PRESCRIBE; DECISIONS; DISEASE; GUIDE; CARE		Univ Colorado, Hlth Sci Ctr, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Steiner, JF (corresponding author), Univ Colorado, Hlth Sci Ctr, Box B-180,4200 E 9th Ave, Denver, CO 80262 USA.							[Anonymous], 1991, JAMA, V265, P3255; Atkins CD, 1997, J GEN INTERN MED, V12, P500, DOI 10.1046/j.1525-1497.1997.00089.x; BERWICK DM, 1981, AM J MED, V71, P991, DOI 10.1016/0002-9343(81)90325-9; BOBBIO M, 1994, LANCET, V343, P1209, DOI 10.1016/S0140-6736(94)92407-4; Braitman LE, 1996, ANN INTERN MED, V125, P406, DOI 10.7326/0003-4819-125-5-199609010-00008; BROWNER WS, 1987, JAMA-J AM MED ASSOC, V257, P2459, DOI 10.1001/jama.257.18.2459; BUCHER HC, 1994, BRIT MED J, V309, P761, DOI 10.1136/bmj.309.6957.761; CASSELL EJ, 1997, DOCTORING NATURE PRI; Curb JD, 1996, JAMA-J AM MED ASSOC, V276, P1886, DOI 10.1001/jama.276.23.1886; Detsky A S, 1995, ACP J Club, V122, pA12; ELSON RB, 1995, PRIMARY CARE, V22, P365; FEINSTEIN AR, 1992, AM J MED, V92, P117, DOI 10.1016/0002-9343(92)90099-W; FORROW L, 1992, AM J MED, V92, P121, DOI 10.1016/0002-9343(92)90100-P; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; GLOSSARY ACP, 1997, J CLUB, V126, P28; GREENLICK MR, 1992, JAMA-J AM MED ASSOC, V267, P1645, DOI 10.1001/jama.267.12.1645; GUYATT G, 1988, CAN MED ASSOC J, V139, P497; GUYATT GH, 1990, ANN INTERN MED, V112, P293, DOI 10.7326/0003-4819-112-4-293; HUX JE, 1995, MED DECIS MAKING, V15, P152, DOI 10.1177/0272989X9501500208; KALET A, 1994, J GEN INTERN MED, V9, P402, DOI 10.1007/BF02629523; Katz J., 1984, SILENT WORLD DOCTOR; LARSON EB, 1993, JAMA-J AM MED ASSOC, V270, P2708, DOI 10.1001/jama.270.22.2708; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; Logan RL, 1996, LANCET, V347, P595, DOI 10.1016/S0140-6736(96)91284-2; MALENKA DJ, 1993, J GEN INTERN MED, V8, P543, DOI 10.1007/BF02599636; McQuay HJ, 1997, ANN INTERN MED, V126, P712, DOI 10.7326/0003-4819-126-9-199705010-00007; NAYLOR CD, 1992, ANN INTERN MED, V117, P916, DOI 10.7326/0003-4819-117-11-916; NAYLOR CD, 1995, LANCET, V345, P840, DOI 10.1016/S0140-6736(95)92969-X; OXMAN AD, 1992, ANN INTERN MED, V116, P78, DOI 10.7326/0003-4819-116-1-78; REISER SJ, 1980, ANN INTERN MED, V92, P837, DOI 10.7326/0003-4819-92-6-837; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; SACKETT DL, 1991, ACP J CLUB, V114, pA12; Schwartz LM, 1997, ANN INTERN MED, V127, P966, DOI 10.7326/0003-4819-127-11-199712010-00003; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93	35	28	31	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 6	1999	130	7					618	622		10.7326/0003-4819-130-7-199904060-00029	http://dx.doi.org/10.7326/0003-4819-130-7-199904060-00029			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183BG	10189345				2022-12-28	WOS:000079533300027
J	Quinn, M; Babb, P; Jones, J; Allen, E				Quinn, M; Babb, P; Jones, J; Allen, E			Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics	BRITISH MEDICAL JOURNAL			English	Article							WALES; WOMEN	Objective To assess die impact of screening on the incidence of and mortality from cervical cancer. Design Comparison of age specific incidence and mortality before and after the introduction of the national call and recall system in 1988 Setting England. Subjects Women aged over 19 years. Results From the mid-1960s, the number of smears taken rose continuously to 4.5 million at the end of the 1980s. Between 1988 and 1994, coverage of the larger group doubled to around 85%, Registrations of in situ disease increased broadly in parallel with the numbers of smears taken. The overall incidence of invasive disease remained stable up to the end of the 1980s, although there were strong cohort effects; from 1990 incidence fell continuously and in 1995 was 35% lower than in the 1980s. The fall in overall mortality since 1950 accelerated at the end of the 1980s; there were strong cohort effects. Mortality in women under 55 was much lower in the 1990s than would have been expected. Conclusions The national call and recall system and incentive payments to general practitioners increased coverage to around 85%. This resulted in falls in incidence of in invasive disease in all regions of England and in all age groups from 30 to 74. The falls in mortality in older women were largely unrelated to screening, but without screening there might have been 800 more deaths from cervical cancer in women under 55 in 1997.	Natl Canc Registrat Bur, Off Natl Stat, Demog & Hlth Div, London SW1V 2QQ, England		Quinn, M (corresponding author), Natl Canc Registrat Bur, Off Natl Stat, Demog & Hlth Div, London SW1V 2QQ, England.		Allen, Liz/AAK-3137-2020; Allen, Liz/B-2625-2012	Allen, Liz/0000-0002-9298-3168; Allen, Liz/0000-0002-9298-3168				AUSTOKER J, 1994, BRIT MED J, V309, P241, DOI 10.1136/bmj.309.6949.241; CHAMBERLAIN J, 1988, ONCOLOGY NURSES HLTH, V1, P155; COLEMAN MP, 1993, IARC SCI PUBLICATION, V121; COOK GA, 1984, BRIT J CANCER, V50, P367, DOI 10.1038/bjc.1984.185; DAY NE, 1989, J EPIDEMIOL COMMUN H, V43, P103, DOI 10.1136/jech.43.2.103; *DEP HLTH, 1989, GEN PRACT NHS NEW CO; *DEP HLTH, 1996, STAT B, V3; *DEP HLTH, 1989, CERV CYT 1988 89 199; *DEP HLTH, 1996, STAT B, V26; *DEP HLTH, 1997, STAT B, V27; *DEP HLTH SOC SEC, 1988, HLTH SERV MAN CERV C; *DEP HLTH SOC SEC, 1981, CERV CYT 1980 1987 8; Esteve J., 1994, IARC SCI PUBLICATION, V128; FARMERY E, 1994, REPORT FIRST 5 YEARS; Herbert A, 1996, J Med Screen, V3, P23; HUGGETT C, 1995, REV QUALITY COMPARAB; JOHNSON J, 1997, BRIT MED J, V314, P1630; LANCASTER G, 1992, J PUBLIC HEALTH MED, V16, P50; MILLER AB, 1990, INT J CANCER, V46, P761, DOI 10.1002/ijc.2910460502; MOSS S, 1996, EVALUATION CNC SCREE, P15; MURPHY MFG, 1987, J EPIDEMIOL COMM HLT, V42, P49; *NAT AUD OFF, 1998, PERF NHS CERV SCREEN; *OFF POP CENS SURV, 1979, CANC STAT REG EN MB1; OSMOND C, 1982, BRIT MED J, V284, P1005, DOI 10.1136/bmj.284.6321.1005; PARKIN DM, 1985, BRIT J OBSTET GYNAEC, V92, P150, DOI 10.1111/j.1471-0528.1985.tb01067.x; QUINN M, 1995, BRIT MED J, V311, P1391, DOI 10.1136/bmj.311.7017.1391; Raffle AE, 1997, BRIT MED J, V315, P953; RAFFLE AE, 1995, LANCET, V345, P1469, DOI 10.1016/S0140-6736(95)91036-0; ROBERTS A., 1982, Health Trends, V14, P41; SASIENI P, 1995, LANCET, V346, P1566, DOI 10.1016/S0140-6736(95)92099-4; Sasieni PD, 1996, BRIT J CANCER, V73, P1001, DOI 10.1038/bjc.1996.196; VANWIJNGAARDEN WJ, 1993, BRIT MED J, V306, P967, DOI 10.1136/bmj.306.6883.967; Wilson JMB, 1968, 34 WHO	33	365	383	0	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 3	1999	318	7188					904	+		10.1136/bmj.318.7188.904	http://dx.doi.org/10.1136/bmj.318.7188.904			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185GV	10102852	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000079660500024
J	Goldenfeld, N; Kadanoff, LP				Goldenfeld, N; Kadanoff, LP			Simple lessons from complexity	SCIENCE			English	Editorial Material							SELF-ORGANIZED CRITICALITY; TIME CORRELATION-FUNCTIONS; LATTICE-GAS	The complexity of the world is contrasted with the simplicity of the basic laws of physics. In recent years, considerable study has been devoted to systems that exhibit complex outcomes. This experience has not given us any new Laws of physics, but has instead given us a set of Lessons about appropriate ways of approaching complex systems.	Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Univ Chicago, James Franck Inst, Dept Phys, Chicago, IL 60615 USA; Univ Chicago, James Franck Inst, Dept Math, Chicago, IL 60615 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Chicago; University of Chicago	Goldenfeld, N (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	nigel@uiuc.edu; leoP@uchicago.edu						ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; [Anonymous], 1995, HOME UNIVERSE SEARCH; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; CARLSON JM, 1990, PHYS REV LETT, V65, P2547, DOI 10.1103/PhysRevLett.65.2547; CASTAING B, 1989, J FLUID MECH, V204, P1, DOI 10.1017/S0022112089001643; Chapman S., 1970, MATH THEORY NONUNIFO; FRISCH U, 1986, PHYS REV LETT, V56, P1505, DOI 10.1103/PhysRevLett.56.1505; HARDY J, 1973, J MATH PHYS, V14, P1746, DOI 10.1063/1.1666248; HARDY J, 1976, PHYS REV A, V13, P1949, DOI 10.1103/PhysRevA.13.1949; KADANOFF L, 1991, RECHERCHE, V22, P629; KATCHALSKY A, 1967, NONEQUILIBRIUM PROCE; KAUFFMAN SA, 1993, ORIGIN ORDER; KERSTEIN AR, 1997, J FLUID MECH, V291, P261; Mandelbrot B, 1997, FRACTALS SCALING FIN; Nicolis G, 1977, SELF ORG NONEQUILIBR; SIGGIA E, 1994, PHYS REV E, V49, P2912; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; WUNSCH S, 1998, THESIS U CHICAGO	18	319	345	2	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	1999	284	5411					87	89		10.1126/science.284.5411.87	http://dx.doi.org/10.1126/science.284.5411.87			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182QE	10102823				2022-12-28	WOS:000079509000036
J	van Putten, MHPM				van Putten, MHPM			Superradiance in a torus magnetosphere around a black hole	SCIENCE			English	Article							GAMMA-RAY BURST; WAVE-PROPAGATION; PERTURBATIONS; EXTRACTION; RADIATION; ENERGY; FIELD	The coalescence of a neutron star and a black hole in a binary system is believed to form a torus around a,Kerr black hole. A similarly shaped magnetosphere then results from the remnant magnetic field of the neutron star. In the strong-field case, it contains a cavity for plasma waves Located between the barrier of the gravitational potential and the surrounding torus. This cavity may be unstable to superradiance of electromagnetic waves. Superradiant amplification of such waves, initially excited by turbulence in the torus, should inflate into a bubble in a time as short as similar to 0.75 (1 percent\epsilon\(2))(M/7M(.)) seconds similar to 0.15 to 1.5 seconds, assuming an efficiency \epsilon\(2) = 0.5 to 5 percent and a mass M = 7M(.). These bubbles may burst and repeat, of possible relevance to intermittency in cosmological gamma-ray bursts. The model predicts gamma-ray bursts to be anticorrelated with their gravitational wave emissions.	MIT, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	van Putten, MHPM (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		van Putten, Maurice/R-3171-2019; van Putten, Maurice H./F-5237-2011					ARONS J, 1986, ASTROPHYS J, V302, P120, DOI 10.1086/163978; ARONS J, 1985, ASTROPHYS J, V302, P138; Bailyn CD, 1998, ASTROPHYS J, V499, P367, DOI 10.1086/305614; BARDEEN JM, 1972, ASTROPHYS J, V178, P347, DOI 10.1086/151796; BARDEEN JM, 1970, NATURE, V226, P64, DOI 10.1038/226064a0; BETHE HA, ASTROPH9805355; BLANDFORD RD, 1977, MON NOT R ASTRON SOC, V179, P433, DOI 10.1093/mnras/179.3.433; CANUTO V, 1970, PHYS REV D, V1, P2219, DOI 10.1103/PhysRevD.1.2219; Costa E, 1997, NATURE, V387, P783, DOI 10.1038/42885; FISHBONE LG, 1972, ASTROPHYS J, V175, pL155, DOI 10.1086/181006; GOLDREICH P, 1969, ASTROPHYS J, V157, P869, DOI 10.1086/150119; LAI D, ASTROPH9806378; LATTIMER JM, 1976, ASTROPHYS J, V210, P549, DOI 10.1086/154860; LATTIMER JM, 1974, ASTROPHYS J, V192, pL145, DOI 10.1086/181612; Metzger MR, 1997, NATURE, V387, P878, DOI 10.1038/43132; Paczynski B., 1991, Acta Astronomica, V41, P257; PIRAN T, 1998, 18 TEX S REL ASTR CO, P434; PIRAN T, ASTROPH9810256; PRESS WH, 1972, NATURE, V238, P211, DOI 10.1038/238211a0; PRESS WH, 1971, ASTROPHYS J, V170, pL105, DOI 10.1086/180849; REES MJ, 1998, 18 TEX S REL ASTR CO, P34; Shapiro S.L., 1983, BLACK HOLES WHITE DW; TANAKA Y, 1997, BLACK HOLE BINARIES, P126; TEUKOLSKY SA, 1974, ASTROPHYS J, V193, P443, DOI 10.1086/153180; TEUKOLSKY SA, 1973, ASTROPHYS J, V185, P635, DOI 10.1086/152444; THOMPSON C, 1994, MON NOT R ASTRON SOC, V270, P480, DOI 10.1093/mnras/270.3.480; THORNE KS, 1986, MEMBRANE PRADIGM; Thorsett SE, 1999, ASTROPHYS J, V512, P288, DOI 10.1086/306742; Uchida T, 1997, MON NOT R ASTRON SOC, V291, P125, DOI 10.1093/mnras/291.1.125; WALD RM, 1974, PHYS REV D, V10, P1680, DOI 10.1103/PhysRevD.10.1680; Zel'Dovich Y. B., 1971, JETP LETT, V14, P270; ZNAJEK RL, 1977, MON NOT R ASTRON SOC, V179, P457, DOI 10.1093/mnras/179.3.457	32	86	86	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 2	1999	284	5411					115	118		10.1126/science.284.5411.115	http://dx.doi.org/10.1126/science.284.5411.115			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182QE	10102805				2022-12-28	WOS:000079509000044
J	Lede, R				Lede, R			Where there's will, there's a way	BRITISH MEDICAL JOURNAL			English	Editorial Material									Argentinian Inst Evidence Based Med, Buenos Aires, DF, Argentina		Lede, R (corresponding author), Argentinian Inst Evidence Based Med, Buenos Aires, DF, Argentina.							BELIZAN J, 1993, LANCET, V342, P1517	1	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 27	1999	318	7187					883	883		10.1136/bmj.318.7187.883	http://dx.doi.org/10.1136/bmj.318.7187.883			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185DM	10092292	Green Published			2022-12-28	WOS:000079652900076
J	Carlson, RW; Anderson, MS; Johnson, RE; Smythe, WD; Hendrix, AR; Barth, CA; Soderblom, LA; Hansen, GB; McCord, TB; Dalton, JB; Clark, RN; Shirley, JH; Ocampo, AC; Matson, DL				Carlson, RW; Anderson, MS; Johnson, RE; Smythe, WD; Hendrix, AR; Barth, CA; Soderblom, LA; Hansen, GB; McCord, TB; Dalton, JB; Clark, RN; Shirley, JH; Ocampo, AC; Matson, DL			Hydrogen peroxide on the surface of Europa	SCIENCE			English	Article							SPECTROMETER EXPERIMENT; INFRARED SPECTROSCOPY; GALILEAN SATELLITES; OPTICAL-CONSTANTS; ULTRAVIOLET; ATMOSPHERE; JUPITER; ICES	Spatially resolved infrared and ultraviolet wavelength spectra of Europa's Leading, anti-jovian quadrant observed from the Galileo spacecraft show absorption features resulting from hydrogen peroxide. Comparisons with laboratory measurements indicate surface hydrogen peroxide concentrations of about 0.13 percent, by number, relative to water ice. The inferred abundance is consistent with radiolytic production of hydrogen peroxide by intense energetic particle bombardment and demonstrates that Europa's surface chemistry is dominated by radiolysis.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Virginia, Charlottesville, VA 22903 USA; Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Univ Hawaii, Planetary Geosci Div, Honolulu, HI 96822 USA; US Geol Survey, Denver, CO 80225 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Virginia; University of Colorado System; University of Colorado Boulder; United States Department of the Interior; United States Geological Survey; University of Hawaii System; United States Department of the Interior; United States Geological Survey	Carlson, RW (corresponding author), CALTECH, Jet Prop Lab, Mail Stop 183-601,4800 Oak Grove Dr, Pasadena, CA 91109 USA.	rcarlson@lively.jpl.nasa.gov	Shirley, James/AAR-1264-2020					BAIN O, 1955, CAN J CHEM, V33, P527, DOI 10.1139/v55-063; BERTIE JE, 1969, J CHEM PHYS, V50, P4501, DOI 10.1063/1.1670922; Brown ME, 1996, NATURE, V380, P229, DOI 10.1038/380229a0; CALVIN WM, 1995, J GEOPHYS RES-PLANET, V100, P19041, DOI 10.1029/94JE03349; Carlson R, 1996, SCIENCE, V274, P385, DOI 10.1126/science.274.5286.385; CARLSON RW, 1992, SPACE SCI REV, V60, P457, DOI 10.1007/BF00216865; CARLSON RW, 1993, ANTARCT J US, V28, P256; Carr MH, 1998, NATURE, V391, P363, DOI 10.1038/34857; CLARK RN, 93592 US GEOL SURV; COOPER JF, UNPUB ICARUS; COTTIN M, 1955, J CHIM PHYS PCB, V52, P545; Domingue DL, 1998, GEOPHYS RES LETT, V25, P4421, DOI 10.1029/1998GL900209; Gerakines PA, 1996, ASTRON ASTROPHYS, V312, P289; GHORMLEY JA, 1956, J AM CHEM SOC, V78, P2934, DOI 10.1021/ja01594a004; GIGUERE PA, 1959, J MOL SPECTROSC, V3, P36, DOI 10.1016/0022-2852(59)90005-0; Greeley R, 1998, ICARUS, V135, P4, DOI 10.1006/icar.1998.5969; HALL DT, 1995, NATURE, V373, P677, DOI 10.1038/373677a0; HAPKE B, 1993, THEORY REFLECTANCE E, P197; Hendrix AR, 1998, ICARUS, V135, P79, DOI 10.1006/icar.1998.5983; HORD CW, 1992, SPACE SCI REV, V60, P503, DOI 10.1007/BF00216866; HUDGINS DM, 1993, ASTROPHYS J SUPPL S, V86, P713, DOI 10.1086/191796; HUEBNER WF, 1992, ASTROPHYS SPACE SCI, V195, P1, DOI 10.1007/BF00644558; Ip WH, 1998, GEOPHYS RES LETT, V25, P829, DOI 10.1029/98GL00472; Johnson R.E., 1990, ENERGETIC CHARGED PA, DOI [10.1007/978-3-642-48375-2, DOI 10.1007/978-3-642-48375-2]; Johnson RE, 1997, J GEOPHYS RES-PLANET, V102, P10985, DOI 10.1029/97JE00068; Johnson RE, 1998, GEOPHYS RES LETT, V25, P3257, DOI 10.1029/98GL02565; LANE AL, 1981, NATURE, V292, P38, DOI 10.1038/292038a0; LIN CL, 1978, GEOPHYS RES LETT, V5, P113, DOI 10.1029/GL005i002p00113; McCord TB, 1998, J GEOPHYS RES-PLANET, V103, P8603, DOI 10.1029/98JE00788; McCord TB, 1997, SCIENCE, V278, P271, DOI 10.1126/science.278.5336.271; McCord TB, 1998, SCIENCE, V280, P1242, DOI 10.1126/science.280.5367.1242; MCCORD TB, IN PRESS J GEOPHYS R; MILLER RL, 1961, J CHEM PHYS, V34, P265, DOI 10.1063/1.1731575; NOLL KS, 1997, J GEOPHYS RES, V102, P19057; SCHRIEVER R, 1991, J PHYS CHEM-US, V95, P6124, DOI 10.1021/j100169a016; Sieger MT, 1998, NATURE, V394, P554, DOI 10.1038/29015; SMYTHE WD, 1998, 29 LUN PLAN SCI C HO; WARREN SG, 1984, APPL OPTICS, V23, P1206, DOI 10.1364/AO.23.001206	38	220	223	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	1999	283	5410					2062	2064		10.1126/science.283.5410.2062	http://dx.doi.org/10.1126/science.283.5410.2062			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180DH	10092224				2022-12-28	WOS:000079369800039
J	Goldberg, J				Goldberg, J			Structural and functional analysis of the ARF1-ARFGAP complex reveals a role for coatomer in GTP hydrolysis	CELL			English	Article							ADP-RIBOSYLATION FACTOR-1; NUCLEOTIDE EXCHANGE FACTOR; TRANSITION-STATE ANALOG; COP-COATED VESICLES; ACTIVATING PROTEINS; GUANINE-NUCLEOTIDE; TRANSPORT VESICLES; CRYSTAL-STRUCTURE; BINDING-PROTEIN; ARF PROTEIN	The crystal structure of the complex of ARF1 GTPase bound to GDP and the catalytic domain of ARF GTPase-activating protein (ARFGAP) has been determined at 1.95 Angstrom resolution. The ARFGAP molecule binds to switch 2 and helix alpha 3 to orient ARF1 residues for catalysis, but it supplies neither arginine nor other amino acid side chains to the GTPase active site. In the complex, the effector-binding region appears to be unobstructed, suggesting that ARFGAP could stimulate GTP hydrolysis while ARF1 maintains an interaction with its effector, the coatomer complex of COPI-coated vesicles. Biochemical experiments show that coatomer directly participates in the GTPase reaction, accelerating GTP hydrolysis a further 1000-fold in an ARFGAP-dependent manner. Thus, a tripartite complex controls the GTP hydrolysis reaction triggering disassembly of COPI vesicle coats.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Goldberg, J (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave, New York, NY 10021 USA.	jonathan@ximpact4.ski.mskcc.org						Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Antonny B, 1997, J BIOL CHEM, V272, P30848, DOI 10.1074/jbc.272.49.30848; Aoe T, 1997, EMBO J, V16, P7305, DOI 10.1093/emboj/16.24.7305; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOLLAG G, 1991, NATURE, V351, P576, DOI 10.1038/351576a0; Brown MT, 1998, MOL CELL BIOL, V18, P7038, DOI 10.1128/MCB.18.12.7038; Brunger A.T., 1992, X PLOR VERSION 3 1 M; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; HANNON R, 1991, P NATL ACAD SCI USA, V88, P3004, DOI 10.1073/pnas.88.8.3004; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; Huber I, 1998, J BIOL CHEM, V273, P24786, DOI 10.1074/jbc.273.38.24786; IRELAND LS, 1994, EMBO J, V13, P3812, DOI 10.1002/j.1460-2075.1994.tb06692.x; KAHN RA, 1986, J BIOL CHEM, V261, P7906; Mittal R, 1996, SCIENCE, V273, P115, DOI 10.1126/science.273.5271.115; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; OMICHINSKI JG, 1993, SCIENCE, V261, P438, DOI 10.1126/science.8332909; ORCI L, 1993, NATURE, V364, P732, DOI 10.1038/364732a0; Otwinowski Z., 1993, DATA COLLECTION PROC, P556; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; PALMER DJ, 1993, J BIOL CHEM, V268, P12083; Paris S, 1997, J BIOL CHEM, V272, P22221, DOI 10.1074/jbc.272.35.22221; Pavel J, 1998, P NATL ACAD SCI USA, V95, P2140, DOI 10.1073/pnas.95.5.2140; Poon PP, 1996, P NATL ACAD SCI USA, V93, P10074, DOI 10.1073/pnas.93.19.10074; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; Randazzo PA, 1997, BIOCHEM J, V324, P413, DOI 10.1042/bj3240413; RANDAZZO PA, 1995, J BIOL CHEM, V270, P14809, DOI 10.1074/jbc.270.24.14809; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scheffzek K, 1998, EMBO J, V17, P4313, DOI 10.1093/emboj/17.15.4313; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Spang A, 1998, P NATL ACAD SCI USA, V95, P11199, DOI 10.1073/pnas.95.19.11199; Sydor JR, 1998, BIOCHEMISTRY-US, V37, P14292, DOI 10.1021/bi980764f; TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Vitale N, 1998, J BIOL CHEM, V273, P2553, DOI 10.1074/jbc.273.5.2553; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; ZHAO L, 1999, IN PRESS J BIOL CHEM; Zhao LY, 1997, P NATL ACAD SCI USA, V94, P4418, DOI 10.1073/pnas.94.9.4418	49	246	250	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	1999	96	6					893	902		10.1016/S0092-8674(00)80598-X	http://dx.doi.org/10.1016/S0092-8674(00)80598-X			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	178ZY	10102276	Bronze			2022-12-28	WOS:000079300100015
J	Williams, J; Wolff, A; Daly, A; MacDonald, A; Aukett, A; Booth, IW				Williams, J; Wolff, A; Daly, A; MacDonald, A; Aukett, A; Booth, IW			Iron supplemented formula milk related to reduction in psychomotor decline in infants from inner city areas: randomised study	BRITISH MEDICAL JOURNAL			English	Article							DEFICIENCY ANEMIA; PREVENTION; RISK	Objective To compare the effect of unmodified cows milk and iron supplemented formula milk on psychomotor development in infants from inner city areas when used as the main milk source. Design Double blind, randomised intervention trial. Setting Birmingham health centre. Subjects 100 infants, mean age 7.8 months (range 5.7 to 8.6 months), whose mothers had already elected to use unmodified cows' milk as their infant's milk source. Intervention Changing to an iron supplemented formula milk from enrolment to 18 months of age, or continuing with unmodified cows' milk. Main outcome measures Developmental assessments using Griffiths scales at enrolment and at 18 and 24 months. Results 85 participants completed the trial. There were no significant differences in haemoglobin concentration between the tw groups at enrolment, but by 18 months of age 33% of the unmodified cows' milk group, but only 2% of the iron supplemented group, were anaemic (P < 0.001). The experimental groups had Griffiths general quotient scores that were not significantly different at enrolment, but the scores in both groups declined during the study. By 24 months the decrease in the mean scores in the unmodified cows' milk group was 14.7 whereas the decrease in the mean scores in the iron supplemented group was 9.3 (P < 0.02, 95% confidence interval 0.4 to 10.4). Mean subquotient scores were considerably lower in the unmodified cows' milk group at 24 months; significantly so for personal and social scores (P < 0.02, - 5.4 to 17.2). Conclusion Replacing unmodified cows' milk with an iron supplemented formula milk up to 18 months of age in infants from inner city areas prevents iron deficiency anaemia and reduces the decline in psychomotor development seen in such infants from the second half of the first year.	Univ Birmingham, Inst Child Hlth, Birmingham B4 6NH, W Midlands, England; Birmingham Childrens Hosp NHS Trust, Birmingham B4 6NH, W Midlands, England; Carnegie Inst, No Birmingham Community Trust, Birmingham, W Midlands, England	University of Birmingham	Booth, IW (corresponding author), Univ Birmingham, Inst Child Hlth, Birmingham B4 6NH, W Midlands, England.		Wolff, Antonio C./T-8796-2019	Wolff, Antonio C./0000-0003-3734-1063				AUKETT MA, 1986, ARCH DIS CHILD, V61, P849, DOI 10.1136/adc.61.9.849; AYLWARD GP, 1992, J DEV BEHAV PEDIATR, V13, P222; Booth IW, 1997, ARCH DIS CHILD, V76, P549, DOI 10.1136/adc.76.6.549; DALMAN PR, 1993, TXB PAEDIAT NUTR; Daly A, 1996, ARCH DIS CHILD, V75, P9, DOI 10.1136/adc.75.1.9; Gregory JR, 1995, NATL DIET NUTR SURVE, V1; GRIFFITHS R, 1954, ABILITIES BABIES; HALL D, 1996, HLTH CHILDREN; Holland B., 1991, MCCANCE WIDDOWSONS C, V5th; IDJRADINATA P, 1993, LANCET, V341, P1, DOI 10.1016/0140-6736(93)92477-B; LANSDOWN R, 1995, IRON NUTR PHYSL SIGN; LAWSON M, 1995, IRON NUTR PHYSL SIGN; LOZOFF B, 1987, PEDIATRICS, V79, P981; MOFFATT MEK, 1994, J PEDIATR-US, V125, P527, DOI 10.1016/S0022-3476(94)70003-6; POLLITT E, 1993, ANNU REV NUTR, V13, P521, DOI 10.1146/annurev.nu.13.070193.002513; RAMSAY M, 1977, EARLY HUM DEV, V1, P151, DOI 10.1016/0378-3782(77)90016-0	16	70	76	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 13	1999	318	7185					693	697						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182JK	10074011	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000079495700020
J	Satcher, D				Satcher, D			Global health at the crossroads - Surgeon General's report on the 50th World Health Assembly	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									US Dept HHS, Off Int & Refugee Hlth, Rockville, MD 20857 USA		Satcher, D (corresponding author), US Dept HHS, Off Int & Refugee Hlth, 5600 Fishers Ln,Room 18-75, Rockville, MD 20857 USA.							Calman KC, 1997, BRIT MED J, V314, P1187, DOI 10.1136/bmj.314.7088.1187a; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P1205; *CDCP, 1998, REP TUB US 1997; *CDCP, 1998, MMWR-MORBID MORTAL W, V47, P273; Institute of Medicine, 1997, AM VIT INT GLOB HLTH; Institute of Medicine, 1992, EM INF MICR THREATS; Murray C. J. L., 1996, GLOBAL BURDEN DIS; National Science and Technology Council Committee on International Science Engineering and Technology Working Group on Emerging and Re-Emerging Infectious Diseases, 1995, INF DIS GLOB HLTH TH; PUTNAM JJ, 1997, STAT B USDA, V939; *UN POP DIV, 1998, WORLD POP PROSP REV; *WHO, 1998, PUBL A, V515; ZARRILLI S, 1998, INT TRADE HLTH SERVI; 1990, WKLY EPIDEMIOL  0508	13	10	10	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	1999	281	10					942	943		10.1001/jama.281.10.942	http://dx.doi.org/10.1001/jama.281.10.942			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172XH	10078493				2022-12-28	WOS:000078950600041
J	Brabin, B				Brabin, B			Iron pots for cooking: wishful thinking or traditional common sense?	LANCET			English	Editorial Material									Univ Liverpool, Liverpool Sch Trop Med, Trop Child Hlth Grp, Liverpool L3 5QA, Merseyside, England; Univ Amsterdam, Acad Med Ctr, Dept Paediat, NL-1012 WX Amsterdam, Netherlands	Liverpool School of Tropical Medicine; University of Liverpool; University of Amsterdam; Academic Medical Center Amsterdam	Brabin, B (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Trop Child Hlth Grp, Liverpool L3 5QA, Merseyside, England.		Brabin, Bernard/AAJ-7389-2020	Brabin, Bernard/0000-0001-6860-2508				GILLESPIE S, 1997, P C SEPT 16 17 1997; GORDEUK V, 1992, NEW ENGL J MED, V326, P95, DOI 10.1056/NEJM199201093260204; HALLBERG L, 1996, ASP N G IRON NUTR HL; IDJRADINATA P, 1994, LANCET, V343, P1252, DOI 10.1016/S0140-6736(94)92151-2; NESTEL P, 1995, P OMNI M LOND MAY 17; NOKES C, 1998, EFFECTS IRON DEFICIE; SAYERS MH, 1973, BRIT J HAEMATOL, V24, P209, DOI 10.1111/j.1365-2141.1973.tb05741.x; STALTZFUS RJ, 1998, GUIDELINES USE IRON	8	2	2	1	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 27	1999	353	9154					690	691		10.1016/S0140-6736(98)00370-5	http://dx.doi.org/10.1016/S0140-6736(98)00370-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173DR	10073508				2022-12-28	WOS:000078966400006
J	Stapleton, J				Stapleton, J			Progress on nicotine replacement therapy for smokers - Commentary	BRITISH MEDICAL JOURNAL			English	Editorial Material							SMOKING CESSATION; PATCH		Inst Psychiat, Dept Psychiat, Tobacco Res Stn, London SE5 8AF, England; Inst Psychiat, Natl Addict Ctr, London SE5 8AF, England	University of London; King's College London; University of London; King's College London	Stapleton, J (corresponding author), Inst Psychiat, Dept Psychiat, Tobacco Res Stn, London SE5 8AF, England.		Stapleton, John A/I-6550-2012					JORENBY DE, 1995, JAMA-J AM MED ASSOC, V274, P1347, DOI 10.1001/jama.274.17.1347; KORNITZER M, 1995, PREV MED, V24, P41, DOI 10.1006/pmed.1995.1006; Puska P., 1995, TOB CONTROL, V4, P231, DOI [DOI 10.1136/TC.4.3.231, 10.1136/tc.4.3.231]; SILAGY C, 1998, COCHRANE LIB; Stapleton JA, 1998, BRIT MED J, V316, P830, DOI 10.1136/bmj.316.7134.830; TANG JL, 1994, BRIT MED J, V308, P21, DOI 10.1136/bmj.308.6920.21	6	12	12	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 30	1999	318	7179					289	289						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	163ZH	10075460				2022-12-28	WOS:000078436700019
J	Amlani, I; Orlov, AO; Toth, G; Bernstein, GH; Lent, CS; Snider, GL				Amlani, I; Orlov, AO; Toth, G; Bernstein, GH; Lent, CS; Snider, GL			Digital logic gate using quantum-dot cellular automata	SCIENCE			English	Article							BISTABLE SATURATION; FUNCTIONAL CELL; SYSTEM	A functioning logic gate based on quantum-dot cellular automata is presented, where digital data are encoded in the positions of only two electrons. The logic gate consists of a cell, composed of four dots connected in a ring by tunnel junctions, and two single-dot electrometers. The device is operated by applying inputs to the gates of the cell. The Logic AND and OR operations are verified using the electrometer outputs. Theoretical simulations of the Logic gate output characteristics are in excellent agreement with experiment.	Univ Notre Dame, Dept Elect Engn, Notre Dame, IN 46556 USA; Neuromorph Informat Technol Grad Ctr, H-1111 Budapest, Hungary	University of Notre Dame	Amlani, I (corresponding author), Univ Notre Dame, Dept Elect Engn, Notre Dame, IN 46556 USA.	islamshah.amlani.1@nd.edu	Toth, Geza/A-6693-2008	Toth, Geza/0000-0002-9602-751X; Lent, Craig/0000-0002-0026-516X				Amlani I, 1997, APPL PHYS LETT, V71, P1730, DOI 10.1063/1.120018; Amlani I, 1998, APPL PHYS LETT, V72, P2179, DOI 10.1063/1.121314; FULTON TA, 1987, PHYS REV LETT, V59, P109, DOI 10.1103/PhysRevLett.59.109; GRABERT H, 1992, SINGLE ELECT TUNNELI, P181; LAFARGE P, 1991, Z PHYS B CON MAT, V85, P327, DOI 10.1007/BF01307627; LENT CS, 1993, APPL PHYS LETT, V62, P714, DOI 10.1063/1.108848; Lent CS, 1997, P IEEE, V85, P541, DOI 10.1109/5.573740; LENT CS, 1994, J APPL PHYS, V75, P4077, DOI 10.1063/1.356032; LENT CS, 1994, P WORKSH PHYS COMP, V5; LIKHAREV KK, 1988, IBM J RES DEV, V32, P144, DOI 10.1147/rd.321.0144; Orlov AO, 1997, SCIENCE, V277, P928, DOI 10.1126/science.277.5328.928; Snider GL, 1998, SOLID STATE ELECTRON, V42, P1355, DOI 10.1016/S0038-1101(98)00030-6; SNIDER GL, UNPUB	13	437	452	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 9	1999	284	5412					289	291		10.1126/science.284.5412.289	http://dx.doi.org/10.1126/science.284.5412.289			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184WH	10195887				2022-12-28	WOS:000079636400033
J	Abbasi, K				Abbasi, K			The World Bank and world health - Healthcare strategy	BRITISH MEDICAL JOURNAL			English	Article									BMJ, London WC1H 9JR, England		Abbasi, K (corresponding author), BMJ, London WC1H 9JR, England.							Mach A, 1998, BRIT MED J, V317, P302; *WORLD BANK, 1999, ANN REP 1998; *WORLD BANK, 1997, SECT STRAT HLTH NUTR; 1998, ECONOMIST       0509	4	10	10	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 3	1999	318	7188					933	936		10.1136/bmj.318.7188.933	http://dx.doi.org/10.1136/bmj.318.7188.933			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	185GV	10102866	Green Published			2022-12-28	WOS:000079660500034
J	Rind, D				Rind, D			Complexity and climate	SCIENCE			English	Editorial Material							ICE	The climate that we experience results from both ordered forcing and chaotic behavior; the result is a system with characteristics of each. in forecasting prospective climate changes for the next century, the focus has been on the ordered system's responses to anthropogenic forcing. The chaotic component may be much harder to predict, but at this point it is not known how important it will be.	NASA, Goddard Space Flight Ctr, Inst Space Studies, New York, NY 10025 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Rind, D (corresponding author), NASA, Goddard Space Flight Ctr, Inst Space Studies, 2880 Broadway, New York, NY 10025 USA.							Broccoli AJ, 1998, J CLIMATE, V11, P2743, DOI 10.1175/1520-0442(1998)011<2743:TCOWLP>2.0.CO;2; BROECKER WS, 1985, NATURE, V315, P21, DOI 10.1038/315021a0; FANG ZF, 1994, J CLIMATE, V7, P1897, DOI 10.1175/1520-0442(1994)007<1897:ASIVOA>2.0.CO;2; Hansen J, 1997, J GEOPHYS RES-ATMOS, V102, P25679, DOI 10.1029/97JD01495; Intergovernmental Panel on Climate Change, 1996, CLIM CHANG 1995 SCI; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2; Palmer TN, 1998, B AM METEOROL SOC, V79, P1411, DOI 10.1175/1520-0477(1998)079<1411:NDACCR>2.0.CO;2; RIND D, 1989, J GEOPHYS RES-ATMOS, V94, P12851, DOI 10.1029/JD094iD10p12851; Russell GL, 1999, J CLIMATE, V12, P531, DOI 10.1175/1520-0442(1999)012<0531:RTCTII>2.0.CO;2; SHINDELL DT, IN PRESS NATURE; Soden BJ, 1997, J CLIMATE, V10, P1050, DOI 10.1175/1520-0442(1997)010<1050:VITTGE>2.0.CO;2; WILHITE DA, 1988, SOC RESPONSES REGION, P353; [No title captured]	13	137	162	4	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 2	1999	284	5411					105	107		10.1126/science.284.5411.105	http://dx.doi.org/10.1126/science.284.5411.105			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182QE	10102804				2022-12-28	WOS:000079509000042
J	Sieradzki, K; Brankovic, SR; Dimitrov, N				Sieradzki, K; Brankovic, SR; Dimitrov, N			Electrochemical defect-mediated thin-film growth	SCIENCE			English	Article							BY-LAYER GROWTH; SCANNING TUNNELING MICROSCOPY; IN-SITU STM; COPPER DEPOSITION; INITIAL-STAGES; ELECTRODES; AG(111); AG; ELECTROCRYSTALLIZATION; NUCLEATION	An electrodeposition technique is described that produces atomically flat epitaxial metal overlayers of quality similar to that obtained by ultrahigh vacuum techniques at elevated temperature. In this approach. a metal of interest such as silver is co-deposited with a reversibly deposited mediator metal. The mediator is periodically deposited and stripped from the surface, and this serves to significantly increase the density of two-dimensional islands of silver atoms, promoting a layer-by-layer thin-film growth mode. In situ scanning tunneling microscopy was used to demonstrate the growth process for the heteroepitaxial system silver/gold (111) with either Lead or copper as the mediator.	Arizona State Univ, Dept Mech & Aerosp Engn, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Sieradzki, K (corresponding author), Arizona State Univ, Dept Mech & Aerosp Engn, Tempe, AZ 85287 USA.	karl@icarus.eas.asu.ed	Dimitrov, Nikolay/AAE-9148-2021; Way, James Douglas/A-9408-2010	Dimitrov, Nikolay/0000-0003-1787-4575; Way, James Douglas/0000-0001-9612-8508				BORT H, 1978, J ELECTROANAL CHEM, V90, P413, DOI 10.1016/S0022-0728(78)80076-X; Camarero J, 1998, PHYS REV LETT, V81, P850, DOI 10.1103/PhysRevLett.81.850; CORCORAN SG, 1994, J ELECTROANAL CHEM, V377, P85, DOI 10.1016/0022-0728(94)03452-4; CORCORAN SG, 1993, PHYS REV LETT, V71, P1585, DOI 10.1103/PhysRevLett.71.1585; DIETTERLE M, 1995, SURF SCI, V342, P29, DOI 10.1016/0039-6028(95)00756-3; Dietterle M, 1998, SURF SCI, V396, P189, DOI 10.1016/S0039-6028(97)00668-7; EHRLICH G, 1966, J CHEM PHYS, V44, P1039, DOI 10.1063/1.1726787; FELDMAN LC, 1982, MAT ANAL ION CHANNEL, P44; GABE DR, 1978, PRINCIPLES METAL SUR, P29; Harris S, 1995, PHYS REV B, V52, P16793, DOI 10.1103/PhysRevB.52.16793; Kolb D., 1978, ADV ELECTROCH EL ENG, V11, P125; Kolb DM, 1997, SCIENCE, V275, P1097, DOI 10.1126/science.275.5303.1097; Kolb DM, 1997, MATER RES SOC SYMP P, V451, P19; Magnussen OM, 1997, MATER RES SOC SYMP P, V451, P43; MAZOR A, 1988, PHYS REV LETT, V60, P424, DOI 10.1103/PhysRevLett.60.424; MEYER JA, 1995, PHYS REV B, V51, P14790, DOI 10.1103/PhysRevB.51.14790; NICHOLS RJ, 1992, J ELECTROANAL CHEM, V330, P381, DOI 10.1016/0022-0728(92)80319-Y; OBRETENOV W, 1993, J ELECTROCHEM SOC, V140, P692, DOI 10.1149/1.2056144; PLIETH W, 1992, ELECTROCHIM ACTA, V37, P2115, DOI 10.1016/0013-4686(92)85101-P; ROSENFELD G, 1993, PHYS REV LETT, V71, P895, DOI 10.1103/PhysRevLett.71.895; SCHWOEBEL RL, 1966, J APPL PHYS, V37, P3682, DOI 10.1063/1.1707904; SEAH MP, 1990, PRACTICAL SURFACE AN, V1, pCH1; SIERADZKI K, UNPUB; SIERADZKI K, 1998, Patent No. 60077; TANG LH, 1993, J PHYS I, V3, P935, DOI 10.1051/jp1:1993174; TERSOFF J, 1994, PHYS REV LETT, V72, P266, DOI 10.1103/PhysRevLett.72.266; VANDERVEGT HA, 1992, PHYS REV LETT, V68, P3335, DOI 10.1103/PhysRevLett.68.3335; Zhang ZY, 1997, SCIENCE, V276, P377, DOI 10.1126/science.276.5311.377; ZHANG ZY, 1994, PHYS REV LETT, V72, P693, DOI 10.1103/PhysRevLett.72.693	29	89	90	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	1999	284	5411					138	141		10.1126/science.284.5411.138	http://dx.doi.org/10.1126/science.284.5411.138			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182QE	10102812				2022-12-28	WOS:000079509000051
J	Wakasugi, K; Schimmel, P				Wakasugi, K; Schimmel, P			Two distinct cytokines released from a human aminoacyl-tRNA synthetase	SCIENCE			English	Article							TRANSFER-RNA-SYNTHETASE; ACTIVATING POLYPEPTIDE-II; GROWTH-STIMULATORY ACTIVITY; MULTISYNTHETASE COMPLEX; INTERLEUKIN-8 RECEPTORS; HUMAN NEUTROPHILS; PEPTIDE-III; CELL-LINE; IN-VITRO; PROTEIN	Aminoacyl-tRNA synthetases catalyze aminoacylation of transfer RNAs (tRNAs). It is shown that human tyrosyl-tRNA synthetase can be split into two fragments with distinct cytokine activities, The endothelial monocyte-activating polypeptide Ii-Like carboxy-terminal domain has potent leukocyte and monocyte chemotaxis activity and stimulates production of myeloperoxidase, tumor necrosis factor-alpha, and tissue factor. The catalytic amino-terminal domain binds to the interleukin-8 type A receptor and functions as an interleukin-8-like cytokine. Under apoptotic conditions in cell culture, the full-length enzyme is secreted, and the two cytokine activities can be generated by Leukocyte elastase, an extracellular protease. Secretion of this tRNA synthetase may contribute to apoptosis both by arresting translation and producing needed cytokines.	Scripps Res Inst, Skaggs Inst Chem Biol, Beckman Ctr, La Jolla, CA 92037 USA	Scripps Research Institute	Schimmel, P (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, Beckman Ctr, 10555 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schimmel@scripps.edu	Wakasugi, Keisuke/AAQ-1642-2020	Wakasugi, Keisuke/0000-0002-8408-5616	NIGMS NIH HHS [GM23562] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023562] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agou F, 1997, EUR J BIOCHEM, V243, P259, DOI 10.1111/j.1432-1033.1997.0259a.x; AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; BARKER DG, 1982, FEBS LETT, V150, P419, DOI 10.1016/0014-5793(82)80781-3; BECKER EL, 1977, ARCH PATHOL LAB MED, V101, P509; Bjornland K, 1998, INT J ONCOL, V12, P535; BRANDT E, 1991, CYTOKINE, V3, P311, DOI 10.1016/1043-4666(91)90499-4; CERINI C, 1991, EMBO J, V10, P4267, DOI 10.1002/j.1460-2075.1991.tb05005.x; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P23128; DALY TJ, 1995, J BIOL CHEM, V270, P23282, DOI 10.1074/jbc.270.40.23282; dePouplana LR, 1996, P NATL ACAD SCI USA, V93, P166, DOI 10.1073/pnas.93.1.166; GHIBELLI L, 1994, FEBS LETT, V344, P35, DOI 10.1016/0014-5793(94)00287-8; HEBERT CA, 1991, J BIOL CHEM, V266, P18989; Hoch RC, 1996, J LAB CLIN MED, V128, P134, DOI 10.1016/S0022-2143(96)90005-0; KAO J, 1992, J BIOL CHEM, V267, P20239; KAO J, 1994, J BIOL CHEM, V269, P25106; KAO J, 1994, J BIOL CHEM, V269, P9774; Kleeman TA, 1997, J BIOL CHEM, V272, P14420, DOI 10.1074/jbc.272.22.14420; KORNELYUK AI, 1988, MOL BIOL+, V22, P149; LAZARD M, 1993, GENE, V132, P237, DOI 10.1016/0378-1119(93)90201-D; LEE J, 1992, J BIOL CHEM, V267, P16283; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; MENEGAZZI R, 1992, J LEUKOCYTE BIOL, V52, P619, DOI 10.1002/jlb.52.6.619; MIRANDE M, 1985, EUR J BIOCHEM, V147, P281, DOI 10.1111/j.1432-1033.1985.tb08748.x; MIRANDE M, 1991, PROG NUCLEIC ACID RE, V40, P95; MOSER B, 1991, J BIOL CHEM, V266, P10666; MOSER B, 1993, J BIOL CHEM, V268, P7125; PETERSEN F, 1994, J IMMUNOL, V152, P2467; Rho SB, 1996, P NATL ACAD SCI USA, V93, P10128, DOI 10.1073/pnas.93.19.10128; Rho SB, 1998, J BIOL CHEM, V273, P11267, DOI 10.1074/jbc.273.18.11267; RICHMOND A, 1988, EMBO J, V7, P2025, DOI 10.1002/j.1460-2075.1988.tb03042.x; Schraufstatter IU, 1998, BIOCHEM BIOPH RES CO, V244, P243, DOI 10.1006/bbrc.1998.8246; SHIBA K, 1994, P NATL ACAD SCI USA, V91, P7435, DOI 10.1073/pnas.91.16.7435; STARZYK RM, 1987, SCIENCE, V237, P1614, DOI 10.1126/science.3306924; Tas MPR, 1997, CYTOKINE, V9, P535, DOI 10.1006/cyto.1997.0198; Wakasugi K, 1998, EMBO J, V17, P297, DOI 10.1093/emboj/17.1.297; WAKASUGI K, UNPUB; WALZ A, 1990, J EXP MED, V171, P449, DOI 10.1084/jem.171.2.449; WOLFSON AD, 1990, J CHROMATOGR, V503, P277, DOI 10.1016/S0021-9673(01)81511-9; WRIGHT SC, 1992, J CELL BIOCHEM, V48, P344, DOI 10.1002/jcb.240480403	41	392	449	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	1999	284	5411					147	151		10.1126/science.284.5411.147	http://dx.doi.org/10.1126/science.284.5411.147			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182QE	10102815				2022-12-28	WOS:000079509000054
J	Campbell, JL; Proctor, S				Campbell, JL; Proctor, S			Towards primary care groups - Joining up care in London - establishing the North Southwark Primary Care Group	BRITISH MEDICAL JOURNAL			English	Article									Guys Kings & St Thomass Sch Med, Dept Gen Practice & Primary Care, London SE11 6SP, England	University of London; King's College London	Campbell, JL (corresponding author), Guys Kings & St Thomass Sch Med, Dept Gen Practice & Primary Care, London SE11 6SP, England.		Campbell, John/A-5792-2011	Campbell, John/0000-0002-6752-3493				*DEP HLTH, 1998, PARTN ACT NEW OPP WO; *DEP HTLH, 1997, NEW NHS; Department of Health, 1998, MOD HLTH SOC SERV NA; *LAMB SOUTHW LEW H, 1993, SOUTH HLTH CHART	4	2	2	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 27	1999	318	7187					850	852		10.1136/bmj.318.7187.850	http://dx.doi.org/10.1136/bmj.318.7187.850			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185DM	10092265	Green Published, Green Submitted			2022-12-28	WOS:000079652900029
J	Mulley, AG				Mulley, AG			The Cochrane Library 1998 Issue 4	BRITISH MEDICAL JOURNAL			English	Database Review									Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Mulley, AG (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.								0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 27	1999	318	7187					881	881		10.1136/bmj.318.7187.881	http://dx.doi.org/10.1136/bmj.318.7187.881			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185DM	10092288	Green Published			2022-12-28	WOS:000079652900074
J	Moreo, A; Yunoki, S; Dagotto, E				Moreo, A; Yunoki, S; Dagotto, E			Solid state physics - Phase separation scenario for manganese oxides and related materials	SCIENCE			English	Review							HIGH-TEMPERATURE SUPERCONDUCTORS; METAL-INSULATOR-TRANSITION; PULSED-NEUTRON DIFFRACTION; COLOSSAL-MAGNETORESISTANCE; MAGNETOTRANSPORT PROPERTIES; GIANT MAGNETORESISTANCE; CORRELATED ELECTRONS; MAGNETIC POLARONS; LA1-XSRXMNO3; CHARGE	Recent computational studies of models for manganese oxides have revealed a rich phase diagram, which was not anticipated in early calculations in this context performed in the 1950s and 1960s. In particular, the transition between the antiferromagnetic insulator state of the hole-undoped limit and the ferromagnetic metal at finite hole density was found to occur through a mixed-phase process. When extended Coulomb interactions are included, a microscopically charged inhomogeneous state should be stabilized. These phase separation tendencies, also present at low electronic densities, influence the properties of the ferromagnetic region by increasing charge fluctuations. Experimental data reviewed here by applying several techniques for manganites and other materials are consistent with this scenario. Similarities with results previously discussed in the context of cuprates are clear from this analysis, although the phase segration tendencies in manganites appear stronger.	Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA; Florida State Univ, Dept Phys, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Moreo, A (corresponding author), Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA.		Yunoki, Seiji/B-1831-2008	Yunoki, Seiji/0000-0002-8167-452X				Akimoto T, 1998, PHYS REV B, V57, pR5594, DOI 10.1103/PhysRevB.57.R5594; Allodi G, 1998, PHYS REV B, V57, P1024, DOI 10.1103/PhysRevB.57.1024; Allodi G, 1998, PHYS REV LETT, V81, P4736, DOI 10.1103/PhysRevLett.81.4736; Allub R, 1997, PHYS REV B, V55, P14113, DOI 10.1103/PhysRevB.55.14113; Arovas DP, 1998, PHYS REV B, V58, P9150, DOI 10.1103/PhysRevB.58.9150; Bao W, 1996, SOLID STATE COMMUN, V98, P55, DOI 10.1016/0038-1098(95)00786-5; Bao W, 1997, PHYS REV LETT, V78, P543, DOI 10.1103/PhysRevLett.78.543; Billinge SJL, 1996, PHYS REV LETT, V77, P715, DOI 10.1103/PhysRevLett.77.715; Booth CH, 1998, PHYS REV B, V57, P10440, DOI 10.1103/PhysRevB.57.10440; Booth CH, 1998, PHYS REV LETT, V80, P853, DOI 10.1103/PhysRevLett.80.853; Calderon MJ, 1998, PHYS REV B, V58, P3286, DOI 10.1103/PhysRevB.58.3286; Calvani P, 1998, PHYS REV LETT, V81, P4504, DOI 10.1103/PhysRevLett.81.4504; Cao G, 1997, PHYS REV B, V56, P5387, DOI 10.1103/PhysRevB.56.5387; CASTELLANI C, 1995, PHYS REV LETT, V75, P4650, DOI 10.1103/PhysRevLett.75.4650; CHEONG SW, IN PRESS MONOGRAPHS; Chiba H, 1996, SOLID STATE COMMUN, V99, P499, DOI 10.1016/0038-1098(96)00305-5; Cox DE, 1998, PHYS REV B, V57, P3305, DOI 10.1103/PhysRevB.57.3305; Dagotto E, 1998, PHYS REV B, V58, P6414, DOI 10.1103/PhysRevB.58.6414; DAGOTTO E, 1994, PHYS REV B, V49, P3548, DOI 10.1103/PhysRevB.49.3548; DAGOTTO E, 1994, REV MOD PHYS, V66, P763, DOI 10.1103/RevModPhys.66.763; DAGOTTO E, 1998, P WORKSH PHYS MANG M; DAI P, PREPRINT; Darling TW, 1998, PHYS REV B, V57, P5093, DOI 10.1103/PhysRevB.57.5093; DEGENNES PG, 1960, PHYS REV, V118, P141, DOI 10.1103/PhysRev.118.141; Dessau DS, 1998, PHYS REV LETT, V81, P192, DOI 10.1103/PhysRevLett.81.192; DeTeresa JM, 1997, PHYS REV B, V56, P3317, DOI 10.1103/PhysRevB.56.3317; DeTeresa JM, 1997, NATURE, V386, P256, DOI 10.1038/386256a0; Egami T, 1997, J SUPERCOND, V10, P323, DOI 10.1007/BF02765712; Egami T, 1996, J LOW TEMP PHYS, V105, P791, DOI 10.1007/BF00768480; Fernandez-Baca JA, 1998, PHYS REV LETT, V80, P4012, DOI 10.1103/PhysRevLett.80.4012; Fujishiro H, 1998, J PHYS SOC JPN, V67, P1799, DOI 10.1143/JPSJ.67.1799; FURUKAWA N, 1994, J PHYS SOC JPN, V63, P3214, DOI 10.1143/JPSJ.63.3214; Gavilano JL, 1998, PHYS REV LETT, V81, P5648, DOI 10.1103/PhysRevLett.81.5648; GAVILANO JL, 1995, PHYS REV B, V52, P13106, DOI 10.1103/PhysRevB.52.R13106; GOODENOUGH JB, 1955, PHYS REV, V100, P564, DOI 10.1103/PhysRev.100.564; Goodenough JB, 1997, NATURE, V386, P229, DOI 10.1038/386229a0; GORKOV LP, 1987, JETP LETT+, V46, P420; Heffner RH, 1996, PHYS REV LETT, V77, P1869, DOI 10.1103/PhysRevLett.77.1869; Hennion M, 1998, PHYS REV LETT, V81, P1957, DOI 10.1103/PhysRevLett.81.1957; Hennion M, 1997, PHYS REV B, V56, pR497, DOI 10.1103/PhysRevB.56.R497; Ibarra MR, 1998, PHYS REV B, V57, P7446, DOI 10.1103/PhysRevB.57.7446; Jaime M, 1996, PHYS REV B, V54, P11914, DOI 10.1103/PhysRevB.54.11914; JIN S, 1994, SCIENCE, V264, P413, DOI 10.1126/science.264.5157.413; KASUYA T, 1968, REV MOD PHYS, V40, P684, DOI 10.1103/RevModPhys.40.684; Kawano H, 1997, PHYS REV LETT, V78, P4253, DOI 10.1103/PhysRevLett.78.4253; KAWANO H, 1998, PHYS B, V289, P241; Kim KH, 1998, PHYS REV LETT, V81, P1517, DOI 10.1103/PhysRevLett.81.1517; Kiryukhin V, 1997, NATURE, V386, P813, DOI 10.1038/386813a0; KUBOTA M, PREPRINT; KUWAHARA H, 1995, SCIENCE, V270, P961, DOI 10.1126/science.270.5238.961; Lanzara A, 1998, PHYS REV LETT, V81, P878, DOI 10.1103/PhysRevLett.81.878; Liu HL, 1998, PHYS REV LETT, V81, P4684, DOI 10.1103/PhysRevLett.81.4684; LORENZ CP, 1993, PHYS REV LETT, V70, P379, DOI 10.1103/PhysRevLett.70.379; Louca D, 1997, J APPL PHYS, V81, P5484, DOI 10.1063/1.364595; Louca D, 1997, PHYS REV B, V56, pR8475, DOI 10.1103/PhysRevB.56.R8475; Lynn JW, 1996, PHYS REV LETT, V76, P4046, DOI 10.1103/PhysRevLett.76.4046; Machida A, 1998, PHYS REV B, V58, P12540, DOI 10.1103/PhysRevB.58.12540; Maezono R, 1998, PHYS REV B, V57, P13993, DOI 10.1103/PhysRevB.57.R13993; Maignan A, 1998, PHYS REV B, V58, P2758, DOI 10.1103/PhysRevB.58.2758; MALVEZZI A, IN PRESS PHYS REV B; MILLIS AJ, 1995, PHYS REV LETT, V74, P5144, DOI 10.1103/PhysRevLett.74.5144; Millis AJ, 1996, PHYS REV LETT, V77, P175, DOI 10.1103/PhysRevLett.77.175; Mizokawa T, 1997, PHYS REV B, V56, pR493, DOI 10.1103/PhysRevB.56.R493; Mori S, 1998, PHYS REV LETT, V81, P3972, DOI 10.1103/PhysRevLett.81.3972; MORITOMO Y, 1995, PHYS REV B, V51, P3297, DOI 10.1103/PhysRevB.51.3297; Moussa F, 1997, PHYSICA B, V241, P445, DOI 10.1016/S0921-4526(97)00615-7; MULLER KA, 1993, P C PHAS SEP CUPR SU; MullerHartmann E, 1996, PHYS REV B, V54, pR6819, DOI 10.1103/PhysRevB.54.R6819; Murakami Y, 1998, PHYS REV LETT, V80, P1932, DOI 10.1103/PhysRevLett.80.1932; Nagaev EL, 1998, PHYS REV B, V58, P2415, DOI 10.1103/PhysRevB.58.2415; NAGAEV EL, 1994, PHYS STATUS SOLIDI B, V186, P9, DOI 10.1002/pssb.2221860102; Nagaev EL, 1996, USP FIZ NAUK+, V166, P833, DOI 10.1070/PU1996v039n08ABEH000161; Nyhus P, 1997, PHYS REV B, V56, P2717, DOI 10.1103/PhysRevB.56.2717; OHNO H, 1992, PHYS REV LETT, V68, P2664, DOI 10.1103/PhysRevLett.68.2664; Osborn R, 1998, PHYS REV LETT, V81, P3964, DOI 10.1103/PhysRevLett.81.3964; Papavassiliou G, 1997, PHYS REV B, V55, P15000, DOI 10.1103/PhysRevB.55.15000; Perring TG, 1997, PHYS REV LETT, V78, P3197, DOI 10.1103/PhysRevLett.78.3197; Ramirez AP, 1996, PHYS REV LETT, V76, P3188, DOI 10.1103/PhysRevLett.76.3188; Ramirez AP, 1997, J PHYS-CONDENS MAT, V9, P8171, DOI 10.1088/0953-8984/9/39/005; Rhyne JJ, 1998, J APPL PHYS, V83, P7339, DOI 10.1063/1.367633; Riera J, 1997, PHYS REV LETT, V79, P713, DOI 10.1103/PhysRevLett.79.713; Roder H, 1996, PHYS REV LETT, V76, P1356, DOI 10.1103/PhysRevLett.76.1356; Rosenkranz S, 1998, J APPL PHYS, V83, P7348, DOI 10.1063/1.367796; Roy M, 1998, PHYS REV B, V58, P5185, DOI 10.1103/PhysRevB.58.5185; SCHIFFER P, 1995, PHYS REV LETT, V75, P3336, DOI 10.1103/PhysRevLett.75.3336; Shen SQ, 1998, PHYS REV B, V58, pR8877, DOI 10.1103/PhysRevB.58.R8877; Sheng L, 1997, PHYS REV LETT, V79, P1710, DOI 10.1103/PhysRevLett.79.1710; Tokura Y, 1996, J APPL PHYS, V79, P5288, DOI 10.1063/1.361353; TOKURA Y, IN PRESS MONOGRAPHS; TOMIOKA Y, 1995, J PHYS SOC JPN, V64, P3626, DOI 10.1143/JPSJ.64.3626; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Troyanchuk I. O., 1992, Soviet Physics - JETP, V75, P132; Tyson TA, 1996, PHYS REV B, V53, P13985, DOI 10.1103/PhysRevB.53.13985; URUSHIBARA A, 1995, PHYS REV B, V51, P14103, DOI 10.1103/PhysRevB.51.14103; Varma CM, 1996, PHYS REV B, V54, P7328, DOI 10.1103/PhysRevB.54.7328; Vasiliu-Doloc L, 1998, PHYS REV B, V58, P14913, DOI 10.1103/PhysRevB.58.14913; Viret M, 1998, EUROPHYS LETT, V42, P301, DOI 10.1209/epl/i1998-00246-4; von Molnar S, 1998, CURR OPIN SOLID ST M, V3, P171, DOI 10.1016/S1359-0286(98)80084-3; VONMOLNA.S, 1967, J APPL PHYS, V38, P959, DOI 10.1063/1.1709702; Yamada Y, 1996, PHYS REV LETT, V77, P904, DOI 10.1103/PhysRevLett.77.904; Yamanaka M, 1998, PHYS REV LETT, V81, P5604, DOI 10.1103/PhysRevLett.81.5604; Yi H, 1998, PHYS REV B, V58, P11123, DOI 10.1103/PhysRevB.58.11123; Yoon S, 1998, PHYS REV B, V58, P2795, DOI 10.1103/PhysRevB.58.2795; Yoshizawa H, 1996, J PHYS SOC JPN, V65, P1043, DOI 10.1143/JPSJ.65.1043; Yoshizawa H, 1998, PHYS REV B, V58, pR571, DOI 10.1103/PhysRevB.58.R571; Yunoki S, 1998, PHYS REV B, V58, P6403, DOI 10.1103/PhysRevB.58.6403; Yunoki S, 1998, PHYS REV LETT, V81, P5612, DOI 10.1103/PhysRevLett.81.5612; Yunoki S, 1998, PHYS REV LETT, V80, P845, DOI 10.1103/PhysRevLett.80.845; YUNOKI S, UNPUB; ZENER C, 1951, PHYS REV, V82, P403, DOI 10.1103/PhysRev.82.403; Zhao GM, 1996, NATURE, V381, P676, DOI 10.1038/381676a0; Zhou JS, 1998, PHYS REV LETT, V80, P2665, DOI 10.1103/PhysRevLett.80.2665; Zhou JS, 1998, PHYS REV B, V58, pR579, DOI 10.1103/PhysRevB.58.R579; Zhou JS, 1997, PHYS REV LETT, V79, P3234, DOI 10.1103/PhysRevLett.79.3234	116	1231	1248	7	334	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	1999	283	5410					2034	2040		10.1126/science.283.5410.2034	http://dx.doi.org/10.1126/science.283.5410.2034			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180DH	10092219				2022-12-28	WOS:000079369800034
J	Larkum, ME; Zhu, JJ; Sakmann, B				Larkum, ME; Zhu, JJ; Sakmann, B			A new cellular mechanism for coupling inputs arriving at different cortical layers	NATURE			English	Article							ACTION-POTENTIALS; PYRAMIDAL NEURONS; DENDRITES; HIPPOCAMPUS; INHIBITION; CORTEX	Pyramidal neurons in layer 5 of the neocortex of the brain extend their axons and dendrites into all layers. They are also unusual in having both an axonal and a dendritic zone for the initiation of action potentials(1-6). Distal dendritic inputs, which normally appear greatly attenuated at the axon, must cross a high threshold at the dendritic initiation zone to evoke calcium action potentials(1,7) but can then generate bursts of axonal action potentials. Here we show that a single back-propagating sodium action potential generated in the axons(8) facilitates the initiation of these calcium action potentials when it coincides with distal dendritic input within a time window of several milliseconds. Inhibitory dendritic input can selectively block the initiation of dendritic calcium action potentials, preventing bursts of axonal action potentials. Thus, excitatory and inhibitory postsynaptic potentials arising in the distal dendrites can exert significantly greater control over action potential initiation in the axon than would be expected from their electrotonically isolated locations. The coincidence of a single back-propagating action potential with a subthreshold distal excitatory postsynaptic potential to evoke a burst of axonal action potentials represents a new mechanism by which the main cortical output neurons can associate inputs arriving at different cortical layers.	Max Planck Inst Med Forsch, Zellphysiol Abt, D-69120 Heidelberg, Germany	Max Planck Society	Larkum, ME (corresponding author), Max Planck Inst Med Forsch, Zellphysiol Abt, Jahnstr 29, D-69120 Heidelberg, Germany.			Larkum, Matthew/0000-0001-9799-2656				Buzsaki G, 1996, P NATL ACAD SCI USA, V93, P9921, DOI 10.1073/pnas.93.18.9921; CAULLER LJ, 1991, EXP BRAIN RES, V84, P607; Chen HM, 1997, J NEUROPHYSIOL, V78, P3484, DOI 10.1152/jn.1997.78.6.3484; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; DODT HU, 1993, ADV EXP MED BIOL, V333, P245; Heilman K. M, 1993, CLIN NEUROPSYCHOLOGY; HIRSCH JA, 1995, NATURE, V378, P612, DOI 10.1038/378612a0; Jones EG, 1999, CEREB CORTEX, V13, P139; KIM HG, 1993, J NEUROSCI, V13, P5301, DOI 10.1523/JNEUROSCI.13-12-05301.1993; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Llinas R, 1994, TEMPORAL CODING BRAI, P251; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; SPENCER WA, 1961, J NEUROPHYSIOL, V24, P272, DOI 10.1152/jn.1961.24.3.272; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; Zhu J. Julius, 1998, Society for Neuroscience Abstracts, V24, P1512; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171; ZHU JJ, 1997, SOC NEUR ABSTR, V23, P2283	22	726	734	2	34	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 25	1999	398	6725					338	341		10.1038/18686	http://dx.doi.org/10.1038/18686			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180DF	10192334				2022-12-28	WOS:000079369600052
J	Paus, T; Zijdenbos, A; Worsley, K; Collins, DL; Blumenthal, J; Giedd, JN; Rapoport, JL; Evans, AC				Paus, T; Zijdenbos, A; Worsley, K; Collins, DL; Blumenthal, J; Giedd, JN; Rapoport, JL; Evans, AC			Structural maturation of neural pathways in children and adolescents: In vivo study	SCIENCE			English	Article							HUMAN BRAIN-DEVELOPMENT; CENTRAL NERVOUS-SYSTEM; MAGNETIC STIMULATION; CORPUS-CALLOSUM; AUDITORY-CORTEX; MOTOR CORTEX; MYELINATION; ADULTHOOD; SPEECH; SCHIZOPHRENIA	Structural maturation of fiber tracts in the human brain, including an increase in the diameter and myelination of axons, may play a role in cognitive development during childhood and adolescence. A computational analysis of structural magnetic resonance images obtained in 111 children and adolescents revealed age-related increases in white matter density in fiber tracts constituting putative corticospinal and frontotemporal pathways. The maturation of the corticospinal tract was bilateral. whereas that of the frontotemporal pathway was found predominantly in the left (speech-dominant) hemisphere. These findings provide evidence for a gradual maturation, during late childhood and adolescence, of fiber pathways presumably supporting motor and speech functions.	McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; NIMH, Clin Psychiat Branch, Bethesda, MD 20892 USA	McGill University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Paus, T (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	tomas@bic.mni.mcgill.ca	Giedd, Jay/J-9644-2015; Collins, D. Louis/ABD-7708-2021; Giedd, Jay N/B-7302-2012; Giedd, Jay N./A-3080-2008	Giedd, Jay/0000-0003-2002-8978; Collins, D. Louis/0000-0002-8432-7021; Giedd, Jay N/0000-0003-0827-3460; 				ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; ANDREASEN NC, 1994, SCIENCE, V266, P294, DOI 10.1126/science.7939669; Armand J., 1996, P125, DOI 10.1016/B978-012759440-8/50010-4; BENES FM, 1994, ARCH GEN PSYCHIAT, V51, P477; BENES FM, 1989, SCHIZOPHRENIA BULL, V15, P585, DOI 10.1093/schbul/15.4.585; BOLLER F, 1978, NEUROPSYCHOLOGIA, V16, P521, DOI 10.1016/0028-3932(78)90078-7; BRODY BA, 1987, J NEUROPATH EXP NEUR, V46, P283, DOI 10.1097/00005072-198705000-00005; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Connor JR, 1996, GLIA, V17, P83, DOI 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7; CREUTZFELDT O, 1989, EXP BRAIN RES, V77, P476, DOI 10.1007/BF00249601; Evans A., 1998, NEUROIMAGE, V7S, P783; EYRE JA, 1991, J PHYSIOL-LONDON, V434, P441, DOI 10.1113/jphysiol.1991.sp018479; FORSSBERG H, 1991, EXP BRAIN RES, V85, P451; Giedd JN, 1996, CEREB CORTEX, V6, P551, DOI 10.1093/cercor/6.4.551; Giedd JN, 1996, DEV BRAIN RES, V91, P274; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; HYDE TM, 1992, ARCH NEUROL-CHICAGO, V49, P401, DOI 10.1001/archneur.1992.00530280095028; Ilmoniemi RJ, 1997, NEUROREPORT, V8, P3537, DOI 10.1097/00001756-199711100-00024; LAWRENCE DG, 1976, BRAIN, V99, P235, DOI 10.1093/brain/99.2.235; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; MCDONALD WI, 1970, BRAIN, V93, P583, DOI 10.1093/brain/93.3.583; MOORE JK, 1997, ASS RES OTOLARYNGOLO, V20, P28; MULLER K, 1992, NEUROSCI LETT, V144, P57, DOI 10.1016/0304-3940(92)90715-J; MULLER K, 1991, ELECTROEN CLIN NEURO, V81, P63, DOI 10.1016/0168-5597(91)90105-7; MULLERPREUSS P, 1981, BRAIN RES, V215, P61, DOI 10.1016/0006-8993(81)90491-1; Nezu A, 1997, BRAIN DEV-JPN, V19, P176, DOI 10.1016/S0387-7604(96)00552-9; Olivier E, 1997, J NEUROSCI, V17, P267, DOI 10.1523/JNEUROSCI.17-01-00267.1997; OZKAN M, 1993, IEEE T MED IMAGING, V12, P534, DOI 10.1109/42.241881; Paus T, 1996, EUR J NEUROSCI, V8, P2236, DOI 10.1111/j.1460-9568.1996.tb01187.x; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; PUJOL J, 1993, ANN NEUROL, V34, P71, DOI 10.1002/ana.410340113; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; SCHALTENBRAND G, 1977, INTRO STEREOTAXIS AT; Sokal R. R, 1981, BIOMETRY; St-Jean P, 1998, IEEE T MED IMAGING, V17, P672, DOI 10.1109/42.736017; Talairach I., 1988, COPLANAR STEREOTACTI; TALLAL P, 1993, ANN NY ACAD SCI, V682, P27, DOI 10.1111/j.1749-6632.1993.tb22957.x; Vargha-Khadem F, 1998, P NATL ACAD SCI USA, V95, P12695, DOI 10.1073/pnas.95.21.12695; VERHAART WJC, 1950, J COMP NEUROL, V92, P1, DOI 10.1002/cne.900920102; Vymazal J, 1996, MAGN RESON MED, V36, P61, DOI 10.1002/mrm.1910360111; Vymazal J, 1996, MAGN RESON MED, V35, P56, DOI 10.1002/mrm.1910350108; Wright IC, 1995, NEUROIMAGE, V2, P244, DOI 10.1006/nimg.1995.1032; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3; ZIJDENBOS AP, 1996, P 4 INT C VIS BIOM C, P439	45	952	964	2	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	1999	283	5409					1908	1911		10.1126/science.283.5409.1908	http://dx.doi.org/10.1126/science.283.5409.1908			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177UC	10082463				2022-12-28	WOS:000079228600046
J	Bradley, F; Wiles, R; Kinmonth, AL; Mant, D; Gantley, M				Bradley, F; Wiles, R; Kinmonth, AL; Mant, D; Gantley, M		SHIP Collaborative Grp	Development and evaluation of complex interventions in health services research: case study of the Southampton heart integrated care project (SHIP)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MYOCARDIAL-INFARCTION		Inst Publ Hlth, Gen Practice & Primary Care Res Unit, Cambridge CB2 2SR, England; Univ Dublin Trinity Coll, Dept Community Hlth & Gen Practice, Dublin 2, Ireland; Univ Southampton, Sch Occupat Therapy & Physiotherapy, Hlth Res Unit, Southampton SO17 1BJ, Hants, England; Univ Oxford, Dept Primary Hlth Care, Inst Hlth Sci, Oxford OX3 7LF, England; Queen Mary Univ London, St Bartholomews & Royal London Sch Med & Dent, Dept Gen Practice & Primary Care, London E1 4NS, England	University of Cambridge; Trinity College Dublin; University of Southampton; University of Oxford; University of London; Queen Mary University London	Kinmonth, AL (corresponding author), Inst Publ Hlth, Gen Practice & Primary Care Res Unit, Cambridge CB2 2SR, England.	alk25@medschl.cam.ac.uk	Mant, David CA/C-7763-2009					*ACT SEC PREV INT, 1996, HEART, V75, P334; [Anonymous], 1994, BMJ, V308, P313; BLOOR MJ, 1976, J LARYNGOL OTOL, V92, P883; BLOOR MJ, 1976, J LARYNGOL OTOL, V92, P791; BOX EGP, 1956, APPL STAT, V6, P81; Bradley F, 1997, FAM PRACT, V14, P220, DOI 10.1093/fampra/14.3.220; Brannen J., 1991, MANAGING MOTHERS DUA; COULTER A, 1995, BRIT MED J, V310, P1099; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; Johnson AM, 1994, SEXUAL ATTITUDES LIF; *KINGS FUND, 1994, WAY FOLL PUBL OXCH F; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; Oakley A., 1992, SOCIAL SUPPORT MOTHE; Patton M. Q., 1990, QUALITATIVE EVALUATI; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037/0022-006X.51.3.390; Rollnick S, 1992, J MENT HEALTH, V1, P25, DOI DOI 10.3109/09638239209034509; Schwarzer R., 1992, SELF EFFICACY THOUGH, P217; SHEPPERD S, 1995, BRIT MED J, V310, P125, DOI 10.1136/bmj.310.6972.125d; *SOUTH HEART INT C, 1999, BRIT MED J, V318, P706; *SOUTH HEART INT C, 1994, INF PAT; Stott NCH, 1995, FAM PRACT, V12, P413, DOI 10.1093/fampra/12.4.413; STRAUSS A, 1990, BASICS QUALITATIV RE; WHITFORD DL, 1994, BMJ-BRIT MED J, V309, P1268, DOI 10.1136/bmj.309.6964.1268; Wiles R, 1998, SOC SCI MED, V46, P1477, DOI 10.1016/S0277-9536(97)10140-X; Wiles R, 1997, J ADV NURS, V26, P729, DOI 10.1046/j.1365-2648.1997.00409.x	26	129	132	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	1999	318	7185					711	715						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	182JK	10074018				2022-12-28	WOS:000079495700027
J	Burney, P				Burney, P			Air pollution and asthma: the dog that doesn't always bark	LANCET			English	Editorial Material							OUTBREAKS		Guys Kings & St Thomas Sch Med, Dept Publ Hlth Sci, London SE1 3QD, England	University of London; King's College London	Burney, P (corresponding author), Guys Kings & St Thomas Sch Med, Dept Publ Hlth Sci, London SE1 3QD, England.			Burney, Peter/0000-0001-8635-5678				ANTO JM, 1989, NEW ENGL J MED, V320, P1097, DOI 10.1056/NEJM198904273201701; Delfino RJ, 1997, ENVIRON HEALTH PERSP, V105, P622, DOI 10.2307/3433608; DEVALIA JL, 1998, EUR RESPIR REV, V8, P175; FRY J, 1953, LANCET, V264, P235; Neas LM, 1996, AM J EPIDEMIOL, V143, P797, DOI 10.1093/oxfordjournals.aje.a008818; OHOLLAREN MT, 1991, NEW ENGL J MED, V324, P359, DOI 10.1056/NEJM199102073240602; ORDMAN D, 1955, INT ARCH ALLER A IMM, V7, P10, DOI 10.1159/000228201; Roemer W, 1998, EUR RESPIR REV, V8, P125; Rosas I, 1998, ALLERGY, V53, P394, DOI 10.1111/j.1398-9995.1998.tb03911.x; SANDSTROM T, 1998, EUR RESPIR REV, V8, P168; SORIANO JB, 1995, THORAX, V50, P1101, DOI 10.1136/thx.50.10.1101; TARGONSKI PV, 1995, J ALLERGY CLIN IMMUN, V95, P955, DOI 10.1016/S0091-6749(95)70095-1; USSETTI P, 1983, LANCET, V2, P280; WICHMANN HE, 1989, ENVIRON HEALTH PERSP, V79, P89, DOI 10.2307/3430534; WILLIAMS PB, 1995, J ALLERGY CLIN IMMUN, V95, P88, DOI 10.1016/S0091-6749(95)70156-7	15	11	12	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 13	1999	353	9156					859	860		10.1016/S0140-6736(99)00002-1	http://dx.doi.org/10.1016/S0140-6736(99)00002-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BU	10093974				2022-12-28	WOS:000079421400004
J	Avides, MD; Glover, DM				Avides, MD; Glover, DM			Abnormal spindle protein, asp, and the integrity of mitotic centrosomal microtubule organizing centers	SCIENCE			English	Article							XENOPUS EGG EXTRACTS; GAMMA-TUBULIN; SELF-ORGANIZATION; DROSOPHILA; NUCLEATION; MUTATIONS; MUTANT	The product of the abnormal spindle (asp) gene was found to be an asymmetrically Localized component of the centrosome during mitosis, required to focus the poles of the mitotic spindle in vivo. Removing Asp protein function from Drosophila melanogaster embryo extracts, either by mutation or immunodepletion, resulted in Loss of their ability to restore microtubule-organizing center activity to salt-stripped centrosome preparations. This was corrected by addition of purified Asp protein. Thus, Asp appears to hold together the microtubule-nucleating gamma-tubulin ring complexes that organize the mitotic centrosome.	Univ Dundee, Inst Med Sci, Canc Res Campaign, Cell Cycle Genet Lab, Dundee DD1 4HN, Scotland	University of Dundee	Glover, DM (corresponding author), Univ Dundee, Inst Med Sci, Canc Res Campaign, Cell Cycle Genet Lab, Dundee DD1 4HN, Scotland.	d.m.glover@dundee.ac.uk		Glover, David/0000-0003-0956-0103				BARTON NR, 1995, MOL BIOL CELL, V6, P1563, DOI 10.1091/mbc.6.11.1563; CASAL J, 1990, DEVELOPMENT, V108, P251; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; DOXSEY SJ, 1994, CELL, V76, P639, DOI 10.1016/0092-8674(94)90504-5; GONZALEZ C, 1990, J CELL SCI, V96, P605; Heald R, 1997, J CELL BIOL, V138, P615, DOI 10.1083/jcb.138.3.615; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; MITCHISON TJ, 1986, METHOD ENZYMOL, V134, P261; Moritz M, 1998, J CELL BIOL, V142, P775, DOI 10.1083/jcb.142.3.775; MORITZ M, 1995, NATURE, V378, P638, DOI 10.1038/378638a0; RIPOLL P, 1985, CELL, V41, P907, DOI 10.1016/S0092-8674(85)80071-4; Saunders RDC, 1997, J CELL BIOL, V137, P881, DOI 10.1083/jcb.137.4.881; Schnackenberg BJ, 1998, P NATL ACAD SCI USA, V95, P9295, DOI 10.1073/pnas.95.16.9295; STEARNS T, 1994, CELL, V76, P623, DOI 10.1016/0092-8674(94)90503-7; Tavares AAM, 1996, EMBO J, V15, P4873, DOI 10.1002/j.1460-2075.1996.tb00868.x; WhiteCooper H, 1996, GENETICS, V144, P1097, DOI 10.1534/genetics.112.1097.test; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	17	136	139	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	1999	283	5408					1733	1735		10.1126/science.283.5408.1733	http://dx.doi.org/10.1126/science.283.5408.1733			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175PF	10073938				2022-12-28	WOS:000079102800051
J	Fischer, H; Wahlen, M; Smith, J; Mastroianni, D; Deck, B				Fischer, H; Wahlen, M; Smith, J; Mastroianni, D; Deck, B			Ice core records of atmospheric CO2 around the last three glacial terminations	SCIENCE			English	Article							CLIMATE-CHANGE; GREENLAND; PERIOD; INCREASE; AGE	Air trapped in bubbles in polar ice cores constitutes an archive for the reconstruction of the global carbon cycle and the relation between greenhouse gases and climate in the past. High-resolution records from Antarctic ice cores show that carbon dioxide concentrations increased by 80 to 100 parts per million by volume 600 +/- 400 years after the warming of the Last three deglaciations. Despite strongly decreasing temperatures, high carbon dioxide concentrations can be sustained for thousands of years during glaciations; the size of this phase Lag is probably connected to the duration of the preceding warm period, which controls the change in land ice coverage and the buildup of the terrestrial biosphere.	Univ Calif San Diego, Scripps Inst Oceanog, Geosci Res Div, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Fischer, H (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Geosci Res Div, La Jolla, CA 92093 USA.		Fischer, Hubertus/A-1211-2014	Fischer, Hubertus/0000-0002-2787-4221				BARNOLA JM, 1991, TELLUS B, V43, P83, DOI 10.1034/j.1600-0889.1991.t01-1-00002.x; BARNOLA JM, 1987, NATURE, V329, P408, DOI 10.1038/329408a0; Blunier T, 1998, NATURE, V394, P739, DOI 10.1038/29447; Blunier T, 1997, GEOPHYS RES LETT, V24, P2683, DOI 10.1029/97GL02658; IMBRIE J, 1984, MILANKOVITCH CLIMA 1, P269; INDERMUHLE A, IN PRESS NATURE; JOHNSEN SJ, 1972, NATURE, V235, P429, DOI 10.1038/235429a0; Jouzel J, 1996, CLIM DYNAM, V12, P513, DOI 10.1007/BF00207935; JOUZEL J, 1993, NATURE, V364, P407, DOI 10.1038/364407a0; KEELING CD, 1995, NATURE, V375, P666, DOI 10.1038/375666a0; LEUENBERGER M, 1992, NATURE, V357, P488, DOI 10.1038/357488a0; LORIUS C, 1990, NATURE, V347, P139, DOI 10.1038/347139a0; MARTINSON DG, 1987, QUATERNARY RES, V27, P1, DOI 10.1016/0033-5894(87)90046-9; NEFTEL A, 1988, NATURE, V331, P609, DOI 10.1038/331609a0; NEFTEL A, 1985, NATURE, V315, P45, DOI 10.1038/315045a0; Petit JR, 1997, NATURE, V387, P359, DOI 10.1038/387359a0; RAYNAUD D, 1993, SCIENCE, V259, P926, DOI 10.1126/science.259.5097.926; SCHWANDER J, 1993, J GEOPHYS RES-ATMOS, V98, P2831, DOI 10.1029/92JD02383; SMITH H, UNPUB; Stauffer B, 1998, NATURE, V392, P59, DOI 10.1038/32133; Steig EJ, 1998, SCIENCE, V282, P92, DOI 10.1126/science.282.5386.92; WAHLEN M, 1991, GEOPHYS RES LETT, V18, P1457, DOI 10.1029/91GL01724	22	190	208	0	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	1999	283	5408					1712	1714		10.1126/science.283.5408.1712	http://dx.doi.org/10.1126/science.283.5408.1712			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175PF	10073931	Green Submitted			2022-12-28	WOS:000079102800044
J	Meng, WY; Sawasdikosol, S; Burakoff, SJ; Eck, MJ				Meng, WY; Sawasdikosol, S; Burakoff, SJ; Eck, MJ			Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase	NATURE			English	Article							PROTOONCOGENE C-CBL; TYROSINE KINASE; EGF RECEPTOR; V-CBL; PROTEIN; RECOGNITION; ASSOCIATION; REGULATOR; PEPTIDE; PRODUCT	Cbl is an adaptor protein that functions as a negative regulator of many signalling pathways that start from receptors at the cell surface(1-4). The evolutionarily conserved amino-terminal region of Cbl (Cbl-N) binds to phosphorylated tyrosine residues and has cell-transforming activity. Point mutations in Cbl, that disrupt its recognition of phosphotyrosine also interfere with its negative regulatory function and, in the case of v-cbl, with its oncogenic potential(5). In T cells, Cbl-N binds to the tyrosine-phosphorylated inhibitory site of the protein tyrosine kinase ZAP-70(6). Here we describe the crystal structure of Cbl-N, both alone and in complex with a phosphopeptide that represents its binding site in ZAP-70. The structures show that Cbl-N is composed of three interacting domains: a four-helix bundle (4H), an EF-hand(7) calcium-binding domain, and a divergent SH2 domain(8) that was not recognizable from the amino-acid sequence of the protein. The calcium-hound EF hand wedges between the 4H and SH2 domains and roughly determines their relative orientation. In the ligand-occupied structure, the 4H domain packs against the SH2 domain and completes its phosphotyrosine-recognition pocket. Disruption of this binding to ZAP-70 as a result of structure-based mutations in the 4H, EF-hand and SH2 domains confirms that the three domains together form an integrated phosphoprotein-recognition module.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Eck, MJ (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	eck@red.dfci.harvard.edu						BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; BLAKE TJ, 1991, ONCOGENE, V6, P653; Brunger AT, 1992, X PLOR VERSION 3 0 S; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; de Beer T, 1998, SCIENCE, V281, P1357, DOI 10.1126/science.281.5381.1357; Deckert M, 1998, J BIOL CHEM, V273, P8867, DOI 10.1074/jbc.273.15.8867; ECK MJ, 1993, NATURE, V362, P87, DOI 10.1038/362087a0; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; GALISTEO ML, 1995, J BIOL CHEM, V270, P20242, DOI 10.1074/jbc.270.35.20242; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/0968-0004(96)80879-6; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kretsinger RH, 1997, NAT STRUCT BIOL, V4, P514, DOI 10.1038/nsb0797-514; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Liu YC, 1998, CELL SIGNAL, V10, P377, DOI 10.1016/S0898-6568(97)00179-4; Lupher ML, 1997, J BIOL CHEM, V272, P33140, DOI 10.1074/jbc.272.52.33140; Meisner H, 1997, MOL CELL BIOL, V17, P2217, DOI 10.1128/MCB.17.4.2217; Miyake S, 1997, CRIT REV ONCOGENESIS, V8, P189, DOI 10.1615/CritRevOncog.v8.i2-3.30; NAVAZA J, 1992, AMORE NEW PACKAGE MO; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ota Y, 1997, SCIENCE, V276, P418, DOI 10.1126/science.276.5311.418; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; Thien CBF, 1997, ONCOGENE, V14, P2239, DOI 10.1038/sj.onc.1201193; Thien CBF, 1998, IMMUNOL CELL BIOL, V76, P473, DOI 10.1046/j.1440-1711.1998.00768.x; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; YOON CH, 1995, SCIENCE, V269, P1102, DOI 10.1126/science.7652556	30	238	243	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	1999	398	6722					84	90		10.1038/18050	http://dx.doi.org/10.1038/18050			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174KG	10078535				2022-12-28	WOS:000079033900057
J	Irvine, RE				Irvine, RE			Michael Bertrand Devas - Obituary	BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 3	1999	318	7188					946	946		10.1136/bmj.318.7188.946	http://dx.doi.org/10.1136/bmj.318.7188.946			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185GV	10102885	Green Published			2022-12-28	WOS:000079660500067
J	Viswanathan, A; You, HJ; Doetsch, PW				Viswanathan, A; You, HJ; Doetsch, PW			Phenotypic change caused by transcriptional bypass of uracil in nondividing cells	SCIENCE			English	Article							BASE EXCISION-REPAIR; ESCHERICHIA-COLI; DNA-DAMAGE; TRANSCRIBED STRAND; COCKAYNE-SYNDROME; RNA-POLYMERASE; COUPLED REPAIR; MUTT PROTEIN; MUTATION; SITES	Cytosine deamination to uracil occurs frequently in cellular DNA. In vitro, RNA polymerase efficiently inserts adenine opposite to uracil, resulting in Ci to A base substitutions. In vivo, uracil could potentially alter transcriptional fidelity, resulting in production of mutant proteins. This study demonstrates that in nondividing Escherichia coli cells, a DNA template base replaced with uracil in a stop codon in the firefly Luciferase gene results in conversion of inactive to active Luciferase, The Level of transcriptional base substitution is dependent on the capacity to repair uracil, These results provide evidence for a DNA damage-dependent, transcription-driven pathway for generating mutant proteins in nondividing cells.	Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Grad Program Genet & Mol Biol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Doetsch, PW (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.			You, Ho Jin/0000-0002-0530-4017	NCI NIH HHS [CA73041, CA78622] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078622, R01CA073041] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Althaus IW, 1996, BIOCHEM PHARMACOL, V51, P1373, DOI 10.1016/0006-2952(96)00061-5; BRIDGES BA, 1995, NATURE, V375, P741, DOI 10.1038/375741a0; Bridges BA, 1996, CANCER SURV, V28, P155; CAIRNS J, 1988, NATURE, V335, P142, DOI 10.1038/335142a0; CHEN YH, 1993, J BIOL CHEM, V268, P5849; Cooper PK, 1997, SCIENCE, V275, P990, DOI 10.1126/science.275.5302.990; DEMARINI DM, 1992, MUTAT RES, V267, P1, DOI 10.1016/0027-5107(92)90106-C; DIANOV G, 1994, CURR BIOL, V4, P1069, DOI 10.1016/S0960-9822(00)00245-1; DOETSCH P, 1998, DNA DAMAGE REPAIR OX, P97; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; ECHOLS H, 1990, MUTAT RES, V236, P301, DOI 10.1016/0921-8777(90)90013-U; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; GALLANT J, 1979, MECH AGEING DEV, V10, P27, DOI 10.1016/0047-6374(79)90068-X; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P4474, DOI 10.1073/pnas.73.12.4474; Harris RS, 1997, GENE DEV, V11, P2426, DOI 10.1101/gad.11.18.2426; KATO M, 1993, BIOL PHARM BULL, V16, P552; KRAMER B, 1984, CELL, V38, P879, DOI 10.1016/0092-8674(84)90283-6; LEADON SA, 1993, P NATL ACAD SCI USA, V90, P10499, DOI 10.1073/pnas.90.22.10499; LIU J, 1995, MOL CELL BIOL, V15, P6729; Liu J, 1998, NUCLEIC ACIDS RES, V26, P1707, DOI 10.1093/nar/26.7.1707; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; MELLON I, 1986, P NATL ACAD SCI USA, V83, P8878, DOI 10.1073/pnas.83.23.8878; Mellon I, 1996, SCIENCE, V272, P557, DOI 10.1126/science.272.5261.557; Nicholl ID, 1997, BIOCHEMISTRY-US, V36, P7557, DOI 10.1021/bi962950w; ORGEL LE, 1963, P NATL ACAD SCI USA, V49, P517, DOI 10.1073/pnas.49.4.517; SALANEWBY GB, 1994, BBA-PROTEIN STRUCT M, V1206, P155, DOI 10.1016/0167-4838(94)90084-1; Sandigursky M, 1998, NUCLEIC ACIDS RES, V26, P1282, DOI 10.1093/nar/26.5.1282; SEEBERG E, 1995, TRENDS BIOCHEM SCI, V20, P391, DOI 10.1016/S0968-0004(00)89086-6; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; STAHL FW, 1988, NATURE, V335, P112, DOI 10.1038/335112a0; Taddei F, 1997, SCIENCE, V278, P128, DOI 10.1126/science.278.5335.128; van Leeuwen FW, 1998, SCIENCE, V279, P242, DOI 10.1126/science.279.5348.242; Vassylyev DG, 1996, STRUCTURE, V4, P1381, DOI 10.1016/S0969-2126(96)00145-1; Viswanathan A, 1998, J BIOL CHEM, V273, P21276, DOI 10.1074/jbc.273.33.21276; Yamaguchi M, 1997, MOL CELL BIOCHEM, V173, P169, DOI 10.1023/A:1006833111236; ZHOU W, 1993, P NATL ACAD SCI USA, V90, P6601, DOI 10.1073/pnas.90.14.6601	38	83	86	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 2	1999	284	5411					159	162		10.1126/science.284.5411.159	http://dx.doi.org/10.1126/science.284.5411.159			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182QE	10102819				2022-12-28	WOS:000079509000058
J	Bonenkamp, JJ; Hermans, J; Sasako, M; van de Velde, CJH				Bonenkamp, JJ; Hermans, J; Sasako, M; van de Velde, CJH		Dutch Gastric Canc Grp	Extended lymph-node dissection for gastric cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SURVIVAL RATES; LYMPHADENECTOMY; MORBIDITY; SURGERY; CARCINOMA; JAPANESE; GERMAN; TRIAL	Background Curative resection is the treatment of choice for gastric cancer, but it is unclear whether this operation should include an extended (D2) lymphnode dissection, as recommended by the Japanese medical community, or a limited (D1) dissection. We conducted a randomized trial in 80 Dutch hospitals in which we compared D1 with D2 lymph-node dissection for gastric cancer in terms of morbidity, postoperative mortality, long-term survival, and cumulative risk of relapse after surgery. Methods Between August 1989 and July 1993, a total of 996 patients entered the study. Of these patients, 711 (380 in the D1 group and 331 in the D2 group) underwent the randomly assigned treatment with curative intent, and 285 received palliative treatment. The procedures for quality control included instruction and supervision in the operating room and monitoring of the pathological results. Results Patients in the D2 group had a significantly higher rate of complications than did those in the D1 group (43 percent vs. 25 percent, P<0.001), more postoperative deaths (10 percent vs. 4 percent, P=0.004), and longer hospital stays (median, 16 vs. 14 days; P<0.001). Five-year survival rates were similar in the two groups: 45 percent for the D1 group and 47 percent for the D2 group (95 percent confidence interval for the difference, -9.6 percent to +5.6 percent). The patients who had R0 resections (i.e., who had no microscopical evidence of remaining disease), excluding those who died postoperatively, had cumulative risks of relapse at five years of 43 percent with D1 dissection and 37 percent with D2 dissection (95 percent confidence interval for the difference, -2.4 percent to +14.4 percent). Conclusions Our results in Dutch patients do not support the routine use of D2 lymph-node dissection in patients with gastric cancer. (N Engl J Med 1999; 340:908-14.) (C) 1999, Masschusetts Medical Society.	Leiden Univ, Med Ctr, Dept Surg, NL-2300 RC Leiden, Netherlands; Leiden Univ, Dept Med Stat, NL-2300 RA Leiden, Netherlands; Natl Canc Ctr Hosp, Tokyo, Japan; Vrije Univ Amsterdam, Univ Hosp Amsterdam, Amsterdam, Netherlands; Univ Groningen Hosp, Groningen, Netherlands; Geertruiden Hosp, Deventer, Netherlands; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; Reinier de Graaf Hosp, Delft, Netherlands; Univ Hosp Maastricht, Maastricht, Netherlands; Univ Hosp Dijkzigt, NL-3015 GD Rotterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; National Cancer Center - Japan; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; Reinier de Graaf Hospital; Maastricht University; Maastricht University Medical Centre (MUMC); Erasmus University Rotterdam; Erasmus MC	van de Velde, CJH (corresponding author), Leiden Univ, Med Ctr, Dept Surg, POB 9600, NL-2300 RC Leiden, Netherlands.		van de Velde, Cornelis/AAY-8360-2020					AKOH JA, 1992, BRIT J SURG, V79, P293, DOI 10.1002/bjs.1800790404; Beahrs O. H., 1992, MANUAL STAGING CANC, V4th; Bonenkamp JJ, 1996, BRIT J SURG, V83, P672, DOI 10.1002/bjs.1800830526; BONENKAMP JJ, 1995, LANCET, V345, P745, DOI 10.1016/S0140-6736(95)90637-1; BONENKAMP JJ, 1993, WORLD J SURG, V17, P410, DOI 10.1007/BF01658714; BONENKAMP JJ, IN PRESS GASTRIC CAN; BUNT AMG, 1995, J CLIN ONCOL, V13, P19, DOI 10.1200/JCO.1995.13.1.19; BUNT AMG, 1994, J CLIN ONCOL, V12, P417, DOI 10.1200/JCO.1994.12.2.417; CADY B, 1984, ARCH SURG-CHICAGO, V119, P1067; Cuschieri A, 1996, LANCET, V347, P995, DOI 10.1016/S0140-6736(96)90144-0; Estes NC, 1998, AM SURGEON, V64, P680; GRIFFITH JP, 1995, GUT, V36, P684, DOI 10.1136/gut.36.5.684; Hermanek P, 1997, TNM ATLAS; KAJITANI T, 1981, JPN J SURG, V11, P127; MCNEER G, 1956, CANCER, V9, P1153, DOI 10.1002/1097-0142(195611/12)9:6<1153::AID-CNCR2820090614>3.0.CO;2-1; PACELLI F, 1993, BRIT J SURG, V80, P1153, DOI 10.1002/bjs.1800800930; RODER JD, 1993, CANCER-AM CANCER SOC, V72, P2089, DOI 10.1002/1097-0142(19931001)72:7<2089::AID-CNCR2820720706>3.0.CO;2-H; SASAKO M, 1997, BRIT J SURG, V84, P567; SMITH JW, 1991, ARCH SURG-CHICAGO, V126, P1469; Sue-Ling H M, 1994, Eur J Surg Oncol, V20, P179; WAGNER PK, 1991, BRIT J SURG, V78, P825, DOI 10.1002/bjs.1800780719; Wanebo HJ, 1997, J AM COLL SURGEONS, V185, P177, DOI 10.1016/S1072-7515(01)00901-2	22	1240	1304	0	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 25	1999	340	12					908	914		10.1056/NEJM199903253401202	http://dx.doi.org/10.1056/NEJM199903253401202			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180AM	10089184	Bronze			2022-12-28	WOS:000079362600002
J	Kasprzak, L; Foulkes, WD; Shelling, AN				Kasprzak, L; Foulkes, WD; Shelling, AN			Fortnightly review - Hereditary ovarian carcinoma	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ORAL-CONTRACEPTIVE USE; PROPHYLACTIC OOPHORECTOMY; POSTMENOPAUSAL WOMEN; BREAST-CANCER; MUTATIONS; BRCA1; RISK; GENE; FAMILIES; HETEROGENEITY		McGill Univ, Dept Med, Div Med Genet, Montreal, PQ H3G 1A4, Canada; Natl Womens Hosp, Dept Obstet & Gynaecol, Res Ctr Reprod Med, Auckland, New Zealand	McGill University	Foulkes, WD (corresponding author), Montreal Gen Hosp, Dept Med, L10-116,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	mdwf@musica.mcgill.ca	Shelling, Andrew/E-7496-2010; Foulkes, William D./AAR-9586-2021	Shelling, Andrew/0000-0002-5300-1934; Foulkes, William D./0000-0001-7427-4651				Aarnio M, 1995, INT J CANCER, V64, P430, DOI 10.1002/ijc.2910640613; Aida H, 1998, CLIN CANCER RES, V4, P235; AMOS CI, 1993, CANCER-AM CANCER SOC, V71, P566; AMOS CI, 1992, JAMA-J AM MED ASSOC, V268, P1896, DOI 10.1001/jama.268.14.1896; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; BEWTRA C, 1992, INT J GYNECOL PATHOL, V11, P180, DOI 10.1097/00004347-199207000-00003; Brunet JS, 1997, NEW ENGL J MED, V336, P1256; BULLER RE, 1995, GYNECOL ONCOL, V58, P368, DOI 10.1006/gyno.1995.1244; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P997, DOI 10.1001/jama.277.12.997; CAMPBELL S, 1989, BMJ-BRIT MED J, V299, P1363, DOI 10.1136/bmj.299.6712.1363; CHANG J, 1995, ANN ONCOL, V6, P80, DOI 10.1093/oxfordjournals.annonc.a059053; CLAUS EB, 1995, CANCER-AM CANCER SOC, V76, P1998, DOI 10.1002/1097-0142(19951115)76:10+<1998::AID-CNCR2820761316>3.0.CO;2-9; CUCKLE HS, 1990, OVARIAN CANCER BIOL, P229; FORD D, 1995, AM J HUM GENET, V57, P1457; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; FOULKES WD, 1998, INHERITED SUSCEPTIBI, P205; Gayther SA, 1997, NAT GENET, V15, P103, DOI 10.1038/ng0197-103; Godard B, 1998, AM J OBSTET GYNECOL, V179, P403, DOI 10.1016/S0002-9378(98)70372-2; GROSS TP, 1994, OBSTET GYNECOL, V83, P419; HANKINSON SE, 1992, OBSTET GYNECOL, V80, P708; JACOBS I, 1993, BRIT MED J, V306, P1030, DOI 10.1136/bmj.306.6884.1030; Johannsson OT, 1998, J CLIN ONCOL, V16, P397, DOI 10.1200/JCO.1998.16.2.397; JOLLY KW, 1994, ONCOGENE, V9, P97; KERBER RA, 1995, ARCH INTERN MED, V155, P905, DOI 10.1001/archinte.155.9.905; KERLIKOWSKE K, 1992, OBSTET GYNECOL, V80, P700; KURJAK A, 1992, OVARIAN CANCER, V2, P249; Liede A, 1998, AM J MED GENET, V75, P55, DOI 10.1002/(SICI)1096-8628(19980106)75:1<55::AID-AJMG12>3.0.CO;2-R; LYNCH HT, 1991, CANCER, V67, P1460, DOI 10.1002/1097-0142(19910301)67:5<1460::AID-CNCR2820670534>3.0.CO;2-S; MACKEY SE, 1995, J CLIN ONCOL, V13, P783, DOI 10.1200/JCO.1995.13.3.783; NAROD SA, 1994, CANCER-AM CANCER SOC, V74, P2341, DOI 10.1002/1097-0142(19941015)74:8<2341::AID-CNCR2820740819>3.0.CO;2-Z; Narod SA, 1998, NEW ENGL J MED, V339, P424, DOI 10.1056/NEJM199808133390702; NAROD SA, 1995, AM J HUM GENET, V56, P254; Parkin DM, 1997, CANC INCIDENCE 5 CON, VVII; PIVER MS, 1993, CANCER-AM CANCER SOC, V71, P582; PROSSER J, 1992, BRIT J CANCER, V65, P527, DOI 10.1038/bjc.1992.109; Roth S, 1998, BRIT J CANCER, V77, P1199, DOI 10.1038/bjc.1998.202; Rubin SC, 1996, NEW ENGL J MED, V335, P1413, DOI 10.1056/NEJM199611073351901; SELTZER V, 1995, JAMA-J AM MED ASSOC, V273, P491, DOI 10.1001/jama.1995.03520300065039; SerovaSinilnikova OM, 1997, AM J HUM GENET, V60, P1236; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; STEICHENGERSDORF E, 1994, AM J HUM GENET, V55, P870; Stratton JF, 1997, NEW ENGL J MED, V336, P1125, DOI 10.1056/NEJM199704173361602; TOBACMAN JK, 1982, LANCET, V2, P795; Tonin PN, 1998, AM J HUM GENET, V63, P1341, DOI 10.1086/302099; VANNAGELL JR, 1991, CANCER, V68, P458, DOI 10.1002/1097-0142(19910801)68:3<458::AID-CNCR2820680303>3.0.CO;2-3	46	22	23	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	1999	318	7186					786	+		10.1136/bmj.318.7186.786	http://dx.doi.org/10.1136/bmj.318.7186.786			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BX	10082707	Green Published			2022-12-28	WOS:000079421700031
J	Berger, A				Berger, A			Science commentary: what is involved in intracyoplasmic sperm injection?	BRITISH MEDICAL JOURNAL			English	Article																		Bonduelle M, 1996, HUM REPROD, V11, P131, DOI 10.1093/humrep/11.suppl_4.131; Storeng RT, 1998, ACTA OBSTET GYN SCAN, V77, P191, DOI 10.1034/j.1600-0412.1998.770212.x; Tuerlings JHAM, 1998, FERTIL STERIL, V69, P899, DOI 10.1016/S0015-0282(98)00050-8	3	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 13	1999	318	7185					705	705						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182JK	10074015				2022-12-28	WOS:000079495700025
J	Kitchener, HC; Symonds, P				Kitchener, HC; Symonds, P			Detection of cervical intraepithelial neoplasia in developing countries	LANCET			English	Editorial Material							VISUAL INSPECTION; CANCER		Univ Manchester, Acad Div Obstet & Gynaedol & Reprod Healthcare, Manchester M13 0JH, Lancs, England; Univ Leicester, Dept Clin Oncol, Leicester, Leics, England	University of Manchester; University of Leicester	Kitchener, HC (corresponding author), Univ Manchester, Acad Div Obstet & Gynaedol & Reprod Healthcare, Manchester M13 0JH, Lancs, England.							Cox TJ, 1999, LANCET, V353, P941; KJAER SK, 1999, P 17 INT PAP C CHARL, P333; LORINCZ AT, 1999, P 17 INT PAP C CHARL, P26; Nene BM, 1996, INT J CANCER, V68, P770, DOI 10.1002/(SICI)1097-0215(19961211)68:6<770::AID-IJC14>3.0.CO;2-4; PONTEN J, 1995, INT J CANCER, V60, P1, DOI 10.1002/ijc.2910600102; Sankaranarayanan R, 1998, CANCER-AM CANCER SOC, V83, P2150, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2150::AID-CNCR13>3.3.CO;2-S; SEHGAL A, 1991, LANCET, V338, P282, DOI 10.1016/0140-6736(91)90420-T; SINGH V, 1992, BRIT MED J, V304, P534, DOI 10.1136/bmj.304.6826.534; Wesley R, 1997, BRIT J CANCER, V75, P436, DOI 10.1038/bjc.1997.72; 1996, B WHO, V74, P345	10	47	48	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 13	1999	353	9156					856	857		10.1016/S0140-6736(98)00417-6	http://dx.doi.org/10.1016/S0140-6736(98)00417-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BU	10093972				2022-12-28	WOS:000079421400002
J	Carrington, M; Nelson, GW; Martin, MP; Kissner, T; Vlahov, D; Goedert, JJ; Kaslow, R; Buchbinder, S; Hoots, K; O'Brien, SJ				Carrington, M; Nelson, GW; Martin, MP; Kissner, T; Vlahov, D; Goedert, JJ; Kaslow, R; Buchbinder, S; Hoots, K; O'Brien, SJ			HLA and HIV-1: Heterozygote advantage and B*35-Cw*04 disadvantage	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CYTOTOXIC T-CELL; HEPATITIS-B VIRUS; CLASS-I MOLECULES; TYPE-1 INFECTION; DISEASE PROGRESSION; CHEMOKINE RECEPTOR; GENETIC-VARIATION; AIDS; COMPLEX	A selective advantage against infectious disease associated with increased heterozygosity at the human major histocompatibility complex [human Leukocyte antigen (HLA) class I and class II] is believed to play a major role in maintaining the extraordinary allelic diversity of these genes. Maximum HLA heterozygosity of class I loci (A, B, and C) delayed acquired immunodeficiency syndrome (AIDS) onset among patients infected with human immunodeficiency virus-type 1 (HIV-1), whereas individuals who were homozygous for one or more Loci progressed rapidly to AIDS and death. The HLA class I alleles B*35 and Cw*04 were consistently associated with rapid development of: AIDS-defining conditions in Caucasians. The extended survival of 28 to 40 percent of HIV1-infected Caucasian patients who avoided AIDS for ten or more years can be attributed to their being Fully heterozygous at HLA class I Loci, to their Lacking the AIDS-associated alleles B*35 and Cw*04, or to both.	NCI, Lab Genom Divers, Frederick, MD 21702 USA; NCI, Sci Applicat Corp Frederick, Intramural Res Support Program, Frederick, MD 21702 USA; Johns Hopkins Sch Hyg & Publ Hlth, Baltimore, MD 21205 USA; NCI, Viral Epidemiol Branch, Bethesda, MD 20892 USA; Univ Alabama Birmingham, Multictr Hemophilia Cohort Study, Birmingham, AL 35294 USA; San Francisco City Clin Cohort, San Francisco, CA 94102 USA; Univ Texas, Hlth Sci Ctr, Gulf States Hemophilia Ctr, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Health Science Center Houston	O'Brien, SJ (corresponding author), NCI, Lab Genom Divers, Frederick, MD 21702 USA.	obrien@mail.ncifcrf.gov	OBRIEN, STEPHEN/ABD-1346-2020	OBRIEN, STEPHEN/0000-0001-7857-0757	OFFICE OF THE DIRECTOR, NCI [N01CO056000] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-56000] Funding Source: Medline	OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAUR MP, 1984, HISTOCOMPATIBILITY T, P333; Black FL, 1997, P NATL ACAD SCI USA, V94, P12452, DOI 10.1073/pnas.94.23.12452; BLACK FL, 1992, SCIENCE, V258, P1739, DOI 10.1126/science.1465610; BODMER WF, 1989, MATH EVOLUTIONARY TH, P315; BROWN AJL, 1994, ANNU REV ECOL SYST, V25, P127, DOI 10.1146/annurev.ecolsys.25.1.127; Bruunsgaard H, 1997, SCAND J IMMUNOL, V46, P91, DOI 10.1046/j.1365-3083.1997.d01-98.x; BUCHBINDER SP, 1994, AIDS, V8, P1123, DOI 10.1097/00002030-199408000-00014; Bunce M, 1995, TISSUE ANTIGENS, V46, P355, DOI 10.1111/j.1399-0039.1995.tb03127.x; CEREB N, 1995, TISSUE ANTIGENS, V45, P1, DOI 10.1111/j.1399-0039.1995.tb02408.x; CHARRON D, 1997, GENETIC DIVERSITY HL; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; COX DR, 1972, J R STAT SOC B, V34, P187; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; DETELS R, 1994, J ACQ IMMUN DEF SYND, V12, P1263; Doherty P C, 1975, Nature, V256, P50; Donefield SM, 1998, SCIENCE, V280, P1819, DOI 10.1126/science.280.5371.1815f; DUBEY DP, 1994, J EXP MED, V179, P1193, DOI 10.1084/jem.179.4.1193; DUPONT B, 1995, IMMUNOBIOLOGY HLA; Evans DT, 1997, J IMMUNOL, V159, P1374; Gilbert SC, 1998, SCIENCE, V279, P1173, DOI 10.1126/science.279.5354.1173; GOEDERT JJ, 1989, NEW ENGL J MED, V321, P1141, DOI 10.1056/NEJM198910263211701; Gotch F, 1996, IMMUNOL LETT, V51, P125, DOI 10.1016/0165-2478(96)02566-7; Harrer T, 1996, AIDS RES HUM RETROV, V12, P585, DOI 10.1089/aid.1996.12.585; Haynes BF, 1996, SCIENCE, V271, P324, DOI 10.1126/science.271.5247.324; HEDRICK PW, 1991, P NATL ACAD SCI USA, V88, P5897, DOI 10.1073/pnas.88.13.5897; HILGARTNER MW, 1993, AM J PEDIAT HEMATOL, V15, P208; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Hughes AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/annurev.genet.32.1.415; ITESCU S, 1992, J ACQ IMMUN DEF SYND, V5, P37; Just JJ, 1995, HUM IMMUNOL, V44, P156, DOI 10.1016/0198-8859(95)00034-8; KHOURY MJ, 1993, FUNDAMENTAL GENETIC; KLEIN J, 1986, NATURAL HIST MAJOR H; KLEIN MR, 1994, J INFECT DIS, V169, P1244, DOI 10.1093/infdis/169.6.1244; KRONER BL, 1995, AIDS, V9, P275, DOI 10.1097/00002030-199509030-00009; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; Martin MP, 1998, IMMUNOGENETICS, V47, P131; McNicholl JM, 1997, EMERG INFECT DIS, V3, P261, DOI 10.3201/eid0303.970302; NOWAK MA, 1991, SCIENCE, V254, P963, DOI 10.1126/science.1683006; OBRIEN SJ, 1985, SCIENCE, V227, P1428, DOI 10.1126/science.2983425; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; PHAIR J, 1992, J ACQ IMMUN DEF SYND, V5, P490; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; SAHMOUD T, 1993, AIDS, V7, P497, DOI 10.1097/00002030-199304000-00007; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; SCHWEDER T, 1982, BIOMETRIKA, V69, P493; Shiga H, 1996, AIDS, V10, P1075, DOI 10.1097/00002030-199609000-00004; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Smith MW, 1998, SCIENCE, V280, P1820; Smith MW, 1997, NAT MED, V3, P1052, DOI 10.1038/nm1097-1052c; TAKAHATA N, 1990, GENETICS, V124, P967; THURSZ MR, 1995, NEW ENGL J MED, V332, P1065, DOI 10.1056/NEJM199504203321604; Thursz MR, 1997, NAT GENET, V17, P11, DOI 10.1038/ng0997-11; Tomiyama H, 1997, J IMMUNOL, V158, P5026; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; *US CDCP, 1992, MMWR-MORBID MORTAL W, V41, P1; *US CDCP, 1987, MORB MORTAL WKLY S1, V36, P1; VLAHOV D, 1991, NIDA RES MONOGR SER, V103; WATKINS DI, 1988, P NATL ACAD SCI USA, V85, P7714, DOI 10.1073/pnas.85.20.7714; Weir BS, 1990, GENETIC DATA ANAL; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389; Yang OO, 1997, J VIROL, V71, P3120, DOI 10.1128/JVI.71.4.3120-3128.1997	66	948	986	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	1999	283	5408					1748	1752		10.1126/science.283.5408.1748	http://dx.doi.org/10.1126/science.283.5408.1748			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175PF	10073943				2022-12-28	WOS:000079102800056
J	Grandbois, M; Beyer, M; Rief, M; Clausen-Schaumann, H; Gaub, HE				Grandbois, M; Beyer, M; Rief, M; Clausen-Schaumann, H; Gaub, HE			How strong is a covalent bond?	SCIENCE			English	Article							ATOMIC-FORCE MICROSCOPE; DNA	The rupture force of single covalent bonds under an external Load was measured with an atomic force microscope (AFM). Single polysaccharide molecules were covalently anchored between a surface and an AFM tip and then stretched until they became detached. By using different surface chemistries for the attachment, it was found that the silicon-carbon bond ruptured at 2.0 +/- 0.3 nanonewtons, whereas the sulfur-gold anchor ruptured at 1.4 +/- 0.3 nanonewtons at force-loading rates of 10 nanonewtons per second. Bond rupture probability calculations that were based on density functional theory corroborate the measured values.	Univ Munich, Lehrstuhl Angew Phys, D-80799 Munich, Germany; Tech Univ Munich, Inst Phys & Theoret Chem, D-85748 Garching, Germany; Stanford Univ, Sch Med, Dept Biochem B400, Stanford, CA 94305 USA	University of Munich; Technical University of Munich; Stanford University	Gaub, HE (corresponding author), Univ Munich, Lehrstuhl Angew Phys, Amalienstr 54, D-80799 Munich, Germany.		Beyer, Martin/A-5793-2009; Clausen-Schaumann, Hauke/W-1830-2017	Beyer, Martin/0000-0001-9373-9266; Clausen-Schaumann, Hauke/0000-0002-9413-0310				BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Chatellier X, 1998, EUROPHYS LETT, V41, P303, DOI 10.1209/epl/i1998-00147-6; Cluzel P, 1996, SCIENCE, V271, P792, DOI 10.1126/science.271.5250.792; Dammer U, 1996, BIOPHYS J, V70, P2437, DOI 10.1016/S0006-3495(96)79814-4; DEGENNES PG, 1976, J PHYS-PARIS, V37, P1445, DOI 10.1051/jphys:0197600370120144500; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; FRISCH MJ, 1995, GAUSSIAN 94; HUHEEY JE, ANORGANISCHE CHEM; Jarvis SP, 1996, NATURE, V384, P247, DOI 10.1038/384247a0; LEE H, 1998, ADV MATER, V3, P316; LOFAS S, 1990, J CHEM SOC CHEM COMM, P1526, DOI 10.1039/c39900001526; Marszalek PE, 1998, NATURE, V396, P661, DOI 10.1038/25322; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; RADMACHER M, 1994, SCIENCE, V265, P1577, DOI 10.1126/science.8079171; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1997, SCIENCE, V275, P1295, DOI 10.1126/science.275.5304.1295; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; VINCENT PI, 1972, POLYMER, V13, P558, DOI 10.1016/0032-3861(72)90116-4	21	832	860	7	306	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	1999	283	5408					1727	1730		10.1126/science.283.5408.1727	http://dx.doi.org/10.1126/science.283.5408.1727			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175PF	10073936				2022-12-28	WOS:000079102800049
J	Carrion, AM; Link, WA; Ledo, F; Mellstrom, B; Naranjo, JR				Carrion, AM; Link, WA; Ledo, F; Mellstrom, B; Naranjo, JR			DREAM is a Ca2+-regulated transcriptional repressor	NATURE			English	Article							GENE-EXPRESSION; CALCIUM; PATHWAYS; FOS; ACTIVATION; NEURONS; KINASES	Fluxes in amounts of intracellular calcium ions are important determinants of gene expression(1-3). So far, Ca2+-regulated kinases and phosphatases have been implicated in changing the phosphorylation status of key transcription factors and thereby modulating their function(4,5). In addition, direct effecters of Ca2+ induced gene expression have been suggested to exist in the nucleus(2), although no such effecters have been identified yet. Expression of the human prodynorphin gene, which is involved in memory acquisition and pain(6,7), is regulated through its downstream regulatory element (DRE) sequence, which acts as a location-dependent gene silencer(8). Here we isolate a new transcriptional repressor, DRE-antagonist modulator (DREAM), which specifically binds to the DRE. DREAM contains four Ca2+-binding domains of the EF-hand type. Upon stimulation by Ca2+, DREAM's ability to bind to the DRE and its repressor function are prevented. Mutation of the EF-hands abolishes the response of DREAM to Ca2+. In addition to the prodynorphin promoter, DREAM represses transcription from the early response gene c-fos. Thus, DREAM represents the first known Ca2+-binding protein to function as a DNA-binding transcriptional regulator.	CSIC, Inst Neurobiol S Ramon & Cajal, Madrid 28002, Spain	Consejo Superior de Investigaciones Cientificas (CSIC)	Naranjo, JR (corresponding author), CSIC, Inst Neurobiol S Ramon & Cajal, Av Dr Arce 37, Madrid 28002, Spain.	jrnaranjo@samba.cnb.uam.es	Carrion, Angel Manuel/K-5875-2014; Link, Wolfgang/F-4435-2012; NARANJO, Jose R/K-1950-2014	Carrion, Angel Manuel/0000-0001-8158-9512; Link, Wolfgang/0000-0002-3340-5165; NARANJO, Jose R/0000-0002-0270-3469				BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Carrion AM, 1998, MOL CELL BIOL, V18, P6921, DOI 10.1128/MCB.18.12.6921; CORNELIUSSEN B, 1994, NATURE, V368, P760, DOI 10.1038/368760a0; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; EHRLICH BE, 1994, TRENDS PHARMACOL SCI, V15, P145, DOI 10.1016/0165-6147(94)90074-4; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; HERNANDEZCRUZ A, 1990, SCIENCE, V247, P858, DOI 10.1126/science.2154851; Johnson CM, 1997, J NEUROSCI, V17, P6189; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; NAKAYAMA S, 1994, ANNU REV BIOPH BIOM, V23, P473, DOI 10.1146/annurev.bb.23.060194.002353; NARANJO JR, 1991, NEURON, V6, P607, DOI 10.1016/0896-6273(91)90063-6; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Stegh AH, 1998, EMBO J, V17, P5974, DOI 10.1093/emboj/17.20.5974; WEISSKOPF MG, 1993, NATURE, V362, P423, DOI 10.1038/362423a0	18	479	499	1	24	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 4	1999	398	6722					80	84		10.1038/18044	http://dx.doi.org/10.1038/18044			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174KG	10078534				2022-12-28	WOS:000079033900056
J	Sigal, LJ; Crotty, S; Andino, R; Rock, KL				Sigal, LJ; Crotty, S; Andino, R; Rock, KL			Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen	NATURE			English	Article							MHC CLASS-I; MAJOR HISTOCOMPATIBILITY COMPLEX; HUMAN POLIOVIRUS RECEPTOR; MINOR H-ANTIGENS; VACCINIA VIRUS; TRANSGENIC MICE; CROSS-REACT; MOLECULES; PATHWAY; VIVO	Cytotoxic T lymphocytes (CTLs) are thought to detect viral infections by monitoring the surface of all cells for the presence of viral peptides bound to major histocompatibility complex (MHC) class I molecules. In most cells, peptides presented by MHC class I molecules are derived exclusively from proteins synthesized by the antigen-bearing cells'. Macrophages and dendritic cells also have an alternative MHC class I pathway that can present peptides derived from extracellular antigens; however, the physiological role of this process is unclear(2). Here we show that virally infected non-haematopoietic cells are unable to stimulate primary CTL-mediated immunity directly. Instead, bone-marrow-derived cells are required as antigen-presenting cells (APCs) to initiate anti-viral CTL responses. In these APCs, the alternative (exogenous) MHC class I pathway is the obligatory mechanism for the initiation of CTL responses to viruses that infect only non-haematopoietic cells.	Univ Massachusetts, Med Ctr, Dept Pathol, Worcester, MA 01655 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Francisco	Rock, KL (corresponding author), Univ Massachusetts, Med Ctr, Dept Pathol, Worcester, MA 01655 USA.		Crotty, Shane/AAE-8446-2019; Sigal, Luis/AAL-1849-2021; Crotty, Shane/AAC-6703-2019	Crotty, Shane/0000-0002-6484-6262; Sigal, Luis/0000-0001-6642-5472				Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; BACHMANN MF, 1995, EUR J IMMUNOL, V25, P1739, DOI 10.1002/eji.1830250637; BEVAN MJ, 1976, J IMMUNOL, V117, P2233; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; BULLER RML, 1985, NATURE, V317, P813, DOI 10.1038/317813a0; Huang AYC, 1996, IMMUNITY, V4, P349, DOI 10.1016/S1074-7613(00)80248-4; KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; KUNDIG TM, 1995, SCIENCE, V268, P1343, DOI 10.1126/science.7761853; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; LEE MS, 1992, J VIROL, V66, P2617, DOI 10.1128/JVI.66.5.2617-2630.1992; MNDL S, 1998, P NATL ACAD SCI USA, V95, P8216; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; PFEIFER JD, 1993, NATURE, V361, P359, DOI 10.1038/361359a0; Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248; REN R, 1992, J VIROL, V66, P296, DOI 10.1128/JVI.66.1.296-304.1992; REN R, 1990, CELL, V63, P353, DOI 10.1016/0092-8674(90)90168-E; RESTIFO NP, 1995, J IMMUNOL, V154, P4414; Rock KL, 1996, J IMMUNOL, V156, P3721; Rock KL, 1996, IMMUNOL TODAY, V17, P131, DOI 10.1016/0167-5699(96)80605-0; ROTZSCHKE O, 1991, EUR J IMMUNOL, V21, P2891, DOI 10.1002/eji.1830211136; Shen ZH, 1997, J IMMUNOL, V158, P2723; Sigal LJ, 1998, J IMMUNOL, V161, P2740; SOUSA CRE, 1995, J EXP MED, V182, P841, DOI 10.1084/jem.182.3.841; TAYLOR G, 1991, J GEN VIROL, V72, P125, DOI 10.1099/0022-1317-72-1-125; VANKAER L, 1992, CELL, V71, pS120; York IA, 1996, ANNU REV IMMUNOL, V14, P369, DOI 10.1146/annurev.immunol.14.1.369; ZINKERNAGEL RM, 1980, CLIN IMMUNOL IMMUNOP, V15, P565, DOI 10.1016/0090-1229(80)90067-7	29	474	486	0	5	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 4	1999	398	6722					77	80		10.1038/18038	http://dx.doi.org/10.1038/18038			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174KG	10078533				2022-12-28	WOS:000079033900055
J	Hannon, GJ; Sun, PQ; Carnero, A; Xie, LY; Maestro, R; Conklin, DS; Beach, D				Hannon, GJ; Sun, PQ; Carnero, A; Xie, LY; Maestro, R; Conklin, DS; Beach, D			Molecular genetics - MaRX: An approach to genetics in mammalian cells	SCIENCE			English	Article							TRANSFORMATION; YEAST; CDNA; LIBRARIES; CLONING		Inst Child Hlth, London WC1N 1EH, England; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Genetica Inc, Cold Spring Harbor, NY 11724 USA; Ctr Riferimento Oncol, I-33081 Aviano, Italy	University of London; University College London; Cold Spring Harbor Laboratory; IRCCS Aviano (CRO)	Beach, D (corresponding author), Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England.		IBIS, CANCER/P-3323-2015; Maestro, Roberta/P-9748-2019; Maestro, Roberta/M-1846-2015; Hannon, Gregory/AAB-3568-2019	Maestro, Roberta/0000-0002-6642-5592; Maestro, Roberta/0000-0002-6642-5592; Conklin, Douglas/0000-0003-4922-4307; Carnero, Amancio/0000-0003-4357-3979				BEACH D, 1981, NATURE, V290, P140, DOI 10.1038/290140a0; BEADLE GW, 1941, P NATL ACAD SCI USA, V27, P541; BEGGS JD, 1978, NATURE, V275, P104, DOI 10.1038/275104a0; CAMERO A, UNPUB; CONKLIN DS, UNPUB; DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15; GOLDFARB M, 1982, NATURE, V296, P404, DOI 10.1038/296404a0; GUDKOV AV, 1993, P NATL ACAD SCI USA, V90, P3231, DOI 10.1073/pnas.90.8.3231; HINNEN A, 1978, P NATL ACAD SCI USA, V75, P1929, DOI 10.1073/pnas.75.4.1929; Hudson John W., UNPUB; MAESTRO R, UNPUB; Nellen W, 1996, MOL BIOTECHNOL, V6, P7, DOI 10.1007/BF02762319; RAYNER JR, 1994, MOL CELL BIOL, V14, P880, DOI 10.1128/MCB.14.2.880; SLATER ML, 1976, CELL, V7, P289, DOI 10.1016/0092-8674(76)90028-3; SUN P, UNPUB; Sun PQ, 1998, SCIENCE, V282, P2270, DOI 10.1126/science.282.5397.2270; WHITEHEAD I, 1995, MOL CELL BIOL, V15, P704	17	80	87	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 19	1999	283	5405					1129	1130		10.1126/science.283.5405.1129	http://dx.doi.org/10.1126/science.283.5405.1129			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169GD	10075573				2022-12-28	WOS:000078738400036
J	Miller, V; Mocroft, A; Reiss, P; Katlama, C; Papadopoulos, AI; Katzenstein, T; van Lunzen, J; Antunes, F; Phillips, AN; Lundgren, JD				Miller, V; Mocroft, A; Reiss, P; Katlama, C; Papadopoulos, AI; Katzenstein, T; van Lunzen, J; Antunes, F; Phillips, AN; Lundgren, JD		EuroSIDA Study Grp	Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: Results from the EuroSIDA study	ANNALS OF INTERNAL MEDICINE			English	Article						human immunodeficiency; virus infections; disease progression; CD4 lymphocyte count; anti-HIV agents; acquired immunodeficiency syndrome	IMMUNODEFICIENCY-VIRUS INFECTION; CUBIC MILLIMETER; RITONAVIR; INHIBITOR; INDINAVIR; MORTALITY; PROTEASE; MARKERS; ADULTS; EUROPE	Background: The effect of previous CD4 cell count nadir on clinical progression in patients with increases in CD4 cell counts has not been investigated. Objective: To assess risk for progression of HIV disease in patients with CD4 counts of at least 200 cells/mm(3) (stratified by the lowest previous CD4 count) and compare the rate of progression in patients with CD4 counts less than 50 cells/ mm(3) with that in patients whose CD4 counts rebounded from less than 50 cells/mm(3) to at least 200 cells/mm(3) Design: Prospective, observational multicenter study, Setting: 52 HIV outpatient clinics in Europe. Patients: Two groups were identified: those with CD4 counts of at least 200 cells/mm(3) (group A) and those with CD4 counts less than 50 cells/mm(3) (group B). Group A was stratified according to the lowest previous CD4 count: at least 150 cells/mm(3) (stratum 1), 100 to 149 cells/mm(3) (stratum 2), 50 to 99 cells/mm(3) (stratum 3), and 1 to 50 cells/ mm(3) (stratum 4). Measurements: Patients were followed until a progression event occurred (first AIDS-defining event, new AIDS-defining event, or death) or until the CD4 count decreased to less than 200 cells/mm(3) (group A) or increased to more than 50 cells/mm(3) (group B). Incidence rates were based on a patient-years analysis and reported as events per 100 patient-years of follow-up; the relative hazards for progression were based on Cox proportional hazards models. Results: The overall rate of disease progression in group A was 3.9 per 100 patient-years (95% CI, 3.5 to 4.3 per 100 patient-years), whereas in group B it was much higher (72.9 per 100 patient-years [CI, 69.0 to 76.8 per 100 patient-years]). in group A, the rate increased in patients with previous low CD4 cell count nadirs, resulting in a significant increase in the relative hazard for progression. The relative hazards for strata 2, 3, and 4 were 2.29 (CI, 1.30 to 4.03), 3.65 (CI, 1.94 to 6.85), and 2.94 (CI, 1.44 to 6.00), respectively. Conclusions: Increases in CD4 counts from very low levels to at least 200 cells/mm(3) are associated with a much reduced rate of disease progression. However, a previously low CD4 cell count nadir remains associated with a moderately higher risk for disease progression among patients with CD4 counts of at least 200 cells/mm(3).	Goethe Univ Frankfurt, Zentrum Inneren Med, Infekt Ambulanz Haus 68, D-60590 Frankfurt, Germany; Univ Hamburg, Hosp Eppendorf, Zentrum Inneren Med, Infekt Ambulanz, D-20246 Hamburg, Germany; UCL Royal Free & Univ Coll Med Sch, Royal Free Ctr HIV Med, London NW3 2PF, England; Univ Amsterdam, Acad Med Ctr, NATEC, NL-1105 AZ Amsterdam, Netherlands; Hop La Pitie Salpetriere, Dept Trop Med, F-75013 Paris, France; 1st IKA Hosp Penteli, Athens 15127, Greece; 7721 Rigshosp, Dept Infect Dis, DK-2200 Copenhagen N, Denmark; Univ Copenhagen, Hvidovre Hosp, Dept Infect Dis, DK-2650 Hvidovre, Denmark; Hosp Santa Maria, Dept Infect Dis, P-1600 Lisbon, Portugal	Goethe University Frankfurt; University of Hamburg; University of London; University College London; UCL Medical School; University of Amsterdam; Academic Medical Center Amsterdam; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Copenhagen; Universidade de Lisboa; Hospital Santa Maria	Miller, V (corresponding author), Univ Frankfurt Klinikum, Zentrum Inneren Med, Infekt Ambulanz Haus 68, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	miller@em.uni-frankfurt.de	PAPADOPOULOS, ANTONIOS/AAD-7808-2019; Mocroft, Amanda/C-1527-2008; Phillips, Andrew N/B-4427-2008; Mocroft, Amanda/G-8748-2011; Lundgren, Jens/AAE-6876-2019	Phillips, Andrew N/0000-0003-2384-4807; Mocroft, Amanda/0000-0001-8316-1122; Antunes, Francisco/0000-0001-7932-1154; Katzenstein, Terese L/0000-0002-2233-500X; Lundgren, Jens/0000-0001-8901-7850; Johnson, Anne/0000-0003-1330-7100				*1997 USPHS IDSA, 1997, ANN INTERN MED, V127, P922; Angel JB, 1998, J INFECT DIS, V177, P898, DOI 10.1086/515244; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Brodt HR, 1997, AIDS, V11, P1731, DOI 10.1097/00002030-199714000-00010; DANNER SA, 1995, NEW ENGL J MED, V333, P1528, DOI 10.1056/NEJM199512073332303; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Katzenstein DA, 1996, NEW ENGL J MED, V335, P1091, DOI 10.1056/NEJM199610103351502; Kelleher AD, 1996, J INFECT DIS, V173, P321, DOI 10.1093/infdis/173.2.321; Kirk O, 1998, AIDS, V12, P2031, DOI 10.1097/00002030-199815000-00015; Marschner IC, 1998, J INFECT DIS, V177, P40, DOI 10.1086/513823; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; OBrien WA, 1997, ANN INTERN MED, V126, P939, DOI 10.7326/0003-4819-126-12-199706150-00002; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Sepkowitz KA, 1998, LANCET, V351, P228, DOI 10.1016/S0140-6736(05)78279-9	16	123	127	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 6	1999	130	7					570	577		10.7326/0003-4819-130-7-199904060-00005	http://dx.doi.org/10.7326/0003-4819-130-7-199904060-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183BG	10189326				2022-12-28	WOS:000079533300004
J	Schuurmans, FJP; Vanmaekelbergh, D; van de Lagemaat, J; Lagendijk, A				Schuurmans, FJP; Vanmaekelbergh, D; van de Lagemaat, J; Lagendijk, A			Strongly photonic macroporous gallium phosphide networks	SCIENCE			English	Article							INTERNAL-REFLECTION; DISORDERED MEDIUM; TRANSPORT; LIGHT; GAP; LOCALIZATION	A photo-assisted electrochemical etching technique to fabricate macropores in single-crystalline gallium phosphide (GaP) with variable porosity has been developed. Scanning electron microscopy and x-ray diffraction experiments confirm that the material consists of three-dimensional, interconnected random networks with pore sizes of about 150 nanometers. Optical transmission measurements demonstrate that the nonabsorbing disordered structures strongly scatter Light. The photonic strength is controlled by filling the pores with liquids of different refractive indices, Macroporous gallium phosphide filled with air has the highest scattering efficiency for Visible light.	Univ Amsterdam, VanderWaals Zeeman Inst, NL-1018 XE Amsterdam, Netherlands; Univ Utrecht, Debye Inst, NL-3508 TA Utrecht, Netherlands	University of Amsterdam; Utrecht University	Schuurmans, FJP (corresponding author), Univ Amsterdam, VanderWaals Zeeman Inst, Valckenlerstr 65, NL-1018 XE Amsterdam, Netherlands.		Vanmaekelbergh, Daniël/G-2104-2010; van de Lagemaat, Jao/J-9431-2012; Lagendijk, Ad/I-5409-2013	van de Lagemaat, Jao/0000-0001-5851-6163				ANDERSON PW, 1985, PHILOS MAG B, V52, P505, DOI 10.1080/13642818508240619; ASPNES DE, 1983, PHYS REV B, V27, P985, DOI 10.1103/PhysRevB.27.985; BRESSER W, 1986, PHYS REV LETT, V56, P2493, DOI 10.1103/PhysRevLett.56.2493; BUSCH K, 1995, PHYS REV LETT, V75, P3442, DOI 10.1103/PhysRevLett.75.3442; CHASE BD, 1972, J ELECTROCHEM SOC, V119, P314, DOI 10.1149/1.2404193; DATTA S, 1993, PHYS REV B, V48, P14936, DOI 10.1103/PhysRevB.48.14936; DURIAN DJ, 1994, PHYS REV E, V50, P857, DOI 10.1103/PhysRevE.50.857; ERNE BH, 1995, ADV MATER, V7, P739, DOI 10.1002/adma.19950070813; GENACK AZ, 1987, PHYS REV LETT, V58, P2043, DOI 10.1103/PhysRevLett.58.2043; Gruning U, 1996, APPL PHYS LETT, V68, P747, DOI 10.1063/1.116729; Holland BT, 1998, SCIENCE, V281, P538, DOI 10.1126/science.281.5376.538; Ishimaru A., 1978, WAVE PROPAGATION SCA, VII; Ishimaru A., 1978, WAVE PROPAGATION SCA, V1; JOHN S, 1984, PHYS REV LETT, V53, P2169, DOI 10.1103/PhysRevLett.53.2169; LAGENDIJK A, 1989, PHYS LETT A, V136, P81, DOI 10.1016/0375-9601(89)90683-X; LAMB W, 1980, PHYS REV B, V21, P2248, DOI 10.1103/PhysRevB.21.2248; LANDAUER R, 1978, AM I PHYSICS C P, V40; Marin FI, 1996, J ELECTROCHEM SOC, V143, P1137, DOI 10.1149/1.1836597; Sheng P., 1995, INTRO WAVE SCATTERIN, Vsecond; Vanmaekelbergh D, 1998, PHYS REV LETT, V80, P821, DOI 10.1103/PhysRevLett.80.821; Warren B, 1990, XRAY DIFFRACTION, P253; WIERSMA DS, 1995, PHYS REV LETT, V74, P4193, DOI 10.1103/PhysRevLett.74.4193; Wiersma DS, 1997, NATURE, V390, P671, DOI 10.1038/37757; Wijnhoven JEGJ, 1998, SCIENCE, V281, P802, DOI 10.1126/science.281.5378.802; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059; ZENER C, 1934, P ROYAL SOC, V145, P523, DOI DOI 10.1098/RSPA.1934.0116; ZHU JX, 1991, PHYS REV A, V44, P3948, DOI 10.1103/PhysRevA.44.3948	27	162	179	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 2	1999	284	5411					141	143		10.1126/science.284.5411.141	http://dx.doi.org/10.1126/science.284.5411.141			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182QE	10102813				2022-12-28	WOS:000079509000052
J	Soengas, MS; Alarcon, RM; Yoshida, H; Giaccia, AJ; Hakem, R; Mak, TW; Lowe, SW				Soengas, MS; Alarcon, RM; Yoshida, H; Giaccia, AJ; Hakem, R; Mak, TW; Lowe, SW			Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition	SCIENCE			English	Article							MYC-INDUCED APOPTOSIS; SUPPRESSOR GENES; P53; PROTEIN	The ability of p53 to promote apoptosis in response to mitogenic oncogenes appears to be critical for its tumor suppressor function, Caspase-9 and its cofactor Apaf-1 were found to be essential downstream components of p53 in Myc-induced apoptosis. Like p53 null cells, mouse embryo fibroblast cells deficient in Apaf-1 and caspase-9, and expressing c-Myc, were resistant to apoptotic stimuli that mimic conditions in developing tumors. Inactivation of Apaf-1 or caspase-9 substituted for p53 Loss in promoting the oncogenic transformation of Myc-expressing cells. These results imply a role for Apaf-1 and caspase-9 in controlling tumor development.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Stanford Univ, Med Ctr, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA; Univ Toronto, Ontario Canc Inst, Dept Med Biophys & Immunol, Toronto, ON M5G 2C1, Canada; Univ Toronto, Amgen Inst, Toronto, ON M5G 2C1, Canada	Cold Spring Harbor Laboratory; Stanford University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Lowe, SW (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.		Soengas, Maria S/H-6455-2015	Soengas, Maria S/0000-0003-0612-6299; Hakem, Razqallah/0000-0001-5948-7931	NATIONAL CANCER INSTITUTE [R01CA064489, P01CA013106] Funding Source: NIH RePORTER; NCI NIH HHS [CA64489, CA13106] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; CHENG NC, 1995, ONCOGENE, V10, P291; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Fearnhead HO, 1998, P NATL ACAD SCI USA, V95, P13664, DOI 10.1073/pnas.95.23.13664; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hatta Y, 1997, BRIT J CANCER, V75, P1256, DOI 10.1038/bjc.1997.214; HERMEKING H, 1994, SCIENCE, V265, P2091, DOI 10.1126/science.8091232; Hu YM, 1998, J BIOL CHEM, V273, P33489, DOI 10.1074/jbc.273.50.33489; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; KOMURO H, 1993, CANCER RES, V53, P5284; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Lanni JS, 1997, P NATL ACAD SCI USA, V94, P9679, DOI 10.1073/pnas.94.18.9679; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; LOWE SW, 1993, GENE DEV, V7, P535, DOI 10.1101/gad.7.4.535; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; McCarthy NJ, 1997, J CELL BIOL, V136, P215, DOI 10.1083/jcb.136.1.215; McCurrach ME, 1997, P NATL ACAD SCI USA, V94, P2345, DOI 10.1073/pnas.94.6.2345; MIYASHITA T, 1995, CELL, V80, P293; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; PALMERO I, 1998, NATURE, V92, P713; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; Radfar A, 1998, P NATL ACAD SCI USA, V95, P13194, DOI 10.1073/pnas.95.22.13194; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; WAGNER AJ, 1994, GENE DEV, V8, P2817, DOI 10.1101/gad.8.23.2817; WANG X, 1998, GENE DEV, V12, P1764; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Yang XL, 1998, SCIENCE, V281, P1355, DOI 10.1126/science.281.5381.1355; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; YUAN J, UNPUB; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	48	566	587	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 2	1999	284	5411					156	159		10.1126/science.284.5411.156	http://dx.doi.org/10.1126/science.284.5411.156			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182QE	10102818				2022-12-28	WOS:000079509000057
J	Menell, JS; Cesarman, GM; Jacovina, AT; McLaughlin, MA; Lev, EA; Hajjar, KA				Menell, JS; Cesarman, GM; Jacovina, AT; McLaughlin, MA; Lev, EA; Hajjar, KA			Annexin II and bleeding in acute promyelocytic leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANS-RETINOIC ACID; DISSEMINATED INTRAVASCULAR COAGULATION; TISSUE-PLASMINOGEN-ACTIVATOR; ENDOTHELIAL-CELL RECEPTOR; DIFFERENTIATION THERAPY; UROKINASE ACTIVITY; TRANEXAMIC ACID; SURFACE; EXPRESSION; TRANSCRIPTION	Background Acute promyelocytic leukemia (APL) is associated with a hemorrhagic disorder of unknown cause that responds to treatment with all trans-retinoic acid. Methods We studied a newly described receptor for fibrinolytic proteins, annexin II, in cells from patients with APL or other leukemias. We examined initial rates of in vitro generation of plasmin by tissue plasminogen activator (t-PA) in the presence of APL cells that did or did not have the characteristic translocation of APL, t(15;17). We also determined the effect of all-trans-retinoic acid on the expression of annexin II and the generation of cell-surface plasmin. Results The expression of annexin II, as detected by a fluorescein-tagged antibody, was greater on leukemic cells from patients with APL than on other types of leukemic cells (mean fluorescence intensity, 6.9 and 2.9, respectively; P<0.01). The t(15;17)-positive APL cells stimulated the generation of cell-surface, t-PA-dependent plasmin twice as efficiently as the t(15;17)-negative cells. This increase in plasmin was blocked by an anti-annexin II antibody and was induced by transfection of t(15;17)-negative cells with annexin II complementary DNA. The t(15;17)positive APL cells contained abundant messenger RNA for annexin II, which disappeared through a transcriptional mechanism after treatment with all-trans-retinoic acid. Conclusions Abnormally high levels of expression of annexin II on APL cells increase the production of plasmin, a fibrinolytic protein. Overexpression of annexin II may be a mechanism for the hemorrhagic complications of APL. (N Engl J Med 1999;340:994-1004,) (C)1999, Massachusetts Medical Society.	Cornell Univ, Weill Med Coll, Dept Pediat, Div Hematol Oncol, New York, NY USA; Cornell Univ, Weill Med Coll, Dept Med, New York, NY USA; Inst Nacl Nutr Salvador Zubiran, Dept Med, Div Hematol Oncol, Mexico City 14000, DF, Mexico; Mt Sinai Med Ctr, Dept Med, Div Cardiol, New York, NY 10029 USA	Cornell University; Cornell University; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Icahn School of Medicine at Mount Sinai	Menell, JS (corresponding author), Columbia Univ Coll Phys & Surg, 180 Ft Washington Ave,HP5, New York, NY 10032 USA.	menellj@sjhmc.org		Cesarman-Maus, Gabriela Cesarman/0000-0002-8397-0330	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046403, R01HL058981, R01HL042493] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 46403, HL 42493, HL 58981] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AOKI N, 1977, J CLIN INVEST, V60, P361, DOI 10.1172/JCI108784; AVVISATI G, 1989, LANCET, V2, P122; AVVISATI G, 1988, BRIT J HAEMATOL, V70, P43, DOI 10.1111/j.1365-2141.1988.tb02432.x; BAUER KA, 1984, BLOOD, V64, P791; BAUER KA, 1984, J CLIN INVEST, V74, P2033, DOI 10.1172/JCI111626; BENNETT B, 1989, BRIT J HAEMATOL, V71, P511, DOI 10.1111/j.1365-2141.1989.tb06311.x; BENNETT M, 1976, BRIT MED J, V2, P565, DOI 10.1136/bmj.2.6035.565; CASTAIGNE S, 1990, BLOOD, V76, P1704; CESARMAN GM, 1994, J BIOL CHEM, V269, P21198; CHANG KS, 1992, BLOOD, V79, P1802; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; DALTON WT, 1988, BLOOD, V71, P242; DOMBRET H, 1995, LEUKEMIA, V9, P19; DOMBRET H, 1993, LEUKEMIA, V7, P2; Escudier SM, 1996, LEUKEMIA LYMPHOMA, V20, P435, DOI 10.3109/10428199609052425; FALCONE DJ, 1995, FASEB J, V9, pA412; Federici AB, 1996, BRIT J HAEMATOL, V92, P733, DOI 10.1046/j.1365-2141.1996.401939.x; FEDERICI AB, 1993, BLOOD, V81, P720; FENAUX P, 1993, BLOOD, V82, P3241; FRANCIS RB, 1987, J LAB CLIN MED, V110, P541; FRANKEL SR, 1994, ANN INTERN MED, V120, P278, DOI 10.7326/0003-4819-120-4-199402150-00004; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GRIGNANI F, 1994, BLOOD, V83, P10; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; HAJJAR KA, 1986, J BIOL CHEM, V261, P1656; HAJJAR KA, 1994, J BIOL CHEM, V269, P21191; Hajjar KA, 1996, J BIOL CHEM, V271, P21652, DOI 10.1074/jbc.271.35.21652; Hajjar KA, 1997, ANN NY ACAD SCI, V811, P337, DOI 10.1111/j.1749-6632.1997.tb52013.x; Hajjar KA, 1998, NATHAN OSKIS HEMATOL, P1557; HASHIMOTO S, 1994, LEUKEMIA, V8, P1113; Hembrough TA, 1996, J BIOL CHEM, V271, P25684, DOI 10.1074/jbc.271.41.25684; HU ZB, 1993, LEUKEMIA, V7, P1817; HUANG KS, 1986, CELL, V46, P191, DOI 10.1016/0092-8674(86)90736-1; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; IMAOKA S, 1986, CANCER-AM CANCER SOC, V58, P1736, DOI 10.1002/1097-0142(19861015)58:8<1736::AID-CNCR2820580825>3.0.CO;2-8; KARIO K, 1992, THROMB RES, V66, P435, DOI 10.1016/0049-3848(92)90292-I; KEANE TJ, 1976, ACTA HAEMATOL-BASEL, V56, P202, DOI 10.1159/000207938; LANOTTE M, 1991, BLOOD, V77, P1080; MILLER WH, 1993, BLOOD, V82, P1689; MYERS TJ, 1981, BLOOD, V57, P518; OGSTON D, 1968, J CLIN PATHOL, V21, P136, DOI 10.1136/jcp.21.2.136; PLOW EF, 1986, J CELL BIOL, V103, P2411, DOI 10.1083/jcb.103.6.2411; Rand JH, 1997, NEW ENGL J MED, V337, P1327; Rand JH, 1997, NEW ENGL J MED, V337, P154, DOI 10.1056/NEJM199707173370303; RUNDE V, 1992, BLOOD, V79, P534; SAKATA Y, 1991, BLOOD, V77, P1949; SARKAR A, 1994, BLOOD, V84, P279; SCHWARTZ BS, 1986, ANN INTERN MED, V105, P873, DOI 10.7326/0003-4819-105-6-873; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; STERRENBERG L, 1985, HAEMOSTASIS, V15, P126; SUGAWARA T, 1992, ACTA HAEMATOL-BASEL, V87, P109; TALLMAN MS, 1992, BLOOD, V79, P543; TAPIOVAARA H, 1994, BLOOD, V83, P1883; TAPIOVAARA H, 1993, BLOOD, V82, P914; THOMPSON J, 1987, ANAL BIOCHEM, V163, P281, DOI 10.1016/0003-2697(87)90225-9; WARRELL RP, 1991, NEW ENGL J MED, V324, P1385, DOI 10.1056/NEJM199105163242002; WARRELL RP, 1993, NEW ENGL J MED, V329, P177, DOI 10.1056/NEJM199307153290307; WU XZ, 1993, AM J HEMATOL, V43, P183, DOI 10.1002/ajh.2830430305; ZOKAS L, 1987, J CELL BIOL, V105, P2111, DOI 10.1083/jcb.105.5.2111	60	268	293	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 1	1999	340	13					994	1004		10.1056/NEJM199904013401303	http://dx.doi.org/10.1056/NEJM199904013401303			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182GA	10099141				2022-12-28	WOS:000079489800003
J	Castro-Tirado, AJ; Zapatero-Osorio, MR; Caon, N; Cairos, LM; Hjorth, J; Pedersen, H; Andersen, MI; Gorosabel, J; Bartolini, C; Guarnieri, A; Piccioni, A; Frontera, F; Masetti, N; Palazzi, E; Pian, E; Greiner, J; Hudec, R; Sagar, R; Pandey, AK; Mohan, V; Yadav, RKS; Nilakshi; Bjornsson, G; Jakobsson, P; Burud, I; Courbin, F; Valentini, G; Piersimoni, A; Aceituno, J; Montoya, LM; Pedraz, S; Gredel, R; Claver, CF; Rector, TA; Rhoads, JE; Walter, F; Ott, J; Hippelein, H; Sanchez-Bejar, V; Gutierrez, C; Oscoz, A; Zhu, J; Chen, JS; Zhang, HT; Wei, JY; Zhou, AY; Guziy, S; Shlyapnikov, A; Heise, J; Costa, E; Feroci, M; Piro, L				Castro-Tirado, AJ; Zapatero-Osorio, MR; Caon, N; Cairos, LM; Hjorth, J; Pedersen, H; Andersen, MI; Gorosabel, J; Bartolini, C; Guarnieri, A; Piccioni, A; Frontera, F; Masetti, N; Palazzi, E; Pian, E; Greiner, J; Hudec, R; Sagar, R; Pandey, AK; Mohan, V; Yadav, RKS; Nilakshi; Bjornsson, G; Jakobsson, P; Burud, I; Courbin, F; Valentini, G; Piersimoni, A; Aceituno, J; Montoya, LM; Pedraz, S; Gredel, R; Claver, CF; Rector, TA; Rhoads, JE; Walter, F; Ott, J; Hippelein, H; Sanchez-Bejar, V; Gutierrez, C; Oscoz, A; Zhu, J; Chen, JS; Zhang, HT; Wei, JY; Zhou, AY; Guziy, S; Shlyapnikov, A; Heise, J; Costa, E; Feroci, M; Piro, L			Decay of the GRB 990123 optical afterglow: Implications for the fireball model	SCIENCE			English	Article							GAMMA-RAY BURSTS; 28 FEBRUARY 1997; EMISSION	Broad-band (ultraviolet to near-infrared) observations of the intense gamma ray burst GRB 990123 started similar to 8.5 hours after the event and continued until 18 February 1999. When combined with other data, in particular from the Robotic Telescope and Transient Source Experiment (ROTSE) and the Hubble Space Telescope (HST), evidence emerges for a smoothly declining light curve, suggesting some color dependence that could be related to a cooling break passing the ultraviolet-optical band at about 1 day after the high-energy event. The steeper decline rate seen after 1.5 to 2 days may be evidence for a collimated jet pointing toward the observer.	CSIC, Inst Astrofis Andalucia, Granada, Spain; Inst Astrofis Canarias, Tenerife, Spain; Univ Copenhagen, Astron Observ, Copenhagen, Denmark; Nord Opt Telescope, Tenerife, Spain; INTA, Lab Astrofis Espacial & Fis Fundamental, Madrid, Spain; Univ Bologna, Dipartimento Astron, Bologna, Italy; Univ Ferrara, Dipartimento Fis, I-44100 Ferrara, Italy; CNR, Ist Tecnol & Studio Radiaz Extraterr, Bologna, Italy; Inst Astrophys, Potsdam, Germany; Astron Inst, CZ-25165 Ondrejov, Czech Republic; Uttar Pradesh State Observ, Naini Tal 263129, India; Univ Iceland, Inst Sci, IS-107 Reykjavik, Iceland; Univ Liege, Inst Astrophys & Geophys, B-4000 Liege, Belgium; Osserv Astron V Cerulli, Teramo, Italy; Calar Alto Observ, Almeria, Spain; Kitt Peak Natl Observ, Tucson, AZ 85726 USA; Univ Bonn, Astron Observ, D-5300 Bonn, Germany; Radio Astron Inst, D-53121 Bonn, Germany; Max Planck Inst Astron, D-69117 Heidelberg, Germany; Chinese Acad Sci, Beijing Astron Observ, Beijing 100080, Peoples R China; Nikolaev Univ Observ, UA-327030 Nikolayev, Ukraine; Nikolaev Astron Observ, Nikolaev Space Res Grp, UA-327030 Nikolayev, Ukraine; Space Res Org Netherlands, Utrecht, Netherlands; CNR, Ist Astrofis Spaziale, I-00044 Frascati, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); Instituto de Astrofisica de Canarias; University of Copenhagen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); University of Bologna; University of Ferrara; Consiglio Nazionale delle Ricerche (CNR); Leibniz Institut fur Astrophysik Potsdam (AIP); University of Iceland; University of Liege; Istituto Nazionale Astrofisica (INAF); National Optical Astronomy Observatory; University of Bonn; Max Planck Society; Chinese Academy of Sciences; Ministry of Education & Science of Ukraine; Mykolaiv Astronomical Observatory; V.O. Sukhomlynskyi Mykolaiv National University; Ministry of Education & Science of Ukraine; Mykolaiv Astronomical Observatory; Consiglio Nazionale delle Ricerche (CNR)	Castro-Tirado, AJ (corresponding author), CSIC, Inst Astrofis Andalucia, Granada, Spain.	ajct@laeff.esa.es	Pedraz, Santos/M-5207-2015; Guziy, Sergiy/HGC-0149-2022; Hjorth, Jens/M-5787-2014; Zhou, Xiaofang/C-6169-2013; Hudec, Rene/G-9018-2014; GUTIERREZ, CARLOS/AAE-4677-2019; Andersen, Michael/H-6403-2018; Caon, Nicola/B-5113-2008; Zapatero Osorio, Maria Rosa/C-2744-2017; Jakobsson, Pall/L-9950-2015; PIRO, LUIGI/E-4954-2013; Palazzi, Eliana/N-4746-2015; Shlyapnikov, Aleksey A./Q-1646-2016	Pedraz, Santos/0000-0003-1346-208X; Hjorth, Jens/0000-0002-4571-2306; Zhou, Xiaofang/0000-0001-6343-1455; Caon, Nicola/0000-0002-1653-5806; Zapatero Osorio, Maria Rosa/0000-0001-5664-2852; Jakobsson, Pall/0000-0002-9404-5650; PIRO, LUIGI/0000-0003-4159-3984; Shlyapnikov, Aleksey A./0000-0002-2752-2429; Pian, Elena/0000-0001-8646-4858; Castro-Tirado, A. J./0000-0003-2999-3563; Bjornsson, Gunnlaugur/0000-0003-1800-6382; Aceituno, Jesus/0000-0003-0487-1105; Feroci, Marco/0000-0002-7617-3421; Walter, Fabian/0000-0003-4793-7880; zhang, haotong/0000-0002-6617-5300; Costa, Enrico/0000-0003-4925-8523; Montoya, Luz Maria/0000-0001-5405-7166; Palazzi, Eliana/0000-0002-8691-7666; Ott, Juergen/0000-0001-8224-1956				AKERLOF CW, IN PRESS NATURE; AKERLOF CW, 1999, 7100 IAU; Andersen MI, 1999, SCIENCE, V283, P2075, DOI 10.1126/science.283.5410.2075; ANTONELLI LA, 1999, 232 GCN; ANTONELLI LA, 1999, 229 GCN; Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; BLOOM JS, ASTROPH9902182; BLOOM JS, 1999, 206 GCN; BLOOM JS, 1999, 240 GCN; Castro-Tirado AJ, 1998, SCIENCE, V279, P1011, DOI 10.1126/science.279.5353.1011; CASTROTIRADO AJ, 1999, ASTROPHYS J, V502, pL111; CASTROTIRADO AJ, ASTROPH9903187; CONNORS A, 1999, 230 GCN; Costa E, 1997, NATURE, V387, P783, DOI 10.1038/42885; FALCO E, 1999, 214 GCN; FEROCI M, 1999, 7095 IAU; FISHMAN GJ, 1995, ANNU REV ASTRON ASTR, V33, P415, DOI 10.1146/annurev.astro.33.1.415; FRUCHTER A, 1999, 255 GCN; FRUCHTER AS, ASTROPH9902236; GALAMA T, 1999, 207 GCN; Galama TJ, 1998, ASTROPHYS J, V500, pL97, DOI 10.1086/311425; GAMAVICH P, 1999, 215 GCN; GINZBURG VL, 1965, ANNU REV ASTRON ASTR, V3, P297, DOI 10.1146/annurev.aa.03.090165.001501; Guarnieri A, 1997, ASTRON ASTROPHYS, V328, pL13; GUETTER H, 1999, COMMUNICATION; Halpern JP, 1998, NATURE, V393, P41, DOI 10.1038/29935; HALPERN JP, 1999, 257 GCN; HEISE J, IN PRESS NATURE; HEISE J, 1999, 7099 IAU; Hjorth J, 1999, SCIENCE, V283, P2073, DOI 10.1126/science.283.5410.2073; HUDEC R, 1993, ASTROPHYS LETT COMM, V28, P359; KIPPEN RM, 1999, 224 CCN; KULKARNI SR, IN PRESS NATURE; MATZ SM, 1999, 231 GCN; Meszaros P, 1997, ASTROPHYS J, V476, P232, DOI 10.1086/303625; MESZAROS P, IN PRESS MON NOT R A; NILAKSHI RKS, IN PRESS B ASTRON SO; NILAKSHI RKS, 1999, 252 GCN; ODEWAHN SC, 1999, 7094 IAU; OFEK E, 1999, 7096 IAU; OFFUT W, 1999, 7098 IAU; PANAITESCU A, 1998, ASTROPH9806016; PIRAN T, IN PRESS PHYSICS REP; PIRO L, 1999, 203 GCN; PIRO L, 1999, 199 GCN; Reichart DE, 1997, ASTROPHYS J, V485, pL57, DOI 10.1086/310819; Rhoads JE, 1997, ASTROPHYS J, V487, pL1, DOI 10.1086/310876; Sari R, 1998, ASTROPHYS J, V497, pL17, DOI 10.1086/311269; SARI R, ASTROPH9902009; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; SOKOLOV V, 1999, 209 GCN; vanParadijs J, 1997, NATURE, V386, P686, DOI 10.1038/386686a0; VEILLET C, 1999, 255 GCN; VEILLET C, 1999, 253 GCN; Waxman E, 1997, ASTROPHYS J, V491, pL19, DOI 10.1086/311057; Wijers RAMJ, 1997, MON NOT R ASTRON SOC, V288, pL51, DOI 10.1093/mnras/288.4.L51; YADIGAROGLU IA, 1999, 242 GCN; YADIGAROGLU IA, 1999, 248 GCN	59	117	117	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	1999	283	5410					2069	2073		10.1126/science.283.5410.2069	http://dx.doi.org/10.1126/science.283.5410.2069			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180DH	10092226				2022-12-28	WOS:000079369800041
J	Sanders, LC; Matsumura, F; Bokoch, GM; de Lanerolle, P				Sanders, LC; Matsumura, F; Bokoch, GM; de Lanerolle, P			Inhibition of myosin light chain kinase by p21-activated kinase	SCIENCE			English	Article							SMOOTH-MUSCLE; CELL MOTILITY; FOCAL ADHESIONS; PROTEIN-KINASE; STRESS FIBERS; PHOSPHORYLATION; ACTIN; CONTRACTILITY; INCREASE; RHO	p21-activated kinases (PAKs) are implicated in the cytoskeletal changes induced by the Rho family of guanosine triphosphatases. Cytoskeletal dynamics are primarily modulated by interactions of actin and myosin II that are regulated by myosin light chain kinase (MLCK)-mediated phosphorylation of the regulatory myosin Light chain (MLC). p21-activated kinase 1 (PAK1) phosphorylates MLCK, resulting in decreased MLCK activity. MLCK activity and MLC phosphorylation were decreased, and cell spreading was inhibited in baby hamster kidney-21 and HeLa cells expressing constitutively active PAK1. These data indicate that MLCK is a target for PAKs and that PAKs may regulate cytoskeletal dynamics by decreasing MLCK activity and MLC phosphorylation.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA; Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA	Scripps Research Institute; Scripps Research Institute; Rutgers State University New Brunswick; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bokoch, GM (corresponding author), Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA.			Matsumura, Fumio/0000-0002-8204-153X				AMANO M, 1996, J BIOL CHEM, V271, P29246; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; CRAMER LP, 1995, J CELL BIOL, V131, P179, DOI 10.1083/jcb.131.1.179; Daniels RH, 1998, EMBO J, V17, P754, DOI 10.1093/emboj/17.3.754; DEBIASIO RL, 1988, J CELL BIOL, V107, P2631, DOI 10.1083/jcb.107.6.2631; DELANEROLLE P, 1984, SCIENCE, V223, P1415, DOI 10.1126/science.6322302; DELANEROLLE P, 1991, CIRC RES, V68, P457, DOI 10.1161/01.RES.68.2.457; DELANEROLLE P, 1993, J BIOL CHEM, V268, P16883; DELANEROLLE P, 1991, AM J PHYSIOL, V261, pL1, DOI 10.1152/ajplung.1991.261.2.L1; DELANEROLLE P, UNPUB; Dharmawardhane S, 1997, J CELL BIOL, V138, P1265, DOI 10.1083/jcb.138.6.1265; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Howard J, 1997, NATURE, V389, P561, DOI 10.1038/39247; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; KNAUS UG, 1995, SCIENCE, V269, P221, DOI 10.1126/science.7618083; LUNDSTROM K, 1994, EUR J BIOCHEM, V224, P917, DOI 10.1111/j.1432-1033.1994.00917.x; Matsumura F, 1998, J CELL BIOL, V140, P119, DOI 10.1083/jcb.140.1.119; MATSUMURA F, UNPUB; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; SAITOH M, 1997, J BIOL CHEM, V262, P7801; SANDERS LM, UNPUB; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; TANSEY MG, 1992, J BIOL CHEM, V267, P12511; WILSON AK, 1992, CANCER METAST REV, V11, P79, DOI 10.1007/BF00047605; WILSON AK, 1991, J CELL BIOL, V114, P277, DOI 10.1083/jcb.114.2.277; YAMAKITA Y, 1994, J CELL BIOL, V124, P129, DOI 10.1083/jcb.124.1.129	31	491	498	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	1999	283	5410					2083	2085		10.1126/science.283.5410.2083	http://dx.doi.org/10.1126/science.283.5410.2083			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180DH	10092231				2022-12-28	WOS:000079369800046
J	Kurts, C; Carbone, FR; Krummel, MF; Koch, KM; Miller, JFAP; Heath, WR				Kurts, C; Carbone, FR; Krummel, MF; Koch, KM; Miller, JFAP; Heath, WR			Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells	NATURE			English	Article							HODGKINS-DISEASE; ANTIGENS; SELECTION; INDUCTION; DELETION; DEATH; MICE	Autoantigens found on pancreatic islets can move to draining lymph nodes, where they are able to cause the activation and consequent deletion of autoreactive T cells by a mechanism termed cross-tolerance(1,2), This deletion depends on signalling through CD95 (also known as Fas), a member of the superfamily of tumour-necrosis-factor receptors(3). Here we describe a new mechanism that protects against autoimmunity: this mechanism involves another member of this superfamily, CD30, whose function was largely unknown. CD30-deficient islet-specific CD8-positive T cells are roughly 6,000-fold more autoaggressive than wild-type cells, with the transfer of as few as 160 CD30-deficient T cells leading to the complete destruction of pancreatic islets and the rapid onset of diabetes. We show that, in the absence of CD30 signalling, cells activated but not yet deleted by the CD95-dependent cross-tolerance mechanism gain the ability to proliferate extensively upon secondary encounter with antigen on parenchymal tissues, such as the pancreatic islets. Thus, CD30 signalling limits the proliferative potential of autoreactive CD8 effector T cells and protects the body against autoimmunity.	Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic 3050, Australia; Monash Med Sch, Dept Pathol & Immunol, Prahran, Vic 3181, Australia; Med Hsch Hannover, Dept Nephrol, D-30625 Hannover, Germany	Royal Melbourne Hospital; Walter & Eliza Hall Institute; Monash University; Hannover Medical School	Heath, WR (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic 3050, Australia.	carbone@cobra.path.monash.edu.au; Heath@wehi.edu.au	Carbone, Francis/ABF-2141-2020	Heath, William/0000-0001-9670-259X				Amakawa R, 1996, CELL, V84, P551, DOI 10.1016/S0092-8674(00)81031-4; BERTOLINO P, 1995, EUR J IMMUNOL, V25, P1932, DOI 10.1002/eji.1830250721; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; BOWEN MA, 1993, J IMMUNOL, V151, P5896; Bowen MA, 1996, J IMMUNOL, V156, P442; Duckett CS, 1997, GENE DEV, V11, P2810, DOI 10.1101/gad.11.21.2810; Gilfillan MC, 1998, J IMMUNOL, V160, P2180; Hamann D, 1996, J IMMUNOL, V156, P1387; Heath WR, 1998, J EXP MED, V187, P1549, DOI 10.1084/jem.187.10.1549; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Jondal M, 1996, IMMUNITY, V5, P295, DOI 10.1016/S1074-7613(00)80255-1; Kurts C, 1997, J EXP MED, V186, P2057, DOI 10.1084/jem.186.12.2057; Kurts C, 1998, J EXP MED, V188, P415, DOI 10.1084/jem.188.2.415; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Lee SY, 1996, J EXP MED, V183, P669, DOI 10.1084/jem.183.2.669; Lee SY, 1996, P NATL ACAD SCI USA, V93, P9699, DOI 10.1073/pnas.93.18.9699; MACKAY CR, 1993, CURR OPIN IMMUNOL, V5, P423, DOI 10.1016/0952-7915(93)90063-X; NIKOLICZUGIC J, 1990, EUR J IMMUNOL, V20, P2431, DOI 10.1002/eji.1830201111; SCHWAB U, 1982, NATURE, V299, P65, DOI 10.1038/299065a0; SCHWARTING R, 1989, BLOOD, V74, P1678; Telford WG, 1997, CELL IMMUNOL, V182, P125, DOI 10.1006/cimm.1997.1228; VELLA AT, 1995, IMMUNITY, V2, P261, DOI 10.1016/1074-7613(95)90050-0	23	103	104	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	1999	398	6725					341	344		10.1038/18692	http://dx.doi.org/10.1038/18692			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180DF	10192335				2022-12-28	WOS:000079369600053
J	Pitkin, RM; Branagan, MA; Burmeister, LF				Pitkin, RM; Branagan, MA; Burmeister, LF			Accuracy of data in abstracts of published research articles	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ORIGINAL RESEARCH ARTICLES; QUALITY	Context The section of a research article most likely to be read is the abstract, and therefore it is particularly important that the abstract reflect the article faithfully. Objective To assess abstracts accompanying research articles published in 6 medical journals with respect to whether data in the abstract could be verified in the article itself. Design Analysis of simple random samples of 44 articles and their accompanying abstracts published during 1 year (July 1, 1996-June 30, 1997) in each of 5 major general medical journals (Annals of Internal Medicine, BMI, JAMA, Lancet, and New England Journal of Medicine) and a consecutive sample of 44 articles published during 1 5 months (July 1, 1996-August 15, 1997) in the CMAJ. Main Outcome Measure Abstracts were considered deficientif they contained data that were either inconsistent with corresponding data in the article's body (including tables and figures) or not found in the body at all. Results The proportion of deficient abstracts varied widely (18%-68%) and to a statistically significant degree (P<.001) among the 6 journals studied. Conclusions Data in the abstract that are inconsistent with or absent from the article's body are common, even in large-circulation general medical journals.	Obstet & Gynecol, Los Angeles, CA USA; Chest, Northbrook, IL USA; Univ Iowa, Dept Prevent Med, Iowa City, IA 52242 USA	University of Iowa	Pitkin, RM (corresponding author), 10921 Wilshire Blvd,Suite 403, Los Angeles, CA 90024 USA.	rpitkin@greenjournal.org						Comans M L, 1990, Ned Tijdschr Geneeskd, V134, P2338; FROOM P, 1993, J CLIN EPIDEMIOL, V46, P591, DOI 10.1016/0895-4356(93)90029-Z; GOODMAN SN, 1994, ANN INTERN MED, V121, P11, DOI 10.7326/0003-4819-121-1-199407010-00003; HAYNES RB, 1987, ANN INTERN MED, V106, P598; NARINE L, 1991, CAN MED ASSOC J, V144, P449; Pitkin RM, 1998, JAMA-J AM MED ASSOC, V280, P267, DOI 10.1001/jama.280.3.267; Rothwell PM, 1997, BMJ-BRIT MED J, V314, P1580, DOI 10.1136/bmj.314.7094.1580; Socie G, 1996, LANCET, V348, P573, DOI 10.1016/S0140-6736(95)12360-1; TADDIO A, 1994, CAN MED ASSOC J, V150, P1611	9	193	196	0	29	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	1999	281	12					1110	1111		10.1001/jama.281.12.1110	http://dx.doi.org/10.1001/jama.281.12.1110			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177EP	10188662	Bronze			2022-12-28	WOS:000079197100033
J	Kolmos, HJ				Kolmos, HJ			Should general practitioners perform diagnostic tests on patients before prescribing antibiotics? For	BRITISH MEDICAL JOURNAL			English	Article									Univ Copenhagen, Hvidovre Hosp, Dept Clin Microbiol, DK-2650 Hvidovre, Denmark	University of Copenhagen	Kolmos, HJ (corresponding author), Univ Copenhagen, Hvidovre Hosp, Dept Clin Microbiol, DK-2650 Hvidovre, Denmark.			Little, Paul/0000-0003-3664-1873				Andersen J S, 1994, Ugeskr Laeger, V156, P6869; Butler CC, 1998, BMJ-BRIT MED J, V317, P637, DOI 10.1136/bmj.317.7159.637; Kolmos H J, 1992, Ugeskr Laeger, V154, P2810; Munck A P, 1995, Ugeskr Laeger, V157, P2851; NOE-NYGAARD E, 1987, Ugeskrift for Laeger, V149, P2325; Wise R, 1998, BMJ-BRIT MED J, V317, P609, DOI 10.1136/bmj.317.7159.609	6	24	24	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 20	1999	318	7186					799	800		10.1136/bmj.318.7186.799	http://dx.doi.org/10.1136/bmj.318.7186.799			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BX	10082712	Green Published			2022-12-28	WOS:000079421700037
J	Gonzalez, L; Scheller, RH				Gonzalez, L; Scheller, RH			Regulation of membrane trafficking: Structural insights from a Rab/effector complex	CELL			English	Review							RABPHILIN-3A; TRANSPORT; EFFECTOR		Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Scheller, RH (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.	scheller@cmgm.stanford.edu	Gonzalez, Lino/E-4102-2012	Gonzalez, Lino/0000-0003-3817-6450				Bean AJ, 1997, NATURE, V385, P826, DOI 10.1038/385826a0; DASCHER C, 1991, MOL CELL BIOL, V11, P872, DOI 10.1128/MCB.11.2.872; Diaz E, 1997, J CELL BIOL, V138, P283, DOI 10.1083/jcb.138.2.283; Diaz E, 1998, CELL, V93, P433, DOI 10.1016/S0092-8674(00)81171-X; DUMAS JJ, 1999, IN PRESS STRUCTURE; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Geppert M, 1998, ANNU REV NEUROSCI, V21, P75, DOI 10.1146/annurev.neuro.21.1.75; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Kato M, 1996, J BIOL CHEM, V271, P31775, DOI 10.1074/jbc.271.50.31775; KISHIDA S, 1993, J BIOL CHEM, V268, P22259; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; Nonet ML, 1997, J NEUROSCI, V17, P8061; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Peterson MR, 1999, CURR BIOL, V9, P159, DOI 10.1016/S0960-9822(99)80071-2; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Vitale G, 1998, EMBO J, V17, P1941, DOI 10.1093/emboj/17.7.1941; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649	21	133	135	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	1999	96	6					755	758		10.1016/S0092-8674(00)80585-1	http://dx.doi.org/10.1016/S0092-8674(00)80585-1			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	178ZY	10102263	Bronze			2022-12-28	WOS:000079300100002
J	Kellogg, LH; Hager, BH; van der Hilst, RD				Kellogg, LH; Hager, BH; van der Hilst, RD			Compositional stratification in the deep mantle	SCIENCE			English	Article							THERMAL-CHEMICAL INSTABILITIES; LARGE-SCALE STRUCTURE; EARTHS MANTLE; CONVECTION; BOUNDARY; CORE; CONSTRAINTS; MODELS; HETEROGENEITY; DENSITY	A boundary between compositionally distinct regions at a depth of about 1600 kilometers may explain the seismological observations pertaining to Earth's lower mantle, produce the isotopic signatures of mid-ocean ridge basalts and oceanic island basalts, and reconcile the discrepancy between the observed heat flux and the heat production of the mid-ocean ridge basalt source region. Numerical models of thermochemical convection imply that a layer of material that is intrinsically about 4 percent more dense than the overlying mantle is dynamically stable. Because the deep layer is hot, its net density is only slightly greater than adiabatic and its surface develops substantial topography.	Univ Calif Davis, Dept Geol, Livermore, CA 95616 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	University of California System; University of California Davis; Massachusetts Institute of Technology (MIT)	Kellogg, LH (corresponding author), Univ Calif Davis, Dept Geol, Livermore, CA 95616 USA.		Kellogg, Louise/J-2171-2012	Kellogg, Louise/0000-0001-5874-0472				Albarede F, 1998, CHEM GEOL, V145, P413, DOI 10.1016/S0009-2541(97)00152-6; Allegre CJ, 1996, GEOPHYS RES LETT, V23, P3555, DOI 10.1029/96GL03373; ALLEGRE CJ, 1983, NATURE, V303, P762, DOI 10.1038/303762a0; ALLEGRE CJ, 1985, GEOPHYS RES LETT, V12, P207, DOI 10.1029/GL012i004p00207; Chamorro-Perez E, 1998, NATURE, V393, P352, DOI 10.1038/30706; CRAIG H, 1976, EARTH PLANET SC LETT, V31, P369, DOI 10.1016/0012-821X(76)90118-7; DAVIES GF, 1986, GEOPHYS RES LETT, V13, P1517, DOI 10.1029/GL013i013p01517; GILBERT F, 1973, P NATL ACAD SCI USA, V70, P1410, DOI 10.1073/pnas.70.5.1410; GLATZMAIER GA, 1990, NATURE, V347, P274, DOI 10.1038/347274a0; HANSEN U, 1988, NATURE, V334, P237, DOI 10.1038/334237a0; HANSEN U, 1989, GEOPHYS RES LETT, V16, P629, DOI 10.1029/GL016i007p00629; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; HOFMANN AW, 1982, EARTH PLANET SC LETT, V57, P421, DOI 10.1016/0012-821X(82)90161-3; Jackson I, 1998, GEOPHYS J INT, V134, P291, DOI 10.1046/j.1365-246x.1998.00560.x; JACOBSEN SB, 1979, J GEOPHYS RES, V84, P7411, DOI 10.1029/JB084iB13p07411; JEANLOZ R, 1989, PHILOS T R SOC A, V328, P377, DOI 10.1098/rsta.1989.0042; JOCHUM KP, 1983, NATURE, V306, P431, DOI 10.1038/306431a0; Kellogg LH, 1997, GEOPHYS RES LETT, V24, P2749, DOI 10.1029/97GL02952; KELLOGG LH, 1993, GEOPHYS RES LETT, V20, P379, DOI 10.1029/93GL00045; Kennett BLN, 1998, GEOPHYS J INT, V132, P374, DOI 10.1046/j.1365-246x.1998.00451.x; Kennett BLN, 1998, J GEOPHYS RES-SOL EA, V103, P12469, DOI 10.1029/98JB00150; KING SD, 1990, PHYS EARTH PLANET IN, V59, P195, DOI 10.1016/0031-9201(90)90225-M; KING SD, 1992, GEOPHYS J INT, V109, P481, DOI 10.1111/j.1365-246X.1992.tb00111.x; KNITTLE E, 1991, SCIENCE, V251, P1438, DOI 10.1126/science.251.5000.1438; Kunz J, 1998, SCIENCE, V280, P877, DOI 10.1126/science.280.5365.877; Liu XF, 1998, GEODYNAMICS, V28, P21; OCONNELL RJ, 1980, P E FERMI INT SCH PH, V78, P270; OLSON P, 1990, NATURE, V344, P209, DOI 10.1038/344209a0; ONIONS RK, 1979, J GEOPHYS RES, V84, P6091, DOI 10.1029/JB084iB11p06091; ONIONS RK, 1983, NATURE, V306, P429, DOI 10.1038/306429a0; ONIONS RK, 1978, PHILOS T R SOC A, V288, P547, DOI 10.1098/rsta.1978.0033; RICHTER FM, 1985, EARTH PLANET SC LETT, V73, P350, DOI 10.1016/0012-821X(85)90083-4; SCHILLING JG, 1973, NATURE, V242, P565, DOI 10.1038/242565a0; SILVER PG, 1988, ANNU REV EARTH PL SC, V16, P477, DOI 10.1146/annurev.ea.16.050188.002401; SILVER PG, 1993, GEOPHYS RES LETT, V20, P1135, DOI 10.1029/92GL02464; SLEEP NH, 1988, GEOPHYS J INT, V95, P437, DOI 10.1111/j.1365-246X.1988.tb06695.x; STEIN CA, 1995, HEAT FLOW EARTH, P144, DOI DOI 10.1112/S0024609301008396; Su WJ, 1997, PHYS EARTH PLANET IN, V100, P135, DOI 10.1016/S0031-9201(96)03236-0; SU WJ, 1994, J GEOPHYS RES-SOL EA, V99, P6945, DOI 10.1029/93JB03408; Tackley PJ, 1998, GEODYNAMICS, V28, P231; TURCOTTE DL, 1988, ICARUS, V74, P36, DOI 10.1016/0019-1035(88)90029-2; van der Hilst RD, 1999, SCIENCE, V283, P1885, DOI 10.1126/science.283.5409.1885; vanderHilst RD, 1997, NATURE, V386, P578, DOI 10.1038/386578a0; vanKeken PE, 1997, J GEOPHYS RES-SOL EA, V102, P22477, DOI 10.1029/97JB01353; Wang YB, 1996, PURE APPL GEOPHYS, V146, P533, DOI 10.1007/BF00874732; WANG YB, 1994, PHYS EARTH PLANET IN, V83, P13, DOI 10.1016/0031-9201(94)90109-0; WASSERBURG GJ, 1964, SCIENCE, V143, P465, DOI 10.1126/science.143.3605.465; WASSERBURG GJ, 1979, P NATL ACAD SCI USA, V76, P3594, DOI 10.1073/pnas.76.8.3594; Wysession ME, 1998, GEODYNAMICS, V28, P273	49	599	619	2	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	1999	283	5409					1881	1884		10.1126/science.283.5409.1881	http://dx.doi.org/10.1126/science.283.5409.1881			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177UC	10082454	Green Submitted			2022-12-28	WOS:000079228600037
J	Leaning, J; Vollen, L; Palmer, C				Leaning, J; Vollen, L; Palmer, C			Physicians for Human Rights documents systematic abuse against ethnic Albanian physicians and patients	LANCET			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Ctr Populat & Dev Studies, Cambridge, MA 02138 USA; Phys Human Rights, Bosnia Projects, Boston, MA 02167 USA	Harvard University; Harvard T.H. Chan School of Public Health	Leaning, J (corresponding author), Harvard Univ, Sch Publ Hlth, Ctr Populat & Dev Studies, Cambridge, MA 02138 USA.								0	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 13	1999	353	9156					921	922		10.1016/S0140-6736(99)90043-0	http://dx.doi.org/10.1016/S0140-6736(99)90043-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BU	10094001				2022-12-28	WOS:000079421400046
J	Zander, L; Chamberlain, G				Zander, L; Chamberlain, G			Place of birth	BRITISH MEDICAL JOURNAL			English	Review									Guys Hosp, Sch Med, Dept Gen Practice & Primary Care, London, England; Kings Hosp, Sch Med, Dept Gen Practice, London, England; St Thomas Hosp, Sch Med, Dept Gen Practice, London, England	Guy's & St Thomas' NHS Foundation Trust; King's College Hospital NHS Foundation Trust; King's College Hospital; Guy's & St Thomas' NHS Foundation Trust	Zander, L (corresponding author), Guys Hosp, Sch Med, Dept Gen Practice & Primary Care, London, England.							CAMPBELL R, 1994, WHERE BE BORN; CHAMBERLAIN G, 1995, HOME BIRTHS; *DEP HLTH, 1994, CHANG CHILDB; *GEN SERV MED COUN, 1997, GEN PRACT INTR CAR I; *MAT TASK GROUP RO, 1995, 72 MAT TASK GROUP RO; *NHS, 1997, STAT B NHS; *WELSH OFF, 1998, HLTH EV B MAT CHILD	7	14	14	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 13	1999	318	7185					721	723						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182JK	10074022				2022-12-28	WOS:000079495700031
J	Hofmeister, AM				Hofmeister, AM			Mantle values of thermal conductivity and the geotherm from phonon lifetimes	SCIENCE			English	Review							HIGH-PRESSURE; SINGLE-CRYSTAL; VIBRATIONAL SPECTROSCOPY; INFRARED REFLECTIVITY; MGSIO3 PEROVSKITE; HIGH-TEMPERATURES; LATTICE-DYNAMICS; TRANSITION ZONE; IR SPECTROSCOPY; ALKALI-HALIDES	A model for thermal conductivity kappa, based on phonon Lifetimes obtained from infrared reflectivity, replicates experimental data at ambient conditions. The pressure and absolute temperature dependences of transport properties are accurately obtained from the Gruneisen parameter gamma(Th), bulk modulus K-T, and thermal expansivity alpha: The Lattice contribution kappa(lat) equals kappa(298)(298/T)(a) exp[-(4 gamma(Th) + 1/3) integral(298)(T)alpha(theta)d theta] with a = 0.33 for silicates (or 0.9 for MgO), and partial derivative[ln(kappa(lat))]/partial derivative P = (1/3 + 4 gamma(Th))/K-T. The smaller, pressure-independent radiative contribution kappa(rad) equals 0.0175 - 0.0001037T + (2.245T(2)/10(7)) - (3.407T(3)/10(11)), in units of watts per meter-kelvin, if Fe2+ is present. The resulting Lithospheric geotherm is steep. Consequently, the mantle geotherm is hot if the Low-velocity zone is anhydrous, but cold if hydrated.	Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA	Washington University (WUSTL)	Hofmeister, AM (corresponding author), Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA.		Hofmeister, Anne/ABH-6054-2020					Abramson EH, 1996, J CHEM PHYS, V104, P5424, DOI 10.1063/1.471775; AGEE CB, 1993, ANNU REV EARTH PL SC, V21, P19, DOI 10.1146/annurev.earth.21.1.19; ALM O, 1974, J PHYS CHEM SOLIDS, V35, P421, DOI 10.1016/S0022-3697(74)80035-1; ANDERSON DL, 1989, THEORY EARTH; Anderson OL, 1998, PHYS EARTH PLANET IN, V109, P179, DOI 10.1016/S0031-9201(98)00123-X; ANDERSSON S, 1986, REV SCI INSTRUM, V57, P1633, DOI 10.1063/1.1138542; ASHIDA T, 1988, PHYS CHEM MINER, V16, P239; BACKSTROM G, 1977, P 7 S THERM PROP, P169; BASS JD, 1995, MINERAL PHYSICS CRYS, P45; BECK AE, 1978, PHYS EARTH PLANET IN, V17, P35, DOI 10.1016/0031-9201(78)90008-0; Boehler R, 1996, ANNU REV EARTH PL SC, V24, P15, DOI 10.1146/annurev.earth.24.1.15; BOEHLER R, 1992, EARTH PLANET SC LETT, V111, P217, DOI 10.1016/0012-821X(92)90180-4; BREWSTER MQ, 1992, THERMAL RAD TRANSFER, P229; BROWN JM, 1981, GEOPHYS J ROY ASTR S, V66, P579, DOI 10.1111/j.1365-246X.1981.tb04891.x; BROWN JM, 1986, GEOPHYS RES LETT, V13, P1509, DOI 10.1029/GL013i013p01509; BRYDSTEN U, 1983, J PHYS C SOLID STATE, V16, P143, DOI 10.1088/0022-3719/16/1/016; BURNS G, 1973, PHYS REV B, V7, P3088, DOI 10.1103/PhysRevB.7.3088; Burns G, 1990, SOLID STATE PHYS; BURNS RG, 1970, MINERALOGICAL APPL C, P80; CAHILL DG, 1992, PHYS REV B, V46, P6131, DOI 10.1103/PhysRevB.46.6131; Carslaw H.S., 1986, CONDUCTION HEAT SOLI; Chai M, 1996, PHYS CHEM MINER, V23, P470, DOI 10.1007/BF00202033; Choudhury N, 1998, PHYS REV B, V58, P756, DOI 10.1103/PhysRevB.58.756; CLARK SP, 1957, T AM GEOPHYS UNION, V38, P931; Clauser C., 1995, ROCK PHYS PHASE RELA, VVolume 3, P105, DOI DOI 10.1029/RF003P0105; COLLINS MD, 1997, EOS, V79, pF753; CYNN H, 1994, J GEOPHYS RES-SOL EA, V99, P17717, DOI 10.1029/94JB01661; DEBYE P, 1914, VORTRAGE KINETISCHE, P19; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Farmer V. C., 1974, INFRARED SPECTRA MIN; Fei Y, 1995, MINERAL PHYS CRYSTAL, P29, DOI DOI 10.1029/RF002P0029; FRANSON A, 1983, J PHYS C SOLID STATE, V12, P219; FUJISAWA H, 1968, J GEOPHYS RES, V73, P4727, DOI 10.1029/JB073i014p04727; Gaherty JB, 1996, J GEOPHYS RES-SOL EA, V101, P22291, DOI 10.1029/96JB01882; GOTO T, 1980, PHYS EARTH PLANET IN, V22, P277, DOI 10.1016/0031-9201(80)90044-8; Hofmeister A.M., 1995, PRACTICAL GUIDE INFR, P377; Hofmeister AM, 1997, PHYS REV B, V56, P5835, DOI 10.1103/PhysRevB.56.5835; HOFMEISTER AM, 1991, PHYS CHEM MINER, V17, P503; Hofmeister AM, 1996, AM MINERAL, V81, P418; Hofmeister AM, 1997, PHYS CHEM MINER, V24, P535, DOI 10.1007/s002690050069; HOFMEISTER AM, 1989, AM MINERAL, V74, P281; HOFMEISTER AM, 1996, MINERAL SPECTROSCOPY, P215; HOFMEISTER AM, UNPUB; HORAI K, 1989, PHYS EARTH PLANET IN, V55, P292, DOI 10.1016/0031-9201(89)90077-0; HORAI KI, 1971, J GEOPHYS RES, V76, P1278, DOI 10.1029/JB076i005p01278; Inoue T, 1992, HIGH PRESSURE RES AP, P323; ITO E, 1989, GEOPHYS RES LETT, V16, P425, DOI 10.1029/GL016i005p00425; ITO E, 1989, J GEOPHYS RES-SOLID, V94, P10637, DOI 10.1029/JB094iB08p10637; Ito E., 1992, HIGH PRESSURE RES AP, P315; JULIAN CL, 1965, PHYS REV, V137, pA128, DOI 10.1103/PhysRev.137.A128; KANIMORI H, 1968, J GEOPHYS RES, V73, P595; Katsura T, 1997, PHYS EARTH PLANET IN, V101, P73, DOI 10.1016/S0031-9201(96)03223-2; KATSURA T, 1989, J GEOPHYS RES-SOLID, V94, P15663, DOI 10.1029/JB094iB11p15663; KATSURA T, 1995, GEOPHYS J INT, V122, P67; KIEFFER SW, 1976, J GEOPHYS RES, V81, P3018, DOI 10.1029/JB081i017p03018; KIEFFER SW, 1979, REV GEOPHYS, V17, P20, DOI 10.1029/RG017i001p00020; KIEFFER SW, 1976, J GEOPHYS RES, V81, P3025, DOI 10.1029/JB081i017p03025; Kittel C, 2007, INTRO SOLID STATE PH, V7th; KLEMENS PG, 1958, SOLID STATE PHYS, V7, P1, DOI 10.1016/S0081-1947(08)60551-2; KNITTLE E, 1995, MINERAL PHYSICS CRYS, P98; KOYABASHI Y, 1974, J PHYS EARTH, V22, P359; LIEBFRIED G, 1954, NACH GES WISSENSCH K, V1, P71; LU R, 1994, J GEOPHYS RES-SOL EA, V99, P11795, DOI 10.1029/94JB00501; Manga M, 1997, J GEOPHYS RES-SOL EA, V102, P2999, DOI 10.1029/96JB02696; MCMILLAN PF, 1988, REV MINERAL, V18, P99; MCPHERSON WR, 1982, PHYS EARTH PLANET IN, V29, P58; Ohtani E, 1998, PHYS EARTH PLANET IN, V107, P75, DOI 10.1016/S0031-9201(97)00125-8; OSAKO M, 1979, PHYS EARTH PLANET IN, V18, pP1, DOI 10.1016/0031-9201(79)90128-6; OSAKO M, 1991, GEOPHYS RES LETT, V18, P239, DOI 10.1029/91GL00212; PARSONS B, 1977, J GEOPHYS RES, V82, P803, DOI 10.1029/JB082i005p00803; Presnall DC, 1998, PHYS EARTH PLANET IN, V107, P83, DOI 10.1016/S0031-9201(97)00126-X; PRICE DL, 1991, PHYSICA B, V174, P87, DOI 10.1016/0921-4526(91)90583-Z; RAO KR, 1988, PHYS CHEM MINER, V16, P83, DOI 10.1007/BF00201334; REICHMANN HJ, 1996, MINERAL SPECTROSCOPY, P229; REIF F, 1965, FUNDAMENTALS STAT TH, P251; RENKIN ML, 1988, J GEOPHYS RES-SOLID, V93, P2919, DOI 10.1029/JB093iB04p02919; REYNARD B, 1991, PHYS CHEM MINER, V18, P19; Ringwood A.E, 1975, COMPOSITION PETROLOG; ROSS NL, 1989, PHYS CHEM MINER, V16, P415, DOI 10.1007/BF00197010; ROSS RG, 1984, REP PROG PHYS, V47, P1347, DOI 10.1088/0034-4885/47/10/002; ROSSMAN GR, 1988, REV MINERAL, V18, P207; ROUFOSSE M, 1973, PHYS REV B, V7, P5379, DOI 10.1103/PhysRevB.7.5379; ROUFOSSE MC, 1983, J GEOPHYS RES, V88, P7399, DOI 10.1029/JB088iB09p07399; Scharmeli G.H., 1982, HIGH PRESSURE RES GE, P349; SCHATZ JF, 1972, J GEOPHYS RES, V77, P6966, DOI 10.1029/JB077i035p06966; SCHLOESSIN HH, 1972, GEOPHYS J ROY ASTR S, V27, P499, DOI 10.1111/j.1365-246X.1972.tb06105.x; SCLATER JG, 1986, GEOLOGY N AM W N A M, P257; SERVOIN JL, 1973, PHYS STATUS SOLIDI B, V55, P677, DOI 10.1002/pssb.2220550224; SHANKLAND TJ, 1979, J GEOPHYS RES, V84, P1603, DOI 10.1029/JB084iB04p01603; SIEGEL R, 1972, THERMAL RAD HEAT TRA, P468; SINDZINGRE P, 1990, J PHYS-CONDENS MAT, V2, P7033, DOI 10.1088/0953-8984/2/33/014; SPITZER WG, 1962, PHYS REV, V126, P1710, DOI 10.1103/PhysRev.126.1710; STACEY FD, 1977, PHYS EARTH PLANET IN, V15, P341, DOI 10.1016/0031-9201(77)90096-6; STACEY FD, 1983, PHYS EARTH PLANET IN, V33, P45, DOI 10.1016/0031-9201(83)90006-7; STACEY FD, 1992, PHYSICS EARTH; STACEY FD, UNPUB; STEIN CA, 1992, NATURE, V359, P123, DOI 10.1038/359123a0; SUMINO Y, 1984, HDB PHYSICAL PROPERT, V3, P139; TAKAHASHI E, 1986, J GEOPHYS RES-SOLID, V91, P9367, DOI 10.1029/JB091iB09p09367; TRAYLOR JG, 1975, PHYS REV B, V10, P3457; Turcotte D., 2014, GEODYNAMICS, V3rd edn.; Verhoogen J., 1973, Physics of the Earth and Planetary Interiors, V7, P47, DOI 10.1016/0031-9201(73)90039-3; WHITE GK, 1989, HIGH TEMP HIGH PRESS, V21, P233; Wooten F., 2013, OPTICAL PROPERTIES S; Xu YB, 1997, J GEOPHYS RES-SOL EA, V102, P27439, DOI 10.1029/97JB02564; YUTATAKE H, 1978, PHYS EARTH PLANET IN, V17, P193; Zaug J., 1992, HIGH PRESSURE RES AP, P157; Zerr A, 1998, SCIENCE, V281, P243, DOI 10.1126/science.281.5374.243; ZHONG SJ, 1994, J GEOPHYS RES-SOL EA, V99, P15683, DOI 10.1029/94JB00809; Ziman J. M., 1962, ELECT PHONONS THEORY	110	451	464	3	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	1999	283	5408					1699	1706		10.1126/science.283.5408.1699	http://dx.doi.org/10.1126/science.283.5408.1699			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175PF	10073928				2022-12-28	WOS:000079102800041
J	Fimia, GM; De Cesare, D; Sassone-Corsi, P				Fimia, GM; De Cesare, D; Sassone-Corsi, P			CBP-independent activation of CREM and CREB by the LIM-only protein ACT	NATURE			English	Article							TRANSCRIPTION FACTOR CREB; CYCLIC-AMP; CAMP; GENE; SPERMATOGENESIS; PHOSPHORYLATION; ASSOCIATION; EXPRESSION; MULTIPLE; PROMOTER	Transcriptional activation by CREB and CREM requires phosphorylation of a serine residue within the activation domain (Ser 133 in CREB; Ser 117 in CREM) which as a result interacts with the coactivator CBP1,2. The activator CREM is highly expressed in male germ cells and is required for post-meiotic gene expression(2-4). Using a two-hybrid screen, we have isolated a testis-derived complementary DNA encoding a protein that we term ACT (for activator of CREM in testis), a LIM-only protein which specifically associates with CREM, ACT is expressed coordinately with CREM in a tissue- and developmentally regulated manner. It strongly stimulates CREM transcriptional activity in yeast and mammalian cells and contains an intrinsic activation function. As ACT bypasses the classical requirements for activation, namely phosphorylation of Ser 117 and interaction with CBP, it represents a new route for transcriptional activation by CREM and CREB. ACT may define a previously undiscovered class of tissue-specific coactivators whose function could be specific for distinct cellular differentiation programmes.	ULP, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, F-67404 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sassone-Corsi, P (corresponding author), ULP, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, BP 163, F-67404 Strasbourg, France.	paolosc@igbmc.u-strasbg.fr	Sassone-Corsi, Paolo/H-6182-2011; Fimia, Gian Maria/K-3232-2016	Fimia, Gian Maria/0000-0003-4438-3325				ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Curtiss J, 1998, BIOESSAYS, V20, P58, DOI 10.1002/(SICI)1521-1878(199801)20:1&lt;58::AID-BIES9&gt;3.0.CO;2-O; Dawid IB, 1998, TRENDS GENET, V14, P156, DOI 10.1016/S0168-9525(98)01424-3; DEGROOT RP, 1993, EMBO J, V12, P3903, DOI 10.1002/j.1460-2075.1993.tb06068.x; DELMAS V, 1993, MOL ENDOCRINOL, V7, P1502, DOI 10.1210/me.7.11.1502; FERRERI K, 1994, P NATL ACAD SCI USA, V91, P1210, DOI 10.1073/pnas.91.4.1210; FOULKES NS, 1992, NATURE, V355, P80, DOI 10.1038/355080a0; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; Kong YF, 1997, MOL CELL BIOL, V17, P4750, DOI 10.1128/MCB.17.8.4750; KUNZLER M, 1994, EMBO J, V13, P641, DOI 10.1002/j.1460-2075.1994.tb06302.x; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; LAOIDE BM, 1993, EMBO J, V12, P1179, DOI 10.1002/j.1460-2075.1993.tb05759.x; Martinez-Balbas MA, 1998, EMBO J, V17, P2886, DOI 10.1093/emboj/17.10.2886; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; OSADA H, 1995, P NATL ACAD SCI USA, V92, P9585, DOI 10.1073/pnas.92.21.9585; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; SassoneCorsi P, 1997, CELL, V88, P163, DOI 10.1016/S0092-8674(00)81834-6; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SUN ZM, 1995, MOL CELL BIOL, V15, P561, DOI 10.1128/MCB.15.1.561; VALGEARCHER VE, 1994, P NATL ACAD SCI USA, V91, P8617, DOI 10.1073/pnas.91.18.8617; WADMAN I, 1994, EMBO J, V13, P4831, DOI 10.1002/j.1460-2075.1994.tb06809.x; Zhou YD, 1996, P NATL ACAD SCI USA, V93, P12262, DOI 10.1073/pnas.93.22.12262	29	191	204	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	1999	398	6723					165	169		10.1038/18237	http://dx.doi.org/10.1038/18237			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176DG	10086359				2022-12-28	WOS:000079135200048
J	Amaya-Farfan, J				Amaya-Farfan, J			Aflatoxin B-1-induced hepatic steatosis: role of carbonyl compounds and active diols on steatogenesis	LANCET			English	Article							SERUM-ALBUMIN ADDUCT; RATS; LIPOPROTEINS; BINDING; PLASMA; INVIVO	Aflatoxin B1 (AFB1) exerts a chronic carcinogenic and an acute toxic effect on animals. Whereas the mechanism for carcinogenicity is known, no mechanism has been proposed for the toxic action. Among the most prominent signs of aflatoxicosis in several species, including birds and mammals, are hypolipidaemia, hypocholesterolaemia, and hypocarotenaemia, associated with severe hepatic steatosis and weight loss. We suggest that these signs of acute imbalance of lipid metabolism can be the result of the chemical modification (blocking) of key lysyl residues on the LDL protein B-100 by the activated AFB1 molecule. Modified LDLs are not recognised by their specific receptors and thus are rejected by peripheral cells. Upon return to the liver, the modified particles bind to the sinusoidal lining cells. Lipid starvation of peripheral tissues takes place while fat accumulates in the liver. This abnormal state is maintained and reinforced by further modification of nascent apoproteins, which in turn become unable to receive a lipid load for as long as aflatoxin continues to be available in the liver.	State Univ Campinas, Dept Food Planning & Nutr, FEA, BR-13083970 Campinas, SP, Brazil	Universidade Estadual de Campinas	Amaya-Farfan, J (corresponding author), State Univ Campinas, Dept Food Planning & Nutr, FEA, CP 6121, BR-13083970 Campinas, SP, Brazil.							Bakillah A, 1998, BIOCHEMISTRY-US, V37, P3727, DOI 10.1021/bi972629t; DIRR HW, 1986, BIOCHIM BIOPHYS ACTA, V881, P383, DOI 10.1016/0304-4165(86)90030-9; HAMILTON PB, 1977, FED PROC, V36, P1899; MAHLEY RW, 1979, P NATL ACAD SCI USA, V76, P1746, DOI 10.1073/pnas.76.4.1746; MAINIGI KD, 1977, CANCER RES, V37, P4304; MILLER BL, 1985, POULTRY SCI, V64, P1637, DOI 10.3382/ps.0641637; NEWBERNE PM, 1979, CANCER RES, V39, P3986; OHarte FPM, 1996, PEPTIDES, V17, P1323, DOI 10.1016/S0196-9781(96)00231-8; SABBIONI G, 1990, CHEM-BIOL INTERACT, V75, P1, DOI 10.1016/0009-2797(90)90018-I; SABBIONI G, 1987, CARCINOGENESIS, V8, P819, DOI 10.1093/carcin/8.6.819; SHIREMAN RB, 1982, TOXICOL LETT, V14, P213, DOI 10.1016/0378-4274(82)90054-6; TAGGART P, 1986, P SOC EXP BIOL MED, V182, P68, DOI 10.3181/00379727-182-42310; VULOVIC D, 1992, ACTA VET-BEOGRAD, V42, P29; WEISENSBERG BI, 1985, ATHEROSCLEROSIS, V57, P87; WILD CP, 1990, CANCER RES, V50, P245	15	10	10	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 27	1999	353	9154					747	748		10.1016/S0140-6736(98)09261-7	http://dx.doi.org/10.1016/S0140-6736(98)09261-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173DR	10073532				2022-12-28	WOS:000078966400046
J	Heath, I				Heath, I			There must be limits to the medicalization of human distress - Commentary	BRITISH MEDICAL JOURNAL			English	Editorial Material									Caversham Grp Practice, London NW5 2UP, England		Heath, I (corresponding author), Caversham Grp Practice, London NW5 2UP, England.							BARSKY AJ, 1995, JAMA-J AM MED ASSOC, V274, P1931, DOI 10.1001/jama.274.24.1931; DOWRICK C, 1995, BMJ-BRIT MED J, V311, P1274, DOI 10.1136/bmj.311.7015.1274; Howie J. G., 1997, 75 ROYAL COLL GEN PR; TOOMBS SK, 1993, MEANING ILLNESS PHEN, P12	4	55	55	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	FEB 13	1999	318	7181					439	440						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	168BF	10084832				2022-12-28	WOS:000078670100030
J	Besterman, E				Besterman, E			Deaf wife	BRITISH MEDICAL JOURNAL			English	Article									Univ W Indies, Kingston 7, Jamaica	University West Indies Mona Jamaica	Besterman, E (corresponding author), Univ W Indies, Kingston 7, Jamaica.								0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 20	1999	318	7186					798	798		10.1136/bmj.318.7186.798	http://dx.doi.org/10.1136/bmj.318.7186.798			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BX	10082711	Green Published			2022-12-28	WOS:000079421700036
J	Minor, DL; Masseling, SJ; Jan, YN; Jan, LY				Minor, DL; Masseling, SJ; Jan, YN; Jan, LY			Transmembrane structure of an inwardly rectifying potassium channel	CELL			English	Article							RECTIFIER K+ CHANNEL; NEGATIVELY CHARGED RESIDUE; 2 PORE DOMAINS; MEMBRANE-PROTEINS; FUNCTIONAL EXPRESSION; SUBUNIT STOICHIOMETRY; LACTOSE PERMEASE; ESCHERICHIA-COLI; HELIX PACKING; FAMILY	Inwardly rectifying potassium channels (K-ir), comprising four subunits each with two transmembrane domains, M1 and M2, regulate many important physiological processes. We employed a yeast genetic screen to identify functional channels from libraries of K-ir 2.1 containing mutagenized M1 or M2 domains. Patterns in the allowed sequences indicate that M1 and M2 are helices. Protein-lipid and protein-water interaction surfaces identified by the patterns were verified by sequence minimization experiments. Second-site suppressor analyses of helix packing indicate that the M2 pore-lining inner helices are surrounded by the M1 lipid-facing outer helices, arranged such that the M1 helices participate in subunit-subunit interactions. This arrangement is distinctly different from the structure of a bacterial potassium channel with the same topology and identifies helix-packing residues as hallmark sequences common to all K-ir superfamily members.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, LY (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.	gkw@itsa.ucsf.edu						Babenko AP, 1998, ANNU REV PHYSIOL, V60, P667, DOI 10.1146/annurev.physiol.60.1.667; BARGMANN CI, 1988, EMBO J, V7, P2043, DOI 10.1002/j.1460-2075.1988.tb03044.x; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; BOND CT, 1994, RECEPTOR CHANNEL, V2, P183; Bowie JU, 1997, J MOL BIOL, V272, P780, DOI 10.1006/jmbi.1997.1279; BOWIE JU, 1990, SCIENCE, V247, P1306, DOI 10.1126/science.2315699; COHEN C, 1990, PROTEINS, V7, P1, DOI 10.1002/prot.340070102; Corey S, 1998, J BIOL CHEM, V273, P5271, DOI 10.1074/jbc.273.9.5271; CORNETTE JL, 1987, J MOL BIOL, V195, P659, DOI 10.1016/0022-2836(87)90189-6; DONNELLY D, 1993, PROTEIN SCI, V2, P55; DOUPNIK CA, 1995, CURR OPIN NEUROBIOL, V5, P268, DOI 10.1016/0959-4388(95)80038-7; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Hille B., 1992, IONIC CHANNELS EXCIT; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9; Imredy JP, 1998, BIOCHEMISTRY-US, V37, P14867, DOI 10.1021/bi980929k; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Ishii TM, 1997, J BIOL CHEM, V272, P23195, DOI 10.1074/jbc.272.37.23195; JAN LY, 1994, NATURE, V371, P119, DOI 10.1038/371119a0; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; Jin WL, 1998, BIOCHEMISTRY-US, V37, P13291, DOI 10.1021/bi981178p; Kaback HR, 1997, CURR OPIN STRUC BIOL, V7, P537, DOI 10.1016/S0959-440X(97)80119-4; KERJAN P, 1986, NUCLEIC ACIDS RES, V14, P7861, DOI 10.1093/nar/14.20.7861; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; Krapivinsky G, 1998, NEURON, V20, P995, DOI 10.1016/S0896-6273(00)80480-8; Kraut R, 1996, DEV BIOL, V174, P65, DOI 10.1006/dbio.1996.0052; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; LEMMON MA, 1994, Q REV BIOPHYS, V27, P157, DOI 10.1017/S0033583500004522; LEMMON MA, 1994, NAT STRUCT BIOL, V1, P157, DOI 10.1038/nsb0394-157; Lemmon MA., 1992, CURR OPIN STRUC BIOL, V2, P511; Lesage F, 1996, J BIOL CHEM, V271, P4183; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; Lu Z, 1997, BIOCHEMISTRY-US, V36, P6936, DOI 10.1021/bi9702849; LUMB KJ, 1995, BIOCHEMISTRY-US, V34, P8642, DOI 10.1021/bi00027a013; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; MILLER C, 1995, NEURON, V15, P5, DOI 10.1016/0896-6273(95)90057-8; Nestorowicz A, 1997, DIABETES, V46, P1743, DOI 10.2337/diabetes.46.11.1743; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; OAS TG, 1988, NATURE, V336, P42, DOI 10.1038/336042a0; PARK CS, 1992, BIOCHEMISTRY-US, V31, P7749, DOI 10.1021/bi00149a002; Perozo E, 1998, NAT STRUCT BIOL, V5, P459, DOI 10.1038/nsb0698-459; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; Raab-Graham KF, 1998, J BIOL CHEM, V273, P19699, DOI 10.1074/jbc.273.31.19699; REES DC, 1989, SCIENCE, V245, P510, DOI 10.1126/science.2667138; REIDHAAROLSON JF, 1991, METHOD ENZYMOL, V208, P564; Reuveny E, 1996, BIOPHYS J, V70, P754, DOI 10.1016/S0006-3495(96)79615-7; SAHINTOTH M, 1992, P NATL ACAD SCI USA, V89, P10547, DOI 10.1073/pnas.89.21.10547; SCHREMPF H, 1995, EMBO J, V14, P5170, DOI 10.1002/j.1460-2075.1995.tb00201.x; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Smith BC, 1996, REAL-TIME IMAGING, V2, P3, DOI 10.1006/rtim.1996.0002; STANFIELD PR, 1994, J PHYSIOL-LONDON, V478, P1; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; TAKUMI T, 1995, J BIOL CHEM, V270, P16339, DOI 10.1074/jbc.270.27.16339; TANG WM, 1995, MOL BIOL CELL, V6, P1231, DOI 10.1091/mbc.6.9.1231; VonHeijne G, 1996, PROG BIOPHYS MOL BIO, V66, P113, DOI 10.1016/S0079-6107(97)85627-1; Wallin E, 1997, PROTEIN SCI, V6, P808; Wei A, 1996, NEUROPHARMACOLOGY, V35, P805, DOI 10.1016/0028-3908(96)00126-8; Wen JA, 1996, NAT STRUCT BIOL, V3, P141, DOI 10.1038/nsb0296-141; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; WICKMAN KD, 1995, CURR OPIN NEUROBIOL, V5, P278, DOI 10.1016/0959-4388(95)80039-5; Yang J, 1995, NEURON, V15, P1441, DOI 10.1016/0896-6273(95)90021-7; ZERANGUE N, 1999, IN PRESS NEURON; Zhou YF, 1997, NAT STRUCT BIOL, V4, P986, DOI 10.1038/nsb1297-986; [No title captured]	70	131	134	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	1999	96	6					879	891		10.1016/S0092-8674(00)80597-8	http://dx.doi.org/10.1016/S0092-8674(00)80597-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	178ZY	10102275	Bronze			2022-12-28	WOS:000079300100014
J	Raju, TNK				Raju, TNK			The Nobel Chronicles - 1945: Sir Alexander Fleming (1881-1955); Sir Ernst Boris Chain (1906-79); and Baron Howard Walter Florey (1898-1968)	LANCET			English	Article									Univ Illinois, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Raju, TNK (corresponding author), Univ Illinois, Chicago, IL 60680 USA.								0	8	9	0	19	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 13	1999	353	9156					936	936		10.1016/S0140-6736(05)75055-8	http://dx.doi.org/10.1016/S0140-6736(05)75055-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BU	10094026				2022-12-28	WOS:000079421400073
J	Weiss, S				Weiss, S			Fluorescence spectroscopy of single biomolecules	SCIENCE			English	Review							TIME-RESOLVED SPECTROSCOPY; LASER-INDUCED FLUORESCENCE; RESONANCE ENERGY-TRANSFER; NEAR-FIELD; ROOM-TEMPERATURE; MOLECULE SPECTROSCOPY; INDIVIDUAL MOLECULES; 2-PHOTON EXCITATION; OPTICAL MICROSCOPY; PROTEINS	Recent advances in single-molecule detection and single-molecule spectroscopy at room temperature by Laser-induced fluorescence offer new tools for the study of individual macromolecules under physiological conditions. These tools relay conformational states, conformational dynamics, and activity of single biological molecules to physical observables, unmasked by ensemble averaging. Distributions and time trajectories of these observables can therefore be measured during a reaction without the impossible need to synchronize all the molecules in the ensemble. The progress in applying these tools to biological studies with the use of fluorophores that are site-specifically attached to macromolecules is reviewed.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Weiss, S (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA.		weiss, shimon/B-4164-2009; mert, sevda/D-9524-2018	weiss, shimon/0000-0002-0720-5426; mert, sevda/0000-0002-0481-2829				AMBROSE WP, 1994, PHYS REV LETT, V72, P160, DOI 10.1103/PhysRevLett.72.160; AMBROSE WP, 1994, SCIENCE, V265, P364, DOI 10.1126/science.265.5170.364; AMBROSE WP, IN PRESS BIOIMAGING; ANTHONYCAHILL SJ, 1989, TRENDS BIOCHEM SCI, V14, P400, DOI 10.1016/0968-0004(89)90287-9; Basche T., 1997, SINGLE MOL OPTICAL D; BETZIG E, 1995, OPT LETT, V20, P237, DOI 10.1364/OL.20.000237; BETZIG E, 1993, SCIENCE, V262, P1422, DOI 10.1126/science.262.5138.1422; Bian RX, 1995, PHYS REV LETT, V75, P4772, DOI 10.1103/PhysRevLett.75.4772; Brand L, 1997, J PHYS CHEM A, V101, P4313, DOI 10.1021/jp963729w; BRUCHEZ MJ, 1998, NATURE, V281, P2013; CHAN WCW, 1998, NATURE, V281, P2016; CORNISH VW, 1994, P NATL ACAD SCI USA, V91, P2910, DOI 10.1073/pnas.91.8.2910; Craig DB, 1996, J AM CHEM SOC, V118, P5245, DOI 10.1021/ja9540839; DAHAN M, UNPUB; DENIZ AA, IN PRESS P NATL ACAD; Dickson RM, 1996, SCIENCE, V274, P966, DOI 10.1126/science.274.5289.966; DOVICHI NJ, 1983, SCIENCE, V219, P845, DOI 10.1126/science.6823553; Eggeling C, 1998, P NATL ACAD SCI USA, V95, P1556, DOI 10.1073/pnas.95.4.1556; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Gimzewski JK, 1999, SCIENCE, V283, P1683, DOI 10.1126/science.283.5408.1683; GLASS JT, UNPUB; Ha T, 1996, IEEE J SEL TOP QUANT, V2, P1115, DOI 10.1109/2944.577342; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Ha T, 1998, PHYS REV LETT, V80, P2093, DOI 10.1103/PhysRevLett.80.2093; Ha T, 1996, PHYS REV LETT, V77, P3979, DOI 10.1103/PhysRevLett.77.3979; Ha TJ, 1999, P NATL ACAD SCI USA, V96, P893, DOI 10.1073/pnas.96.3.893; HA TL, UNPUB, P55215; Hill SC, 1996, APPL OPTICS, V35, P6278, DOI 10.1364/AO.35.006278; HIRSCHFELD T, 1976, APPL OPTICS, V15, P3135, DOI 10.1364/AO.15.003135; HIRSCHFELD T, 1979, J HISTOCHEM CYTOCHEM, V27, P96, DOI 10.1177/27.1.86585; HIRSCHFELD T, 1976, APPL OPTICS, V15, P2965, DOI 10.1364/AO.15.002965; Hopkins S. C., 1997, Biophysical Journal, V72, pA1; Ishijima A, 1998, CELL, V92, P161, DOI 10.1016/S0092-8674(00)80911-3; Iwane AH, 1997, FEBS LETT, V407, P235, DOI 10.1016/S0014-5793(97)00359-1; JETT JH, 1989, J BIOMOL STRUCT DYN, V7, P301, DOI 10.1080/07391102.1989.10507773; Keller RA, 1996, APPL SPECTROSC, V50, pA12, DOI 10.1366/0003702963905600; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Macklin JJ, 1996, SCIENCE, V272, P255, DOI 10.1126/science.272.5259.255; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Mehta AD, 1999, SCIENCE, V283, P1689, DOI 10.1126/science.283.5408.1689; Mertz J, 1995, OPT LETT, V20, P2532, DOI 10.1364/OL.20.002532; Mets U, 1994, J Fluoresc, V4, P259, DOI 10.1007/BF01878461; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Moerner WE, 1999, SCIENCE, V283, P1670, DOI 10.1126/science.283.5408.1670; MOERNER WE, 1989, ANAL CHEM, V61, pA1217, DOI 10.1021/ac00196a002; NGUYEN DC, 1987, J OPT SOC AM B, V4, P138, DOI 10.1364/JOSAB.4.000138; NIE SM, 1994, SCIENCE, V266, P1018, DOI 10.1126/science.7973650; Nie SM, 1997, ANNU REV BIOPH BIOM, V26, P567, DOI 10.1146/annurev.biophys.26.1.567; Pierce DW, 1997, NATURE, V388, P338, DOI 10.1038/41009; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Romberg L, 1998, J CELL BIOL, V140, P1407, DOI 10.1083/jcb.140.6.1407; Sanchez EJ, 1997, J PHYS CHEM A, V101, P7019, DOI 10.1021/jp971915b; Sase I, 1997, P NATL ACAD SCI USA, V94, P5646, DOI 10.1073/pnas.94.11.5646; SASE I, 1995, BIOPHYS J, V69, P323, DOI 10.1016/S0006-3495(95)79937-4; Sauer M, 1998, BIOIMAGING, V6, P14, DOI 10.1002/1361-6374(199803)6:1<14::AID-BIO3>3.0.CO;2-O; SCHMIDT T, 1995, J PHYS CHEM-US, V99, P17662, DOI 10.1021/j100049a030; Schutz GJ, 1998, BIOPHYS J, V74, P2223, DOI 10.1016/S0006-3495(98)77931-7; Schutz GJ, 1997, BIOPHYS J, V73, P1073, DOI 10.1016/S0006-3495(97)78139-6; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; SHERA EB, 1990, CHEM PHYS LETT, V174, P553, DOI 10.1016/0009-2614(90)85485-U; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Suzuki Y, 1998, NATURE, V396, P380, DOI 10.1038/24640; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Tan WH, 1997, ANAL CHEM, V69, P4242, DOI 10.1021/ac970631k; Trautman JK, 1996, CHEM PHYS, V205, P221, DOI 10.1016/0301-0104(95)00391-6; TRAUTMAN JK, 1994, NATURE, V369, P40, DOI 10.1038/369040a0; TRAUTMANN J, 1997, SINGLE MOL OPTICAL D, P191; Tskhovrebova L, 1997, NATURE, V387, P308, DOI 10.1038/387308a0; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; van Oijen AM, 1998, CHEM PHYS LETT, V292, P183, DOI 10.1016/S0009-2614(98)00673-3; Warshaw DM, 1998, P NATL ACAD SCI USA, V95, P8034, DOI 10.1073/pnas.95.14.8034; Wu H, 1998, P NATL ACAD SCI USA, V95, P9226, DOI 10.1073/pnas.95.16.9226; Xie XS, 1996, ACCOUNTS CHEM RES, V29, P598, DOI 10.1021/ar950246m; XIE XS, 1994, SCIENCE, V265, P361, DOI 10.1126/science.265.5170.361; Xie XS, 1998, ANNU REV PHYS CHEM, V49, P441, DOI 10.1146/annurev.physchem.49.1.441; XIE XS, 1997, FOCUS MULTIDIMENSION, V1; Xu XH, 1997, SCIENCE, V275, P1106, DOI 10.1126/science.275.5303.1106; Xu XHN, 1998, SCIENCE, V281, P1650, DOI 10.1126/science.281.5383.1650; XUE QF, 1995, NATURE, V373, P681, DOI 10.1038/373681a0	85	1719	1820	12	826	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	1999	283	5408					1676	1683		10.1126/science.283.5408.1676	http://dx.doi.org/10.1126/science.283.5408.1676			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175PF	10073925				2022-12-28	WOS:000079102800038
J	Guggino, WB				Guggino, WB			Cystic fibrosis and the salt controversy	CELL			English	Review							AIRWAY SURFACE LIQUID; LUNG INFECTIONS; EPITHELIA; TRANSPORT; BACTERIA; CELLS; CFTR		Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Guggino, WB (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.							BOUCHER RC, 1994, AM J RESP CRIT CARE, V150, P271, DOI 10.1164/ajrccm.150.1.8025763; Devidas S, 1997, CURR OPIN CELL BIOL, V9, P547, DOI 10.1016/S0955-0674(97)80032-4; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; Farinas J, 1997, J GEN PHYSIOL, V110, P283, DOI 10.1085/jgp.110.3.283; GILLJAM H, 1989, SCAND J CLIN LAB INV, V49, P121, DOI 10.3109/00365518909105409; IMUNDO L, 1995, P NATL ACAD SCI USA, V92, P3019, DOI 10.1073/pnas.92.7.3019; KEREM E, 1997, PEDIATR PULM, V14, P78; Knowles MR, 1997, J CLIN INVEST, V100, P2588, DOI 10.1172/JCI119802; Ko YH, 1997, FEBS LETT, V405, P200, DOI 10.1016/S0014-5793(97)00189-0; LEVISON H, 1983, EUR J RESP DIS S, V127, P102; LIEDTKE CM, 1989, ANNU REV PHYSIOL, V51, P143, DOI 10.1146/annurev.physiol.51.1.143; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Nielsen S, 1996, KIDNEY INT, V49, P1718, DOI 10.1038/ki.1996.254; Pier GB, 1996, SCIENCE, V271, P64, DOI 10.1126/science.271.5245.64; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rosenstein BJ, 1998, CLIN CHEST MED, V19, P423, DOI 10.1016/S0272-5231(05)70091-5; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Smith JJ, 1996, CELL, V85, P229, DOI 10.1016/S0092-8674(00)81099-5; WIDDICOMBE JH, 1995, RESP PHYSIOL, V99, P3, DOI 10.1016/0034-5687(94)00095-H; Zabner J, 1998, MOL CELL, V2, P397, DOI 10.1016/S1097-2765(00)80284-1	20	106	106	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 5	1999	96	5					607	610		10.1016/S0092-8674(00)80570-X	http://dx.doi.org/10.1016/S0092-8674(00)80570-X			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	174TB	10089875	hybrid			2022-12-28	WOS:000079050100003
J	Martin, DF; Kuppermann, BD; Wolitz, RA; Palestine, AG; Li, H; Robinson, CA				Martin, DF; Kuppermann, BD; Wolitz, RA; Palestine, AG; Li, H; Robinson, CA		Roche Ganciclovir Study Grp	Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; IMMUNODEFICIENCY-VIRUS INFECTION; KAPOSIS-SARCOMA; CONTROLLED TRIAL; ANTIRETROVIRAL THERAPY; SEXUAL TRANSMISSION; NATURAL-HISTORY; DNA-SEQUENCES; AIDS; DISEASE	Background The intraocular ganciclovir implant is effective for local treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome (AIDS), but it does not treat or prevent other systemic manifestations of cytomegalovirus infection. Methods Three hundred seventy-seven patients with AIDS and unilateral cytomegalovirus retinitis were randomly assigned to one of three treatments: a ganciclovir implant plus oral ganciclovir (4.5 g daily), a ganciclovir implant plus oral placebo, or intravenous ganciclovir alone. The primary outcome measure was the development of new cytomegalovirus disease, either contralateral retinitis or biopsy-proved extraocular disease. Results The incidence of new cytomegalovirus disease at six months was 44.3 percent in the group assigned to the ganciclovir implant plus placebo, as compared with 24.3 percent in the group assigned to the ganciclovir implant plus oral ganciclovir (P=0.002) and 19.6 percent in the group assigned to intravenous ganciclovir alone (P<0.001). As compared with placebo, oral ganciclovir reduced the overall risk of new cytomegalovirus disease by 37.6 percent over the one-year period of the study (P=0.02). However, in the subgroup of 103 patients who took protease inhibitors, the rates of new cytomegalovirus disease were low and of similar magnitude, regardless of treatment assignment. Progression of retinitis in the eye that initially received an implant was delayed by the addition of oral ganciclovir, as compared with placebo (P=0.03). Treatment with oral or intravenous ganciclovir reduced the risk of Kaposi's sarcoma by 75 percent (P=0.008) and 93 percent (P<0.001), respectively, as compared with placebo. Conclusions In patients with AIDS and cytomegalovirus retinitis, oral ganciclovir in conjunction with a ganciclovir implant reduces the incidence of new cytomegalovirus disease and delays progression of the retinitis. Treatment with oral or intravenous ganciclovir also reduces the risk of Kaposi's sarcoma. (N Engl J Med 1999;340:1063-70.) (C) 1999, Massachusetts Medical Society.	Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA; Univ Calif Irvine, Dept Ophthalmol, Irvine, CA 92717 USA; Kaiser Permanente, San Francisco, CA USA; Georgetown Univ, Washington, DC USA; Roche Global Dev, Palo Alto, CA USA	Emory University; University of California System; University of California Irvine; Kaiser Permanente; Georgetown University; Roche Holding	Martin, DF (corresponding author), Emory Univ, Sch Med, Dept Ophthalmol, 1365B Clifton Rd NE, Atlanta, GA 30322 USA.	dmart04@emory.edu						AMBROZIAK JA, 1995, SCIENCE, V268, P582, DOI 10.1126/science.7725108; AREVALO JF, 1995, J INFECT DIS, V172, P951, DOI 10.1093/infdis/172.4.951; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; BARIL L, 37 INT C ANT AG CHEM; BOSHOFF C, 1995, NAT MED, V1, P1274, DOI 10.1038/nm1295-1274; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Collier AC, 1996, NEW ENGL J MED, V334, P1011, DOI 10.1056/NEJM199604183341602; DREW WL, 1995, NEW ENGL J MED, V333, P615, DOI 10.1056/NEJM199509073331002; FERRIS FL, 1982, AM J OPHTHALMOL, V94, P91, DOI 10.1016/0002-9394(82)90197-0; GALLANT JE, 1992, J INFECT DIS, V166, P1223, DOI 10.1093/infdis/166.6.1223; Ganem D, 1997, CELL, V91, P157, DOI 10.1016/S0092-8674(00)80398-0; Gao SJ, 1996, NEW ENGL J MED, V335, P233, DOI 10.1056/NEJM199607253350403; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; HOOVER DR, 1993, NEW ENGL J MED, V329, P1922, DOI 10.1056/NEJM199312233292604; HUANG YQ, 1995, LANCET, V345, P759, DOI 10.1016/S0140-6736(95)90641-X; Jabs DA, 1997, AM J OPHTHALMOL, V124, P227, DOI 10.1016/S0002-9394(14)70789-5; JABS DA, 1994, OPHTHALMOLOGY, V101, P1250; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kedes DH, 1996, NAT MED, V2, P1041; Kedes DH, 1997, JAMA-J AM MED ASSOC, V277, P478, DOI 10.1001/jama.277.6.478; Kedes DH, 1996, NAT MED, V2, P918, DOI 10.1038/nm0896-918; Kedes DH, 1997, J CLIN INVEST, V99, P2082, DOI 10.1172/JCI119380; KUPPERMANN BD, 1993, AM J OPHTHALMOL, V115, P575, DOI 10.1016/S0002-9394(14)71453-9; KUPPERMANN BD, 1993, J INFECT DIS, V168, P1506, DOI 10.1093/infdis/168.6.1506; Lalezari JP, 1997, ANN INTERN MED, V126, P257, DOI 10.7326/0003-4819-126-4-199702150-00001; LALEZARI JP, 1996, 11TH INT C AIDS VANC, V2, P226; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Lewis RA, 1997, ANN INTERN MED, V126, P264, DOI 10.7326/0003-4819-126-4-199702150-00002; MARTIN DF, 1994, ARCH OPHTHALMOL-CHIC, V112, P1531, DOI 10.1001/archopht.1994.01090240037023; MARTIN DF, 1990, ARCH OPHTHALMOL-CHIC, V108, P411, DOI 10.1001/archopht.1990.01070050109043; Martin JN, 1998, NEW ENGL J MED, V338, P948, DOI 10.1056/NEJM199804023381403; Medveczky MM, 1997, AIDS, V11, P1327, DOI 10.1097/00002030-199711000-00006; Moore PS, 1996, AIDS, V10, P175, DOI 10.1097/00002030-199602000-00007; MOORE PS, 1995, NEW ENGL J MED, V332, P1181, DOI 10.1056/NEJM199505043321801; Musch DC, 1997, NEW ENGL J MED, V337, P83, DOI 10.1056/NEJM199707103370203; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Spector SA, 1996, NEW ENGL J MED, V334, P1491, DOI 10.1056/NEJM199606063342302; WHITBY D, 1995, LANCET, V346, P799, DOI 10.1016/S0140-6736(95)91619-9	40	344	358	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 8	1999	340	14					1063	1070		10.1056/NEJM199904083401402	http://dx.doi.org/10.1056/NEJM199904083401402			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	184AK	10194235				2022-12-28	WOS:000079587000002
J	Sporer, KA				Sporer, KA			Acute heroin overdose	ANNALS OF INTERNAL MEDICINE			English	Review							INJECTING DRUG-USERS; SWISS-WEBSTER MICE; BLACK TAR HEROIN; MORPHINE CONCENTRATIONS; PULMONARY-EDEMA; WOUND BOTULISM; FOLLOW-UP; INTRAVENOUS HEROIN; NARCOTIC ADDICTS; OPIOID ADDICTS	Acute heroin overdose is a common daily experience in the urban and suburban United States and accounts for many preventable deaths. Heroin acts as a pro-drug that allows rapid and complete central nervous system absorption; this accounts for the drug's euphoric and toxic effects. The heroin overdose syndrome (sensitivity for diagnosing heroin overdose, 92%; specificity, 76%) consists of abnormal mental status, substantially decreased respiration, and miotic pupils. The response of naloxone does not improve the sensitivity of this diagnosis. Most overdoses occur at home in the company of others and are more common in the setting of other drugs. Heroin-related deaths are strongly associated with use of alcohol or other drugs. Patients with clinically significant respiratory compromise need treatment, which includes airway management and intravenous or subcutaneous naloxone. Hospital observation for several hours is necessary for recurrence of hypoventilation or other complications. About 3% to 7% of treated patients require hospital admission for pneumonia, noncardiogenic pulmonary edema, or other complications. Methadone maintenance is an effective preventive measure, and others strategies should be studied.	San Francisco Gen Hosp, Emergency Serv, San Francisco, CA 94110 USA	San Francisco General Hospital Medical Center	Sporer, KA (corresponding author), San Francisco Gen Hosp, Emergency Serv, Room 1E21,1001 Potrero Ave, San Francisco, CA 94110 USA.							Abbasi K, 1998, BRIT MED J, V316, P331; ADDINGTON WW, 1972, CHEST, V62, P199, DOI 10.1378/chest.62.2.199; ADERJAN R, 1995, J ANAL TOXICOL, V19, P163, DOI 10.1093/jat/19.3.163; Anderson MW, 1997, ACAD EMERG MED, V4, P805, DOI 10.1111/j.1553-2712.1997.tb03790.x; BAMMER G, 1994, MED J AUSTRALIA, V161, P572, DOI 10.5694/j.1326-5377.1994.tb127616.x; BASELT RC, 1975, WESTERN J MED, V122, P455; BENOWITZ NL, 1979, MED CLIN N AM, V63, P267, DOI 10.1016/S0025-7125(16)31728-X; BERKOWITZ B A, 1976, Clinical Pharmacokinetics, V1, P219, DOI 10.2165/00003088-197601030-00004; BERKOWITZ BA, 1975, J PHARMACOL EXP THER, V195, P499; BERTINI G, 1992, CRIT CARE MED, V20, P493, DOI 10.1097/00003246-199204000-00011; BOERNER U, 1975, DRUG METAB REV, V4, P39, DOI 10.3109/03602537508993748; BRZOZOWSKI M, 1993, ANN EMERG MED, V22, P1638, DOI 10.1016/S0196-0644(05)81276-4; Caplehorn JRM, 1996, SUBST USE MISUSE, V31, P177, DOI 10.3109/10826089609045806; CHAMBERLAIN JM, 1994, AM J EMERG MED, V12, P650, DOI 10.1016/0735-6757(94)90033-7; CHERUBIN CE, 1967, ANN INTERN MED, V67, P23, DOI 10.7326/0003-4819-67-1-23; CUSS FM, 1984, BRIT MED J, V288, P363, DOI 10.1136/bmj.288.6414.363; Darke S, 1997, DRUG ALCOHOL DEPEN, V47, P45, DOI 10.1016/S0376-8716(97)00070-7; Darke S, 1997, ADDICTION, V92, P1195; Darke S, 1996, ADDICTION, V91, P413, DOI 10.1046/j.1360-0443.1996.91341310.x; Darke S, 1996, ADDICTION, V91, P405, DOI 10.1111/j.1360-0443.1996.tb02289.x; Darke S, 1996, ADDICTION, V91, P1765, DOI 10.1111/j.1360-0443.1996.tb03800.x; DAVIS EA, 1994, PREHOSP DISASTER MED, V9, pS60; DAVOLI M, 1993, INT J EPIDEMIOL, V22, P273, DOI 10.1093/ije/22.2.273; DERIDDER M, 1994, J PSYCHOACTIVE DRUGS, V26, P65, DOI 10.1080/02791072.1994.10472603; DUBERSTEIN JL, 1971, AM J MED, V51, P704, DOI 10.1016/0002-9343(71)90298-1; ELLENHORN MJ, 1997, ELLENHORNS MED TOXIC, P405; FRAND UI, 1972, ANN INTERN MED, V77, P29, DOI 10.7326/0003-4819-77-1-29; GADDIS GM, 1992, ANN PHARMACOTHER, V26, P196, DOI 10.1177/106002809202600211; Gaeta TJ, 1997, ANN EMERG MED, V29, P193; GARRIOTT JC, 1973, NEW ENGL J MED, V289, P1276, DOI 10.1056/NEJM197312132892404; GOLDBERGER BA, 1994, J ANAL TOXICOL, V18, P22, DOI 10.1093/jat/18.1.22; GOLDFRANK LR, 1994, GOLDFRANKS TOXICOLOG, P769; Gollober M, 1996, JAMA-J AM MED ASSOC, V275, P95; GOPINATH.K, 1970, CIRCULATION, V42, pII44; Gossop M, 1996, BRIT MED J, V313, P402; GREENBERG MI, 1980, ANN EMERG MED, V9, P289, DOI 10.1016/S0196-0644(80)80060-6; GREENBLATT J, 1997, YEAR END PRELIMINARY; GUTIERREZCEBOLLADA J, 1991, EUR J CLIN PHARMACOL, V40, P635, DOI 10.1007/BF00279986; GUTLERREZCEBOLL.J, 1994, DRUG ALCOHOL DEPEN, V35, P169; HAASTRUP S, 1988, ACTA PSYCHIAT SCAND, V77, P22, DOI 10.1111/j.1600-0447.1988.tb05071.x; Hall WD, 1996, MED J AUSTRALIA, V164, P197, DOI 10.5694/j.1326-5377.1996.tb94132.x; Hamid A, 1997, J PSYCHOACTIVE DRUGS, V29, P375, DOI 10.1080/02791072.1997.10400565; HANDAL KA, 1983, ANN EMERG MED, V12, P438, DOI 10.1016/S0196-0644(83)80343-6; HOFFMAN JR, 1991, ANN EMERG MED, V20, P246, DOI 10.1016/S0196-0644(05)80933-3; HOFFMAN RS, 1995, JAMA-J AM MED ASSOC, V274, P562, DOI 10.1001/jama.274.7.562; Horowitz Z, 1998, ACAD EMERG MED, V5, P283, DOI 10.1111/j.1553-2712.1998.tb02705.x; INTURRISI CE, 1984, NEW ENGL J MED, V310, P1213, DOI 10.1056/NEJM198405103101902; JAFFE RB, 1970, AMER J ROENTGENOL RA, V109, P107, DOI 10.2214/ajr.109.1.107; JOE GW, 1987, AM J PUBLIC HEALTH, V77, P347, DOI 10.2105/AJPH.77.3.347; KAPLAN JL, 1993, ANN EMERG MED, V22, P187, DOI 10.1016/S0196-0644(05)80200-8; KAPLAN JL, 1994, ACAD EMERG MED, V1, pA74; KATZ S, 1972, AM REV RESPIR DIS, V106, P472, DOI 10.1164/arrd.1972.106.3.472; KAUFMAN DM, 1972, PEDIATRICS, V50, P746; KHANTZIAN EJ, 1979, ANN INTERN MED, V90, P361, DOI 10.7326/0003-4819-90-3-361; Klockgether T, 1997, NEUROLOGY, V48, P275, DOI 10.1212/WNL.48.1.275; Lao PN, 1997, CLIN REV ALLERG IMMU, V15, P291, DOI 10.1007/BF02737702; LIGHT RW, 1975, CHEST, V67, P61, DOI 10.1378/chest.67.1.61; LOCKRIDGE O, 1980, J PHARMACOL EXP THER, V215, P1; LOURIA DB, 1967, ANN INTERN MED, V67, P1, DOI 10.7326/0003-4819-67-1-1; MARIANI PJ, 1989, AM J EMERG MED, V7, P127, DOI 10.1016/0735-6757(89)90119-8; Maselli RA, 1997, MUSCLE NERVE, V20, P1284, DOI 10.1002/(SICI)1097-4598(199710)20:10<1284::AID-MUS11>3.0.CO;2-3; MERIGIAN KS, 1993, AM J EMERG MED, V11, P96, DOI 10.1016/0735-6757(93)90074-L; MONFORTE JR, 1977, J FORENSIC SCI, V22, P718; MORRISON WJ, 1970, RADIOLOGY, V97, P347, DOI 10.1148/97.2.347; OLDENDORF WH, 1972, SCIENCE, V178, P984, DOI 10.1126/science.178.4064.984; OPPENHEIMER E, 1994, ADDICTION, V89, P1299, DOI 10.1111/j.1360-0443.1994.tb03309.x; OSBORNE R, 1988, LANCET, V1, P828; OSBORNE R, 1990, CLIN PHARMACOL THER, V47, P12, DOI 10.1038/clpt.1990.2; Osterwalder JJ, 1996, J TOXICOL-CLIN TOXIC, V34, P409, DOI 10.3109/15563659609013811; OTERO A, 1992, NEPHRON, V62, P245, DOI 10.1159/000187050; PARANTHAMAN SK, 1976, CHEST, V69, P117, DOI 10.1378/chest.69.1.117; PARE EM, 1984, J ANAL TOXICOL, V8, P213, DOI 10.1093/jat/8.5.213; Passaro DJ, 1998, JAMA-J AM MED ASSOC, V279, P859, DOI 10.1001/jama.279.11.859; *PLIN ELD, 1961, NAT HIST, P114; POPPER C, 1989, LANCET, V2, P446; Rady JJ, 1997, PHARMACOL BIOCHEM BE, V56, P243, DOI 10.1016/S0091-3057(96)00219-5; RADY JJ, 1994, J PHARMACOL EXP THER, V268, P1222; REED CR, 1991, CHEST, V100, P1120, DOI 10.1378/chest.100.4.1120; Reisine T, 1996, GOODMAN GILMANS PHAR, P521; Richards R G, 1976, J Forensic Sci, V21, P467; Rop PP, 1997, J ANAL TOXICOL, V21, P232, DOI 10.1093/jat/21.3.232; RUTTENBER AJ, 1984, SCIENCE, V226, P14, DOI 10.1126/science.6474188; RUTTENBER AJ, 1990, J FORENSIC SCI, V35, P891; SCHWARTZ M, 1998, CLIN MANAGEMENT POIS, P505; Seaman SR, 1998, BRIT MED J, V316, P426, DOI 10.1136/bmj.316.7129.426; Seidler D, 1996, AM J EMERG MED, V14, P436, DOI 10.1016/S0735-6757(96)90069-8; SELZMAN HAROLD M., 1967, CARDIOV RES CENT BULL, V6, P77; SILBER R, 1959, AM J MED, V27, P187, DOI 10.1016/0002-9343(59)90075-0; Skopp G, 1997, J ANAL TOXICOL, V21, P105, DOI 10.1093/jat/21.2.105; SMITH DA, 1992, ANN EMERG MED, V21, P1326, DOI 10.1016/S0196-0644(05)81896-7; SPLEHLER VR, 1978, J ANAT TOXICOL, V2, P62; Sporer KA, 1996, ACAD EMERG MED, V3, P660, DOI 10.1111/j.1553-2712.1996.tb03487.x; Steentoft A, 1996, INT J LEGAL MED, V108, P248, DOI 10.1007/BF01369819; STEINBERG AD, 1968, ARCH INTERN MED, V122, P122, DOI 10.1001/archinte.122.2.122; STERN WZ, 1968, AMER J ROENTGENOL RA, V103, P522, DOI 10.2214/ajr.103.3.522; Strang J, 1996, BRIT MED J, V312, P1435, DOI 10.1136/bmj.312.7044.1435; STRANG J, 1992, BRIT MED J, V304, P1127, DOI 10.1136/bmj.304.6835.1127; TANDBERG D, 1982, ANN EMERG MED, V11, P443, DOI 10.1016/S0196-0644(82)80045-0; TROEN P, 1953, NEW ENGL J MED, V248, P364, DOI 10.1056/NEJM195302262480903; TUNVING K, 1988, ACTA PSYCHIAT SCAND, V77, P551, DOI 10.1111/j.1600-0447.1988.tb05168.x; UMANS JG, 1981, J PHARMACOL EXP THER, V218, P409; UMANS JG, 1982, EUR J PHARMACOL, V85, P317, DOI 10.1016/0014-2999(82)90218-7; *US DEP HHS, 1997, HER AB US; VAILLANT GE, 1973, ARCH GEN PSYCHIAT, V29, P237; VUCAK MJ, 1991, AUST NZ J SURG, V61, P533, DOI 10.1111/j.1445-2197.1991.tb00282.x; Wang Ma-Li, 1994, Journal of the Formosan Medical Association, V93, P170; Wanger K, 1998, ACAD EMERG MED, V5, P293, DOI 10.1111/j.1553-2712.1998.tb02707.x; Watson WA, 1998, J TOXICOL-CLIN TOXIC, V36, P11, DOI 10.3109/15563659809162577; WAY EL, 1960, J PHARMACOL EXP THER, V129, P144; WAY EL, 1965, B NARCOTICS, V17, P25; YANG CC, 1995, J TOXICOL-CLIN TOXIC, V33, P591, DOI 10.3109/15563659509010614; YEALY DM, 1990, ANN EMERG MED, V19, P902, DOI 10.1016/S0196-0644(05)81566-5; Zador D, 1996, MED J AUSTRALIA, V164, P204, DOI 10.5694/j.1326-5377.1996.tb94136.x; Zuckerman GB, 1996, ANN PHARMACOTHER, V30, P778, DOI 10.1177/106002809603000714	114	222	236	0	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 6	1999	130	7					584	590		10.7326/0003-4819-130-7-199904060-00019	http://dx.doi.org/10.7326/0003-4819-130-7-199904060-00019			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	183BG	10189329				2022-12-28	WOS:000079533300007
J	Williams, S; Poulton, R				Williams, S; Poulton, R			Twins and maternal smoking: ordeals for the fetal origins hypothesis? A cohort study	BRITISH MEDICAL JOURNAL			English	Article							BLOOD-PRESSURE; BIRTH-WEIGHT; ADOLESCENCE; MORTALITY; DISEASE; SIZE	Objective To assess the direct and indirect effects of being a twin, maternal smoking, birth weight, and mother's height on blood pressure at ages 9 and 18 years. Design Longitudinal study. Subjects Cohort born in 1972-3. Setting Dunedin, New Zealand. Main outcome measure Blood pressure at ages 9 and 18 years. Results Compared with singletons, twins had a systolic blood pressure 4.55 (95% confidence interval 1.57 to 7.52) mm Hg lower at age 9 after adjustment for direct and indirect effects of sex, maternal smoking, mother's height socioeconomic status, and birth weight, as well as concurrent height and body mass index. Blood pressure in children whose mothers had smoked during pregnancy was 1.54 (0.46 to 2.62) mm Hg higher than in those whose mothers did not The total effect of birth weight on systolic blood pressure at age 9 was - 0.78 (- 1.76 to 0.20) mm Hg and that fur mother's height was 0.10 (0.06 to 0.14) mm Hg. Similar results were obtained for systolic blood pressure at age 18. The total effect of twins, maternal smoking, and birth weight on diastolic blood pressure was not significant at either age. Conclusions Twins had lower birth weight and lower systolic blood pressure at ages 9 and 18 than singletons. This finding challenges the fetal origins hypothesis, The effect of maternal smoking was consistent with the fetal origin hypothesis in that the infants of smokers were smaller and had higher blood pressure at both ages. This may be explained by pharmacological rather than nutritional effects. The total effect of birth weight on systolic blood pressure, after its indirect effect working through concurrent measures of height and body mass index was taken into account, was small.	Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand; Univ Otago, Dunedin Multidisciplinary Hlth & Dev Res Univ, Dept Prevent & Social Med, Dunedin, New Zealand	University of Otago; University of Otago	Williams, S (corresponding author), Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Box 913, Dunedin, New Zealand.	sheila.williams@stonebow.otago.ac.nz						Barker D. J. P., 1994, MOTHERS BABIES DIS L; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Barker DJP, 1992, FETAL INFANT ORIGINS; BUCKFIELD PM, 1978, NEW ZEAL MED J, V88, P244; CHRISTENSEN K, 1995, BRIT MED J, V310, P432, DOI 10.1136/bmj.310.6977.432; ELLEY WB, 1972, NEW ZEAL J EDUC STUD, V7, P153; Laor A, 1997, BRIT MED J, V315, P449, DOI 10.1136/bmj.315.7106.449; LAW CM, 1991, ARCH DIS CHILD, V66, P1291, DOI 10.1136/adc.66.11.1291; Logan S, 1996, ARCH DIS CHILD, V74, P176, DOI 10.1136/adc.74.2.176; MATTHES JWA, 1994, BMJ-BRIT MED J, V308, P1074, DOI 10.1136/bmj.308.6936.1074; OLAMAN SJ, 1997, DUNEDIN WOMENS HLTH; PANETH N, 1995, BRIT MED J, V310, P411, DOI 10.1136/bmj.310.6977.411; SEIDMAN DS, 1991, BMJ-BRIT MED J, V302, P1235, DOI 10.1136/bmj.302.6787.1235; Silva P., 1996, CHILD ADULT DUNEDIN; Su┬rbom, 1993, LISREL8 USERS REFERE; Taylor SJC, 1997, BRIT MED J, V314, P475, DOI 10.1136/bmj.314.7079.475; WILLIAMS S, 1992, J CLIN EPIDEMIOL, V45, P1257, DOI 10.1016/0895-4356(92)90167-L	17	82	83	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 3	1999	318	7188					897	900		10.1136/bmj.318.7188.897	http://dx.doi.org/10.1136/bmj.318.7188.897			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185GV	10102850	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000079660500022
J	Wernsdorfer, W; Sessoli, R				Wernsdorfer, W; Sessoli, R			Quantum phase interference and parity effects in magnetic molecular clusters	SCIENCE			English	Article							IRON CLUSTER; INTEGER-SPIN; FIELD; PARTICLES; DYNAMICS; SOLITONS; MODEL	An experimental method based on the Landau-Zener model was developed to measure very small tunnel splittings in molecular clusters of eight iron atoms, which at Low temperature behave like a nanomagnet with a spin ground state of S = 10. The observed oscillations of the tunnel splittings as a function of the magnetic field applied along the hard anisotropy axis are due to topological quantum interference of two tunnel paths of opposite windings. Transitions between quantum numbers M = -S and (S - n), with n even or odd, revealed a parity effect that is analogous to the suppression of tunneling predicted for half-integer spins. This observation is direct evidence of the topological part of the quantum spin phase (Berry phase) in a magnetic system.	CNRS, Lab Louis Neel, F-38042 Grenoble, France; Univ Florence, Dept Chem, I-50144 Florence, Italy	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Florence	Wernsdorfer, W (corresponding author), CNRS, Lab Louis Neel, BP166, F-38042 Grenoble, France.	wernsdor@labs.polycnrs-gre.fr	Sessoli, Roberta/K-5863-2015; Wernsdorfer, Wolfgang/M-2280-2016	Sessoli, Roberta/0000-0003-3783-2700; Wernsdorfer, Wolfgang/0000-0003-4602-5257				Barra AL, 1996, EUROPHYS LETT, V35, P133, DOI 10.1209/epl/i1996-00544-3; BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; Braun HB, 1996, PHYS REV B, V53, P3237, DOI 10.1103/PhysRevB.53.3237; Caciuffo R, 1998, PHYS REV LETT, V81, P4744, DOI 10.1103/PhysRevLett.81.4744; Dobrovitski VV, 1997, EUROPHYS LETT, V38, P377, DOI 10.1209/epl/i1997-00254-x; FEYNMAN PP, 1970, FEYNMAN LECT PHYSICS, V3; Friedman JR, 1996, PHYS REV LETT, V76, P3830, DOI 10.1103/PhysRevLett.76.3830; GARG A, 1993, EUROPHYS LETT, V22, P205, DOI 10.1209/0295-5075/22/3/008; Gunther L, 1997, EUROPHYS LETT, V39, P1, DOI 10.1209/epl/i1997-00545-8; Gunther L., 1995, QUANTUM TUNNELING MA; HALDANE FDM, 1988, PHYS REV LETT, V61, P1029, DOI 10.1103/PhysRevLett.61.1029; Imry Y., 1997, INTRO MESOSCOPIC PHY; Loss D, 1998, NATO ADV SCI I E-APP, V349, P29; LOSS D, 1992, PHYS REV LETT, V69, P3232, DOI 10.1103/PhysRevLett.69.3232; MANOUSAKIS E, 1991, REV MOD PHYS, V63, P1, DOI 10.1103/RevModPhys.63.1; MIYASHITA S, 1995, J PHYS SOC JPN, V64, P3207, DOI 10.1143/JPSJ.64.3207; NOVAK MA, 1995, QUANTUM TUNNELING MA, P189; Ohm T, 1998, EUR PHYS J B, V6, P195, DOI 10.1007/s100510050541; Ohm T, 1998, J LOW TEMP PHYS, V113, P1141, DOI 10.1023/A:1022545510114; Perenboom JAAJ, 1998, PHYS REV B, V58, P330, DOI 10.1103/PhysRevB.58.330; PROKOFEV NV, 1993, J PHYS-CONDENS MAT, V5, pL663, DOI 10.1088/0953-8984/5/50/002; Prokofev NV, 1996, J LOW TEMP PHYS, V104, P143, DOI 10.1007/BF00754094; Rose G, 1998, J LOW TEMP PHYS, V113, P1153, DOI 10.1023/A:1022549611023; Sangregorio C, 1997, PHYS REV LETT, V78, P4645, DOI 10.1103/PhysRevLett.78.4645; SESSOLI R, 1993, NATURE, V365, P141, DOI 10.1038/365141a0; Thomas L, 1996, NATURE, V383, P145, DOI 10.1038/383145a0; Tupitsyn IS, 1997, INT J MOD PHYS B, V11, P2901, DOI 10.1142/S0217979297001416; Wernsdorfer W, 1997, PHYS REV LETT, V78, P1791, DOI 10.1103/PhysRevLett.78.1791; WERNSDORFER W, 1996, THESIS J FOURIER U G; WIEGHARDT K, 1984, ANGEW CHEM INT EDIT, V23, P77; Zener C, 1932, P R SOC LOND A-CONTA, V137, P696, DOI 10.1098/rspa.1932.0165	32	1316	1318	2	214	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	1999	284	5411					133	135		10.1126/science.284.5411.133	http://dx.doi.org/10.1126/science.284.5411.133			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182QE	10102810				2022-12-28	WOS:000079509000049
J	Lo, HK; Chau, HF				Lo, HK; Chau, HF			Unconditional security of quantum key distribution over arbitrarily long distances	SCIENCE			English	Article							BIT COMMITMENT; NOISY CHANNELS; CRYPTOGRAPHY; STATE	Quantum key distribution is widely thought to offer unconditional security in communication between two users. Unfortunately, a widely accepted proof of its security in the presence of source, device, and channel noises has been missing. This long-standing problem is solved here by showing that, given fault-tolerant quantum computers, quantum key distribution over an arbitrarily long distance of a realistic noisy channel can be made unconditionally secure. The proof is reduced from a noisy quantum scheme to a noiseless quantum scheme and then from a noiseless quantum scheme to a noiseless classical scheme, which can then be tackled by classical probability theory.	Hewlett Packard Labs, Bristol BS34 8QZ, Avon, England; Univ Hong Kong, Dept Phys, Hong Kong, Peoples R China	Hewlett-Packard; University of Hong Kong	Lo, HK (corresponding author), Hewlett Packard Labs, Filton Rd, Bristol BS34 8QZ, Avon, England.	hkl@hplb.hpl.hp.com	Chau, Hoi Fung/D-3054-2009					Aharonov D., 1998, P 29 ANN ACM S THEOR, P176; Bell JS., 1964, PHYS, V1, P195, DOI [10.1103/PhysicsPhysiqueFizika.1.195, 10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; Bennett C. H., 1992, Journal of Cryptology, V5, P3, DOI 10.1007/BF00191318; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Bennett CH, 1996, PHYS REV A, V54, P3824, DOI 10.1103/PhysRevA.54.3824; Bennett CH, 1996, PHYS REV A, V54, P2675, DOI 10.1103/PhysRevA.54.2675; Bennett CH., 1984, P IEEE INT C COMP SY, P175; Biham E, 1997, PHYS REV LETT, V78, P2256, DOI 10.1103/PhysRevLett.78.2256; Brassard G., 1993, Proceedings. 34th Annual Symposium on Foundations of Computer Science (Cat. No.93CH3368-8), P362, DOI 10.1109/SFCS.1993.366851; Brassard G., 1996, SIGACT News, V27, P13, DOI 10.1145/235666.235669; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; BRIEGEL HJ, 1998, PHILOS T R SOC LON A, V356, P1713; Chau HF, 1998, FORTSCHR PHYS, V46, P507, DOI 10.1002/(SICI)1521-3978(199806)46:4/5<507::AID-PROP507>3.0.CO;2-4; Deutsch D, 1996, PHYS REV LETT, V77, P2818, DOI 10.1103/PhysRevLett.77.2818; Dur W, 1999, PHYS REV A, V59, P169, DOI 10.1103/PhysRevA.59.169; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; EKERT AK, 1991, PHYS REV LETT, V67, P661, DOI 10.1103/PhysRevLett.67.661; Fuchs CA, 1997, PHYS REV A, V56, P1163, DOI 10.1103/PhysRevA.56.1163; Fuchs CA, 1998, FORTSCHR PHYS, V46, P535, DOI 10.1002/(SICI)1521-3978(199806)46:4/5<535::AID-PROP535>3.0.CO;2-0; Griffiths RB, 1996, PHYS REV LETT, V76, P3228, DOI 10.1103/PhysRevLett.76.3228; Griffiths RB, 1997, PHYS REV A, V56, P1173, DOI 10.1103/PhysRevA.56.1173; Lo H-K., 1998, INTRO QUANTUM COMPUT; Lo HK, 1998, PHYSICA D, V120, P177, DOI 10.1016/S0167-2789(98)00053-0; Lo HK, 1997, PHYS REV A, V56, P1154, DOI 10.1103/PhysRevA.56.1154; Lo HK, 1997, PHYS REV LETT, V78, P3410, DOI 10.1103/PhysRevLett.78.3410; LO HK, 1998, INTRO QUANTUM COMPUT, P76; Lutkenhaus N, 1996, PHYS REV A, V54, P97, DOI 10.1103/PhysRevA.54.97; Mayers D., 1996, Advances in Cryptology - CRYPTO'96. 16th Annual International Cryptology Conference. Proceedings, P343; Mayers D, 1997, PHYS REV LETT, V78, P3414, DOI 10.1103/PhysRevLett.78.3414; Mayers D, 1998, ANN IEEE SYMP FOUND, P503, DOI 10.1109/SFCS.1998.743501; Mayers D, 1995, LECT NOTES COMPUT SC, V963, P124; Muller A, 1996, EUROPHYS LETT, V33, P335, DOI 10.1209/epl/i1996-00343-4; Preskill J, 1998, P ROY SOC A-MATH PHY, V454, P385, DOI 10.1098/rspa.1998.0167; SHOR PW, 1995, PHYS REV A, V52, pR2493, DOI 10.1103/PhysRevA.52.R2493; SMOLIN J, COMMUNICATION; Steane AM, 1996, PHYS REV LETT, V77, P793, DOI 10.1103/PhysRevLett.77.793; TOWNSEND PD, 1994, ELECTRON LETT, V30, P809, DOI 10.1049/el:19940558; vanEnk SJ, 1997, PHYS REV LETT, V78, P4293, DOI 10.1103/PhysRevLett.78.4293; Wheeler J.A., 1983, QUANTUM THEORY MEASU, P138; WHEELER JA, 1983, QUANTUM THEORY MEASU, P403; WOOTTERS WK, 1982, NATURE, V299, P802, DOI 10.1038/299802a0; Zbinden H., 1998, INTRO QUANTUM COMPUT, P120; [No title captured]	48	1157	1210	9	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	1999	283	5410					2050	2056		10.1126/science.283.5410.2050	http://dx.doi.org/10.1126/science.283.5410.2050			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180DH	10092221	Green Submitted			2022-12-28	WOS:000079369800036
J	Tanimoto, K; Liu, QH; Bungert, J; Engel, JD				Tanimoto, K; Liu, QH; Bungert, J; Engel, JD			Effects of altered gene order or orientation of the locus control region on human beta-globin gene expression in mice	NATURE			English	Article							YEAST ARTIFICIAL CHROMOSOME; DEVELOPMENTAL REGULATION; TRANSGENIC MICE; EPSILON-GLOBIN; GAMMA-GLOBIN; TRANSCRIPTION	The five human beta-type-globin genes, epsilon, G gamma, A gamma, delta and beta, are close together and are regulated by a locus control region (LCR) located at the 5' end of the locus(1,2). Here we investigate the functional consequences of this organization with respect to temporal regulation of the individual genes, by using recombination techniques to invert the order of either the genes or the LCR in vivo. Our analysis of transgenic mice bearing either normal or mutant transgenes leads to two new observations. First, the position of the epsilon-globin gene next to the LCR is mandatory for its expression during the yolk-sac stage of erythropoiesis. Second, LCR activity is orientation dependent, and so the LCR does not act as a simple enhancer to stimulate transcription of the globin genes. Thus, in the absence of any change in transgene integration position, transgene copy number, trans-acting factors or other resident genetic information, simple inversion of the human genes or the LCR fundamentally alters the transcription of beta-type globin genes.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Engel, JD (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.		Tanimoto, Keiji/B-2600-2014	Tanimoto, Keiji/0000-0003-1971-6546	NHLBI NIH HHS [R01 HL024415] Funding Source: Medline; NIDDK NIH HHS [R01 DK052356, R01 DK052356-04] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052356] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bungert J, 1995, GENE DEV, V9, P3083, DOI 10.1101/gad.9.24.3083; CHOI ORB, 1988, CELL, V55, P17, DOI 10.1016/0092-8674(88)90005-0; DILLON N, 1997, MOL CELL, V1, P13; ENVER T, 1990, NATURE, V344, P309, DOI 10.1038/344309a0; FOLEY KP, 1992, GENE DEV, V6, P730, DOI 10.1101/gad.6.5.730; FRASER P, 1993, GENE DEV, V7, P106, DOI 10.1101/gad.7.1.106; GAENSLER KML, 1993, P NATL ACAD SCI USA, V90, P11381, DOI 10.1073/pnas.90.23.11381; HANSCOMBE O, 1991, GENE DEV, V5, P1387, DOI 10.1101/gad.5.8.1387; Hardison R, 1997, GENE, V205, P73, DOI 10.1016/S0378-1119(97)00474-5; HOGAN B, 1986, MANIPULATING MOUSE E; LI QL, 1994, BLOOD, V84, P1399; Liu QH, 1998, P NATL ACAD SCI USA, V95, P9944, DOI 10.1073/pnas.95.17.9944; Liu QH, 1997, P NATL ACAD SCI USA, V94, P169, DOI 10.1073/pnas.94.1.169; Martin DIK, 1996, CURR OPIN GENET DEV, V6, P488, DOI 10.1016/S0959-437X(96)80072-4; Milot E, 1996, CELL, V87, P105, DOI 10.1016/S0092-8674(00)81327-6; PETERSON KR, 1993, MOL CELL BIOL, V13, P4836, DOI 10.1128/MCB.13.8.4836; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Reik A, 1998, MOL CELL BIOL, V18, P5992, DOI 10.1128/MCB.18.10.5992; SAUER B, 1989, NUCLEIC ACIDS RES, V17, P147, DOI 10.1093/nar/17.1.147; SAUER B, 1990, New Biologist, V2, P441; Stamatoyannopolous G., 1994, MOL BASIS BLOOD DIS, P107; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; YU JH, 1994, GENE, V139, P139, DOI 10.1016/0378-1119(94)90747-1; ZAFARANA G, 1995, MOL BIOL HEMOGLOBIN, P39	24	139	141	0	4	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 25	1999	398	6725					344	348		10.1038/18698	http://dx.doi.org/10.1038/18698			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180DF	10192336				2022-12-28	WOS:000079369600054
J	Goldstein, AO; Sobel, RA; Newman, GR				Goldstein, AO; Sobel, RA; Newman, GR			Tobacco and alcohol use in G-rated children's animated films	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CAMEL	Context Tobacco and alcohol use among youth are major public health problems, but the extent to which children are routinely exposed to tobacco and alcohol products in children's films is unknown. Objective To identify the prevalence and characteristics associated with tobacco and alcohol use portrayed in C-rated, animated feature films. Design All C-rated, animated feature films released between 1937 and 1997 by 5 major production companies (Walt Disney Co, MGM/United Artists, Warner Brothers Studios, Universal Studios, and 20th Century Fox) that were available on videotape were reviewed for episodes of tobacco and alcohol use. Main Outcome Measures Presence of tobacco and alcohol use in each film, type of tobacco or alcohol used, duration of use, type of character using substance (bad, neutral, or good), and any associated effects. Results Of 50 films reviewed, 34 (68%) displayed at least 1 episode of tobacco or alcohol use. Twenty-eight (56%) portrayed 1 or more incidences of tobacco use, including all 7 films released in 1996 and 1997. Twenty-five films (50%) included alcohol use. Smoking was portrayed on screen by 76 characters for more than 45 minutes in duration; alcohol use was portrayed by 63 characters for 27 minutes. Good characters use tobacco and alcohol as frequently as bad characters. Cigars and wine are shown in these films more often than other tobacco or alcohol substances. Conclusions More than two thirds of animated children's films feature tobacco or alcohol use in story plots without dear verbal messages of any negative long-term health effects associated with use of either substance.	Univ N Carolina, Sch Med, Dept Family Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Publ Hlth, Dept Hlth Policy & Adm, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Goldstein, AO (corresponding author), Univ N Carolina, Sch Med, Dept Family Med, CB 7595, Chapel Hill, NC 27599 USA.							*AM LUNG ASS SACR, EM TRAILS; [Anonymous], 1994, PREVENTING TOBACCO U; DEWOLF R, 1998, RALEIGH NEWS OB 0713, pC1; DEWOLF R, 1998, RALEIGH NEWS OB 0713, pC3; DIFRANZA JR, 1991, JAMA-J AM MED ASSOC, V266, P3149, DOI 10.1001/jama.266.22.3149; FISCHER PM, 1991, JAMA-J AM MED ASSOC, V266, P3145, DOI 10.1001/jama.266.22.3145; Grant J, 1998, ENCY W DISNEYS ANIMA; HAZAN AR, 1994, AM J PUBLIC HEALTH, V84, P998, DOI 10.2105/AJPH.84.6.998; KLEIN R, 1997, NY TIMES        0824; LACKEY W, 1993, U CHIC LEG FOR, P275; McIntosh WD, 1998, ADDICT BEHAV, V23, P395, DOI 10.1016/S0306-4603(97)00071-3; *NIH, 1998, NIH PUBL; Parker-Pope T., 1997, WALL STREET J, p[B1, B8]; PIERCE JP, 1991, JAMA-J AM MED ASSOC, V266, P3154, DOI 10.1001/jama.266.22.3154; Stockwell T F, 1997, Tob Control, V6, P282, DOI 10.1136/tc.6.4.282; THOMAS K, 1997, US TODAY        0228; 1998, RALEIGH NEWS OB 0321, pA8	17	72	72	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	1999	281	12					1131	1136		10.1001/jama.281.12.1131	http://dx.doi.org/10.1001/jama.281.12.1131			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177EP	10188668				2022-12-28	WOS:000079197100039
J	Minami, M; Kinoshita, M; Kamoshida, Y; Tanimoto, H; Tabata, T				Minami, M; Kinoshita, M; Kamoshida, Y; Tanimoto, H; Tabata, T			Brinker is a target of Dpp in Drosophila that negatively regulates Dpp-dependent genes	NATURE			English	Article							WING DEVELOPMENT; EXPRESSION; GRADIENT; XENOPUS; MOTHERS; CELLS	Growth and patterning of the Drosophila wing is controlled in part by the long-range organizing activities of the Decapentaplegic protein (Dpp)(1-4). Dpp is synthesized by cells that line the anterior side of the anterior/posterior compartment border of the wing imaginal disc. From this source, Dpp is thought to generate a concentration gradient that patterns both anterior and posterior compartments. Among the gene targets that it regulates are optomotor blind (omb)(5), spalt (sal)(6), and daughters against dpp (dad)(7). We report here the molecular cloning of brinker (brk), and show that brk expression is repressed by npp. brk encodes, a protein that negatively regulates Dpp-dependent genes. Expression of brk in Xenopus embryos indicates that brk can also repress the targets of a vertebrate homologue of Dpp, bone morphogenetic protein 4 (BMP-4). The evolutionary conservation of Brk function underscores the importance of its negative role in proportioning Dpp activity.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Tokyo Metropolitan Inst Neurosci, Dept Neurophysiol, Fuchu, Tokyo 1838526, Japan	University of Tokyo; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science	Tabata, T (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1130032, Japan.		Tanimoto, Hiromu/J-6810-2016	Kinoshita, Noriyuki/0000-0002-1362-4045				BLITZ IL, 1995, DEVELOPMENT, V121, P993; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0; Duffy JB, 1998, DEVELOPMENT, V125, P2263; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Ferguson EL, 1996, CURR OPIN GENET DEV, V6, P424, DOI 10.1016/S0959-437X(96)80063-3; Graff JM, 1997, CELL, V89, P171, DOI 10.1016/S0092-8674(00)80196-8; Grimm S, 1996, SCIENCE, V271, P1601, DOI 10.1126/science.271.5255.1601; HEMMATIBRIVANLO.A, 1989, DEVELOPMENT, V106, P611; HEMMATIBRIVANLOU A, 1994, CELL, V77, P273, DOI 10.1016/0092-8674(94)90319-0; Inoue H, 1998, MOL BIOL CELL, V9, P2145, DOI 10.1091/mbc.9.8.2145; JAZWINSKA A, 1998, A C DROS RES, V39, pA244; KAO KR, 1989, DEV BIOL, V132, P81, DOI 10.1016/0012-1606(89)90207-8; KINTNER CR, 1984, NATURE, V308, P67, DOI 10.1038/308067a0; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Newfeld SJ, 1996, DEVELOPMENT, V122, P2099; RUSHLOW C, 1998, A C DROS RES, V39, pB245; SEKELSKY JJ, 1995, GENETICS, V139, P1347; Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362; WAGNERBERNHOLZ JT, 1991, GENE DEV, V5, P2467, DOI 10.1101/gad.5.12b.2467; WILSON PA, 1994, CURR BIOL, V4, P676, DOI 10.1016/S0960-9822(00)00152-4; XU T, 1993, DEVELOPMENT, V117, P1223; ZECCA M, 1995, DEVELOPMENT, V121, P2265	27	190	193	0	6	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 18	1999	398	6724					242	246		10.1038/18451	http://dx.doi.org/10.1038/18451			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177UA	10094047				2022-12-28	WOS:000079228400054
J	Lewis, JD; Asch, DA				Lewis, JD; Asch, DA			Barriers to office-based screening sigmoidoscopy: Does reimbursement cover costs?	ANNALS OF INTERNAL MEDICINE			English	Article							COLORECTAL-CANCER; RECOMMENDATIONS; MORTALITY	Screening with flexible sigmoidoscopy may reduce mortality rates from colorectal cancer. Primary care physicians are able to provide this screening procedure, but many have been reluctant to do so, partly because of the impression that reimbursement rates are inadequate to cover physician costs. This study examines the cost of performing flexible sigmoidoscopy in a primary care practice and compares this cost with the new Medicare reimbursement rate for flexible sigmoidoscopy. Fixed and variable costs associated with the performance of office-based flexible sigmoidoscopy were derived from the published literature. The principal assumption in the analyses is that the time required to perform flexible sigmoidoscopy represents an opportunity cost because the physician could use that time to see additional patients during routine office hours. Sensitivity analyses were done across a range of estimates for the cost variables. When Medicare reimbursement rates were used, the physician's total cost for flexible sigmoidoscopy without biopsy was $86.86, which is similar to the Medicare reimbursement rate for screening flexible sigmoidoscopy (code 45330, $87.84). The calculations were most sensitive to estimates of equipment cost, procedure time, number of procedures performed per year, additional malpractice coverage, and revenue generated per hour of outpatient care. The estimated cost per procedure in a screening prog ram that includes the ability to perform biopsy is $152.93, which exceeds Medicare reimbursement rates across the range of all variables included in the sensitivity analyses. Thus, low reimbursement may limit the adoption of screening flexible sigmoidoscopy with or without biopsy in primary care practices.	Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Vet Affairs Med Ctr, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Lewis, JD (corresponding author), Univ Penn, Ctr Clin Epidemiol & Biostat, 8th Floor,Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	jlewis@cceb.med.upenn.edu		Asch, David/0000-0002-7970-286X	NIDDK NIH HHS [1-T32-DK07740-0] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007740] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		*AM CANC SOC, 1989, SUMM CURR GUID CANC; *AM COLL PHYS, 1990, CLIN EFF ASS PROJ SC; BALLAS MT, 1995, J FAM PRACTICE, V40, P535; *BOST SCI CORP, 1997, MICR 1997 CAT; Brill J R, 1997, Fam Med, V29, P580; Cooper GS, 1997, ARCH INTERN MED, V157, P1946, DOI 10.1001/archinte.157.17.1946; *CTR HLTH POL RES, 1996, PHYS MARK STAT PROF; FAVUS LH, 1989, AM FAM PHYSICIAN, V40, P119; HSIAO WC, 1988, JAMA-J AM MED ASSOC, V260, P2361, DOI 10.1001/jama.260.16.2361; Leider P J, 1997, Fam Med, V29, P318; MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002; National Cancer Institute, 1987, WORK GUID EARL CANC; NEWCOMB PA, 1992, JNCI-J NATL CANCER I, V84, P1572, DOI 10.1093/jnci/84.20.1572; *OL AM INC, 1995, OL END PROD PRIC LIS; RANSOHOFF DF, 1993, JAMA-J AM MED ASSOC, V26, P91278; Rodriguez-Bigas M A, 1993, J Cancer Educ, V8, P213; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; *XACT MED SERV, 1997, MED PART B REF MAN; 1996, MMWR MORB MORTAL WKL, V45, P107	21	65	65	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	1999	130	6					525	530		10.7326/0003-4819-130-6-199903160-00017	http://dx.doi.org/10.7326/0003-4819-130-6-199903160-00017			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	176RL	10075621				2022-12-28	WOS:000079165500009
J	Moreland, LW; Schiff, MH; Baumgartner, SW; Tindall, EA; Fleischmann, RM; Bulpitt, KJ; Weaver, AL; Keystone, EC; Furst, DE; Mease, PJ; Ruderman, EM; Horwitz, DA; Arkfeld, DG; Garrison, L; Burge, DJ; Blosch, CM; Lange, MLM; McDonnell, ND; Weinblatt, ME				Moreland, LW; Schiff, MH; Baumgartner, SW; Tindall, EA; Fleischmann, RM; Bulpitt, KJ; Weaver, AL; Keystone, EC; Furst, DE; Mease, PJ; Ruderman, EM; Horwitz, DA; Arkfeld, DG; Garrison, L; Burge, DJ; Blosch, CM; Lange, MLM; McDonnell, ND; Weinblatt, ME			Etanercept therapy in rheumatoid arthritis - A randomized, controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article						etanercept; arthritis, rheumatoid; dose-response relationship, drug; health status indicators; quality of life	TUMOR-NECROSIS-FACTOR; MODIFYING ANTIRHEUMATIC DRUGS; FACTOR-BINDING-PROTEIN; FACTOR-ALPHA CA2; MONOCLONAL-ANTIBODY; FUSION PROTEIN; FOLLOW-UP; TOXICITY; RECEPTOR; DISEASE	Background: In a phase II study, etanercept (recombinant human tumor necrosis factor receptor [p75]:Fc fusion protein) safely produced rapid, dose-dependent improvement in rheumatoid arthritis over 3 months. Objective: To confirm the benefit of etanercept therapy of longer duration and simplified dosing in patients with rheumatoid arthritis. Design: Randomized, double-blind, placebo-controlled trial with blinded joint assessors. Setting: 13 North American centers. Patients: 234 patients with active rheumatoid arthritis who had an inadequate response to disease-modifying antirheumatic drugs. Intervention: Twice-weekly subcutaneous injections of etanercept, 10 or 25 mg, or placebo for 6 months. Measurements: The primary end points were 20% and 50% improvement in disease activity according to American College of Rheumatology (ACR) responses at 3 and 6 months. Other end points were 70% ACR responses at 3 and 6 months and other measures of disease activity at 3 and 6 months. Results: Etanercept significantly reduced disease activity in a dose-related fashion. At 3 months, 62% of the patients receiving 25 mg of etanercept and 23% of the placebo recipients achieved 20% ACR response (P < 0.001). At 6 months, 59% of the 25-mg group and 11% of the placebo group achieved a 20% ACR response (P < 0.001); 40% and 5%, respectively, achieved a 50% ACR response (P < 0.01). The respective mean percentage reduction in the number of tender and swollen joints at 6 months was 56% and 47% in the 25-mg group and 6% and -7% in the placebo group (P < 0.05). Significantly more etanercept recipients achieved a 70% ACR response, minimal disease status (0 to 5 affected joints), and improved quality of life. Etanercept was well tolerated, with no dose-limiting toxic effects. Conclusions: Etanercept can safely provide rapid, significant, and sustained benefit in patients with active rheumatoid arthritis.	Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Arthrit Clin Intervent Program, Birmingham, AL 35294 USA; Denver Arthrit Clin, Denver, CO 80220 USA; Physicians Clin Spokane, Spokane, WA 99204 USA; Portland Med Associates, Portland, OR 97216 USA; Metroplex Clin Res Ctr, Dallas, TX 75235 USA; Univ Calif Los Angeles, Dept Med, Div Rheumatol, Los Angeles, CA 90095 USA; Univ So Calif, Sch Med, Los Angeles, CA 90033 USA; Arthrit Ctr Nebraska, Lincoln, NE 68506 USA; Mt Sinai Hosp, Ctr Adv Therapeut, Toronto, ON M5G 1X5, Canada; Virginia Mason Med Ctr, Seattle, WA 98101 USA; Minor & James Med, Seattle, WA 98104 USA; Immunex Res & Dev Corp, Seattle, WA 98101 USA; Rush Med Coll, Chicago, IL 60612 USA; Brigham & Womens Hosp, Boston, MA 02115 USA	University of Alabama System; University of Alabama Birmingham; Metroplex Clinical Research Center; University of California System; University of California Los Angeles; University of Southern California; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Virginia Mason Medical Center; Rush University; Harvard University; Brigham & Women's Hospital	Moreland, LW (corresponding author), Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Arthrit Clin Intervent Program, 1717 6th Ave,SRC 068, Birmingham, AL 35294 USA.			Moreland, Larry/0000-0003-4483-0359				ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bendix G, 1996, ANN RHEUM DIS, V55, P169, DOI 10.1136/ard.55.3.169; BERTOLINI DR, 1986, NATURE, V319, P516, DOI 10.1038/319516a0; CASH JM, 1994, NEW ENGL J MED, V330, P1368; DAYER JM, 1985, J EXP MED, V162, P2163, DOI 10.1084/jem.162.6.2163; DOWER SK, 1990, J CLIN IMMUNOL, V10, P289, DOI 10.1007/BF00917473; Elkayam O, 1997, RHEUMATOL INT, V17, P49, DOI 10.1007/PL00006851; ELLIOTT MJ, 1994, LANCET, V344, P1105, DOI 10.1016/S0140-6736(94)90628-9; ELLIOTT MJ, 1993, ARTHRITIS RHEUM, V36, P1681, DOI 10.1002/art.23362; ELLIOTT MJ, 1994, LANCET, V344, P1125, DOI 10.1016/S0140-6736(94)90632-7; ENGELMANN H, 1989, J BIOL CHEM, V264, P11974; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Fries JF, 1996, ARTHRITIS RHEUM, V39, P616, DOI 10.1002/art.1780390412; FRIES JF, 1982, J RHEUMATOL, V9, P789; HARRIS ED, 1990, NEW ENGL J MED, V322, P1277, DOI 10.1056/nejm199005033221805; HAZES JMW, 1990, BRIT J RHEUMATOL, V29, P310; HOCHBERG MC, 1992, ARTHRITIS RHEUM, V35, P498, DOI 10.1002/art.1780350502; JONES EY, 1989, NATURE, V338, P225, DOI 10.1038/338225a0; KREMER JM, 1994, ARTHRITIS RHEUM-US, V37, P316, DOI 10.1002/art.1780370304; Mavrikakis M, 1996, ANN RHEUM DIS, V55, P187, DOI 10.1136/ard.55.3.187; MITCHELL JM, 1988, ARTHRITIS RHEUM, V31, P348, DOI 10.1002/art.1780310306; Moreland LW, 1997, NEW ENGL J MED, V337, P141, DOI 10.1056/NEJM199707173370301; Moreland LW, 1996, J RHEUMATOL, V23, P1849; Moreland LW, 1998, ARTHRITIS RHEUM, V41, pS364; OLSSON I, 1989, EUR J HAEMATOL, V42, P270, DOI 10.1111/j.1600-0609.1989.tb00111.x; PAULUS HE, 1990, ARTHRITIS RHEUM, V33, P477, DOI 10.1002/art.1780330403; ROBAYE B, 1989, BIOCHEM BIOPH RES CO, V163, P301, DOI 10.1016/0006-291X(89)92135-9; SAKLATVALA J, 1986, NATURE, V322, P547, DOI 10.1038/322547a0; SCHUTZE S, 1989, J BIOL CHEM, V264, P3562; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; STUART A, 1955, BIOMETRIKA, V42, P412, DOI 10.2307/2333387; THORNTON SC, 1991, CLIN EXP IMMUNOL, V86, P79; VANDENBROUCKE JP, 1984, J RHEUMATOL, V11, P158; VONASMUTH EJU, 1991, J IMMUNOL, V147, P3869; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Wilke WS, 1996, CLIN IMMUNOTHER, V5, P309, DOI 10.1007/BF03259329	36	1159	1239	0	37	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	1999	130	6					478	+		10.7326/0003-4819-130-6-199903160-00004	http://dx.doi.org/10.7326/0003-4819-130-6-199903160-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	176RL	10075615				2022-12-28	WOS:000079165500003
J	Holtz, TH				Holtz, TH			Labour rights are human rights	LANCET			English	Editorial Material									Doctors Global Hlth, Decatur, GA 30031 USA		Holtz, TH (corresponding author), Doctors Global Hlth, Box 1761, Decatur, GA 30031 USA.							*HUM RIGHTS WATCH, 1996, NO GUAR SEX DISCR ME; *INT CONF FREE TRA, 1998, ANN SURV VIOL TRAD U; *WHO, 1997, 84 WHO; [No title captured]	4	2	2	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 13	1999	353	9156					923	923		10.1016/S0140-6736(99)90058-2	http://dx.doi.org/10.1016/S0140-6736(99)90058-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BU	10094003				2022-12-28	WOS:000079421400048
J	Redondo, MJ; Rewers, M; Yu, LP; Garg, S; Pilcher, CC; Elliot, RB; Eisenbarth, GS				Redondo, MJ; Rewers, M; Yu, LP; Garg, S; Pilcher, CC; Elliot, RB; Eisenbarth, GS			Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study	BRITISH MEDICAL JOURNAL			English	Article							FIRST-DEGREE RELATIVES; IDENTICAL-TWINS; INSULIN; MELLITUS; AUTOANTIBODIES; IDDM; CONCORDANCE; PROGRESSION; DISCORDANT; ANTIBODIES	Objective To test the hypothesis that non-diabetic dizygotic and monozygotic twin siblings of patients with type 1 diabetes have a similar high prevalence of islet cell autoantibodies, thus suggesting that islet cell autoimmunity is mainly environmentally determined. Design Prospective twin study. Setting Two specialist centres for diabetes in the United States. Participants Non-diabetic monozygotic twin (n = 53). dizygotic twin (n = 90), and non-twin (n = 149) siblings of patients with type 1 diabetes; 101 controls. Main outcome measures Analysis of progression to diabetes and expression of anti-islet autoantibodies. Results Monozygotic twin siblings had a higher risk of progression to diabetes (12/53) than dizygotic twin siblings (0/30; P < 0.005). At the last follow up 22 (41.5%) monozygotic twin siblings expressed autoantibodies compared with 6 (20%) dizygotic twin siblings (P < 0.05), 16 (10.7%) non-twin siblings (P < 0.0001), and 6 (5.9%) controls (P < 0.0001). Monozygotic twin siblings expressed multiple (greater than or equal to 2) antibodies more often than dizygotic twin siblings (10/38 v 1/23; P < 0.05). By life table analysis the probability of developing positive autoantibodies was higher among the monozygotic twin siblings bearing the diabetes associated HLA DQ8/DQ2 genotype than in those without this genotype (64.2% (95% confidence interval 32.5% to 96%) v 23.5% (7% to 40%) at 10 years of discordance; P < 0.05). Conclusion Monozygotic and dizygotic twins differ in progression to diabetes and expression of islet cell autoantibodies. Dizygotic twin siblings are similar to non-twin siblings. These two observations suggest that genetic factors play an important part in determination of islet cell autoimmunity, thus rejecting the hypothesis. In addition, there is a high penetrance of islet cell autoimmunity on DQ8/DQ2 monozygotic twin siblings.	Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA; Univ Auckland, Sch Med, Dept Paediat, Auckland 1, New Zealand	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Auckland	Eisenbarth, GS (corresponding author), Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Box B 140, Denver, CO 80262 USA.	george.eisenbarth@UCHSC.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032083, R01DK032493, R37DK032083] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK032493, 5 R01 DK 32493, R37 DK032083, R01 DK032083] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ATKINSON MA, 1993, J CLIN INVEST, V92, P1608, DOI 10.1172/JCI116745; BUGAWAN TL, 1991, IMMUNOGENETICS, V33, P163, DOI 10.1007/BF01719235; DIB S, 1986, BRIT MED J, V292, P1670, DOI 10.1136/bmj.292.6536.1670; FALORNI A, 1995, J IMMUNOL METHODS, V186, P89, DOI 10.1016/0022-1759(95)00139-2; GIANANI R, 1995, DIABETES, V44, P1340, DOI 10.2337/diabetes.44.11.1340; Hawa M, 1997, DIABETES, V46, P1270, DOI 10.2337/diabetes.46.8.1270; HAWKES CH, 1997, DIABETIC MED, V17, P347; JOHNSTON C, 1983, BMJ-BRIT MED J, V286, P253, DOI 10.1136/bmj.286.6361.253; Kawasaki E, 1997, J CLIN ENDOCR METAB, V82, P375, DOI 10.1210/jc.82.2.375; KUMAR D, 1993, DIABETES, V42, P1351, DOI 10.2337/diabetes.42.9.1351; KYVIK KO, 1995, BRIT MED J, V311, P913; KYVIK KO, 1996, UGESKAA LAEGER, V158, P3156; LORENZEN T, 1994, DIABETOLOGIA, V37, P321, DOI 10.1007/BF00398061; Petersen JS, 1997, BRIT MED J, V314, P1575, DOI 10.1136/bmj.314.7094.1575; PILCHER CC, 1990, J IMMUNOL METHODS, V129, P111, DOI 10.1016/0022-1759(90)90427-W; Rewers M, 1996, DIABETOLOGIA, V39, P807, DOI 10.1007/s001250050514; ROWE RE, 1995, DIABETES METAB REV, V11, P121, DOI 10.1002/dmr.5610110204; SRIKANTA S, 1983, NEW ENGL J MED, V308, P322, DOI 10.1056/NEJM198302103080607; SRIKANTA S, 1983, ANN INTERN MED, V99, P320, DOI 10.7326/0003-4819-99-3-320; Svendsen A J, 1997, Ugeskr Laeger, V159, P1257; Verge CF, 1998, DIABETES, V47, P1857, DOI 10.2337/diabetes.47.12.1857; Verge CF, 1996, DIABETES, V45, P926, DOI 10.2337/diabetes.45.7.926; VERGE CF, 1995, DIABETES, V44, P1176, DOI 10.2337/diabetes.44.10.1176; ZIEGLER AG, 1989, DIABETES, V38, P1320, DOI 10.2337/diabetes.38.10.1320	24	90	92	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 13	1999	318	7185					698	702						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182JK	10074012				2022-12-28	WOS:000079495700022
J	Birnbaumer, L				Birnbaumer, L			Martin Rodbell (1925-1998) - Retrospective	SCIENCE			English	Biographical-Item									Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Anesthesiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Birnbaumer, L (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.								0	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	1999	283	5408					1656	1656		10.1126/science.283.5408.1656	http://dx.doi.org/10.1126/science.283.5408.1656			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175PF	10189319				2022-12-28	WOS:000079102800032
J	Malnic, B; Hirono, J; Sato, T; Buck, LB				Malnic, B; Hirono, J; Sato, T; Buck, LB			Combinatorial receptor codes for odors	CELL			English	Article							OLFACTORY-BULB; CAENORHABDITIS-ELEGANS; LOCAL-DISTRIBUTION; MULTIGENE FAMILY; GENE-EXPRESSION; NEURONS; ORGANIZATION; EPITHELIUM; SYSTEM; CELLS	The discriminatory capacity of the mammalian olfactory system is such that thousands of volatile chemicals are perceived as having distinct odors. Here we used a combination of calcium imaging and single-cell RT-PCR to identify odorant receptors (ORs) for odorants with related structures but varied odors. We found that one OR recognizes multiple odorants and that one odorant is recognized by multiple ORs, but that different odorants are recognized by different combinations of ORs. Thus, the olfactory system uses a combinatorial receptor coding scheme to encode odor identities. Our studies also indicate that slight alterations in an odorant, or a change in its concentration, can change its "code," potentially explaining how such changes can alter perceived odor quality.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA; Electrotech Lab, Life Elect Res Ctr, Amagasaki, Hyogo 661, Japan	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; National Institute of Advanced Industrial Science & Technology (AIST)	Sato, T (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA.	tasato@etl.go.jp; lbuck@hms.harvard.edu	Sato, Takaaki/K-2898-2018; Malnic, Bettina/A-4905-2008	Sato, Takaaki/0000-0003-0746-9074; Malnic, Bettina/0000-0002-5877-4784				ADRIAN ED, 1950, BRIT MED BULL, V6, P330, DOI 10.1093/oxfordjournals.bmb.a073625; Amoore, 1970, MOL BASIS ODOR; Arctander S., 1969, PERFUME FLAVOR CHEM, VI; BEETS MGJ, 1970, PHARMACOL REV, V22, P1; BRUNJES PC, 1994, BRAIN RES REV, V19, P146; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; CAIN WS, 1988, STEVENS HDB EXPT PSY, V1, P409; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Chou JH, 1996, COLD SPRING HARB SYM, V61, P157; FIRESTEIN S, 1993, J PHYSIOL-LONDON, V468, P1; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUTHRIE KM, 1993, P NATL ACAD SCI USA, V90, P3329, DOI 10.1073/pnas.90.8.3329; HIRONO J, 1992, J NEUROSCI METH, V42, P185, DOI 10.1016/0165-0270(92)90098-X; HIRONO J, 1994, NEUROSCI LETT, V174, P201, DOI 10.1016/0304-3940(94)90021-3; JOURDAN F, 1980, BRAIN RES, V188, P139, DOI 10.1016/0006-8993(80)90563-6; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; LAING DG, 1989, PHYSIOL BEHAV, V46, P809, DOI 10.1016/0031-9384(89)90041-3; LANCET D, 1993, CURR BIOL, V3, P668, DOI 10.1016/0960-9822(93)90064-U; Laurent G, 1997, CURR OPIN NEUROBIOL, V7, P547, DOI 10.1016/S0959-4388(97)80035-9; LEVETEAU J, 1966, SCIENCE, V153, P175, DOI 10.1126/science.153.3732.175; LEVY NS, 1991, J STEROID BIOCHEM, V39, P633, DOI 10.1016/0960-0760(91)90262-4; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MORI K, 1992, J NEUROPHYSIOL, V67, P786, DOI 10.1152/jn.1992.67.3.786; NEF P, 1992, P NATL ACAD SCI USA, V89, P8948, DOI 10.1073/pnas.89.19.8948; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; POLAK EH, 1973, J THEOR BIOL, V40, P469, DOI 10.1016/0022-5193(73)90005-2; RAMING K, 1993, NATURE, V361, P353, DOI 10.1038/361353a0; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; RESTREPO D, 1993, J GEN PHYSIOL, V102, P907, DOI 10.1085/jgp.102.5.907; Sambrook J., 2002, MOL CLONING LAB MANU; SATO T, 1994, J NEUROPHYSIOL, V72, P2980, DOI 10.1152/jn.1994.72.6.2980; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Shepherd G. M., 1988, NEUROBIOLOGY; SICARD G, 1984, BRAIN RES, V292, P283, DOI 10.1016/0006-8993(84)90764-9; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; STROTMANN J, 1994, CELL TISSUE RES, V278, P11, DOI 10.1007/s004410050189; STROTMANN J, 1992, NEUROREPORT, V3, P1053, DOI 10.1097/00001756-199212000-00005; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; Zhang Y, 1997, P NATL ACAD SCI USA, V94, P12162, DOI 10.1073/pnas.94.22.12162; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237	46	1552	1615	9	229	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 5	1999	96	5					713	723		10.1016/S0092-8674(00)80581-4	http://dx.doi.org/10.1016/S0092-8674(00)80581-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	174TB	10089886	Bronze			2022-12-28	WOS:000079050100014
J	Ridker, PM; Stampfer, MJ				Ridker, PM; Stampfer, MJ			Assessment of genetic markers for coronary thrombosis: promise and precaution	LANCET			English	Editorial Material							PLATELET GLYCOPROTEIN IIIA; ANGIOTENSIN-CONVERTING-ENZYME; FACTOR-V-LEIDEN; MYOCARDIAL-INFARCTION; RISK FACTOR; VENOUS THROMBOSIS; PIA POLYMORPHISM; DISEASE; MUTATION; MEN		Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Ridker, PM (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA.							CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0; Carter AM, 1996, LANCET, V348, P485, DOI 10.1016/S0140-6736(05)64592-8; Carter AM, 1997, CIRCULATION, V96, P1424, DOI 10.1161/01.CIR.96.5.1424; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; HERRMANN SM, 1997, THROMB HAEMOSTASIS, V77, P1170; HOLM J, 1994, LANCET, V344, P952, DOI 10.1016/S0140-6736(94)92302-7; Kuivenhoven JA, 1998, NEW ENGL J MED, V338, P86, DOI 10.1056/NEJM199801083380203; Kunicki TJ, 1997, BLOOD, V89, P1939, DOI 10.1182/blood.V89.6.1939; LINDPAINTNER K, 1995, NEW ENGL J MED, V332, P706, DOI 10.1056/NEJM199503163321103; Moshfegh K, 1999, LANCET, V353, P351, DOI 10.1016/S0140-6736(98)06448-4; Price DT, 1997, ANN INTERN MED, V127, P895, DOI 10.7326/0003-4819-127-10-199711150-00007; RIDKER PM, 1995, NEW ENGL J MED, V332, P912, DOI 10.1056/NEJM199504063321403; Ridker PM, 1997, JAMA-J AM MED ASSOC, V277, P1305, DOI 10.1001/jama.277.16.1305; Ridker PM, 1997, LANCET, V349, P385, DOI 10.1016/S0140-6736(97)80010-4; Verhoef P, 1998, J AM COLL CARDIOL, V32, P353, DOI 10.1016/S0735-1097(98)00244-7; Walter DH, 1997, LANCET, V350, P1217, DOI 10.1016/S0140-6736(97)05399-3; Weiss EJ, 1996, NEW ENGL J MED, V334, P1090, DOI 10.1056/NEJM199604253341703	17	33	33	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	1999	353	9154					687	688		10.1016/S0140-6736(99)00067-7	http://dx.doi.org/10.1016/S0140-6736(99)00067-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173DR	10073505				2022-12-28	WOS:000078966400003
J	Sequeira, W				Sequeira, W			Yoga in treatment of carpal-tunnel syndrome	LANCET			English	Editorial Material									Cook Cty Hosp, Rush Med Coll, Div Rheumatol, Chicago, IL 60612 USA	John H Stroger Junior Hospital Cook County; Rush University	Sequeira, W (corresponding author), Cook Cty Hosp, Rush Med Coll, Div Rheumatol, Chicago, IL 60612 USA.							GARFINKEL MS, 1994, J RHEUMATOL, V21, P2341; Garfinkel MS, 1998, JAMA-J AM MED ASSOC, V280, P1601, DOI 10.1001/jama.280.18.1601; HASLOCK I, 1994, BRIT J RHEUMATOL, V33, P787; MEHTA S, 1990, YOGA INVENGAR WAY; MEYERS E, 1996, YOUGA YOU, P9; Vedanthan PK, 1998, ALLERGY ASTHMA PROC, V19, P3, DOI 10.2500/108854198778557971; vonSchroeder HP, 1996, HAND CLIN, V12, P643	7	7	7	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 27	1999	353	9154					689	690		10.1016/S0140-6736(98)00393-6	http://dx.doi.org/10.1016/S0140-6736(98)00393-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173DR	10073507				2022-12-28	WOS:000078966400005
J	Mitchell, KE; Schultz, BD				Mitchell, KE; Schultz, BD			Looking good from this window - Clampex 7.0	SCIENCE			English	Software Review									Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA	Kansas State University	Mitchell, KE (corresponding author), Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA.		Schultz, Bruce/F-8854-2013					NEHER E, 1976, NATURE, V260, P799, DOI 10.1038/260799a0	1	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 19	1999	283	5405					1131	1132		10.1126/science.283.5405.1131	http://dx.doi.org/10.1126/science.283.5405.1131			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169GD	10075574				2022-12-28	WOS:000078738400037
J	Beecham, L				Beecham, L			More doctors want to work flexibly	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 27	1999	318	7187					879	879						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185DM	10092285				2022-12-28	WOS:000079652900072
J	Daley, J; Hartman, EE				Daley, J; Hartman, EE			A 24-year-old woman with anorexia nervosa, 1 year later	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		Halmi KA, 1998, JAMA-J AM MED ASSOC, V279, P1992, DOI 10.1001/jama.279.24.1992	1	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	1999	281	12					1126	1126		10.1001/jama.281.12.1126	http://dx.doi.org/10.1001/jama.281.12.1126			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177EP	10188665				2022-12-28	WOS:000079197100036
J	Aslund, F; Beckwith, J				Aslund, F; Beckwith, J			Bridge over troubled waters: Sensing stress by disulfide bond formation	CELL			English	Review									Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Beckwith, J (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, 200 Longwood Ave, Boston, MA 02115 USA.							ASLUND F, 1999, IN PRESS P NATL ACAD; Dukan S, 1998, GENE DEV, V12, P3431, DOI 10.1101/gad.12.21.3431; Godon C, 1998, J BIOL CHEM, V273, P22480, DOI 10.1074/jbc.273.35.22480; Hidalgo E, 1997, CELL, V88, P121, DOI 10.1016/S0092-8674(00)81864-4; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; Paget MSB, 1998, EMBO J, V17, P5776, DOI 10.1093/emboj/17.19.5776; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; WEISSMAN JS, 1991, SCIENCE, V253, P1386, DOI 10.1126/science.1716783; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	10	208	221	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 19	1999	96	6					751	753		10.1016/S0092-8674(00)80584-X	http://dx.doi.org/10.1016/S0092-8674(00)80584-X			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	178ZY	10102262				2022-12-28	WOS:000079300100001
J	Blake, GA; Qi, C; Hogerheijde, MR; Gurwell, MA; Muhleman, DO				Blake, GA; Qi, C; Hogerheijde, MR; Gurwell, MA; Muhleman, DO			Sublimation from icy jets as a probe of the interstellar volatile content of comets	NATURE			English	Article							HALE-BOPP C/1995-O1; WATER; ABUNDANCES; EVOLUTION; CHEMISTRY; HYAKUTAKE; RATIO	Comets are some of the most primitive bodies left over from the Solar System's early history. They may preserve both interstellar material and material from the proto-solar nebula, and so studies of their volatile components can provide dues about the evolution of gases and ices, as a collapsing molecular cloud transforms into a mature planetary system(1,2). Previous observations of emission from rotational transitions in molecules have averaged over large areas of the inner coma, and therefore include both molecules that sublimed from the nucleus and those that result from subsequent chemical processes in the coma. Here we present high-resolution observations of emission from the molecules HNC, DCN and HDO associated with comet Hale-Bopp, Our data reveal are-like structures-icy jets-offset from (but close to) the nucleus. The measured abundance ratios on 1-3" scales are substantially different from those on larger scales(3-5), and cannot be accounted for by models of chemical processes in the coma(2,6,7); they ape, however, similar to the values observed in the cores of dense interstellar clouds and young stellar objects. We therefore propose that sublimation from millimetre-sized icy grains ejected from the nucleus provides access to relatively unaltered volatiles. The D/H ratios inferred from our data suggest that, by mass, Hale-Bopp (and by inference the outer regions of the early solar nebula) consists of greater than or equal to 15-40% of largely unprocessed interstellar material.	CALTECH 150 21, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Univ Colorado, JILA, Boulder, CO 80309 USA; Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	California Institute of Technology; University of Colorado System; University of Colorado Boulder; University of California System; University of California Berkeley; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Blake, GA (corresponding author), CALTECH 150 21, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.			Gurwell, Mark/0000-0003-0685-3621				Biver N, 1997, SCIENCE, V275, P1915, DOI 10.1126/science.275.5308.1915; Bockelee-Morvan D, 1998, ICARUS, V133, P147, DOI 10.1006/icar.1998.5916; BOCKELEEMORVAN D, 1995, IN PRESS EARTH MOON; Crovisier J, 1997, SCIENCE, V275, P1904, DOI 10.1126/science.275.5308.1904; CROVISIER J, 1987, ASTRON ASTROPHYS SUP, V68, P223; EBERHARDT P, 1995, ASTRON ASTROPHYS, V302, P301; FESTOU MC, 1993, ASTRON ASTROPHYS REV, V5, P37, DOI 10.1007/BF00872923; Gautier D, 1997, ASTRON ASTROPHYS, V323, pL9; GREEN S, 1993, ASTROPHYS J SUPPL S, V85, P181, DOI 10.1086/191760; Harmon JK, 1997, SCIENCE, V278, P1921, DOI 10.1126/science.278.5345.1921; HOGERHEIJDE MR, 1998, THESIS LEIDEN U; Irvine WM, 1998, FARADAY DISCUSS, V109, P475, DOI 10.1039/a709289j; Irvine WM, 1998, NATURE, V393, P547, DOI 10.1038/31171; IRVINE WM, IN PRESS PROTOSTARS, V4; JACQ T, 1990, ASTRON ASTROPHYS, V228, P447; Jenniskens P, 1997, J CHEM PHYS, V107, P1232, DOI 10.1063/1.474468; Licandro J, 1998, ASTROPHYS J, V501, pL221, DOI 10.1086/311465; Meier R, 1998, SCIENCE, V279, P842, DOI 10.1126/science.279.5352.842; Meier R, 1998, SCIENCE, V279, P1707, DOI 10.1126/science.279.5357.1707; MUELLER BEA, IN PRESS EARTH MOON; Notesco G, 1997, ICARUS, V125, P471, DOI 10.1006/icar.1996.5648; Rodgers SD, 1998, ASTROPHYS J, V501, pL227, DOI 10.1086/311459; SCHILKE P, 1992, ASTRON ASTROPHYS, V256, P595; STERN A, UNPUB SCIENCE; VANDISHOECK EF, 1995, ASTROPHYS J, V447, P760, DOI 10.1086/175915; Willacy K, 1998, ASTRON ASTROPHYS, V338, P995; Wootten A., 1987, ASTROCHEMISTRY, V120, P311	28	55	56	0	5	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 18	1999	398	6724					213	216		10.1038/18372	http://dx.doi.org/10.1038/18372			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177UA	10094044				2022-12-28	WOS:000079228400044
J	Kulke, MH; Mayer, RJ				Kulke, MH; Mayer, RJ			Carcinoid tumors	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							METASTATIC NEUROENDOCRINE TUMORS; MULTIPLE ENDOCRINE NEOPLASIA; ZOLLINGER-ELLISON SYNDROME; HEPATIC ARTERIAL CHEMOEMBOLIZATION; ISLET-CELL CARCINOMAS; GASTRIC CARCINOIDS; HEART-DISEASE; LIVER-TRANSPLANTATION; SOMATOSTATIN ANALOG; PERNICIOUS-ANEMIA		Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Kulke, MH (corresponding author), Dana Farber Canc Inst, Dept Adult Oncol, 44 Binney St, Boston, MA 02115 USA.				NATIONAL CANCER INSTITUTE [T32CA009172] Funding Source: NIH RePORTER; NCI NIH HHS [5T32CA09172] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AHLMAN H, 1994, DIGESTION, V55, P77, DOI 10.1159/000201206; AKERSTROM G, 1991, ACTA ONCOL, V30, P547, DOI 10.3109/02841869109092416; ANDERSON JR, 1985, BRIT J SURG, V72, P545, DOI 10.1002/bjs.1800720715; BALLANTYNE GH, 1992, CANCER, V69, P2400, DOI 10.1002/1097-0142(19920515)69:10<2400::AID-CNCR2820691003>3.0.CO;2-Z; BARCLAY THC, 1983, CANCER, V51, P878, DOI 10.1002/1097-0142(19830301)51:5<878::AID-CNCR2820510521>3.0.CO;2-V; BECHSTEIN WO, 1994, ANN NY ACAD SCI, V733, P507, DOI 10.1111/j.1749-6632.1994.tb17301.x; BERARDI RS, 1972, DIS COLON RECTUM, V15, P383, DOI 10.1007/BF02587418; BERGE T, 1976, ACTA PATH MICRO IM A, V84, P322; BISHOPRIC GA, 1986, CANCER, V58, P1316, DOI 10.1002/1097-0142(19860915)58:6<1316::AID-CNCR2820580622>3.0.CO;2-D; BORCH K, 1987, AM J SURG PATHOL, V11, P435, DOI 10.1097/00000478-198706000-00004; BORDI C, 1991, CANCER-AM CANCER SOC, V67, P663, DOI 10.1002/1097-0142(19910201)67:3<663::AID-CNCR2820670323>3.0.CO;2-L; BOWMAN GA, 1983, AM J SURG, V146, P700, DOI 10.1016/0002-9610(83)90321-5; BUKOWSKI RM, 1987, CANCER, V60, P2891, DOI 10.1002/1097-0142(19871215)60:12<2891::AID-CNCR2820601207>3.0.CO;2-6; Burke AP, 1997, CANCER-AM CANCER SOC, V79, P1086, DOI 10.1002/(SICI)1097-0142(19970315)79:6<1086::AID-CNCR5>3.3.CO;2-8; BURKE M, 1987, BRIT J SURG, V74, P358, DOI 10.1002/bjs.1800740509; CADIOT G, 1993, GASTROENTEROLOGY, V105, P579, DOI 10.1016/0016-5085(93)90736-V; CAPELLA C, 1995, VIRCHOWS ARCH, V425, P547; CARRASCO CH, 1986, AM J ROENTGENOL, V147, P149, DOI 10.2214/ajr.147.1.149; CARROLL DG, 1987, AUST NZ J MED, V17, P63, DOI 10.1111/j.1445-5994.1987.tb05054.x; Chughtai TS, 1997, SURGERY, V122, P801, DOI 10.1016/S0039-6060(97)90090-8; CLOUSE ME, 1994, DIGESTION, V55, P92, DOI 10.1159/000201208; CONNOLLY HM, 1995, J AM COLL CARDIOL, V25, P410, DOI 10.1016/0735-1097(94)00374-Y; Connolly HM, 1997, NEW ENGL J MED, V337, P1783; COOPER DKC, 1976, THORAX, V31, P44, DOI 10.1136/thx.31.1.44; DiBartolomeo M, 1996, CANCER-AM CANCER SOC, V77, P402, DOI 10.1002/(SICI)1097-0142(19960115)77:2<402::AID-CNCR25>3.0.CO;2-4; Dousset B, 1996, WORLD J SURG, V20, P908, DOI 10.1007/s002689900138; Dusmet ME, 1996, WORLD J SURG, V20, P189, DOI 10.1007/s002689900029; ECKHAUSER FE, 1981, SURGERY, V90, P720; ECKHAUSER FE, 1988, SURGERY, V104, P1046; ENGSTROM PF, 1984, J CLIN ONCOL, V2, P1255, DOI 10.1200/JCO.1984.2.11.1255; ERIKSSON B, 1990, ACTA ENDOCRINOL-COP, V122, P145, DOI 10.1530/acta.0.1220145; FEDERSPIEL BH, 1990, MODERN PATHOL, V3, P586; FELDMAN JM, 1985, METABOLISM, V34, P255, DOI 10.1016/0026-0495(85)90009-5; FELDMAN JM, 1986, AM J MED, V81, P41, DOI 10.1016/0002-9343(86)90583-8; GODWIN JD, 1975, CANCER, V36, P560, DOI 10.1002/1097-0142(197508)36:2<560::AID-CNCR2820360235>3.0.CO;2-4; GOUGH DB, 1994, WORLD J SURG, V18, P473, DOI 10.1007/BF00353739; GOULD VE, 1983, LAB INVEST, V49, P519; HARPOLE DH, 1992, ANN THORAC SURG, V54, P50, DOI 10.1016/0003-4975(92)91139-Z; HAVU N, 1986, DIGESTION, V35, P42, DOI 10.1159/000199381; HIRSCHOWITZ BI, 1992, GASTROENTEROLOGY, V102, P1409; JANSON ET, 1994, EUR J ENDOCRINOL, V131, P577, DOI 10.1530/eje.0.1310577; Janson ET, 1997, ANN ONCOL, V8, P685, DOI 10.1023/A:1008215730767; JANSON ET, 1993, ACTA ONCOL, V32, P225, DOI 10.3109/02841869309083916; JETMORE AB, 1992, DIS COLON RECTUM, V35, P717, DOI 10.1007/BF02050318; Jick H, 1998, NEW ENGL J MED, V339, P719, DOI 10.1056/NEJM199809103391102; JONSSON T, 1989, ACTA CHIR SCAND, V155, P113; Khan MA, 1998, NEW ENGL J MED, V339, P713, DOI 10.1056/NEJM199809103391101; KLINKENBERGKNOL EC, 1994, ANN INTERN MED, V121, P161, DOI 10.7326/0003-4819-121-3-199408010-00001; Koura AN, 1997, CANCER, V79, P1294, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1294::AID-CNCR4>3.0.CO;2-H; KRENNING EP, 1994, ANN NY ACAD SCI, V733, P416, DOI 10.1111/j.1749-6632.1994.tb17291.x; KUBOTA A, 1994, J CLIN INVEST, V93, P1321, DOI 10.1172/JCI117090; KVOLS LK, 1986, NEW ENGL J MED, V315, P663, DOI 10.1056/NEJM198609113151102; LAMBERTS R, 1993, GASTROENTEROLOGY, V104, P1356, DOI 10.1016/0016-5085(93)90344-C; LAMBERTS SWJ, 1990, NEW ENGL J MED, V323, P1246, DOI 10.1056/NEJM199011013231805; Lang H, 1997, ANN SURG, V225, P347, DOI 10.1097/00000658-199704000-00002; LEHY T, 1992, GUT, V33, P1275, DOI 10.1136/gut.33.9.1275; LeTreut YP, 1997, ANN SURG, V225, P355, DOI 10.1097/00000658-199704000-00003; LIMPER AH, 1992, ANN INTERN MED, V117, P209, DOI 10.7326/0003-4819-117-3-209; Lubarsch O., 1888, VIRCHOWS ARCH PATHOL, V111, P280, DOI DOI 10.1007/BF01966242; LUCAS KJ, 1986, CANCER, V58, P2290, DOI 10.1002/1097-0142(19861115)58:10<2290::AID-CNCR2820581022>3.0.CO;2-4; LUNDIN L, 1988, CIRCULATION, V77, P264, DOI 10.1161/01.CIR.77.2.264; LUNDQVIST M, 1986, J PATHOL, V148, P141, DOI 10.1002/path.1711480204; LUNDQVIST M, 1987, CANCER, V60, P201, DOI 10.1002/1097-0142(19870715)60:2<201::AID-CNCR2820600214>3.0.CO;2-2; MACGILLIVRAY DC, 1992, SURGERY, V111, P466; MAKRIDIS C, 1990, WORLD J SURG, V14, P377, DOI 10.1007/BF01658532; MARTYANE CH, 1995, ANN THORAC SURG, V59, P78, DOI 10.1016/0003-4975(94)00630-P; MATON PN, 1983, BRIT MED J, V287, P932, DOI 10.1136/bmj.287.6397.932; McCarthy KE, 1998, CANCER J SCI AM, V4, P94; MCCAUGHAN BC, 1985, J THORAC CARDIOV SUR, V89, P8; MCENTEE GP, 1990, SURGERY, V108, P1091; MITTY HA, 1985, RADIOLOGY, V155, P623, DOI 10.1148/radiology.155.3.4001362; MODLIN IM, 1995, ARCH SURG-CHICAGO, V130, P250; Modlin IM, 1997, CANCER-AM CANCER SOC, V79, P813, DOI 10.1002/(SICI)1097-0142(19970215)79:4<813::AID-CNCR19>3.0.CO;2-2; Moertel C G, 1979, Cancer Clin Trials, V2, P327; MOERTEL CG, 1994, ANN INTERN MED, V120, P302, DOI 10.7326/0003-4819-120-4-199402150-00008; MOERTEL CG, 1961, CANCER, V14, P901, DOI 10.1002/1097-0142(196109/10)14:5<901::AID-CNCR2820140502>3.0.CO;2-Q; MOERTEL CG, 1987, NEW ENGL J MED, V317, P1699, DOI 10.1056/NEJM198712313172704; MOERTEL CG, 1968, CANCER-AM CANCER SOC, V21, P270, DOI 10.1002/1097-0142(196802)21:2<270::AID-CNCR2820210217>3.0.CO;2-9; MOERTEL CG, 1991, CANCER, V68, P227, DOI 10.1002/1097-0142(19910715)68:2<227::AID-CNCR2820680202>3.0.CO;2-I; MOERTEL CL, 1990, J PEDIATR SURG, V25, P1073, DOI 10.1016/0022-3468(90)90221-T; MOSES RE, 1986, J CLIN GASTROENTEROL, V8, P61, DOI 10.1097/00004836-198602000-00013; MOYANA TN, 1992, CANCER, V70, P1081, DOI 10.1002/1097-0142(19920901)70:5<1081::AID-CNCR2820700512>3.0.CO;2-9; NAUNHEIM KS, 1983, SURGERY, V94, P670; NOBIN A, 1989, ACTA ONCOL, V28, P419, DOI 10.3109/02841868909111216; OBERG K, 1983, NEW ENGL J MED, V309, P129, DOI 10.1056/NEJM198307213090301; OBERG K, 1991, ACTA ONCOL, V30, P519; Oberndorfer S., 1907, FRANKFURT Z PATHOL, V1, P426; OKIKE N, 1976, ANN THORAC SURG, V22, P270, DOI 10.1016/S0003-4975(10)64915-6; OKIKE N, 1978, J THORAC CARDIOV SUR, V76, P281; Otte A, 1998, LANCET, V351, P417, DOI 10.1016/S0140-6736(05)78355-0; PALADUGU RR, 1985, CANCER, V55, P1303, DOI 10.1002/1097-0142(19850315)55:6<1303::AID-CNCR2820550625>3.0.CO;2-A; PARKES SE, 1993, BRIT J SURG, V80, P502, DOI 10.1002/bjs.1800800433; PATEL YC, 1994, ENDOCRINOLOGY, V135, P2814, DOI 10.1210/en.135.6.2814; PEARLMAN DM, 1971, NEW YORK STATE J MED, V71, P1529; PELLIKKA PA, 1993, CIRCULATION, V87, P1188, DOI 10.1161/01.CIR.87.4.1188; PERNOW B, 1957, AM J MED, V23, P16, DOI 10.1016/0002-9343(57)90354-6; PONKA JL, 1973, AM J SURG, V126, P77, DOI 10.1016/S0002-9610(73)80099-6; QUE FG, 1995, AM J SURG, V169, P36, DOI 10.1016/S0002-9610(99)80107-X; REA F, 1989, ANN THORAC SURG, V47, P412, DOI 10.1016/0003-4975(89)90383-4; REICHLIN S, 1983, NEW ENGL J MED, V309, P1495, DOI 10.1056/NEJM198312153092406; REISINE T, 1995, ENDOCR REV, V16, P427, DOI 10.1210/er.16.4.427; REUBI JC, 1990, CANCER RES, V50, P5969; RINDI G, 1993, GASTROENTEROLOGY, V104, P994, DOI 10.1016/0016-5085(93)90266-F; Rindi G, 1996, WORLD J SURG, V20, P168, DOI 10.1007/s002689900026; ROBIOLIO PA, 1995, CIRCULATION, V92, P790, DOI 10.1161/01.CIR.92.4.790; ROBIOLIO PA, 1995, AM J CARDIOL, V75, P485, DOI 10.1016/S0002-9149(99)80586-4; ROGGO A, 1993, ANN SURG, V217, P385, DOI 10.1097/00000658-199304000-00010; ROSENBERG JM, 1985, AM J SURG, V149, P775, DOI 10.1016/S0002-9610(85)80184-7; Ruszniewski P, 1996, GUT, V39, P279, DOI 10.1136/gut.39.2.279; RUSZNIEWSKI P, 1993, CANCER, V71, P2624, DOI 10.1002/1097-0142(19930415)71:8<2624::AID-CNCR2820710830>3.0.CO;2-B; SANDLER M, 1968, LANCET, V2, P1053; SAUVEN P, 1990, ANN SURG, V211, P67, DOI 10.1097/00000658-199001000-00012; SCHREURS AJM, 1992, J THORAC CARDIOV SUR, V104, P1470; SCHUPAK KD, 1991, INT J RADIAT ONCOL, V20, P489; SHAW PAV, 1990, J PATHOL, V162, P189, DOI 10.1002/path.1711620303; SHAW PAV, 1991, J PATHOL, V164, P235, DOI 10.1002/path.1711640308; SJOBLOM SM, 1993, GUT, V34, P28, DOI 10.1136/gut.34.1.28; SJOBLOM SM, 1989, J CLIN PATHOL, V42, P371, DOI 10.1136/jcp.42.4.371; SKRABANEK P, 1978, IRISH J MED SCI, V147, P47, DOI 10.1007/BF02939369; SMOLLEJUTTNER FM, 1993, EUR J CARDIO-THORAC, V7, P121, DOI 10.1016/1010-7940(93)90033-8; SOGA J, 1982, Acta Medica et Biologica, V29, P157; SOGA J, 1971, CANCER-AM CANCER SOC, V28, P990, DOI 10.1002/1097-0142(1971)28:4<990::AID-CNCR2820280424>3.0.CO;2-K; SOLCIA E, 1990, AM J SURG PATHOL, V14, P503, DOI 10.1097/00000478-199006000-00001; SOLCIA E, 1991, SCAND J GASTROENTERO, V26, P146, DOI 10.3109/00365529109093193; SUGIMOTO E, 1995, ACTA RADIOL, V36, P367; SYRACUSE DC, 1979, ANN SURG, V190, P58, DOI 10.1097/00000658-197907000-00013; THIRLBY RC, 1984, DIS COLON RECTUM, V27, P42, DOI 10.1007/BF02554075; THOMAS RM, 1994, CANCER, V73, P2053, DOI 10.1002/1097-0142(19940415)73:8<2053::AID-CNCR2820730807>3.0.CO;2-0; THORSON A, 1954, AM HEART J, V47, P795, DOI 10.1016/0002-8703(54)90152-0; TORRE M, 1989, RESP MED, V83, P305, DOI 10.1016/S0954-6111(89)80201-X; VADASZ P, 1993, EUR J CARDIO-THORAC, V7, P8, DOI 10.1016/1010-7940(93)90140-7; WARREN WH, 1985, J THORAC CARDIOV SUR, V89, P819; Weissman NJ, 1998, NEW ENGL J MED, V339, P725, DOI 10.1056/NEJM199809103391103; WILLIAMS ED, 1963, LANCET, V1, P238; WOODARD PK, 1995, J COMPUT ASSIST TOMO, V19, P400, DOI 10.1097/00004728-199505000-00012	135	599	636	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 18	1999	340	11					858	868		10.1056/NEJM199903183401107	http://dx.doi.org/10.1056/NEJM199903183401107			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	176ZW	10080850				2022-12-28	WOS:000079183200007
J	Opferman, JT; Ober, BT; Ashton-Rickardt, PG				Opferman, JT; Ober, BT; Ashton-Rickardt, PG			Linear differentiation of cytotoxic effectors into memory T lymphocytes	SCIENCE			English	Article							CELL-MEDIATED CYTOTOXICITY; GERMINAL-CENTERS; TRANSGENIC MICE; B-CELLS; APOPTOSIS; PROLIFERATION; MOLECULES; DELETION; PROTEIN	A central question in immunology is the origin of Long-Lived T cell memory that confers protection against recurrent infection. The differentiation of nai:ve T cell receptor transgenic CD8(+) cells into effector cytotoxic T Lymphocytes (CTLs) and memory CD8(+) cells was studied. Memory CD8(+) cells that were generated after strong antigenic stimulation were the progeny of cytotoxic effecters and retained antigen-specific cytolytic activity 10 weeks after adoptive transfer to antigen-free recipient mice. Thus, potential vaccines based on CTL memory will require the differentiation of naiive cells into post-effector memory T cells.	Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, Comm Immunol, Chicago, IL 60637 USA; Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, Dept Pathol, Chicago, IL 60637 USA; Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, Comm Dev Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Ashton-Rickardt, PG (corresponding author), Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, Comm Immunol, Chicago, IL 60637 USA.		Opferman, Joseph T/M-5331-2018	Opferman, Joseph T/0000-0002-1147-5621	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007090] Funding Source: NIH RePORTER; NIAID NIH HHS [5T32 AI07090] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Baltimore D, 1998, SCI AM, V279, P98, DOI 10.1038/scientificamerican0798-98; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; BRUNO L, 1995, IMMUNITY, V2, P37, DOI 10.1016/1074-7613(95)90077-2; GEISBERG M, 1992, INT IMMUNOL, V4, P1273, DOI 10.1093/intimm/4.11.1273; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; KAWASAKI AEA, 1990, INT IMMUNOL, V7, P677; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; LAIVANI A, 1997, J EXP MED, V186, P859; Letvin NL, 1998, SCIENCE, V280, P1875, DOI 10.1126/science.280.5371.1875; Liu Y, 1997, J EXP MED, V185, P251, DOI 10.1084/jem.185.2.251; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; LIU YJ, 1991, EUR J IMMUNOL, V21, P1107, DOI 10.1002/eji.1830210504; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Markiewicz MA, 1998, P NATL ACAD SCI USA, V95, P3065, DOI 10.1073/pnas.95.6.3065; McMichael A, 1998, CURR OPIN IMMUNOL, V10, P379, DOI 10.1016/S0952-7915(98)80107-6; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; NEURATH MF, 1995, P NATL ACAD SCI USA, V92, P5336, DOI 10.1073/pnas.92.12.5336; OPFERMAN JT, UNPUB; RAZVI ES, 1995, ADV VIRUS RES, V45, P1, DOI 10.1016/S0065-3527(08)60057-3; Renner C, 1997, IMMUNOBIOLOGY, V197, P122, DOI 10.1016/S0171-2985(97)80062-9; RENNO T, 1995, J EXP MED, V181, P2283, DOI 10.1084/jem.181.6.2283; STUBER E, 1995, IMMUNITY, V2, P507, DOI 10.1016/1074-7613(95)90031-4; TEH HS, 1989, J EXP MED, V169, P795, DOI 10.1084/jem.169.3.795; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	28	305	320	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	1999	283	5408					1745	1748		10.1126/science.283.5408.1745	http://dx.doi.org/10.1126/science.283.5408.1745			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175PF	10073942				2022-12-28	WOS:000079102800055
J	Holmes, MD; Hunter, DJ; Colditz, GA; Stampfer, MJ; Hankinson, SE				Holmes, MD; Hunter, DJ; Colditz, GA; Stampfer, MJ; Hankinson, SE			Association of dietary intake of fat and fatty acids with risk of breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RAT MAMMARY-TUMORS; NUDE-MICE; OLIVE OIL; DOCOSAHEXAENOIC ACID; LIPID-COMPOSITION; ADIPOSE-TISSUE; FISH-OIL; GROWTH; METASTASIS; DISEASE	Context High intakes of fat and specific fatty acids, including total, animal, saturated, polyunsaturated, and trans-unsaturated fats, have been postulated to increase breast cancer risk. Objective To determine whether intakes of fat and fatty acids are associated with breast cancer. Design and Setting Cohort study (Nurses' Health Study) conducted in the United States beginning in 1976. Participants A total of 88 795 women free of cancer in 1980 and followed up for 14 years. Main Outcome Measure Relative risk (RR) of invasive breast cancer for an incremental increase of fat intake, ascertained by food frequency questionnaire in 1980, 1984, 1986, and 1990. Results A total of 2956 women were diagnosed as having breast cancer. Compared with women obtaining 30.1% to 35% of energy from fat, women consuming 20% or less had a multivariate RR of breast cancer of 1.15 (95% confidence interval [CI], 0.73-1.80). In multivariate models, the RR (95% CI) for a 5%-of-energy increase was 0.97 (0.94-1.00) for total fat, 0.98 (0.96-1.01) for animal fat, 0.97 (0.93-1.02) for vegetable fat, 0.94 (0.88-1.01) for saturated fat, 0.91 (0.79-1.04) for polyunsaturated fat, and 0.94 (0.88-1.00) for monounsaturated fat. For a 1% increase in energy from trans-unsaturated fat, the values were 0.92 (0.86-0.98), and for a 0.1% increase in energy from omega-3 fat from fish, the values were 1.09 (1.03-1.16). In a model including fat, protein, and energy, the RR for a 5% increase in total fat, which can be interpreted as the risk of substituting this amount of fat for an equal amount of energy from carbohydrate, was 0.96 (95% CI, 0.93-0.99). In similar models, no significant association of risk was evident with any major types of fat. Conclusion We found no evidence that lower intake of total fat or specific major types of fat was associated with a decreased risk of breast cancer.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA; Cambridge Hosp, Dept Med, Cambridge, MA 02139 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Cambridge Health Alliance; Cambridge Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Holmes, MD (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, 181 Longwood Ave, Boston, MA 02115 USA.		Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291	NATIONAL CANCER INSTITUTE [R01CA040356, R37CA040356] Funding Source: NIH RePORTER; NCI NIH HHS [CA40356] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AYLSWORTH CF, 1984, J NATL CANCER I, V72, P637; Black AE, 1996, NUTR REV, V54, P170, DOI 10.1111/j.1753-4887.1996.tb03924.x; Carroll K K, 1975, Prog Biochem Pharmacol, V10, P308; CAVE WT, 1984, J NATL CANCER I, V73, P185; Caygill CPJ, 1996, BRIT J CANCER, V74, P159, DOI 10.1038/bjc.1996.332; COHEN LA, 1986, J NATL CANCER I, V77, P43; COLDITZ GA, 1995, AM J EPIDEMIOL, V142, P371, DOI 10.1093/oxfordjournals.aje.a117644; Connolly JM, 1996, NUTR CANCER, V25, P231, DOI 10.1080/01635589609514447; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; ENIG MG, 1983, J AM OIL CHEM SOC, V60, P1788, DOI 10.1007/BF02680357; Freudenheim JL, 1996, JNCI-J NATL CANCER I, V88, P340, DOI 10.1093/jnci/88.6.340; GIOVANNUCCI E, 1993, AM J EPIDEMIOL, V137, P502, DOI 10.1093/oxfordjournals.aje.a116703; GODLEY PA, 1995, BREAST CANCER RES TR, V35, P91, DOI 10.1007/BF00694749; GONZALEZ MJ, 1993, LIPIDS, V28, P827, DOI 10.1007/BF02536237; HOWE GR, 1990, JNCI-J NATL CANCER I, V82, P561, DOI 10.1093/jnci/82.7.561; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Huang ZP, 1997, JAMA-J AM MED ASSOC, V278, P1407, DOI 10.1001/jama.278.17.1407; HUBBARD NE, 1987, CANCER RES, V47, P671; Hunter DJ, 1996, NEW ENGL J MED, V334, P356, DOI 10.1056/NEJM199602083340603; HUNTER DJ, 1993, EPIDEMIOL REV, V15, P110, DOI 10.1093/oxfordjournals.epirev.a036096; Johnson RK, 1998, NEW ENGL J MED, V338, P918; JURKOWSKI JJ, 1985, J NATL CANCER I, V74, P1145; KARMALI RA, 1984, J NATL CANCER I, V73, P457, DOI 10.1093/jnci/73.2.457; KATZ EB, 1987, J NATL CANCER I, V79, P351; Kinoshita K, 1994, In Vivo, V8, P371; LAVECCHIA C, 1995, CANCER CAUSE CONTROL, V6, P545, DOI 10.1007/BF00054164; LONDON SJ, 1993, JNCI-J NATL CANCER I, V85, P785, DOI 10.1093/jnci/85.10.785; LUND E, 1993, CANCER CAUSE CONTROL, V4, P283; MARSHALL JR, 1992, EUR J CANCER, V28A, P1720, DOI 10.1016/0959-8049(92)90077-F; MARTINMORENO JM, 1994, INT J CANCER, V58, P774, DOI 10.1002/ijc.2910580604; National Research Council, 1989, DIET HLTH IMPL RED C; NOGUCHI M, 1995, ONCOLOGY-BASEL, V52, P265; PETREK JA, 1994, J NATL CANCER I, V86, P53, DOI 10.1093/jnci/86.1.53; PRENTICE RL, 1988, JNCI-J NATL CANCER I, V80, P802, DOI 10.1093/jnci/80.11.802; Prentice RL, 1996, J NATL CANCER I, V88, P1738, DOI 10.1093/jnci/88.23.1738; Price GM, 1997, BRIT J NUTR, V77, P833, DOI 10.1079/BJN19970083; ROSE DP, 1995, JNCI-J NATL CANCER I, V87, P587, DOI 10.1093/jnci/87.8.587; ROSE DP, 1993, JNCI-J NATL CANCER I, V85, P1743, DOI 10.1093/jnci/85.21.1743; Simonsen N, 1998, AM J EPIDEMIOL, V147, P342; SLOVER HT, 1985, J AM OIL CHEM SOC, V62, P775, DOI 10.1007/BF03028753; TRICHOPOULOU A, 1995, JNCI-J NATL CANCER I, V87, P110, DOI 10.1093/jnci/87.2.110; *USDA, 1993, AGR HDB SER, V8; Willett W., 2012, NUTR EPIDEMIOLOGY; WILLETT WC, 1992, JAMA-J AM MED ASSOC, V268, P2037, DOI 10.1001/jama.268.15.2037; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Witte JS, 1997, BREAST CANCER RES TR, V42, P243, DOI 10.1023/A:1005710211184; Wolk A, 1998, ARCH INTERN MED, V158, P41, DOI 10.1001/archinte.158.1.41; WYNDER EL, 1991, CANCER-AM CANCER SOC, V67, P746, DOI 10.1002/1097-0142(19910201)67:3<746::AID-CNCR2820670336>3.0.CO;2-1; ZHU ZR, 1995, NUTR CANCER, V24, P151, DOI 10.1080/01635589509514403	49	244	250	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	1999	281	10					914	920		10.1001/jama.281.10.914	http://dx.doi.org/10.1001/jama.281.10.914			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172XH	10078488	Bronze			2022-12-28	WOS:000078950600036
J	Chou, JJ; Li, HL; Salvesen, GS; Yuan, JY; Wagner, G				Chou, JJ; Li, HL; Salvesen, GS; Yuan, JY; Wagner, G			Solution structure of BID, an intracellular amplifier of apoptotic signaling	CELL			English	Article							CYTOCHROME-C; CELL-DEATH; NMR RELAXATION; PROTEINS; BCL-2; PROTEASE; COMPLEX; DOMAIN; MITOCHONDRIA; SENSITIVITY	We report the solution structure of BID, an intracellular cross-talk agent that can amplify FAS/TNF apoptotic signal through the mitochondria death pathway after Caspase 8 cleavage. BID contains eight alpha helices where two central hydrophobic helices are surrounded by six amphipathic ones. The fold resembles pore-forming bacterial toxins and shows similarity to BCL-X-L although sequence homology to BCL-X-L is limited to the 16-residue BH3 domain. Furthermore, we modeled a complex of BCL-X-L and BID by aligning the BID and BAK BH3 motifs in the known BCL-X-L-BAK BH3 complex. Additionally, we show that the overall structure of BID is preserved after cleavage by Caspase 8. We propose that BID has both BH3 domain-dependent and -independent modes of action in inducing mitochondrial damage.	Harvard Univ, Comm Higher Degrees Biophys, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Burnham Inst, La Jolla, CA 92037 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Sanford Burnham Prebys Medical Discovery Institute	Wagner, G (corresponding author), Harvard Univ, Comm Higher Degrees Biophys, Cambridge, MA 02138 USA.	wagner@wagner.med.harvard.edu	Chou, James/AAD-6230-2022; Chou, James J/N-9840-2013	Chou, James/0000-0002-4442-0344; Chou, James J/0000-0002-4442-0344	NIGMS NIH HHS [P01 GM047467, GM 38608, GM 47467] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038608, P01GM047467] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; BAX A, 1990, J MAGN RESON, V86, P304, DOI 10.1016/0022-2364(90)90262-8; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; BRUNGER A, 1993, XPLOR VERSION 3 1; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Chou JJ, 1998, CELL, V94, P171, DOI 10.1016/S0092-8674(00)81417-8; CLORE GM, 1994, METHOD ENZYMOL, V239, P349; Cosulich SC, 1997, CURR BIOL, V7, P913, DOI 10.1016/S0960-9822(06)00410-6; DELRIOPORTILLA F, 1994, J MAGN RESON SER A, V111, P132, DOI 10.1006/jmra.1994.1238; DUNBRACK RL, 1993, J MOL BIOL, V230, P543, DOI 10.1006/jmbi.1993.1170; Eberstadt M, 1998, NATURE, V392, P941, DOI 10.1038/31972; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Knudson CM, 1997, NAT GENET, V16, P358, DOI 10.1038/ng0897-358; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kuwana T, 1998, J BIOL CHEM, V273, P16589, DOI 10.1074/jbc.273.26.16589; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Matsuo H, 1996, J MAGN RESON SER B, V113, P91, DOI 10.1006/jmrb.1996.0161; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Matsuyama S, 1998, J BIOL CHEM, V273, P30995, DOI 10.1074/jbc.273.47.30995; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NILGES M, 1988, FEBS LETT, V239, P129, DOI 10.1016/0014-5793(88)80559-3; Pan GH, 1998, J BIOL CHEM, V273, P5841, DOI 10.1074/jbc.273.10.5841; PENG JW, 1992, J MAGN RESON, V98, P308, DOI 10.1016/0022-2364(92)90135-T; Rosse T, 1998, NATURE, V391, P496, DOI 10.1038/35160; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; SZYPERSKI T, 1992, J BIOMOL NMR, V2, P323, DOI 10.1007/BF01874811; Wang K, 1998, MOL CELL BIOL, V18, P6083, DOI 10.1128/MCB.18.10.6083; WISHART DS, 1994, J BIOMOL NMR, V4, P171; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yang XL, 1998, MOL CELL, V1, P319, DOI 10.1016/S1097-2765(00)80032-5	47	413	428	0	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 5	1999	96	5					615	624		10.1016/S0092-8674(00)80572-3	http://dx.doi.org/10.1016/S0092-8674(00)80572-3			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	174TB	10089877	Bronze			2022-12-28	WOS:000079050100005
J	Crabtree, GR				Crabtree, GR			Generic signals and specific outcomes: Signaling through Ca2+, calcineurin, and NF-AT	CELL			English	Review							ANTIGEN RECEPTOR; CYCLOSPORINE-A; NUCLEAR; TRANSDUCTION		Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94062 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94062 USA	Stanford University; Stanford University	Crabtree, GR (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94062 USA.							Abbott KL, 1998, MOL BIOL CELL, V9, P2905, DOI 10.1091/mbc.9.10.2905; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Chow CW, 1997, SCIENCE, V278, P1638, DOI 10.1126/science.278.5343.1638; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; GOLDSMITH MA, 1989, J BIOL CHEM, V264, P17190; GOLDSMITH MA, 1988, SCIENCE, V240, P1029, DOI 10.1126/science.3259335; Henikoff S, 1997, SCIENCE, V278, P609, DOI 10.1126/science.278.5338.609; Hojo M, 1999, NATURE, V397, P530, DOI 10.1038/17401; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Klemm JD, 1997, CURR BIOL, V7, P638, DOI 10.1016/S0960-9822(06)00290-9; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Oukka M, 1998, IMMUNITY, V9, P295, DOI 10.1016/S1074-7613(00)80612-3; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Sussman MA, 1998, SCIENCE, V281, P1690, DOI 10.1126/science.281.5383.1690; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; Zhou P, 1998, CELL, V92, P687, DOI 10.1016/S0092-8674(00)81136-8; Zhu JY, 1998, CELL, V93, P851, DOI 10.1016/S0092-8674(00)81445-2	25	636	662	0	16	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 5	1999	96	5					611	614		10.1016/S0092-8674(00)80571-1	http://dx.doi.org/10.1016/S0092-8674(00)80571-1			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	174TB	10089876	Bronze			2022-12-28	WOS:000079050100004
J	Partan, S; Marler, P				Partan, S; Marler, P			Behavior - Communication goes multimodal	SCIENCE			English	Editorial Material							REPRESENTATION; COURTSHIP; DISPLAYS; SIGNALS; SPACE		Univ Calif Davis, Ctr Anim Behav, Livermore, CA 95616 USA; Univ Calif Davis, Dept Neurobiol Physiol & Behav, Livermore, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Partan, S (corresponding author), Univ Calif Davis, Ctr Anim Behav, Livermore, CA 95616 USA.	srpartan@ucdavis.edu						Andersen RA, 1997, PHILOS T ROY SOC B, V352, P1421, DOI 10.1098/rstb.1997.0128; BEKOFF M, 1972, Q REV BIOL, V47, P412, DOI 10.1086/407400; BRAINARD MS, 1993, J NEUROSCI, V13, P4589; CONNER WE, 1987, EXPERIENTIA, V43, P1029, DOI 10.1007/BF01952230; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; DRIVER J, 1996, ATTENTION PERFORMANC, V16; HOLLDOBLER B, IN PRESS J COMP PH A; HORN E, 1983, MULTIMODAL CONVERGEN; Hughes M, 1996, ANIM BEHAV, V52, P247, DOI 10.1006/anbe.1996.0170; Johnstone RA, 1996, PHILOS T R SOC B, V351, P329, DOI 10.1098/rstb.1996.0026; Krebs J., 1978, BEHAV ECOLOGY, P380; Marler P., 1965, P544; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; MOLLER AP, 1993, BEHAV ECOL SOCIOBIOL, V32, P167; PARTAN SR, 1998, THESIS U CALIFORNIA; RISANI L, 1997, BEHAVIOUR, V134, P321; ROVNER JS, 1981, SCIENCE, V214, P464, DOI 10.1126/science.214.4519.464; Rowe C, 1996, NATURE, V383, P520, DOI 10.1038/383520a0; Scheffer SJ, 1996, BEHAV ECOL SOCIOBIOL, V38, P17, DOI 10.1007/s002650050212; Stein Barry E., 1995, P683; TINBERGEN N., 1959, BEHAVIOUR, V15, P1; Wilson E.O., 1975, P1	22	459	459	3	180	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	1999	283	5406					1272	1273		10.1126/science.283.5406.1272	http://dx.doi.org/10.1126/science.283.5406.1272			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171AM	10084931				2022-12-28	WOS:000078839900025
J	Chandra, B				Chandra, B			A good pair of hands	ANNALS OF INTERNAL MEDICINE			English	Editorial Material											Chandra, B (corresponding author), Box 7694, Northridge, CA 91326 USA.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 6	1999	130	7					610	611		10.7326/0003-4819-130-7-199904060-00024	http://dx.doi.org/10.7326/0003-4819-130-7-199904060-00024			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183BG	10189334				2022-12-28	WOS:000079533300012
J	Turney, JH				Turney, JH			Transferring patients - Times have changed	BRITISH MEDICAL JOURNAL			English	Article																			0	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 3	1999	318	7188					936	936		10.1136/bmj.318.7188.936	http://dx.doi.org/10.1136/bmj.318.7188.936			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185GV	10102867	Green Published			2022-12-28	WOS:000079660500035
J	Waibel, AE; Peter, T; Carslaw, KS; Oelhaf, H; Wetzel, G; Crutzen, PJ; Poschl, U; Tsias, A; Reimer, E; Fischer, H				Waibel, AE; Peter, T; Carslaw, KS; Oelhaf, H; Wetzel, G; Crutzen, PJ; Poschl, U; Tsias, A; Reimer, E; Fischer, H			Arctic ozone loss due to denitrification	SCIENCE			English	Article							POLAR STRATOSPHERIC CLOUDS; VERTICAL PROFILES; VORTEX; DEPLETION; WINTER; DEHYDRATION; CLIMATE; CO2	Measurements from the winter of 1994-95 indicating removal of total reactive nitrogen from the Arctic stratosphere by particle sedimentation were used to constrain a microphysical model. The model suggests that denitrification is caused predominantly by nitric acid trihydrate particles in small number densities. The denitrification is shown to increase Arctic ozone Loss substantially. Sensitivity studies indicate that the Arctic stratosphere is currently at a threshold of denitrification. This implies that future stratospheric cooling, induced by an increase in the anthropogenic carbon dioxide burden, is likely to enhance denitrification and to delay until late in the next century the return of Arctic stratospheric ozone to preindustrial values.	Max Planck Inst Chem, D-55020 Mainz, Germany; Forschungszentrum Karlsruhe, Inst Meteorol & Klimaforsch, D-76021 Karlsruhe, Germany; Free Univ Berlin, Inst Meteorol, D-12165 Berlin, Germany	Max Planck Society; Helmholtz Association; Karlsruhe Institute of Technology; Free University of Berlin	Peter, T (corresponding author), Swiss Fed Inst Technol, HPP Honggerberg, Inst Atmospher Sci, CH-8093 Zurich, Switzerland.	thomas.peter@atmos.umnw.ethz.ch	Pöschl, Ulrich/A-6263-2010; Oelhaf, Hermann A/A-7895-2013; Peter, Thomas/B-2529-2018; Carslaw, Ken S/C-8514-2009; Crutzen, Paul J/F-6044-2012; Wetzel, Gerald/A-7065-2013	Pöschl, Ulrich/0000-0003-1412-3557; Peter, Thomas/0000-0002-7218-7156; Carslaw, Ken S/0000-0002-6800-154X; Wetzel, Gerald/0000-0002-6671-0297				AUSTIN J, 1992, NATURE, V360, P221, DOI 10.1038/360221a0; Carslaw KS, 1997, REV GEOPHYS, V35, P125, DOI 10.1029/97RG00078; Carslaw KS, 1997, GEOPHYS RES LETT, V24, P1747, DOI 10.1029/97GL01684; Chipperfield MP, 1998, J GEOPHYS RES-ATMOS, V103, P28389, DOI 10.1029/98JD01960; Coy L, 1997, GEOPHYS RES LETT, V24, P2693, DOI 10.1029/97GL52832; Dameris M, 1998, GEOPHYS RES LETT, V25, P3579, DOI 10.1029/98GL02778; DYE JE, 1992, J GEOPHYS RES-ATMOS, V97, P8015, DOI 10.1029/91JD02740; FAHEY DW, 1990, NATURE, V344, P321, DOI 10.1038/344321a0; Fischer H, 1996, APPL OPTICS, V35, P2787, DOI 10.1364/AO.35.002787; Graf HF, 1998, J GEOPHYS RES-ATMOS, V103, P11251, DOI 10.1029/98JD00341; LOEWENSTEIN M, 1993, GEOPHYS RES LETT, V20, P2531, DOI 10.1029/93GL03004; MAHFOUF JF, 1994, CLIM DYNAM, V9, P345, DOI 10.1007/s003820050028; MANNEY GL, 1994, J ATMOS SCI, V51, P2973, DOI 10.1175/1520-0469(1994)051<2973:OTMOAT>2.0.CO;2; Michelsen HA, 1998, J GEOPHYS RES-ATMOS, V103, P28347, DOI 10.1029/98JD02850; Montzka SA, 1996, SCIENCE, V272, P1318, DOI 10.1126/science.272.5266.1318; Muller R, 1996, J GEOPHYS RES-ATMOS, V101, P12531; Naujokat B, 1996, GEOPHYS RES LETT, V23, P3703, DOI 10.1029/96GL03614; OLTMANS SJ, 1995, NATURE, V374, P146, DOI 10.1038/374146a0; Peter T, 1997, ANNU REV PHYS CHEM, V48, P785, DOI 10.1146/annurev.physchem.48.1.785; PITARI G, 1994, GEOPHYS RES LETT, V21, P1791, DOI 10.1029/94GL01136; Portmann RW, 1996, J GEOPHYS RES-ATMOS, V101, P22991, DOI 10.1029/96JD02608; PYLE JA, 1996, POLAR STRATOSPHERIC, P9; Rex M, 1999, J ATMOS CHEM, V32, P35, DOI 10.1023/A:1006093826861; Rinsland CP, 1996, GEOPHYS RES LETT, V23, P2397, DOI 10.1029/96GL00048; SALAWITCH RJ, 1993, SCIENCE, V261, P1146, DOI 10.1126/science.261.5125.1146; Shindell DT, 1998, NATURE, V392, P589, DOI 10.1038/33385; SOLOMON S, 1990, NATURE, V347, P347, DOI 10.1038/347347a0; SOLOMON S, 1995, SCI ASSESSMENT OZONE, pCH13; vonClarmann T, 1997, J GEOPHYS RES-ATMOS, V102, P16157, DOI 10.1029/97JD00605; Wetzel G, 1997, J GEOPHYS RES-ATMOS, V102, P19177, DOI 10.1029/97JD01311; Zurek RW, 1996, GEOPHYS RES LETT, V23, P289, DOI 10.1029/95GL03336	31	175	185	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	1999	283	5410					2064	2069		10.1126/science.283.5410.2064	http://dx.doi.org/10.1126/science.283.5410.2064			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180DH	10092225				2022-12-28	WOS:000079369800040
J	Baker, R; Lakhani, M; Fraser, R; Cheater, F				Baker, R; Lakhani, M; Fraser, R; Cheater, F			A model for clinical governance in primary care groups	BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE		Univ Leicester, Leicester Gen Hosp, Dept Gen Practice & Primary Hlth Care, Eli Lilly Natl Clin Audit Ctr, Leicester LE5 4PW, Leics, England	Eli Lilly; University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester	Baker, R (corresponding author), Univ Leicester, Leicester Gen Hosp, Dept Gen Practice & Primary Hlth Care, Eli Lilly Natl Clin Audit Ctr, Leicester LE5 4PW, Leics, England.							Baker R, 1997, FAM PRACT, V14, P107, DOI 10.1093/fampra/14.2.107; BAKER R, 1992, BRIT J GEN PRACT, V42, P415; Bero LA, 1998, BMJ-BRIT MED J, V317, P465; Berwick D. M., 1992, QUALITY HLTH CARE S, V1, P2; *C POSTGR ADV GEN, 1996, SUMM ASS GEN PRACT T; *CHIEF MED OFF, 1998, REV CONT PROF DEV GE; *CLIN STAND ADV GR, 1998, CLIN EFF; *DEP HLTH, 1992, 1992635 SI DEP HLTH; FRASER RC, 1994, BRIT J GEN PRACT, V44, P109; Fraser RC, 1998, EVIDENCE BASED AUDIT; *GEN MED COUNC, 1998, GOOD MED PRACT; Grol R, 1998, BRIT MED J, V317, P858, DOI 10.1136/bmj.317.7162.858; Grol R, 1997, BRIT MED J, V315, P418, DOI 10.1136/bmj.315.7105.418; Hearnshaw H, 1998, BRIT J GEN PRACT, V48, P979; *NH EX, 1998, 1998139 NHS EX; Robertson N, 1996, QUAL HEALTH CARE, V5, P51, DOI 10.1136/qshc.5.1.51; Scally G, 1998, BRIT MED J, V317, P61, DOI 10.1136/bmj.317.7150.61; *SECR STAT HLTH, 1998, 1 CLASS SERV; *SECR STAT HLTH, 1997, CM3807; Smith R, 1998, BMJ-BRIT MED J, V316, P1917, DOI 10.1136/bmj.316.7149.1917; *UK CENTR COUNC NU, 1992, COD COND NURS MIDW H; Williams S, 1998, IMPROVING HLTH NHS W; Zazove P, 1998, Jt Comm J Qual Improv, V24, P391	23	35	36	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 20	1999	318	7186					779	783		10.1136/bmj.318.7186.779	http://dx.doi.org/10.1136/bmj.318.7186.779			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BX	10082705	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000079421700029
J	Josefson, D				Josefson, D			Women with heart disease cautioned about HRT	BRITISH MEDICAL JOURNAL			English	News Item																		Schrott HG, 1997, JAMA-J AM MED ASSOC, V277, P1281, DOI 10.1001/jama.277.16.1281	1	3	3	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 20	1999	318	7186					753	753		10.1136/bmj.318.7186.753	http://dx.doi.org/10.1136/bmj.318.7186.753			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BX	10082682	Green Published			2022-12-28	WOS:000079421700006
J	van der Hilst, RD; Karason, H				van der Hilst, RD; Karason, H			Compositional heterogeneity in the bottom 1000 kilometers of Earth's mantle: Toward a hybrid convection model	SCIENCE			English	Review							SPARSE LINEAR-EQUATIONS; SUBDUCTED LITHOSPHERE; TRENCH MIGRATION; PHASE-TRANSFORMATIONS; LAYERED CONVECTION; NORTHWEST PACIFIC; LEAST-SQUARES; ISLAND ARCS; VISCOSITY; DEPTH	Tomographic imaging indicates that slabs of subducted lithosphere can sink deep into Earth's lower mantle. The view that convective flow is stratified at 660-kilometer depth and preserves a relatively pristine lower mantle is therefore not tenable. However, a range of geophysical evidence indicates that compositionally distinct, hence convectively isolated, mantle domains may exist in the bottom 1000 kilometers of the mantle. Survival of these domains, which are perhaps related to local iron enrichment and silicate-to-oxide transformations, implies that mantle convection is more complex than envisaged by conventional end-member flow models.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	van der Hilst, RD (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	hilst@mit.edu						AGEE CB, COMMUNICATION; AHRENS KTJ, 1998, EOS S, V79, pF846; Albarede F, 1998, CHEM GEOL, V145, P413, DOI 10.1016/S0009-2541(97)00152-6; Allegre CJ, 1996, GEOPHYS RES LETT, V23, P3555, DOI 10.1029/96GL03373; ANDERSON DL, 1998, OBSERVATIONAL THEORE, P255; BERCOVICI D, 1989, SCIENCE, V244, P950, DOI 10.1126/science.244.4907.950; Bina CR, 1998, REV MINERAL, V37, P205; BIRCH F, 1952, J GEOPHYS RES, V57, P227, DOI 10.1029/JZ057i002p00227; BOLTON H, IN PRESS J GEOPHYS R; BROWN JM, 1981, GEOPHYS J ROY ASTR S, V66, P579, DOI 10.1111/j.1365-246X.1981.tb04891.x; Brunet D, 1998, J GEOPHYS RES-SOL EA, V103, P4929, DOI 10.1029/97JB01357; Bunge HP, 1996, NATURE, V379, P436, DOI 10.1038/379436a0; Bunge HP, 1998, SCIENCE, V280, P91, DOI 10.1126/science.280.5360.91; Christensen UR, 1996, EARTH PLANET SC LETT, V140, P27, DOI 10.1016/0012-821X(96)00023-4; CHRISTENSEN UR, 1984, J GEOPHYS RES, V89, P4389, DOI 10.1029/JB089iB06p04389; DAVIES GF, 1984, J GEOPHYS RES, V89, P6017, DOI 10.1029/JB089iB07p06017; DAVIES GF, 1995, EARTH PLANET SC LETT, V133, P507, DOI 10.1016/0012-821X(95)00039-F; Dubrovinsky LS, 1997, NATURE, V388, P362, DOI 10.1038/41066; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Engdahl ER, 1998, B SEISMOL SOC AM, V88, P722; Farnetani CG, 1997, GEOPHYS RES LETT, V24, P1583, DOI 10.1029/97GL01548; Forte AM, 1997, J GEOPHYS RES-SOL EA, V102, P17981, DOI 10.1029/97JB01276; FUKAO Y, 1992, J GEOPHYS RES-SOL EA, V97, P4809, DOI 10.1029/91JB02749; Grand SP., 1997, GSA TODAY, V7, P1; GRIFFITHS RW, 1995, EARTH PLANET SC LETT, V133, P1, DOI 10.1016/0012-821X(95)00027-A; GUDMUNDSSON O, 1990, GEOPHYS J INT, V102, P25, DOI 10.1111/j.1365-246X.1990.tb00528.x; GUILLOU-FROTTIER L, 1995, EARTH PLANET SC LETT, V133, P19, DOI 10.1016/0012-821X(95)00045-E; GURNIS M, 1988, NATURE, V335, P317, DOI 10.1038/335317a0; GURNIS M, 1986, GEOPHYS RES LETT, V13, P1474, DOI 10.1029/GL013i013p01474; GURNIS M, 1998, OBSERVATIONAL THEORE; Haddon R. A. W., 1974, Physics of the Earth and Planetary Interiors, V8, P211, DOI 10.1016/0031-9201(74)90088-0; HANSEN U, 1988, NATURE, V334, P237, DOI 10.1038/334237a0; Hedlin MAH, 1997, NATURE, V387, P145, DOI 10.1038/387145a0; HEINZ D, 1982, J GEOPHYS RES, V87, P7772, DOI 10.1029/JB087iB09p07772; HEINZ DL, 1983, NATURE, V301, P138, DOI 10.1038/301138a0; Helmberger DV, 1998, NATURE, V396, P251, DOI 10.1038/24357; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; IRIFUNE T, 1993, EARTH PLANET SC LETT, V117, P101, DOI 10.1016/0012-821X(93)90120-X; Jackson I, 1998, GEOPHYS J INT, V134, P291, DOI 10.1046/j.1365-246x.1998.00560.x; JEANLOZ R, 1980, GEOPHYS J ROY ASTR S, V62, P505, DOI 10.1111/j.1365-246X.1980.tb02588.x; Jeanloz R, 1998, REV MINERAL, V37, P241; Kaneshima S, 1998, J GEOPHYS RES-SOL EA, V103, P4825, DOI 10.1029/97JB02565; Kellogg LH, 1999, SCIENCE, V283, P1881, DOI 10.1126/science.283.5409.1881; Kennett BLN, 1998, GEOPHYS J INT, V132, P374, DOI 10.1046/j.1365-246x.1998.00451.x; Kennett BLN, 1998, J GEOPHYS RES-SOL EA, V103, P12469, DOI 10.1029/98JB00150; KENNETT BLN, 1998, EOS S, V79, pF599; KESSON SE, 1994, NATURE, V372, P767, DOI 10.1038/372767a0; Kesson SE, 1998, NATURE, V393, P252, DOI 10.1038/30466; KINCAID C, 1987, J GEOPHYS RES-SOLID, V92, P13832, DOI 10.1029/JB092iB13p13832; KINGMA KJ, 1995, NATURE, V374, P243, DOI 10.1038/374243a0; Lay T, 1998, NATURE, V392, P461, DOI 10.1038/33083; LAY T, 1994, ANNU REV EARTH PL SC, V22, P33, DOI 10.1146/annurev.ea.22.050194.000341; Li XD, 1996, J GEOPHYS RES-SOL EA, V101, P22245, DOI 10.1029/96JB01306; LIU XF, 1998, OBSERVATIONAL THEORE, P21; LOPER DE, 1995, J GEOPHYS RES-SOL EA, V100, P6397, DOI 10.1029/94JB02048; MACHETEL P, 1991, NATURE, V350, P55, DOI 10.1038/350055a0; Manga M, 1996, GEOPHYS RES LETT, V23, P403, DOI 10.1029/96GL00242; Mao HK, 1996, PHYS EARTH PLANET IN, V96, P135, DOI 10.1016/0031-9201(96)03146-9; Mao HK, 1997, SCIENCE, V278, P2098, DOI 10.1126/science.278.5346.2098; Masters G, 1996, PHILOS T R SOC A, V354, P1385, DOI 10.1098/rsta.1996.0054; MCSWEENEY TJ, 1995, THESIS U WASHINGTON; MEADE C, 1995, SCIENCE, V268, P1743, DOI 10.1126/science.268.5218.1743; Mitrovica JX, 1997, J GEOPHYS RES-SOL EA, V102, P2751, DOI 10.1029/96JB03175; Montagner JP, 1996, GEOPHYS J INT, V125, P229, DOI 10.1111/j.1365-246X.1996.tb06548.x; MONTAGNER JP, 1994, REV GEOPHYS, V32, P115, DOI 10.1029/94RG00099; Niu FL, 1997, GEOPHYS RES LETT, V24, P429, DOI 10.1029/97GL00216; NOLET G, 1985, J COMPUT PHYS, V61, P463, DOI 10.1016/0021-9991(85)90075-0; Olbertz D, 1997, GEOPHYS RES LETT, V24, P221, DOI 10.1029/96GL03971; ONEILL B, 1994, J GEOPHYS RES-SOL EA, V99, P19901, DOI 10.1029/94JB01752; ONions RK, 1996, EARTH PLANET SC LETT, V139, P213, DOI 10.1016/0012-821X(96)00004-0; PAIGE CC, 1982, ACM T MATH SOFTWARE, V8, P43, DOI 10.1145/355984.355989; PAIGE CC, 1982, ACM T MATH SOFTWARE, V8, P195, DOI 10.1145/355993.356000; Reynard B, 1996, AM MINERAL, V81, P45; RICARD Y, 1991, GEOPHYS J INT, V105, P561, DOI 10.1111/j.1365-246X.1991.tb00796.x; RIGDEN S, 1998, EARTHS MANTLE COMPOS, P405; Ritsema J, 1998, GEOPHYS RES LETT, V25, P4245, DOI 10.1029/1998GL900127; RITZWOLLER MH, 1995, REV GEOPHYS, V33, P1, DOI 10.1029/94RG03020; Serghiou G, 1998, SCIENCE, V280, P2093, DOI 10.1126/science.280.5372.2093; SHANKLAND TJ, 1985, PHYS EARTH PLANET IN, V38, P51, DOI 10.1016/0031-9201(85)90121-9; Shannon MC, 1998, SCIENCE, V280, P1059, DOI 10.1126/science.280.5366.1059; SHEARER PM, 1998, OBSERVATIONAL THEORE, P37; SLEEP NH, 1988, GEOPHYS J INT, V95, P437, DOI 10.1111/j.1365-246X.1988.tb06695.x; SPOHN T, 1982, J GEOPHYS RES, V87, P4682, DOI 10.1029/JB087iB06p04682; Stacey FD, 1998, PHYS EARTH PLANET IN, V106, P219, DOI 10.1016/S0031-9201(98)00084-3; Stacey FD, 1997, PHYS EARTH PLANET IN, V99, P189, DOI 10.1016/S0031-9201(96)03218-9; STIXRUDE L, 1990, J GEOPHYS RES-SOLID, V95, P19311, DOI 10.1029/JB095iB12p19311; Su WJ, 1997, PHYS EARTH PLANET IN, V100, P135, DOI 10.1016/S0031-9201(96)03236-0; SU WJ, 1994, J GEOPHYS RES-SOL EA, V99, P6945, DOI 10.1029/93JB03408; Tackley PJ, 1996, GEOPHYS RES LETT, V23, P1985, DOI 10.1029/96GL01980; TACKLEY PJ, 1993, NATURE, V361, P699, DOI 10.1038/361699a0; TACKLEY PJ, 1998, OBSERVATIONAL THEORE, P231; THORAVAL C, 1995, NATURE, V375, P777, DOI 10.1038/375777a0; Tromp J., 1998, EOS T AGU S, V79, pF598; TSUCHIDA Y, 1998, NATURE, V25, P4253; van den Berg AP, 1998, PHYS EARTH PLANET IN, V108, P219, DOI 10.1016/S0031-9201(98)00101-0; van Keken PE, 1998, EARTH PLANET SC LETT, V156, P19, DOI 10.1016/S0012-821X(98)00023-5; VANDERHILST R, 1993, EARTH PLANET SC LETT, V120, P395, DOI 10.1016/0012-821X(93)90253-6; VANDERHILST R, 1995, NATURE, V374, P154, DOI 10.1038/374154a0; VANDERHILST R, 1991, NATURE, V353, P37, DOI 10.1038/353037a0; vanderHilst RD, 1997, NATURE, V386, P578, DOI 10.1038/386578a0; VANDERHILST RD, 1997, J GEOPHYS RES, V96, P5; VANKEKEN PE, 1994, SCIENCE, V264, P1437, DOI 10.1126/science.264.5164.1437; WEN LX, 1995, EARTH PLANET SC LETT, V133, P185, DOI 10.1016/0012-821X(95)00064-J; WILLIAMS Q, 1998, OBSERVATIONAL THEORE, P73; Wood BJ, 1996, SCIENCE, V273, P1522, DOI 10.1126/science.273.5281.1522; YUEN DA, 1996, SEISMIC MODELLING EA, P463; Zerr A, 1998, SCIENCE, V281, P243, DOI 10.1126/science.281.5374.243; ZHONG SJ, 1995, SCIENCE, V267, P838, DOI 10.1126/science.267.5199.838; ZHOU HW, 1990, J GEOPHYS RES-SOLID, V95, P6829, DOI 10.1029/JB095iB05p06829	109	314	318	5	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	1999	283	5409					1885	1888		10.1126/science.283.5409.1885	http://dx.doi.org/10.1126/science.283.5409.1885			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177UC	10082455	Green Submitted			2022-12-28	WOS:000079228600038
J	Gatzoulis, MA; Freeman, MA; Siu, SC; Webb, GD; Harris, L				Gatzoulis, MA; Freeman, MA; Siu, SC; Webb, GD; Harris, L			Atrial arrhythmia after surgical closure of atrial septal defects in adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COX-MAZE PROCEDURE; VENTRICULAR-FUNCTION; NATURAL-HISTORY; FOLLOW-UP; FIBRILLATION; SURGERY; CONCOMITANT; MANAGEMENT; REPAIR	Background Atrial flutter and atrial fibrillation are causes of morbidity in adults with an atrial septal defect. In this study, we attempted to identify risk factors for atrial flutter and fibrillation both before and after the surgical closure of an atrial septal defect. Methods We searched for preoperative and postoperative atrial flutter or fibrillation in 213 adult patients (82 men and 131 women) who underwent surgical closure of atrial septal defects because of symptoms, a substantial left-to-right shunt (ratio of pulmonary to systemic blood flow, >1.5:1), or both at Toronto Hospital between 1986 and 1997. Results Forty patients (19 percent) had sustained atrial flutter or fibrillation before surgery. As compared with the patients who did not have atrial flutter or fibrillation before surgery, those who did were older (mean [+/-SD] age, 59+/-11 vs. 37+/-3 years, P<0.001) and had higher mean pulmonary arterial pressures (25.0+/-9.7 vs. 19.7+/-8.2 mm Hg, P=0.001). There were no perioperative deaths. After a mean follow-up period of 3.8+/-2.5 years, 24 of the 40 patients (60 percent) continued to have atrial flutter or fibrillation. The mean age of these patients was greater than that of the 16 who converted to sinus rhythm (P=0.02). New-onset atrial flutter or atrial fibrillation was more likely to have developed at follow-up in patients who were older than 40 years at the time of surgery than in those who were 40 or younger (5 of 67 vs. 0 of 106, P=0.008). Late events (those occurring more than one month after surgery) included stroke in six patients (all but one with atrial flutter or fibrillation, one of whom died) and death from noncardiac causes in two patients. Multivariate analysis showed that older age (>40 years) at the time of surgery (P=0.001), the presence of preoperative atrial flutter or fibrillation (P<0.001), and the presence of postoperative atrial flutter or fibrillation or junctional rhythm (P=0.02) were predictive of late postoperative atrial flutter or fibrillation. Conclusions The risk of atrial flutter or atrial fibrillation in adults with atrial septal defects is related to the age at the time of surgical repair and the pulmonary arterial pressure. To reduce the morbidity associated with atrial flutter and fibrillation, the timely closure of atrial septal defects is warranted. (N Engl J Med 1999;340:839-46.) (C) 1999, Massachusetts Medical Society.	Univ Toronto, Toronto Hosp, Congenital Cardiac Ctr Adults, Toronto, ON, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; Toronto Congenital Cardiac Centre for Adults; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Gatzoulis, MA (corresponding author), Toronto Gen Hosp, Toronto Congenital Cardiac Ctr, 200 Elizabeth St, Toronto, ON M5G 2C4, Canada.	gatzoul@ibm.net	Siu, Sam C/G-3346-2011	Siu, Sam C/0000-0002-1104-3669				[Anonymous], 1994, ARCH INTERN MED, V154, P2254; Blackshear JL, 1996, ANN THORAC SURG, V61, P755, DOI 10.1016/0003-4975(95)00887-X; BONCHEK LI, 1993, ANN THORAC SURG, V55, P607, DOI 10.1016/0003-4975(93)90262-G; BONOW RO, 1981, CIRCULATION, V63, P1315, DOI 10.1161/01.CIR.63.6.1315; BOOTH DC, 1988, J AM COLL CARDIOL, V12, P1231, DOI 10.1016/0735-1097(88)92605-8; CAMPBELL M, 1970, BRIT HEART J, V32, P820; COX DR, 1972, J R STAT SOC B, V34, P187; COX JL, 1995, J THORAC CARDIOV SUR, V110, P485, DOI 10.1016/S0022-5223(95)70245-8; Cox JL, 1996, NEW ENGL J MED, V334, P57; CRAIG RJ, 1968, CIRCULATION, V37, P805, DOI 10.1161/01.CIR.37.5.805; Gatzoulis MA, 1996, ANN THORAC SURG, V61, P657, DOI 10.1016/0003-4975(95)01043-2; Helber U, 1997, J AM COLL CARDIOL, V29, P1345, DOI 10.1016/S0735-1097(97)00058-2; HORVATH KA, 1992, J AM COLL CARDIOL, V20, P1156, DOI 10.1016/0735-1097(92)90372-T; Kamata J, 1997, ANN THORAC SURG, V64, P394, DOI 10.1016/S0003-4975(97)00139-2; KONSTANTINIDES S, 1995, NEW ENGL J MED, V333, P469, DOI 10.1056/NEJM199508243330801; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; LIBERTHSON RR, 1981, AM J CARDIOL, V47, P56, DOI 10.1016/0002-9149(81)90289-7; Lin FY, 1996, J THORAC CARDIOV SUR, V111, P231, DOI 10.1016/S0022-5223(96)70420-8; MATTILA S, 1979, SCAND J THORAC CARD, V13, P21, DOI 10.3109/14017437909101781; MORILLO CA, 1995, CIRCULATION, V91, P1588, DOI 10.1161/01.CIR.91.5.1588; MURPHY JG, 1990, NEW ENGL J MED, V323, P1645, DOI 10.1056/NEJM199012133232401; NASRALLAH AT, 1976, CIRCULATION, V53, P329, DOI 10.1161/01.CIR.53.2.329; PERLOFF JK, 1995, NEW ENGL J MED, V333, P513, DOI 10.1056/NEJM199508243330809; POPIO KA, 1975, AM J CARDIOL, V36, P302, DOI 10.1016/0002-9149(75)90480-4; Prystowsky EN, 1996, CIRCULATION, V93, P1262, DOI 10.1161/01.CIR.93.6.1262; Sandoval N, 1996, AM J CARDIOL, V77, P591, DOI 10.1016/S0002-9149(97)89312-5; Satoh T, 1996, J CARDIOVASC ELECTR, V7, P833, DOI 10.1111/j.1540-8167.1996.tb00596.x; SHAH D, 1994, BRIT HEART J, V71, P224; SUTTON MGS, 1981, CIRCULATION, V64, P402, DOI 10.1161/01.CIR.64.2.402; SUTTON MGSJ, 1979, CIRCULATION, V60, P1082, DOI 10.1161/01.CIR.60.5.1082; Vigano M, 1996, EUR J CARDIO-THORAC, V10, P490, DOI 10.1016/S1010-7940(96)80413-1; WARD C, 1994, BRIT HEART J, V71, P219	32	305	328	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 18	1999	340	11					839	846		10.1056/NEJM199903183401103	http://dx.doi.org/10.1056/NEJM199903183401103			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	176ZW	10080846				2022-12-28	WOS:000079183200003
J	Teran-Santos, J; Jimenez-Gomez, A; Cordero-Guevara, J				Teran-Santos, J; Jimenez-Gomez, A; Cordero-Guevara, J		Cooperative Grp Burgos-Santander	The association between sleep apnea and the risk of traffic accidents	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AUTOMOBILE ACCIDENTS; DAYTIME SLEEPINESS; POPULATION; DISORDERS; ADULTS; SCALE	Background and Methods Drowsiness and lack of concentration may contribute to traffic accidents. We conducted a case-control study of the relation between sleep apnea and the risk of traffic accidents. The case patients were 102 drivers who received emergency treatment at hospitals in Burgos or Santander, Spain, after highway traffic accidents between April and December 1995. The controls were 152 patients randomly selected from primary care centers in the same cities and matched with the case patients for age and sex. Respiratory polygraphy was used to screen the patients for sleep apnea at home, and conventional polysomnography was used to confirm the diagnosis. The apnea-hypopnea index (the total number of episodes of apnea and hypopnea divided by the number of hours of sleep) was calculated for each participant. Results The mean age of the participants was 44 years; 77 percent were men. As compared with those without sleep apnea, patients with an apnea-hypopnea index of 10 or higher had an odds ratio of 6.3 (95 percent confidence interval, 2.4 to 16.2) for having a traffic accident. This relation remained significant after adjustment for potential confounders, such as alcohol consumption, visual-refraction disorders, body-mass index, years of driving, age, history with respect to traffic accidents, use of medications causing drowsiness, and sleep schedule. Among subjects with an apnea-hypopnea index of 10 or more, the risk of an accident was higher among those who had consumed alcohol on the day of the accident than among those who had not. Conclusions There is a strong association between sleep apnea, as measured by the apnea-hypopnea index, and the risk of traffic accidents. (N Engl J Med 1999; 340:847-51.) (C) 1999, Massachusetts Medical Society.	Gen Yague Hosp, Burgos, Spain; HUM Valdecilla, Serv Resp, Santander 3900, Spain	Hospital General Yague; Hospital Universitario Marques de Valdecilla (HUMV)	Jimenez-Gomez, A (corresponding author), HUM Valdecilla, Serv Resp, Avda de Valdeilla S-N, Santander 3900, Spain.							ALDRICH MS, 1989, SLEEP, V12, P487, DOI 10.1093/sleep/12.6.487; ALTISENT R, 1992, MED CLIN-BARCELONA, V99, P584; ARMITAGE P., 1992, ESTADISTICA INVESTIG; Barbe F, 1995, Arch Bronconeumol, V31, P460; Duran J, 1996, ARCH BRONCONEUMOL, V32, P3; FINDLEY LJ, 1991, ARCH INTERN MED, V151, P1451, DOI 10.1001/archinte.151.7.1451; FINDLEY LJ, 1989, AM REV RESPIR DIS, V140, P529, DOI 10.1164/ajrccm/140.2.529; FINDLEY LJ, 1988, AM REV RESPIR DIS, V138, P337, DOI 10.1164/ajrccm/138.2.337; HARALDSSON PO, 1990, ACTA OTO-LARYNGOL, V110, P136, DOI 10.3109/00016489009122528; HOSMER DW, 1989, APPL LOGISTIC REGRES; JENNUM P, 1992, CHEST, V102, P1371, DOI 10.1378/chest.102.5.1371; JOHNS MW, 1993, CHEST, V103, P30, DOI 10.1378/chest.103.1.30; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; LEGER D, 1994, SLEEP, V17, P84, DOI 10.1093/sleep/17.1.84; Norusis M.J., 1994, SPSS ADV STAT 61; PRADA C, 1995, MED CLIN-BARCELONA, V105, P601; RECHTSCHAFFEN A, 1968, 204 NIH PUBL; Strollo PJ, 1996, NEW ENGL J MED, V334, P99, DOI 10.1056/NEJM199601113340207; Wu H, 1996, NEUROLOGY, V46, P1254, DOI 10.1212/WNL.46.5.1254; Young T, 1997, SLEEP, V20, P608, DOI 10.1093/sleep/20.8.608; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	21	830	857	0	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 18	1999	340	11					847	851		10.1056/NEJM199903183401104	http://dx.doi.org/10.1056/NEJM199903183401104			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	176ZW	10080847				2022-12-28	WOS:000079183200004
J	Chervin, RD; Murman, DL; Malow, BA; Totten, V				Chervin, RD; Murman, DL; Malow, BA; Totten, V			Cost-utility of three approaches to the diagnosis of sleep apnea: Polysomnography, home testing, and empirical therapy	ANNALS OF INTERNAL MEDICINE			English	Article						steep apnea syndromes; cost-benefit analysis; polysomnography; positive-pressure respiration; quality-adjusted life years	MORTALITY; PRESSURE	Background: Obstructive sleep apnea syndrome (OSAS) is usually diagnosed with overnight polysomnography in a sleep laboratory. Home sleep studies can be performed at lower cost, but results are somewhat less reliable. Bedside diagnosis of OSAS without any testing has also been discussed. Objective: To model the costs and utility of laboratory polysomnography, home study, and no testing during the 5 years after initial evaluation for OSAS. Design: Cost-utility analysis. Data Sources: Published data. Target Population: Hypothetical cohort of persons suspected of having OSAS. Time Horizon: The 5 years after initial evaluation for OSAS. Perspective: Societal. Intervention: Nasal continuous positive airway pressure when OSAS was diagnosed. Measurements: Quality of life, survival and charges (as proxies for costs) for each diagnostic method. Results of Base-Case Analysis: Under almost all modeled conditions, polysomnography provided maximal quality-adjusted life-years in the 5 years after the initial diagnostic evaluation. The incremental charges for polysomnography over home study or no testing were about $13 400 and $9200, respectively, per quality-adjusted life-year gained during this period. Results of Sensitivity Analysis: Results were sensitive to the utility of treatment in the absence of OSAS. Conclusions: The cost-utility of polysomnography instead of home study or no testing in the diagnosis of OSAS compares favorably with that of other procedures for which society judges the added utility per dollar spent to be worthwhile. More precise determination of certain key variables in this model should be a goal of future research.	Univ Michigan, Ann Arbor, MI 48109 USA; Michigan State Univ, E Lansing, MI 48824 USA; Catholic Med Ctr Brooklyn & Queens Inc, Dept Emergency Med, Jamaica, NY 11432 USA	University of Michigan System; University of Michigan; Michigan State University	Chervin, RD (corresponding author), Univ Michigan Hosp 8D8702, Sleep Disorders Ctr, Box 0117,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.							*AM SLEEP DIS ASS, 1997, INT CLASS SLEEP DIS, P1; [Anonymous], 1989, AM REV RESPIR DIS, V139, P559; Chesson AL, 1997, SLEEP, V20, P423, DOI 10.1093/sleep/20.6.423; CROCKER BD, 1990, AM REV RESPIR DIS, V142, P14, DOI 10.1164/ajrccm/142.1.14; Deegan PC, 1996, EUR RESPIR J, V9, P117, DOI 10.1183/09031936.96.09010117; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; EMSELLEM HA, 1990, SOUTHERN MED J, V83, P748, DOI 10.1097/00007611-199007000-00006; FERBER R, 1994, SLEEP, V17, P378, DOI 10.1093/sleep/17.4.378; FLEMONS WW, 1994, AM J RESP CRIT CARE, V150, P1279, DOI 10.1164/ajrccm.150.5.7952553; GUILLEMINAULT C, 1993, CHEST, V104, P781, DOI 10.1378/chest.104.3.781; HE J, 1988, CHEST, V94, P9, DOI 10.1378/chest.94.1.9; Kryger MH, 1996, SLEEP, V19, pS111, DOI 10.1093/sleep/19.suppl_9.S111; LAVIE P, 1995, SLEEP, V18, P149, DOI 10.1093/sleep/18.3.149; Lee TT, 1997, ANN INTERN MED, V126, P337, DOI 10.7326/0003-4819-126-5-199703010-00001; Lipscomb J., 1996, COST EFFECTIVENESS H, P214; Luce BR, 1996, COST EFFECTIVENESS H, P176; MEYER TJ, 1993, CHEST, V103, P756, DOI 10.1378/chest.103.3.756; PARTINEN M, 1988, CHEST, V94, P1200, DOI 10.1378/chest.94.6.1200; ROBERTS SD, 1980, ANN INTERN MED, V92, P243, DOI 10.7326/0003-4819-92-2-243; SANDBLOM R, 1997, SLEEP RES, V26, P491; SCHMIDTNOWARA W, 1995, SLEEP, V18, P501, DOI 10.1093/sleep/18.6.501; Strohl K P, 1997, Sleep Breath, V2, P45, DOI 10.1007/BF03038972; SULLIVAN CE, 1981, LANCET, V1, P862; THORPY M, 1994, SLEEP, V17, P372; TOUSIGNANT P, 1994, SLEEP, V17, P52; VINER S, 1991, ANN INTERN MED, V115, P356, DOI 10.7326/0003-4819-115-5-356; WEINSTEIN MC, 1982, CIRCULATION, V66, P56; White DP, 1998, SLEEP, V21, P198, DOI 10.1093/sleep/21.2.198; WITTIG RM, 1984, AM REV RESPIR DIS, V129, P244; Wright J, 1997, BRIT MED J, V314, P851; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705	32	92	93	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	1999	130	6					496	+		10.7326/0003-4819-130-6-199903160-00006	http://dx.doi.org/10.7326/0003-4819-130-6-199903160-00006			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	176RL	10075617				2022-12-28	WOS:000079165500005
J	Eisinger, F; Geller, G; Burke, W; Holtzman, NA				Eisinger, F; Geller, G; Burke, W; Holtzman, NA			Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancer	LANCET			English	Editorial Material							SHARED DECISION-MAKING; CHOICE		Johns Hopkins Med Inst, Baltimore, MD 21205 USA; Inst J Paoli I Calmettes, Dept Canc Control, F-13009 Marseille, France; Inst J Paoli I Calmettes, INSERM CRI 9703, F-13009 Marseille, France; Univ Washington, Dept Med, Seattle, WA USA	Johns Hopkins University; Johns Hopkins Medicine; UNICANCER; Institut Paoli-Calmette (IPC); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Paoli-Calmette (IPC); University of Washington; University of Washington Seattle	Holtzman, NA (corresponding author), Johns Hopkins Med Inst, 550 N Broadway,Suite 511, Baltimore, MD 21205 USA.			Eisinger, Francois/0000-0002-8794-0681				Burke W, 1997, JAMA-J AM MED ASSOC, V277, P997, DOI 10.1001/jama.277.12.997; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Eisinger F, 1998, ANN ONCOL, V9, P939, DOI 10.1023/A:1008389021382; Eisinger F, 1997, AM J HUM GENET, V61, pA188; Geller G, 1997, JAMA-J AM MED ASSOC, V277, P1467, DOI 10.1001/jama.277.18.1467; Geller G, 1998, J CLIN ONCOL, V16, P2868, DOI 10.1200/JCO.1998.16.8.2868; HALL ET, 1984, LANGUAGE SILENCIEUX; Julian-Reynier C, 1997, AM J HUM GENET, V61, pA222; McCormick L, 1998, J SCHOOL HEALTH, V68, P43, DOI 10.1111/j.1746-1561.1998.tb07188.x; PAYER L, 1988, MED CULTURE, P35; Quill TE, 1996, ANN INTERN MED, V125, P763, DOI 10.7326/0003-4819-125-9-199611010-00010; Reagan LJ, 1997, AM J PUBLIC HEALTH, V87, P1779, DOI 10.2105/AJPH.87.11.1779; Rovner J, 1998, LANCET, V352, P1453, DOI 10.1016/S0140-6736(05)61285-8; Woolf SH, 1997, J FAM PRACTICE, V45, P205	14	89	95	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 13	1999	353	9156					919	920		10.1016/S0140-6736(98)07516-3	http://dx.doi.org/10.1016/S0140-6736(98)07516-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	181BU	10094000	hybrid			2022-12-28	WOS:000079421400045
J	Merz, JF; Leonard, DGB; Miller, ER				Merz, JF; Leonard, DGB; Miller, ER			Medicine - IRB review and consent in human tissue research	SCIENCE			English	Editorial Material							INFORMED CONSENT; GENETIC RESEARCH; RESEARCH ETHICS; STORED TISSUE; APPROVAL; BOARD		Univ Penn, Dept Mol & Cellular Engn, Philadelphia, PA 19104 USA; Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Carnegie Mellon Univ, Dept Philosophy, Pittsburgh, PA 15230 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Carnegie Mellon University	Merz, JF (corresponding author), Univ Penn, Dept Mol & Cellular Engn, Philadelphia, PA 19104 USA.	merz@mail.med.upenn.edu		Merz, Jon/0000-0002-0612-7104	NCRR NIH HHS [M01 RR000040] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Amdur RJ, 1997, JAMA-J AM MED ASSOC, V277, P909, DOI 10.1001/jama.277.11.909; [Anonymous], 1997, JAMA-J AM MED ASSOC, V277, P925; CLAYTON EW, 1995, JAMA-J AM MED ASSOC, V274, P1786, DOI 10.1001/jama.274.22.1786; COMPARE GJ, 1995, GENETIC PRIVACY ACT; *DEP HLTH HUM SERV, 1998, I REV BOARDS SYST JE; *DEP HLTH HUM SERV, 1995, INT MISC RES REP COM; Grody WW, 1996, DIAGN MOL PATHOL, V5, P74, DOI 10.1097/00019606-199603000-00012; JEUNGST ET, 1996, ETHICS RES INVOLVING, P401; KARLAWISH HT, IN PRESS J AM GERIAT; KIM DT, 1994, ANN EMERG MED, V23, P70, DOI 10.1016/S0196-0644(94)70011-7; Marshall E, 1996, SCIENCE, V271, P440, DOI 10.1126/science.271.5248.440; Matot I, 1998, CRIT CARE MED, V26, P1596, DOI 10.1097/00003246-199809000-00035; Merz JF, 1998, ANN EPIDEMIOL, V8, P479; Merz JF, 1997, J INVEST MED, V45, P252; Merz Jon F, 1996, IRB, V18, P7, DOI 10.2307/3564524; Moreno J, 1998, JAMA-J AM MED ASSOC, V280, P1951, DOI 10.1001/jama.280.22.1951; *NAT BIOETH ADV CO, 1998, US HUM BIOL MAT RES; Olson CM, 1996, RESUSCITATION, V31, P255, DOI 10.1016/0300-9572(95)00928-0; PHILLIPS JA, 1995, AM J HUM GENET, V57, P1499; Reilly PR, 1997, NAT GENET, V15, P16, DOI 10.1038/ng0197-16; Rikkert MGMO, 1996, BMJ-BRIT MED J, V313, P1117, DOI 10.1136/bmj.313.7065.1117; Stephenson J, 1996, JAMA-J AM MED ASSOC, V275, P503, DOI 10.1001/jama.275.7.503; Strass E, 1996, AM J HUM GENET, V59, P471	23	29	29	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	1999	283	5408					1647	1648		10.1126/science.283.5408.1647	http://dx.doi.org/10.1126/science.283.5408.1647			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175PF	10189317				2022-12-28	WOS:000079102800026
J	Gunn, TM; Miller, KA; He, L; Hyman, RV; Davis, RW; Azarani, A; Schlossman, SF; Duke-Cohan, JS; Barsh, GS				Gunn, TM; Miller, KA; He, L; Hyman, RV; Davis, RW; Azarani, A; Schlossman, SF; Duke-Cohan, JS; Barsh, GS			The mouse mahogany locus encodes a transmembrane form of human attractin	NATURE			English	Article							ALPHA-MSH; IN-VITRO; IV CD26; AGOUTI; PROTEIN; RECEPTORS; YELLOW; MICE; ANTAGONISM; MUTATIONS	Agouti protein and agouti-related protein are homologous paracrine signalling molecules that normally regulate hair colour and body weight, respectively, by antagonizing signalling through melanocortin receptors(1-7). Expression of Agouti is normally limited to the skin, but rare alleles from which Agouti is expressed ubiquitously, such as lethal yellow; have pleiotropic effects that include a yellow coat, obesity, increased linear growth, and immune defects(8-11). The mahogany (mg) mutation suppresses the effects of lethal yellow on pigmentation and body weight, and results of our previous genetic studies place mg downstream of transcription of Agouti but upstream of melanocortin receptors(12). Here we use positional cloning to identify a candidate gene for mahogany, Mgca. The predicted protein encoded by Mgca is a 1,428-amino-acid, single-transmembrane-domain protein that is expressed in many tissues, including pigment cells and the hypothalamus. The extracellular domain of the Mgca protein is the orthologue of human attractin, a circulating molecule produced by activated T cells that has been implicated in immune-cell interactions(13,14). These observations provide new insight into the regulation of energy metabolism and indicate a molecular basis for crosstalk between melanocortin-receptor signalling and immune function.	Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Stanford DNA Sequencing & Technol Ctr, Stanford, CA 94305 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Tumor Immunol, Boston, MA 02115 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Barsh, GS (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.		Duke-Cohan, Jonathan/A-5812-2010	Duke-Cohan, Jonathan/0000-0002-9478-9609; Gunn, Teresa/0000-0003-2688-6420				BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; BLANCHARD SG, 1995, BIOCHEMISTRY-US, V34, P10406, DOI 10.1021/bi00033a012; Catania A, 1996, PEPTIDES, V17, P675, DOI 10.1016/0196-9781(96)00037-X; Dinulescu DM, 1998, P NATL ACAD SCI USA, V95, P12707, DOI 10.1073/pnas.95.21.12707; DUHL DMJ, 1994, NAT GENET, V8, P59, DOI 10.1038/ng0994-59; Duke-Cohan JS, 1998, P NATL ACAD SCI USA, V95, P11336, DOI 10.1073/pnas.95.19.11336; DUKECOHAN JS, 1995, J BIOL CHEM, V270, P14107, DOI 10.1074/jbc.270.23.14107; DukeCohan JS, 1996, J IMMUNOL, V156, P1714; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; GASSER DL, 1973, J IMMUNOL, V110, P305; Hishida R, 1996, EMBO J, V15, P4111, DOI 10.1002/j.1460-2075.1996.tb00786.x; JACKSON IJ, 1994, PIGM CELL RES, V7, P73, DOI 10.1111/j.1600-0749.1994.tb00024.x; KAKIZUKA A, 1992, GENE DEV, V6, P578, DOI 10.1101/gad.6.4.578; LANE PRISCILLA W., 1960, JOUR HEREDITY, V51, P228; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; MICHAUD EJ, 1994, P NATL ACAD SCI USA, V91, P2562, DOI 10.1073/pnas.91.7.2562; Miller KA, 1997, GENETICS, V146, P1407; Nagase T, 1998, DNA Res, V5, P31, DOI 10.1093/dnares/5.1.31; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Ollmann MM, 1998, GENE DEV, V12, P316, DOI 10.1101/gad.12.3.316; OLLMANN MM, UNPUB J BIOL CHEM; Rajora N, 1997, J NEUROSCI, V17, P2181; RAMABO MJ, 1997, J MOL BIOL, V274, P650; ROBERTS DW, 1984, P NATL ACAD SCI-BIOL, V81, P2152, DOI 10.1073/pnas.81.7.2152; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; SIEGRIST W, 1994, CANCER RES, V54, P2604; Yang YK, 1997, MOL ENDOCRINOL, V11, P274, DOI 10.1210/me.11.3.274; Yang YK, 1999, MOL ENDOCRINOL, V13, P148, DOI 10.1210/me.13.1.148; Zuberi AR, 1996, GENOMICS, V33, P75, DOI 10.1006/geno.1996.0161	29	166	181	0	9	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 11	1999	398	6723					152	156		10.1038/18217	http://dx.doi.org/10.1038/18217			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176DG	10086356				2022-12-28	WOS:000079135200045
J	Cancela, JM; Churchill, GC; Galione, A				Cancela, JM; Churchill, GC; Galione, A			Coordination of agonist-induced Ca2+-signalling patterns by NAADP in pancreatic acinar cells	NATURE			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; CYCLIC-ADP-RIBOSE; INDUCED CA2+ RELEASE; INOSITOL TRISPHOSPHATE; CALCIUM; OSCILLATIONS; CHANNELS; INACTIVATION; ACTIVATION; SYSTEM	Many hormones and neurotransmitters evoke Ca2+ release from intracellular stores, often triggering agonist-specific signatures of intracellular Ca2+ concentration(1-5), Inositol trisphosphate (InsP(3))(1) and cyclic adenosine 5 '-diphosphate-ribose (cADPR)(6,7) are established Ca2+-mobilizing messengers that activate Ca2+ release through intracellular InsP(3) and ryanodine receptors, respectively(8-10). However, in pancreatic acinar cells, neither mess enger can explain the complex pattern of Ca2+ signals triggered by the secretory hormone cholecystokinin (CCK). We show here that the Ca2+-mobilizing molecule nicotinic acid adenine dinucleotide phosphate (NAADP)(7,11-13), and endogenous metabolite of P-NADP, triggers a Ca2+ response that varies from short-lasting Ca2+ spikes to a complex mixture of short-lasting (1-2s) and long-lasting (0.2-1 min) Ca2+ spikes. Cells were significantly more sensitive to NAADP than to either cADPR or InsP(3), whereas higher conEeni trations of NAADP selectively inactivated CCK-evoked Ca2+ signals in pancreatic acinar cells, indicating that NAADP may function as an intracellular messenger in mammalian cells.	Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	University of Oxford	Galione, A (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.		Galione, Antony/E-5884-2011	Galione, Antony/0000-0002-4132-7646; Cancela, Jose-Manuel/0000-0002-6234-1500	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aarhus R, 1996, J BIOL CHEM, V271, P8513, DOI 10.1074/jbc.271.15.8513; Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Albrieux M, 1998, J BIOL CHEM, V273, P14566, DOI 10.1074/jbc.273.23.14566; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P291, DOI 10.1113/jphysiol.1997.sp021927; Cancela JM, 1998, CURR BIOL, V8, P865, DOI 10.1016/S0960-9822(07)00347-8; Cancela JM, 1998, PFLUG ARCH EUR J PHY, V435, P746, DOI 10.1007/s004240050578; Chini EN, 1996, BIOCHEM J, V316, P709, DOI 10.1042/bj3160709; CHINI EN, 1995, J BIOL CHEM, V270, P3216, DOI 10.1074/jbc.270.7.3216; COBBOLD PH, 1991, CELL CALCIUM, V12, P87, DOI 10.1016/0143-4160(91)90011-3; EHRLICH BE, 1994, TRENDS PHARMACOL SCI, V15, P145, DOI 10.1016/0165-6147(94)90074-4; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; Genazzani AA, 1997, TRENDS PHARMACOL SCI, V18, P108, DOI 10.1016/S0165-6147(96)01036-X; Genazzani AA, 1996, BIOCHEM J, V315, P721, DOI 10.1042/bj3150721; Genazzani AA, 1996, J BIOL CHEM, V271, P11599, DOI 10.1074/jbc.271.20.11599; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 1997, PHYSIOL REV, V77, P1133, DOI 10.1152/physrev.1997.77.4.1133; Lee HC, 1997, J BIOL CHEM, V272, P4172, DOI 10.1074/jbc.272.7.4172; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; OSIPCHUK YV, 1990, EMBO J, V9, P697, DOI 10.1002/j.1460-2075.1990.tb08162.x; PETERSEN CCH, 1991, EMBO J, V10, P527, DOI 10.1002/j.1460-2075.1991.tb07979.x; PETERSEN OH, 1994, ANNU REV PHYSIOL, V56, P297, DOI 10.1146/annurev.ph.56.030194.001501; TAYLOR CW, 1992, TRENDS BIOCHEM SCI, V17, P403, DOI 10.1016/0968-0004(92)90009-X; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; THORN P, 1993, CELL, V74, P661, DOI 10.1016/0092-8674(93)90513-P; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; WALSETH TF, 1993, BIOCHIM BIOPHYS ACTA, V1178, P235, DOI 10.1016/0167-4889(93)90199-Y; Wilson HL, 1998, BIOCHEM J, V331, P837, DOI 10.1042/bj3310837	29	307	311	0	16	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 4	1999	398	6722					74	76		10.1038/18032	http://dx.doi.org/10.1038/18032			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174KG	10078532				2022-12-28	WOS:000079033900054
J	Laule, M; Cascorbi, I; Stangl, V; Bielecke, C; Wernecke, KD; Mrozikiewicz, PM; Felix, SB; Roots, I; Baumann, G; Stangl, K				Laule, M; Cascorbi, I; Stangl, V; Bielecke, C; Wernecke, KD; Mrozikiewicz, PM; Felix, SB; Roots, I; Baumann, G; Stangl, K			A1/A2 polymorphism of glycoprotein IIIa and association with excess procedural risk for coronary catheter interventions: a case-controlled study	LANCET			English	Article							PLATELET MEMBRANE-GLYCOPROTEINS; MYOCARDIAL-INFARCTION; PIA POLYMORPHISM; THROMBOSIS; ANGIOPLASTY; RECEPTOR; STENTS	Background A five-fold increase in risk of stent thrombosis in carriers of A1/A2 (Leu33Pro) polymorphism of glycoprotein IIIa has been described. Whether this increased procedural risk applies to other coronary interventions is unknown. We investigated the role of A1/A2 polymorphism as a putative risk factor. Methods We genotyped 1000 consecutive patients with angiographically confirmed coronary-artery disease and 1000 controls matched for age and sex. 653 of the 1000 patients received interventions (271 coronary angioplasty, 102 directional coronary atherectomy, and 280 stenting) and were assessed for a 30-day composite endpoint of need for target-vessel revascularisation, myocardial infarction, and death. Findings The composite endpoint occurred in 41 (6.3%) patients. There was no evidence that the A2 allele was associated with excess procedural risk (relative risk 1.36 [95% CI 0.70-2.70], p=0.37). Nor, in subgroup analyses, did A2 predict events that complicated coronary angioplasty (1.17 [0.40-2.70]), directional coronary atherectomy (1.50 [0.30-8.70]), or stenting (1.45 [0.60-3.50]). Neither heterozygotes (A1/A2) nor homozygotes (A2/A2) were over-represented in any subgroup, including those with acute coronary syndromes, early disease manifestation (age <40 years), and histories of myocardial infarction. Interpretation A1/A2 polymorphism is not a major risk factor for 30-day adverse events that complicate coronary angioplasty, directional coronary atherectomy, or stenting. Furthermore, A1/A2 polymorphism has no apparent impact on more chronic processes such as atherogenesis of the coronary arteries.	Humboldt Univ, Med Klin, Schwerpunkt Kardiol Angiol & Pneumol, D-10098 Berlin, Germany; Humboldt Univ, Inst Med Biometrie, D-10098 Berlin, Germany; Inst Klin Pharmakol, Berlin, Germany	Humboldt University of Berlin; Humboldt University of Berlin	Stangl, V (corresponding author), Humboldt Univ, Med Klin, Schwerpunkt Kardiol Angiol & Pneumol, Campus Mitte,Schumannstr 20-21, D-10098 Berlin, Germany.	karl.stangl@charite.de	Laule, Michael E/A-6548-2013; Cascorbi, Ingolf/AAT-1927-2021; Cascorbi, Ingolf/A-4519-2009	Cascorbi, Ingolf/0000-0002-2182-9534; Laule, Michael/0000-0002-7579-295X				Alderman EL, 1996, NEW ENGL J MED, V335, P217; [Anonymous], 1979, Circulation, V59, P607; Baim DS, 1998, CIRCULATION, V97, P322; BENNETT JS, 1990, SEMIN HEMATOL, V27, P186; Carter AM, 1996, LANCET, V348, P485, DOI 10.1016/S0140-6736(05)64592-8; Carter AM, 1997, CIRCULATION, V96, P1424, DOI 10.1161/01.CIR.96.5.1424; FITZGERALD LA, 1987, J BIOL CHEM, V262, P3936; Herrmann SM, 1997, THROMB HAEMOSTASIS, V77, P1179; King SB, 1998, J AM COLL CARDIOL, V31, P558, DOI 10.1016/S0735-1097(97)10523-X; KING SB, 1994, NEW ENGL J MED, V331, P1044, DOI 10.1056/NEJM199410203311602; NURDEN AT, 1995, THROMB HAEMOSTASIS, V74, P345; NURDEN AT, 1993, BAILLIERE CLIN HAEM, V6, P653, DOI 10.1016/S0950-3536(05)80193-3; Nurden AT, 1997, LANCET, V350, P1189, DOI 10.1016/S0140-6736(05)63447-2; Ridker PM, 1997, LANCET, V349, P385, DOI 10.1016/S0140-6736(97)80010-4; RYAN TJ, 1993, CIRCULATION, V88, P2987, DOI 10.1161/01.CIR.88.6.2987; Schomig A, 1996, NEW ENGL J MED, V334, P1084, DOI 10.1056/NEJM199604253341702; Serruys PW, 1996, CIRCULATION, V93, P412, DOI 10.1161/01.CIR.93.3.412; Walter DH, 1997, LANCET, V350, P1217, DOI 10.1016/S0140-6736(97)05399-3; Weiss EJ, 1996, NEW ENGL J MED, V334, P1090, DOI 10.1056/NEJM199604253341703	19	71	72	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	1999	353	9154					708	712		10.1016/S0140-6736(98)07257-2	http://dx.doi.org/10.1016/S0140-6736(98)07257-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173DR	10073513				2022-12-28	WOS:000078966400011
J	Whitacre, CC; Reingold, SC; O'Looney, PA				Whitacre, CC; Reingold, SC; O'Looney, PA		Task Force Gender Multiple Sclerosis Autoimmuni	Biomedicine - A gender cap in autoimmunity	SCIENCE			English	Editorial Material							DISEASES		Ohio State Univ, Dept Med Microbiol & Immunol, Columbus, OH 43210 USA; Natl Multiple Sclerosis Soc, Res Programs Dept, New York, NY 10017 USA	University System of Ohio; Ohio State University	Whitacre, CC (corresponding author), Ohio State Univ, Dept Med Microbiol & Immunol, Columbus, OH 43210 USA.			Reingold, Stephen/0000-0003-4485-8634; Reiss, Carol/0000-0003-4353-8882				BEESON PB, 1994, AM J MED, V96, P457, DOI 10.1016/0002-9343(94)90173-2; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; Sawcer S, 1997, TRENDS GENET, V13, P234, DOI 10.1016/S0168-9525(97)01140-2	3	654	665	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 26	1999	283	5406					1277	1278		10.1126/science.283.5406.1277	http://dx.doi.org/10.1126/science.283.5406.1277			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171AM	10084932				2022-12-28	WOS:000078839900028
J	Basham, B				Basham, B			Protein structure at your desk - PepTool	SCIENCE			English	Software Review							AMINO-ACID-SEQUENCE; SECONDARY-STRUCTURE		DNAX Res Inst Mol & Cellular Biol Inc, Palo Alto, CA 94304 USA	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	Basham, B (corresponding author), DNAX Res Inst Mol & Cellular Biol Inc, 901 Calif Ave, Palo Alto, CA 94304 USA.							Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; WISHART DS, 1994, COMPUT APPL BIOSCI, V10, P121; WISHART DS, 1994, J BIOMOL NMR, V4, P171	5	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 19	1999	283	5405					1132	1132		10.1126/science.283.5405.1132	http://dx.doi.org/10.1126/science.283.5405.1132			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169GD	10075575				2022-12-28	WOS:000078738400038
J	Garver, RI; Zorn, GL; Wu, X; McGiffin, DC; Young, KR; Pinkard, NB				Garver, RI; Zorn, GL; Wu, X; McGiffin, DC; Young, KR; Pinkard, NB			Recurrence of bronchioloalveolar carcinoma in transplanted lungs	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MARROW; TUMOR-CELLS; CANCER; MICROMETASTASES; ADENOCARCINOMA	Background Bronchioloalveolar carcinoma is a distinctive subtype of typical adenocarcinoma of the lung that tends to metastasize widely throughout the lungs but less commonly elsewhere. Because conventional therapies for intrapulmonary metastatic bronchioloalveolar carcinoma are generally ineffective, we treated seven patients who had intrapulmonary metastatic bronchioloalveolar carcinoma with lung transplantation. Methods Seven patients with biopsy-proved bronchioloalveolar carcinoma and no evidence of extrapulmonary disease received transplants of either one or two cadaveric lungs. At transplantation, all native lung tissue was removed and replaced with a donor lung or lungs. The patients received the usual post-transplantation care given at the institution. Results Four of the seven patients had recurrent bronchioloalveolar carcinoma within the donor lungs; the recurrences appeared from 10 to 48 months after transplantation. All recurrences were limited to the donor lungs. Histologic and molecular analyses showed that the recurrent tumors in three patients originated from the recipients of the transplants. Conclusions Lung transplantation for bronchioloalveolar carcinoma is technically feasible, but recurrence of the original tumor within the donor lungs up to four years after transplantation was common. (N Engl J Med 1999;340:1071-4.) (C) 1999, Massachusetts Medical Society.	Univ Alabama, Sch Med, Dept Med, Birmingham, AL 35294 USA; Univ Alabama, Sch Med, Dept Surg, Birmingham, AL 35294 USA; Univ Alabama, Sch Med, Dept Pathol, Birmingham, AL 35294 USA; UAB Hosp, Lung Transplant Program, Birmingham, AL USA; UAB Hosp, Lung Canc Program, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Garver, RI (corresponding author), Univ Alabama, Sch Med, Dept Med, 701 S 10th St,LHRB 339, Birmingham, AL 35294 USA.							AUERBACH O, 1991, CANCER, V68, P1973, DOI 10.1002/1097-0142(19911101)68:9<1973::AID-CNCR2820680921>3.0.CO;2-Z; BARSKY SH, 1994, CANCER-AM CANCER SOC, V73, P1163, DOI 10.1002/1097-0142(19940215)73:4<1163::AID-CNCR2820730407>3.0.CO;2-J; COTE RJ, 1995, ANN SURG, V222, P415; Daly RC, 1997, MAYO CLIN PROC, V72, P79, DOI 10.4065/72.1.79; FELDMAN ER, 1992, MAYO CLIN PROC, V67, P27, DOI 10.1016/S0025-6196(12)60273-0; GRECO RJ, 1986, ANN THORAC SURG, V41, P652, DOI 10.1016/S0003-4975(10)63082-2; GROVER FL, 1989, ANN SURG, V209, P779, DOI 10.1097/00000658-198906000-00016; Izbicki JR, 1996, J THORAC CARDIOV SUR, V112, P623, DOI 10.1016/S0022-5223(96)70044-2; Landis SH, 1998, CA-CANCER J CLIN, V48, P6, DOI 10.3322/canjclin.48.1.6; Landis SH, 1998, CA-CANCER J CLIN, V48, P192; Maruyama R, 1997, J THORAC CARDIOV SUR, V114, P535, DOI 10.1016/S0022-5223(97)70041-2; Ohgami A, 1997, ANN THORAC SURG, V64, P363, DOI 10.1016/S0003-4975(97)00543-2; Pantel K, 1996, LANCET, V347, P649, DOI 10.1016/S0140-6736(96)91203-9; Peck K, 1998, CANCER RES, V58, P2761; SCHRAUFNAGEL D, 1982, AM REV RESPIR DIS, V125, P74; TRAVIS WD, 1995, CANCER-AM CANCER SOC, V75, P191, DOI 10.1002/1097-0142(19950101)75:1+<191::AID-CNCR2820751307>3.0.CO;2-Y; TRAVIS WD, 1995, CANCER, V75, P2979; WEBER JL, 1989, AM J HUM GENET, V44, P388	18	70	74	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 8	1999	340	14					1071	1074		10.1056/NEJM199904083401403	http://dx.doi.org/10.1056/NEJM199904083401403			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	184AK	10194236				2022-12-28	WOS:000079587000003
J	Sherman, SI; Gopal, J; Haugen, BR; Chiu, AC; Whaley, K; Nowlakha, P; Duvic, M				Sherman, SI; Gopal, J; Haugen, BR; Chiu, AC; Whaley, K; Nowlakha, P; Duvic, M			Central hypothyroidism associated with retinoid X receptor-selective ligands	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	5th International Pituitary Congress	JUN 28-30, 1998	FT MYERS, FL				THYROTROPIN-BETA PROMOTER; THYROID-HORMONE; MYCOSIS-FUNGOIDES; LGD1069 TARGRETIN; MAMMARY-CARCINOMA; DIFFERENTIATION; AGONISTS; SUBUNIT; THERAPY; CELLS	Background The occurrence of symptomatic central hypothyroidism (characterized by low serum thyrotropin and thyroxine concentrations) in a patient with cutaneous T-cell lymphoma during therapy with the retinoid X receptor-selective ligand bexarotene led us to hypothesize that such ligands could reversibly suppress thyrotropin production by a thyroid hormone-independent mechanism and thus cause central hypothyroidism. Methods We evaluated thyroid function in 27 patients with cutaneous T-cell lymphoma who were enrolled in trials of high-dose oral bexarotene at one institution. in addition, we evaluated the in vitro effect of triiodothyronine, 9-cis-retinoic acid, and the retinoid X receptor-selective ligand LGD346 on the activity of the thyrotropin beta-subunit gene promoter. Results The mean serum thyrotropin concentration declined from 2.2 mU per liter at base line to 0.05 mU per liter during treatment with bexarotene (P<0.001), and the mean serum free thyroxine concentration declined from 1.0 ng per deciliter (12.9 pmol per liter) at base line to 0.45 ng per deciliter (5.8 pmol per liter) (P<0.001) during treatment. The degree of suppression of thyrotropin secretion tended to be greater in patients treated with higher doses of bexarotene (>300 mg per square meter of body-surface area per day) and in those with a history of treatment with interferon alfa. Nineteen patients had symptoms or signs of hypothyroidism, particularly fatigue and cold intolerance. The symptoms improved after the initiation of thyroxine therapy, and all patients became euthyroid after treatment with bexarotene was stopped. In vitro, LGD346 suppressed the activity of the thyrotropin beta-subunit gene promoter in thyrotrophs by as much as 50 percent, an effect similar to that of triiodothyronine and 9-cis-retinoic acid. Conclusions Hypothyroidism may develop in patients with cutaneous T-cell lymphoma who are treated with high-dose bexarotene, most likely because the retinoid X receptor-selective ligand suppresses thyrotropin secretion. (N Engl J Med 1999;340:1075-9.) (C) 1999, Massachusetts Medical Society.	Univ Texas, MD Anderson Canc Ctr, Sect Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dermatol Sect, Houston, TX 77030 USA; Univ Colorado, Hlth Sci Ctr, Div Endocrinol, Denver, CO USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Sherman, SI (corresponding author), Univ Texas, MD Anderson Canc Ctr, Sect Endocrine Neoplasia & Hormonal Disorders, 1515 Holcombe Blvd, Houston, TX 77030 USA.	sisherma@mdanderson.org		Gopal, Jayashree/0000-0001-8951-4726; Sherman, Steven/0000-0002-3079-5153				ABEL EA, 1993, CA-CANCER J CLIN, V43, P93, DOI 10.3322/canjclin.43.2.93; Bischoff ED, 1998, CANCER RES, V58, P479; BOEHM MF, 1994, J MED CHEM, V37, P2930, DOI 10.1021/jm00044a014; Breen JJ, 1997, MOL CELL ENDOCRINOL, V131, P137, DOI 10.1016/S0303-7207(97)00099-3; BREEN JJ, 1995, ENDOCRINOLOGY, V136, P543, DOI 10.1210/en.136.2.543; BUNN PA, 1994, ANN INTERN MED, V121, P592, DOI 10.7326/0003-4819-121-8-199410150-00007; Coya R, 1997, LIFE SCI, V60, pPL247, DOI 10.1016/S0024-3205(97)00091-X; Duvic M, 1996, J AM ACAD DERMATOL, V34, P1022, DOI 10.1016/S0190-9622(96)90282-0; Duvic M, 1996, J AM ACAD DERMATOL, V35, P587; Fitzgerald P, 1997, CANCER RES, V57, P2642; Gottardis MM, 1996, CANCER RES, V56, P5566; Haugen BR, 1997, MOL ENDOCRINOL, V11, P481, DOI 10.1210/me.11.4.481; HAUGEN BR, 1993, J BIOL CHEM, V268, P20818; HEYMAN RA, 1998, 80 ANN M END SOC NEW, P22; Kakizawa T, 1997, J BIOL CHEM, V272, P23799, DOI 10.1074/jbc.272.38.23799; Kizaki M, 1996, BLOOD, V87, P1977; Koh LKH, 1997, THYROID, V7, P891, DOI 10.1089/thy.1997.7.891; LANGLOIS MF, 1997, THYROID S, V7, pS40; Lee HY, 1996, CELL GROWTH DIFFER, V7, P997; Miller VA, 1997, J CLIN ONCOL, V15, P790, DOI 10.1200/JCO.1997.15.2.790; Mukherjee R, 1998, ARTERIOSCL THROM VAS, V18, P272, DOI 10.1161/01.ATV.18.2.272; Mukherjee R, 1997, NATURE, V386, P407, DOI 10.1038/386407a0; WOOD WM, 1989, J BIOL CHEM, V264, P14840	23	183	211	9	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 8	1999	340	14					1075	1079		10.1056/NEJM199904083401404	http://dx.doi.org/10.1056/NEJM199904083401404			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	184AK	10194237				2022-12-28	WOS:000079587000004
J	von Schacky, C; Angerer, P; Kothny, W; Theisen, K; Mudra, H				von Schacky, C; Angerer, P; Kothny, W; Theisen, K; Mudra, H			The effect of dietary omega-3 fatty acids on coronary atherosclerosis - A randomized, double-blind, placebo-controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article						coronary arteriosclerosis; fatty acids, omega-3; fish oils; coronary angiography; dietary fats, unsaturated	COLESTIPOL-NIACIN THERAPY; FISH OILS; ARTERY DISEASE; INTERVENTION TRIAL; RISK; ANGIOPLASTY; PROGRESSION; REGRESSION; RESTENOSIS; OMEGA-3-FATTY-ACIDS	Background: Epidemiologic studies, studies of mechanisms of action, and many animal studies indicate that dietary intake of omega-3 fatty acids has antiatherosclerotic potential. Few trials in humans have examined this potential. Objective: To determine the effect of dietary intake of w-3 fatty acids on the course of coronary artery atherosclerosis in humans. Design: Randomized, double-blind, placebo-controlled, clinically controlled trial. Setting: University preventive cardiology unit. Patients: 223 patients with angiographically proven coronary artery disease. Intervention: Fish oil concentrate (55% eicosapentaenoic and docosahexaenoic acids)or a placebo with a fatty acid composition resembling that of the average European diet, 6 g/d for 3 months and then 3 g/d for 21 months. Measurements: The results of standardized coronary angiography, done before and after 2 years of treatment, were evaluated by an expert panel (primary end point) and by quantitative coronary angiography. Patients were followed for clinical and laboratory status. Results: Pairs of angiograms tone taken at baseline and one taken at 2 years) were evaluated for 80 of 112 placebo recipients and 82 of 111 fish oil recipients. At the end of treatment, 48 coronary segments in the placebo group showed changes (36 showed mild progression, 5 showed moderate progression, and 7 showed mild regression) and 55 coronary segments in the fish oil group showed changes (35 showed mild progression, 4 showed moderate progression, 14 showed mild regression, and 2 showed moderate regression) (P = 0.041). toss in minimal luminal diameter, as assessed by quantitative coronary angiography, was somewhat less in the fish oil group (P > 0.1). Fish oil recipients had fewer cardiovascular events (P = 0.10); other clinical variables did not differ between the study groups. Low-density lipoprotein cholesterol levels tended to be greater in the fish oil group. Conclusion: Dietary intake of omega-3 fatty acids modestly mitigates the course of coronary atherosclerosis in humans.	Univ Munich, Klinikum Innenstadt, Med Klin, D-80336 Munich, Germany	University of Munich	von Schacky, C (corresponding author), Univ Munich, Klinikum Innenstadt, Med Klin, Ziemssenstr 1, D-80336 Munich, Germany.	vonschacky@medinn.med.uni-muenchen.de						Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; Baumann KH, 1999, ARTERIOSCL THROM VAS, V19, P59, DOI 10.1161/01.ATV.19.1.59; BLANKENHORN DH, 1992, CIRCULATION, V86, P1701, DOI 10.1161/01.CIR.86.6.1701; BLANKENHORN DH, 1987, JAMA-J AM MED ASSOC, V257, P3233, DOI 10.1001/jama.257.23.3233; BROWN BG, 1995, EUR HEART J, V16, P2, DOI 10.1093/eurheartj/16.suppl_E.2; BULL NL, 1983, HUM NUTR-APPL NUTR, V37, P373; BURR ML, 1989, LANCET, V2, P757; Cairns JA, 1996, CIRCULATION, V94, P1553, DOI 10.1161/01.CIR.94.7.1553; Daviglus ML, 1997, NEW ENGL J MED, V336, P1046, DOI 10.1056/NEJM199704103361502; DOLECEK TA, 1992, P SOC EXP BIOL MED, V200, P177, DOI 10.3181/00379727-200-43413; DYERBERG J, 1979, LANCET, V2, P433, DOI 10.1016/S0140-6736(79)91490-9; Endres S, 1996, CURR OPIN LIPIDOL, V7, P48, DOI 10.1097/00041433-199602000-00011; Eritsland J, 1996, AM J CARDIOL, V77, P31, DOI 10.1016/S0002-9149(97)89130-8; FOX PL, 1988, SCIENCE, V241, P453, DOI 10.1126/science.3393911; GAPINSKI JP, 1993, ARCH INTERN MED, V153, P1595, DOI 10.1001/archinte.153.13.1595; Hambrecht R, 1993, J AM COLL CARDIOL, V22, P468, DOI 10.1016/0735-1097(93)90051-2; Harris WS, 1997, AM J CLIN NUTR, V65, P1645, DOI 10.1093/ajcn/65.5.1645S; HASKELL WL, 1994, CIRCULATION, V89, P975, DOI 10.1161/01.CIR.89.3.975; Hausleiter J, 1997, CORONARY ARTERY DIS, V8, P83, DOI 10.1097/00019501-199702000-00003; JUKEMA JW, 1995, CIRCULATION, V91, P2528, DOI 10.1161/01.CIR.91.10.2528; KAMINSKI WE, 1993, BLOOD, V81, P1871; Kothny W, 1998, ATHEROSCLEROSIS, V140, P181, DOI 10.1016/S0021-9150(98)00131-2; LEAF A, 1994, CIRCULATION, V90, P2248, DOI 10.1161/01.CIR.90.5.2248; MUDRA H, 1994, CIRCULATION, V90, P1252, DOI 10.1161/01.CIR.90.3.1252; OLSEN SF, 1995, BRIT J NUTR, V73, P387, DOI 10.1079/BJN19950041; ORNISH D, 1990, LANCET, V336, P129, DOI 10.1016/0140-6736(90)91656-U; Reiber J. H. C., 1991, CARDIAC IMAGING COMP, P211; ROZENMAN Y, 1995, AM J CARDIOL, V76, P1126, DOI 10.1016/S0002-9149(99)80320-8; SACKS FM, 1995, J AM COLL CARDIOL, V25, P1492, DOI 10.1016/0735-1097(95)00095-L; SISCOVICK DS, 1995, JAMA-J AM MED ASSOC, V274, P1363, DOI 10.1001/jama.274.17.1363; SMITH SC, 1995, CIRCULATION, V92, P2; VONSCHACKY C, 1987, ANN INTERN MED, V107, P890, DOI 10.7326/0003-4819-107-6-890; VONSCHACKY C, 1985, J CLIN INVEST, V76, P1626, DOI 10.1172/JCI112147; VONSCHACKY C, 1992, FISH FISH OIL HUMAN, P167; WATERS D, 1994, CIRCULATION, V89, P959, DOI 10.1161/01.CIR.89.3.959	35	354	427	0	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 6	1999	130	7					554	562		10.7326/0003-4819-130-7-199904060-00003	http://dx.doi.org/10.7326/0003-4819-130-7-199904060-00003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183BG	10189324				2022-12-28	WOS:000079533300002
J	Enzel, Y; Ely, LL; Mishra, S; Ramesh, R; Amit, R; Lazar, B; Rajaguru, SN; Baker, VR; Sandler, A				Enzel, Y; Ely, LL; Mishra, S; Ramesh, R; Amit, R; Lazar, B; Rajaguru, SN; Baker, VR; Sandler, A			High-resolution Holocene environmental changes in the Thar Desert, northwestern India	SCIENCE			English	Article							MONSOON; RAJASTHAN; LEVEL; LAKE	Sediments from Lunkaransar dry Lake in northwestern India reveal regional water table and lake Level fluctuations over decades to centuries during the Holocene that are attributed to changes in the southwestern Indian monsoon rains. The Lake levels were Very shallow and fluctuated often in the early Holocene and then rose abruptly around 6300 carbon-14 years before the present (C-14 yr B.P.). The lake completely desiccated around 4800 C-14 yr B.P. The end of this 1500-year wet period coincided with a period of intense dune destabilization. The major Harrapan-Indus-civilization began and flourished in this region 1000 years after desiccation of the Lake during arid climate and was not synchronous with the lacustral phase.	Hebrew Univ Jerusalem, Inst Earth Sci, IL-91904 Jerusalem, Israel; Penn State Univ, Ctr Earth Syst Sci, University Pk, PA 16802 USA; Hebrew Univ Jerusalem, Dept Geog, IL-91904 Jerusalem, Israel; Cent Washington Univ, Dept Geol, Ellensburg, WA 98926 USA; Deccan Coll, Pune 411006, Maharashtra, India; Phys Res Lab, Div Earth Sci, Ahmadabad 380009, Gujarat, India; Geol Survey Israel, IL-95501 Jerusalem, Israel; Univ Arizona, Dept Hydrol & Water Resources, Tucson, AZ 85721 USA	Hebrew University of Jerusalem; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Hebrew University of Jerusalem; Central Washington University; Department of Space (DoS), Government of India; Physical Research Laboratory - India; Geological Survey Israel; University of Arizona	Enzel, Y (corresponding author), Hebrew Univ Jerusalem, Inst Earth Sci, IL-91904 Jerusalem, Israel.		Enzel, Yehouda/AAV-5829-2021	Lazar, Boaz/0000-0002-2304-8993				Allchin B., 1982, RISE CIVILIZATION IN; ALLCHIN R, 1997, ORIGINS CIVLIZATION; ALLEN BD, 1993, SCIENCE, V260, P1920, DOI 10.1126/science.260.5116.1920; ALLEN BD, 1991, NEW MEXICO BUREAU MI, V137, P166; BAERTSCHI P, 1952, HELV CHIM ACTA, V53, P1030; BRYSON RA, 1981, QUATERNARY RES, V16, P135, DOI 10.1016/0033-5894(81)90041-7; BRYSON RA, 1989, CLIM DYNAM, V3, P169; CRAIG H, 1953, GEOCHIM COSMOCHIM AC, V3, P53, DOI 10.1016/0016-7037(53)90001-5; JONES BF, 1988, REV MINERAL, V19, P631; Krishnan A, 1977, DESERTIFICATION ITS, P42; Kutzbach J. E., 1987, MONSOON, P247; KUTZBACH JE, 1985, NATURE, V317, P130, DOI 10.1038/317130a0; LAZAR B, 1990, GEOLOGY, V18, P1191, DOI 10.1130/0091-7613(1990)018<1191:ECDISD>2.3.CO;2; Misra V. N, 1984, FRONTIERS INDUS CIVI, P461; NORTHFELT DW, 1981, GEOCHIM COSMOCHIM AC, V45, P1895, DOI 10.1016/0016-7037(81)90019-3; Overpeck J, 1996, CLIM DYNAM, V12, P213, DOI 10.1007/BF00211619; POSSEHL GL, 1993, S ASIAN ARCHAEOLOGY, P231; PRELL WL, 1992, NATURE, V360, P647, DOI 10.1038/360647a0; RAMESH R, 1988, SCI ARCHEOLOGY, V196, P591; Roberts Neil, 1993, P194; SINGH G, 1972, Quaternary Research (Orlando), V2, P496, DOI 10.1016/0033-5894(72)90088-9; SINGH G, 1990, REV PALAEOBOT PALYNO, V64, P351, DOI 10.1016/0034-6667(90)90151-8; SINGH G, 1974, PHILOS T ROY SOC B, V267, P467, DOI 10.1098/rstb.1974.0006; Singh G., 1971, ARCHAEOLOGY PHYSICAL, V6, P177; SIROCKO F, 1993, NATURE, V364, P322, DOI 10.1038/364322a0; SWAIN AM, 1983, QUATERNARY RES, V19, P1, DOI 10.1016/0033-5894(83)90024-8; VISHNUMITTRE, 1978, PALEOBOTANIST, V25, P549; VISHNUMITTRE, 1974, GEOPHYTOLOGY, V4; WASSON RJ, 1984, PALAEOGEOGR PALAEOCL, V46, P345, DOI 10.1016/0031-0182(84)90006-3; WASSON RJ, 1995, QUATERNARY ENV GEOAR, P22; Wasson RJ., 1983, Z FUER GEOMORPHOLOGI, V45, P117; WRIGHT HE, 1993, GLOBAL CLIMATES LAST, P194	32	343	361	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	1999	284	5411					125	128		10.1126/science.284.5411.125	http://dx.doi.org/10.1126/science.284.5411.125			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182QE	10102808				2022-12-28	WOS:000079509000047
J	Cole, CH; Colton, T; Shah, BL; Abbasi, S; MacKinnon, BL; Demissie, S; Frantz, ID				Cole, CH; Colton, T; Shah, BL; Abbasi, S; MacKinnon, BL; Demissie, S; Frantz, ID			Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESPIRATORY-DISTRESS SYNDROME; METERED-DOSE INHALER; BIRTH-WEIGHT INFANTS; CONTROLLED TRIAL; BECLOMETHASONE DIPROPIONATE; DEXAMETHASONE THERAPY; PREMATURE-INFANTS; JET NEBULIZER; DELIVERY; AEROSOL	Background The safety and efficacy of inhaled glucocorticoid therapy for asthma stimulated its use in infants to prevent bronchopulmonary dysplasia. We tested the hypothesis that early therapy with inhaled glucocorticoids would decrease the frequency of bronchopulmonary dysplasia in premature infants. Methods We conducted a randomized, multicenter trial of inhaled beclomethasone or placebo in 253 infants, 3 to 14 days old, born before 33 weeks of gestation and weighing 1250 g or less at birth, who required ventilation therapy. Beclomethasone was delivered in a decreasing dosage, from 40 to 5 mu g per kilogram of body weight per day, for four weeks. The primary outcome measure was bronchopulmonary dysplasia at 28 days of age. Secondary outcomes included bronchopulmonary dysplasia at 36 weeks of postmenstrual age, the need for systemic glucocorticoid therapy, the need for bronchodilator therapy, the duration of respiratory support, and death. Results One hundred twenty-three infants received beclomethasone, and 130 received placebo. The frequency of bronchopulmonary dysplasia was similar in the two groups: 43 percent in the bedomethasone group and 45 percent in the placebo group at 28 days of age, and 18 percent in the beclomethasone group and 20 percent in the placebo group at 36 weeks of postmenstrual age. At 28 days of age, fewer infants in the beclomethasone group than in the placebo group were receiving systemic glucocorticoid therapy (relative risk, 0.6; 95 percent confidence interval, 0.4 to 1.0) and mechanical ventilation (relative risk, 0.8; 95 percent confidence interval, 0.6 to 1.0). Conclusions Early beclomethasone therapy did not prevent bronchopulmonary dysplasia but was associated with lower rates of use of systemic glucocorticoid therapy and mechanical ventilation. (N Engl J Med 1999;340:1005-10.) (C) 1999, Massachusetts Medical Society.	Tufts Univ New England Med Ctr, Floating Hosp Children, Dept Pediat, Boston, MA 02111 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; Boston Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Boston, MA USA; Baystate Med Ctr, Childrens Hosp, Div Newborn Med, Springfield, MA USA; Tufts Univ, Sch Med, Springfield, MA 01199 USA; Penn Hosp, Div Neonatol, Philadelphia, PA 19107 USA	Floating Hospital For Children; Tufts Medical Center; Tufts University; Boston University; Baystate Medical Center; Tufts University; University of Pennsylvania; Pennsylvania Medicine	Cole, CH (corresponding author), Tufts Univ New England Med Ctr, Box 84,750 Washington St, Boston, MA 02111 USA.	cynthia.cole@es.nemc.org		Demissie, Serkalem/0000-0002-8009-0987	NCRR NIH HHS [M01-RR00054] Funding Source: Medline; NHLBI NIH HHS [U01 HL49803] Funding Source: Medline; FDA HHS [FD-R-000917] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000054] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL049803] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); FDA HHS; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arnon S, 1996, PEDIATR PULM, V21, P231; ARNON S, 1992, PEDIATR PULM, V13, P172, DOI 10.1002/ppul.1950130309; BARNES PJ, 1993, AM REV RESPIR DIS, V148, pS1, DOI 10.1164/ajrccm/148.4_Pt_2.S1; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Bhuta T, 1998, ARCH DIS CHILD-FETAL, V79, pF26, DOI 10.1136/fn.79.1.F26; CLOUTIER MM, 1993, PEDIATR PULM, V15, P111, DOI 10.1002/ppul.1950150208; COLE CH, 1997, CURRENT TOPICS NEONA, V2, P256; DURAND M, 1995, PEDIATRICS, V95, P584; Edwards DK, 1982, LUNG DEV BIOL CLIN P, V2, P47; Everard ML, 1996, J AEROSOL MED, V9, P71, DOI 10.1089/jam.1996.9.71; FARDY CH, 1996, NEONATAL RESP DIS, V6; Fok TF, 1996, PEDIATR PULM, V21, P301, DOI 10.1002/(SICI)1099-0496(199605)21:5<301::AID-PPUL5>3.0.CO;2-P; GREENE MG, 1991, H LANE HDB MANUAL PE, P378; GRIGG J, 1992, ARCH DIS CHILD-FETAL, V67, P25, DOI 10.1136/adc.67.1_Spec_No.25; Kovacs L, 1998, ACTA PAEDIATR, V87, P792, DOI 10.1080/080352598750013905; LAFORCE WR, 1993, J PEDIATR-US, V122, P285, DOI 10.1016/S0022-3476(06)80134-4; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; LINDER N, 1995, J PEDIATR-US, V127, P651, DOI 10.1016/S0022-3476(95)70133-8; *MED EC, 1997, PHYS DESK REF, P1063; OCALLAGHAN C, 1992, ARCH DIS CHILD-FETAL, V67, P20, DOI 10.1136/adc.67.1_Spec_No.20; OCALLAGHAN C, 1993, THORAX, V48, P603, DOI 10.1136/thx.48.6.603; OCALLAGHAN C, 1990, THORAX, V45, P109, DOI 10.1136/thx.45.2.109; OCallaghan C, 1997, PEDIATR PULM, P51; PIERCE MR, 1995, PEDIATR PULM, V19, P371, DOI 10.1002/ppul.1950190611; Rastogi A, 1996, PEDIATRICS, V98, P204; SALMON B, 1990, ARCH DIS CHILD, V65, P401, DOI 10.1136/adc.65.4.401; SANDERS RJ, 1994, PEDIATR RES, V36, P122, DOI 10.1203/00006450-199407001-00022; TAN KL, 1988, J PEDIATR-US, V112, P266, DOI 10.1016/S0022-3476(88)80068-4; Tapia JL, 1998, J PEDIATR-US, V132, P48, DOI 10.1016/S0022-3476(98)70483-4; YEH TF, 1990, J PEDIATR-US, V117, P273, DOI 10.1016/S0022-3476(05)80547-5; Yeh TF, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.4.e3; YUKSEL B, 1992, THORAX, V47, P910, DOI 10.1136/thx.47.11.910	32	98	104	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 1	1999	340	13					1005	1010		10.1056/NEJM199904013401304	http://dx.doi.org/10.1056/NEJM199904013401304			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182GA	10099142	Bronze			2022-12-28	WOS:000079489800004
J	Ogawa, T; Tomita, K; Ueda, T; Watanabe, K; Uozumi, T; Masaki, H				Ogawa, T; Tomita, K; Ueda, T; Watanabe, K; Uozumi, T; Masaki, H			A cytotoxic ribonuclease targeting specific transfer RNA anticodons	SCIENCE			English	Article							ESCHERICHIA-COLI; POLYNUCLEOTIDE KINASE; RIBOSOMAL-RNA; BIOSYNTHESIS; COLICIN-E3; QUEUOSINE; SEQUENCE; PROTEIN; GENES; ACID	The carboxyl-terminal domain of colicin E5 was shown to inhibit protein synthesis of Escherichia coli. Its target, as revealed through in vivo and in vitro experiments, was not ribosomes as in the case of E3, but the transfer RNAs (tRNAs) for Tyr, His, Asn, and Asp, which contain a modified base, queuine, at the wobble position of each anticodon. The E5 carboxyl-terminal domain hydrolyzed these tRNAs just on the 3' side of this nucleotide. Tight correlation was observed between the toxicity of E5 and the cleavage of intracellular tRNAs of this group, implying that these tRNAs are the primary targets of colicin E5.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138654, Japan	University of Tokyo; University of Tokyo	Masaki, H (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.		Ogawa, Tetsuhiro/AAO-2961-2021; Ueda, Takuya/K-5217-2014; Tomita, Kozo/J-5746-2013; Tomita, Kozo/E-9390-2017	Ueda, Takuya/0000-0002-7760-8271; Tomita, Kozo/0000-0002-7374-3898				AKUTSU A, 1989, J BACTERIOL, V171, P6430, DOI 10.1128/jb.171.12.6430-6436.1989; AMITSUR M, 1987, EMBO J, V6, P2499, DOI 10.1002/j.1460-2075.1987.tb02532.x; BAAN RA, 1976, FEBS LETT, V71, P351, DOI 10.1016/0014-5793(76)80968-4; Blackburn P, 1982, ENZYMES, VXV, P317; BOWMAN CM, 1971, P NATL ACAD SCI USA, V68, P964, DOI 10.1073/pnas.68.5.964; CAMERON V, 1977, BIOCHEMISTRY-US, V16, P5120, DOI 10.1021/bi00642a027; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAHLBERG AE, 1975, P NATL ACAD SCI USA, V72, P2940, DOI 10.1073/pnas.72.8.2940; DONISKELLER H, 1980, NUCLEIC ACIDS RES, V8, P3133, DOI 10.1093/nar/8.14.3133; Gerlt J. A., 1993, NUCLEASES, P1; Jakes KS., 1982, MOL ACTION TOXINS VI, P131; James R, 1996, MICROBIOL-SGM, V142, P1569, DOI 10.1099/13500872-142-7-1569; KASAI H, 1975, BIOCHEMISTRY-US, V14, P4198, DOI 10.1021/bi00690a008; KEITH G, 1995, BIOCHIMIE, V77, P142, DOI 10.1016/0300-9084(96)88118-1; KUCHINO Y, 1987, METHOD ENZYMOL, V155, P379; LAU PCK, 1989, MOL GEN GENET, V217, P269, DOI 10.1007/BF02464892; LAU PCK, 1992, BACTERIOCINS MICROCI, P353; MASAKI H, 1991, GENE, V107, P133; MASAKI H, 1985, J MOL BIOL, V182, P217, DOI 10.1016/0022-2836(85)90340-7; MASAKI H, 1992, BACTERIOCINS MICROCI, P379; Masaki H, 1997, NUCL ACIDS S SER, V37, P287; MOCK M, 1982, J BACTERIOL, V150, P1069, DOI 10.1128/JB.150.3.1069-1076.1982; Morse DP, 1997, BIOCHEMISTRY-US, V36, P8429, DOI 10.1021/bi9709607; Nakamura Y, 1996, CELL, V87, P147, DOI 10.1016/S0092-8674(00)81331-8; NIRENBERG MW, 1963, METHOD ENZYMOL, V6, P17, DOI 10.1016/0076-6879(63)06142-5; NISHIMURA S, 1983, PROG NUCLEIC ACID RE, V28, P49, DOI 10.1016/S0079-6603(08)60082-3; NOGUCHI S, 1982, J BIOL CHEM, V257, P6544; OGAWA T, UNPUB; OHNO S, 1978, J BIOCHEM-TOKYO, V84, P1637, DOI 10.1093/oxfordjournals.jbchem.a132291; Pugsley A, 1987, METHODS STUDYING COL; REUTER K, 1991, J BACTERIOL, V173, P2256, DOI 10.1128/JB.173.7.2256-2264.1991; Sagara JI, 1998, NUCLEIC ACIDS RES, V26, P1974, DOI 10.1093/nar/26.8.1974; SAXENA SK, 1992, J BIOL CHEM, V267, P21982; STEYAERT J, 1990, BIOCHEMISTRY-US, V29, P9064, DOI 10.1021/bi00490a025; WOOL IG, 1992, TRENDS BIOCHEM SCI, V17, P266, DOI 10.1016/0968-0004(92)90407-Z; 24 S NUCL AC CHEM TO	36	143	148	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	1999	283	5410					2097	2100		10.1126/science.283.5410.2097	http://dx.doi.org/10.1126/science.283.5410.2097			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180DH	10092236				2022-12-28	WOS:000079369800051
J	Berry, MJ; Brivanlou, IH; Jordan, TA; Meister, M				Berry, MJ; Brivanlou, IH; Jordan, TA; Meister, M			Anticipation of moving stimuli by the retina	NATURE			English	Article							CONTRAST GAIN-CONTROL; MOTION EXTRAPOLATION; ATTENTION SHIFT; GANGLION-CELLS; LATENCY; SIGNALS; CORTEX; MAPS	A flash of light evokes neural activity in the brain with a delay of 30-100 milliseconds', much of which is due to the slow process of visual transduction in photoreceptors(2,3). A moving object can cover a considerable distance in this time, and should therefore be seen noticeably behind its actual location. As this conflicts with everyday experience, it has been suggested that the visual cortex uses the delayed visual data from the eye to extrapolate the trajectory of a moving object, so that it is perceived at its actual location(4-7). Here we report that such anticipation of moving stimuli begins in the retina. A moving bar elicits a moving wave of spiking activity in the population of retinal ganglion cells. Rather than lagging behind the visual image, the population activity travels near the leading edge of the moving bar. This response is observed over a wide range of speeds and apparently compensates for the visual response latency. We show how this anticipation follows from known mechanisms of retinal processing.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Berry, MJ (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.			Meister, Markus/0000-0003-2136-6506				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; BALDO MVC, 1995, NATURE, V378, P565, DOI 10.1038/378565a0; BENARDETE EA, 1992, VISUAL NEUROSCI, V8, P483, DOI 10.1017/S0952523800004995; Carandini M, 1997, J NEUROSCI, V17, P8621; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; Crevier DW, 1998, J NEUROPHYSIOL, V79, P1869, DOI 10.1152/jn.1998.79.4.1869; DEVALOIS RL, 1991, VISION RES, V31, P1619, DOI 10.1016/0042-6989(91)90138-U; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; HUNTER IW, 1986, BIOL CYBERN, V55, P135; Jacobs AL, 1998, J NEUROPHYSIOL, V80, P447, DOI 10.1152/jn.1998.80.1.447; KHURANA B, 1995, NATURE, V378, P566, DOI 10.1038/378566a0; KNUDSEN EI, 1987, ANNU REV NEUROSCI, V10, P41, DOI 10.1146/annurev.ne.10.030187.000353; KNUDSEN EI, 1982, J NEUROSCI, V2, P1177; LENNIE P, 1981, VISION RES, V21, P815, DOI 10.1016/0042-6989(81)90180-2; MAUNSELL JHR, 1992, J NEUROPHYSIOL, V68, P1332, DOI 10.1152/jn.1992.68.4.1332; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Nijhawan R, 1997, NATURE, V386, P66, DOI 10.1038/386066a0; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; Purushothaman G, 1998, NATURE, V396, P424, DOI 10.1038/24766; RODIECK R. W., 1965, VISION RES, V5, P583, DOI 10.1016/0042-6989(65)90033-7; SAKAI HM, 1995, J GEN PHYSIOL, V105, P815, DOI 10.1085/jgp.105.6.815; SCHNAPF JL, 1987, NATURE, V325, P439, DOI 10.1038/325439a0; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; SPARKS DL, 1986, PHYSIOL REV, V66, P118, DOI 10.1152/physrev.1986.66.1.118; VICTOR JD, 1987, J PHYSIOL-LONDON, V386, P219, DOI 10.1113/jphysiol.1987.sp016531; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; Whitney D, 1998, NAT NEUROSCI, V1, P656, DOI 10.1038/3659	29	316	322	0	29	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 25	1999	398	6725					334	338		10.1038/18678	http://dx.doi.org/10.1038/18678			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180DF	10192333				2022-12-28	WOS:000079369600051
J	Steer, P; Flint, C				Steer, P; Flint, C			ABC of labour care - Physiology and management of normal labour	BRITISH MEDICAL JOURNAL			English	Review									Chelsea & Westminster Hosp, Imperial Coll Sch Med, London, England; Thames Valley Univ, London, England	Imperial College London; University of West London	Steer, P (corresponding author), Chelsea & Westminster Hosp, Imperial Coll Sch Med, London, England.							BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; DAVIES R, 1995, TURNBULLS OBSTET; LIU DTY, 1991, LABOUR WARD MANUAL; PHILPOTT RH, 1972, BRIT MED J, V4, P163, DOI 10.1136/bmj.4.5833.163; Rogers J, 1998, LANCET, V351, P693, DOI 10.1016/S0140-6736(97)09409-9; WHITTLE M, 1995, TURNBULLS OBSTET	6	11	11	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 20	1999	318	7186					793	796		10.1136/bmj.318.7186.793	http://dx.doi.org/10.1136/bmj.318.7186.793			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BX	10082709	Green Published, Green Submitted			2022-12-28	WOS:000079421700033
J	Maletic-Savatic, M; Malinow, R; Svoboda, K				Maletic-Savatic, M; Malinow, R; Svoboda, K			Rapid dendritic morphogenesis in CA1 hippocampal dendrites induced by synaptic activity	SCIENCE			English	Article							LONG-TERM POTENTIATION; ASPARTATE RECEPTOR ANTAGONIST; GREEN FLUORESCENT PROTEIN; VISUAL-CORTEX; RAT HIPPOCAMPUS; DENTATE GYRUS; SPINES; EXPERIENCE; PLASTICITY; SYNAPSES	Activity shapes the structure of neurons and their circuits. Two-photon imaging of CA1 neurons expressing enhanced green fluorescent protein in developing hippocampal slices from rat brains was used to characterize dendritic morphogenesis in response to synaptic activity. High-frequency focal synaptic stimulation induced a period (longer than 30 minutes) of enhanced growth of small filopodia-like protrusions (typically less than 5 micrometers long). Synaptically evoked growth was long-lasting and localized to dendritic regions close (less than 50 micrometers) to the stimulating electrode and was prevented by blockade of N-methyl-D-aspartate receptors. Thus, synaptic activation can produce rapid input-specific changes in dendritic structure. Such persistent structural changes could contribute to the development of neural circuitry.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Maletic-Savatic, M (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.			Maletic-Savatic, Mirjana/0000-0002-6548-4662				BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BORTOLOTTO ZA, 1994, NATURE, V368, P740, DOI 10.1038/368740a0; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CLINE HT, 1989, NEURON, V3, P413, DOI 10.1016/0896-6273(89)90201-8; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; Collin C, 1997, J NEUROPHYSIOL, V77, P1614, DOI 10.1152/jn.1997.77.3.1614; COLLINGRIDGE GL, 1988, J PHYSIOL-LONDON, V399, P301; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Dailey ME, 1996, J NEUROSCI, V16, P2983; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; DESMOND NL, 1986, J COMP NEUROL, V253, P466, DOI 10.1002/cne.902530404; DESMOND NL, 1990, SYNAPSE, V5, P139, DOI 10.1002/syn.890050208; FIFKOVA E, 1977, J NEUROCYTOL, V6, P211, DOI 10.1007/BF01261506; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; FOX K, 1992, J NEUROSCI, V12, P2672; Fox K, 1996, P NATL ACAD SCI USA, V93, P5584, DOI 10.1073/pnas.93.11.5584; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; HOSOKAWA T, 1995, J NEUROSCI, V15, P5560; KALB RG, 1994, DEVELOPMENT, V120, P3063; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; LUND JS, 1977, J COMP NEUROL, V176, P149, DOI 10.1002/cne.901760203; MAINEN ZF, IN PRESS METHODS; MALINOW R, IN PRESS IMAGING LIV; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; Miller KD, 1998, NEURAL COMPUT, V10, P529, DOI 10.1162/089976698300017647; MILLER M, 1981, J COMP NEUROL, V203, P555, DOI 10.1002/cne.902030402; Minkwitz H G, 1975, J Hirnforsch, V16, P37; PAPA M, 1995, J NEUROSCI, V15, P1; PURPURA DP, 1975, ADV NEUROL, V12, P91; Rajan I, 1998, J NEUROSCI, V18, P7836; SAITO Y, 1992, NEUROSCI LETT, V147, P81, DOI 10.1016/0304-3940(92)90779-7; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; SCHLESINGER S, 1993, TRENDS BIOTECHNOL, V11, P18, DOI 10.1016/0167-7799(93)90070-P; SIEGEL S, 1956, NONPARAMETRIC STAT; Sorra KE, 1998, J NEUROSCI, V18, P658; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; VANHARREVELD A, 1975, EXP NEUROL, V49, P736, DOI 10.1016/0014-4886(75)90055-2; VOGEL MW, 1995, J NEUROBIOL, V26, P537, DOI 10.1002/neu.480260407; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	46	941	961	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	1999	283	5409					1923	1927		10.1126/science.283.5409.1923	http://dx.doi.org/10.1126/science.283.5409.1923			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177UC	10082466				2022-12-28	WOS:000079228600050
J	Neuzil, KM; Reed, GW; Mitchel, EF; Griffin, MR				Neuzil, KM; Reed, GW; Mitchel, EF; Griffin, MR			Influenza-associated morbidity and mortality in young and middle-aged women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE RESPIRATORY-DISEASE; EPIDEMIC INFLUENZA; UNITED-STATES; VACCINATION; INFECTION; HOSPITALIZATION; PNEUMONIA; COMMUNITY; IMPACT; ADULTS	Context Data are limited on rates of influenza-associated hospitalizations and deaths among adults younger than 65 years. Objective To quantify serious morbidity and mortality from influenza for women younger than 65 years with and without certain chronic medical conditions, including human immunodeficiency virus infection. Design Retrospective cohort study. Setting and Population Women aged 15 to 64 years enrolled in the Tennessee Medicaid program from 1974 to 1993, Main Outcome Measure All hospitalizations for and deaths from pneumonia, influenza, and other selected acute cardiopulmonary conditions for women with and without selected chronic medical conditions during 19 consecutive years. Influenza-attributable risk was calculated by subtracting event rates during peri-influenza season (November through April of each year when influenza virus was not circulating) from adjusted rates during influenza season (November through April when influenza virus was circulating). Results During the 19 years of the study, we identified 53 607 acute cardiopulmonary hospitalizations and deaths, Rates of such events were consistently higher during influenza seasons than peri-influenza seasons, Among high-risk women, the estimated annual excess was 23 hospitalizations and deaths per 10 000 women aged 15 to 44 years and 58 such events per 10 000 women aged 45 to 64 years, The estimated annual excess mortality due to influenza was 2 deaths per 10 000 high-risk women for both age groups combined. Among women with no identified high-risk conditions, estimated annual excess hospitalizations and deaths were 4 and 6 per 10 000 women aged 15 to 44 and 45 to 64 years, respectively. Conclusions Women younger than 65 years with certain chronic medical conditions experience substantial morbidity and mortality from acute cardiopulmonary events during influenza season. More effective targeting of these populations for annual influenza immunization is warranted.	Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; Vet Affairs Med Ctr, Seattle, WA 98108 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37212 USA; New England Res Inst, Watertown, MA 02172 USA	University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vanderbilt University; Vanderbilt University; HealthCore, Inc	Griffin, MR (corresponding author), Vanderbilt Univ, Dept Prevent Med, A-1124 Med Ctr N, Nashville, TN 37232 USA.	marie.griffin@mcmail.vanderbilt.edu						AHMED AEH, 1995, LANCET, V346, P591, DOI 10.1016/S0140-6736(95)91434-X; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; Armitage P., 2001, STAT METHODS MED RES; BARKER WH, 1980, AM J EPIDEMIOL, V112, P798, DOI 10.1093/oxfordjournals.aje.a113052; BARKER WH, 1986, AM J PUBLIC HEALTH, V76, P761, DOI 10.2105/AJPH.76.7.761; Bishop Y.M., 2007, DISCRETE MULTIVARIAT; BOUTER KP, 1991, DIABETES RES CLIN PR, V12, P61, DOI 10.1016/0168-8227(91)90131-V; *CDCP, 1994, VIT HLTH STAT, V10, P89; *CDCP, 1998, MMWR-MORBID MORTAL W, V47, P797; *EP INT SERV, 1998, 47 ANN EP INT SERV C; EVANS KD, 1995, PEDIATR INFECT DIS J, V14, P332, DOI 10.1097/00006454-199504000-00022; FALSEY AR, 1996, J INFECT DIS, V174, P456; Fisher RG, 1997, PEDIATRICS, V99, pE71, DOI 10.1542/peds.99.2.e7; FOX JP, 1982, AM J EPIDEMIOL, V116, P212, DOI 10.1093/oxfordjournals.aje.a113407; Glesby MJ, 1996, J INFECT DIS, V174, P1332, DOI 10.1093/infdis/174.6.1332; GLEZEN WP, 1987, AM REV RESPIR DIS, V136, P550, DOI 10.1164/ajrccm/136.3.550; HANCKOM WA, 1998, PEDIATR RES, P43; HOUSWORTH J, 1974, AM J EPIDEMIOL, V100, P40, DOI 10.1093/oxfordjournals.aje.a112007; MONTO AS, 1993, EPIDEMIOL INFECT, V110, P145, DOI 10.1017/S0950268800050779; *NAT CTR HLTH STAT, 1995, HLTH PEOPL 2000 MIDC; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; NICHOL KL, 1995, NEW ENGL J MED, V333, P889, DOI 10.1056/NEJM199510053331401; NICHOL KL, 1994, NEW ENGL J MED, V331, P778, DOI 10.1056/NEJM199409223311206; Osborne ML, 1996, CHEST, V110, P1458, DOI 10.1378/chest.110.6.1458; PERROTTA DM, 1985, AM J EPIDEMIOL, V122, P468, DOI 10.1093/oxfordjournals.aje.a114128; Piper J M, 1991, Paediatr Perinat Epidemiol, V5, P402, DOI 10.1111/j.1365-3016.1991.tb00726.x; RAY WA, 1989, AM J EPIDEMIOL, V129, P837, DOI 10.1093/oxfordjournals.aje.a115198; SAFRIN S, 1990, CHEST, V98, P33, DOI 10.1378/chest.98.1.33; Simonsen L, 1997, EPIDEMIOLOGY, V8, P390, DOI 10.1097/00001648-199707000-00007; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Teichtahl H, 1997, CHEST, V112, P591, DOI 10.1378/chest.112.3.591; THUM JR, 1989, CHEST, V95, P807; YERLY S, 1994, AIDS, V8, P1503, DOI 10.1097/00002030-199410000-00022	33	168	178	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	1999	281	10					901	907		10.1001/jama.281.10.901	http://dx.doi.org/10.1001/jama.281.10.901			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172XH	10078486				2022-12-28	WOS:000078950600034
J	Keating, NL; Cleary, PD; Rossi, AS; Zaslavsky, AM; Ayanian, JZ				Keating, NL; Cleary, PD; Rossi, AS; Zaslavsky, AM; Ayanian, JZ			Use of hormone replacement therapy by postmenopausal women in the United States	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	20th Annual Meeting of the Society-of-General-Internal-Medicine	MAY 01-03, 1997	WASHINGTON, D.C.	Soc Gen Internal Med		estrogen replacement therapy; demography; socioeconomic factors; educational status; hysterectomy	NUTRITION EXAMINATION SURVEY; CORONARY HEART-DISEASE; ESTROGEN REPLACEMENT; CARDIOVASCULAR-DISEASE; RANCHO-BERNARDO; NATIONAL-HEALTH; RISK; OSTEOPOROSIS; PROGESTIN; DETERMINANTS	Background: The benefits and risks of hormone replacement therapy (HRT) in postmenopausal women are not fully defined, and individual characteristics and preferences may influence decisions to use this therapy. Previous studies of postmenopausal women who use HRT have been conducted in local or highly selected cohorts or have not focused on current use. Objective: To examine sociodemographic, clinical, and psychological factors associated with current use of HRT in a national population-based cohort. Design: Random-digit telephone survey. Setting: Probability sample of U.S. households with a telephone. Participants: 495 postmenopausal women 50 to 74 years of age in 1995. Measurements: Current use of HRT. Results: Current use of HRT was reported by 37.6% of women (58.7% of those who underwent hysterectomy and 19.6% of those who did not undergo hysterectomy; P = 0.001). In multivariable analyses, use of HRT was more common among women in the South (adjusted odds ratio, 2.67 [95% CI, 1.08 to 6.59]) and West (odds ratio, 2.76 [CI, 1.01 to 7.53]) than the Northeast. Use was more common among college graduates (odds ratio, 3.72 [CI, 1.29 to 10.71]) and less common among women with diabetes mellitus (odds ratio, 0.17 [CI, 0.05 to 0.51]). Other cardiac risk factors and most psychological characteristics were not associated with HRT use. Conclusions: Sociodemographic factors, such as region and education, may be more strongly associated with use of HRT than clinical factors, such as risk for cardiovascular disease. Future efforts should focus on understanding sociodemographic variations, defining which women are most likely to benefit, and targeting therapy to them.	Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Univ Massachusetts, Amherst, MA 01003 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Massachusetts System; University of Massachusetts Amherst	Ayanian, JZ (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.		Cleary, Paul/AAF-7048-2019; Keating, Nancy L/I-9968-2019	Keating, Nancy L/0000-0002-8274-4681				[Anonymous], 1987, BRIT MED J, V295, P914; BARRETTCONNOR E, 1989, JAMA-J AM MED ASSOC, V261, P2095, DOI 10.1001/jama.261.14.2095; BARRETTCONNOR E, 1991, ANN INTERN MED, V115, P455, DOI 10.7326/0003-4819-115-6-455; BARRETTCONNOR EL, 1991, JAMA-J AM MED ASSOC, V265, P627, DOI 10.1001/jama.265.5.627; BARSKY AJ, 1988, PSYCHOSOM MED, V50, P510, DOI 10.1097/00006842-198809000-00007; BELCHETZ PE, 1994, NEW ENGL J MED, V330, P1062; Bem S. L., 1981, J PERS SOC PSYCHOL; Brett KM, 1997, AM J EPIDEMIOL, V145, P536; Brinton LA, 1997, NEW ENGL J MED, V336, P1821, DOI 10.1056/NEJM199706193362509; Bush TL, 1996, JAMA-J AM MED ASSOC, V276, P1389, DOI 10.1001/jama.276.17.1389; CAULEY JA, 1990, AM J OBSTET GYNECOL, V163, P1438, DOI 10.1016/0002-9378(90)90602-4; Col N. F., 1997, JGIM, V12, P60; Col NF, 1997, JAMA-J AM MED ASSOC, V277, P1140, DOI 10.1001/jama.277.14.1140; COLDITZ GA, 1995, NEW ENGL J MED, V332, P1589, DOI 10.1056/NEJM199506153322401; Connelly M. T., 1997, JGIM, V12, P126; DERBY CA, 1993, AM J EPIDEMIOL, V137, P1125, DOI 10.1093/oxfordjournals.aje.a116616; Dunn LB, 1997, ARCH DERMATOL, V133, P339, DOI 10.1001/archderm.133.3.339; EGELAND GM, 1991, PREV MED, V20, P343, DOI 10.1016/0091-7435(91)90033-Z; EGELAND GM, 1988, PREV MED, V17, P403, DOI 10.1016/0091-7435(88)90039-4; ETTINGER B, 1985, ANN INTERN MED, V102, P319, DOI 10.7326/0003-4819-102-3-319; Ford ES, 1998, J CLIN EPIDEMIOL, V51, P55, DOI 10.1016/S0895-4356(97)00225-4; FOWLER FJ, 1993, SURVEY RES METHODS, P40; FRANE J, 1989, SUDAAN PROFESSIONAL; Goldberg LR., 1992, PSYCHOL ASSESSMENT, V4, P26, DOI [10.1037/1040-3590.4.1.26, DOI 10.1037/1040-3590.4.1.26]; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; GRADY D, 1992, ANN INTERN MED, V117, P1038; GREENDALE GA, 1990, J GEN INTERN MED, V5, P464, DOI 10.1007/BF02600870; Grodstein F, 1996, AM J EPIDEMIOL, V143, P979; Grodstein F, 1996, NEW ENGL J MED, V335, P453, DOI 10.1056/NEJM199608153350701; Grodstein F, 1997, NEW ENGL J MED, V336, P1769, DOI 10.1056/NEJM199706193362501; Handa VL, 1996, J AM GERIATR SOC, V44, P1; HARRIS RB, 1990, AM J PUBLIC HEALTH, V80, P1266, DOI 10.2105/AJPH.80.10.1266; Heitjan DF, 1997, AM J PUBLIC HEALTH, V87, P548, DOI 10.2105/AJPH.87.4.548; HEMMINKI E, 1988, AM J PUBLIC HEALTH, V78, P1478, DOI 10.2105/AJPH.78.11.1479; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; John O. P., 1990, HDB PERSONALITY THEO; KJERULFF K, 1993, AM J PUBLIC HEALTH, V83, P106, DOI 10.2105/AJPH.83.1.106; LEAPE LL, 1992, ANNU REV PUBL HEALTH, V13, P363, DOI 10.1146/annurev.pu.13.050192.002051; Levy P., 1991, SAMPLING POPULATIONS; MANTEL N, 1959, J NATL CANCER I, V22, P719; Matthews KA, 1996, AM J EPIDEMIOL, V143, P971; Matthews KA, 1996, AM J EPIDEMIOL, V143, P983; McNagny SE, 1997, ANN INTERN MED, V127, P1093, DOI 10.7326/0003-4819-127-12-199712150-00007; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; NACHTIGALL LE, 1979, OBSTET GYNECOL, V53, P277; Newton KM, 1997, J WOMENS HEALTH, V6, P459, DOI 10.1089/jwh.1997.6.459; Persson I, 1997, J CLIN EPIDEMIOL, V50, P611, DOI 10.1016/S0895-4356(97)00004-8; POKRAS R, 1988, AM J PUBLIC HEALTH, V78, P852, DOI 10.2105/AJPH.78.7.852; RAVNIKAR VA, 1987, AM J OBSTET GYNECOL, V156, P1332, DOI 10.1016/0002-9378(87)90173-6; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; Rose G, 1982, CARDIOVASCULAR SURVE; Rossouw J E, 1995, J Am Med Womens Assoc (1972), V50, P50; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Rubin DB., 1978, P SURV RES METH SECT, P20, DOI DOI 10.1631/JZUS.C10B0359; SCALLEY EK, 1993, J WOMENS HEALTH, V2, P289; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Schneider DL, 1997, JAMA-J AM MED ASSOC, V277, P543, DOI 10.1001/jama.277.7.543; SCHWARTZ M, 1985, CLIN ORTHOP RELAT R, P180; Sidney S, 1997, ANN INTERN MED, V127, P501, DOI 10.7326/0003-4819-127-7-199710010-00001; SOLOMON CG, 1996, CIRCULATION S1, V94, P339; Stafford RS, 1997, AM J OBSTET GYNECOL, V177, P381, DOI 10.1016/S0002-9378(97)70202-3; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102; STAMPFER MJ, 1991, PREV MED, V20, P47, DOI 10.1016/0091-7435(91)90006-P; STANDEVEN M, 1986, AM J EPIDEMIOL, V124, P268, DOI 10.1093/oxfordjournals.aje.a114385; THORNBERRY TO, 1988, TELEPHONE SURVEY MET, P25; TRAPNELL PD, 1990, J PERS SOC PSYCHOL, V59, P781, DOI 10.1037/0022-3514.59.4.781; Wennberg J E, 1984, Health Manage Q, P6, DOI 10.1377/hlthaff.3.2.6; *WHO, 1996, COMP INT DIAGN INT 2; WYSOWSKI DK, 1995, OBSTET GYNECOL, V85, P6, DOI 10.1016/0029-7844(94)00339-F	69	266	277	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 6	1999	130	7					545	553		10.7326/0003-4819-130-7-199904060-00002	http://dx.doi.org/10.7326/0003-4819-130-7-199904060-00002			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	183BG	10189323				2022-12-28	WOS:000079533300001
J	Raitakari, OT; Adams, MR; McCredie, RJ; Griffiths, KA; Celermajer, DS				Raitakari, OT; Adams, MR; McCredie, RJ; Griffiths, KA; Celermajer, DS			Arterial endothelial dysfunction related to passive smoking is potentially reversible in healthy young adults	ANNALS OF INTERNAL MEDICINE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; CARDIOVASCULAR-DISEASE; HEART-DISEASE; RISK; ATHEROSCLEROSIS; CHOLESTEROL; DILATATION; MEN	Background: Passive smoking is associated with early arterial damage, but the potential for reversibility of this damage is unknown. objective: To assess the reversibility of arterial endothelial dysfunction, a key marker of early atherosclerosis. Design: Cross-sectional study. Setting: Academic medical center. Participants: 60 healthy persons 15 to 39 years of age: 20 with no exposure to active or passive smoking, 20 nonsmoking passive smokers (exposure to environmental tobacco smoke for greater than or equal to 1 hour per day for greater than or equal to 2 years), and 20 former passive smokers. Measurements: Arterial endothelial function measured by noninvasive ultrasonography. Results: Endothelium-dependent dilatation was significantly better in former passive smokers (5.1% +/- 4.1% [range, -1.2% to 15.6%]) than in current passive smokers (2.3% +/- 2.1% [range, -0.2% to 6.7%]) (P = 0.01), although both groups were significantly impaired compared with nonsmoking controls (8.9% +/- 3.2% [range, 2.1% to 16.7%]) (P less than or equal to 0.01 for both comparisons). Conclusions: In healthy young adults, arterial endothelial dysfunction related to passive smoking seems to be partially reversible.	Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW 2050, Australia; Heart Res Inst, Sydney, NSW, Australia; Univ Sydney, Sydney, NSW 2006, Australia; Univ Turku, Turku, Finland	University of Sydney; University of Sydney; Heart Research Institute; University of Sydney; University of Turku	Celermajer, DS (corresponding author), Royal Prince Alfred Hosp, Dept Cardiol, Missenden Rd, Sydney, NSW 2050, Australia.		Raitakari, Olli/AAQ-7389-2021					Brownson RC, 1997, ANNU REV PUBL HEALTH, V18, P163, DOI 10.1146/annurev.publhealth.18.1.163; CELERMAJER DS, 1993, CIRCULATION, V88, P2149, DOI 10.1161/01.CIR.88.5.2149; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Celermajer DS, 1997, J AM COLL CARDIOL, V30, P325, DOI 10.1016/S0735-1097(97)00189-7; Celermajer DS, 1996, NEW ENGL J MED, V334, P150, DOI 10.1056/NEJM199601183340303; DUTHIE GG, 1991, AM J CLIN NUTR, V53, pS1061, DOI 10.1093/ajcn/53.4.1061S; DWYER EM, 1989, NEW ENGL J MED, V321, P1474, DOI 10.1056/NEJM198911233212110; FEYERABEND C, 1990, J PHARM PHARMACOL, V42, P450, DOI 10.1111/j.2042-7158.1990.tb06592.x; GLANTZ SA, 1995, JAMA-J AM MED ASSOC, V273, P1047, DOI 10.1001/jama.273.13.1047; GLANTZ SA, 1991, CIRCULATION, V83, P1, DOI 10.1161/01.CIR.83.1.1; JOANNIDES R, 1995, CIRCULATION, V91, P1314, DOI 10.1161/01.CIR.91.5.1314; PENN A, 1993, CIRCULATION, V88, P1820, DOI 10.1161/01.CIR.88.4.1820; PIERCE JP, 1987, J CHRON DIS, V40, P689, DOI 10.1016/0021-9681(87)90105-6; ROSENBERG L, 1985, NEW ENGL J MED, V313, P1511, DOI 10.1056/NEJM198512123132404; SORENSEN KE, 1995, BRIT HEART J, V74, P247; Stefanadis C, 1998, ANN INTERN MED, V128, P426, DOI 10.7326/0003-4819-128-6-199803150-00002; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; TAYLOR AE, 1992, CIRCULATION, V86, P699, DOI 10.1161/01.CIR.86.2.699; ZHU BQ, 1993, J AM COLL CARDIOL, V21, P225, DOI 10.1016/0735-1097(93)90741-I	19	100	103	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 6	1999	130	7					578	581		10.7326/0003-4819-130-7-199904060-00017	http://dx.doi.org/10.7326/0003-4819-130-7-199904060-00017			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183BG	10189327				2022-12-28	WOS:000079533300005
J	Jozan, P; Forster, DP				Jozan, P; Forster, DP			Social inequalities and health: ecological study of mortality in Budapest, 1980-3 and 1990-3	BRITISH MEDICAL JOURNAL			English	Article									Hungarian Cent Stat Off, Populat & Hlth Stat Div, H-1525 Budapest 2, Hungary		Forster, DP (corresponding author), 11 Ashdale, Ponteland NE20 9DR, Northd, England.							BOYS RJ, 1991, BMJ-BRIT MED J, V303, P879, DOI 10.1136/bmj.303.6807.879; Carstairs V., 1991, DEPRIVATION HLTH SCO; Gardner M. J., 1989, STAT CONFIDENCE; LISITSYN Y, 1972, HLTH PROTECTION USSR; WHO World Health Organisation, 1985, TARG HLTH ALL	5	18	19	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 3	1999	318	7188					914	915		10.1136/bmj.318.7188.914	http://dx.doi.org/10.1136/bmj.318.7188.914			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185GV	10102855	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000079660500027
J	Whitehead, M; Drever, F				Whitehead, M; Drever, F			Short version 1 - Narrowing social inequalities in health? Analysis of trends in mortality among babies of lone mothers	BRITISH MEDICAL JOURNAL			English	Article							ACCIDENTS; CHILDREN	Objectives To examine trends in mortality among babies registered solely by their mother (lone mothers) and to compare these with trends in infant mortality for couple registrations overall and couple registrations subdivided by social class of father. Design Analysis of trends in infant death rates from 1975 to 1996 for the three groups. The data source was the national linked infant mortality file, containing all records of infant death in England and Wales linked to the respective birth records. Setting England and Wales. Participants All live births (n = 14.3 million) from 1975 to 1996; all deaths of infants from birth to 12 months of age over the same period (n = 135 800), Main outcome measures Death rates in the perinatal, neonatal, and postneonatal periods and for infancy overall. Results For the babies of lone mothers infant mortality has fallen to less than a third of the 1975 level, with a clear reduction in the gap between the mortality in these babies compared with all couple registrations: the excess mortality in solely registered births was 79% in 1975 reducing to 33% in 1996, Most of the narrowing of the sole-couple differential was associated with the neonatal period, for which there is now no appreciable gap. For couple registrations analysed by social class of father, infant death rates have more than halved in each social class from 1975 to 1996. The reductions in mortality were greater in the late 1970s and early 1990s, Infant death rates in classes I-V remained between 50% and 65% higher than in classes I-II. Differentials between social classes were largest in the postneonatal period and smallest in the perinatal and neonatal periods. The gap in perinatal and neonatal mortality between the babies of lone mothers and couple parents in social classes IV-V has disappeared. Conclusions The differential in infant mortality between social classes still exists, whereas the differential between sole and couple registrations has decreased, showing positive progress in the reduction of inequalities. As die reduction in the differential was confined to the neonatal period these improvements may be more a reflection of healthcare factors than of factors associated with lone mothers' social and economic circumstances.	Kings Fund, Policy & Dev Div, London W1M 0AN, England; Off Natl Stat, Social & Reg Div, London SW1V 2QQ, England		Whitehead, M (corresponding author), Old Sch, Ash Magna, Whitchurch SY13 4DR, Shrops, England.							BABB P, 1995, POPUL TRENDS, V81, P17; BRADSHAW J, 1998, PRIVATE LIVES PUBLIC; BRESLOW NE, 1985, BIOSTATISTICS STAT B; *DEP HLTH, 1997, 4 DEP HLTH; Howell DC, 1982, STAT METHODS PSYCHOL; LEON DA, 1992, BMJ-BRIT MED J, V305, P687, DOI 10.1136/bmj.305.6855.687; MACFARLANE A, 1980, BIRTH COUNTS STAT PR; *OFF NAT STAT, 1997, BIRTH STAT 1995 FMI, V27; *OFF NAT STAT, 1998, MORT STAT CHILD DH3; *OFF NAT STAT, 1998, BIRTH STAT 1996 FM1, V25; *OFF POP CENS SURV, 1987, BIRTH STAT HIST FM1, V13; Office of Population Censuses and Surveys, 1991, STAND OCC CLASS, V3; PHAROAH P O D, 1990, Archives of Disease in Childhood, V65, P147; PHAROAH POD, 1982, STUDIES MED POPULATI, V45; ROBERTS I, 1995, BRIT MED J, V311, P925; Shouls S., 1999, POPUL TRENDS, V95, P5; Spencer N, 1996, POVERTY CHILD HLTH; WADSWORTH J, 1983, J EPIDEMIOL COMMUN H, V37, P100, DOI 10.1136/jech.37.2.100	18	28	28	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 3	1999	318	7188					908	912		10.1136/bmj.318.7188.908	http://dx.doi.org/10.1136/bmj.318.7188.908			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185GV	10102853	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000079660500025
J	Hjorth, J; Bjornsson, G; Andersen, MI; Caon, N; Cairos, LM; Castro-Tirado, AJ; Osorio, MRZ; Pedersen, H; Costa, E				Hjorth, J; Bjornsson, G; Andersen, MI; Caon, N; Cairos, LM; Castro-Tirado, AJ; Osorio, MRZ; Pedersen, H; Costa, E			Polarimetric constraints on the optical afterglow emission from GRB 990123	SCIENCE			English	Article							SHOCKED RELATIVISTIC JETS; SYNCHROTRON EMISSION; GRAVITATIONAL LENS; BL-LACERTAE; POLARIZATION; ROTATION	Polarization of the optical emission from GRB 990123 was measured on 24.17 January 1999 universal time with the Nordic Optical Telescope. An upper Limit of 2.3% on the Linear polarization was found. Accurate polarization measurements provide important clues to the blast wave geometry and magnetic field structure of gamma-ray bursts (GRBs). The lack of detectable polarization for GRB 990123 indicates that the optical afterglow was produced by a blast wave of unknown geometry with an insignificant coherent magnetic field or by a beamed outflow at high Lorentz factor seen at a small viewing angle. Such a collimated jet would help solve the problem of energy release in this exceptionally luminous cosmological burst.	Univ Copenhagen, Astron Observ, DK-2100 Copenhagen O, Denmark; Univ Iceland, Inst Sci, IS-107 Reykjavik, Iceland; Nord Opt Telescope, E-38700 Canarias, Spain; Inst Astrofis Canarias, E-38200 Tenerife, Spain; Inst Nacl Tecn Aeroespacial, Lab Astrofis Espacial & Fis Fundamental, E-28080 Madrid, Spain; CSIC, Inst Astrofis Andalucia, E-18080 Granada, Spain; CNR, Ist Astrofis Spaziale, I-00133 Rome, Italy	University of Copenhagen; University of Iceland; Instituto de Astrofisica de Canarias; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale Astrofisica (INAF)	Hjorth, J (corresponding author), Univ Copenhagen, Astron Observ, Juliane Maries Vej 30, DK-2100 Copenhagen O, Denmark.	jens@astro.ku.dk	Caon, Nicola/B-5113-2008; Andersen, Michael/H-6403-2018; Hjorth, Jens/M-5787-2014; Zapatero Osorio, Maria Rosa/C-2744-2017	Caon, Nicola/0000-0002-1653-5806; Hjorth, Jens/0000-0002-4571-2306; Zapatero Osorio, Maria Rosa/0000-0001-5664-2852; Bjornsson, Gunnlaugur/0000-0003-1800-6382; Costa, Enrico/0000-0003-4925-8523; Castro-Tirado, A. J./0000-0003-2999-3563				AKERLOF CW, 1999, 7100 IAU; AKERLOF CW, 1999, 205 GCN; AKERLOF CW, IN PRESS NATURE; Andersen MI, 1999, SCIENCE, V283, P2075, DOI 10.1126/science.283.5410.2075; BLOOM JS, ASTROPH9902182; BROWN JC, 1977, ASTRON ASTROPHYS, V57, P141; Castro-Tirado AJ, 1999, SCIENCE, V283, P2069, DOI 10.1126/science.283.5410.2069; CELOTTI A, 1994, MON NOT R ASTRON SOC, V268, P451, DOI 10.1093/mnras/268.2.451; CHUGAI NN, 1992, SOV ASTRON LETT+, V18, P168; Dar A, 1998, ASTROPHYS J, V500, pL93, DOI 10.1086/311401; DJORGOVSKI SG, 1999, 216 GCN; DYER CC, 1992, ASTROPHYS J, V390, pL5, DOI 10.1086/186358; Fan JH, 1997, ASTRON ASTROPHYS, V327, P947; FARAONI V, 1993, ASTRON ASTROPHYS, V272, P385; FARGION D, ASTROPH9808005; FRAIL DA, 1998, 141 GCN; Fruchter AS, 1999, ASTROPHYS J, V512, pL1, DOI 10.1086/311864; FRUCHTER AS, ASTROPH9902236; GALAMA TJ, ASTROPH9903021; Gruzinov A, 1999, ASTROPHYS J, V511, P852, DOI 10.1086/306720; HEISE J, UNPUB; HOLLAND S, ASTROPH9903175; HUGHES PA, 1989, ASTROPHYS J, V341, P54, DOI 10.1086/167471; HUGHES PA, 1989, ASTROPHYS J, V341, P68, DOI 10.1086/167472; KULKARNI SR, ASTROPH9902272; Meszaros P, 1997, ASTROPHYS J, V476, P232, DOI 10.1086/303625; MESZAROS P, ASTROPH9808106; MESZAROS P, ASTROPH9902196; MIRABEL IF, IN PRESS ANN REV AST; NILAKSHI RKS, IN PRESS B ASTRON SO; ODEWAHN SC, 1999, 7094 IAU; PIRAN T, IN PRESS PHYS REP; RHOADS JE, UNPUB; Sari R, 1998, ASTROPHYS J, V497, pL17, DOI 10.1086/311269; SARI R, ASTROPH9902009; SARI R, ASTROPH9901338; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; SERKOWSKI K, 1975, ASTROPHYS J, V196, P261, DOI 10.1086/153410; STETSON PB, 1994, PUBL ASTRON SOC PAC, V106, P250, DOI 10.1086/133378; Taylor GB, 1998, ASTROPHYS J, V502, pL115, DOI 10.1086/311513; TRAMMELL SR, 1993, ASTROPHYS J, V414, pL21, DOI 10.1086/186986; WARDLE JFC, 1974, ASTROPHYS J, V194, P249, DOI 10.1086/153240; YADIGAROGLU IA, 1999, 248 GCN	44	51	52	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	1999	283	5410					2073	2075		10.1126/science.283.5410.2073	http://dx.doi.org/10.1126/science.283.5410.2073			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180DH	10092227				2022-12-28	WOS:000079369800042
J	Sanford, E				Sanford, E			Regulation of keystone predation by small changes in ocean temperature	SCIENCE			English	Article							INTERACTION STRENGTH; CALIFORNIA CURRENT; CLIMATE-CHANGE	Key species interactions that are sensitive to temperature may act as Leverage points through which small changes in climate could generate Large changes in natural communities. Field and laboratory experiments showed that a slight decrease in water temperature dramatically reduced the effects of a keystone predator. the sea star Pisaster ochraceus, on its principal prey. Ongoing changes in patterns of cold water upwelling, associated with El Nino events and Longer term geophysical changes. may thus have far-reaching impacts on the composition and diversity of these rocky intertidal communities.	Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA	Oregon State University	Sanford, E (corresponding author), Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA.							BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; BELL EC, 1994, J EXP MAR BIOL ECOL, V181, P9; LUBCHENCO J, 1991, ECOLOGY, V72, P371, DOI 10.2307/2937183; MAUZEY KP, 1966, BIOL BULL-US, V131, P127, DOI 10.2307/1539653; McGowan JA, 1998, SCIENCE, V281, P210, DOI 10.1126/science.281.5374.210; Menge BA, 1997, P NATL ACAD SCI USA, V94, P14530, DOI 10.1073/pnas.94.26.14530; MENGE BA, 1994, ECOL MONOGR, V64, P249, DOI 10.2307/2937163; Navarrete SA, 1996, ECOL MONOGR, V66, P409, DOI 10.2307/2963488; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PAINE RT, 1992, NATURE, V355, P73, DOI 10.1038/355073a0; Parmesan C, 1996, NATURE, V382, P765, DOI 10.1038/382765a0; Peters R. L., 1992, GLOBAL WARMING BIOL; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; SANFORD E, UNPUB; Schwing FB, 1997, J GEOPHYS RES-OCEANS, V102, P3421, DOI 10.1029/96JC03591; Trenberth KE, 1997, GEOPHYS RES LETT, V24, P3057, DOI 10.1029/97GL03092	17	377	387	22	222	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	1999	283	5410					2095	2097		10.1126/science.283.5410.2095	http://dx.doi.org/10.1126/science.283.5410.2095			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180DH	10092235				2022-12-28	WOS:000079369800050
J	Patton, GC; Selzer, R; Coffey, C; Carlin, JB; Wolfe, R				Patton, GC; Selzer, R; Coffey, C; Carlin, JB; Wolfe, R			Onset of adolescent eating disorders: population based cohort study over 3 years	BRITISH MEDICAL JOURNAL			English	Article							ANOREXIA-NERVOSA; BULIMIA-NERVOSA; RISK-FACTORS	Objective To study the predictors of new eating disorders in an adolescent cohort. Design Cohort study over 3 years with six waves. Subjects Students, initially aged 14-15 years, from 44 secondary schools in the state of Victoria, Australia. Outcome measures Weight (kg), height (cm), dieting (adolescent dieting scale), psychiatric morbidity (revised clinical interview schedule), and eating disorder (branched eating disorders test). Eating disorder (partial syndrome) was defined when a subject met two criteria for either anorexia nervosa or bulimia nervosa according to the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV). Results At the start of the study, 3.3% (29/888) of female subjects and 0.3% (2/811) of male subjects had partial syndromes of eating disorders. The rate of development of new eating disorder per 1000 person years of observation was 21.8 in female subjects and 6.0 in male subjects. Female subjects who dieted at a severe level were 18 times more likely to develop an eating disorder than those who did not diet, and female subjects who dieted at a moderate level were five times more likely to develop an eating disorder than those who did not diet. Psychiatric morbidity predicted the onset of eating disorder independently of dieting status so that those subjects in the highest morbidity category had an almost sevenfold increased risk of developing an eating disorder. After adjustment for earlier dieting and psychiatric morbidity, body mass index, extent of exercise, and sex were not predictive of new eating disorders. Conclusions Dieting is the most important predictor of new eating disorders. Differences in the incidence of eating disorders between sexes were largely accounted for by the high rates of earlier dieting and psychiatric morbidity in the female subjects. In adolescents, controlling weight by exercise rather than diet restriction seems to carry less risk of development of eating disorders.	Univ Melbourne, Dept Paediat, Ctr Adolescent Hlth, Parkville, Vic 3052, Australia; Royal Childrens Hosp, Res Inst, Parkville, Vic 3052, Australia	University of Melbourne; Royal Children's Hospital Melbourne	Patton, GC (corresponding author), Univ Melbourne, Dept Paediat, Ctr Adolescent Hlth, Parkville, Vic 3052, Australia.	patton@cryptic.rch.unimelb.edu.au	charrat, jean philippe/ABF-3898-2020; Carlin, John/AAG-4332-2020; Carlin, John B/B-3492-2012; Patton, George C/B-5246-2013; Zamora, Cristina Cuesta/E-2864-2016; Ribeiro, Ana Cristina/HHN-7466-2022	Carlin, John/0000-0002-2694-9463; Carlin, John B/0000-0002-2694-9463; Patton, George C/0000-0001-5039-8326; Zamora, Cristina Cuesta/0000-0003-1121-9561; Ribeiro, Ana Cristina/0000-0002-0493-8376; Wolfe, Rory/0000-0002-2126-1045				American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; *AUSTR BUR STAT, 1993, AUSTR YOUNG PEOPL; CARLIN JB, 1999, IN PRESS STAT MED; Fairburn CG, 1997, ARCH GEN PSYCHIAT, V54, P509; FRENCH SA, 1994, J ADOLESCENT HEALTH, V15, P286, DOI 10.1016/1054-139X(94)90601-7; GIDDING SS, 1995, J PEDIATR-US, V127, P868, DOI 10.1016/S0022-3476(95)70020-X; Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11; Hsu LKG, 1997, PSYCHOL MED, V27, P509, DOI 10.1017/S0033291797004753; JOHNSONSABINE E, 1988, PSYCHOL MED, V18, P615, DOI 10.1017/S0033291700008291; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; KENDLER KS, 1991, AM J PSYCHIAT, V148, P1627; KING MB, 1987, PSYCHOL MED, V17, P249, DOI 10.1017/S0033291700013131; LEON GR, 1991, SPORTS MED, V12, P219, DOI 10.2165/00007256-199112040-00001; LEWIS G, 1988, PSYCHOL MED, V18, P737, DOI 10.1017/S0033291700008448; Lewis G., 1992, MANUAL CIS R; PAPERNY DM, 1990, J PEDIATR-US, V116, P456, DOI 10.1016/S0022-3476(05)82844-6; Patton GC, 1997, J CHILD PSYCHOL PSYC, V38, P299, DOI 10.1111/j.1469-7610.1997.tb01514.x; PATTON GC, 1990, PSYCHOL MED, V20, P382; RASTAM M, 1989, BRIT J PSYCHIAT, V155, P642; Selzer R, 1996, INT J EAT DISORDER, V20, P57, DOI 10.1002/(SICI)1098-108X(199607)20:1&lt;57::AID-EAT7&gt;3.0.CO;2-3; WALTERS EE, 1995, AM J PSYCHIAT, V152, P64	21	402	423	0	51	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 20	1999	318	7186					765	768		10.1136/bmj.318.7186.765	http://dx.doi.org/10.1136/bmj.318.7186.765			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	181BX	10082698	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000079421700023
J	Carpenter, AF; Georgopoulos, AP; Pellizzer, G				Carpenter, AF; Georgopoulos, AP; Pellizzer, G			Motor cortical encoding of serial order in a context-recall task	SCIENCE			English	Article							PREFRONTAL CORTEX; MONKEY; MEMORY; VISUOMOTOR; MOVEMENTS; DIRECTION	The neural encoding of serial order was studied in the motor cortex of monkeys performing a context-recall memory scanning task. Up to five visual stimuli were presented successively on a circle (List presentation phase), and then one of them (test stimulus) changed color; the monkeys had to make a single motor response toward the stimulus that immediately followed the test stimulus in the List. Correct performance in this task depends on memorization of the serial order of the stimuli during their presentation. It was found that changes in neural activity during the list presentation phase reflected the serial order of the stimuli; the effect on cell activity of the serial order of stimuli during their presentation was at Least as strong as the effect of motor direction on cell activity during the execution of the mot or response. This establishes the serial order of stimuli in a motor task as an important determinant of motor cortical activity during stimulus presentation and in the absence of changes in peripheral motor events, in contrast to the commonly held view of the motor cortex as just an "upper motor neuron."	Vet Affairs Med Ctr, Brain Sci Ctr, Minneapolis, MN 55417 USA; Univ Minnesota, Ctr Cognit Sci, Minneapolis, MN 55455 USA; Univ Minnesota, Grad Program Neurosci, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Physiol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Georgopoulos, AP (corresponding author), Vet Affairs Med Ctr, Brain Sci Ctr, Minneapolis, MN 55417 USA.		Pellizzer, Giuseppe/B-7540-2017	Pellizzer, Giuseppe/0000-0002-9254-5555	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017413] Funding Source: NIH RePORTER; NINDS NIH HHS [NS17413] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARONE P, 1989, EXP BRAIN RES, V78, P447; Beiser DG, 1998, J NEUROPHYSIOL, V79, P3168, DOI 10.1152/jn.1998.79.6.3168; Carpenter A. F., 1998, Society for Neuroscience Abstracts, V24, P1426; Cox DR, 1966, STAT ANAL SERIES EVE; FUCHS AF, 1966, J APPL PHYSIOL, V21, P1068, DOI 10.1152/jappl.1966.21.3.1068; FUNAHASHI S, 1993, NEUROSCI RES, V18, P171, DOI 10.1016/0168-0102(93)90019-M; GEORGOPOULOS AP, 1991, EXP BRAIN RES, V83, P453; GEORGOPOULOS AP, 1991, ANNU REV NEUROSCI, V14, P361, DOI 10.1146/annurev.ne.14.030191.002045; GEORGOPOULOS AP, 1993, SCIENCE, V260, P47, DOI 10.1126/science.8465199; Goldman-Rakic P S, 1992, Curr Opin Neurobiol, V2, P830, DOI 10.1016/0959-4388(92)90141-7; HOUK JC, 1995, CEREB CORTEX, V5, P95, DOI 10.1093/cercor/5.2.95; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KERMADI I, 1995, J NEUROPHYSIOL, V74, P911, DOI 10.1152/jn.1995.74.3.911; Kettner RE, 1996, EXP BRAIN RES, V112, P347, DOI 10.1007/BF00227941; LACHENBRUCH PA, 1975, DISCRIMINANT ANAL; Lashley K., 1951, CEREBRAL MECH BEHAV, P112, DOI DOI 10.1093/RFS/HHQ153; Lee D, 1998, NEURONAL ENSEMBLES: STRATEGIES FOR RECORDING AND DECODING, P117; MILLER EK, 1993, J NEUROSCI, V13, P1460; MILNER B, 1985, HUM NEUROBIOL, V4, P137; MOUNTCASTLE VB, 1991, J NEUROSCI METH, V36, P77, DOI 10.1016/0165-0270(91)90140-U; MUSHIAKE H, 1991, J NEUROPHYSIOL, V66, P705, DOI 10.1152/jn.1991.66.3.705; MUSHIAKE H, 1995, J NEUROPHYSIOL, V74, P2784; PELLIZZER G, 1993, EXP BRAIN RES, V93, P165; PELLIZZER G, 1995, SCIENCE, V269, P702, DOI 10.1126/science.7624802; SCHWARTZ AB, 1988, J NEUROSCI, V8, P2913; Snedecor G.W., 1989, AMES IOWA STATE U PR; STERNBERG S, 1969, AM SCI, V57, P421; Sternberg S., 1967, PSYCHON SCI, V5, P55, DOI DOI 10.3758/BF03330664; Taira M, 1996, EXP BRAIN RES, V109, P367; TUKEY JW, 1977, EXPLORATORY DATA ANA, P543	30	144	147	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	1999	283	5408					1752	1757		10.1126/science.283.5408.1752	http://dx.doi.org/10.1126/science.283.5408.1752			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175PF	10073944				2022-12-28	WOS:000079102800057
J	Stocker, K; Waitzkin, H; Iriart, C				Stocker, K; Waitzkin, H; Iriart, C			The exportation of managed care to Latin America	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH; MEDICAID; COMPETITION		Univ New Mexico, Div Community Med, Dept Family & Community Med, Albuquerque, NM 87131 USA; Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; Univ Buenos Aires, Fac Social Sci, Buenos Aires, DF, Argentina	University of New Mexico; University of New Mexico; University of Buenos Aires	Waitzkin, H (corresponding author), Univ New Mexico, Div Community Med, Dept Family & Community Med, 2400 Tucker Ave NE, Albuquerque, NM 87131 USA.				AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS009703] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [F06TW001982] Funding Source: NIH RePORTER; AHRQ HHS [1R01 HS09703] Funding Source: Medline; FIC NIH HHS [TW01982] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		*ALAMES, 1998, ALAMES B INF, V11, P3; *AS GREM ISAPRES C, 1996, ISAPRES HAC MOD SAL; *ASS COL SAL, 1997, NEWSLETTER INT CLEAR, P4; Azevedo D, 1996, Med Econ, V73, P71; Bodenheimer T, 1996, NEW ENGL J MED, V335, P1601, DOI 10.1056/NEJM199611213352112; Buchanan JL, 1996, MED CARE, V34, P249, DOI 10.1097/00005650-199603000-00005; Carrasquillo O, 1998, AM J PUBLIC HEALTH, V88, P464, DOI 10.2105/AJPH.88.3.464; CENICEROS R, 1997, BUSINESS INSURA 1006, P6; CENICEROS R, 1997, BUSINESS INSURA 1006, P3; *EC COMM LAT AM CA, 1997, TOT GROSS DOM PROD; ESTRADA A, 1998, ATENCION GERENCIADA; FeltLisk S, 1997, HEALTH AFFAIR, V16, P125, DOI 10.1377/hlthaff.16.5.125; *FUENT EMPR EXXEL, 1997, REV NOT ED PERF, P8; Ginzberg E, 1997, NEW ENGL J MED, V336, P1018, DOI 10.1056/NEJM199704033361411; GLASER WA, 1993, LANCET, V341, P805, DOI 10.1016/0140-6736(93)90572-X; Guitian M., 1992, PAMPHLET SERIES, V46; HIDALGO F, 1997, REFORMA SALUD PRIVAD; *INT DEV BANK, 1997, AM DEC REF EC SOC PR; *INT DEV BANK, 1997, REP EC SOC PROGR; IRIART C, 1997, REFORMA SALUD PRIVAD; IRIART C, 1998, ATENCION GERENCIADA; IRIART C, 1995, CUADERNOS MED SOCIAL, V70, P5; IRIART C, 1995, EVALUACION HOSP ESTA; Jacobs A, 1998, J HEALTH POLIT POLIC, V23, P1; KERTESZ L, 1997, MODERN HEALTHCAR NOV; Kuttner R, 1998, NEW ENGL J MED, V338, P1558, DOI 10.1056/NEJM199805213382123; Laurell AC, 1996, INT J HEALTH SERV, V26, P1, DOI 10.2190/PBX9-N89E-4QFE-046V; LEWIS JC, 1996, 8 C ASS LAT AM PREP; LIGHT DW, 1997, COMPETITIVE MANAGED, P322; MCAFFEE K, 1991, STORM SIGNALS STRUCT; Moseley Fred, 1991, FALLING RATE PROFIT; OSTERMILLER M, 1998, BESTS REV, V98, P63; *PAN AM HLTH ORG, 1995, HSPSILOS40 PAN AM HL; ROMAN O, 1997, CUADERNOS MED SOCIAL, V38, P13; SCMITT F, 1997, NATL UNDERWRITER, V101, P57; Smith TH, 1997, ELEC SOC S, V97, P11; TANGEMAN M, 1997, I INVESTOR, V31, P69; VERDERA F, 1992, SCOT J POLIT ECON, V39, P100, DOI 10.1111/j.1467-9485.1992.tb00608.x; WAITZKIN H, 1994, AM J PUBLIC HEALTH, V84, P482, DOI 10.2105/AJPH.84.3.482-a; WELSH J, 1995, WORLD TRADE, V8, P24; *WORLD BANK, 1993, WORLD DEV REP 1993 I; 1996, LATIN FINANCE, V83, P55; 1997, FINANCIAL TIMES 0910, P40	43	87	95	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 8	1999	340	14					1131	1136		10.1056/NEJM199904083401425	http://dx.doi.org/10.1056/NEJM199904083401425			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	184AK	10194246				2022-12-28	WOS:000079587000030
J	Humphreys, W				Humphreys, W			Lesson of the week - The painful red foot - inflammation or ischaemia?	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Dept Vasc Surg, Bangor LL37 2PW, Gwynedd, Wales		Humphreys, W (corresponding author), Dept Vasc Surg, Bangor LL37 2PW, Gwynedd, Wales.	381944@msn.com						BOYLCO EJ, 1997, J CLIN EPIDEMIOL, V50, P659; BREARLEY S, 1992, ANN ROY COLL SURG, V74, P169; CLEMENT DL, 1980, ANGIOLOGY, V31, P272, DOI 10.1177/000331978003100407; HARRIS PL, 1995, EUR J VASC ENDOVASC, V10, P108; McGee SR, 1998, ARCH INTERN MED, V158, P1357, DOI 10.1001/archinte.158.12.1357; Stoffers HEJH, 1997, MED DECIS MAKING, V17, P61, DOI 10.1177/0272989X9701700107; 1998, J MDU, V14, P15	7	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	1999	318	7188					925	926		10.1136/bmj.318.7188.925	http://dx.doi.org/10.1136/bmj.318.7188.925			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185GV	10102862	Green Published			2022-12-28	WOS:000079660500031
J	Weng, GZ; Bhalla, US; Iyengar, R				Weng, GZ; Bhalla, US; Iyengar, R			Complexity in biological signaling systems	SCIENCE			English	Editorial Material							SIMPLE 2-STATE MODEL; CYCLASE; ULTRASENSITIVITY; TRANSDUCTION; TRANSIENT; RECEPTOR; PROTEINS; TERMS	Biological signaling pathways interact with one another to form complex networks. Complexity arises from the Large number of components, many with isoforms that have partially overlapping functions; from the connections among components; and from the spatial relationship between components. The origins of the complex behavior of signaling networks and analytical approaches to deal with the emergent complexity are discussed here.	CUNY Mt Sinai Sch Med, Dept Pharmacol, New York, NY 10029 USA; Univ Agr Sci Bangalore, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Agricultural Sciences Bangalore	Iyengar, R (corresponding author), CUNY Mt Sinai Sch Med, Dept Pharmacol, Box 1215, New York, NY 10029 USA.		Han, Liqi/K-6127-2013		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054508] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM054508, GM-54508] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALEX LA, 1994, TRENDS GENET, V10, P133, DOI 10.1016/0168-9525(94)90215-1; Amundson J, 1993, Curr Opin Neurobiol, V3, P375, DOI 10.1016/0959-4388(93)90131-H; ANGLISTER L, 1994, NEURON, V12, P783, DOI 10.1016/0896-6273(94)90331-X; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; BHALLA US, 1998, BOOK GENESIS EXPLORI; BIRNBAUMER L, 1980, J BIOL CHEM, V255, P3542; BIRNBAUMER L, 1980, J BIOL CHEM, V255, P3552; BLACK JW, 1986, BRIT J PHARMACOL, V89, P547, DOI 10.1111/j.1476-5381.1986.tb11155.x; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BRAUN S, 1979, BIOCHEMISTRY-US, V18, P2134, DOI 10.1021/bi00577a045; BRAY D, 1995, NATURE, V378, P419, DOI 10.1038/378419e0; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Faux MC, 1996, CELL, V85, P9, DOI 10.1016/S0092-8674(00)81075-2; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; IYENGAR R, 1980, J BIOL CHEM, V255, P3558; LAPORTE DC, 1984, J BIOL CHEM, V259, P4068; Leadlay PF, 1997, CURR OPIN CHEM BIOL, V1, P162, DOI 10.1016/S1367-5931(97)80005-1; Marder E, 1996, NATURE, V384, P113, DOI 10.1038/384113a0; MCADAMS HH, 1995, SCIENCE, V269, P650, DOI 10.1126/science.7624793; MEYER T, 1990, P NATL ACAD SCI USA, V87, P3841, DOI 10.1073/pnas.87.10.3841; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; Segel IH, 1975, ENZYME KINETICS BEHA; Stiles JR, 1996, P NATL ACAD SCI USA, V93, P5747, DOI 10.1073/pnas.93.12.5747; TANG YH, 1995, PHILOS T ROY SOC B, V349, P179, DOI 10.1098/rstb.1995.0102; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671	29	443	481	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 2	1999	284	5411					92	96		10.1126/science.284.5411.92	http://dx.doi.org/10.1126/science.284.5411.92			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182QE	10102825	Green Accepted			2022-12-28	WOS:000079509000038
J	Farfel, Z; Bourne, HR; Iiri, T				Farfel, Z; Bourne, HR; Iiri, T			The expanding spectrum of G protein diseases	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MCCUNE-ALBRIGHT SYNDROME; HETEROTRIMERIC G-PROTEIN; STIMULATORY G-PROTEIN; G-ALPHA-Q; CRYSTAL-STRUCTURE; HEREDITARY OSTEODYSTROPHY; ACTIVATING MUTATIONS; ADENYLYL-CYCLASE; RECEPTOR; PSEUDOHYPOPARATHYROIDISM		Univ Tokyo, Sch Med, Dept Internal Med 4, Bunkyo Ku, Tokyo 112, Japan; Tel Aviv Univ, Chaim Sheba Med Ctr, Dept Med E, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, Chaim Sheba Med Ctr, Biochem Pharmacol Lab, IL-52621 Tel Hashomer, Israel; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of Tokyo; Chaim Sheba Medical Center; Tel Aviv University; Chaim Sheba Medical Center; Tel Aviv University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Iiri, T (corresponding author), Univ Tokyo, Sch Med, Dept Internal Med 4, Bunkyo Ku, 3-28-6 Mejirodai, Tokyo 112, Japan.	tiiri-tky@umin.ac.jp						Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Bourne HR, 1997, NATURE, V389, P673, DOI 10.1038/39470; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; DAngelo DD, 1997, P NATL ACAD SCI USA, V94, P8121, DOI 10.1073/pnas.94.15.8121; DAVIES SJ, 1993, J MED GENET, V30, P101, DOI 10.1136/jmg.30.2.101; Dhanasekaran N., 1995, Endocrine Reviews, V16, P259; Dryja TP, 1996, NAT GENET, V13, P358, DOI 10.1038/ng0796-358; FARFEL Z, 1980, NEW ENGL J MED, V303, P237, DOI 10.1056/NEJM198007313030501; FARFEL Z, 1982, MINER ELECTROL METAB, V8, P227; Farfel Z, 1996, J BIOL CHEM, V271, P19653, DOI 10.1074/jbc.271.33.19653; FARFEL Z, 1981, P NATL ACAD SCI-BIOL, V78, P3098, DOI 10.1073/pnas.78.5.3098; Goldstein J, 1995, FAMILIAL HYPERCHOLES, P1981; Hall JG, 1997, ANNU REV MED, V48, P35; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; HAPPLE R, 1986, CLIN GENET, V29, P321; Iiri T, 1997, P NATL ACAD SCI USA, V94, P5656, DOI 10.1073/pnas.94.11.5656; Iiri T, 1998, NATURE, V394, P35, DOI 10.1038/27831; IIRI T, 1994, NATURE, V371, P164, DOI 10.1038/371164a0; Iiri T, 1998, NAT GENET, V18, P8, DOI 10.1038/ng0198-8; Iwase M, 1997, AM J PHYSIOL-HEART C, V272, pH585, DOI 10.1152/ajpheart.1997.272.1.H585; Jiang MS, 1998, P NATL ACAD SCI USA, V95, P3269, DOI 10.1073/pnas.95.6.3269; Juppner H, 1998, P NATL ACAD SCI USA, V95, P11798, DOI 10.1073/pnas.95.20.11798; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LATHAM KE, 1995, INT REV CYTOL, V160, P53, DOI 10.1016/S0074-7696(08)61553-3; LEVINE MA, 1980, BIOCHEM BIOPH RES CO, V94, P1319, DOI 10.1016/0006-291X(80)90563-X; LEVINE MA, 1995, ENDOCRNOILOGY, V2, P1136; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; MERRITT EA, 1995, CURR OPIN STRUC BIOL, V5, P165, DOI 10.1016/0959-440X(95)80071-9; MICHIELS FM, 1994, P NATL ACAD SCI USA, V91, P10488, DOI 10.1073/pnas.91.22.10488; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Offermanns S, 1997, P NATL ACAD SCI USA, V94, P14089, DOI 10.1073/pnas.94.25.14089; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; POLLAK MR, 1993, CELL, V75, P1297, DOI 10.1016/0092-8674(93)90617-Y; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; SCHWINDINGER WF, 1994, J BIOL CHEM, V269, P25387; SHAPIRO MS, 1980, J CLIN ENDOCR METAB, V51, P483, DOI 10.1210/jcem-51-3-483; Sharp GWG, 1971, NATURE, V229, P266, DOI 10.1038/229266a0; SHENKER A, 1993, J PEDIATR-US, V123, P509, DOI 10.1016/S0022-3476(05)80943-6; SHENKER A, 1993, NATURE, V365, P652, DOI 10.1038/365652a0; SIFFERT W, 1995, J CLIN INVEST, V96, P759, DOI 10.1172/JCI118120; Siffert W, 1998, NAT GENET, V18, P45, DOI 10.1038/ng0198-45; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Spiegel AM, 1997, HORM RES, V47, P89, DOI 10.1159/000185441; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Valenzuela D, 1997, P NATL ACAD SCI USA, V94, P1727, DOI 10.1073/pnas.94.5.1727; VALLAR L, 1987, NATURE, V330, P566, DOI 10.1038/330566a0; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715	54	203	213	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 1	1999	340	13					1012	1020		10.1056/NEJM199904013401306	http://dx.doi.org/10.1056/NEJM199904013401306			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182GA	10099144				2022-12-28	WOS:000079489800006
J	Beecham, L				Beecham, L			Police forces offer contract to private company	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 27	1999	318	7187					879	879						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185DM	10092285				2022-12-28	WOS:000079652900073
J	Gaffikin, L; Blumenthal, PD; McGrath, J; Chirenje, ZM; Sanghvi, H; Chipato, T; Makunike, R; Kasule, J; Ngwalle, E; Rusakaniko, S				Gaffikin, L; Blumenthal, PD; McGrath, J; Chirenje, ZM; Sanghvi, H; Chipato, T; Makunike, R; Kasule, J; Ngwalle, E; Rusakaniko, S		Univ Zimbabwe; JHPIEGO Cervical Canc Project	Visual inspection with acetic acid for cervical-cancer screening: test qualities in a primary-care setting	LANCET			English	Article							VISUALIZATION; SENSITIVITY; SPECIFICITY; SMEARS; BIAS	Background Naked-eye visual inspection of the cervix with acetic-acid wash (VIA), or cervicoscopy, is an alternative to cytology in screening for cervical cancer in poorly resourced locations. We tested the sensitivity, specificity, and predictive value of VIA done by nurse-midwives in a less-developed country. Methods Women were screened by six trained nurse-midwives in a two-phase, cross-sectional study at 15 primary-care clinics in Zimbabwe. VIA and Pap smears were done concurrently, and their sensitivity and specificity compared. Colposcopy, with biopsy as indicated, was used as the reference test to allow a direct comparison of the test unaffected by verification bias. Findings 10 934 women were screened. In phase II, 2148 (97.5%) of the 2203 participants for whom there was a screening result also had a reference test result. Also in phase II, VIA was more sensitive but less specific than cytology. Sensitivity (95% CI) was 76.7% (70.3-82.3) for VIA and 44.3% (37.3-51.4) for cytology, Specificity was 64.1% (61.9-66.2) for VIA and 90.6% (89.2-91.9) for cytology. Interpretation The high sensitivity of VIA shows that the test could be valuable in detection of precancerous lesions of the cervix. However, there are costs to the patient and system costs associated with high numbers of false-positive results, so attention should be given to improving the specificity of VIA.	Univ Zimbabwe, Dept Obstet & Gynaecol, Zimbabwe Off, Harare, Zimbabwe; JHPIEGO Corp, Res & Evaluat Off, Baltimore, MD 21212 USA	University of Zimbabwe; Jhpiego	Gaffikin, L (corresponding author), Univ Zimbabwe, Dept Obstet & Gynaecol, Zimbabwe Off, POB A178, Harare, Zimbabwe.							ABRAMS J, 1990, AM J GYNECOL HLTH, V4, P37; BEGG CB, 1983, BIOMETRICS, V39, P207, DOI 10.2307/2530820; Blumenthal P., 1997, ATLAS UNAIDED VISUAL; CECCHINI S, 1993, TUMORI, V79, P22, DOI 10.1177/030089169307900104; CHOI BCK, 1992, J CLIN EPIDEMIOL, V45, P581, DOI 10.1016/0895-4356(92)90129-B; deWolf CJM, 1997, NEW DEVELOPMENTS IN CERVICAL CANCER SCREENING AND PREVENTION, P209; DUTOIT JP, 1988, INT J GYNECOL OBSTET, V26, P261, DOI 10.1016/0020-7292(88)90271-8; FAHEY MT, 1995, AM J EPIDEMIOL, V141, P680, DOI 10.1093/oxfordjournals.aje.a117485; FRISCH LE, 1994, J FAM PRACTICE, V39, P457; GAFFIKIN L, 1997, WORKSH P MAY 21 22 1; Jonsson M, 1997, OBSTET GYNECOL, V90, P744, DOI 10.1016/S0029-7844(97)00418-3; KASULE J, 1989, E AFR MED J, V66, P393; LUNT R, 1984, OBSTET GYNECOL, V63, P708; MACHOKI JMN, 1990, INT J GYNECOL OBSTET, V34, P55; Megevand E, 1996, OBSTET GYNECOL, V88, P383, DOI 10.1016/0029-7844(96)00189-5; Mitchell MF, 1998, OBSTET GYNECOL, V91, P626, DOI 10.1016/S0029-7844(98)00006-4; NIEMINEN P, 1995, OBSTET GYNECOL, V85, P1017, DOI 10.1016/0029-7844(95)00063-W; OTTAVIANO M, 1982, AM J OBSTET GYNECOL, V143, P139, DOI 10.1016/0002-9378(82)90642-1; Sankaranarayanan R, 1997, NEW DEVELOPMENTS IN CERVICAL CANCER SCREENING AND PREVENTION, P411; Sankaranarayanan R, 1997, NEW DEVELOPMENTS IN CERVICAL CANCER SCREENING AND PREVENTION, P70; Sankaranarayanan R, 1999, INT J CANCER, V80, P161, DOI 10.1002/(SICI)1097-0215(19990105)80:1<161::AID-IJC28>3.3.CO;2-#; SHERRIS JD, 1993, CERVICAL CANC DEV CO; SLAWSON DC, 1992, J FAM PRACTICE, V35, P271; STJERNSWARD J, 1987, World Health Forum, V8, P42; *US PREV SERV TASK, 1990, AM FAM PHYSICIAN, V41, P853; VANLE L, 1993, OBSTET GYNECOL, V81, P293; Wertlake PT, 1997, OBSTET GYNECOL, V90, P421, DOI 10.1016/S0029-7844(97)00288-3; WILKINSON EJ, 1990, CLIN OBSTET GYNECOL, V33, P817, DOI 10.1097/00003081-199012000-00017; Wright TC, 1996, OBSTET GYNECOL, V87, P515, DOI 10.1016/0029-7844(95)00472-6	29	218	228	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 13	1999	353	9156					869	873						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BU	10093978				2022-12-28	WOS:000079421400008
J	van Weel, C; Knottnerus, JA				van Weel, C; Knottnerus, JA			Evidence-based interventions and comprehensive treatment	LANCET			English	Article							GENERAL-PRACTITIONERS		Catholic Univ Nijmegen, Dept Gen Practice, Netherlands Sch Primary Care Res, NL-6500 HB Nijmegen, Netherlands; Univ Maastricht, Dept Gen Practice, Maastricht, Netherlands	Radboud University Nijmegen; Maastricht University	van Weel, C (corresponding author), Catholic Univ Nijmegen, Dept Gen Practice, Netherlands Sch Primary Care Res, POB 9101, NL-6500 HB Nijmegen, Netherlands.	C.vanWeel@hsv.kun.nl	van Weel, Chris/D-4375-2009; Knottnerus, Johannes A/A-3829-2009; Knottnerus, Andre/F-4866-2013	van Weel, Chris/0000-0003-3653-4701; 				Appelman CLM, 1990, HUISARTS WET, V33, P242; Culpepper L, 1999, LANCET, V353, P829, DOI 10.1016/S0140-6736(98)09101-6; Custovic A, 1998, THORAX, V53, P63, DOI 10.1136/thx.53.1.63; GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032; KNOTTNERUS JA, 1991, FAM PRACT, V8, P305, DOI 10.1093/fampra/8.4.305; Mant D, 1999, LANCET, V353, P743, DOI 10.1016/S0140-6736(98)09102-8; Maynard A, 1997, LANCET, V349, P126, DOI 10.1016/S0140-6736(96)05153-7; McWhinney I, 1997, TXB FAMILY MED; Rosser WW, 1999, LANCET, V353, P661, DOI 10.1016/S0140-6736(98)09103-X; Rosser WW, 1998, EVIDENCE BASED FAMIL; Schonberger HJAM, 1998, CLIN EXP ALLERGY, V28, P1325; SMEENK FWJ, 1998, PATIENT END COUNSEL, V35, pG18; SMITH TC, 1995, HIERARCHICAL MODELS, P95; Sweeney KG, 1998, LANCET, V351, P134, DOI 10.1016/S0140-6736(97)06316-2; VANBUCHEM FL, 1981, LANCET, V2, P883; VANWEEL C, 1996, EUR J GEN PRACT, V2, P17; VIERHOUT WPM, 1995, LANCET, V346, P990, DOI 10.1016/S0140-6736(95)91686-5	17	47	48	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 13	1999	353	9156					916	918		10.1016/S0140-6736(98)08024-6	http://dx.doi.org/10.1016/S0140-6736(98)08024-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	181BU	10093999				2022-12-28	WOS:000079421400044
J	Wahlgren, M; Fernandez, V; Chen, QJ; Svard, S; Hagblom, P				Wahlgren, M; Fernandez, V; Chen, QJ; Svard, S; Hagblom, P			Waves of malarial var-iations	CELL			English	Review							PLASMODIUM-KNOWLESI MALARIA; ANTIGENIC VARIATION; VARIANT ANTIGEN; INFECTED ERYTHROCYTES		Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden; Swedish Inst Infect Dis Control, S-17177 Stockholm, Sweden	Karolinska Institutet; Swedish Institute for Infectious Disease Control	Wahlgren, M (corresponding author), Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden.			Svard, Staffan/0000-0002-7392-1746				Al-Khedery B, 1999, MOL CELL, V3, P131, DOI 10.1016/S1097-2765(00)80304-4; BARNWELL JW, 1983, INFECT IMMUN, V40, P985, DOI 10.1128/IAI.40.3.985-994.1983; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; BROWN KN, 1965, NATURE, V208, P1286, DOI 10.1038/2081286a0; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Cheng Q, 1998, MOL BIOCHEM PARASIT, V97, P161, DOI 10.1016/S0166-6851(98)00144-3; Fernandez V, 1998, INFECT IMMUN, V66, P2969, DOI 10.1128/IAI.66.6.2969-2975.1998; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; HOWARD RJ, 1983, P NATL ACAD SCI-BIOL, V80, P4129, DOI 10.1073/pnas.80.13.4129; MILLER LH, 1994, SCIENCE, V264, P1878, DOI 10.1126/science.8009217; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; SCHERF A, 1999, IN PRESS MALARIA MOL; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; WAHLGREN M, 1999, IN PRESS MALARIA MOL	15	23	25	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 5	1999	96	5					603	606		10.1016/S0092-8674(00)80569-3	http://dx.doi.org/10.1016/S0092-8674(00)80569-3			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	174TB	10089874	Bronze			2022-12-28	WOS:000079050100002
J	Pereira, GD; Hajenius, PJ; Mol, BWJ; Ankum, WM; Hemrika, DJ; Bossuyt, PMM; van der Veen, F				Pereira, GD; Hajenius, PJ; Mol, BWJ; Ankum, WM; Hemrika, DJ; Bossuyt, PMM; van der Veen, F			Fertility outcome after systemic methotrexate and laparoscopic salpingostomy for tubal pregnancy	LANCET			English	Article									Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, NL-1012 WX Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1012 WX Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynaecol, NL-1012 WX Amsterdam, Netherlands; Onze Lieve Vrouw Hosp, Dept Obstet & Gynaecol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Onze Lieve Vrouwe Gasthuis Hospital	Pereira, GD (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, NL-1012 WX Amsterdam, Netherlands.	g.diaspereira@amc.uva.nl	Bossuyt, Patrick M/AAR-1183-2021; Bossuyt, Patrick M./B-4557-2016; Mol, Ben/I-4526-2012	Bossuyt, Patrick M/0000-0003-4427-0128; Bossuyt, Patrick M./0000-0003-4427-0128; 				Hajenius PJ, 1997, LANCET, V350, P774, DOI 10.1016/S0140-6736(97)05487-1; MOL BWJ, 1996, 52 M AM SOC REPR MED, pS133; Nieuwkerk PT, 1998, FERTIL STERIL, V70, P518, DOI 10.1016/S0015-0282(98)00213-1; Nieuwkerk PT, 1998, FERTIL STERIL, V70, P511, DOI 10.1016/S0015-0282(98)00212-X	4	27	29	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	1999	353	9154					724	725		10.1016/S0140-6736(98)02250-8	http://dx.doi.org/10.1016/S0140-6736(98)02250-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173DR	10073522				2022-12-28	WOS:000078966400020
J	Covinsky, KE; Kahana, E; Chin, MH; Palmer, RM; Fortinsky, RH; Landefeld, CS				Covinsky, KE; Kahana, E; Chin, MH; Palmer, RM; Fortinsky, RH; Landefeld, CS			Depressive symptoms and 3-year mortality in older hospitalized medical patients	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	Annual Meeting of the American-Geriatrics-Society/American-Federation-for-Aging-Research	MAY 06-10, 1998	SEATTLE, WA	Amer Geriatr Soc, Amer Federat Aging Res		depression; hospitalization; age factors; mortality; health status	MAJOR DEPRESSION; MYOCARDIAL-INFARCTION; HEALTH; ADULTS; OUTCOMES; SURVIVAL; ILLNESS; IMPACT; CARE; DISABILITY	Background: Depressive symptoms are common in hospitalized older persons. However, their relation to longterm mortality is unclear because few studies have rigorously considered potential confounders of the relation between depression and mortality, such as comorbid illness, functional impairment, and cognitive impairment. Objective: To measure the association between depressive symptoms and long-term mortality in hospitalized older persons. Design: Prospective cohort study. Setting: General medical service of a teaching hospital. Patients: 573 patients 70 years of age or older. Measurements: Depressive symptoms (Geriatric Depression Scale score), severity of acute illness (Acute Physiology and Chronic Health Evaluation II score), burden of comorbid illness (Charlson comorbidity index score), physical function (a nurse assessed dependence in six activities of daily living), and cognitive function (modified Mini-Mental State Examination) were measured at hospital admission. Mortality over the 3 years after admission was determined from the National Death Index. Mortality rates among patients with six or more depressive symptoms were compared with those among patients with five or fewer symptoms. Results: The mean age of the patients was 80 years; 68% of patients were women. Patients with six or more depressive symptoms had greater comorbid illness, functional impairment, and cognitive impairment at admission than patients with fewer depressive symptoms. Three-year mortality was higher in patients with six or more depressive symptoms (56% compared with 40%; hazard ratio, 1.56 [95% CI, 1.22 to 2.00]; P < 0.001). After adjustment for age, acute illness severity, comorbid illness, functional impairment, and cognitive impairment at the time of admission, patients with six or more depressive symptoms continued to have a higher mortality rate during the 3 years after admission (hazard ratio, 1.34 [CI, 1.03 to 1.73]). Although depressive symptoms contributed less to the mortality rate than did the total burden of comorbid medical illnesses, the excess mortality rate associated with depressive symptoms was greater than that conferred by one additional comorbid medical condition. Conclusions: Depressive symptoms are associated with long-term mortality in older patients hospitalized with medical illnesses. This association is not fully explained by greater levels of comorbid illness, functional impairment, and cognitive impairment in patients with more depressive symptoms.	Vet Affairs Med Ctr, San Francisco, CA 94121 USA; Univ Calif San Francisco, Sch Med, San Francisco, CA USA; Case Western Reserve Univ, Dept Sociol, Cleveland, OH 44106 USA; Cleveland Clin Fdn, Cleveland, OH 44195 USA; Univ Chicago, Med Ctr, Chicago, IL 60637 USA; Univ Connecticut, Ctr Aging, Adm Off MC5215, Farmington, CT 06030 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; Case Western Reserve University; Cleveland Clinic Foundation; University of Chicago; University of Chicago Medical Center; University of Connecticut	Covinsky, KE (corresponding author), Vet Affairs Med Ctr, 111G,4150 Clement St,Bldg 1, San Francisco, CA 94121 USA.	covinsky@medicine.ucsf.edu			NIA NIH HHS [5K12-AG00488, K08AG00714, AG-10418-04] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K12AG000488, P60AG010418, K08AG000714] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		*AM PSYCH ASS, 1994, DIAGN STAT MAN MENT, P323; BROADHEAD WE, 1990, JAMA-J AM MED ASSOC, V264, P2524, DOI 10.1001/jama.264.19.2524; BRUCE ML, 1994, AM J PSYCHIAT, V151, P716; BRUCE ML, 1994, AM J PUBLIC HEALTH, V84, P1796, DOI 10.2105/AJPH.84.11.1796; Burke W J, 1991, J Geriatr Psychiatry Neurol, V4, P173, DOI 10.1177/089198879100400310; CALLAHAN CM, 1994, J GERONTOL, V49, pM9, DOI 10.1093/geronj/49.1.M9; CHAMPION LA, 1995, BRIT J CLIN PSYCHOL, V34, P485, DOI 10.1111/j.2044-8260.1995.tb01484.x; CHARLSON ME, 1986, JAMA-J AM MED ASSOC, V255, P1316, DOI 10.1001/jama.255.10.1316; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CHEAH KC, 1980, J AM GERIATR SOC, V28, P153, DOI 10.1111/j.1532-5415.1980.tb00508.x; Covinsky KE, 1996, J GEN INTERN MED, V11, P249, DOI 10.1007/BF02642486; Covinsky KE, 1997, J GEN INTERN MED, V12, P203, DOI 10.1007/s11606-006-5041-5; Covinsky KE, 1997, ANN INTERN MED, V126, P417, DOI 10.7326/0003-4819-126-6-199703150-00001; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; DETLEFS DR, 1996, GUIDE SOCIAL SECURIT; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRASURESMITH N, 1993, JAMA-J AM MED ASSOC, V270, P1819, DOI 10.1001/jama.270.15.1819; Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585; FRIEDHOFF AJ, 1992, JAMA-J AM MED ASSOC, V268, P1018, DOI 10.1001/jama.1992.03490080092032; GALLO JJ, 1994, J GERONTOL, V49, pP251, DOI 10.1093/geronj/49.6.P251; Ganzini L, 1997, J AM GERIATR SOC, V45, P307, DOI 10.1111/j.1532-5415.1997.tb00945.x; Garrard J, 1998, J GERONTOL A-BIOL, V53, pM92, DOI 10.1093/gerona/53A.2.M92; GERETY MB, 1994, J AM GERIATR SOC, V42, P1103, DOI 10.1111/j.1532-5415.1994.tb06217.x; GILLICK MR, 1982, SOC SCI MED, V16, P1033, DOI 10.1016/0277-9536(82)90175-7; GLASSMAN AH, 1990, JAMA-J AM MED ASSOC, V264, P1546, DOI 10.1001/jama.264.12.1546; GORDON HS, 1995, ARCH INTERN MED, V155, P2465, DOI 10.1001/archinte.155.22.2465; Gullette ECD, 1997, JAMA-J AM MED ASSOC, V277, P1521, DOI 10.1001/jama.277.19.1521; Inouye SK, 1998, JAMA-J AM MED ASSOC, V279, P1187, DOI 10.1001/jama.279.15.1187; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; KIECOLTGLASER JK, 1995, LANCET, V346, P1194, DOI 10.1016/S0140-6736(95)92899-5; KITCHELL MA, 1982, J AM GERIATR SOC, V30, P174, DOI 10.1111/j.1532-5415.1982.tb01300.x; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Koenig HG, 1998, AM J GERIAT PSYCHIAT, V6, P14; KOENIG HG, 1991, J AM GERIATR SOC, V39, P881, DOI 10.1111/j.1532-5415.1991.tb04455.x; KOENIG HG, 1988, ARCH INTERN MED, V148, P1929, DOI 10.1001/archinte.148.9.1929; KOENIG HG, 1989, J AM GERIATR SOC, V37, P599, DOI 10.1111/j.1532-5415.1989.tb01249.x; KOENIG HG, 1988, J AM GERIATR SOC, V36, P699, DOI 10.1111/j.1532-5415.1988.tb07171.x; KOHN RR, 1982, JAMA-J AM MED ASSOC, V247, P2793, DOI 10.1001/jama.247.20.2793; LADWIG KH, 1994, LANCET, V343, P20, DOI 10.1016/S0140-6736(94)90877-X; LANDEFELD CS, 1995, NEW ENGL J MED, V332, P1338, DOI 10.1056/NEJM199505183322006; MORLEY JE, 1988, ANN INTERN MED, V109, P890, DOI 10.7326/0003-4819-109-11-890; RAPP SR, 1988, J CONSULT CLIN PSYCH, V56, P851, DOI 10.1037/0022-006X.56.6.851; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Roach MJ, 1998, ARCH INTERN MED, V158, P397, DOI 10.1001/archinte.158.4.397; ROVNER BW, 1991, JAMA-J AM MED ASSOC, V265, P993, DOI 10.1001/jama.265.8.993; Sager MA, 1996, J AM GERIATR SOC, V44, P251, DOI 10.1111/j.1532-5415.1996.tb00910.x; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; *US DEP HHS, 1993, AG HLTH CAR POL RES; WAXMAN HM, 1984, GERONTOLOGIST, V24, P593, DOI 10.1093/geront/24.6.593; Whooley MA, 1998, ARCH INTERN MED, V158, P2129, DOI 10.1001/archinte.158.19.2129; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zheng DY, 1997, ANN EPIDEMIOL, V7, P213, DOI 10.1016/S1047-2797(97)00014-8	52	210	212	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 6	1999	130	7					563	569		10.7326/0003-4819-130-7-199904060-00004	http://dx.doi.org/10.7326/0003-4819-130-7-199904060-00004			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	183BG	10189325				2022-12-28	WOS:000079533300003
J	Straus, SE; Sneller, M; Lenardo, MJ; Puck, JM; Strober, W				Straus, SE; Sneller, M; Lenardo, MJ; Puck, JM; Strober, W			An inherited disorder of lymphocyte apoptosis: The autoimmune lymphoproliferative syndrome	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SYSTEMIC LUPUS-ERYTHEMATOSUS; FAS GENE-MUTATIONS; NEGATIVE T-CELLS; MONOCLONAL-ANTIBODY; AUTOANTIBODY PRODUCTION; CYTOKINE PRODUCTION; ICE/CED-3 PROTEASE; IL-12 PRODUCTION; DEATH DOMAIN; IFN-GAMMA		NIAID, Mucosal Immun Sect, Clin Invest Lab, NIH, Bethesda, MD 20892 USA; NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; Natl Human Genome Res Inst, Immunol Genet Branch, NIH, Bethesda, MD 20892 USA; NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Straus, SE (corresponding author), NIAID, Mucosal Immun Sect, Clin Invest Lab, NIH, Bldg 10,Room 11N228,10 Ctr Dr, Bethesda, MD 20892 USA.	sstraus@nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000769, ZIAAI000732, ZIAAI000769, Z01AI000732] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; BEHRMANN I, 1994, EUR J IMMUNOL, V24, P3057, DOI 10.1002/eji.1830241221; Bettinardi A, 1997, BLOOD, V89, P902, DOI 10.1182/blood.V89.3.902; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; CANALE VC, 1967, J PEDIATR-US, V70, P891, DOI 10.1016/S0022-3476(67)80262-2; Chinnaiyan A M, 1997, Semin Immunol, V9, P69, DOI 10.1006/smim.1996.0055; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; COHEN JJ, 1992, ANNU REV IMMUNOL, V10, P267, DOI 10.1146/annurev.immunol.10.1.267; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Cohen SBA, 1997, IMMUNOLOGY, V92, P1, DOI 10.1046/j.1365-2567.1997.00348.x; DACIE J, 1992, HAEMOTYTIC ANEMIAS, V3; DALE DC, 1993, IMMUNOL ALLERGY CLIN, V13, P359; Dameshek W, 1938, AM J MED SCI, V196, P769, DOI 10.1097/00000441-193812000-00002; DARTE JMM, 1971, NEW ENGL J MED, V284, P431, DOI 10.1056/NEJM197102252840807; Dianzani U, 1997, BLOOD, V89, P2871, DOI 10.1182/blood.V89.8.2871; Drappa J, 1996, NEW ENGL J MED, V335, P1643, DOI 10.1056/NEJM199611283352204; ENARI M, 1995, NATURE, V375, P78, DOI 10.1038/375078a0; EVANS RS, 1951, ARCH INTERN MED, V87, P48, DOI 10.1001/archinte.1951.03810010058005; Ferrante P, 1998, J IMMUNOL, V160, P1514; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Fuss IJ, 1997, J IMMUNOL, V158, P1912; Fuss IJ, 1996, J IMMUNOL, V157, P1261; GERDES J, 1984, J IMMUNOL, V133, P1710; GIESE T, 1994, J IMMUNOL, V152, P2000; GIESE T, 1993, J IMMUNOL, V151, P597; GUTIERREZRAMOS JC, 1990, NATURE, V346, P271, DOI 10.1038/346271a0; HARMS D, 1965, ACTA HAEMATOL-BASEL, V34, P30, DOI 10.1159/000209427; HENNEMANN HH, 1964, DEUT MED WOCHENSCHR, V89, P1161, DOI 10.1055/s-0028-1111269; Hess AF, 1916, ARCH INTERN MED, V17, P203; Holimon J L, 1971, Va Med Mon (1918), V98, P644; HOROWITZ SD, 1984, CLIN IMMUNOL IMMUNOP, V33, P313, DOI 10.1016/0090-1229(84)90302-7; Horwitz DA, 1998, ARTHRITIS RHEUM, V41, P838, DOI 10.1002/1529-0131(199805)41:5<838::AID-ART10>3.0.CO;2-S; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Infante AJ, 1998, J PEDIATR-US, V133, P629, DOI 10.1016/S0022-3476(98)70102-7; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; LeDeist F, 1996, LANCET, V348, P719, DOI 10.1016/S0140-6736(96)02293-3; Lenardo M J, 1997, Semin Immunol, V9, P1, DOI 10.1006/smim.1996.0050; Lenardo MJ, 1996, J EXP MED, V183, P721, DOI 10.1084/jem.183.3.721; LEVY Y, 1994, J CLIN INVEST, V93, P424, DOI 10.1172/JCI116977; Li L, 1997, CELL IMMUNOL, V178, P33, DOI 10.1006/cimm.1997.1129; Lim MS, 1998, AM J PATHOL, V153, P1541, DOI 10.1016/S0002-9440(10)65742-2; Liu TF, 1998, CYTOKINE, V10, P148, DOI 10.1006/cyto.1997.0269; LOS M, 1995, NATURE, V375, P81, DOI 10.1038/375081a0; MCKINLEY RA, 1987, BRIT J HAEMATOL, V67, P393, DOI 10.1111/j.1365-2141.1987.tb06159.x; Mongan AE, 1997, SCAND J IMMUNOL, V46, P406, DOI 10.1046/j.1365-3083.1997.d01-140.x; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; MOUNTZ JD, 1987, J IMMUNOL, V138, P157; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; RANDALL DL, 1965, AM J DIS CHILD, V110, P479, DOI 10.1001/archpedi.1965.02090030503001; RAO LM, 1974, CLIN GENET, V5, P379; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; ROBINSON D, 1993, J ALLERGY CLIN IMMUN, V92, P313, DOI 10.1016/0091-6749(93)90175-F; Sarris A. H., 1997, Blood, V90, p335A; Segal BM, 1998, J EXP MED, V187, P537, DOI 10.1084/jem.187.4.537; Segal R, 1997, J IMMUNOL, V158, P3009; SEIP M, 1969, ACTA PAEDIATR SCAND, V58, P275, DOI 10.1111/j.1651-2227.1969.tb04717.x; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; SNELLER MC, 1992, J CLIN INVEST, V90, P334, DOI 10.1172/JCI115867; Sneller MC, 1997, BLOOD, V89, P1341, DOI 10.1182/blood.V89.4.1341; TANAKA H, 1994, LIFE SCI, V62, pPL169; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WEISDORF SA, 1982, CLIN IMMUNOL IMMUNOP, V23, P492, DOI 10.1016/0090-1229(82)90133-7; WILSON C, 1890, T CLIN SOC, V23, P16; Wu JG, 1996, J CLIN INVEST, V98, P1107, DOI 10.1172/JCI118892; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0	68	230	233	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 6	1999	130	7					591	601		10.7326/0003-4819-130-7-199904060-00020	http://dx.doi.org/10.7326/0003-4819-130-7-199904060-00020			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183BG	10189330				2022-12-28	WOS:000079533300008
J	Findley, I; Chamberlain, G				Findley, I; Chamberlain, G			ABC of labour care - Relief of pain	BRITISH MEDICAL JOURNAL			English	Review									Univ London St Georges Hosp, London, England	St Georges University London	Findley, I (corresponding author), Univ London St Georges Hosp, London, England.							CHAMBERLAIN G, 1997, PAIN ITS RELIEF LABO; REYNOLDS F, 1998, PRESCRIBERS J, V38, P26; Russell R, 1996, BRIT MED J, V312, P1384	3	23	30	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 3	1999	318	7188					927	930		10.1136/bmj.318.7188.927	http://dx.doi.org/10.1136/bmj.318.7188.927			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185GV	10102864	Green Published			2022-12-28	WOS:000079660500032
J	Hayes, AJ; Li, LY; Lippman, ME				Hayes, AJ; Li, LY; Lippman, ME			Science, medicine, and the future - Antivascular therapy: a new approach to cancer treatment	BRITISH MEDICAL JOURNAL			English	Review							FIBROBLAST GROWTH-FACTOR; VASCULAR-PERMEABILITY FACTOR; TUMOR-GROWTH; ANGIOGENIC SWITCH; IN-VIVO; INHIBITOR; DORMANCY; VESSELS; CELLS; TIE2		Georgetown Univ, Med Ctr, Vincent T Lombardi Canc Res Ctr, Washington, DC 20007 USA	Georgetown University	Hayes, AJ (corresponding author), Georgetown Univ, Med Ctr, Vincent T Lombardi Canc Res Ctr, 3970 Reservoir Rd, Washington, DC 20007 USA.	hayesa@gunet.georgetown.edu	Li, Luyuan/E-8951-2012					ALGUIRE GH, 1947, S APPROACHES TUMOUR, P13; Bailar JC, 1997, NEW ENGL J MED, V336, P1569, DOI 10.1056/NEJM199705293362206; Boehm T, 1997, NATURE, V390, P404, DOI 10.1038/37126; BOWEN W, 1908, SCI REP IMPERIAL CAN, V3, P146; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Czubayko F, 1997, NAT MED, V3, P1137, DOI 10.1038/nm1097-1137; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FOLKMAN J, 1972, ANN SURG, V175, P409, DOI 10.1097/00000658-197203000-00014; GIMBRONE MA, 1972, J EXP MED, V136, P261, DOI 10.1084/jem.136.2.261; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Huang XM, 1997, SCIENCE, V275, P547, DOI 10.1126/science.275.5299.547; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Kudelka AP, 1998, NEW ENGL J MED, V338, P991, DOI 10.1056/NEJM199804023381412; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; LIOTTA LA, 1974, CANCER RES, V34, P997; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; MCLESKEY S, 1993, CANCER RES, V53, P2169; NGUYEN M, 1994, J NATL CANCER I, V86, P356, DOI 10.1093/jnci/86.5.356; OReilly MS, 1996, NAT MED, V2, P689, DOI 10.1038/nm0696-689; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Relf M, 1997, CANCER RES, V57, P963; SCHWEIKI D, 1992, NATURE, V359, P843; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; SENGER DR, 1986, CANCER RES, V46, P5629; SMITHMCCUNE KK, 1994, CANCER RES, V54, P800; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; TANNOCK IF, 1968, BRIT J CANCER, V22, P258, DOI 10.1038/bjc.1968.34; VLODAVSKY I, 1991, ANN NY ACAD SCI, V638, P207; WEIDNER N, 1995, BREAST CANCER RES TR, V36, P169, DOI 10.1007/BF00666038	32	45	61	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 27	1999	318	7187					853	+		10.1136/bmj.318.7187.853	http://dx.doi.org/10.1136/bmj.318.7187.853			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185DM	10092266	Green Published			2022-12-28	WOS:000079652900030
J	Trotter, Y; Celebrini, S				Trotter, Y; Celebrini, S			Gaze direction controls response gain in primary visual-cortex neurons	NATURE			English	Article							POSTERIOR PARIETAL NEURONS; EYE POSITION; PRESTRIATE CORTEX; VIEWING DISTANCE; MACAQUE MONKEY; GENICULATE; ACTIVATION; MODULATION; STRIATE; MST	To localize objects in space, the brain needs to combine information about the position of the stimulus on the retinae with information about the location of the eyes in their orbits. Interaction between these two types of information occurs in several cortical areas(1-12), but the role of the primary visual cortex (area V1) in this process has remained unclear. Here we show that, for half the cells recorded in area V1 of behaving monkeys, the classically described visual responses are strongly modulated by gaze direction, Specifically, we find that selectivity for horizontal retinal disparity-the difference in the position of a stimulus on each retina which relates to relative object distance-and for stimulus orientation may be present at a given gaze direction, but be absent or poorly expressed at another direction. Shifts in preferred disparity also occurred in several neurons. These neural changes were most often present at the beginning of the visual response, suggesting a feedforward gain control by eye position signals. Cortical neural processes for encoding information about the three-dimensional position of a stimulus in space therefore start as early as area V1.	Univ Toulouse 3, Fac Med Rangueil, Ctr Rech Cerveau & Cognit, F-31062 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Trotter, Y (corresponding author), Univ Toulouse 3, Fac Med Rangueil, Ctr Rech Cerveau & Cognit, 133 Route Narbonne, F-31062 Toulouse, France.	trotter@cerco.ups-tlse.fr	celebrini, simona/H-2169-2011; Trotter, Yves/G-7333-2011					ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; ANDERSEN RA, 1990, J NEUROSCI, V10, P1176; ANDERSEN RA, 1983, J NEUROSCI, V3, P532; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; BOUSSAOUD D, 1993, EXP BRAIN RES, V93, P423; DONALDSON IML, 1980, EXP BRAIN RES, V38, P245; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; GALLETTI C, 1989, J NEUROSCI, V9, P1112; Galletti C, 1995, EUR J NEUROSCI, V7, P2486, DOI 10.1111/j.1460-9568.1995.tb01047.x; GIBLERT CD, 1998, PHYSIOL REV, V78, P467; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; Guo K, 1997, NEUROREPORT, V8, P1405, DOI 10.1097/00001756-199704140-00017; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; LAL R, 1989, SCIENCE, V243, P93, DOI 10.1126/science.2911723; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; MOLOTCHNIKOFF S, 1985, J NEUROSCI RES, V14, P105, DOI 10.1002/jnr.490140110; MORRISON LC, 1977, AM J OPTOM PHYSL OPT, V54, P536; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; OGLE KN, 1962, PROBLEM HOROPTER, P325; OGLE KN, 1962, SPATIAL LOCALIZATION, P271; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1392, DOI 10.1152/jn.1977.40.6.1392; Squatrito S, 1996, VISUAL NEUROSCI, V13, P385, DOI 10.1017/S0952523800007628; Trotter Y, 1996, J NEUROPHYSIOL, V76, P2872, DOI 10.1152/jn.1996.76.5.2872; TROTTER Y, 1992, SCIENCE, V257, P1279, DOI 10.1126/science.1519066; WEYAND TG, 1993, J NEUROPHYSIOL, V69, P2258, DOI 10.1152/jn.1993.69.6.2258; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0; Zipser K, 1996, J NEUROSCI, V16, P7376	28	141	143	0	6	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 18	1999	398	6724					239	242		10.1038/18444	http://dx.doi.org/10.1038/18444			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177UA	10094046				2022-12-28	WOS:000079228400053
J	Smith, EE; Jonides, J				Smith, EE; Jonides, J			Neuroscience - Storage and executive processes in the frontal lobes	SCIENCE			English	Review							SPATIAL WORKING-MEMORY; POSITRON EMISSION TOMOGRAPHY; STIMULUS-RESPONSE COMPATIBILITY; PRIMATE PREFRONTAL CORTEX; BRAIN ACTIVATION; STROOP TASK; PET; INTERFERENCE; SYSTEM; OBJECT	The human frontal cortex helps mediate working memory, a system that is used for temporary storage and manipulation of information and that is involved in many higher cognitive functions. Working memory includes two components: short-term storage (on the order of seconds) and executive processes that operate on the contents of storage. Recently, these two components have been investigated in functional neuroimaging studies. Studies of storage indicate that different frontal regions are activated for different kinds of information: storage for verbal materials activates Broca's area and Left-hemisphere supplementary and premotor areas; storage of spatial information activates the right-hemisphere premotor cortex; and storage of object information activates other areas of the prefrontal cortex. Two of the fundamental executive processes are selective attention and task management. Both processes activate the anterior cingulate and dorsolateral prefrontal cortex.	Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; Univ Michigan, Mental Hlth Res Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Smith, EE (corresponding author), Univ Michigan, Dept Psychol, 580 Union Dr, Ann Arbor, MI 48109 USA.	eesmith@umich.edu						Awh E, 1998, J EXP PSYCHOL HUMAN, V24, P780, DOI 10.1037/0096-1523.24.3.780; Awh E, 1996, PSYCHOL SCI, V7, P25, DOI 10.1111/j.1467-9280.1996.tb00662.x; Awh E, 1998, ATTENTIVE BRAIN, P353; Baddeley A.D., 1986, WORKING MEMORY THOUG; Badgaiyan RD, 1998, NEUROIMAGE, V7, P255, DOI 10.1006/nimg.1998.0326; BENCH CJ, 1993, NEUROPSYCHOLOGIA, V31, P907, DOI 10.1016/0028-3932(93)90147-R; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Bush G, 1998, HUM BRAIN MAPP, V6, P270, DOI 10.1002/(SICI)1097-0193(1998)6:4<270::AID-HBM6>3.0.CO;2-0; CARPENTER PA, 1990, PSYCHOL REV, V97, P404, DOI 10.1037/0033-295X.97.3.404; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 1995, NEUROIMAGE, V2, P264, DOI 10.1006/nimg.1995.1034; Cohen J D, 1994, Hum Brain Mapp, V1, P293, DOI 10.1002/hbm.460010407; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; Courtney SM, 1996, CEREB CORTEX, V6, P39, DOI 10.1093/cercor/6.1.39; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; Derbyshire SWG, 1998, EXP BRAIN RES, V118, P52, DOI 10.1007/s002210050254; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; DESPOSITO M, IN PRESS ATTENTION P, V18; DESPOSITO M, COGN NEUR SOC M SAN; DYER FN, 1973, MEM COGNITION, V1, P106, DOI 10.3758/BF03198078; Faillenot I, 1997, NEUROREPORT, V8, P859, DOI 10.1097/00001756-199703030-00010; Fiez JA, 1996, J NEUROSCI, V16, P808; Fuster J., 2015, PREFRONTAL CORTEX, V5th; Fuster JM, 1995, MEMORY CEREBRAL CORT; George MS, 1997, J NEUROPSYCH CLIN N, V9, P55; Goldman-Rakic P.S., 2011, HDB PHYSL, P373, DOI DOI 10.1002/CPHY.CP010509; Iacoboni M, 1996, J NEUROPHYSIOL, V76, P321, DOI 10.1152/jn.1996.76.1.321; Jonides J, 1997, J COGNITIVE NEUROSCI, V9, P462, DOI 10.1162/jocn.1997.9.4.462; Jonides J, 1998, P NATL ACAD SCI USA, V95, P8410, DOI 10.1073/pnas.95.14.8410; JONIDES J, 1993, NATURE, V363, P623, DOI 10.1038/363623a0; JONIDES J, IN PRESS; Luria A.R., 1966, HIGHER CORTICAL FUNC, P3; MCCARTHY G, 1994, P NATL ACAD SCI USA, V91, P8690, DOI 10.1073/pnas.91.18.8690; Owen AM, 1996, CEREB CORTEX, V6, P31, DOI 10.1093/cercor/6.1.31; Owen AM, 1997, EUR J NEUROSCI, V9, P1329, DOI 10.1111/j.1460-9568.1997.tb01487.x; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P873, DOI 10.1073/pnas.90.3.873; POSNER MI, 1988, SCIENCE, V240, P1627, DOI 10.1126/science.3289116; Rainer G, 1998, P NATL ACAD SCI USA, V95, P15008, DOI 10.1073/pnas.95.25.15008; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; Schumacher EH, 1996, NEUROIMAGE, V3, P79, DOI 10.1006/nimg.1996.0009; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; Smith EE, 1998, P NATL ACAD SCI USA, V95, P876, DOI 10.1073/pnas.95.3.876; SMITH EE, 1995, J COGNITIVE NEUROSCI, V7, P337, DOI 10.1162/jocn.1995.7.3.337; Smith EE, 1996, CEREB CORTEX, V6, P11, DOI 10.1093/cercor/6.1.11; SPECTOR A, 1976, AM J PSYCHOL, V89, P669, DOI 10.2307/1421465; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss D.T., 1986, FRONTAL LOBES; Sweeney JA, 1996, J NEUROPHYSIOL, V75, P454, DOI 10.1152/jn.1996.75.1.454; Talairach J., 1988, COPLANAR STEREOTAXIC; TAYLOR SF, 1994, NEUROPSYCHOLOGIA, V32, P249, DOI 10.1016/0028-3932(94)90010-8; Taylor SF, 1997, NEUROIMAGE, V6, P81, DOI 10.1006/nimg.1997.0285; Ungerleider LG, 1998, P NATL ACAD SCI USA, V95, P883, DOI 10.1073/pnas.95.3.883; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836	58	2027	2137	6	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	1999	283	5408					1657	1661		10.1126/science.283.5408.1657	http://dx.doi.org/10.1126/science.283.5408.1657			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	175PF	10073923				2022-12-28	WOS:000079102800033
J	Westphal, CH; Muller, L; Zhou, A; Zhu, XR; Bonner-Weir, S; Schambelan, M; Steiner, DF; Lindberg, I; Leder, P				Westphal, CH; Muller, L; Zhou, A; Zhu, XR; Bonner-Weir, S; Schambelan, M; Steiner, DF; Lindberg, I; Leder, P			The neuroendocrine protein 7B2 is required for peptide hormone processing in vivo and provides a novel mechanism for pituitary Cushing's disease	CELL			English	Article							PROHORMONE CONVERTASE PC2; DOPAMINERGIC REGULATION; PROPROTEIN CONVERTASES; GENE-EXPRESSION; POLYPEPTIDE 7B2; TRANSGENIC MICE; RAT PITUITARY; GROWTH-FACTOR; CELLS; PROOPIOMELANOCORTIN	The neuroendocrine protein 7B2 has been implicated in activation of prohormone convertase 2 (PC2), an important neuroendocrine precursor processing endoprotease. To test this hypothesis, we created a null mutation in 7B2 employing a novel transposon-facilitated technique and compared the phenotypes of 7B2 and PC2 nulls. 7B2 null mice have no demonstrable PC2 activity, are deficient in processing islet hormones, and display hypoglycemia, hyperproinsulinemia, and hypoglucagonemia. In contrast to the PC2 null phenotype, these mice show markedly elevated circulating ACTH and corticosterone levels, with adrenocortical expansion. They die before 9 weeks of severe Cushing's syndrome arising from pituitary intermediate lobe ACTH hypersecretion. We conclude that 7B2 is indeed required for activation of PC2 in vivo but has additional important functions in regulating pituitary hormone secretion.	Louisiana State Univ, Med Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Biochem, Chicago, IL 60637 USA; Joslin Diabet Ctr 535, Boston, MA 02215 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Louisiana State University System; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Howard Hughes Medical Institute; University of Chicago; University of Chicago; Harvard University; Joslin Diabetes Center, Inc.; University of California System; University of California San Francisco	Lindberg, I (corresponding author), Louisiana State Univ, Med Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA.	ilindb@lsumc.edu; leder@rascal.med.harvard.edu	muller, laurent/S-1990-2016; Lindberg, Iris/Q-3825-2019	muller, laurent/0000-0001-9634-4323; Bonner-Weir, Susan/0000-0003-4682-0656	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R56DA005084, R01DA005084] Funding Source: NIH RePORTER; NIDA NIH HHS [DA00204, DA05084, R56 DA005084] Funding Source: Medline; NIDDK NIH HHS [R01 DK049703, DK49703] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AUTELITANO DJ, 1989, ANNU REV PHYSIOL, V51, P715, DOI 10.1146/annurev.physiol.51.1.715; Benjannet S, 1998, FEBS LETT, V428, P37, DOI 10.1016/S0014-5793(98)00480-3; BENJANNET S, 1995, FEBS LETT, V362, P151, DOI 10.1016/0014-5793(95)00228-2; BENJANNET S, 1995, J NEUROCHEM, V64, P2303; BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; BLOOMQUIST BT, 1991, MOL ENDOCRINOL, V5, P2014, DOI 10.1210/mend-5-12-2014; BORRELLI E, 1992, P NATL ACAD SCI USA, V89, P2764, DOI 10.1073/pnas.89.7.2764; Bosse R, 1997, NEURON, V19, P127, DOI 10.1016/S0896-6273(00)80353-0; BRAKS JAM, 1994, CELL, V78, P263, DOI 10.1016/0092-8674(94)90296-8; Braks JAM, 1996, EUR J BIOCHEM, V236, P60, DOI 10.1111/j.1432-1033.1996.00060.x; CASTRO MG, 1989, MOL CELL ENDOCRINOL, V65, P165, DOI 10.1016/0303-7207(89)90177-9; CHRONWALL BM, 1987, ENDOCRINOLOGY, V120, P1201, DOI 10.1210/endo-120-3-1201; Collini P, 1998, VIRCHOWS ARCH, V432, P505, DOI 10.1007/s004280050198; DAY R, 1992, MOL ENDOCRINOL, V6, P485, DOI 10.1210/me.6.3.485; DEVINE SE, 1994, NUCLEIC ACIDS RES, V22, P3765, DOI 10.1093/nar/22.18.3765; Furuta M, 1998, J BIOL CHEM, V273, P3431, DOI 10.1074/jbc.273.6.3431; Furuta M, 1997, P NATL ACAD SCI USA, V94, P6646, DOI 10.1073/pnas.94.13.6646; HSI KL, 1982, FEBS LETT, V147, P261, DOI 10.1016/0014-5793(82)81055-7; HU NP, 1994, ONCOGENE, V9, P1021; IGUCHI H, 1984, NEUROENDOCRINOLOGY, V39, P453, DOI 10.1159/000124020; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Johanning K, 1998, J BIOL CHEM, V273, P22672, DOI 10.1074/jbc.273.35.22672; Johanning K, 1996, J BIOL CHEM, V271, P27871, DOI 10.1074/jbc.271.44.27871; Kelly MA, 1997, NEURON, V19, P103, DOI 10.1016/S0896-6273(00)80351-7; LAMBERTS SWJ, 1980, J CLIN ENDOCR METAB, V51, P307, DOI 10.1210/jcem-51-2-307; LINDBERG I, 1995, BIOCHEMISTRY-US, V34, P5486, DOI 10.1021/bi00016a020; MARCINKIEWICZ M, 1994, NEUROSCI LETT, V177, P91, DOI 10.1016/0304-3940(94)90052-3; MCANDREW J, 1995, ENDOCRINOLOGY, V136, P4479, DOI 10.1210/en.136.10.4479; Meier CA, 1997, ENDOCRIN METAB CLIN, V26, P741, DOI 10.1016/S0889-8529(05)70280-2; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; Muller L, 1997, J CELL BIOL, V139, P625, DOI 10.1083/jcb.139.3.625; OHASHI M, 1990, HORM METAB RES, V22, P114, DOI 10.1055/s-2007-1004862; ORTH DN, 1982, ENDOCRINOLOGY, V111, P559, DOI 10.1210/endo-111-2-559; Oyarce AM, 1996, J NEUROCHEM, V67, P229; ROEBROEK AJM, 1989, CANCER RES, V49, P4154; Rosenfeld MG, 1996, RECENT PROG HORM RES, V51, P217; Rouille Y, 1997, FEBS LETT, V413, P119, DOI 10.1016/S0014-5793(97)00892-2; ROUILLE Y, 1994, P NATL ACAD SCI USA, V91, P3242, DOI 10.1073/pnas.91.8.3242; ROUILLE Y, 1995, FRONT NEUROENDOCRIN, V16, P322, DOI 10.1006/frne.1995.1012; Saiardi A, 1998, MOL ENDOCRINOL, V12, P1133, DOI 10.1210/me.12.8.1133; SCHNABEL E, 1989, MOL ENDOCRINOL, V3, P1223, DOI 10.1210/mend-3-8-1223; Seidah NG, 1997, CURR OPIN BIOTECH, V8, P602, DOI 10.1016/S0958-1669(97)80036-5; Seidel B, 1998, DNA CELL BIOL, V17, P1017, DOI 10.1089/dna.1998.17.1017; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; STENZELPOORE MP, 1992, ENDOCRINOLOGY, V130, P3378, DOI 10.1210/en.130.6.3378; THOMAS L, 1991, P NATL ACAD SCI USA, V88, P5297, DOI 10.1073/pnas.88.12.5297; Van Horssen AM, 1998, MOL CELL ENDOCRINOL, V137, P7, DOI 10.1016/S0303-7207(97)00237-2; VIEAU D, 1992, CLIN ENDOCRINOL, V36, P597, DOI 10.1111/j.1365-2265.1992.tb02271.x; Wang CC, 1997, GENOMICS, V39, P303, DOI 10.1006/geno.1996.4519; Westphal GH, 1997, CURR BIOL, V7, P530, DOI 10.1016/S0960-9822(06)00224-7; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; ZHOU A, 1993, J BIOL CHEM, V268, P1763; ZHU XR, 1995, J CELL BIOL, V129, P1641, DOI 10.1083/jcb.129.6.1641; Zhu XR, 1998, J BIOL CHEM, V273, P1158, DOI 10.1074/jbc.273.2.1158; Zhu XR, 1996, J BIOL CHEM, V271, P23582, DOI 10.1074/jbc.271.38.23582	55	154	159	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	1999	96	5					689	700		10.1016/S0092-8674(00)80579-6	http://dx.doi.org/10.1016/S0092-8674(00)80579-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	174TB	10089884	Bronze			2022-12-28	WOS:000079050100012
J	Wilde, A; Beattie, EC; Lem, L; Riethof, DA; Liu, SH; Mobley, WC; Soriano, P; Brodsky, FM				Wilde, A; Beattie, EC; Lem, L; Riethof, DA; Liu, SH; Mobley, WC; Soriano, P; Brodsky, FM			EGF receptor signaling stimulates SRC kinase phosphorylation of clathrin, influencing clathrin redistribution and EGF uptake	CELL			English	Article							EPIDERMAL GROWTH-FACTOR; COATED PIT FORMATION; PROTEIN TYROSINE KINASE; SYMPATHETIC NEURONS; SURFACE-MORPHOLOGY; FAMILY KINASES; RAPID CHANGES; C-SRC; ENDOCYTOSIS; CELLS	Epidermal growth factor (EGF) binding to its receptor causes rapid phosphorylation of the clathrin heavy chain at tyrosine 1477, which lies in a domain controlling clathrin assembly. EGF-mediated clathrin phosphorylation is followed by clathrin redistribution to the cell periphery and is the product of downstream activation of SRC kinase by EGF receptor (EGFR) signaling. In cells lacking SRC kinase, or cells treated with a specific SRC family kinase inhibitor, EGF stimulation of clathrin phosphorylation and redistribution does not occur, and EGF endocytosis is delayed. These observations demonstrate a role for SRC kinase in modification and recruitment of clathrin during ligand-induced EGFR endocytosis and thereby define a novel effector mechanism for regulation of endocytosis by receptor signaling.	Univ Calif San Francisco, Dept Immunol & Microbiol, GW Hooper Fdn, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Fred Hutchinson Cancer Center	Brodsky, FM (corresponding author), Univ Calif San Francisco, Dept Immunol & Microbiol, GW Hooper Fdn, San Francisco, CA 94143 USA.	fmarbro@itsa.ucsf.edu	Soriano, Philippe M/E-5797-2015	Soriano, Philippe M/0000-0002-0427-926X; Brodsky, Frances/0000-0002-1334-9258	NIGMS NIH HHS [GM57657, GM38093] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038093, R01GM057657] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAASS PC, 1995, TRENDS CELL BIOL, V5, P465, DOI 10.1016/S0962-8924(00)89116-3; Baur AS, 1997, IMMUNITY, V6, P283, DOI 10.1016/S1074-7613(00)80331-3; BLANK GS, 1987, J CELL BIOL, V105, P2011, DOI 10.1083/jcb.105.5.2011; BRODSKY FM, 1988, SCIENCE, V242, P1396, DOI 10.1126/science.2904698; BRODSKY FM, 1985, J CELL BIOL, V101, P2047, DOI 10.1083/jcb.101.6.2047; CADENA DL, 1994, J BIOL CHEM, V269, P260; CHEN WS, 1987, NATURE, V328, P820, DOI 10.1038/328820a0; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; CONNOLLY JL, 1984, J CELL BIOL, V98, P457, DOI 10.1083/jcb.98.2.457; CONNOLLY JL, 1981, J CELL BIOL, V90, P176, DOI 10.1083/jcb.90.1.176; CORVERA S, 1990, J BIOL CHEM, V265, P2413; DIGUGLIELMO GM, 1994, EMBO J, V13, P4269, DOI 10.1002/j.1460-2075.1994.tb06747.x; FALLON RJ, 1994, J BIOL CHEM, V269, P11011; FEDER D, 1990, J BIOL CHEM, V265, P8205; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Foti M, 1997, J CELL BIOL, V139, P37, DOI 10.1083/jcb.139.1.37; FREEDMAN NJ, 1996, RECENT PROG HORM RES, V51, P352; GEISOW MJ, 1985, EUR J CELL BIOL, V38, P51; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Grimes ML, 1996, J NEUROSCI, V16, P7950; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; HOLEN I, 1995, J BIOL CHEM, V270, P12823, DOI 10.1074/jbc.270.21.12823; LAMAZE C, 1995, J CELL BIOL, V129, P47, DOI 10.1083/jcb.129.1.47; LIN PH, 1995, ONCOGENE, V10, P401; LIU SH, 1995, CELL, V83, P257, DOI 10.1016/0092-8674(95)90167-1; Liu SH, 1998, J CELL BIOL, V140, P1023, DOI 10.1083/jcb.140.5.1023; Lowell CA, 1996, GENE DEV, V10, P1845, DOI 10.1101/gad.10.15.1845; LUTZFREYERMUTH C, 1990, P NATL ACAD SCI USA, V87, P6393, DOI 10.1073/pnas.87.16.6393; MARTINPEREZ J, 1989, J CELL BIOL, V109, P577, DOI 10.1083/jcb.109.2.577; MORGAN DO, 1991, METHOD ENZYMOL, V200, P645; NATHKE IS, 1992, CELL, V68, P899, DOI 10.1016/0092-8674(92)90033-9; NESTEROV A, 1995, J BIOL CHEM, V270, P6320, DOI 10.1074/jbc.270.11.6320; Nomura N, 1994, DNA Res, V1, P27, DOI 10.1093/dnares/1.1.27; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cb.06.110190.001055; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Santini F, 1996, J CELL BIOL, V132, P1025, DOI 10.1083/jcb.132.6.1025; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; Stenberg PE, 1997, BLOOD, V89, P2384, DOI 10.1182/blood.V89.7.2384; THOMAS JE, 1991, SCIENCE, V254, P568, DOI 10.1126/science.1719633; UNGEWICKELL E, 1991, J BIOL CHEM, V266, P12710; Ware MF, 1997, J BIOL CHEM, V272, P30185, DOI 10.1074/jbc.272.48.30185; Wilde A, 1996, J CELL BIOL, V135, P635, DOI 10.1083/jcb.135.3.635; WONG DH, 1992, J CELL BIOL, V117, P1171, DOI 10.1083/jcb.117.6.1171; Ybe JA, 1998, EMBO J, V17, P1297, DOI 10.1093/emboj/17.5.1297; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	48	289	292	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	1999	96	5					677	687		10.1016/S0092-8674(00)80578-4	http://dx.doi.org/10.1016/S0092-8674(00)80578-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	174TB	10089883	Bronze			2022-12-28	WOS:000079050100011
J	Chapman, S				Chapman, S			Scare tactics cut smoking rates in Australia to all time low	BRITISH MEDICAL JOURNAL			English	News Item																			0	7	7	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 5	1999	318	7197					1508	1508		10.1136/bmj.318.7197.1508b	http://dx.doi.org/10.1136/bmj.318.7197.1508b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	204HC	10082735	Green Published			2022-12-28	WOS:000080757300015
